Full text of "The Maryland Pharmacist 47:no. 1-12 (1971)"

See other formats

BLE eh He M08 red Footie
os od ohare

eo =
eieet

ty ? + ~ ck

s ie ae : :
bis Nee tir wrt ee = Hehe tae Mae ha = Te Ne Tey Mea ahs Fea

og te Or are tetee ; a * > ES tt IE Ae eet eer

Feat Ton
ie Heh tetts

recone

bee
fe
Gathesa Sa mts Ma He 3 - : cee ; : : as =
* > ied
ee Sas
oe eee Be Fee
Tae Mar ne Sas Rete
Narn Ne
Ke teteRe —
a ae
ay (Bote he Wee Rt the eee

—_ rather
eters A eer e S =
See at a i 3 Fee : haat em Peay

ced

a ee ed
. Tirta a wa ee ee ye eel - oS a . A ? -' - . =
oe ; rare ihe, & . = g 2 ¥ ‘ rae cade
Rettig aha iat i ya te Tear Pp Rs as Be tin ete : i ace arte et : = Spoke oye es S “2,
rin, Bag Pon Poet ag Ma Be rutin “ p - F Tstimciat 7 sf : = a r < c , Sa “ Ee te

ots
eae

seh Mo Seyh = Me AAR Ee Fe iad wm A
a BT keF ettas Mn PeteW a) x ena Ria aTotted

———,

oper
ange dh
phere Ke

Saw Fro Mer’
Sits th

ete
Prete

Sa sh i bad debt
hee Lista PTe Tee ot
eae 2 atone? ~ :
Sr Ste a Tey BT Ly ARG ay ret hh ee Oe me
seiko! : . eT as = to ee ne ait

Co ee gee meas ha esta louie txt patel Nabe teste Meta ee MACE OES POO ae
oe tanec athe too tin yng Pastime aha Naa Ea

a the a tas Bee Fate Tate Meh reas 4 ere vt
3 3 : é Tee Tey ca as Py te Ne Toes Fim ay he Fe =e
Eats Pas eS Pts Sopot Ga brag re ats PEIN Ra Din ew hs Map RS ate Oe Ne la TET IIS Sete EAH os a : pel %
Po Be Ain Role Bee 2 Fe te 15 Tate Malate ieee rr - 3 0 oe at a es zs 6 Pete aee ‘
Sieh hl Yin PP he Te rath cone s aos al Fer tenant eneene re sls
ee te Ree Fa Qa P> Ms" » Ah a Cat BEI EN LEAD LOO A ar FIO Mo
Sw . So Pa TINE en er in gn ig ‘ a Pairard > ee eaten. ea at atin rn 0 Tart ot ihe pe
~tr-ar easter ~ de. . ieee ae ee Pieters eee Se - aia - A asa a os Cenonebaie stare’ wie’
sectetrrers ieee - “ saat : sae poe a Site ie pat r cout ’ - oh ed Asient
gin tate bre Pres * 3 - ; Pap ee OR Ren AS EE a Beet ate hus tone 7 ‘ ” mts ia ae Maren ees aorta
~ eu rolerete tate berate Pee

Te go ONE LE eR A Po pion
SE aire
. Eder ge arrest hl Fe
eh Cate te
ate = Po

Treats ee
Serta: danas

Hw dc

ig. ott 5. ee
3 Fea the Map SS Pepe Nom z fs 4 4 an oat . Fea ages ea ee
Teeter eS * ard 5 - ' ate aT in gta

SEF
aaa ain tg ta he

ne tara et

ote Tene

Pfs
Od a

Digitized by the Internet Archive
in 2022 with funding from
Maryland Pharmacists Association Foundation

httos://archive.org/details/marylandpharmaci47mary

Volume 47

the
maryland

ASSOCIATION

= Dharmacist

Editorial:

State Legislation 1971
Board of Pharmacy Changes
Commission on Pharmacy Discipline
Relicensure on Continuing Education

Pharmacy Power

by Nathan I. Gruz

Discounting and Pharmacy Management

by Richard Schott

JANUARY 1971

Number 1

Compliments of

oxell

CORPORATION

NOXZEMA SKIN CREAMS

Makers of

NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS

and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

r each prescription

a test of your
professional

knowledge

Even the simplest-appearing prescription requires the
exercise of your professional skill and judgment. Is it the
proper strength? Is the dosage within usual or

accepted limits? Is it compatible with other medication your

prescription patient may be taking?

This same judgment also tells you . . . when it comes
to your prescription patient’s health (and your reputation), you

want to dispense the finest-quality pharmaceuticals available.

There are no finer-quality products than those from Lilly.

100215

Eli Lilly and Company - Indianapolis, Indiana 46206 Lilly

IN COLD COUNTRY
DON’T FOOL AROUND WITH
SALES AND PROFITS

Now that winter's here, and temperatures
have dropped, everywhere is Cold Country.

So don't fool around...stick with the leader.
For an avalanche of sales, and a blizzard of
profits, stock, display, and promote the fastest
moving, most popular brand of cold products
in Cold Country —Contac!

— —
Country

Deal up to 44% profit
thru February 19

Menley & James Laboratories, Philadelphia, Pa. 19101

The Maryland Pharmacist

NATHAN 1. GRUZ, Editor
650 WEST LOMBARD STREET

NORMAND A. PELISSIER, Assistant Editor
BALTIMORE, MARYLAND 21201

ASSOCIATION
VoLUME 47 JANUARY 1971 NuMBER 1
OFFICERS 1970-71
Honorary President
MORRIS L. COOPER—Baltimore
President TABLE OF CONTENTS
DONALD O. FEDDER—Dundalk Page
President Elect Editorial— i i
oes Sebel Gare wore 1G IS LALERLESISIALION aL Ol Limit siakee tetas cn cer ooae rs eat tac cee ss basa cearsesant 6
mriretriaiion: | PharmacveCalendarierceerc te ee ee ae ee eee tere et tad ee cee ee. 6
SYDNEY eRe eS R.—Baltimore University of Maryland School of Pharmacy 8
ea rk EE | I ne sis te ek Ne ee
BERNARD B. LACHMAN—Baltimore MarvyiandeDOalc@olmlbarinacveN CW Smee emer e cate tn eee 10
Vice President ; :

MELVIN J. SOLLOD— Adelphi TLOSpltalePharmacve SOCtlON mers meats ceaeu ie cece enin on ire eee ere, sas 12
Mrecutivercecretary PNarmacveLOwere Dy Nat nae Lee GLU siete cesses eres reed evens es 14
NATHAN I. GRUZ : : :

650) Wi Lombard’Strest.-Baltimore 21201 Washing tones pOGlentelO bee Nabiac] Sts meer emeree create ee ene ee ee, 16
Treasurer Discounting and Pharmacy Management by Richard Schott.........000........ 18
MORRIS LINDENBAUM A ih
Ee Main Strestl Reisterstown Allegany-Garrett County Pharmaceutical Association ..00.......0..ccccceeeseeerees 22
ODItUAaTiCs ee ee ee eS 7 ee ee NA ee eee 26
Executive Committee
Chairman
I. EARL KERPELMAN—Salisbury
District 1—Eastern Shore
PHILIP D. LINDEMAN—Berlin
JAMES W. TRUITT, JR.—Federalsburg INDEX TO ADVERTISERS
District 2—Central
MORRIS ape Segre cre Page
JOSEPH U. DORSCH—Baltimore ;
PAUL FREIMAN Baltimore geey TA DOLTACOTICS Men nee ne Cem ere cane et cat hts so) ee BOE ok. Vent 28
IRVIN KAMENETZ—Baltimore American Hygienic Company ...................00.... 21
ret eee paltin see AENEAN COLTS ORE Cath oo SPS NE Nato roam eC
ANTHONY G. PADUSSIS—Baltimore iBarre- Nationale Proce COMPANY ms LDC ee eee eee 21
ae Tre SC Pee 131k irs ON nem | Oe se Re ih ee eS
H. NELSON WARFIELD—Baltimore ‘Borden-HendleralcerCream pee i ie ee 23
District 3—Southern Berke yerilm eer OCCSSING merece ae coer eee we Ns gene eee ee iv!
PAUL R. BERGERON, II—Bethesda
SAUL B. FRIEDM AN—Potomac CalvVerteDruceCOMDAan VamLIiG saree ree eens ee eee Oe ete eee 23
EDWARD NUSSBAUM—Rockville The Dru
DOMINIC J. VICINO—Mt. Rainier e PAELOUSC He LIC seer teseterere reese cerns ene oie te es I Oe ke 20
RICHARD D. PARKER—Silver Spring Henrye bs Gilpin COMPA Varese eee hace 9
District 4—Northern ELVNISON MEW CSLCOLGEACEE UDITNIN) Om 111 Cte reer 27
ARNOLD L. AMASS—Taneytown :
ROBERT K. MOLER—Brunswick Eli Lilly and Company POSIT TTI ITEP E ETT TT TEL TTTTTTTTTrT eee riiiririerriririreeererirreererriereeriee 3
District 5—_Western TEOC WV DTU SE COMI DANY eerrr eran ee eee nce eee Cen Pe eee tee ea 7
HARRY G. EISENTROUT, JR. ManzinigandeASSOCIALCS aln Camere ener nee ees 15
Fe RISO SHINS Cp 01 NG Bags Papen tt renee sie i te or Ones mae Cana an Sree
STEPHEN HOSPODAVIS—Cumberland Marvyland@ News COMDan Vig ee ee ee en ae. 25
Committeemen at Large Menlevaandsd aMeSeLADOLALOLICS mererte ee eteer tere terete re erenr cee see ee 4
JOHN R. McHUGH ;
ROBERT E. SNYDER INOXE]IRCOLDOL ACL ON er eee aa ee ener Tene ee eee ee 2
ML Officigs Menihers PATAMOUNESEPNOTORSCLV ICC werner her eee cree: 19
FRANCIS 8. BALASSONE Pension and Investment Association of America, Inc.............00cc... 22
WILLIAM J. KINNARD, JR. iat aOR Te CS
DMStuarte W EDDRAGVELLISING ESET VICES i eeerrreree eee eerees ree aee ene 20

Honorary Life Member of the : j

Executive Committee LY. OUN Se DTIC mELOCUCtSmCOXDOTALION me meerttere rertere te erase ene 11

SIMON SOLOMON

MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON
President
NORMAN J. LEVIN—Pikesville

Secretary
Fr. S. BALASSONE—Baltimore

FRANK BLOCK—Baltimore
HOWARD L. GORDY—Salisbury
MORRIS R. YAFFE—Potomac

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number. Allow four weeks for
changeover.

The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical
Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a
year. Entered as second class matter December 10, 1925, at the Post Office at Balti-
more, Maryland, under the Act of March 8, 1879.

Editorial ...

State Legislation 1971
Board of Pharmacy Changes
Commission on Pharmacy Discipline
Relicensure on Continuing Education

There are several legislative proposals which have
been endorsed by the Maryland Pharmaceutical Associa-
tion. First, we will again propose that the Maryland Board
of Pharmacy be expanded from five to seven members.
The present geographical restrictions requiring two mem-
bers to reside in the counties, two in Baltimore City, with
one from either area, will be eliminated.

The declining number of pharmacists residing in
Baltimore City unduly restrict the eligibility of qualified
pharmacists to serve on the Board of Pharmacy. It is im-
portant that vacancies be filled using the entire state as
the basis for selection, although it would certainly be
advisable to have representation from as many areas as
possible. Enlargement of the Board will enable more
facets of pharmacy to be represented. Every attempt
should be made to include pharmacists from community,
hospital and other kinds of practice. Ideally, proprietor,
managerial and salaried pharmacists should be included.

The second bill is a “Commission on Pharmacy Dis-
cipline,” modelled after the “Commission on Medical Dis-
cipline”’ initiated by the State Medical Society and enacted
in 1969. It would provide for greater participation by the
profession of pharmacy in disciplinary procedures. The
Commission would be made up of representatives of the
Maryland Pharmaceutical Association, the Maryland
Board of Pharmacy and pharmacists appointed by the

Governor.

The Maryland Pharmaceutical Association would
have a role in the disciplinary process by referral of cases
by the Commission for investigation and report, by initiat-
ing action and by recommending actions to the Commis-
sion.

The Commission would be able to act on violations
of a code of unprofessional conduct. Its actions would be
guided by the legal safeguards afforded all persons under
the Administrative Procedures Act, with the right of ap-
peal. Such a commission by involving the entire profes-
sion, through the state professional society, with the au-
thority required to act would be a giant step in curbing
the “bad apples” present in every group.

Certainly every pharmacist would prefer to be judged
by his own peers who are expert in the unique problems
of the practice of pharmacy, rather than find himself sud-
denly before a judge and jury unfamiliar with his pro-
fession. In other words, by setting and maintaining high
ethical and professional standards, pharmacy can truly
serve the public interest and the health needs of all real
self-policing is the mark of a profession.

The third proposal involves the need for every prac-
titioner to constantly maintain a current state of knowl-
edge. Changes, innovations and scientific and professional
breakthroughs require each health professional to par-
ticipate in meaningful organized and supervised continu-
ing education.

The proposal of the Maryland Pharmaceutical Asso-
ciation is to require that relicensure (reregistration) be
contingent upon reexamination by the Board of Pharmacy
periodically or by presentation of proof of completion of
suitable continuing education. The criteria for this con-
tinuing education would be developed by a tripartite com-
mittee composed of representatives of the University of
Maryland School of Pharmacy, Board of Pharmacy and

Maryland Pharmaceutical Association.

Surely, there will be differences of opinion about
these proposals. As the details become available, we hope
that thorough discussion will convince the large majority
of the soundness of these legislative remedies.

If the profession of pharmacy does not take the initi-
ative in developing the legislative framework to assure the
public of the best possible pharmaceutical service, others
will. Let us act before others act for us.

Nathan I. Gruz

Baltimore Veteran Druggists’ Association

Installs New Officers

The Baltimore Veteran Druggists’ Association held
its 355th meeting on January 20, 1971 at the University
of Maryland Hospital. Installed as officers for the com-
ing year were: Carl Caplan, President; Paul Gaver, Ist
Vice-President; Albert Rosenfeld, 2nd Vice-President and
Dr. Benjamin F. Allen, Secretary-Treasurer.

The Association was first organized in 1926 and
has been meeting regularly since that time.

PHARMACY CALENDAR

March 7—AZO Fraternity, Joint Dinner Meeting with
Auxiliary, Martin’s West.

March 11—School of Pharmacy Alumni Association Din-
ner Meeting, Eudowood Gardens.

March 21-27—Poison Prevention Week.
March 27-April 2—APhA Annual Meeting, San Francis-

co, California.

May 16-17—MPhA Annual Convention, Hunt Valley
Inn.

May 26—School of Pharmacy Alumni Association An-
nual Meeting.

June 2—School of Pharmacy Annual Alumni Banquet in -
Honor of Graduates.

June 5—School of Pharmacy Commencement Exercises.

June 11-13—6th Annual MSHP Hospital Pharmacy Sem-
inar, Ocean City, Md.

THE MARYLAND PHARMACIST

There’s alot more going for you at LOEwy

Sfectre PERSONALIZED SERVICE PLUS

provides you with the flawless backing of 100% computerization—
along with the specia! personal follow-through of people who care

Drug wholesaling divisions of Spectro were among the first in the industry to
know the unprecedented advantages of fully computerized warehousing and
delivery service. But as a retailing-oriented distributor, we know, too, that
nothing can take the place of personalized understanding and service follow-
through. That’s why every one of us at the management, sales and service levels
is vitally concerned about any phase of service that is of special concern to you.
This happy combination of automation and personalization adds up to a quality
and completeness of service that just isn’t likely to be matched through any
other source.

Got a special supply, financial or service problem? Why not give us a ring during
any working hour any day of the week. That’s one way you'll really know what
we mean by personalized service. See why more and more retailers throughout
the eastern seaboard are saying right outloud...

FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY

After hours, 485-8105 for order taking. (301) 485-8100 for office and daytime order taking.
aT,

LOEWY DRUG COMPANY 3S! Yoctr Srchustoiis, Ine

a) S
6801 Quad Avenue, Baltimore, Md. 21237 Tel.: (301) 485-8100 2 ino?

DIVISION OF

University of Maryland
School of Pharmacy

Alumni Association
Nominations open for Honored Alumnus

All alumni of the University of Maryland School of
Pharmacy are invited to submit nominees for considera-
tion for the Alumni Association Honored Alumnus Award
for 1971. Most recent honorees are: Frank Block, Dean
Warren Weaver, H. Nelson Warfield, Alexander J. Ogrinz,
Jr., Dean George P. Hager, and Francis S. Balassone.

Please submit names and supporting information by
March 15 to Nathan I. Gruz, Chairman, 650 W. Lom-
bard St., Baltimore, Maryland 21201. The Annual Alum-
ni Dinner Meeting will be held March 11, 1971 at Eudo-

wood Gardens.

Handbook of Non-Prescription Drugs
(APhA) 1969-1970 Edition

A limited number of the 1969-1970 APhA Hand-
book of Non-Prescription Drugs are available at a special
price of $2.50 (regular price $5.00) from Mr. Henry
Seidman, Office of Continuing Education, Room 104,
University of Maryland School of Pharmacy, 636 W.
Lombard St., Baltimore, Maryland 21201.

Vitamin C and the Common Cold

The claims made recently by Dr. Linus Pauling on
the benefits of vitamin C in preventing and relieving the
common cold must be questioned for the time being until
a large scale, controlled trial is conducted. This study
must be conducted over a long period and include many
hundreds of persons to give meaningful resuits. No such
study has been performed.

According to the December 25 issue of The Medical
Letter, (Vol. 12, No. 26), vitamin C in large doses can
have adverse effects, Professor Pauling recommends doses
as high as 15 Gm. daily for the treatment of colds. When
4 to 12 Gm. of vitamin C are taken daily for acidifica-
tion of the urine, however, as in the management of some
chronic urinary tract infections, precipitation of urate
and cystine stones in the urinary tract can occur. Very
large doses of vitamin C, therefore, should be avoided in
patients with a tendency to gout, to formation of urate
stones, or to cystinuria. Nor can the possibility of other
adverse effects of very large doses be excluded.

It should also be noted that the ingestion of large
amounts of vitamin C and its excretion in the urine make

the results obtained with “dip” and Testape tests for

sugar in the urine unreliable.

The article goes on to conclude “in the absence of ©

convincing evidence of its effectiveness and safety, The

Medical Letter does not recommend the use of large ©

doses of vitamin C for the prevention or treatment of the
common cold.”

University of Maryland to Conduct Test
on Vitamin C Effectiveness

The University of Maryland will soon begin one of
the first definitive tests in this country on whether vita-
min C is effective in preventing the common cold. The
test will be conducted by the school’s infectious disease re-
search unit at the Maryland House of Corrections in
Jessup. A total of 40 prisoner-volunteers will participate
in the test. Twenty men will receive 4 Gm. of ascorbic
acid daily for one month while a control group will re-
ceive placebos for the one-month period. At the end of
the second week all of the subjects will be injected with
live cold viruses. Their conditions will be monitored
closely during the final two weeks.

Results of the double-blind study will not be known
for three or four months as additional tests will be con-
ducted after the four-week period. The test is being spon-
sored by the Hoffman-LaRoche Pharmaceutical Company.

Morgenroth to Participate in ACA
Management Conference

The Third Annual American College of Apothe-
caries Management Conference will be held February 19
to 21 in Fort Worth, Texas. Victor H. Morgenroth, Jr.,
FACA, and past-president of MPhA, will moderate a
workshop session along with M. Donald Pritchard, FACA,
Buffalo, N.Y., Joseph G. King, FACA, Chattanooga,
Tenn., and Casimir H. Srutwa, FACA, Scottsdale Arizona.

Included among the other sessions will be the fol-
lowing presentations: “The Pharmacist and The Com-
puter in the 70’s, Robert E. Abrams, FACA, President
PAID Prescriptions and “The Formulary and Pharmacist
Legal Liability,” Robert F. Steeves, Attorney at Law.

Other presentations include: “Think Before You

Sign,” Dr. M. M. Wolfred, FACA, Beverly Hills, Cali- —

fornia and “Profitable Physician Communication: Work-
shop and Action Plan,” John T. Fay, V.P. and Director
of Professional Relations of McKesson and Robbins Drug
Company.

THE MARYLAND PHARMACIST

let’s get down to
“brass tacks”

We ve got a long story to tell .. . but it would take 125 years to tell it.

BN TNs
Aa,

The beginning would be in 1845, the year the Henry B. Gilpin Company was founded. Over the years, our primary
concern has been to provide the most modern and complete services to you and to your business operation.

At the outset, our services were comparatively simple but complete. Today our services are not quite so simple but

are stili complete in every detail.

A comprehensive and up-to-date convalescent
aids program. Professional assistance is available
to design a program to meet your space and
inventory requirements and train appropriate
personnel in your store to make this a profitable
department.

A complete sundries program providing sundries
departments and inventories designed specifically
for your store, with a built-in provision for
economical and reliable restocking of your shelves.
Along with this, we maintain expanding stocks of
new promotional sundries and programs for
increasing traffic and sales.

A professional planning and remodeling service
within our organization which includes complete
service in floor design, fixture and installation.
Professional help in site selection, store
development and in lease acquisition for
desirable sites.

Computerized inventory and billing systems. This
modern computerization also makes possible a wide
range of additional data services including regular
issuance of individual monthly reports of DACA drugs
showing quantities and dates on which they were
submitted.

BALTIMORE + DOVER + NORFOLK +» WASHINGTON

7.
8.

10.

A financial service consultant to service you on
request.

Professional Services Department. A professional
services department which provides you with vital
assistance in the form of direct services and/or
consultation in areas including: Medicare, Medicaid,
third party payment programs, pharmaceutical
inventory control, federal and state regulations, and
many other areas.

Two giant product shows each year: in January

=. featuring summer goods; in July featuring selections

of fall and gift merchandise and emphasizing
promotional sundries.

An Accounts Receivable program. A computerized
system that knows pharmacists. The program
handles your charge accounts and gives your
customers a monthly statement showing all their
deductible medical expenses, both for the current
month and for the year to date. It also provides a
monthly report on the aging of your accounts in the
summary.

Professional advertising and promotional assistance.
Our specialists in this area now provide on-going
advertising and promotional programs for many of
our customers and are available to assist you in this
increasingly important area of your operation. With
complete stocks and complete lines of merchandise
provided with it, we are well qualified to provide

the services required to nail down the profit dollars
which you need and deserve from your business.

Check the area of your particular interest or need on the
coupon below and mail it to us or phone us. We'll arrange
for Gilpin specialists to tailor the services which your
particular interest or situation requires.

Sirs:
| am interested in the following programs. Please have your
representative contact me in this regard.

Name

Name of Pharmacy
___Phone
Slate 21D

Address
City

IN
a
We.

“=

tees et

Maryland Board
of Pharmacy News

Pharmacy Changes...

The following are the pharmacy changes of the

month of December:

New Pharmacies

Drug Fair No. 132, Milton L. Elsberg, President,
Route 2 and 402, P.O. Box 356, Prince Frederick, Mary-
land 20678.

Peoples Service Drug Store, Inc. No. 277, W. E.
Pannill, President, 7050 Allentown Road, Camp Springs,
Maryland 20031.

Peoples Service Drug Store, Inc. No. 296, W. E.
Pannill, President, 5560 Norbeck Road, Rockville, Mary-
land 20853.

Sentry Drug Center, Philip Bogash, President, 140
Village Shopping Center, Westminster, Maryland 21157.

Pride Pharmacy, Samuel Adams, President, 2305
East Chase Street, Baltimore, Maryland 21213.

No Longer Operating As Pharmacies

William Rossberg Pharmacy, John T. Meeth, Presi-
dent, 3255 Frederick Avenue, Baltimore, Maryland
21229.

Model Drug Store, Nathan Cohen, 1828 East Balti-
more Street, Baltimore, Maryland 21231.

Waldorf Drug Company, Inc., Harry B. Rosenstein,
President, P.O. Box 65, Waldorf, Maryland 20601.

Changes Of Address, Ownership, Ete.

Eakles Pharmacy, Leon R. Catlett, President, Holi-
day Acres, Route 2, Smithsburg, Maryland 21783.

Patterson Park Pharmacy, Inc., Bernard F. Macek,
President, 2245 Eastern Avenue, Baltimore, Maryland
2123 Lb;

Provident Hospital—Pharmacy, George L. Russell,
Jr., President, 2600 Liberty Heights Avenue, Baltimore,
Maryland 21215.

Sale of Needles and Syringes

Mr. F. S. Balassone, Chief of the Division of Drug
Control, Maryland Department of Health and Mental Hy-
giene, has announced the following regulation governing
the sale of needles and syringes.

REGULATION 43C08 GOVERNING THE SALE OF
NEEDLES AND SYRINGES OR OTHER PARA-
PHERNALIA.

The following regulation adopted December 11, 1970
became effective December 21, 1970.

The sale of needles and syringes or other parapher-
nalia shall be made by the pharmacist only in good faith
to patients showing proper identification and indication
of need. Such record of sales shall be recorded in a Regis-
try to be established for this purpose which shall contain
the purchaser’s name and address, date of sale, item and
quantity sold and the signature of the pharmacist.

Milton L. Elsberg Named
Chairman of D.C. Savings
Bond Committee

Mliton L. Elsberg, President of Drug Fair, was ap-
pointed volunteer Chairman of the District of Columbia
Savings Bonds Committee by Secretary of the Treasury
David M. Kennedy.

Mr. Elsberg will head a committee of District busi-
ness, financial, labor, and governmental leaders which—
working with the U. S. Savings Bonds Division—assists
in promoting the sale of Savings Bonds. He also con-
tinues as a member of the U. S. Industrial Payroll Sav- |
ings Committee.

The Baltimore native came to Washington in 1935,
working as a pharmacist. In 1938 he and a partner, Rob-
ert Gerber opened the first Drug Fair. The drug depart-
ment store chain has since grown to more than 120 out-
lets.

He is a member of the Executive Committee of the
Board of Directors, Riggs National Bank; the Washing-
ton Board of Trade, Washington Board of Realtors, Inc.;
National Association of Real Estate Boards, and member
of the Boards of Directors, Brand Names Foundation, Inc.,
and of the National Association of Chain Drug Stores.

Mr. Elsberg, also serves as trustee, Boys’ Club of
Greater Washington; member of the Board of Trustees,
United Jewish Appeal of Greater Washington; and mem-
ber, Board of Directors, United Givers Fund. He is a
member of the President’s Council of Brandeis Univer-
sity, Waltham, Massachusetts.

He has received the Washington Advertising Club
Award of Achievement and the Brand Name Retailers of
the Year Award for Chains in the United States and
Canada and was named “American Marketing Man of
the Year” by the American Marketing Association.

Mr. Elsberg graduated from the University of Mary-
land, School of Pharmacy in 1932 and is a member of
the Maryland Pharmaceutical Association.

He and his wife, the former Rita Kahn of New
York City, have one son and one grandchild. The Els-
bergs reside in Washington.

Cigarette Packs Carry New Warning

By Act of Congress, the following statement must be
placed on all cigarettes manufactured for sale in the
United States on or after November 1, 1970. Warning:
The Surgeon General Has Determined That Cigarette
Smoking is Dangerous to Your Health. The American
Pharmaceutical Association as well as several state asso-
ciations have urged their members to discontinue the sale |
of cigarettes.

While this action is an important factor in controll-
ing cigarette-caused diseases, pharmacists have a positive
contribution to offer in the form of public education re-
garding the hazards of smoking.

THE MARYLAND PHARMACIST

Sell him Guardian

Extie | VYenslive

Prick

: TWELVE ROLLED LATEX OS :

L oe
Ga NV. f en, Mite

og oS
~
ORIEN.

aes ROLLED LATEX PROPHYLACTICS de
i a

go Sf
Cli Sensitive

<
Ppicnr®
TWELVE ROLLED LATEX PROPHYLACTICS

OLLED LATEX #)

TWELVE FR

and he’ll never ask
for just prophylactics
again

Once a customer uses Guardian,
the chances are he'll ask for them
every time. Lubricated prophylactics
are becoming increasingly more
popular every day, and Guardian
prophylactics are by far the finest
truly lubricated rubber prophylactics
made. They’re extra sensitive, thin,
and sealed in foil—an excellent
product for your customer. Plus, the
extra profit makes Guardian a

great product for you to sell.

So the next time he asks for just
prophylactics, sell him Guardian,

the Trojan brand premium lubricated
product from Youngs, the company
tuned to today’s pharmacy
customers.

he
Youngs Drug Products Corporation,
. Piscataway, New Jersey 08854

Hospital Pharmacy
Section

Maryland Society of Hospital Pharmacists
Meeting of January 14, 1971

The January 14th meeting was held at Mercy Hos-
pital in Baltimore. A dinner was served at 6 P.M. Dr.
Joseph A. Mead, Chief of Ambulatory Services and Act-
ing Chief of Medicine at Mercy Hospital, presented a
talk entitled “Hospital Based Group Practice.” Dr. Mead
described a program of health care in which private phy-
sicians devote part of their time in seeing service patients
in a hospital clinic.

Robert Snyder noted that the Society was proceed-
ing with the printing of the “Suggested Guidelines and
Principles for the Practice of Pharmacy in Hospitals”
and that the Maryland Pharmaceutical Association had
voted to contribute $100.00 towards the expense involved
in the printing and distribution.

Mr. Snyder announced that the recipient of the W.
Arthur Purdum Award will be selected by the Board of
Directors this year but hereafter the recipient will be
chosen by a committee consisting of former award win-
ners.

A statement on drug dispensing and drug adminis-
tration drafted by Pat Birmingham and the Nursing Liai-
son Committee is under review by the Board of Directors.

Robert Snyder reported for June Shaw on upcoming
programs. Sam Lichter described the program for the
Swain Pharmacy Seminar. The February meeting of the
MSHP will be held following the Swain Seminar at
Good Samaritan Hospital on February 11th.

The March meeting, sponsored by Roerig, will be
held at the North Arundel Hospital. David Nurco, Com-
missioner of the State of Maryland Drug Abuse Au-
thority, will be our speaker. This meeting will also be
the Annual meeting as prescribed in the MSHP By-Laws.
The April meeting will be a joint meeting with the D.C.
Society at the Schraft’s Colony Motor Lodge. The pro-
gram for this meeting is still being planned.

Mary Connelly reported on the Medicaid meeting
of the MPhA. The MPhA wants the state to accept Red
Book cost of ingredients on Medicaid prescriptions. The
Committee anticipates an increase on July Ist of the Medi-
caid Fee from $1.75 to $1.85 and a minimum reimburse-
ment of $1.00 for OTC prescriptions.

Robert Snyder announced that he was going to sub-
mit Dr. Peter P. Lamy’s name in nomination to the
Board of Directors of the American Society of Hospital
Pharmacists. A motion was made and seconded that the
nomination of Dr. Lamy, which will be submitted by

Robert Snyder to the ASHP, has the endorsement of the
MSHP.

The following names were approved for member-

ship in the Society: Ronald C. Telak, Pharmacist at
Maryland General; Cal Myer with Beecham Laboratories;

Clay Sisk, Chief of Pharmacy at National Institute of
Health; and Douglas Campbell, student at the Phila-
delphia College of Pharmacy and Science, Class of ’73.

Robert Snyder announced the following committee
appointments. Howard Sherman and Alan Jaskulski will
be co-chairmen of the membership committee. Steven
Cohen will replace Murray Ginsberg as representative to
the Health Careers Committee of the Maryland Hospital
Association Council on Research and Education. Dr. Peter
P. Lamy will be chairman of the nominating committee.
Also serving on the committee will be Harry Hamet and

Frank Kratz.

Kent Johnson reported that there had not yet been
any final decision on the threatened closing of the USPHS
Hospital at Wyman Park but a decision would probably
be made before February Ist. He asked that the Society
send an official letter to the Department of Health, Edu-
cation and Welfare stating that it recognizes the many
accomplishments of this hospital over the past years and
that it strongly recommends not closing this hospital. A
motion to this effect was made and seconded.

Mary Connelly introduced her Associate Adminis-
trator, Mr. Albert Gilbert and her pharmacy staff. Robert
Snyder thanked Mary Connelly for hosting the meeting
and thanked The Upjohn Company for sponsoring the
meeting. The meeting adjourned at 8:30 P.M.

Three New Systems
Introduced For Hospitals

Under a new program aimed at developing products
and services for hospitals, Bristol Laboratories has re-
cently introduced three new systems for hospital use. The
first, the “Bristol Emergency Medication System”
(BEMS) features a pre-filled disposable syringe and
needle which speeds the administration of various emer-
gency medications. The second, the “Aspirite System”
provides a completely disposable collection system which
can replace glass bottles now used for body fluids in
aspirating procedures,

Bac-Data, a third new system, supplies participating
hospitals with computerized data on disease-causing or-
ganisms and on the antibiotics to which they are suscepti-

ble.

Bristol Laboratories, a division of Bristol-Myers Com-
pany, since 1943 has pioneered in the development of
antibiotics and other prescription products, particularly
the semisynthetic penicillins.

In explaining the move into a new area of business,
Frank Kilpatrick, Executive Vice President, said that
“although we have long been identified with the develop-
ment of pharmaceutical specialties, we now see a great
need for many new non-pharmaceutical products, serv-

THE MARYLAND PHARMACIST

ices, and devices to improve health care and reduce hos-
pital costs. With the introduction of these three new sys-
tems and in view of our past experience in hospitals, we
feel we can make a major contribution to the future
health care delivery system in hospitals.”

Mr. Kilpatrick went on to say that in test-marketing
the Bristoject disposable syringe, the company has found
that nurses almost universally applaud the saving in
time it provides in medical emergencies.

Bristol sales representatives are presently giving 24-
hour-in-service advance training to operating and emer-
gency room nurses in all hospitals where BEMS is being
adopted. This program insures that all nurses will be
thoroughly familiar with the procedure of quickly as-
sembling the simple two-part syringe in emergency situa-
tions.

Until now, the filing off the tops of ampules and
drawing of solutions into syringes was a time-consuming
and sometimes frustrating experience. In emergencies phy-
sicians seek to minimize time loss. Administering injec-
tions immediately to avoid possible brain damage or other
medical problems that can worsen with each passing sec-
ond. With the Bristoject syringe, several injectable solu-
tions can be prepared in 10 to 15 seconds. The nurse, re-
lieved of that job, can then better utilize her time in
helping the physician care for the patient.

Mr. Kilpatrick pointed out that the medications used
in the pre-filled Bristoject syringes have been available
for many years. The advantage of the system is not in the
medications, but in the device which can deliver them so
much faster, and in larger pre-filled sizes. For instance,
aminophylline has a well established use in treating acute
asthma attacks; the cardiac stimulants calcium chloride
and epinephrine are injected directly into the heart with
Bristoject’s long needle; and sodium bicarbonate is in-
jected in large amounts to overcome acidosis in cardiac
arrest. Other drugs presently available in the Bristoject
syringe include licodaine HCL and dextrose.

Accurate Penicillin Allergy Test Developed

New York University scientists have developed an
inexpensive, simple 15-minute skin test that is virtually
100 per cent accurate in the detection of penicillin allergy.
Routine use of the test in the United States—once ap-
proved by the FDA—could prevent at least 600 deaths a
year from anaphylaxis, an immediate allergic reaction to
penicillin involving shock, cardiac arrest and convulsions.

The test, known as the BPL-MDM test (benzyl-
penialloylpolylsine and minor determinant mixture) in-
volves injecting a small amount of allergen under the
skin of the arm. If the test is positive, the patient’s skin
develops the characteristic “wheal and flare’”—a swollen,
reddened area. According to Dr. Bernard Levine, associ-
ate professor of medicine at New York University, peni-
cillin skin tests in current use are not 100 per cent re-
liable and in some cases the use of even small amounts
of penicillin to perform the skin test caused either a bad
reaction in the patients or sensitized them to a_ subse-
quent, potentially dangerous dose. Instead of using peni-
cillin for testing, Dr. Levine uses products of the break-
down of penicillin or “artificial” allergens.

JANUARY 1971

Paul LeSage to Receive W. Arthur Purdum
Award

Paul LeSage, Chief of Pharmacy at the United States
Public Health Service Hospital in San Francisco, has
been named recipient of the second annual W. Arthur
Purdum Award. The announcement was made by Sam-
uel Lichter, Chairman of the Board of Directors of the
Maryland Society of Hospital Pharmacists. The award is
named in honor of Maryland’s pioneer in the develop-
ment of hospital pharmacy practice, and an early leader
and Past-President in the American Society of Hospital
Pharmacists. The W. Arthur Purdum Award is presented
on an annual basis to the person who has made the most
significant or sustained contribution to hospital pharmacy

in Maryland.

Mr. LeSage received his Bachelor of Science degree
from the Massachusetts College of Pharmacy in 1954.
He completed his residency in hospital pharmacy at the
United States Public Health Service Hospital in New
Orleans in 1955. Since that time he has served as Chief
of Pharmacy at USPHS hospitals in Savannah, Georgia;
Seattle, Washington; Perry Point, Md.; and more recent-
ly in Baltimore from 1965 to 1970. He is a former Lec-
turer in Hospital Pharmacy at the University of Mary-
land School of Pharmacy where he was appointed Clini-
cal Assistant Professor of Pharmacy in 1969. Mr. LeSage
holds membership in the American Pharmaceutical As-
sociation, American Society of Hospital Pharmacists, the
Clinical Society of the United States Public Health Serv-
ice, the United States Public Health Service Commis-
sioned Officer’s Association and is a Past-President of the
Maryland Society of Hospital Pharmacists.

The award will be made at the 6th Annual Hospital
Pharmacy Seminar of the Maryland Society of Hospital
Pharmacists, June 11-13, 1970 in Ocean City, Maryland.

“PHARMACY POWER”

by NATHAN I. GRUZ,
Executive Director
Maryland Pharmaceutical Association

Presented at the Student American
Pharmaceutical Association —
Region II Convention,
Pittsburgh, Pennsylvania, November 7, 1970

Of all the varied aspects of the vocation of state
pharmaceutical association executive, the most rewarding
and personally gratifying, for me has always been work-
ing with the young people preparing for the profession—
the pharmacy students.

When pharmacists gather together, or as they pro-
ceed in their individual practice or employment, they are
not permitted to forget the many problems and frustra-
tions that seem to be inherent in pursuing the profession
of pharmacy. I, too, am sometimes depressed by some of
the problems which appear to be insolvable.

But I am, basically, an optimist and hopefully try
to be a realistic pragmatist. In fact, I believe it is impos-
sible to pursue a career in pharmaceutical association man-
agement, and in the leadership of a profession without an
essentially optimistic, idealistic and positive outlook. After
all, pharmacy is an integral part of life—an essential ele-
ment of service to society.

Problems are a part of life and are the challenges we
must address ourselves to if life is to be stimulating and
satisfying. Problems then, are of course, really opportuni-
ties for us to exercise our initiative imagination and inno-
vative talents in the process of life which characteristi-
cally differentiates us from other species as Homo Sapiens.

Your program indicates that you are addressing your-
selves to some of the vital issues facing pharmacy today,
such as:

Collective Bargaining; National Health Insurance;
Recruitment; Drug Abuse Education; Affiliation;
State Boards; Anti-Substitution Laws; and Education

Many more could be added, including third-party pre-
scription plans, supportive personnel (or technicians, )

APhA-NARD Relations and so forth.

I could speak of the crucial role pharmacy students
can and should play in pharmaceutical association pro-
grams. In fact, we in the Maryland Pharmaceutical Asso-
ciation have appointed students to our committees; they
have participated in our annual meetings and they have
voting representation in our House of Delegates, just
established two weeks ago. The students’ input has been
welcomed and has been valuable and constructive.

We earnestly hope students will be able to extend
their participation in association activities. For example,
we feel they can be an unequalled factor in membership
recruitment which will be expanded in the coming weeks
following the final vote of MPhA on affiliation with the
APhA. A preliminary mail ballot now in progress shows
173 for affiliation and 33 against. This is one of the most
encouraging developments for pharmacy in Maryland. We
hope that adoption and implementation of affiliation as
the sixteenth state, will launch Maryland pharmacists into

a strong posture for progress which will benefit not only —
pharmacy but the public health and welfare as well.

But, what I see as most critical for pharmacy today —
is to look at both the broad picture of pharmacy at pres-
ent and its long range prospects. What can be done about
current trends? Where is pharmacy going? How can phar-
macists influence the nature of the emerging new pro-
fession of pharmacy which will result? How can phar-
macists play a significant role in the control of the pro-
fession of pharmacy and of the varied systems of deliver-
ing pharmaceutical services? What should the responsi-
bilities of a pharmacist encompass as to pharmaceutical
products and services in the areas of research, develop-
ment, distribution, dispensing, clinical pharmacy _prac-
tice, public health, drug abuse, poison control, health edu-
cation and information? What are their responsibilities in
governmental, legislative, political, civic and cultural
levels of our society? All these facets must be considered
as they impinge on both the private and public sectors of
our country.

And finally, we come to what is to me the key issue
which explodes out of all my preceding remarks this eve-
ning.

The body of students who are in the pharmacy
schools of America today can go a long way toward creat-
ing the kind of profession that they believe is best for
the profession and the public, within a period of three to
five years!

Let me repeat this statement:

The body of students who are in the pharmacy schools of
America today can go a long way toward creating the
kind of profession that they believe is best for the profes-
sion and the public, within a period of three to five years!
How? Not by the wave of a magic wand or wishful think-
ing.

It can be done by commitment to certain goals and
by a measure of selflessness and temporary sacrifice. The
desire for immediate temporary financial gain, greed and
short-sighted self-interest are the enemies of what I will
present for your consideration.

My premise is that the young pharmacist today has
the rare opportunity for choosing the kind of pharma-
ceutical career he prefers.

If a pharmacist is really committed to working as a
full time health professional in a health oriented environ-
ment, he can do so today. At times this may require some
additional formal academic education or training, which
can be achieved with little sacrifice by the pharmacist
truly anxious and motivated to be part of the “health
team.”

Employment as a pharmacy student, intern or phar-
macist on the basis of “temporary” expediency or because

THE MARYLAND PHARMACIST

of any unprofessional considerations, in an establishment
exploiting the profession, places the pharmacist in an
untenable position in seeking a place in the sun along
side the physician, dentist and other health professionals.

On what tenable basis can such pharmacists con-
tinue to complain about the difference in law and in
status between the pharmacist and these other profes-
sionals?

In other words, if you accept a position in an estab-
lishment that is using pharmacy merely as an umbrella
of respectability to trade on the health-associated public
interest image of pharmacy, or to serve as bait for the
sale of merchandise, you are selling your pharmacist’s
license to be exploited.

Some pharmacists have rationalized this action on
the basis of temporary employment to get experience and
learn how the commercially successful entrepeneur or
firm operates. Many in confessions to me have lived to

regret the effects of the monster they have helped to
create.

A three to five year period of commitment, such as
I suggest, by pharmacy students, interns, and pharma-

cists as they graduate beginning in 1971 can transform
pharmacy.

Yes, it may mean that some would have to turn
down alluring offers and some might have to turn tem-
porarily to other fields. Some would have to alter the time-
tables they have set up for themselves.

In summary, you can begin today to make decisions
and to be involved in the kind of pharmacy practice
which either:

1) Furthers pharmacy as a health profession de-
voted to more effectively bringing pharmaceutical
services and health care of the highest possible
standards to all our citizens, as an integral part
of the delivery of health service:
or the kind that

2) facilitates the survival or expansion of a mini-
mal kind of a “count and pour” prescription dis-
pensing in which the pharmacist is an impersonal
computer, an easily replaceable technician, avail-
able to any investor desiring to use the pharma-
cist as a tool for loss leader promotions.

The decision is yours. You and your colleagues in the
colleges of pharmacy can be the vanguard influencing
many pharmacists already in practice.

The alternative will be the domination of pharma-
cists (outside of hospitals) by a concentration of power in
the hands of a few faceless conglomerate entities who are
dedicated first and foremost to the interest and demands
of their stockholders.

Whether I have indulged in a useless, time-wasting
fantasy is up to you. You can dismiss these thoughts as
many of your predecessors have relegated similar ideas
to the garbage dump of impractical dreams.

On the other hand, you have it within your power
to be the vanguard—the leaders—for pharmacist power
in retrieving pharmacy from subordination, by the out-
side forces of the “Big’”—“Big Government,” “Big In-
dustry,” “Big Labor,” “Big Medicine,” and now “Big
Consumerism.” “Pharmacist Power,” coordinated and

JANUARY 1971

strengthened to forge a unified organizational structure of
federated local and state pharmaceutical societies linked
to the American Pharmaceutical Association, can only re-
sult in a golden age of pharmacy in America, an era of a
profession of pharmacy universally recognized as superbly
educated and trained to serve the public in the com-
munity, the hospital, the health center and in every
facility organized to deliver health care.

Our goal of all pharmaceutical services and products
provided only under the control and supervision of phar-
macists would then be achieved. No private or govern-
mental agency would then be involved in any activity or
decision-making, pertaining to pharmacy or drugs, with-
out the input and significant participation by the profes-
sion of pharmacy in services, health planning information,
education, legislation or law enforcement.

You can be the creative catalysts and the innovators
for a new era to retrieve and advance pharmacy—or you
can add yourselves to a legion of pharmacists, much too
large, who have and are now debasing and destroying a
free profession.

Your actions in the days ahead—not your words—
will spell out the picture of pharmacy we will see in the
year 1975.

The man who rolls up his sleeves rarely looses his shirt.

We still count! But now we back our
crack inventory teams with computers
that give you selective comparisons, de-
tailed cost factors and more customized
information—faster! Error-free, too!
Mangini’s still the most requested phar-
maceutical inventory service. It figures,
doesn't it?

Mangini & Associates, Inc.
INVENTORY SPECIALISTS

4850 W. Belmont Ave., Chicago, Ill.
Tig22estudt St. St. Louis, Mo;
2760 W. Market St., Akron, Ohio

Our new computer
does more for you
than
count.

Lak

[= JHOtG Gate.
wut =

—————

f
LD 2

Washington Spotlight For
Pharmacists by APhA

Legal Division

Physician Held Liable for Patients
Amphetamine Addiction

Three men who allegedly suffered complete loss of
earning capacity as a result of becoming addicted to
amphetamines have been awarded a total of $435,000 by
a California jury.

The patients were treated for tension, arising from
business pressures over a five year period, with injections
of what they said were described to them as vitamins
plus a relaxant. They contended that the injections were
actually amphetamines of various kinds. The patients
claimed that as a result of this treatment, they became
addicted to the amphetamines to the extent that they
could no longer carry on their business.

Complaint to Grievance Committee of
Professional Association is Privileged

A complaint to a bar association grievance com-
mittee containing libelous statements was held to be a
privileged communication. A suit against the complain-
ing party was dismissed by the court on the basis that the
privileged status of communications made during the
course of a judicial proceeding applies with equal force
in proceedings before a grievance committee. The court
pointed out that the professional conduct of attorneys is a
matter of great importance to the public and that the
power of the bar association to discipline members of
the bar for misconduct is necessary. The court held that
members of the public have a right to make complaints
against attorneys and that such complaints cannot con-
stitute the basis for a civil action in libel or slander.

It would appear from this decision that a pharma-
cist who files a complaint with a disciplinary board at
the local, state or national level would not be vulnerable
to potential liability for libel or slander, provided that
the complaint is made in good faith and in accordance
with the procedures established by the disciplinary body
involved.

Thalidomide Settlement—$30 Million

The principal thalidomide damage suit has finally
ended after a trial of 244 years. The compromise settle-
ment calls for a payment of $27 million plus interest to
the 2,000 surviving West German children with thalido-
mide deformities. $1.1 million will be paid to 800 adults
who suffered nervous disorders because of the drug and
an additional $1.6 million was assessed against the drug
manufacturer for court costs.

The West German court declined to hand down any
formal verdict against five employees of the firm charged
with causing bodily harm through neglect and intent,
negligent homicide and violation of West Germany’s
drug law.

Personal Financial Planning
For The Pharmacist

Personal financial planning should take into account
the years after retirement. The community pharmacist
must consider his personal financial planning needs as
well as the need to hire and retain qualified professional
pharmacists. The employed pharmacist must consider his
personal need to build a sound retirement plan. In many
cases, these needs are intertwined and should be con-
sidered as one.

For the past three years, the Maryland Pharmaceuti-
cal Association has made available to its members a pen-
sion/retirement plan implemented through the facilities
of Pension and Investment Associates of America, Inc.
(P.I.A.A.).

P.I.A.A. has advised us that recent changes in In-—
ternal Revenue Regulations have greatly increased the
flexibility of design available in the establishment of tax-—
qualified pension plans. These changes reflect IRS aware-
ness that the small businessman and self-employed pro-
fessional have been the “forgotten man” in previous pen-—
sion regulations.

The new regulations make available the use of :
“Master prototypes.” This permits an organization such
as Bankers National Life Insurance Company, which im-—
plements our program through its affiliate, Pension and —
Investment Associates of America, Inc., to file basic
prototype plans with IRS. The filing of these plans makes :
available to you as an individual member greater flexi-
bility in the design and installation of your own pension
program. These prototypes are especially suited for mem- :
bers who operate as sole proprietors . . . partnerships . . . |
or corporations. They greatly reduce the burden of initial
costs involved in the establishment of a tax-qualified pen-
sion plan.

In our endeavor to offer you sound association pro-
gramming, we are providing the services of Pension and
Investment Associates of America, Inc. (P.I.A.A.). P.L.-
A.A. representatives shortly will be contacting you to ex-
plain the impact of these new Internal Revenue Regula-
tions. Regardless of whether you are self-employed .. . a_
sole proprietor . . . a partnership . . . or a corporation,
these new regulatory changes can be important to you.
When you are contacted by a P.I.A.A. representative, we
suggest that you give him an opportunity to explain the
benefits which are available, and to discuss your needs
and design a plan for your consideration.

If you require further information or an immediate
appointment, contact Mr. David S. Rosenberg, Pension
and Investment Associates of America, 2000 Spruce

Street, Trenton, New Jersey 08639 (609-883-0696 ).

Illegal Sale of Amphetamines
by Osteopaths

A federal appellate court upheld the conviction of
two osteopaths who sold 5,000 amphetamines to former
patients. The tablets were purchased by former patients
engaged in horse racing, for use in treating the horses.

The court noted that while osteopaths can legally
prescribe stimulant drugs to their patients, it was absurd
to argue that the sale of the tablets for use as “horse
medication” was within the authorized handling of stim-
ulant drugs for an osteopath.

THE MARYLAND PHARMACIST

amiliar service
or strange film

Are customers bringing in “strange” film brands lately? Have these mysterious
“unknowns” been confusing your people?

They don’t have to. Big, small, foreign or domestic, just drop them into
the Berkey bag and leave the rest to us.

Who makes the film or where it comes from doesn’t matter. Whether it’s branded
or unbranded, Berkey will process it.
Our custom quality and custom service means satisfied customers for you.
Customers who come back. Again and again.
Berkey can do things for you that nobody else does, because nobody else can.
Trust all your D and P work to Berkey. It’s good business. You uncomplicate life for
your staff. And with one bill from one supplier, your bookkeeper will love you.

Berkey
Film Processing
of Washington, D.C.
3701 Mt. Vernon Avenue
Berkey Io) Alexandria, Virginia 22305
(703) 549-7500

Photo Inc.

Discounting and Pharmacy

Management

by RICHARD SCHOTT, M.B:S.,
Executive Vice-President,
Merchants Buying Syndicate, Inc., New York

Presented on November 19, 1970 at
the Simon Solomon Pharmacy Eco-
nomics Seminar, Warren House, Pikes-

ville, Maryland.

The discounters today are actually the largest retail
force in America. In footage alone in 1970, the discount
industry is projected to have 276 million square feet of
selling space. This footage is a gain of over 13% over
1969. In 1970, the discount industry will be represented
by over 4,000 retail units which is actually almost 400
retail units more than in 1969. The approximate annual
sales of the discount industry, projected for 1970, are a
staggering 22 billion dollars.

In the area of drugs and cosmetics, the discounter
has managed to make tremendous inroads. As an example,
82% of the drug and cosmetics departments are operated
by stores themselves with only 12% leased.

In the area of pharmacy operations, roughly 12%
of the discounters have pharmacy departments. It is inter-
esting to note that the index of incidence of the drugs
and cosmetics departments is 82% while the pharmacies
index is only 12%.

This type of statistic may be encouraging to some
of you as it shows that the one area that the discounter
has found difficult to capture is the pharmacy depart-
ment.

You should know your competitor better. The aver-
age drug and toiletry department in the discount store
today is approximately 2,000 square feet. It has an annual
turnover of 4.7 times, an initial mark up of 28% and
a maintained margin of 24%.

Just what are the discounters doing this year in
their drug, health and beauty aids department? Their
first concern this year, the year of consolidation, is focus-
ing their efforts on tighter and more profitable depart-
ments by eliminating slower moving categories and add-
ing hot new categories, such as feminine hygiene lines,
hair coloring lines, men’s personal grooming aids, as
well as ladies’ personal care products such as hair curlers,
cosmetic mirrors, etc.

Their next approach in 1970 has been in the mer-
chandising swing to larger and professional sizes to com-
pete with the supermarkets, as well as the addition of
franchise cosmetics which up until now were unavail-
able to the chains, but slowly are being opened and ac-
cepted by the chains because of the additional prestige
and dollars that they contribute.

The discounter will continue to be a formidable com-
petitor to your daily business and the time has come for
you, the independent, to take cognizance of this fact
and begin, if you have not done so as yet, to take action
for survival. I think that I should also bring into focus
the competitive role that is played by the chain drug

operators today. It is the prediction of many experts that
the large drug chains with their know-how could well
control better than 85% of the drug store business in the
next five years. Personally, it is my feeling that your
greatest competition in the next few years will not come
out of the discount chain, but out of the drug, super-
market and variety store units that have been developed
by the discounter.

The merchandising job that has been done by the
independent in the non-drug categories, has been a poor
one. It has been a haphazard approach. A stop gap
measure, and at times a ridiculous mish mash of mer:
chandise that has ruined your professional standing in
the community. The fault does not lie with you alone.
It lies with those who have given misguided guidance,
some of the wholesalers, some of the opportunists who
simply stated that all you have to do to compete with
the discounter or the supermarketeer, or the large drug
operator, is to be cheaper in your product and carry the
most important sundry items.

By now many of you realize, | am sure, that price
alone is not going to bring the consumer to your doors.
The modern store, well fixtured, well merchandised in
the various important drug and health and beauty aids
as well as in the non-drug items, has a far better chance
of surviving the competitive onslaught from both sides,
than one that has decided to ignore the competition.

Those of you who have followed the growth of some
of the drug chains, will notice that stores that are being
put up are no longer in the 3 to 5,000 square feet cate-
gory, but run into the 15,000 and 20,000 and sometimes
even 30,000 square feet size and handle merchandise in
tremendous assortments—housewares, toys, sporting goods,
luggage, china, glass, gifts, notions, stationery, electronics,
and who knows what else. In essence they have become
variety store oriented and have used variety store tech-
niques of merchandising. These chains have developed
not only in major cities but in smaller communities, with

the cluster of stores strategically located and utilizing the ~
same newspaper media, in doing so reducing their ad-—

vertising costs.

It is true that their purchasing power is tremendous,
and it is also true that in many instances they are cap-

able of buying better. Now, buying better does not neces-

sarily mean that they buy cheaper all the time. It does
however mean that the timing and coverage of the vari-
ous markets is such that it may give them a far greater
advantage over the independent who has to depend solely
on the distributor who may not at all times be pro-

gressive or aggressive, to be able to act the supporting

role that is so necessary for the independent.

I have come up with certain observations which I
feel must be acted upon by the independent if he is to
survive the changes in our industry. First he must no
longer think in terms of small stores. The days of the

THE MARYLAND PHARMACIST

Mr. Pharmacist ~

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4, Salesman inventory control

To get the complete story—call collect [301] 243-4439

PARAMOUNT PHOTO SERVICE

3024 Greenmount Avenue
Baltimore, Maryland 21218

ANUARY 1971 19

1500 or 2500 square feet drug store, even on a local
neighborhood basis, are slowly disappearing. Business has
doubled, tripled and quadrupled at the neighborhood local
store level. Now, how do you merchandise a store in that
space? Obviously you do it with better fixturing, and a
far broader merchandising mix than ever before. As we,
in the discount industry have learned from you 15 years
ago when we copied some of your excellent merchan-
dising techniques, you now should learn from us, the dis-
counters, and that is, that in order for you to merchan-
dise the size of the stores that are today acceptable to the
American public, you will have to combine your purchas-
ing power by getting together either in cooperatives, or
call them guilds, or call them whatever you want to call
them, by developing central warehousing on a cooperative
basis and by developing central buying, central advertis-
ing, central store planning and central electronic data
processing.

This I believe is the only way an independent will
survive the giants of today who are spreading through-
out the United States. And who incidentally, in spite of
what you may think, are performing an excellent func-
tion in servicing a local community.

I realize that it is very nice to put your name on a
big sign outside of your store, but I am also aware of the
fact that as a one or two store operation, your cost of ad-
vertising can become tremendously costly.

I visualize 20 or 30 independent drug operators
within a geographic area, getting together, forming a co-
operative, developing their own advertising program, ware-
housing programs, store planning programs, and even
electronic data processing. And at the same time, doing

cn {cr (cs (cn (cs (cn (cms (cr (cree (coe ( coe (cee, (cm (cee

customers.

For information, call or write:

1011 West Butler Street
Philadelphia, Pa. 19101
(215) 223-9000

A Service of The Drug House, Inc.

LET OUR COMPUTER WORK FOR YOU
With
WAP ee

TIP TOP is a computerized procedure by which you are automatically supplied
with a monthly statement of purchases for each of your charge account

PLUS

An immediate monthly (and annual) breakdown of their pharmacy purchases
of deductible items for income tax purposes.

THE DRUG HOUSE, INC.

1880 Princeton Avenue
Trenton, New Jersey 08638
(609) 396-5586

one very important thing in order to present to their
customers a strong and cohesive image, and that is, to
operate under one name.

I don’t know how startling this suggestion might be
to you, but I as an individual, who has seen over the last
15 years the strength and potential capabilities of the
chains, as they have developed, feel that the power of per-
haps quasi chain operators, even if in name only, can
give the customer the image that the national chains
have been able to establish over a period of years. I realize
that my suggestion to give up your name can be a hard
pill to swallow, but as pharmacists you also know, that
while some pills do not taste well at first, they manage to
cure the illness.

Headquarters for

PHOTO-OFFSET PRINTING MAILING
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

en (een (er (ees (ce (en (cm (we (cr (en (sn (cen (come (com (cen (eon (ome (ce (es (en ee (n(n (ws (ee (ee (a (es os (s(n (ce (cs (ee (nen (en

— — = ——

I 3069 Newcastle Avenue

| Newcastle, Del. 17920

H (302) 655-7401

by I I EI IIS
20 THE MARYLAND PHARMACIST

Loyalty is a love affair!

In Maryland you are first and foremost in our
hearts and mind, Why? Because Barre-National is the
last broad-range pharmaceutical manufacturer owned
by Marylanders.

We’re “home folks” with a great sense of loyalty.
And we love to promptly service your needs of OTC
SPECIALTIES, TABLETS & CAPSULES, SUP-
POSITORIES, WET PACK, DRY PACK, LIQUID

PHARMACEUTICALS, OINTMENTS, INJECT-
ABLES, OPHTHALMIC SOLUTIONS. Give us a try.

BARRE - NATIONAL DRUG CO., INC.

4128 HAYWARD AVENUE @ BALTIMORE, MARYLAND 21215 @ PHONE: 542-5272

)

ANUARY 1971

Be Smart!

Stock the One and Only—
Original “SAFETY TIPS”

Think Smart!

Always Sell Them

Smart Users Ask For Them By Name

AMERICAN HYGIENIC CO.

111 S. Paca Street, Baltimore, Md. 21201

727-8328
Represented by
IRV NORWITZ Phone 727-8328
SSS I I SS SS SSS SSAA SAA)

Allegany-Garrett County
Pharmaceutical Association

Retired Pharmacists are Honored

The Allegany-Garrett County Pharmaceutical Asso-
ciation honored six retired pharmacists at a testimonial
dinner at Clarysville Inn recently.

Honored guests were Francis C. Knepper, Harry C.
Lewis, Raymond J. Lowry, Virginia S. Radcliffe, the late
James E. McMichael, who died in May, 1970 and W. D.
Timmons. The six pharmacists have been practicing for
a total of almost three centuries. Their years of health
care service to residents of the Cumberland area collec-
tively number 270.

At the dinner, C. Murray Allen was master of cere-
monies and presented each retired guest with a cup bear-
ing his name and years of service. Mrs. Leta McMichael
accepted the memorial award for her husband _post-
humously.

Presenting remarks were: Henry J. Glick, pharma-
cist at Sacred Heart Hospital; Harry Sellers, from Me-
morial Hospital; George B. Harmon, from Keyser Drug;
Samuel Wertheimer, pharmacist at Memorial Hospital;
M. Joseph Eshelman from Peoples Drug Store and Mr.
Allen.

The dinner was arranged by officers of the Allegany-
Garrett County Pharmaceutical Association: Stephen
Hospodavis, president; James L. Ritchie, vice-president;
and Robert F. Tomsko, secretary-treasurer.

Free Management Service

The Lilly Analysis Service has evaluated individual
financial statements submitted by community pharmacist
owners throughout the United States for 39 consecutive
years. Each year, about 2,500 pharmacists request a finan-
cial review by Lilly staff analysts and receive a complete
report of their operation. The service is offered again
this year.

The report is free and strictly confidential. Anony-
mous statements are also processed and mailed if an ade-
quate address is provided. To receive a free analysis, send
your financial statements and prescription data to the
Lilly Analysis Service, Department M-501, P.O. Box 814,
Indianapolis, Indiana 46206.

New Interaction Handbook

The Handbook of Drug Interactions by Edward A.
Hartshorn, Ph.D., has recently been published by Donald
E. Francke. The Handbook consists of 18 chapters and
discusses drug interactions according to the pharmacologi-
cal and therapeutic index of the American Hospital For-
mulary Service. The material originally appeared in Drug
Intelligence and Clinical Pharmacy. The 88-page Hand-
eee contains a helpful index which includes drug names
only.

The Handbook of Drug Interactions may be ordered
from Drug Intelligence and Clinical Pharmacy, College
of Pharmacy, University of Cincinnati, Cincinnati, Ohio
45221, at a cost of $3.50 each; $4.00 will be charged if

payment is not enclosed with an order.

cM:

FDA Is Developing A 9-Digit ‘“‘Code”
For Non-Drug Health Products

A National Health Related Products Code, corre-
sponding to the existing National Drug Code, is now be-
ing developed by the Food & Drug Administration, in
cooperation with health field organizations, manufac-
turers, and other government agencies.

The new code will cover medical and surgical equip-
ment used in the treatment of institutionalized patients,
as well as a wide range of non-drug health products sold
in retail pharmacies. Among these will be thermometers,
wheelchairs, bandages, hot water bottles, vaporizers, and
bed pans.

The same 9-digit alpha-numerical sequence employed —
in the National Drug Code will be used in the Health
Products Code. Like the drug code, it is intended to make
possible automated electronic ordering, dispensing, cost
accounting, inventory control, and third-party claims
processing for the covered products.

Hot is Better Than Cold—For Teeth

A group of scientists from the University of Utah,
following an extensive two-year study of the thermal
stresses on human teeth caused by the constant tempera-
ture changes inside the mouth, report that hot drinks and
food may be better for teeth than cold ones.

When tooth surface is subjected to sudden tempera-
ture drops caused by drinking or eating something cold,
the enamel tends to contract and is more susceptible to
cracking.

One of the worse things a person can do to his teeth,
the researchers warn, is to chew on ice. They also state
that breathing through your teeth on a cold winter day
may also be inviting a visit to the dentist.

Pension €& Investment
Associates of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)
HR-10.. Plans (Sole Proprietor-Partnerships)

Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

THE MARYLAND PHARMACIST

Congratulations
and
Best Wishes to
the newly elected officers
of the
Baltimore Metropolitan
Pharmaceutical Association

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218
Phone 467-2780

<5 AS SR Q d ! Z
0; CHS First name in ice cream

ICE CRE AM for over a half-century

675-6000

NUARY 1971 23

National Health Insurance

The Committee for National Health Insurance, at a
press conference on July 7, 1970, described its plan to
establish a “Health Security Program.” Senator Edward
M. Kennedy (D) Massachusetts announced that he plans
to introduce legislation to implement the program some-
time before the end of July. He said he hopes to get broad
sponsorship of the measure and anticipates hearings will
be held in August or early September. The Senator indi-
cated the bill will be considered first by the Senate Labor
and Public Welfare Committee because of its health aspects
but will also go before the Senate Finance Committee
which considers legislation involving Federal tax revenues.
In response to questioning, Leonard Woodcock, President
of the United Auto Workers and Chairman of the Com-
mittee for National Health Insurance, advised they were
in agreement with George Meany, President, AFL-CIO, and
the legislation they are endorsing which has been intro-
duced by U.S. Representative Martha W. Griffiths (D)
Michigan, the National Health Insurance Act (H.R. 15779) ,
with only some technical disparities to be resolved.

The Program was described as providing for com-
prehensive health care for everyone living in the United
States, which would include physicians’ services, institu-
tional services, psychiatric services, dental services for
children up to age fifteen, certain drugs provided by hos-
pitals and group practice plans, and supporting services
such as professional services of optometrists and podiatrists,
and ambulance and other emergency transportation, among
others. “Health Security” would be administered by a
five-member Board appointed by the President serving
under the Secretary of Department HEW, assisted by an
advisory council with consumers holding majority mem-
bership.

The plan would absorb Medicare and most other ma-
jor health care programs and replace private insurance for
services which are covered under the program. It would
be financed by taxes which would go into a Health Securi-
ty Trust Fund, similar to the Social Security Trust Fund.
Funds would be raised from three sources:

Forty percent from Federal general tax revenues

Thirty-five percent from a 2.8% tax on employer
payroll

Twenty-five percent from a 1.8% tax on individual
adjusted gross income up to $15,000.

Money from the Trust Fund would be distributed to
the ten Department HEW regions throughout the country,
primarily on the basis of population within the region.
From the regional office, the funds would be distributed
to local areas for each covered category of health care.
Institutions would receive payment on the basis of pros-
pective budgets. From the physicians’ services allotment,
first priority would be given to group health programs
which undertake total physicians’ care on a per person
payment basis, for salaried doctors in institutions and for
physicians receiving stipends. The remaining funds would
be available to pay individual physicians on the basis of
negotiated fee schedules.

A percentage of the Trust Fund, two percent in the
first year and increasing amounts to a maximum of five
percent, would be earmarked as a Resources Development
Fund to increase health personnel and facilities and
strengthen the health care system. Priority would be given

to stimulating the development and growth of group prac-_

tice programs and other innovative and productive health
care alternatives and to help to enhance the practice of

medicine in rural and undermanned urban areas. The Pro-:

gram would provide incentives for more efficient use of

existing manpower, and educational and training funds to

supplement programs for the production of new physicians
nurses, dentists and other health personnel.

—From COTH Report No. 36, July 29,1970

Council on Teaching Hospitals, Washington, D.C.

Methotrexate Dispensing:

Two physicians reported at the recent AMA annual

meeting that Methotrexate may have been responsible fo

the development of tuberculosis in two patients receiving

the drug for treatment of psoriasis. While it has not been

proven that these two patients developed tuberculosis as”

a direct result of the Methotrexate therapy, case reports
and cited animal work led the physicians to suspect that
Methotrexate may have been a factor, due to its effect o
suppressing the patient’s immune competency. This ef-
fect would tend to render a patient more susceptible to
infection.

In another case, a suit is pending against a physi-
cian and the drug’s manufacturer for the death of a
young father of three who died of heptocellular necrosis
allegedly induced by methotrexate during treatment for
psoriasis. Attention is again directed to the fact that
psoriasis is not an FDA approved use of this drug.

The apparent increased non-approved use of Metho-
trexate for treatment of psoriasis has re-opened the long
standing question as to whether a pharmacist should
dispense this drug directly to a patient in contravention
of the warning placed on the label by the manufacturer.
The warning states that the drug should be dispensec
only to physicians.

It is the opinion of the APhA Legal Division that a
pharmacist who dispenses this drug directly to a patient,
increases his risk of civil liability in the event of an ad-
verse reaction. The practical effect of this warning could
be to shift the burden of proof required in a negligence
action. Instead of requiring the patient to prove the phar-
macist negligent, the presence of the warning could re-
quire the pharmacist to prove that he was not negligent
in dispensing it contrary to the stated warning. The saf-
est course for pharmacists is to dispense the drug in the
manner specified by the manufacturer.

CHANGE OF ADDRESS

When you move—
Please inform this office four weeks in advance to avoid
undelivered issues.
"The Maryland Pharmacist" is not forwarded by the
Post Office when you move.

To insure delivery of "The Maryland Pharmacist" and all

mail, kindly notify the office when you plan to move
and state the effective date.

Thank you for your cooperation.

Nathan I. Gruz, Editor
Maryland Pharmacist

650 West Lombard Street
Baltimore, Maryland 21201

THE MARYLAND PHARMACIS

brain.

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
vage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for
the spoken word. Perhaps this is why millions of people
regu'arly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

Readin

iS Still the fastest Way
to program the

human

et /]
At

C2246
Ps

P—<(\km
Ea

Maryland News Company is proud to be your area’s
prime source of fine reading material. We keep pace
with consumers’ reading pleasure by constantly supply-
ing your racks with current reading material that sells.

For every $100 invested in paperbacks and magazines,
you can expect a return of $127 within thirty (30) days
of the initial outlay. Unsold copies are returnable for
full credit. For more information please call 233-4545.

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

FTC Consent Order Forbids 13 Drug
Firms Knowingly To Induce
Preferential Prices:

A consent order provisionally accepted by the Fed-
eral Trade Commission prohibits 13 affiliated drug re-
tailers in North Dakota, South Dakota and Minnesota,
from knowingly inducing and receiving discriminatory
prices from pharmaceutical suppliers.

The group also is forbidden to maintain any ar-
rangement which results in a diversion of prescription
drugs to it from a nonprofit institution, or which passes
on or makes available to it a preferential price offered
by pharmaceutical manufacturers only to nonprofit in-
stitutions.

The FTC complaint had alleged that although the
major part of the group’s pharmaceutical supplies and
equipment purchases are made directly for its own ac-
count, substantial quantities of prescription drugs are
purchased via the account of a nonprofit hospital. This
concerted action between the group and hospital was be-
gun approximately nine years ago and has evolved, in
part, into a means of obtaining discriminatory prices for
the group.

In practice and effect, the complaint continues, the
hospital serves as the medium through which the group
has exerted influence on suppliers by knowingly demand-
ing and receiving on its purchases discriminatory prices,
discounts, allowances, rebates and terms and conditions
of sale. Suppliers not agreeing to its demands allegedly
were usually replaced by others who did.

The complaint also charges that this knowing in-
ducement or receipt of the discriminatory prices has sub-
stantially lessened competition between acceding and non-
acceding suppliers, and also between the group and its
unfavored independent competitors.

The consent agreement is for settlement purposes
only and does not constitute an admission by respondents
that they have violated the law.

Drugstore Sales in 1970—A New High

Sales in the nation’s 50,000 drugstores skyrocketed
to a new peak of $13,501,000,000 during 1970, up 5%
from the year previous, Drug Topics reports. Sales were
divided in the ratio of 63% for independents and 37%
for chain drugstores (one of a group of 4 or more
drugstores ). Independents accounted for $8,510,000,000
of the sales, and chain drugstores for $4,991,000,000.
The average increase per store comes to over $20,000 a
year—a gain in gross sales of $385 per week. Total aver-
age gross per store was $274,420 for the year.

“1971 should prove to be another record-breaking
year for consumer expenditures in drugstores,” said
Harrison S. Fraker, Publisher of Drug Topics. “The num-
ber of prescriptions filled is well past the one billion
mark. New and improved pharmaceuticals, as well as
over-the-counter health products, toiletries and cosmetics,
should boost customer visits in drugstores from 180,000,-
000 a week to over 200,000,000 with a corresponding in-

crease in the pharmacist’s receipts.”

Obituaries...

DR. GAYLORD B. ESTABROOK

Dr. Gaylord B. Estabrook, retired physics professo
at the University of Maryland professional schools i
Baltimore, died December 4, 1970 after a three-mon
illness.

Dr. Estabrook, who taught at the university for 2
years, first came to the university in 1937 as a physics i
structor. In 1939, he was made an assistant professor, i
1947 an associate professor and three years later he w
appointed a full professor. He retired in 1966.

He was a popular figure at the University. The gra
uating classes of 1953 and 1957 of the School of Pha
macy dedicated their yearbooks to him. He is survived b
his wife, the former Marylyn Way; his mother, Mr.
Catherine B. Estabrook, and his sister, Ruth Schoepfle.

DR. CHESTER A. DUNCAN

Dr. Chester A. Duncan, 88, former dean of Baylo
University’s School of Pharmacy, in Dallas, died on De
cember 2, 1970 after a short illness. Dr. Duncan was bor
in Lancaster, Pa., and received his doctorate from th
Philadelphia College of Pharmacy in 1906. He then wen
to Dallas, where he was dean at Baylor until 1928.

He than came to Baltimore where he managed sev
eral pharmacies including the old Tenant’s Pharmacy. H
retired in 1965.

L. REX SPRINGER

R. Rex Springer, 68, of Morrel Park, died recentl
at his home after suffering a heart attack. Mr. Springe
operated the Superior Pharmacy at Washington Boul
vard and DeSoto Road from 1928 to 1945. He was a 192
graduate of the University of Maryland School of Phar

macy.

CLARENCE HENRY PIERSON

Clarence Henry Pierson, 70, former member of th
firm of Armentrout and Pierson, which in the 1920’s and
1930’s owned pharmacies at Park Heights and Belveder
Avenues and Poplar Grove Street and Riggs Avenue,
died December 28 after a long illness. Mr. Pierson grad-
uated from the Milton College of Pharmacy and became
registered in December, 1939. He retired in 1961. |

JOHN KAIRIS |

John Kairis, 65, died on December 9 after a short
illness. He graduated in 1927 from the University of
Maryland School of Pharmacy. Mr. Kairis was associated
with the Aero Pharmacy for 25 years and with the Ser-
pick Pharmacy for 4 years. He was the husband of the
late Catherine C. Matthews and is survived by a daughter
and son. He is also survived by 2 sisters, Nancy Luck:
hardt and Eleanor Bannerman, both graduates of the
University of Maryland School of Pharmacy.

THE MARYLAND PHARMACIST

Thantis, the reliable throat lozenge.

The THANTIS DISPENSER,
containing a roll of 25 individually
foil-wrapped lozenges, is attractively
packaged — 6 dispensers in a fold-up
counter display. The packaging is
right! The profit is good! The time to
purchase Thantis is now!

(#740/171)

HYNSON, WESTCOTT & DUNNING, INC.
Baltimore, Maryland 21201

INEW
ANTI-DANDRU
LOTION |
SHAMPOO

SELS

BLUE

Helps contro§
symptoms wi
use—leaves |
tomanage

No. 6620
Contains
Selenium
Sulfide, 1%

Net Conte

NEW

| ANTI-DANDRUFF
LOTION
SHAMPOO

SELSUN
BLUE”

Helps control
dandruff symptoms
with regular use.
Leaves hair

easy to manage.

No. 6620
Contains
Selenium
Sulfide, 1%

$1.98
Net Contents 4 fl.oz.

ABBOTT

Finally

It isn’t often that a product combines the best
of two possible worlds—the effectiveness of
a professional product with the elegance of a
cosmetic specialty.

New SELSUN BLUE is a refreshing exception.

In double-blind clinical studies, it was shown
to have greater overall effectiveness than

two leading anti-dandruff preparations.*

Yet in every important way SELSUN BLUE re-
sembles a superior cosmetic shampoo. It lath-
ers beautifully. It has a delightful fragrance.
It leaves the hair soft, easy-to-manage.

Isn’t this what a lot of your customers have

been waiting for? 007296

*Tested were a zine pyrithione preparation and a product containing hexachlorophene, sulfur and salicylic acid.

the
maryland

w—~" oharmacist

Children Are
Frequent Victims
of Poisoning
by Ordinary
D Woachild Products

PARTICIPATE IN
NATIONAL POISON PREVENTION WEEK
MARCH 21 to MARCH 27

Volume 47 FEBRUARY 1971 Number 2

Compliments of

oxell

CORPORATION

NOXZEMA SKIN CREAMS

Makers of

NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS

and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

Your prescription patients
may not know the difference
... but you do.

As a pharmacist, you Know that neither brand name
nor generic drugs are any better than the demon-
strated reliability of their manufacturers. The im-
portant thing to you and your prescription patients
is not what the product is called but how expertly
it is made.

Four generations’ experience in producing fine
pharmaceuticals is one of the many reasons you
can have confidence in Lilly products.

Eli Lilly and Company « Indianapolis, Indiana 46206 EZ

100218

THE MARYLAND PHARMACEUTICAL ASSOC.

Play

cation and ONLY 100

ANE neee RESERVATIONS

MAY 18 THRU MAY 23, 1971

MAY 18

MONTEGO
BAY,
JAMAICA

MAY 18
TO
MAY 23

MAY 23

LEFT
... MAKE YOURS NOW!

Depart 9 A.M. from Friendship Airport in Baltimore via Eastern Airlines
non-stop charter flight to your place in the sun. Relax in the gaiety of the
party-like atmosphere, enjoying a leisurely Brunch — Free Open Bar —
soaring over the ocean at nearly the speed of sound.

Arrive at the Montego Bay Airport. After clearing Customs, you will be
whisked, with your luggage, to the HOLIDAY INN, the glamorous, new
exciting tropical island resort. Here you will “live it up” in a breathtaking
succession of six sun-splashed days and balmy starlit nights of sheer pleasure
at Jamaica’s liveliest and loveliest resort hotel.

Glow in a sunshine world of complete vacation activities . .. revel in a
magnificent pool, bask in the sun, plunge in the crystal-clear surf, sail,
snorkel, water ski, skuba dive, deep sea fish . ... enjoy golf, play shuffle-
board, explore the charming Island, shop for exotic things in an international
bazaar or “drive” your cares away on the hotel’s sporty putting green.
Freeport prices on Perfumes, Linen, Cashmere Sweaters, Bone China and
Porcelain, Watches, Crystal, Silver, Diamonds, Pearls, Cameras, Equipment.

When the sun goes down the magic of Jamaica nightlife takes over with
gourmet dining, dancing to the Calypso beat of native drums or to rhythmic
Latin and American music.

Just let your mood set the pace from “dawn to yawn” for an unforgettable
vacation that dreams are made of.

In addition to the many, many resort activities available, we have included:
Multi-course English breakfast each morning in the hotel.

Romantic candlelight dinner each evening in the elegant dining room,
offering a wide selection of taste-tingling delights.

All good things must come to an end. . . and so must your delightful
“playcation” in Jamaica. On checking out . . . before leaving you will be
responsible only for gratuities and personal charges.

Transportation will be provided from the hotel to the airport for your
homeward journey via non-stop charter flight, enjoying a delightful Dinner
and continuous complimentary bar en route.

You will alight from the plane relaxed and refreshed after six wonderful
days in the sun enjoying the best that Jamaica has to offer.

FOR INFORMATION AND RESERVATIONS

CALL MPHA - 727-0746

or NATHAN
269-0212

SCHWARTZ, Chairman § PER
1-956-3300 4EQ® ee

or ALDER SIMON
747-3400 (Day or Nite)

he Maryland Pharmacist

NATHAN |. GRUZ, Editor
'650 WEST LOMBARD STREET

VoLUME 47

| OFFICERS 1970-71

Honorary President
MORRIS L. COOPER—Baltimore

President
DONALD O. FEDDER—Dundalk
President Elect
NATHAN SCHWARTZ—Annapolis
Vice President
SYDNEY L. BURGEE, JR.—Baltimore
Vice President
BERNARD a LACHMAN—Baltimore
ce President
MELVIN y. SOLLOD—A delphi
Executive Director
NATHAN I. GRUZ
650 W. Lombard Street, Baltimore 21201
Treasurer

MORRIS LINDENBAUM
5 Main Street, Reisterstown

Executive Committee
Chairman
I EARL KERPELMAN—Salisbury

District 1—Eastern Shore
PHILIP D. LINDEMAN—Berlin
JAMES W. TRUITT, JR.—Federalsburg

District 2—Central

MORRIS BOOKOFF—Baltimore
JOSEPH U. DORSCH—Baltimore
PAUL FREIMAN—Baltimore
IRVIN KAMENETZ—Baltimore
JEROME MASK—Baltimore
ANTHONY G. PADUSSIS—Baitimore
DAVID I. SCOTT—Baltimore
H. NELSON WARFIELD—Baltimore

District 3—Southern
PAUL R. BERGERON, II—Bethesda
SAUL B. FRIEDMAN—Potomac
EDWARD NUSSBAUM—Rockville
DOMINIC J. VICINO—Mt. Rainier
RICHARD D. PARKER—Silver Spring

District 4—Northern

ARNOLD L. AMASS—Taneytown
ROBERT K. MOLER—Brunswick

District 5—Western

HARRY G. EISENTROUT, JR.
Cumberland
STEPHEN HOSPODAVIS—Cumberland

Committeemen at Large

JOHN R. McHUGH
ROBERT E. SNYDER

Ex-Officio Members

FRANCIS S. BALASSONE
WILLIAM J. KINNARD, JR.

Honorary Life Member of the
f Executive Committee

SIMON SOLOMON

MARYLAND BOARD OF PHARMACY
] Honorary President
SIMON SOLOMON
President
NORMAN J. LEVIN—Pikesville
Secretary
I eS BALASSONE Baltimore

FRANK BLOCK—Baltimore
HOWARD L. GORDY—Salisbury
MORRIS R. YAFFE—Potomac

NORMAND A. PELISSIER, Assistant Editor
BALTIMORE, MARYLAND 21201

ASSOCIATION

FEBRUARY 1971 NUMBER 2

TABLE OF CONTENTS

Page

Editorial—Non-Prescription Medication—A Responsibility
LOTMENATINACIStS sear 2A meee le eek I ee oe 6
PNarMaAcy Calendarg ccs yt ee Nees Cen ee me yee Pineal La iT. 6
BME AG a cscsestctt sarees st Stone eek AEN, Se OOM aM na or teen ee We we 2g Oe 8
AMD A tis sassaasrssrtogeetane nile ores tee, abi ve diye meryes Rene PUNE he recreate Piece bate 10
SS WHITE LIeLT De CUy SCLILINIAT NA rn sk Oi en ee te eet HOR DLC OR. ily:
FOspitalg Pharniacy. Section (ase re te ee se el Re 14
Drug Interactions—Levodopa by David A. Blake.o.........ccccccccccecscesscesseceeeees 16
Thise Month's (News Drugsymers pectin 2 oe iene Mer Pee ee ee 20
CODICUAT IOS ameter te eee ne atria ecel en at eee rie ee 22

INDEX TO ADVERTISERS

Page
AINGCTICANSLITLC PIStS a NSULaNCey CU. nee ee ed ee Ae ce 17
ATMICT CANMELY SICHICE COLD AT) Vame ame teen sra aaa ann eee rt ae ee ee 13
Barre Naonale Drom ONDA yan ll a een ee en een eee 9
BEY RCVERIINE PIOCCSSING ernie tertie ten oad ee ee eee 23
BOrden-Hendlerml Cem Crear eccrine de nate ee ae ey ore 24
@CalverteDruce Compan yam LC aires ean eee ree ee ee ee 24
AT hemDruee HOUSER INC ieee ee mere et een a ene eee ee ee eee es we, oe. 17
Hentve bs Gilping Com pariy cee eee ee eee tee ee ee, 21
ElighillyZand sCOmpany gress nce macs eee een aes oe Rene ca S| 3
Loewy: Drugs Company tr. cammrrie neers eee ren et an ss eens eastern Ss: 7
Mangini ands ASSOCIAteS ah INC ar esc eee ee re ees ae ee 22
Marylande NOW Ss COMPANY irr ccceces ce teten reine tere ee meen ee Se 19
INOXel]E COTDPOTAtION creer cree etree oe ede ea eee ee aL, eee 2
PAT ATO UN Gebel OCOMSCIEV ICC meermerecrem ter tac tem crrnece tenn ere ee ee mn eon 15
De StUarteweDDBAGCVeLLISINS A OCLVICES meee eee ee ee es 9
Moungss Drug serpauet= Corporations... ee eee 11

a a a

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number. Allow four weeks for
changeover.

Editorial ...

Non-Prescription Medication—
A Responsibility for Pharmacists

Traditionally, when the pharmacist thought of his
professional role, he thought only of compounding and
dispensing physicians’ prescriptions. But today the prac-
tice of pharmacy is emerging as a health care profession
concerned with the patient, not just with various aspects
of producing and distributing drug products.

Some of the responsibilities that more and more
pharmacists are assuming are in the areas of patient
medication records, clinical pharmacy practices, drug
interactions and intravenous solutions, to mention just a
few.

A much neglected area for assumption of full pro-
fessional responsibility by pharmacists is that of profes-
sional attention to protecting the public in their choice
of and self-medication with non-prescription medicines or

over-the-counter drugs (OTC).

Certainly, at the very least, OTC preparations con-
taining drugs, which in larger amounts per dosage unit,
are restricted to prescriptions, should be available only
under a pharmacist’s supervision. Certainly these prepa-
rations and all those containing warnings and contraindi-
cations should be under the pharmacist’s control. The
warnings, among others, include the dangers of use by
those who have heart, diabetes or thyroid disease. One
wonders about the percentage among purchasers of such
medicines who unknowingly are suffering from some of
these contraindicated conditions.

Certainly mass display, open display and sale by
self-service of potent medication is incompatible with the
nature of these preparations and with the public health
responsibilities of pharmacists.

Certainly the participation of pharmacists in the
promotion of the promiscuous use of patent medicines is
in conflict with pharmacists’ professional education, re-
sponsibilities and our Code of Ethics.

How about the contribution of advertising and pro-
motion techniques to the attitude of people toward the
use of drugs and their consequent misuse and abuse?

Is it not time for pharmacists to clearly dissociate
themselves from hucksterism in health?

Pharmacists are the only qualified licensed cus-
todians of drugs—prescription and non-prescription.
Pharmacists, if they wish to be recognized as responsible
members of the health care team, with the patient’s wel-
fare always foremost, must not give any appearance of
abetting those proprietary manufacturers who mislead
the public with distortions that the lay public is not
qualified to recognize.

Is it not time that all physiologically active ingredi-
ents and their quantities be revealed on the labels of all
medication and cosmetics?

Many pharmacists have and are assuming full re-
sponsibility for advising their patrons about OTC drugs
and their use. It is time for every pharmacist to join his

colleagues who are sensitive to the ethical and moral
issues involved. The pharmacist can perform a truly
clinical pharmacy function in both the community and
in the institutional setting by asserting professional judg-
ment and discretion in the OTC drugs he stocks, how he
displays and recommends them, in refusing to stock or
sell some, and in the advice he gives those who rely and
trust in him.

There is a growing awareness by responsible persons
in and out of government who understand that the cus-
tomary approach of the market place to ordinary articles
of trade does not apply to drugs. This attitude is demon-
strated by Charles C. Edwards, M.D., the Commissioner
of the Food and Drug Administration, who stated before
the NARD in October: “We must also give serious
thought to how drugs are being sold in this country.
The sale of drugs has tended to move away from the
pharmacy as distribution increases through wholesale
outlets and supermarkets. There may well be a case, in
this area of drug abuse and overuse, to ensure that all
sales are under supervision of the pharmacist who is the
trained person in the field.”

We believe the public expects and deserves from
pharmacists straight, medically sound guidance about
health products. The basis must be facts, not advertising
claims, promotions, advertising allowances, merchandis-
ing deals or the demand artificially created by electronic
or printed media.

It is time for eliminating all aspects of the patent
medicine side-show from pharmacy.

Will you accept this responsibility?

Nathan I. Gruz
|
|

PHARMACY CALENDAR

March 21-27—Poison Prevention Week.

March 24—MPhA Spring Regional Meeting, Colony 7
Motor Inn.

March 27-April 2—APhA Annual Meeting, San Francis-

co, California. |
|

May 16-17—MPhA Annual Convention, Hunt Valley

Inn.

May 26—School of Pharmacy Alumni Association An-
nual Meeting.

April 16—Meeting of Maryland Graduate Chapter of
Kappa Psi.

June 2—School of Pharmacy Annual Alumni Banquet ine
Honor of Graduates.

June 5—School of Pharmacy Commencement Exercises.

June 11-13—6th Annual MSHP Hospital Pharmacy Sem-
inar, Ocean City, Md.

THE MARYLAND PHARMACIST

There’s a lot more
going for you at LOEwy*

VOM

COMPUTERIZED
SERVICE

puts America’s most advanced
warehouse facility behind your store

How much is it worth to you to know
that the most advanced computerized
distribution system in existence isin
motion to process your every order
...instantly, efficiently, completely?
That you needn't ever stock more than
a minimum of a far greater variety of
merchandise than you could ever show
before... and without investment in
excessive inventory? That your
wholesaler is never likely to be out-of
stock on any desirable item? That
every invoice and statement is assured
of up-to-the-minute accuracy? And
that there is never a lapse of more
than 60 minutes from receipt of your
order to the time itis on the loading
platform, ready to roll?

How much? You'll be able to measure
its worth by the number of customers
attracted to your store. Old customers
and new, it’s the kind of service they
aren’t likely to have known before.

FOR SERVICE AT ITS BEST...
BETTER DEAL WITH LOEWY

Call any time, day or night. An automatic order
taker will record your after-hours order.

Call IV 5-8105 for order taking.
(301) 485-8100 for the office.

LOEWY
DRUG COMPANY

: _ , <A
Shectvo
==

j
lustrtes,

wisn carci niente et

~~
DIVISION OF
OY) 9
ies E Spectre SIniusteies, Ine.
% noe

6801 Quad Avenue
Baltimore, Md. 21206
Telephone: (301) 485-8100

Baltimore Metropolitan
Pharmaceutical Association

55th Annual Installation Dinner-Dance

Irving Kamenetz, installed as president of the Balti-
more Metropolitan Pharmaceutical Association for 1971,
called for pharmacists to emphasize the personal service
they provide to their patrons. He asserted that the public
is being mislead about the cost of prescriptions and is ig-
noring the vital role that pharmacists perform in their
communities. President Kamenetz stressed the importance
of every pharmacy maintaining patient medication rec-
ords and urged all pharmacists to establish an effective
system.

Featured speaker at the function, which was at-
tended by 400 members, the allied drug industry and
guests, was Senator Rosalie Silber Abrams of the 5th
District of Baltimore City. Senator Abrams, a registered
nurse who has served a term with distinction in the
House of Delegates, reviewed some of the problems in
the area of health confronting the state. The need for
cost-containment in health care, analysis of hospital and

SENATOR ROSALIE ABRAMS

BMPA Officers 1971

Irvin Kamentz, center, President. Left to right: Charles E. Spigelmire, Treasurer;
Anthony G. Padussis, Chairman of Executive Committee; Joseph U. Dorsch, Presi-

dent-elect; Byron Millenson, Honorary President;

Paul Freiman, Vice-President;

Nathan I. Gruz, Secretary and Executive Director. Absent from photo: Vice-Presi-

dents Harold P. Levin and Harry R. Wille.

THE MARYLAND PHARMACIST

nursing home operations and the government health
programs in the state budget were reviewed.

A special citation was presented to Byron (Bernie)
Millenson, Vice President and General Manager of Radio
Station WCAO, by Executive Director Nathan I. Gruz.
Mr. Millenson was installed as Honorary President and
cited for his cooperation in providing public service time
to both state and local pharmaceutical associations in
various public health programs such as Poison Preven-
tion, Diabetes Detection and Pharmacy Week. The MPhA
Sunday evening program on WCAO, “Your Best Neigh-
bor,” has set a record for public service time with more
than 600 consecutive programs under MPhA and BMPA
Public Relations Chairman, Charles E. Spigelmire.

The other officers and Executives installed at Blue
Crest North, Pikesville, on January 31, 1971, were:
President Elect: Joseph U. Dorsch

Vice Presidents: Paul Freiman
Harry R. Wille
Harold P. Lewis

Secretary and Executive Director: Nathan I. Gruz
Treasurer: Charles E. Spigelmire

Executive Committee
Anthony G. Padussis, Chairman
Robert W. Henderson Charles H. Wagner
Henry Seidman John E. Padussis

William I. Lottier, Jr. Melvin Rubin
David I. Scott Ronald Lubman

Loyalty is a

Ex-Officio
William J. Kinnard, Jr.

Francis S. Balassone
The Banquet Committee consisted of Joseph U.
Dorsch, Chairman, Paul Freiman, Co-Chairman, George
J. Stiffman, Ticket Chairman, Sam A. Goldstein, Co-
Ordinator, Gerald F reedenberg, Ronald A. Lubman, John
E. Padussis, Charles E. Spigelmire and Charles H. Wag-

ner.

He who wakes up rich has not been sleeping.

Headquarters for

PHOTO-OFFSET PRINTING MAILING
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

love affair!

In Maryland you are first and foremost in our

hearts and mind, Why? Because Barre-National is the
last broad-range pharmaceutical manufacturer owned
by Marylanders.

We’re “home folks” with a great sense of loyalty.
And we love to promptly service your needs of OTC
SPECIALTIES, TABLETS & CAPSULES, SUP-
POSITORIES, WET PACK, DRY PACK, LIQUID

PHARMACEUTICALS, OINTMENTS, INJECT-
ABLES, OPHTHALMIC SOLUTIONS. Give us a try.

BARRE - NATIONAL DRUG CO., INC.

4128 HAYWARD AVENUE @ BALTIMORE, MARYLAND 21215 @ PHONE: 542-5272

-EBRUARY 1971

TAMPA Activities

Highlights of recent activities of the Traveler’s Aux-
iliary of the Maryland Pharmaceutical Association (TAM-
PA) were reported by William A. Pokorny, Secretary-
Treasurer and Herman Bloom, Chairman of the Com-
mittee on The Maryland Pharmacist.

The TAMPA Ladies’ Night was held at the Lime-
stone Dinner Theatre on Thursday, November 5, 1970.
The affair was an outstanding social success with an at-
tendance of 300. A Cocktail Hour and Buffet Dinner
preceded a most enjoyable comedy, “Fool’s Paradise.”
Arrangements for the affair were handled hy TAMPA
President, William L. Nelson. The guests included MPhA
President, Donald O. Fedder and Mrs. Fedder and MPhA
and BMPA Executive Director, Nathan I. Gruz and Mrs.

Gruz.

The December meeting was held at The Tail of the
Fox, Timonium, on December 5, 1970. The Baltimore
Colts 1959 Championship Film was presented. Plans
again were announced to make a Christmas Contribu-
tion for the Children’s Southwestern Christian Parish.

The annual Goodwill Meeting was held at Ordelle
Braase’s Flaming Pit on January 14. There was a good
attendance of membership present including the wives
of some of the members. The meeting was opened with
a prayer and Pledge of Allegiance to the Flag. Following
dinner, President William Nelson, announced that all
business would be dispensed with except the voting on
the new member, Mr. Fred C. Brandau, of Abbott Lab-
oratories, which was approved unanimously. The guest
speaker was Miss Roberta Poulton, a registered nurse
from the S. S. Hope. A very interesting talk about the
trips of this ship, the functions of the project and beauti-
ful slides were presented and discussed. This project is
privately sponsored without governmental support. The
contribution to S. S. Hope was approved.

it XILIARY®

ORGANIZED 1916

MACEUT’
J

‘Soc Ce
Nesinge cre

Left to right: TAMPA President William L. Nelson, guest
speaker Roberta Poulton, R.N., Secretary-Treasurer William A.

Pokorny.

APhA Annual Meeting to be Held in

San Francisco

Luxury hotels with lofty skyrooms, the up-turned
roofs of Chinatown, the Golden Gate Bridge, a sparkling
bay and much, much more await pharmacists and their
guests who will be in San Francisco March 27-April 2,
1971, for the APhA Annual Meeting.

More than 4,000 APhA members, their families
and friends are expected to attend this 118th annual
gathering of the profession, which will officially start
with the Opening Session Sunday evening, March 28, and
conclude Thursday evening, April 1, with the APhA
Annual Banquet at the San Francisco Hilton. Exhibits,
registration and meetings will be held at the Civic Audi-
torium, with meetings also scheduled in other hotels.

Hotel reservation forms are now being accepted by

the APhA Housing Bureau.

Child Center Opened at Bon Secours
Hospital

A new child health center has been opened by the
Baltimore City Health Department in the Bon Secours
Hospital, 2025 West Fayette Street, for residents in the
Steuart Hill and Model Cities “G” areas. Located on the
second floor of the east wing of the hospital, the center
will be open Mondays and Thursdays and will offer
families health services and guidance for their children
through the preschool years. The center location at Bon
Secours also provides the advantages of hospital facilities
if clinic evaluations determine that such services are
needed.

Appointments may be made by calling 837-2710 or
by contacting the neighborhood public health nurse.

The gavel of officers goes from Francis J.
Watkins (right), outgoing President to
President William L. Nelson.

THE MARYLAND PHARMACIST

Sell her Bidette...

ELE MORE PIER LEE LL ALE LOE LOPS OLE ELBA LB ER. OX $e LOLS OR ROE PE LRP PE PP BE HE

it means peace of
mind to her and
repeat profit to you

_ Now from the makers of Bidette

_ Towelette comes Bidette Mist, the

_ most modern convenient answer to

_ the odor problem men don’t have.

_ New Bidette Mist is a gentle,
pleasant-to-use vaginal deodorant
that is available in aerosol form.

It offers the same reliable deodorant
rotection to your customer as

he Bidette Towelette you helped us
pioneer. Because of our broad
national advertising campaign
appearing in over 24 of the nation’s
leading women’s magazines with
combined circulations reaching over
00 million, more women will be
asking and looking for Bidette
products in your pharmacy.
ae Why. not give premium products ©

premium display... and watch your
profits cim>

mew (ntimat

Youngs one Products Corporation, -
iscataway, New Jersey 08854

INTIMATE
MININE HYGIENE

@odorant
Mist

INTIBA ATE
FEMININE

| HYGIENE
Deodorant
: Mist
Younge
_ NETWr. 5 02. :

NET wr. 3/4 OL

Swain Pharmacy
Seminar

The Eleventh Annual Swain Pharmacy Seminar was
held on Thursday, February 11, at the Good Samaritan
Hospital in Baltimore. The theme of this year’s seminar
was “Pharmacy in the Seventies” and to explore this
theme, the Swain Seminar Committee chose the follow-
ing speakers and topics: Mary Lou Andersen, Communi-
ty Pharmacist, Wilmington, Delaware—‘Clinical Phar-
macy in Community Practice”; Joseph A. Higgins, Di-
rector, Drug Task Force, Social Security Administration
—‘‘Factors in the Administration of an Out of Hospital
Medicare Drug Program”; Panel Discussion—‘‘Effective
Communications Within the Profession and With Other
Professions,” Winifred Sewell, Co-ordinator Drug Infor-
mation Services, Health Sciences Library, Panel Modera-
tor; Sydney L. Burgee, Jr., Hospital Pharmacist; Noel
David List, M.D.; Frederick Magaziner, D.D.S.; and Mel-

vin N. Rubin, Community Pharmacist.

The first speaker, Mrs. Andersen, described a phar-
macy group-practice known as “Pharmacy Associates,
Inc.” This incorporated group of 22 pharmacists was
formed for the purpose of providing “‘a mechanism where-
by community and hospital pharmacists can play a role
in making health care available to residents of depressed
areas.” The group presently services 2 health centers
located in communities where there is no other phar-
macy service available. Each members of the group serves
at one of the centers on a rotation basis.

The Northeast Service Center serves as a well-baby
center and youth health center during the day until 4
p.m. After 4 p.m. the building becomes a “primary care”
health center, operated by a group practice of physicians
and pharmacists. Payment for prescriptions at this cen-
ter is $1.75 per prescription plus medication cost. The
same 60-drug formulary is also used at the Southbridge
Center, the second center serviced by the group.

At the centers, patients are seen first by a nurse who
records personal data and takes his blood pressure, then
the patient sees the pharmacist, who prepares a medica-
tion profile and drug history. The patient then takes his
chart to the physician who examines him and enters the
diagnosis and suggested treatment. The patient then re-
turns to the pharmacist who fills his prescription directly
from the chart and explains to the patient how to take the
product. Prescriptions are labeled with all information
necessary to enable the patient to have his prescription
refilled elsewhere if necessary when the clinic is closed.
The success of this system demonstrates that clinical
pharmacy can be practiced in an ambulatory setting, as
well as in a hospital.

The second speaker, Joseph Higgins, explained how
the Social Security Administration might process pre-
scription claims under a National Health Insurance Pro-
gram. An estimated 300 to 400 million prescriptions per
year are anticipated to be involved. The reimbursements
to the pharmacists would have to be done through an
electronic process. The administration is aiming at a
processing cost of 20 cents per prescription. If the 300 to
100 million prescriptions per year figure is accurate, the

MRS. MARY LOUISE ANDERSON

government would be reimbursing pharmacists approxi-
mately 1.5 billion dollars per year for prescriptions.

One idea in the planning stages is an “‘auto-input”’
system. A pencil-size scanning device which the pharma-
cist would pass over a series of numbers on a card, i.e.
social security identifying number and NDC number,
would relay information into a magnetic tape set-up
located in the pharmacy. Once a day the information con-
tained on the tape would be relayed over telephone wires
to a central claims processing station. A computer would
analyze the information and reject any incomplete claims
to be returned to the pharmacist for correction. A check
would be sent to the pharmacist for the properly processed
claims.

After a short intermission, the program resumed
with a panel discussion on “Effective Communications
Within The Profession and with Other Professions.” Dr.
Noel List indicated areas where he thought pharmacists
could do more to improve communications. He pointed
out the importance of patient drug profiles. Forty per
cent of all patients have their prescriptions filled at the
same pharmacy all of the time. This percentage is much
higher if we leave out those patients who have prescrip-
tions filled at both hospital pharmacies and community
pharmacies. Studies also show that 90 per cent of patients
will have a second prescription filled at the same phar-
macy they have used before.

He thought pharmacists could do more in the area
of instructing patients on taking drugs, could be instru-
mental in health planning and should act as a referral
service to the physician. As far as improving communica- |

THE MARYLAND PHARMACIST |

is with physicians, he thought that pharmacists must
e the initiative; they must make their capabilities
ywn to the physician.

Melvin Rubin stressed the importance of the phar-
sist-patient relationship. At his pharmacy, Mr. Rubin
ributes a periodic “letter” to his patients. A recent
le gave helpful instructions on the general frequency
t certain categories of drugs should be taken for opti-
| effect. Mr. Rubin believes in educating the public
ut the drugs that they take. He labels all prescrip-
is with the name of the drug unless specifically re-
sted not to by the prescriber. One of the means phar-
sists can develop professional confidence in themselves
yy regularly attending continuing education courses.

Dr. Magaziner noted that 83% of dentists now have
1arcotic registration number and that 200 million
tal prescriptions were written in 1969. He recognized
t dentists in general are weak in their knowledge of
g law and this is one area where more direct contact
ween dentists and pharmacists would be valuable. The
cational role that pharmacists can play in dental care
ybvious when statistics show that less than 50% of
public regularly see a dentist.

Mr. Burgee pointed out that pharmacists who want
mprove their position must make their abilities known
ther people. To develop closer ties with the physician,
pharmacist must demonstrate to him that he is knowl-
eable about drugs. Means available to do this in the
pital setting are teaching and publication of Pharmacy
letins. He stressed the importance of a good drug in-
nation library.

The dinner speaker was Dr. Zsolt H. Koppanyi, Di-
rector, Comprehensive Children’s and Youth Clinic, Bal-
timore City Hospitals. Dr. Koppanyi described the pre-
ventitive medical program at Baltimore City Hospitals.
He spoke highly in favor of safety closures on prescrip-
tion vials. One of the roles he saw for pharmacists of the
future was that of a “triage” specialist. The pharmacist,
with the proper training, could make minor diagnoses
and refer the more serious patient to a physician.

Shirkey to Receive APhA
Hugo H. Schaefer Medal

Harry C. Shirkey, internationally recognized phar-
macist-physician, will receive the Hugh H. Schaefer
Medal of the American Pharmaceutical Association, ac-
cording to an announcement by George Denmark, Chair-
man of the APhA Board of Trustees.

Presentation of the Medal, one of the Association’s
highest awards for outstanding service, will be made
April 1 in San Francisco during the APhA Annual Meet-
ing. Dr. Shirkey will be honored for his “heroic dedica-
tion to rational drug therapy for children.”

Author of APhA’s “1971 Pediatric Dosage Hand-
book,” Dr. Shirkey is internationally recognized as an
authority in the field of pediatrics, particularly pediatric
therapy. He has practiced pharmacy and medicine in
hospitals and the community setting and has served on
several university faculties, teaching pharmacology to
medical students, pharmacy students and nursing stu-
dents.

Be Smart!

Stock the One and Only—
Original “SAFETY TIPS”

Think Smart!

Smart Users Ask For Them By Name

AMERICAN HYGIENIC CO.

111 S. Paca Street, Baltimore, Md. 21201

727-8328
Represented by

IRV NORWITZ

Always Sell Them |

Phone 727-8328

RUARY 1971

Hospital Pharmacy
Section

Service!

by Robert E. Snyder,
President, Maryland Society of Hospital
Pharmacists

Service! Pharmaceutical Service! Delivery of Phar-
maceutical Service! These terms have been appearing in
the pharmacy literature more and more frequently in re-
cent years. They are not new. Pharmacy has always
been a service profession. The advent of Medicare, how-
ever, brought with it a re-examination of these terms as
they relate to patient care. Pharmacists in all areas of
practice are beginning to take a serious look at the
‘service’ they have been providing. Many community
pharmacists have initiated family prescription record
systems and pharmacist-patient consultations in an effort
to improve service. Hospital pharmacists have developed
and are implementing such services as: unit dose drug
distribution, patient medication profiles, and 1.V. admix-
tures. More recently hospital pharmacists are exploring
their contribution to patient care in the clinical setting
as part of the health care team.

Since service is our primary function, I believe it is
important for each hospital pharmacy to develop a state-
ment setting forth in writing it’s “philosophy of service.”
An example of such a statement might be as follows:

“The Pharmacy Department of ..................000s-.
Hospital is dedicated to the ideal of providing
the finest pharmacy service to all persons seek-
ing medical care in this institution. We shall
endeavor to make the services of the department
always available to the patient, the physician,
and the nurse. And we shall constantly strive
to improve the quality of our professional prac-
tice.”

Pharmacists should be proud of their contribution
to the medical profession. Service is not a “bad” word.
We all need to take a long hard look at our practice in
terms of the service we are providing.

Maryland Society of Hospital Pharmacists
Meeting of February 11, 1971

The February 11th meeting was held at the Good
Samaritan Hospital. The secretary read the minutes of
the previous meeting which were approved as read. Mary
Connelly reported that she had been contacted by Eli
Lilly concerning a joint meeting of the D.C. and Mary-
land Society of Hospital Pharmacists. Eli Lilly is plan-
ning on sponsoring this meeting which would be held on
Saturday, October 23rd, 1971.

Robert Snyder reported for Henry Derewicz and the
Liaison Committee with the Maryland Hospital Associa-

tion’s Professional Practices Committee. He also :
ported that Clarence Fortner had reconfirmed the me
ing dates and arrangements for the Sixth Annual H
pital Pharmacy Seminar. The Membership Commit
will soon be starting on a new membership survey of
hospitals in Maryland.

June Shaw reported for the Program Committ
The date of the March meeting, to be held at the No1
Arunde! Hospital, was uncertain because of a conflict
dates with the annual dinner meeting of the alun
association. The D.C. Society requested to postpone 1
April joint D.C. Maryland meeting to May because
the elaborate program planned by the D.C. Society :
this Organon sponsored meeting. In the event that 1
joint meeting is postponed to May, the April meeti
would be sponsored by H. B. Gilpin and Dr. Earl Mase
of the FDA would be the speaker. His topic will be ¢
titled “Disposable Medical Appliances.”

The following new members were approved: Pam
Brown, pharmacist at Maryland General; Kendal Melt
pharmacist at V.A. Hospital at Perry Point; John ©
Ebrite, with Merck Sharp and Dohme; and Dorothy Le

pharmacist at Lutheran Hospital.

Robert Snyder announced that the recipient of 1
1971 W. Arthur Purdum Award is Paul LeSage. T
meeting adjourned at 9:45 P.M.

Ineffective Drugs

Just-completed government studies show that or
about one out of five prescription drugs totally live
to their claimed effectiveness and that one out of sev
fails to meet manufacturers’ claims at all. The stu
showed that only 41.7 per cent of 2,752 drugs tested 1
questionably work as advertised to relieve symptoms
cure diseases.

These figures, representing the final compilation
drug effectiveness studies begun in 1966, were repor'

to a special Senate subcommittee by Dr. Charles C. ]
wards, head of the Food and Drug Administration.
said the misuse of prescription drugs—especially |
taking of too much of too many kinds of medications
is a “serious problem and threatens to become more :
unless “vigorous steps” are taken to stop it.

Dr. Edwards told the subcommittee, headed by S
ator Gaylord Nelson, D-Wis., that the FDA is moving
clear 245 ineffective drugs from the market and to-
quire drug advertisements to carry government effecti
ness ratings. But he conceded that the toughtest probl
will be in persuading the nation’s doctors, who last y
wrote more than two billion prescriptions, to change tk
prescribing habits. |

THE MARYLAND PHARMAC.

Mr. Pharmacist ~

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4, Salesman inventory control

To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE

3024 Greenmount Avenue
Baltimore, Maryland 21218

BRUARY 1971

Drug Interactions

LEVODOPA
by DAVID A. BLAKE, Ph.D.

Associate Professor and Chairman
Department of Pharmacology and Toxicology
School of Pharmacy
University of Maryland

Levodopa (1-DOPA, Dopar®, Larodopa®) offers a
new and effective treatment for Parkinson’s Disease (See
August, 1970 edition of this Journal). Its mechanism of
action is believed to be conversion to dopamine in the
basal ganglia after passage into this area of the brain.
Since 1-DOPA and DOPAmine are plentiful in nervous
tissue in other parts of the body as well, proper dosage
adjustment is critical if the patient is to realize improve-
ment with minimal side effects.

There are few confirmed clinical cases of drug inter-
actions involving levodopa although the potential for in-
teraction is high and particular concern in this regard
should be exercised. (1)

Reserpine (Serpasil) :

This antihypertensive drug causes a loss of serotonin,
norepinephrine and dopamine from neural storage sites
and thus aggrevates the symptoms of Parkinson’s Disease.
Actually, the ability of reserpine to cause tremors and
rigidity was a clue to the biochemical defect of this
disease. Reserpine should be regarded as an absolute con-
traindication in patients with Parkinson’s disease and
also as therapeutically incompatible (2) with levodopa.

Guanethidine (Ismelin) :

This is also an antihypertensive drug but exerts its
effect on blood pressure by causing release of catechola-
mines (dopamine and norepinephrine) in peripheral
sympathetic nerves. Although guanethidine does not read-
ily enter the brain, the concomitant presence of the ele-
vated amounts of dopamine that are formed during ther-
apy with levodopa might interfere with the uptake of
the antihypertensive into sympathetic nerve endings. Thus
the addition of levodopa to the therapy of a hypertensive
patient being treated with guanethidine would be ex-
pected to result in a rise in blood pressure back to hyper-
tensive levels.

Methyldopa (Aldomet) :

The antihypertensive action of methyldopa is the
result of its metabolic conversion to alpha-methyl norepi-
nephrine which replaces norepinephrine in central and
peripheral “adrenergic” nerves but is a false transmitter.
In addition, methyldopa inhibits dopa decarboxylase, the
enzyme responsible for the conversion of levodopa to
dopamine, a requirement for anti-Parkinsonian effects.
Thus the combination of methyldopa with levodopa
would be expected to interfere with the latter drug’s
ability to relieve the symptoms of Parkinson’s disease.

(1) Morgan, J. P. and Bianchine, J. R.: “The Clinical Phar-
macology of Levodopa.” Rational Drug Therapy. 5: 1-8,
1971.

(2) Lamy, P. P. and Blake, D. A.: “Therapeutic Incompati-
bilities,” J. Amer. Pharmaceutical Assn. Vol. NS10, No.
2, February, 1970.

Phenothiazines (Thorazine, Compazine, Mellaril,
etc.) :

The phenothiazines are valuable drugs in the tre:
ment of certain psychoses and also nausea and vomitin
apparently by virtue of their ability to alter the sen
tivity of receptors in the brain. Diskinesias similar
Parkinson’s disease are caused by an action of the
drugs on the extrapyramidal system and can be severe
some patients. Thus not only do phenothiazines aggreva
the symptoms of Parkinson’s disease, they also blo
dopamine receptors in the basal ganglia and like reserpir
should be considered absolutely contraindicated in_ tk
disease even if the patient is not receiving levodopa.

Pyridoxine (Vitamin B,):

As previously mentioned, before levodopa can exe
its anti-Parkinson’s effect it must be converied to dop
mine, this reaction requires the catalytic intervention —
dopa decarboxylase, an enzyme which requires pyridoxi1
as a cofactor. Hence it would appear that this vitam:
would enhance the therapeutic effect of levodopa by i
creasing its conversion to dopamine. Such is not the cas
Even maintenance doses of pyridoxine (0.3 to 1 mg—tl
usual range found in multiple vitamins) can complete
inhibit the therapeutic action of levodopa. The mechnis
of this antagonism has been attributed to an increase
metabolism of levodopa to dopamine in peripheral tissu
and consequently less drug is available to the bas
ganglia. For Parkinson’s patients, being treated wit
levodopa, who must take multiple vitamins, a preparatic
without pyridoxine (Larobec ) is available.

Monoamine Oxidase Inhibitors (Parnate, Eutony

Furoxone, Marplan, etc.) :

These drugs have been previously used in the tree
ment of Parkinson’s disease with some success. Whe
combined with levodopa, hypertensive crisis may resu
presumably because of prolonged sojourn of dopamit
which is a pressor substance.

Tricyclic Antidepressants (Tofranil, Elavil,
Norpramin, etc.):
These valuable antidepressant drugs potentiate tl
pressor activity of dopamine and norepinephrine. Hence

when a “tricyclic” is combined with levodopa, a hype
tensive reaction may be produced.

Summary

The growing popularity of levodopa as the treatme1
of choice for Parkinson’s disease makes it necessary fc
the pharmacist to be vigilant for unintentional hazardov
or antagonistic combinations with other drugs. Becaus
this disease usually strikes middle aged or older person
it is likely that antihypertensive, antidepressant and vit
min therapy may also be indicated. Many of the popule
drugs for treating these conditions have a potential fc
interaction with levodopa and may negate its therapeuti
effects or even aggrevate the symptoms of Parkinson
disease. The pharmacist who is mentally prepared 1
recognize these interactions and who maintains an ind
vidual prescription record system for his patients is i
a position to be of particular value in the successful trea
ment of Parkinson’s disease.

THE MARYLAND PHARMACIS

MAYER & STEINBERG
Maryland State Agents
1101 N. CALVERT STREET
BALTIMORE, MD. 21202
752-7311

AMERICAN

DRUGGISTS’
INSURANCE CO,

700 American Building
Cincinnati, Ohio 45202

WITH AMERICAN DRUGGISTS’ INSURANCE

When you must file a claim for a disaster... fire...theft... liability... you
want prompt assistance from someone with the genuine concern and wide expe-
rience to settle the claim promptly. American Druggists’ Insurance Co. ‘‘cuts the
red tape’’. ADI was created by druggists in 1906 to serve the needs of fellow drug-
gists. They know and appreciate what loss means to a druggist and make every effort
to provide 100% recovery.

Don't wait till you’re in need to ask about our full coverage plans. Contact your ADI
agent, NOW.

A Service of The Drug House, Inc.
LET OUR COMPUTER WORK FOR YOU
With
iithee Abe
TIP TOP is a computerized procedure by which you are automatically supplied
with a monthly statement of purchases for each of your charge account
customers.
PLUS
An immediate monthly (and annual) breakdown of their pharmacy purchases HM
of deductible items for income tax purposes. 1
For information, call or write:
THE DRUG HOUSE, INC.
1011 West Butler Street
Philadelphia, Pa. 19101 l
(215) 223-9000 nt
1880 Princeton Avenue fl
Trenton, New Jersey 08638 i
(609) 396-5586 i
3069 Newcastle Avenue
Newcastle, Del. 17920 i]
(302) 655-7401 i

-BRUARY 1971

Dr. Reed Commends MPhA
For Its Diabetes Detection
Efforts

Doctor Julian W. Reed, Public Education and Dia-
betes Detection Chairman of the Maryland Diabetes Asso-
ciation, recently reported that a large percentage of the
700 pharmacists who belong to the Maryland Pharma-
ceutical Association throughout the city and state have
been rendering an extremely useful public service for the
past several years in the area of diabetes detection. He
reported that in 1969-70, 2,024 mail-in urine tests ( Drey-
paks) purchased by the Maryland Pharmaceutical Asso-
ciation and distributed without charge through the drug
stores, were returned and analyzed in the Maryland State
Department of Health laboratory. Of this number, 338
(16.7% ) were positive.

Where geographically feasible, those who screened pos-
itive were retested at the Western Health District Head-
quarters at 700 W. Lombard Street in Baliimore. The
retest consisted of a capillary blood sugar determination
two hours after ingesting 75 grams of glucose in a dexcola.
Those whose retests were positive were sent to their
family physicians for a definitive diagnosis. Of the 338
individuals whose screening test was positive. 272 were
referred for a definitive diagnosis. Of this number, 60
newly discovered cases of diabetes were identified. This
constituted a yield of 29 per 1000 screened which was
extremely high, and compared quite favorably with the
yield from initial blood screening at several armories dur-
ing diabetes detection week, November 15 through No-
vember 22, 1969. The yield of newly discovered diabetics
from the blood screening was 23 per 1000.

Doctor Reed attributes this high yield from the Drey-
paks to the fact that large numbers of individuals in the
“high risk” group—i.e., those individuals with blood
relatives with diabetes, those over 40 years of age and
those individuals more than 10 percent overweight—are
availing themselves of the tests, which is commendable.

It was additionally reported that this year to date
1,031 Drey-paks have been returned, of which 143
(13.8% ) were positive. More Drey-paks are still available
in most pharmacies. Those individuals who are in the
“high risk” group who have not been tested for diabetes
within the past year are strongly urged to pick up a
Drey-pak and take the test according to the directions.

Whereas most investigators agree that blood screen-
ing is Superior to urine screening, the yield of newly dis-
covered diabetics in Maryland over the past three years,
as a result of Drey-pak screening with blood retesting of
the positives is quite satisfactory, particularly for those
individuals who are unable to get to the blood testing
sites.

Doctor Reed commended the Maryland Pharma-
ceutical Association for its efforts in this endeavor and
encouraged them to make Drey-paks available in drug
stores throughout the year. He stated that an active pub-
licity campaign by the organization would result in a
significant increase in utilization of the Drey-paks.

Wholesale Drug Companies
Offer Service To Pharmacie

:
THE ASTRO PROGRAM

This is the first of a series of articles describing
some of the services that the full-line, full-service dru
wholesalers can offer to assist the pharmacist in establish
ing and maintaining a successful operation in the face 0
rising competition.

The ASTRO program is an advertisirig-merchandi
ing program aimed through the wholesaler, through th
retailer, directly to the consumer. The purpose of th
program, offered by the Calvert Drug Company, is to le
the consumer know that their neighborhood independen
retail pharmacy is also a good place to buy their healtl
and beauty aids at competitive prices in addition to “thi
place” to obtain their medicines.

The ASTRO program utilizes the journal type cit
cular as the principal media for its advertising program
Under the ASTRO plan, a participating pharmacy in thi
Baltimore marketing area would have its location liste
along with all other participants in the same area in th
ASTRO Journal of Health and Beauty. This journa
would be distributed as a supplement to the News Ameri
can and Evening Sun publications. In addition to carry
ing promotional ads, the journal also features severa
pages of health-related articles of general interest to th
consumer.

There are also alternate plans available for phat
macies beyond the range of Baltimore city newspape
coverage. Stores participating in the plan display an iden
tifying emblem or insignia showing that they are ASTR¢

members.

The costs of joining the program involve an initia
membership fee plus a monthly fee to help support th
program and cover the member’s share of advertisin
commitments. The member agrees to participate in al
ASTRO promotions during the year and to carry and pul
chase if necessary (in the required quantities) all healt
and Beauty items advertised in the Astro Journal o

Health and Beauty.

The wholesaler furnishes seven or eight majo
Journal promotions during the year and 15 to 18 weekl
special promotions supplemented by frequent newspape
and radio advertisements. ASTRO membership is avail
able to all Calvert members in good standing.

CHANGE OF ADDRESS

When you move—
Please inform this office four weeks in advance to avoid
undelivered issues.
“The Maryland Pharmacist" is not forwarded by the
Post Office when you move.

To insure delivery of "The Maryland Pharmacist" and all —
mail, kindly notify the office when you plan to move
and state the effective date.

Thank you for your cooperation.

Nathan |. Gruz, Editor
Maryland Pharmacist

650 West Lombard Street
Baltimore, Maryland 21201

THE MARYLAND PHARMACIS

—_—

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
uage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for
the spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

_ __ Reading
iS Still the fa

to progr
human.
brain. -

stest way

mi the

ro °oo

‘
ee

4 iE “
"4 39 Sn
— |

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

This Month’s New Drugs

DRUG NAME: KEFLEX (cephalexin monohydrate )
MANUFACTURER: Eli Lilly and Co.
DESCRIPTION: A semisynthetic cephalosporin anti-

biotic intended for oral administration.

HOW SUPPLIED: Capsules equivalent to 250 mg. cepha-
lexin, are supplied in bottles of 24. Oral suspension
equivalent to 125 mg. cephalexin per 5 ml. is sup-
plied in 100 ml. size.

DRUG NAME: VERSAPEN-K (potassium hetacillin),
VERSAPEN (hetacillin )

MANUFACTURER: Bristol Laboratories
DESCRIPTION: A semisynthetic antibiotic derived from

the penicillin nucleus, 6-amino penicillanic acid. Its
antibiotic activity results from the rapid conversion
of the hetacillin moiety to ampicillin.

HOW SUPPLIED: Capsules of potassium hetacillin
equivalent to 225 or 450 mg. ampicillin per capsule.
Chewable tablets equivalent to 112.5 mg. ampicillin
per tablet. Oral suspension equivalent to 112.5 mg.
ampicillin per 5 ml. Pediatric drops equivalent to
112.5 mg. ampicillin per ml. For intravenous use—
225 mg. and 450 mg. equivalent of ampicillin per
vial. For intramuscular use—225 and 450 mg.
equivalent of ampicillin per vial.

DRUG NAME: CLEOCIN HC1 (clindamycin HC1 hy-
drate )

MANUFACTURER: UPJOHN

DESCRIPTION: A new semisynthetic antibiotic pro-
duced by 7-chloro-substitution of the 7(R)-hydroxyl
group of the parent compound lincomycin. This
chemical alteration gives clindamycin more in vitro
potency, better oral absorption and fewer gastroin-
testinal side effects than the parent compound.

HOW SUPPLIED: Capsules containing equivalent of
75 mg. clindamycin base in bottles of 16’s and
100’s. Capsules containing equivalent of 150 mg.
clindamycin base in bottles of 16’s and 100’s.

Cost of New Drug Development

Did you know that it takes approximately six years
from the time a drug is discovered to when it actually
becomes available—and this under favorable circum-
stances?

Dr. George deStevens, executive vice-president and
director of research of CIBA Corporation, who reported
this recently, estimated also that average development
costs of a single new drug are $7-million. If the drug
does not prove out, this large investment in time and
money can be completely wiped out, according to the
drug industry executive.

Research on a life-saving or life-prolonging drug is
expensive and filled with risks, he explained, but such
risks must be accepted as part of the necessary process of
‘bee new drugs for the improvement of human
realth.

Wonder Drugs of the 70s?

Prostaglandins, a group of body chemicals found i
various human tissues and fluids, now being researche
by various U.S. drug companies, have been found to
effective against a wide range of medical problems. P
tential application of prostaglandins include their use i
aborting pregnancies, inducing labor in pregnant wome
lowering blood pressure, and controlling peptic ulcer
Eventually, they also may be used as a once-a-mont
birth-control pill.

To date, 14 prostaglandins have been found, an ar
cle in a recent issue of Chemical Week reports. Larg
scale production is difficult because the molecules are s
complex.

According to the article, research programs hav
been underway in the U.S. for as long as 10 years. It i
expected that after the U.S. Food and Drug Administr
tion requirements are met, and production problems hav
been solved, prostaglandin drugs should be available i
the U.S. about 1975-78.

The possibility is noted that the first prostaglandi
product may be on the market in Europe by the end o
1971, “probably to induce labor.”

Ih f}iwsrat

A SWAIN Se
WORTH BROADCASTING

THE MARYLAND PHARMACIS

box D
SAY IS)

For 126 years, the Henry B. Gilpin Company has offered a wide range of services to pharmacists and pharmacies. Once
these services were simple. Today they are complex. But the Gilpin service is still complete. Completely modern. Com-
pletely attuned to your needs. Like the Gilpin sundries plan. We provide a complete sundries department with inventory
specially designed for your store, and a built-in provision for economical and reliable restocking of your shelves. Gilpin
also maintains an expanding stock of promotional sundries and programs that build traffic and make sales for you. In addi-
tion, Gilpin offers 10 other services to help you in your practice of pharmacy. One or more of them may just fit your need.

BALTIMORE + DOVER » NORFOLK + WASHINGTON

tie
8.

11.

ee
I
‘
E
i
i

A financial service consultant to service you on
request.

Two giant product shows each year: in January
featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing
promotional sundries.

the services required to nail down the profit dollars
which you need and deserve from your business.

eee ee ee eee
Sirs:

| am interested in the following programs. Please have your
representative contact me in this regard.

Name

Name of Pharmacy

Address Phone.

ys orale

“4
:

:
7
d

GP Academy Plans First Annual Lunch

The Academy of General Practice of Pharmacy of
the American Pharmaceutical Association will hold its
first Annual Luncheon on Thursday, April 1, in Conti-
nental Ballroom No. 5 of the San Francisco Hilton Hotel,
during the APhA Annual Meeting, March 27-April 2.

Describing the Luncheon as a “fitting conclusion
for the Academy programs,’ ’ AGP President C. Albert
Olson noted that “the Luncheon will provide Academy
members with the opportunity to honor the Daniel B.
Smith Award recipient and the incoming Academy Ex-
ecutive Committee.”

The featured speaker will be Milton Silverman,
Ph.D., member of the faculty of the School of Medicine
and the School of Pharmacy and Special Assistant to the
Chancellor at the University of California at San Fran-
cisco. “Now It’s Their Turn!” is the title of his address
regarding the consumer movement. Dr. Silverman was
Executive Secretary of the HEW Task Force on Pre-

scription Drugs.

Tickets for the event will be limited. They will be
available at the special Academy booth and the regular
APhA Ticket Booth, both located in the Registration
area of the Civic Auditorium. The Executive Committee
and Academy Delegates also will have tickets available
for purchase.

The United States of Mangini

Now, Mangini counts in 41 States! And we're
counting with computers that deliver selective com-
parisons, detailed cost factors and more customized
information than ever before! Our experienced in-
ventory teams are now covering more pharmacists
in more areas across the country and doing it faster
with the same, careful, guaranteed Mangini accu-
racy. If your inventory service is not giving you the
answers you need, you need Mangini.
Write/call/wire for DESCRIPTIVE BROCHURE

MANGINI & ASSOCIATES, INC
4850 W. Belmont Ave., Chicago, III. (312) 282-8181

11722 Studt St., St. Louis, Mo.
2760 W. Market St., Akron, Ohio
575 Savin Ave.,West Haven, Conn.
5501 Cherokee Ave., Alexandria, Va.

Francis J. FitzGerald New General Manage
of Gilpin Subsidiary

Claiborne B. Morton, Jr., Vice President of Point o
Purchase Service Merchandisers, Inc., announced tha
Francis J. FitzGerald has joined the firm as Gener
Manager.

Mr. FitzGerald is experienced in the rack jobbin
business, having been a former Vice President of Rich
ray Distributors from 1954 to 1968, and more recently
Vice President of Clayton Sales, an Arlington base
manufacturers representative firm. Born in Washington,
D.C., he attended Gonzaga High School and Mount Sain
Mary’s College in Emmitsburg, Maryland.

Point of Purchase Service Merchandisers, known
“POPS” to its customers, is a subsidiary of The Henry B.
Gilpin Company whose executives offices are in Wash.
ington, D.C. POPS offers a comprehensive merchandis
ing program in sundries to pharmacies and other outlets
in the mid-Atlantic area.

40,000 Covered for Drugs under Maryland
Blue Cross :

More than 40,000 Marylanders currently are pra
tected against the cost of out-of-hospital drugs by the
two-year-old Blue Cross Prescription Drug Program. Blue
Cross is processing some 3,000 claims per week from
Maryland pharmacies for prescriptions obtained by eligi:
ble members. Covered under the program are legend
drugs and insulin obtained by a non-hospitalized mem-
ber. There is no limit to the number of prescriptions or
refills a member or dependent may obtain while covered.

Obituaries...

Samuel Wolfovitz
Samuel Wolfovitz, 61, proprietor of Sussman’s Phar-
macy, Baltimore, died December 22, 1970. He was a
1931 graduate of the University of Maryland, School of
Pharmacy.

Bernard B. Hackett

Bernard B. Hackett, 60, of Baltimore, died January
1. He was a 1934 graduate of the University of Mary-
land, School of Pharmacy.

Harold J. Hocking

Harold J. Hocking, 77, Chillum, died January 15.
He graduated from Northwestern University, School of
Pharmacy in 1917.

Frank M. Noll
Frank M. Noll, 79, Baltimore pharmacist, died on
January 31 after a long ‘illness. A native of Waynesboro,
Pa., Mr. Noll was associated with Read’s, Shuster’s and
Weltner’s Pharmacies during his career. He retired in

1966. He is survived by his wife, the former Frieda
Freund.

THE MARYLAND PHARMACIS1

odd orders processed,
~ naturally

The oddball customer who insists he wants a print cropped “just this way.”

The man who wants cut film developed, or some positive film strips. The guy who
hands your clerk an unheard-of cartridge of film.

Welcome them. They all mean good business.

Just drop the oddball order into the Berkey bag. We'll process it with the
same professional skill, care, and dispatch we apply to all our D and P work.

Berkey’s special facilities and broad experience gives us a distinct edge in processing
every kind of film. From unfamiliar foreign films to Ultra-miniatures in color
and black-and-white, right up to 16 x 20 black-and-white blowups.

We’re ready to service all your needs. Berkey does things for
you that no one else does . . . because no one else can.

Berkey

Film Processing

of Washington, D.C.

3701 Mt. Vernon Avenue
Alexandria, Virginia 22305

& CIVISION OF (= (703) 549-7500
sealed I |

Offering Independent Pharmacies...

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up

to making your best source of supply,

THE

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

KORDEN. First name in ice cream

for over a half-century

675-6000

24 THE MARYLAND PHARMACI:

the
maryland

(2. §69pharmacist

Editorial:

Maryland Pharmaceutical Association Serves
Every Pharmacist and the Public Interest

Annual Report
of the Maryland Board of Pharmacy

An Invitation to All to Attend the
89th Annual Convention
Maryland Pharmaceutical Association
May 16-17, 1971
Hunt Valley Inn
Cockeysville, Maryland

olume 47 MARCH 1971 Number 3

in, —

Compliments of

\oxell

CORPORATION

Makers of
NOXZEMA SKIN CREAMS
NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS

and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

Your written guarantee of quality

Each prescription you fill is an exercise of your pro-
fessional judgment. The drug you dispense may be
vital to your prescription patient’s health and well-
being. Minor differences in dosage form, particle
size, solubility, rate of absorption, or hardness of tab-
let can make major differences in therapeutic effi-
cacy. When the choice is yours, you want to dispense
the best.

Lilly

Eli Lilly and Company : Indianapolis, Indiana 46206

Roche is concerned with the professional needs of all practicing phar-
macists along with the best health-care delivery. The needs of all pharma-
cists start with a drug source that is fairly priced, equitably distributed and
easily available.

services are conceived and implemented by pharmacists for :

pharmacists...to help you participate more fully in the ex- ae

panding contribution of health sciences. Rah ae AA AN Base TAL
Nutley, New Jersey 07110

When it comes
to pricing
you're both.
the same
oRoche

he Maryland Pharmacist

ATHAN I. GRUZ, Editor NORMAND A. PELISSIER, Assistant Editor

O WEST LOMBARD STREET BALTIMORE, MARYLAND 21201

MARCH 1971

OFFICERS 1970-71

Honorary President
MORRIS L. COOPER—Baltimore

President TABLE OF CONTENTS
DONALD O. FEDDER—Dundalk Pa
ge
President Elect A F ‘
- NATHAN SCHWARTZ—Annapolis Editorial—MPhA Serves Every Pharmacist and the Public Interest... 6
Vice President Pharmacy) Calendar te. 5. er eee es ee a 6
SYDNEY L. BURGEE, JR.—Baltimore Annual Revor
Wise oresidant po Y of the etal Boardgorseharmacya eee en 8
BERN ARD B. LACHMAN—Baltimore MEAs ExecutiverCommittee Meetings satin a ee ee 14
Vice President
| MELVINGS SOLLOD-_ Adelphi UAMPAINGWS fee unre cete ke uicn Mee metre een ees ee tats crane: Aton 16
Meee Ditector JIOSDILAlE ENarmacye SOCLON cee Geeta Weer a tami eae ae, ie. 18
NATHAN I. GRUZ Nursing and Pharmacy—Towards Better Patient Care
660 W. Lombard Street, Baltimore 21201 Dy2 Jean ele Macy icar tae cr nil te a ene ok ve eet OP 18
| Treasurer
MORRIS LINDENBAUM pee and Board7oie Pharmacy eNows i ee ee ee ee 22
5 Main Street, Reisterstown Washineton= spotiieht. ror + Pharmacists..2..0..40. one 26
: : Obituaries ...........
Executive Committee 1es OPP eee POPES S TIES ier rr err err rer ererrrere rer Tr rreree rire rere rerereee rire a Oeeerescceesesesese 30
Chairman
I. EARL KERPELMAN—Salisbury
District 1—Eastern Shore INDEX TO ADVERTISERS
. PHILIP D. LINDEMAN—Berlin P
JAMES W. TRUITT, JR.—Federalsburg ) vache
AGU CADOTALOTICS ae teed hd aes ee ee ee ls ee 21
District 2—Central K ; a ety. ped te teed ek eS IS aa rae
MORRIS BOOKOFF—Baltimore TNOTICHITE LLy geOaCs COMDATIV gic nue scntrtecas ce) teactt a fate e een eae ee 19
JOSEPH U. DORSCH—Baltimore el i
rea FREIMAN—Baltimore Batre-NationalsurucsCOmpanve nome ao ar, |e ee nee: 28
IRVIN KAMBNETZ—Baltimore Ber i ;
JEROME MASK~—Baltimore erkeys Rilmag Processing mneerrs ete ce eee) ee en ee 17
ANTHONY G. PADUSSIS—Baltimore Borden-Hend lermices Creamer teen ee ee 29
Pe Eee ary et sd me |i) 2 CLGCD TRON OL ECON CLOARIN a areeghetansccncneenihnnrSdtesntoosdepsnnontecceucannttteosversenteraoch
H. NELSON WARFIELD—Baltimore Calverte Drugs COMpPany = LC weet ae eee ee ee ee ee 29
District 3—Southern New DIU Set OUSCME LNG tre ens eertnre tere rr eens en eee 0 eS ee 13
PAUL R. BERGERON, II—Bethesda pats
3 AUL B. FRIEDM ANP otomac Hen Lye MGLOl Ti aC OMPAl vers cca ne seen aie erect tise cnet: cons at Reese 7
DWARD NUSSBAUM—Rockville :
OOMINIGUT. VICINO_-Mt_ Hatnier Lvnson mW eSsCoOttecza DUNNING 6:1 NC areenrtee ern en ee SL
RICHARD D. PARKER—Silver Spring LederlembaboratOries merce rence er ee re ner teen be 15
District 4—Northern Bis lilly sands COMpPAan Veet: ce cere ape eenrel eee hate oe eacee 3
ARNOLD L. AMASS—Taneytown
ROBERT K. MOLER—Brunswick Loewy Drug Company Sossesdseosacsdesbesedeabshesadeduvcsedeusnsenveuens seaeeseeeuede ses seecccccesccccecees 23
Districts Western Mangini sands ASSOCIALOS SIN Gains stress weer cstta ase tas ceskecnshcaraeacatspananerspetvssasencost os 22
HARRY G. EISENTROUT, JR. Marylanda News aCOMpany tects ween eee eee ee ee ae 25
Cumberland é
STEPHEN HOSPODAVIS—Cumberland NOXC]IS COTDOTACION were cee ae Lee ene ae 2
Committeemen at Large PATAMOUNtS PROLORSEIVICE merc c recente eee Re AA
ap Pension and Investment Association of America, INC. oo.ccccccccccccccccssseseses 22
Ee Otticie Members AH RODINS ECOMPAN Via caer tr eee ee oe ee 11
FRANCIS S. BALASSONE ROCHE= Lia DOLAtOTICS wwe eteeee reece oar ree Tes Meese neon 4
WILLIAM J. KINNARD, JR. Poe F
DeStUarTtaW CDDEAGVeErLiSIngs SCrviCeS mee ee eee ee ee 28
Honorary Life Member of the ‘
Executive Committee VOUNSSH DTI CmeTOCUCESE CONDOL2G]O lime meron tee erent nn enna eee 32
SIMON SOLOMON
MARYLAND BOARD OF PHARMACY
Honorary President Change of address may be made by sending old address (as it appears on
SIMON SOLOMON your journal) and new address with zip code number. Allow four weeks for
President changeover
NORMAN J. LEVIN—Pikesville x
F. Ss. ay a ete Baltimore The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical
Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a
FRANK BLOCK—Baltimore year. Entered as second class matter December 10, 1925, at the Post Office at Balti-

H ARD L. GORDY—Salisbur
onnis R. Stan bears ait more, Maryland, under the Act of March 8, 1879.

Editorial...

Maryland Pharmaceutical Association
Serves Every Pharmacist And
The Public Interest

Through the years MPhA has sought to advance the
legitimate interests of pharmacy and pharmacists, always
keeping in mind the over-riding interests of the general

public.

We have participated in developing guidelines for
providing pharmaceutical services to hospitals so that
pharmacists will assure professional pharmaceutical prac-
tices and safeguards for the benefit of patients.

We want the public assured that they can obtain
pharmaceutical services in community pharmacies, with
all maintaining high standards of professional practice.

Today comprehensive pharmaceutical practice in
community and hospital pharmacies certainly must in-
clude a capability for maintaining, retrieving, and utiliz-
ing patient medication histories for all drugs used by
patients.

Prescription prepayment plans — governmental and
private sector—must provide equitable, adequate com-
pensation sufficient to reimburse pharmacists for both
professional and administrative functions.

As pharmacists move into situations where all or
most of their time is spent functioning as health profes-
sionals, their time must be properly considered and they
must be justly remunerated.

Practicing as a pharmacist necessitates patient-in-
volvement. The pharmacist serves as a first line of medi-
cal contact for many people. He is called upon for advice.
We are approaching the time when health delivering
systems must consider payment for this service. Perhaps
this would be feasible with capitation payment systems
where a flat charge per person or per family will cover
the cost of service.

We urge every pharmacist to give attention to these
issues in pharmacy and participate in developing the
ideas and programs which will serve both pharmacy and
the public.

Nathan |. Gruz

PHARMACY CALENDAR
April 16—Meeting of Maryland Graduate Chapter of

Kappa Psi.
May 16-17—MPhA Annual Convention, Hunt Valley
nn.

May 26—School of Pharmacy Alumni Association An-
nual Meeting.

June 2—School of Pharmacy Annual Alumni Banquet in
Honor of Graduates.

June 5—School of Pharmacy Commencement Exercises.

June 11-13—6th Annual MSHP Hospital Pharmacy Sem-
inar, Ocean City, Md.

The National Formulary XIII

The new National Formulary XIII, published in
January 1970, became official September 1, 1970. It rep-
resents the results of a five-year revision program by the
American Pharmaceutical Association, involving more
than 500 persons from the fields of medicine, pharmacy,
and chemistry.

Of the 992 officially recognized drugs in NF XIII,
411 are newly admitted. Two hundred twenty-one drugs,
recognized in NF XII, have been dropped in going to

the new edition.

A new dosage form, aerosols, will be recognized
officially for the first time in NF XIII through inclusion
of monographs for several therapeutically important aero-
sol preparations. Leak testing, delivery rate, and pres-
sure testing are among the procedures used to establish
standards for aerosol products. In addition to mono-
graphs for six individual aerosol dosage forms, NF XIII
provides standards and specifications for four aerosol pro-
pellants.

In pursuit of its fundamental purpose—to provide
standards and specifications which can be used to evalu-
ate the quality of pharmaceuticals—NF XIII has drawn
upon and utilized the many recent developments in drug
analysis and methodology. The X-ray Diffraction specifi-
cations and the Dissolution Test constitute two important.
examples of the effort made to provide objective means
of assessing drug quality with respect to drug forms and
formulations, as these attributes may influence the bio-
logical performance of the article. :

An admissions policy based on the therapeutic value’
of the drug again serves as the sole criterion for articles
admitted to the NF for medicinal purposes, with combi-
nation drugs gaining admittance only if the combination
offered a “distinct therapeutic advantage” over the sepa-
rate components.

The National Formulary XIII is available from the
Mack Publishing Co., Easton, Pessylvania 18042 at a
cost of $15.00.

Maryland Graduate Chapter
Kappa Psi

The Maryland Graduate Chapter of Kappa Psi Phar-
maceutical Fraternity is sponsoring a dance to be held on
Friday, April 16, 1971 at the Famous Ballroom, 1717 N.
Charles Street, Baltimore, from 9 p.m. to 1 a.m. The
dance, entitled “The Spring Tonic” will feature “A. J.
and the Essentials.” Tickets are available at $7.00 per
couple from Larry Hogue, Mike Luzuriaga or Jim Culp. —

THE MARYLAND PHARMACIST

pia

y
KIT

For 126 years, the Henry B. Gilpin Company has been aiding pharmacists in the practice of their profession. At the
outset, our services were comparatively simple but complete. Today they are more complex but still complete. One
of these services—so vita! to a profitable pharmacy—is promotion and advertising. When it comes to selling, come to
Gilpin. We are prepared to provide you with an on-going advertising and promotional program. We also maintain the
necessary stocks of promotional merchandise and in-store merchandising aids required for a successful program. Now
is the time to nail down your profits with a “brass tacks” advertising plan tailored for you by the specialists at Gilpin.

An experienced, pharmacy oriented sales force
trained to assist you in merchandising and store
operations. in addition to their own experience,
these men are prepared to immediately draw upon
a wealth of experience in every phase of store
operations which exist within the Gilpin company
now.
A comprehensive and up-to-date convalescent
aids program. Professional assistance is available
to design a program to meet your space and
inventory requirements and train appropriate
personnel in your store to make this a profitable
department.
= | A complete sundries program providing sundries
*) departments and inventories designed specifically
for your store, with a built-in provision for
economical and reliable restocking of your shelves,
Along with this, we maintain expanding stocks of
new promotional sundries and programs for
increasing traffic and sales.
A professional planning and remodeling service
= within our organization which includes complete
service in floor design, fixture and installation.
Professional help in site selection, store
* development and in lease acquisition for
desirable sites.

= Computerized inventory and billing systems. This
| modern computerization also makes possible a wide
range of additional data services including regular
issuance of individual monthly reports of DACA drugs
showing quantities and dates on which they were
submitted.

BALTIMORE + DOVER + NORFOLK + WASHINGTON

A financial service consultant to service you on
request.

>) Two giant product shows each year: in January
*) featuring summer goods; in July featuring selections

of fall and gift merchandise and emphasizing
promotional sundries.

Professional advertising and promotional assistance.

>. Our specialists in this area now provide on-going

[jets ese

advertising and promotional programs for many of
our customers and are available to assist you in this
increasingly important area of your operation. With
complete stocks and complete lines of merchandise
provided with it, we are well qualified to provide

the services required to nail down the profit dollars
which you need and deserve from your business,

Check the area of your particular interest or need on the
coupon below and mail it to us or phone us. We'll arrange
tor Gilpin specialists to tailor the services which your
particular interest or situation requires.

ee ee eee
Sirs:

! am interested in the following programs. Please have your i
representative contact me in this regard. 5

Name

Name of Pharmacy

Address Phone.

City Sisles ee i

Annual Report
of the
Maryland Board of Pharmacy

1969 1970

In compliance with the provisions as set forth in
Section 258 of Article 43 of the Annotated Code of Mary-
land, this report is submitted to the Honorable Marvin
Mandel, Governor of Maryland, and to the Maryland
Pharmaceutical Association. This is the sixty-seventh re-
port to the Governor of the State and the fifty-seventh to
the Association. The report covers the activities of the
Maryland Board of Pharmacy for the fiscal year ending
June 30, 1970. For the first time, this report is being
submitted to the Secretary of the Department of Health
and Mental Hygiene.

Personnel

During the year the Board held fourteen meetings,
six of which were held at the School of Pharmacy of the
University of Maryland, for the purpose of conducting
examinations for registration of pharmacists.

At its first meeting the Board reorganized and
elected Mr. A. J. Ogrinz, Jr., President and Mr. F. S.
Balassone, Secretary-Treasurer. The other members of
the Board were: Messrs. Norman J. Levin, Howard L.

Gordy and Morris R. Yaffe.

At the annual meeting of the Maryland Pharma-
ceutical Association held at the Tamiment-in-the-Poconos,
Tamiment, Pennsylvania on July 13-17, 1969, the Nomi-
nating Committee submitted the following names which
were later submitted to the Governor as possible succes-
sors for Alexander J. Ogrinz, Jr. whose term would ex-

pire on April 30, 1970:

Alexander J. Ogrinz, Jr.
Frank Block
Harry Wille

Governor Mandel appointed Frank Block a member
of the Board for a term of five years, beginning May 1,
1970.

Since Mr. Ogrinz was not reappointed, the Board re-
organized and Mr. Norman J. Levin was elected Presi-
dent by unanimous vote.

On June 24th a letter signed by all the Board mem-
bers was given to Mr. Ogrinz, which reads thusly:

“Mr. Alexander J. Ogrinz, President
3200 Parkside Drive
Baltimore, Maryland 21214

Dear Al:

This is to acknowledge your long, dedicated
period of service to the Board of Pharmacy and the
people of the State of Maryland.

The dedication, interest and application to
Board matters shall remain a symbol for all succes-
sive members to emulate.

The cheerful manner and the wealth of pleas-

antries we have shared is a memory we shall always
treasure.

In your personal and professional activities we
wish you great success and happiness, and with ev-
ery hope that you will continue to maintain interest
in our activities, we remain

Cordially,”

Examination

The Board conducted two examinations for regis-
tration of pharmacists during the fiscal year. They were
held at the School of Pharmacy of the University of
Maryland on October 27, 28 and 29, 1969 and on June
22, 23 and 24, 1970.

There were twenty-three applicants for the full Board
in October. Twenty passed both the theoretical and prac-
tical portions of the examination and were subsequently
registered. Three failed the examination.

Having previously passed the theoretical portion of
the examination, fifty-four candidates took the practical
examination in October. All of these candidates passed
and were subsequently registered.

One applicant took only the theoretical portion of
the examination. This applicant passed and will take the
practical examination upon completion of his practical
experience.

One applicant took only the practical portion of the
examination, as he did not have the required experience
for reciprocity. This applicant passed and was subse-
quently licensed by reciprocity in Maryland. |

There were seven candidates who were eligible to
take the full Board. Of these, six passed and were subse-
quently licensed and one failed this examination.

Ninety-one candidates were eligible to take the theo-
retical portion of the examination. Of these, eighty-two
passed and eight failed this portion of the examination.
One student was not able to take the theoretical portion
of the examination due to illness.

Two applicants having previously passed the theo-
retical portion of the examination took the practical ex-
amination. Both of these applicants passed and were sub-
sequently registered with the Board.

Four applicants took only the practical portion of
the examination as they did not have the required ex-
perience for reciprocity. All of these applicants passed
and were subsequently licensed by reciprocity in Mary-
land.

The subjects assigned at both the October, 1969 and

the June, 1970 examinations were as follows:
Chemistry ge eee Alexander J. Ogrinz, Jr.
Frank Block
Pharmacy and Jurisprudence..Norman J. Levin
Materia Medica and Pharmacognosy

Morris R. Yaffe

Chemical and Pharmaceutical Mathematics
F. S. Balassone

Practical Pharmacy ................ Howard L. Gordy

THE MARYLAND PHARMACIS1

Record of Examinations Held

ctober 27, 28 and 29, 1969

pplicants Passed Withheld Failed
85 0 3
une 22, 23 and 24, 1970
pplicants Passed Withheld Failed
99 8 82 9
otal Number Examined for Registration as Pharmacists
pplicants Passed Withheld Failed
187 93 82 12

The following table shows the number of pharma-
ists who were registered by examination during the past
en years:

YEAR NUMBER OF PHARMACISTS
1960-1961 63
1961-1962 62
1962-1963 74
1963-1964 100
1964-1965 11
1965-1966 64
1966-1967 58
1967-1968 41
1968-1969 60
1969-1970 93

As in the past many pharmacists applied for re-
ciprocal registration in Maryland in order to accept posi-
tions with their employers who are opening stores in
Maryland.

Those applicants who did not meet cur require-
ments concerning practical experience prior to or after
registration were advised that they must take our practi-
cal examination in order to verify their qualifications.

In all cases an applicant for reciprocal registration
must appear for a personal interview. The entire Board

ust act on whether or not to grant registration to such
applicants, who must sign an agreement to comply with
Maryland’s laws pertaining to drugs and pharmacy.

The following table shows those granted registration
by reciprocity during the 1970 Fiscal Year:

Registered By Reciprocity

Certificate

Name Number Dated State
Richard L. Marden 7103 Sept. 26, 1969 New Hampshire
Peter A. Moulton 7104 Sept, 26, 1969 New Hampshire
Harry Collins 7105 Oct. 30, 1969 Pennsylvania
Anthony J. Farny 7106 Oct. 30, 1969 Indiana
Audrey R, Liffring 7107 Oct. 30, 1969 Alabama
George S. Buckner, Jr. 7108 Nov. 14, 1969 Nebraska
James R. Guerin 7109 Nov. 14, 1969 Louisiana
Haskel D. McAnear 7110 Nov, 14, 1969 Oklahoma
Suzanne S. Penzotti 7111 Nov. 14, 1969 North Carolina
Richard E. Rumrill 7112 Noy. 14, 1969 Connecticut
Janet T. Carriuolo 7146 Nov. 14, 1969 Massachusetts
Charles R. Perakis 7147 Nov. 20, 1969 Massachusetts
Ronald G. Cohen 7173 Dec 3, 1969 Virginia
Maurice Kooba 7174 Dec 3, 1969 New York
Norman Moritz 7175 Dec 3, 1969 Pennsylvania
Ralph D. Pittle 7176 Dec. 3, 1969 New Jersey
Stephen J. Sweeney 7177 Dec. 3, 1969 Minnesota
Sammy T, Herrod, Jr. 7178 Dec 3, 1969 Louisiana
Troy D. Ballew 7180 Dec. 11, 1969 Oklahoma
John P. Corless 7185 Dec. 23, 1969 Pennsylvania
Joseph L. Pedulla 7186 Dec, 23, 1969 New York
Nathan Weston 7187 Dec. 23, 1969 New York
Jule K. Deloye 7193 Jan. 20, 1970 Wisconsin
Carolyn M. Bowles 7195 Jan. 26, 1970 Oregon
Leroy Bradley 7196 Jan. 26, 1970 Dist. of Columbia
Leon L, Cohen 7197 Jan. 26, 1970 Dist. of Columbia
Thomas D. Langston 7198 Jan. 26, 1970 Dist. of Columbia
Herbert S. Lebowitz 7199 Jan, 26, 1970 Pennsylvania
Kendall W. Lok 7200 Jan. 26, 1970 Utah
Harold D. Thornton 7201 Jan. 26, 1970 Dist, of Columbia
B. Elliot Cohen 7205 Feb. 2, 1970 New York
Mattie T, Simmons 7206 Feb. 2, 1970 Dist, of Columbia
Man Ko Yim 7207 Feb. 2, 1970 North Carolina
Gerald A. Sievers 7209 Feb. 19, 1970 Nebraska
Herbert Gerstenzang 7210 Mar. 6, 1970 New York
Alfred S. Jackson 7211 Mar. 6, 1970 Louisiana
James W. Menzie 7212 Mar. 6, 1970 Oklahoma
William S. Padgett 7213 Mar. 6, 1970 Kansas
Anthony C. Jung 7214 Mar. 19, 1970 Texas
Carol L, Knoth 7215. Mar. 19, 1970 Indiana
Susan J. H. Barnes 7216 April 3, 1970 Iowa
Charles R. Burt 7217 April 28, 1970 Ohio
Robert G. Leventhal 7218 April 28, 1970 New York
Nelden C. McCort, Jr, 7219 April 28, 1970 West Virginia
Jackie R. Simmons 7220 April 28, 1970 Texas
Zulma C. Reaux 7221 May 19, 1970 Texas
Joanne G. Denkevitz 7222 May 13,1970 Michigan
Robert J. McAuley 7223 May 13, 1970 Pennsylvania
Steven C, Shaw 7224 May 13, 1970 New Jersey
Ronald C. Punch 7225 June 11, 1970 Texas
Lawrence H. Levin 7226 June 12, 1970 Pennsylvania
Luigi DeBoni 7227 June 16, 1970 West Virginia
Donald A. Shaw 7228 June 16,

Massachusetts

Certificate
Name Number

James A. Harris 7072 July
Michael A, Krun 7073 July
Brian P. Martin 7074 July
Sidney M. Miller 7075 July
James R. Weitzel 7076 July
Priestly J. Mance 7077 July
Dawn B. Henderson 7078 July
Henry J, Levin 7079 July
Karen M. Pahoresky 7080 July
Gary L. Fox 7081 Aug.
Irving Goldman 7082 Aug,
Catherine S. Putz 7083 Aug,
Henry W. Theis, Jr 7084 Aug.
James C. Cradock 7094 Aug.
Alfred E. Friendman 7095 Aug.
Renard R. Monti 7096 Aug.
Gerson T. Serody 7097 Aug.
Susan C. Wolf 7098 Aug,
James S. Burks 7099 Aug.

avid A, Dodge 7100 Aug.
Lance W. Berkowitz 7101 Sept.
Raymond M. Stewart 7102 Sept.

Dated

10,
10,
10,
10,
10,
16,
31,
31,
31,

1969
1969
1969
1969
1969
1969
1969
1969
1969
1969

6, 1969

1969
1969
1969
1969
1969
1969
1969
1969
1969
1969
1969

State

Oklahoma
Pennsylvania
Rhode Island
Massachusetts
Dist. of Columbia
Dist. of Columbia
Michigan
Pennsylvania
Nebraska

New Hampshire
West Virginia
Minnesota

New Jersey
Missouri

New Jersey
Minnesota
Pennsylvania
Rhode Island
West Virginia
Michigan

Dist. of Columbia
Georgia

Pharmacy Permits

The following table shows the number of pharma-
cists granted registration by reciprocity and the number
who were certified to register by reciprocity in other states
during the past ten years:

Certified for

Fiscal Year Reciprocity Registration in

Other States
1960-1961 aa 18
1961-1962 Do 20
1962-1963 54 18
1963-1964 46 23
1964-1965 63 20
1965-1966 44 25
1966-1967 61 27
1967-1968 64 20
1968-1969 84 27
1969-1970 75 40
Total 5959 238

The table shows Maryland gained 321 pharmacists
by reciprocity during the past ten years.

Counties:

Location 1968-1969 1969-1970
Allegany 23 22
Anne Arundel ae ead
Baltimore 138 144
Calvert 1 Ll
Caroline 3 3
Carroll 12 11
Cecil 9 10
Charles 1 7
Dorchester 3 3
Frederick 14 14
Garrett 3 3
Harford 2h 21
Howard 9 10
Kent 3 3
Montgomery 86 86
Prince George’s 87 98
Queen Anne’s 4 4
Saint Mary’s 4 4
Somerset 5 5
Talbot 8 9
Washington 18 16
Wicomico 13 13
Worcester 7 #

County Totals 530 547
Baltimore City 257 238

State-wide Totals

787 785

The above figures include permits issued to hos-
pitals in the counties as follows:

Allegany 2 Montgomery 3

Anne Arundel 2 Prince George’s *

Baltimore 3 Washington 1

Cecil 1 Wicomico 1

Frederick 1 oa

Harford 1 Total 20
1

Howard

In Baltimore City, 15 hospitals received a permit to
operate a pharmacy. Thus, a total of 35 hospitals have a
licensed pharmacy. Six nursing homes have received a
“limited” pharmacy permit, and one State Penal Institu-
tion was also licensed.

From July 1, 1969 through June 30, 1970 permits
have been issued to 20 new pharmacies. A total of 19
pharmacies have closed and have not, as yet, been re-
opened as pharmacies.

The following table shows the number of pharma-
cies opened, changes in ownership, and closed during
the year:

Changes in Ownership

Opened Corporation, and/or Closed
rit the Address
Counties 16 15 6
Baltimore City 4 6 I;
Total 20 21 19

The following table shows the number of pharma-
cies opened, changes in ownership, etc. and closed in the
past ten years:

Fiscal Year Opened Changes Closed
1960-1961 Al 41 25
1961-1962 34 od is
1962-1963 39 45 ig?
1963-1964 20 38 20
1964-1965 2p 34 20
1965-1966 27 46 44,
1966-1967 41 26 25
1967-1968 24 5a oo :
1968-1969 34 19 51
1969-1870 20 21 19

Certificate of Registration Renewals
There are some who are still not aware of the bi-
ennial registration renewal which became effective in
June 1961. The following shows the renewal periods, the
number of new renewals during the past year, and the
total renewals to date:

:
:
|

Renewals During

Renewal Period Fiscal Year Total Renewals
1961-1962 6 2,341
1963-1964 6 2,397
1965-1966 9 2,632
1967-1968 8 2D
1969-1970 13 2.861

Manufacturer’s Permits

Permits to manufacture drugs, medicines, toilet arti-
cles, dentifrices or cosmetics during 1970 were issued te
50 firms, 40 of which were “limited” permits. An appli-
cant applying for a permit for newly established company
is required to appear before the Board and to furnish all
information the Board considers pertinent to the con-

ducting of such operation.

Dangerous Drug Distributors’ Permits
The Board issued 140 permits to sell, distribute, give
or in any way dispose of dangerous drugs during 1970.
It is not necessary for a subsidiary or subsidiaries of a
company to have a separate permit, as they are covered
under the permit held by the parent company.

Prescription Survey
The following table shows a survey of prescriptions
filled in 1969:

PRESCRIPTION SURVEY — 1969

Baltimore City
Average Number New Prescriptions Filled in

03 *out of) 229) Pharmaciesse ices eee 13,506
Average Number Prescriptions Refilled in

O35 Sout, Ole Om be harmaciesmies: aslctct erent 7,356 20,862
Average Price of Prescriptions

in 93 out of 229 Pharmacies $3.37
Estimated New Prescriptions Filled in

299 ~Pharmactes ) mecca tse siete ieee ane erate 3,092,874
Estimated Prescriptions Refilled in

29 - Pharmaciesies sence aot oes ree oer 1,684,524 4,777,391)

Counties |

Average Number New Prescriptions Filled in |

21 Gtouteotmo0 let narmacles marries cate cherie iaterstons 16,691 !
Average Number Prescriptions Refilled in

D16so0utoteo0 met barmaciesn ean. aee seer aes 13,190 29,88

Average Price of Prescriptions
in 216 out of 507 Pharmacies $3.56
Estimated New Prescriptions Filled in
507: Pharmaciesiisrn sees eee ere oe etle ec ciee 8,462,337

THE MARYLAND PHARMACIS

A-H ROBINS

Donnagel”

it's
profit

plantin
time!

fd
+ ” s

Allbee with C i
MULTIVITAMING :

Each capsule contains: % MOE
Thiamine 4 J
_mononitrate (8B) 15mg 1500% §
Riboflavin (B:) 10 mg -834° {
Pyridoxine
hydrochloride (B.) 5 mg
Niacinamide 50 mg
Calcium pantothenate 10 mg
Ascorbic
acid (Vitamin C) 300 mg 1000®

100 CAPSULES

A++ROBINS:

“ae

i AlibeewithC

MULTIVITAMINS

30 CAPSULES
= AH ROBINS

ANNOUNCING |

z be 3 bs % ic ie 3 %,%, tP- “
“ : bd
; a
j en” , J
i ; if
: te : ao
ed Sa ae eS $
% £

‘buy now for bigger summer and fall profits

A. H. Robins announces money-saving deals on Allbee® with C
and Donnagel®. Allbee with C is the number one vitamin in its Suen,
class in drug store sales, and it also leads in drug store pur- Se or cl
chases with over 25% of the market. This isn’t surprising when
you consider that it’s the B-complex with C most often pre-
“ss scribed by the medical and dental professions. Almost one

‘million scripts are filled annually, and this doesn’t even
“include professional recommendations or over-the-
counter sales. More than one half of all Allbee with C
)

‘sales are OTC. You purchase and sell far more Allbee with C. ae
Isn’t it good business to also give it more facings and shelf space?
The Spring Deals run from April 1-May 28. Your Robins representative
will be around soon to discuss the deals and facings with you. With
Allbee with C and Donnagel you've got Deal Power!

A. H. Robins Company, Richmond, Va. A-H-)20B | NS
Put your facings where your profits arel

Estimated Prescriptions Refilled in

507m bharmactes mnie ntti cents seiteiisieie ler dear. 6,687,330 15,149,667
State
Estimated New Prescriptions Filled in
136 ME NALINACLES te) se rtres eiele cine tor vics taeterer penta apo.
Estimated Prescriptions Refilled in
(30m Pharmacleseuen aise ces cioteeite oe eee tche ake sts 8,371,854 19,927,065
Legislation

There were many Bills introduced in the 1970 ses-
sion of the legislature. However, three Bills are of im-
mediate interest to pharmacists and to the Board.

House Bill 1421

This Bill sought to increase membership of the
Board members from five to seven members, and remove
the geographical limitations to membership on the Board
and to have the per diem established by the Secretary of
Health and Mental Hygiene.

This Bill was not enacted.

Senate Bill 89

A pharmacist shall affix to the container in which
the medication is dispensed, when indicated by the pre-
scriber, a label showing the name and strength of medi-
cation prescribed, in addition to all other information re-
quired by law.

This Bill was enacted into law.
S.B. 89

AN ACT to add new Section 254A to Article 43 of the
Annotated Code of Maryland (1965 Replacement
Volume and 1969 Supplement), title “Health,” sub-
title “Commissioners of Pharmacy,” to follow im-
mediately after Section 254 thereof, to provide that
a label with the name and strength of medication
prescribed may be affixed to the container of any
medication sold or dispensed by a pharmacist on a
prescription issued by a doctor or dentist at the re-
quest of the doctor or dentist and to provide further
for a penalty for violation of the provisions of this
Section.

SECTION 1. Be it enacted by the General Assembly
of Maryland, That new Section 254A be and it is hereby
added to Article 43 of the Annotated Code of Maryland
(1965 Replacement Volume and 1969 Supplement), title
“Health,” subtitle “Commissioners of Pharmacy,” to fol-
low immediately after Section 254 thereof, and to read
as follows:

254A.

Whenever a pharmacist sells or dispenses any medi-
cations on prescription issued by a physician or a dentist,
he shall affix to the container in which the medication is
sold or dispensed, when indicated or requested by the
prescriber, a label showing the name and the strength of
medication prescribed, in addition to all other informa-
tion required by law. In listing the established or trade
name, the label shall conform to the name used by the
practitioner in his prescription. No person shall alter, de-
face, or remove any label so affixed so long as any of
the original contents remain. Any person failing to ob-
serve the provisions of this section is guilty of a mis-
demeanor, and upon conviction thereof, shall be fined
fifty dollars ($50.00). Pharmacists violating this section
shall be subject to disciplinary action by the Board of
Pharmacy.

SEC. 2. And be it further enacted, That this Act
shall take effect July 1, 1970.

Senate Bill 883 |

This Bill repealed several of our present statutes;
namely, the Narcotic Drug Act, Drug Abuse Control Act,
Unsolicited Mailing of Drugs, Possession of Barbiturates
and Amphetamines and in lieu thereof, a new sub-head-
ing known as Controlled Dangerous Substances.

This Bill was enacted into law.

In resume, this Bill provides for Definitions of drugs
covered therein; provides for four schedules of drugs,
registration of persons dispensing or handling drugs; pub-
lishing of schedules; record and inventory keeping; ad-
ministrating inspections; penalties, etc.

Because this Bill comprises some 31 pages and be-
cause some portions are vague and ambiguous, several
Attorney General opinions have already been requested
in order to seek clarification and guidance in the imple-
mentation of the Act. As soon as we receive clarification
of the interpretations, we shall proceed with dispatch to
make this information available to all persons concerned

or affected by the Act. |
Senate Bill 15, which was passed in the 1970 Ses-

sion of the Legislature, removes the special fund pro-
vision. This Board will function as a general fund agency
as of July 1, 1970.

The Board maintained membership in the National
Association of Boards of Pharmacy. The annual meeting
of the Association which was held in conjunction with
the American Pharmaceutical Association was held in
Washington, D.C. on April 12-17, 1970. The Board was
represented by Secretary F. S. Balassone and Morris R.
Yaffe.

The Board also maintained membership in the Con-
ference of Boards and Colleges of Pharmacy of the Na-
tional Association of Boards of Pharmacy, District Num-
ber Two, comprising the States of New York, New Jersey,
Pennsylvania, Delaware, Maryland, the District of Co-
lumbia, Virginia, and West Virginia. The annual meet-
ing was held in Wilmington, Delaware on October 2-4,
1969. Secretary Balassone was the official delegate of the
Board at the meeting.

Secretary-Treasurer F. S. Balassone was made _ the
official delegate of the National Association of Boards of
Pharmacy to the annual meeting of the Association of
Food and Drug Officials of the United States which was
held in San Francisco, California on June 14-19, 1970,
and also served as a member of the Committee on Drugs,
Devices, Cosmetics and Hazardous Substances.

Secretary Balassone served as a member of the
Awards Committee of the Central Atlantic States Associa-
tion of Food and Drug Officials of the United States and
attended the annual meeting in Ocean City, Maryland on
May 25-27, 1970.

Secretary Balassone attended the Decennial Conven:
tion of the United States Pharmacopoeial Convention
which met in Washington, D.C., April 8-10, 1970, repre:
senting the Association of Food and Drug Officials of the
United States.

A Tri Partite Committee was established to study
review and make recommendations regarding internship
which would make this experience more meaningful t
students. The Committee is composed of Mr. Frank

Block and Secretary F. S. Balassone representing the
Board, Dean William J. Kinnard and Dr. R. Shangray

THE MARYLAND PHARMACIS’

epresenting the School of Pharmacy, and Mr. Nathan
Gruz, Executive Director and Paul Freiman representing
the Maryland Pharmaceutical Association.

The Board maintained cooperative activities with
the State Department of Health and Mental Hygiene, the
School of Pharmacy—University of Maryland, the Mary-
land Pharmaceutical Association, the Baltimore Metro-

litan Pharmaceutical Association, Federal Bureau of
Narcotics and Dangerous Drugs, Food and Drug Admin-
istration, City, County and State Police.

Mind-Body Phrases Acknowledge

Psychosomatic Hlness

Psychosomatic illness has its origin in a patient’s
mind. However, such illness is very real, and according
to information from the Duke University Medical Center
division of psychosomatic medicine, patients have been
known to die as a result.

Many patients are unwilling to accept the fact that
emotions and stressful situations can play a part in bring-
ing on physical disability, the Center has found, and ask
the physician for a “cure,” rather than for the help they
really need.

Such “mind-body phrases” as “you make me sick”
or “he gives me a pain” are indicative that unconsciously
people recognize strong emotions can be reflected in physi-
cal illness.

Spm comm (cm ( cen ( con ( cs (cr (cms (cm (crn ( ce (cee (cee (cee (ome eee oon (rom (ee (oe ( ce (em lees eee lee (es (ean (een (ee (ee len (ee (ee (en (em

A Service of The Drug House, Inc. , i

MARCH 1971

The Drug House Reports Sales Increase

The Drug House, Inc., drug wholesaler with loca-
tions in Philadelphia, Trenton, and Newcastle, Delaware,
reports net sales of $33,957,676 for 1970, a gain of 2.8
per cent over 1969, and net income of $539,893, an in-
crease of 17.8 per cent.

TDH Chairman J. Mahlon Buck, Jr. attributes the
improvement “to more agressive merchandising and data
processing activity, together with increasing efficiency
and cost control throughout every phase of the company’s
operations.” Directors of TDH have voted to establish a
1214 cent semi-annual dividend, payable April 12 to
stock of record March 26.

Red Cross Rejects Marihuana Users

A recent blood drive at the University of Maryland
campus at College Park fell short of its goal, apparently
because it refused donors who smoked marijuana. The
drive wound up 136 pints short of its 900 pint goal after
Red Cross officials refused to take the blood of students
who had smoked even one marijuana cigarette.

Dr. Evan Stone, the district Red Cross director, said
the ruling was made because not enough is known about
the effects of marijuana. “If we’re going to have the
safest blood possible, then let’s live up to it,” he said. A
guard was stationed at the door to inform donors of the
rule. It was not known how many students were turned
away. A drive last November without restriction was
successful,

LET OUR COMPUTER WORK FOR YOU
With
WI be

i TIP TOP is a computerized procedure by which you are automatically supplied

J with a monthly statement of purchases for each of your charge account

! customers.

PLUS

! An immediate monthly (and annual) breakdown of their pharmacy purchases

of deductible items for income tax purposes.

For information, call or write:

THE DRUG HOUSE, INC.

1011 West Butler Street

i Philadelphia, Pa. 19101

i (215) 223-9000

i 1880 Princeton Avenue

I Trenton, New Jersey 08638

: (609) 396-5586

! 3069 Newcastle Avenue

Newcastle, Del. 17920

it (302) 655-7401

1 |) Sn) Sn) a) en) oe) ee) ee) ee) ) ee) Se) SS) en) SO) SO) SO) ) ) ) ) ) ) ) =) =) — ==) =) =) |) =) 3) 5) 3])3])3])35)3)2])=>)=>)=)=)=)=)—=)
3

MPhA. Executive Committee

Meetings

The MPhA Executive Committee meetings run

about 3 to 4 hours, sometimes longer. The following are
highlights from the 1971 meetings.

10.

ik Fe

January 7, 1971

Communications included acknowledgement for fur-
nishing speakers on “Drug Abuse” and for assistance
to the Baltimore City Public Schools. Receipt of
regulation by State Department of Health and Men-
tal Hygiene placing sales of needles and syringes by
pharmacists only.

Report on Testimonial Dinner for John Crozier, re-
tiring general manager of Calvert Drug Company.

Review of 1970 financial statement by the Treasurer,
indicating deficit and need for more effort particu-
larly in the areas of dues and sustaining member-

ship.

Executive Director reported on efforts resulting in
completion of MPhA affiliation with APhA. Serv-
ices by APhA to affiliated states were detailed.

A report of two-day meeting at APhA of affiliated
state association executives in Washington was made.
Major problems facing pharmacy were reviewed in
depth. Mr. Gruz reported he emphasized to APhA
the critical need for pharmacy to develop ideas and
programs for pharmaceutical service for incorpora-
tion in the national health insurance plans that are

being proposed.

Executive Director reported on his other activities,
including: Medicaid, convention planning, legisla-
tive conferences with medical society and other
health professions, Maryland Pharmaceutical Foun-
dation, legislator contacts, BMPA Banquet.

The Membership Committee report indicates an in-
crease in total membership to 766 versus 745 for
1969. There was an increase in the salaried pharma-
cist category and a decrease in the owner-managers.

A report was made on the Simon Solomon Pharmacy
Economics Seminar’s excellent program, but a defi-
cit was entailed.

Reports on the Diabetes Detention and Children’s
Dental Health Week were made.

The referral of patients by physicians to certain
pharmacies was discussed and referred to Joint Phar-
macy Liaison Committee with the Medical Society.

“The Principles and Guidelines for Hospital Phar-
macy,” prepared with representatives of MPhA,
Board of Pharmacy and MSHP were endorsed. An
appropriation was made to subsidize publication for
distribution to institutions.

A legislative report was made on proposals for The
Board of Pharmacy, a Commission on Pharmacy
Discipline and a new state Food, Drug and Cosmetic

Act.

12.

13.

14.

15.

16.

The Maryland Pharmaceutical Foundation assumed
financial responsibility for The Swain Model Phar-
macy at the School of Pharmacy. Dr. Samuel Fox,
President, is working on a solicitation campaign.

A report on The National Pharmacy Insurance
Council by the MPhA representative was made on
the universal Rx form, dual fee system, medication
record cards and formulary, and pharmacy identifi-
cation number.

A meeting with the State on the basis of computing
“cost” under the Medicaid Program was held.

State prepaid programs and health centers associ-
ated with hospitals was reported on.

Delegates to the APhA House of Delegates were
approved: Anthony Padussis, Nathan Schwartz, Syd-
ney Burgee, Mary Connelly and Nathan I. Gruz.

The need to delineate the role of MPhA in group
practice and non-profit health organizations was pro-
posed.

February 4, 1971

The President reported on two-day meeting of APhA
Committee on Professional Relations, which includes
a recommendation recognizing the use of supportive
personnel (technicians). A task force on this has
been set up by the School of Pharmacy.

A report was made on the NARD Legislative Con-
ference in Washington.

MPhA is cooperating with Planned Parenthood.

. An appropriation was made for a gift to John

Crozier at his testimonial dinner.

Executive Director reported on Medical Assistance
Advisory Committee meeting, which is working on
reorganization. Other activities included: Inaugura-
tion of Governor, legislative contacts; conference on
survey on “cost of filling an Rx” and other third
party payment plan matters; meeting with other
health professions on legislation; MPhA Convention
and trip; sustaining membership; Poison Preven-
tion.

Plans for the 1971 Convention and reconvened ses-
sions in Jamaica were presented.

Public Information Committee reported on Poison
Prevention and Venereal Disease Education cam-
paigns.

A new prepayment, “Prescription Drugs, Inc.” was

reviewed.

. A report was made on Medicaid, Jaffe Associates

and Paid Prescriptions plans.
Legislative Committee report was approved.

Continued membership of MPhA as an affiliate of
NARD was endorsed.

THE MARYLAND PHARMACIST

Information on

DRUG INTERACTION

important to every pharmacist

se DY
Daniel A. Hussar, Ph.D.

More than a mere compilation of reported drug interactions, this
booklet provides a fuller understanding of how and why drug interactions
occur. Its purpose is to help you anticipate such situations and to
aid you in your role as the physician’s advisor in the prevention and

management of drug interaction problems.

This booklet reflects Lederle’s continuing commitment to

support the efforts of pharmacy in gathering and

disseminating information regarding drug interaction.

Mr. Gale Smith,

Manager, Customer Relations
LEDERLE LABORATORIES
Pearl River, New York 10965

Pleasesend mea copy of DRUG INTERACTIONS —
A REVIEW OF THE MECHANISMS BY WHICH
THEY DEVELOP by Daniel A. Hussar, Ph.D.

NAME

ADDRESS —

CL) eee ee eee SA] ee mene 7 1

LEDERLE LABORATORIES
A Division of
American Cyanamid Company

Pearl River, New York 10965

382-1

LAMPA News

LAMPA Goes to the John A. Crozier

Testimonial Dinner

Thursday evening, February 18, 1971 was indeed a
night to remember—not only for John and Nan Crozier,
but for every one of the 428 who attended the testimonial
dinner given in their honor at the Blue Crest North in

Pikesville, Maryland.

The guest list ran the gamut from fledgling manu-
facturer’s representatives to the president of the Federal
Wholesale Drug Association. Pharmacists, both active and
retired, were very much in evidence. Represented were
those in community service, in education, in government,
and in publishing. The allied drug trades were also pres-
ent. There were friendly competitors and close relatives
attending along with fellow Calvert Drug Company em-
ployees and the son of one of the founders of the com-
pany. Naturally, LAMPA ladies were very much around
—prettying up the occasion in their “mixi” fashions
(““mixi’—meaning pants dresses, midis, maxis, peasant
style and at-the-knee lengths ).

Since a testimonial dinner is almost synonymous
with awards, John was presented with many interesting
gifts. The Federal Wholesale Drug Association, of which
John is the only person to have served two terms as presi-
dent, gave a plaque appointing him an honorary director,
for life, in that organization. The Governor of our State,
through a representative, conferred a Certificate of Dis-
tinguished Citizenship. The Mayor of Baltimore City also
recognized the event by issuing a commemorative letter.

Diamond studded gold cuff links and tie tac were
presented by the Maryland Pharmaceutical Association
and a diamond studded, gold, past president’s pin was
presented by the Travelers Auxiliary of the Maryland
Pharmaceutical Association. The Baltimore Metropolitan
Pharmaceutical Association honored John with a large
crystal compote as a “token of our recognition of his ac-
complishments and contributions to the profession of
pharmacy.”

A framed scroll of appreciation was given by the
Alumni Association of the University of Maryland School
of Pharmacy. A light note was injected into the presen-
tations by the Ladies Auxiliary of the Maryland Pharma-
ceutical Association when they conferred honorary, life
membership in their group. LAMPA also gave a host
jacket, as well as providing the Guest Register and a
Memento Book of the Testimonial. U.S. Savings Bonds in
various denominations were presented by the Wedgewood

Club, the Arex Club and the Calvert Drug Company.

Unique, insofar as they came from competitors, were
gifts from the Loewy Drug Company—a handsome plaque,
and a silver bowl from the H. B. Gilpin Company. The
Calvert Board of Directors gave John a beautiful plaque.
A large framed portrait, a gift from all those attending,
climaxed the evening’s presentation. Paramount Photo
Supply, who took pictures of the evening's festivities,
will present a photo album of the pictures at a later date.

Thorughout the evening, guests were reminiscing—
each had their favorite anecdote—a kindness performed
an unsolicited favor—a decision that went well. Words
like dedication, judgement, friendship, work, patience

New Developments

In Drug Abuse
‘‘Shot Glass’”’ Pipes

Shot glass pipes are replacing hashish and water
pipes, reports the Rotterdam, N.Y., Police Department.
An ordinary shot glass is covered with a piece of alumi-
num foil, and small holes are put into the foil with a
toothpick. A larger hole is made in the foil at the rim
of the glass, and the pipe is complete. A small amount
of hashish is burned on the foil over the holes. The
smoke is then drawn down into the glass and out the
larger hole. After use, the foil is neatly thrown away,
leaving no residue as evidence.

Glassine Envelopes

Glassine envelope production in sizes 144 x 14 and
134 x 1%4 inches has been discontinued by one of the
largest manufacturers, as the result of Congressional hear-
ings.

Parrot Food

Officers of the Portland Oregon Police Department
had noticed over a period of months that youngsters
seemed to be buying quite a bit of parrot food. Pur-
chases from various pet stores in the area by two officers
of the narcotics detail showed the presence of marihuana
seeds, not sufficiently baked to prevent germination. The
pet food suppliers were contacted and, needless to say,
the number of parrot lovers took a drastic drop!

Narcotic Drug Law Arrests Increase
According to the FBI’s 1969 “Uniform Crime Re-

ports,” representing voluntary statistical reporting from
city and county police departments, total arrests in-
creased 24.1% from 1960 to 1969, whereas narcotic drug
law arrests increased 491.9% during this period. The
age breakdown for the arrests is more startling. Tot
arrests for persons under 18 increased 105.4% fro
1960 to 1969. During this same period, arrests for nar-
cotic drug law violations in this age group increase

2,453.2%.

Further analysis reveals that narcotic drug law vi
lations of males under 18 increased 2,281.1% while ar
rests of females increased 3,468.0%. Narcotic drug la
arrests for persons under 15 years of age showed an in-
crease of 27.0%. :

were repeated many times. You cannot summarize 44
years of unselfish devotion quickly, or easily.

Some of the guests travelled long distances for the
sole purpose of attending the Testimonial, but all wer
of one mind—they wanted to and were happy to be a
the John A. Crozier Testimonial.

—Ann Crane
Communications Secretary

THE MARYLAND PHARMACIS

enlarge your service
with enlargements

5x7’s and8x 10's are fine. But the bigger the enlargement,
the bigger you make it. In profits. In customer satisfaction.
Large prints are easy to sell. They’re in demand as wall
portraits, gifts, for framing as wall decor... you name it.
When it comes to big blow-ups, Berkey does it all. 5 x 7,

8x 10, 11 x 14 and larger. In color, up to 11 x 14. Black and
white up to 16 x 20. We even make 11x 14 proofsheets |
from ultra-miniatures. Berkey enlargements are better.
because it’s a specialty with us — handled only by experts.
Compare our color rendition and sparkle. 5 x 7’s and

8 x 10’s returned in a frame at no extra cost. You — and your
customer will appreciate Berkey’s better quality and prompt
service. Just drop the enlargement orders, regular and
over-size into the Berkey bag. We’ll give them the Berkey
treatment. Custom-care printing rigidly checked and
double-checked by the ova quality inspectors in the
business.

Berkey can do things for you that nobody else does,
because nobody else can. And “one supplier, one bill” will
simplify bookkeeping for you too. Call or write your nearest
Berkey Laboratory now for the complete schedule of
Berkey services and prices.

| ~] Berkey Film Processing
ed of Washington, D.C.
3701 Mt. Vernon Avenue Alexandria, Virginia 22305
(703) 549-7500

W Berke
Photo Inc.

SL.

Hospital Pharmacy
Section

Nursing and Pharmacy —
Towards Better Patient Care

by Mrs. Jean T. MacVicar,
Director of Nursing, University Hospital, Baltimore

Presented at the Fifth Annual Hospital Phar-
macy Seminar of the Maryland Society of Hos-
pital Pharmacists at Ocean City, Maryland on
June 13, 1970.

The knowledge explosion is bringing the health pro-
fessionals to a time of interdependence. The public is
concerned with rising hospital costs and is demanding
improvement in health services. Students in the health
professions want to be involved in service to the patient
and want to practice what they are being taught.

There are three prescriptions offered by behavioral
scientists which can be put into practice which will en-
able us to move toward our goal of improved patient care
—as well as improved utilization of our scarce and ex-
pensive resources of knowledge—the pharmacist and the
nurse.

The first one is “‘stretching”—not adding more in-
significant detail but rather permitting the individual to
stretch his intellect. I believe we still have stereotyped
images to overcome—the pharmacist is one who puts a
medication in a small bottle from a big one—the nurse
takes the pill from the bottle and administers it without
any thought. I wish I could say this was funny and not
at all true—but I’m willing to admit as a nurse I’m sure
this is practice—not a high level task for either member
and certainly will not challenge or “stretch” the intel-
lect. In order to change these stereotyped images we must
strive to have students of both disciplines learn as stu-
dents what goes into the educational experiences of each.

The second prescription is participation. If an indi-
vidual is involved in decisions which affect his practice,
he is more likely to be concerned with the results and we
increase the probability he will follow through. If we
wish to bring to bear upon the patient the best each has
to offer, it is best accomplished by participative action
rather than each member acting independently of the
other. Discussion generates ideas. But—to be effective for
the patient—the discussion should be at the operational
level with the nurse and the pharmacist discussing a spe-
cific patient. My philosophy as Director of Nursing and
the philosophy of the Director of Pharmacy means noth-
ing to the recipient of the health service—it is at the
patient unit level where the objectives of the organiza-
tion are met...

The patient benefits when those responsible for his
care are interested and enthusiastic about their work .. .
If those having direct contact with the client are en-
couraged to participate the results should prove beneficial
not only to the patient but also to employers who must
find ways of retaining a valuable human resource.

The third prescription recommended by the behav-
ioral scientists has to do with well defined objectives.
Naturally, the objectives of a department must be met
but the subordinate goal—patient care—gets lost some-
where in the bureaucratic structure of many of our hos-
pitals. We are not dealing with a product where the in-
put—output can be neatly programmed. The variables
we deal with are infinite—not only must the hierarchy
of needs— ... be met but also the hierarchy of needs of
the individuals responsible for providing that care—they
are identical.

In conclusion—the objectives of any organization
are measured at the extremity—in the Hospital the ex-
tremity is the patient in the bed, in the Out-Patient-De-
partment, or the Emergency Room. There are ways not
yet explored, in addition to on-going attempts, by which
we can introduce quality into the services we perform.
It is the responsibility of the leaders to anticipate chang-
ing needs—to be creative—to stimulate—and to influ-
ence. To go back to Plato—that which is honored—will
be cultivated—but—we cannot be passive—cannot wring
our hands and decry the fact that the elusive “they” do
not understand. “Together,” I believe we can make the
necessary impact.

ASHP Staff Reorganized

The Headquarters staff of the American Society of
Hospital Pharmacists has been reorganized, according to
an announcement made recently by Joseph A. Oddis,
Executive Director. The old staff structure consisted of
seven eee reporting directly to the Executive
Director. These departments have been consolidated into
three Bureaus under the new organization. In addition,
three specialized functions report directly to the Execu-
tive Director.

The new staff structure consists of the Bureau of
Administrative and Membership Services; the Bureau of
Communication and Publication Services; and the Bureau
of Professional and Scientific Services. Functions report-
ing directly to the Executive Director are the Office of
Controller, Office of Legal Counsel, and the Executive
Assistant.

Staff reorganization became necessary because of the
tremendous growth of the ASHP and its headquarters
services. Since 1962, the year of the last staff re-organiza-
tion, ASHP membership has increased from 3,200 to
nearly 7,000; the Society’s budget has jumped from
250,000 dollars to 1.3 million dollars; the number of
ASHP Affiliated Chapters has increased from 56 to 77;

and the headquarters staff has grown from 10 persons —

to 40 persons. Also reflecting this growth, the ASHP

THE MARYLAND PHARMACIST

urchased a six-story headquarters office building in
eiasds: Maryland in April, 1970.

The American Society of Hospital Pharmacists is
the national specialty society of pharmacists practicing
in hospitals and related institutions.

ASHP Board of Directors Meet

Preparations Made for ASHP House of Delegates
Meeting

The ASHP Board of Directors, at its January 28-29
meeting, voted to continue the Active Membership status
of Immediate Past President Winston J. Durant through
the 1971 Annual Meeting. Durant recently accepted an
industrial position.

By unanimous vote, the Board of Directors renomi-
nated Milton W. Skolaut for a three-year term as Treas-
urer. Mr. Skolaut is former Chief of Pharmacy at NIH
and a past president of the Maryland Society of Hos-
pital Pharmacists.

Hospital Pharmacy Statistics

Based on licensure data for the calendar year Jan-
uary 1, 1969 to December 31, 1969, the National Asso-
ciation of Boards of Pharmacy has published the book-
let, Licensure Statistics and Census of Pharmacy. The
booklet includes figures on the total number of hospital
pharmacies and hospital pharmacists; however, the accu-
racy of these figures must be questioned since in four

states, ye bao, pharmacies are not registered by the
board of pharmacy but by some other state agency.

The NABP booklet says that out of 55,719 pharma-
cies in this country, 4,617 are hospital pharmacies; and
that out of 106,801 registered pharmacists, 11,001 are
hospital pharmacists. (Data from the 1970 Guide Issue
of Hospitals indicate that there are over 5,600 hospitals
with pharmacies attended by either a full-time or part-
time pharmacist; or about 1,000 more than indicated in
the NABP statistics.) NABP figures on the number of
hospital pharmacists probably have greater accuracy since
hospital pharmacists are listed by NABP even in those
four states where hospital pharmacies are not registered
by the state board of pharmacy.

How many hospital pharmacists really are there in
this country? There are probably more than the 11,001
reported by NABP. ASHP has estimated the number to
be 15,000, which is not unrealistic since American Drug-
gist estimated the number to be 13,566 in 1968 and
HEW’s Bureau of Health Professions Education and
Manpower Training estimated the number to be 13,600
in 1969.

Dr. Blomster Elected ASP Vice President
Dr. Ralph N. Blomster of the University of Mary-

land School of Pharmacy was recently elected Vice Presi-
dent (President elect) of the American Society of Phar-
macognosy.

The 400 member American Society of Pharma-
cognosy will install Dr. Blomster at its annual meeting
in Washington, D.C. in September.

a a ms em (wn (wn (me (me (mw (me (we (we me (ae (me (ee (ce (cm (we we (me (wm (ee (a (we (em (a (= (ee (ees (es (ea

Be Smart!

Think Smart!

PR LL A LL PL CL CL CL Ce PL me Py (Cf RY my Rene CL

Stock the One and Only—
Original “SAFETY TIPS”

Always Sell Them !

Smart Users Ask For Them By Name 1
i

AMERICAN HYGIENIC CO. 1
111 S. Paca Street, Baltimore, Md. 21201 1
727-8328 4

Represented by H

IRV NORWITZ Phone 727-8328 H

rs
19

MARCH 1971

THE MARYLAND PHARMACEUTICAL ASSOC.
Playcation and ONLY 10

CMe RESERVATIONS

MAY 18 THRU MAY 23, 1971

MAY 18

MONTEGO
BAY,
JAMAICA

MAY 18
TO
MAY 23

MAY 23

LEFT
... MAKE YOURS NOW!

Glow in a sunshine world of complete vacation activities . .. revel in a
magnificent pool, bask in the sun, plunge in the crystal-clear surf, sail,
snorkel, water ski, skuba dive, deep sea fish . ... enjoy golf, play shuffle-
board, explore the ¢harming Island, shop for exotic things in an international
bazaar or “drive” your cares away on the hotel’s sporty putting green.
Freeport prices on Perfumes, Linen, Cashmere Sweaters, Bone China and
Porcelain, Watches, Crystal, Silver, Diamonds, Pearls, Cameras, Equipment.

When the sun goes down the magic of Jamaica nightlife takes over with
gourmet dining, dancing to the Calypso beat of native drums or to rhythmic
Latin and American music.

Just let your mood set the pace from “dawn to yawn” for an unforgettable
vacation that dreams are made of.

In addition to the many, many resort activities available, we have included:
Multi-course English breakfast each morning in the hotel.

Romantic candlelight dinner each evening in the elegant dining room,
offering a wide selection of taste-tingling delights.

All good things must come to an end... and so must your delightful
“playcation” in Jamaica. On checking out . . . before leaving you will be

responsible only for gratuities and personal charges.

Transportation will be provided from the hotel to the airport for your
homeward journey via non-stop charter flight, enjoying a delightful Dinner
and continuous complimentary bar en route.

You will alight from the plane relaxed and refreshed after six wonderful
days in the sun enjoying the best that Jamaica has to offer.

FOR INFORMATION AND RESERVATIONS

CALL MPHA - 727-0746

or NATHAN

269-0212
or ALDER SIMON

747-3400 (Day or Nite)

SCHWARTZ, Chairman $ | PER
1-956-3300 4,2)o COUPLE

plus gratuities

~ SELSUN BLUE

the anti-dandruff shampoo

It’s elegant. It’s ethically promoted.
And it keeps her hair in the clouds.

It isn’t often that a product
combines the best of two pos-
sible worlds-——the effectiveness
of a professional product with
the elegance of a cosmetic
specialty.

It’s even rarer when that product is
offered only through ethical drug
channels. On both counts, Selsun Blue
is an exception.

TM—Trademark.

It’s an elegant, effective product that
physicians and pharmacists are highly
recommending. And customers love the
way Selsun Blue billows up into clouds
of gentle, luxurious lather . . . leaves
their hair sparkling clean . . . while
helping to control dandruff symptoms.

We hope you're getting the =)

business that’s rightly-—and
exclusively —yours. 102094

Maryland Board
of Pharmacy News

Pharmacy Changes

The following are the pharmacy changes for the
month of January:

New Pharmacies

Rosewood State Hospital Pharmacy, Norbert G. Las-
sahn, Pharmacist, Owings Mills, Maryland 21117.

Thrifty-Wise, Arthur Solomon, Pres., 10335 Reist-
erstown Road, Garrison Forest Shopping Center, Owings
Mills, Maryland 21117.

Dart Drug Corporation, Maryland City, Herbert H.
Haft, Pres., 3445 Fort Meade Road, Laurel, Maryland
20810 (A. A. Co.).

Peoples Service Drug Store, Inc., No. 244, W. E.
Pannill, Pres., La Plata Shopping Center, La Plata, Mary-
land 20646.

C and P Professional Pharmacy, Alvin Perkins,
Pres., 8605 George Palmer Highway, Seat Pleasant,
Maryland.

No Longer Operating As Pharmacies

Read’s, Inc., Arthur K. Solomon, Pres., 202 West
Main Street, Salisbury, Maryland 21801.

Peoples Service Drug Store, Inc., No. 251, W. E.
Pannill, Pres., 3401 Fort Meade Road, Laurel, Mary-
land 20810.

Jefferson Pharmacy, Eugene Jacobs, 2491 East Jef-
ferson Street, Baltimore, Maryland 21205.

Grosvenor Lane Nursing Home—Pharmacy, Leslie
Berman, Pres., 5721 Grosvenor Lane, Bethesda, Mary-
land 20014.

House in the Pines—Pharmacy, Roger C. Lipitz,
Pres., 2525 West Belvedere Avenue, Baltimore, Mary-
land 21215.

Change of Ownership, Address, Ete.

Burriss and Kemp, Joseph W. Loetell, Jr., Pres.,
2200 Greenmount Avenue, Baltimore. Maryland 21218.

Federal Register Notice — Methadone

Methadone hydrochloride has been approved for use
in suppressing the narcotic abstinence syndrome in the
course of withdrawal therapy for narcotic dependence.
Other approved indications include the belief cf moderate
to severe pain and for the control of cough in those
patients in whom antitussives with less abuse liability
have proven indequate. .

According to FDA regulations, methodone is only
approved for short-term detoxification, generally lasting
10 days or less. The use of methadone in long-term main-
tenance programs for heroin addicts is still investigation-
al and subject to the conditions published in the June 11.
1970 Federal Register.

Pension & Investment
Associates of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)
HR-10.. Plans (Sole Proprietor-Partnerships )

Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

ee SS eee

The United States of Mangini

MANGINI & ASSOCIATES, INC.

4850 W. Belmont Ave., Chicago, Ill. (312) 282-8181
= ape 11722 Studt St., St. Louis, Mo.
2760 W. Market St., Akron, Ohio
575 Savin Ave.,West Haven, Conn.
5501 Cherokee Ave., Alexandria, Va.

THE MARYLAND PHARMACIST

There’s a lot more going for you at LOEWY

a Shectro MEDICAL EQUIPMENT FRANCHISE

can make your store one of the most sought out sources for
equipment and service in America

As the local Spectro Division in your area, we not only offer the unusual advantages

of one of America’s largest drug wholesaling operations, but those of the country’s most
comprehensive medical equipment distributor, producer and servicing organization. As is
being demonstrated right now in Spectro markets throughout the eastern seaboard, physical
aids for the convalescent, the handicapped and the invalid can be the most significant

new profit source available to the pharmacy today. We are uniquely well endowed to
provide you with professional administrative and technical direction, the widest

available range of product, application counsel and in-home servicing.

FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY

Call any time, day or night. An automatic order
taker will record your after-hours order.

Call IV 5-8105 for order taking. (301) 485-8100 for the office.

LOEWY DRUG COMPANY

DIVISION OF
ww)

6801 Quad Avenue, Baltimore, Md. 21206 Tel.: (301) 485-8100 2% Shectvo Industries, Ine.
A

tows?

Wholesale Drug Companies
Offer Service to Pharmacies

Medical Equipment Unlimited

This is the second in a series of articles describ-
ing some of the services that the full-line, full-
service drug wholesalers can offer to assist the
pharmacist in establishing and maintauung a
successful operation in the face of rising com-
petition.

Medical Equipment Unlimited (MEU) operates as
a division of Spectro Industries. The program, offered
through Loewy Drug Company, provides the franchisee
with complete training in all aspects of medical equip-
ment. The prime purpose of the franchise is to establish
outlets for the distribution of medical equipment for the
home and institutional use.

Medical Equipment Unlimited furnishes the follow-
ing services:

1. the franchisee is furnished with a fitting room
equipped with an examination table and proper equip-
ment necessary to adjust and fit orthopedic appli-
ances.

2. a franchise agency sign.

3. the franchisee is given a complete course in home
care treatment covering I.P.P.B. breathing machines,
whirlpools, hospital beds, wheelchairs, traction, con-
valescent supplies, and orthopedic appliances.

4. the personal training course covers all aspects of
fitting cervical braces, sacro-lumbar belts, trusses,
elastic stockings, leg braces and arch supports.

5. advertising in local newspapers and the availability of
promotional materials to be used by the individual
franchisee.

6. the franchisee is taught how to detail physicians, and
how to operate a medical rental business.

heavy equipment, such as a hospital bed, is delivered
directly to the patient’s home.

For more information about the government ap-
proved fitting school, or other aspects of the MEU plan,
please contact the Loewy Drug Company.

Aleohol Abuse Institute Plan Advances

The House Commerce Committee approved a $300
million authorization to create a national institute on
alcohol abuse within the U.S. Public Health Service.
Health officials told the committee that an estimated 18
million Americans have an alcohol problem, and the
problem costs United States industry about $4 billion
annually,

(For a free copy of a full-color booklet on alcohol
abuse—“The Alcoholic American’—write to the Mary-
land Blue Shield Public Relations department, 7800
York Road, Baltimore, Maryland 21203).

Prince George’s-Montgomery County
Pharmaceutical Association Meeting,

February 9, 1971 |

See ee ae
en

Dr. David A. Blake, Chairman of the Department of
Pharmacology, University of Maryland, School of Phar-
macy, addressed the group on “Drug Interactions.” Left
to right: MPhA President-Elect Nathan Schwartz; Dr. —
Blake; Rudolph F. Winternitz, President and Martin
Hauer, Vice-President and Program Chairman, Prince —
George’s-Montgomery County Pharmaceutical Association. —

Handbook of Non-Prescription Drugs

New, Revised Edition Now Available

The new, revised 1971 edition of the Handbook of
Non-Prescription Drugs of the American Pharmaceutical
Association is available for immediate order.

The new 202-page Handbook is 20 percent larger
than the previous (1969) edition. Bound in a light tan
hard cover, it contains 31 chapters, each devoted to a_
specific class of home remedies. It includes the formulas
of more than 1,000 different brand-name products in al-
most 1,200 dosage forms.

In addition to a cross-reference product index, there
is an index of nearly 300 manufacturers, 76 pages con-
taining tables and charts of products and a score of
medical illustrations and scientific graphs.

The Handbook is available at $6.50 per copy from
the Order Desk, American Pharmaceutical Association,
2215 Constitution Avenue, N.W., Washington, D.C.
20037. Orders under $10.00 must be accompanied by
payment.

Bookoff and Greenfeld Lead Charities
Campaign

Pharmacists Morris Bookoff and David D. Green-
feld are Co-Chairmen of the Pharmacists’ Division of
the 1971 Campaign of the Associated Jewish Charities
and Welfare Fund. Assisting them on the Steering Com-
mittee are: Jack Cohen, Samuel Lichter, Max Mendel-
sohn, Irvin Norwitz, Earle Falck, Richard Plotkin, Frank
Block, Sam Block, Ronald Lubman, David Pearlman,
David Rombro, Israel Ruddie, Irwin Epstein, Robert —
Kabik, Alvin Rosenthal, Kurt Sacki and Simon Solomon. :

THE MARYLAND PHARMACIST

_ _.. Reading
iS Still the fas

to program the
human

brain.

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
vage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for
the spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

Ses

estW

test way

\apeanenn PIPES,

—_

shy

Maryland News Company is proud to be your area's
prime source of fine reading material. We keep pace
with consumers’ reading pleasure by constantly supply-
ing your racks with current reading material that sells.

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

Washington Spotlight For

Pharmacists by APhA
Legal Division

Determination of Standard of Care

The Michigan Supreme Court recently applied the
national standard of ‘‘routine care’’ instead of the “‘local-
ity rule” in a medical malpractice case.

An expert medical specialist offered testimony as to
the routine, nationwide use by pediatricians of a standard
procedure to diagnose and treat PKU. His testimony was
held admissible in a suit involving the failure of a De-
troit pediatrician to use such a procedure with the re-
sultant deterioration of the condition in a stricken child.
Such a procedure was not a common practice among De-
troit area pediatricians at the time the suit arose.

The locality rule, widely used to establish standard
of care, set the standard care at the level of care generally
provided by physicians within a certain geographical area
and excludes testimony by experts as to the standard of
care in other areas.

The Michigan Supreme Court, however, ruled that
the expert witness was qualified to testify concerning the
standard of practice of pediatricians generally and ac-
cordingly reinstated the jury’s verdict for the plaintiff
child.

The court reasoned that where a person holds him-
self out as a specialist, he is obligated to perform with
that degree of skill and knowledge possessed by physi-
cians who are similar specialists in the light of present
day scientific knowledge. Public reliance upon the spe-
cialists skills and the specialists knowledge are not lim-
ited to the geographic area in which he practices. The
court held that the standard of care for a_ specialist
should be that of a reasonable specialist practicing medi-
cine in light of present day scientific knowledge. Thus,
geographical circumstances should control neither the
standard of a specialist’s care, nor the competence of an
expert’s testimony.

The move by several states away from the “locality
rule” has implications for pharmacists as well, particu-
larly with regard to the use of patient record systems. As
these systems to detect drug interactions become more
widely used, pharmacists who do not utilize these systems
will run an increased risk of failing to meet the standard
of care which may be required by a court such as the
Michigan Supreme Court which looks beyond the stand-
ard of care in the community. Thus, pharmacists who
argue that they do not want to institute these patient
record systems for fear of potential liability, may find
themselves liable as a result of not having them.

A Guild is a Union

The National Labor Relations Board recently de-
cided that a pharmacists “guild” is qualified to act as
the collective bargaining representative of employed phar-
macists. The employer had contended that the guild had
a “conflict of interest” which barred it from being the
representative. The employer based his argument on the
guild’s past affiliation with a Barbers union which per-

mitted employer membership. The “guild” had also
elected employers to various guild offices.

The NLRB pointed out that “generally, a potential
conflict of interest disqualifies a labor organization when
there is an innate or proximate danger that the interests
of the employees will be subordinated to factors which
are not germane to the employer-employee relationship.”
The Board found, however, that no such danger existed
in this case since the employer members had resigned, a
slate of employee pharmacists officers had been elected
and the Constitution and Bylaws amended to make regu-
lar membership open only to employed pharmacists. The
NLRB ordered an election to be conducted.

Members Resignation no Bar to
Disciplinary Action

The U.S. Court of Appeals for the District of Co-
lumbia recently held in a maritime case that a shipper
may not avoid the consequences of its acts by resigning
from its shipper’s conference before a decision to punish
it has been reached. In this case, the member shipper
resigned prior to the adoption of self-policing procedures
by the conference. The offense, however, occurred prior

<p
Zor? DATA,
pp ANS ABOur
WARMACEUTICAL rTk

ROLE IN THIRD PARTY PAYMENT PLANS

THE MARYLAND PHARMACIST

Mr. Pharmacist -

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4, Salesman inventory control

To get the complete story—call collect [301] 243-4439

PARAMOUNT PHOTO SERVICE

3024 Greenmount Avenue
Baltimore, Maryland 21218

MARCH 1971

to the resignation. The shipper argued that the retroac-
tive application of the procedures would amount to
punishment for conduct that was previously not punish-
able and make it answerable to a private penal system to
which the shipper was not a party.

The court decided that a shipping conference’s effec-
tiveness depends to a large extent upon its ability to po-
lice its own members. To permit an individual shipper,
by exercising an option of resignation, to escape con-
ference action would negate completely the conference
system’s effectiveness.

Applying this principle to disciplinary actions by
professional associations, it is apparent that an association
can proceed against a member who resigns after these
proceedings have been instituted against him. The disci-
plinary mechanism of a voluntary professional association
would be totally ineffective if resignation could act as a
bar to the completion of those actions which were com-
menced against an individual while he was a member.
This is especially true in light of due process considera-
tions which require advance notification of the pending
procedures to the accused member.

Current Good Manufacturing Practice
Regulations

A proposed requirement, in the federal regulations,
governing the good manufacturing practice for drugs,
which would have required bioavailablity information,
was deleted from the final regulations.

Various manufacturing groups had objected to this
proposal on the basis that adequate methods do not exist

to make such testing practical and meaningful. It was
also pointed out that although the development of such
information for all drugs is necessary and desirable, this
requirement has been deleted and will not be restored
until appropriate methods for making and interpreting
such determinations can be widely developed and _ veri-

fied.

National Baby Week—April 22-May 1

National Baby Week is an ideal opportunity for
pharmacies to emphasize their “Baby Departments.”
Items such as nursery ware, infant foods and related
products can be featured. Display material and promo-
tional aids are available from many manufacturers.

Headquarters for

PHOTO-OFFSET PRINTING MAILING
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

Loyalty is a

love affair!

In Maryland you are first and foremost in our

hearts and mind, Why? Because Barre-National is the
last broad-range pharmaceutical manufacturer owned
by Marylanders.

We're “home folks” with a great sense of loyalty.
And we love to promptly service your needs of OTC
SPECIALTIES, TABLETS & CAPSULES, SUP-
POSITORIES, WET PACK, DRY PACK, LIQUID

PHARMACEUTICALS, OINTMENTS, INJECT.
ABLES, OPHTHALMIC SOLUTIONS. Give us a try.

BARRE - NATIONAL DRUG CO., INC.

4128 HAYWARD AVENUE @ BALTIMORE, MARYLAND 21215 ® PHONE: 542-5272

THE MARYLAND PHARMACIST

Offering Independent Pharmacies...

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up
to making your best source of supply,
THE

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

First name in ice cream

IC E G REAM for over a half-century

675-6000

Researchers Find Gases in
Aerosol Sprays can be
Dangerous

The gases used as propellants in aerosol sprays may
affect the heart and lead to sudden death in certain cir-
cumstances, researchers have found. They suggest that
these findings may explain unexpected deaths among
youths who turn on by inhaling these gases deliberately
and among asthma patients who use brochiai sprays ex-
cessively.

George J. Taylor, IV, and Dr. Williard S. Harris con-
ducted this study at the University of Illinois Hospital in
Chicago. Their research was supported in part by the
NIH National Heart and Lung Institute.

In studies with laboratory animals, the researchers
first exposed groups of mice to the propellant gases used
in aerosol sprays. When they then asphyxiated these ani-
mals markedly reducing available oxygen for less than a
minute, they found that the mice’s sinus rate (the heart’s
own pacemaker) slowed and that the mice quickly de-
veloped atrioventricular block. Either or both of these re-
actions slowed or stopped the heartbeat.

By contrast, in groups of control mice who were not
exposed to the sprays but were asphyxiated in the same
way for 4 minutes, their heartbeats increased in response
to the lack of oxygen. The heart changes in the group
of mice tested with the aerosol propellants were rapid,
long-lasting and eventually lethal. When the researchers
repeated these tests on rats and dogs, they noted similar
results.

The researchers caution that their findings in ani-
mals cannot be applied directly to humans without
further study. They emphasize that the slowed heartbeat
which was the most apparent effect of the gases in the
laboratory animals may well be overshadowed in humans
by other cardiac effects, such as fast or irregular con-
tractions of the heart’s main pumping chambers (ventri-
cle), or may combine with other cardiac effects to cause
death. Because both turned on youths and asthma pa-
tients who die suddenly do not get to hospitals in time
for an electrocardiogram, the exact heart changes in these
patients before death is not yet known.

The researchers add that millions of people use
aerosol dispensers for cosmetic, household, and numerous
other purposes, thus releasing propellant gases into the
air they breathe. They suggest that people may vary in
sensitivity to the harmful effects of these gases and that
urgent studies are needed to determine the amount of
propellant gases inhaled every day by people who use
pressurized aerosol sprays.

Mr. Taylor and Dr. Harris published a report of
this research in the Journal of the American Medical
Association of October 5, 1970. They reported similar
findings on the cardiac effects of glue-sniffing in mice in
Science on November 20, 1970.

School of Pharmacy Expansion
Dr. Wilson H. Elkins, President of the University of

Maryland, reported in his annual report on the need for
expansion in the School of Pharmacy.

Obituaries...

Harry Greenberg

Harry Greenberg, 67, owner of Gardenville Phar-
macy on Belair Road for over 30 years, died suddenly on
February 14, 1971. Mr. Greenberg graduated from Balti-
more City College in 1922 and from the University of
Maryland School of Pharmacy in 1924. He was a mem-
ber of the Maryland Pharmaceutical Association, the
Baltimore Metropolitan Pharmaceutical Association, AZO
Fraternity and Belair Road Merchants Association.

Mr. Greenberg was a 32nd degree Mason. He is sur-
vived by his wife, Bertha, two sisters, and two brothers,
one Albert G. who is also a pharmacist.

William Lester Brunnett

William L. Brunnett, 51, pharmacist’ at Leland Me-
morial Hospital, Riverdale, died on February 13, 1971 at
his home in Hyattsville. He was a graduate of the Uni-
versity of Maryland School of Pharmacy Class of 1931.

Mr. Brunnett was an active member of the Maryland
Pharmaceutical Association, serving at one time on its
Executive Committee. He is survived by his wife, De]mar,
two daughters, one sister and three grandchildren.

Arthur A. Musher

Arthur A. Musher, of Silver Spring, graduate of the
University of Maryland School of Pharmacy Class of
Sonat died recently. He had retired from People’s Drug

tores.

John A. Pelezar
John A. Pelezar, of Connecticut, died recently. He
had graduated from the University of Maryland School
of Pharmacy in 1919.

John Henry Bradford

John Henry Bradford, 69, died on February 18,
1970. He graduated from the University of Maryland
School of inne: in 1926. Mr. Bradford operated a
pharmacy at Ashland and Milton Avenues for eight years.
He is survived by his wife, Rita O'Connor Bradford who
graduated from the University of Maryland School of —
pean in 1929, one daughter and four grandchil-
ren.

Sheldon S. Barke

Sheldon S. Barke, 35, died on February 12, 1971.
He was with Read’s for seven years and then with Para-
dise Pharmacy for five years. His father, Daniel S. Barke
is a pharmacist with Drug Fair. He was a 1957 graduate
of the University of Maryland School of Pharmacy.

He is also survived by his mother, Dorothy Sindler
Barke; one brother and one sister.

THE MARYLAND PHARMACIST

smangitestenne

Thantis, the reliable throat lozenge.

(#740/171)

HYNSON, WESTCOTT & DUNNING, INC.
Baltimore, Maryland 21201

Facts and Information

... your customers will want to find out all about
Venereal Disease. They'll also want to know how
you can help them prevent V.D. If you haven’t yet
ordered your FREE supply of this informative 8-
‘page booklet . . . or if you require an additional
quantity just mail in coupon.
This pamphlet is contributed as a public service by:
Youngs Drug Products Corporation—Manufactur-
ers of “Trojan” quality brand prophylactics.
_ Gentlemen: :
[] Please send me —_., --_, copies of

50 100 150
“Plain Talk About Venereal Disease” in English.

[] Please send me___, .._., ___, copies of
50 100 150
“Plain Talk About Venereal Disease” in Spanish.
Name. Ll
Company
Address
City State. vig
Fill in above or affix store label,

up Youngs Drug Products Corporation 865 Centennial Ave., Piscataway, N.J.08854

worn rr errr r nnn ace nn ncn ann nnn nanan anna ny
a ef te ce ee a ae | it ee re a kn eo gn

the
-° maryland

= pharmacis

wees

Photo by Paramount

John A. Crozier

Calvert Drug Executive Tendered Testimonial Dinner
(See Page 10)

Volume 47 APRIL 1971 Number 4

Compliments of

oxell

\UAGH

Makers of
NOXZEMA SKIN CREAMS
NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS

and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

If it's for your family,
which product
would you dispense?

The choice would probably be Crystodigin®
(digitoxin, Lilly).

Pharmacists know that quality is built into Lilly
products... with exacting control procedures to
provide uniform potency and, therefore, consistent
therapeutic effectiveness.

Your professional judgment tells you... when it
comes to your prescription patient’s health (and your
reputation), you want to dispense the best.

&
Og
ae
ole
Be
Rae Sees
£6
$4
at i
he
dt

Naot toh ©

CRYSTODIGIN® (digitoxin, Lilly)

Description: Crystodigin is a crystalline-
pure single cardiac glycoside obtained from
Digitalis purpurea and is identical in phar-
macologic action with whole-leaf digitalis.
Crystodigin is noted for its uniform potency,
complete absorption, and lack of gastro-in-
testinal irritation. It permits accurate dosage
adjustments to produce maximum therapeu-
tic effect smoothly and dependably.

Indications: Heart failure, atrial flutter, atrial
fibrillation, and supraventricular tachycardia.

Contraindications and Precautions: Crysto-
digin should not be used in ventricular tachy-
cardia.

Patients taking digitalis preparations must
not be given the rapid digitalizing dose of
Crystodigin or parenteral calcium.

Adverse Reactions: Overdosage causes side-
effects, such as mental depression, anorexia,
nausea, vomiting, premature beats, complete
heart block, AV dissociation, ventricular
tachycardia, ventricular fibrillation, restless-
ness, yellow vision, mental confusion, dis-
orientation, and delirium. [110570]

Lilly

Eli Lilly and Company

Indianapolis, Indiana 46206

For physicians
and their patients

21 white tablets each containing
).5 mg. norgestrel with 0.05 mg. ethinyl estradiol
and / pink inert tablets

‘To order, contact your Wyeth salesman
or nearest branch.

®
Wyeth Laboratories —_ Philadelphia, Pa.

The Maryland Pharmacist

NATHAN I. GRUZ, Editor
650 WEST LOMBARD STREET

~VoLuME 47

NORMAND A. PELISSIER, Assistant Editor
BALTIMORE, MARYLAND 21201

ASSOCIATION

APRIL 1971 NUMBER 4

OFFICERS 1970-71

Honorary President
MORRIS L. COOPER—Baltimore

President
DONALD O. FEDDER—Dundalk
President Elect
NATHAN SCHWARTZ—Annapolis
Vice President
SYDNEY L. BURGEE, JR.—Baltimore
Vice President
BERNARD B. LACHMAN—Baltimore
Vice President
MELVIN J. SOLLOD—Adelphi
Executive Director
NATHAN I. GRUZ
650 W. Lombard Street, Baltimore 21201
Treasurer

MORRIS LINDENBAUM
5 Main Street, Reisterstown

Executive Committee
Chairman
I. EARL KERPELMAN-—Salisbury

District 1—Eastern Shore
PHILIP D. LINDEMAN—Berlin
JAMES W. TRUITT, JR.—Federalsburg

District 2—Central
MORRIS BOOKOFF—Baltimore
JOSEPH U. DORSCH—Baltimore

PAUL FREIMAN—Baltimore
IRVIN KAMBNETZ—Baltimore
JEROME MASK—Baltimore
ANTHONY G. PADUSSIS—Baltimore
DAVID I. SCOTT—Baltimore
H. NELSON WARFIELD—Baltimore

District 3—Southern

PAUL R. BERGERON, II—Bethesda
SAUL B. FRIEDMAN—Potomac
EDWARD NUSSBAUM—Rockville
DOMINIC J. VICINO—Mt. Rainier
RICHARD D. PARKER—Silver Spring

District 4—Northern

ARNOLD L. AMASS—Taneytown
ROBERT K. MOLER—Brunswick

District 5—Western

HARRY G. EISENTROUT, JR.
Cumberland
STEPHEN HOSPODAVIS—Cumberland

Committeemen at Large

JOHN R. McHUGH
ROBERT E. SNYDER

Ex-Officio Members

FRANCIS S. BALASSONE
WILLIAM J. KINNARD, JR.

Honorary Life Member of the
Executive Committee

SIMON SOLOMON

MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON
President
NORMAN J. LEVIN—Pikesville

Secretary
Fr. S. BALASSONE—Baltimore

FRANK BLOCK—Baltimore
HOWARD L. GORDY—Salisbury
MORRIS R. YAFFE—Potomac

TABLE OF CONTENTS

Editorial— Pi
Pharmacists Can be Partners in Venereal Disease Prevention........ 6
Pharmacy. Caleridarge sa mee? ee ear een) ee eee te, 6
Maryland Board of ENATINACVENOWS Seo cc te oe en ee aes ee ee 8
ODM E ae CrOziere Testimonial eee eens eee pee 10
Maryland Pharmaceutical Association
as Annual sConventions Program me.) 12
HOSDital ee Darnacyscectiong 7 eh em ete ey 14
MSHP Sixth Annual Hospital Pharmacy Seminar Program.................... 14
Spling Regionals Meatingeetin ce see ete hs) Ue de ha eek alu 5G 18
Federal Controlled Substances Act Of 1970 .ccccccccccccssesssssscossssecseseeeeeseececcccccee, 19
DTU A DUSG Wren eee ne nas RITE, carn Sey Meee Br! bln! gone,» 22
A Collection of Compounded Prescriptions Ye ab Pe Aller) eee. eee 26
LAMPARNGWSiE SUG operin Se oa ee he se Pkg. Wy 28
Obituaries eterna eel, emeree hom ee a ee ie 8 AN 30

INDEX TO ADVERTISERS

Page
MING HCA Ueeists = INSirance:COq nse eon ee 27
gnenicangiyrienicaCOMmpan yarn. see ee ee Les 30
Borden: Hendlers) cosCrear mew, ci kee ee eas ea ae Re 29
Calverte DriigsCompanyeyinc sea eee ere le oe: ey Rye ee 29
TP neg Dregs louse NC a, wee ese enn or ee a ee Teel s 16
CelzveOnarmacouricalsr: Incr icone kn i ee ee ee te 32
PICU Vis eecrattyi1 COM Dany meee ne pet ree ee eR et 33
Ei Lilly,ano COM pan Verses 2 en eee ie oe ee) Se crt EEL ere 3
Loewys Drugs Compan yar tees Petre ete genie to ee ea ea 9
Manginigand s Associates ainCs, wee eee ene ey Se 21
Marviands News) Compan vane ee ee ene 25
Noxell’ Corporation Sire entree ren enn oe ee 2
ParAMOUNtEPHOtO SeLViCe mene Aa ee ee ee ee 13
Pension and Investment Association of America, INC... 24
Ax Lie hODings COMPANY mee. = ere eee gn ees Meee any eee Pee ee Gea 34
ROCHE SLADOTALOTI CG mera. 5 cotter cer se Recerca, eR chee al oa ee, 7
Deotuartawebb Advertising. Services 1.05 ee 30
WivethwLADOLafOricsaire sen oe os. anta eee ae ee es ee 4
MOuUngS VOTRE ErOguUCts eCOTDOration ier te ote a Po ee he ee 17

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number. Allow four weeks for
changeover.

The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical]
Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a
year. Entered as second class matter December 10, 1925, at the Post Office at Balti-
more, Maryland, under the Act of March 8, 1879.

Editorial...

Pharmacists Can be Partners
in Venereal Disease Prevention

“An epidemic is ravaging America—needlessly. The
U.S. Public Health Service estimates there were almost
1.8 million new cases of venereal disease last year, well
exceeding the medical definition of an epidemic. More
Americans caught gonorrhea last year than caught the
measles. And half of all new V.D. cases are in the 15 to
24 year old age group.’’*

In Maryland in 1970 there were more than 14,800
reported cases of gonorrhea and 440 reported cases of
primary and secondary syphilis. These are said by authori-
ties to be perhaps 10 to 20 % of the actual cases.

That is why V.D. is referred to as really pandemic,
not just an epidemic.

“America’s teenagers are the chief viciims of the
venereal disease epidemic now ravaging America. Young-
sters in the 15 to 19 year age group have a rate of infec-
tion for syphilis and gonorrhea more than twice that of
all age groups combined. A U.S. youngster is infected
with V.D. every two minutes.”’*

“Too many young people just don’t know what ve-
nereal diseases are, how serious they can be, or how they
can be prevented. In most cases, nobody bothers to tell
them. Parents, schools, churches—any group in touch
with young people—must face the important educational
job of giving our young people the facts about V.D. The
necessary information is readily available from physicians,
clinics, and public health groups. And your local pharma-
cist is the best source for medically recommended prod-
ucts to control V.D.”*

Yes, the pharmacist is the most accessible source
for factual information, for prescribed drugs for treat-
ment and for products for prevention.

The Maryland Pharmaceutical Association is there-
fore, launching an all-out Venereal Disease Awareness
Campaign to bring these facts to the public’s attention.
This effort will be initiated with the observance of ““V.D.
Prevention Month” under MPhA sponsorship in June.

The key will be active personal involvement on the

part of pharmacists by:

1. Distributing “Plain Talk About Venereal Dis-

ease” pamphlets in their drug stores to customers.

Actively displaying an official ““Venereal Disease”
prevention sign.

aS Speaking wherever possible to local groups such

as Lions, Kiwanis, etc., on venereal disease, em-

phasizing knowledge, treatment, and prevention.

4. Marshalling the active interest and support of
public officials, opinion leaders, the press, and
general public. Scope of the program recognizes,
too, that the ““Venereal Disease Awareness” ef-
fort must be a never-ending responsibility of
pharmacy, as a member of the public health
team.

“Based on Youngs Drug Products Corporation advertise-
ments published in the general press.

MPhA, with the important assistance and expertise
of Youngs Drug Products Corporation, will work with
governmental officials, health departments, clinics, youth
groups, schools and colleges and the various public in-
formation media (press, radio and TV).

The public and the profession of pharmacy are for-
tunate that the Youngs Drug Products Corporation is
devoting so much of their resources as well as the time
and efforts of their management and field personnel to
this campaign. Youngs’ personnel from both their head-
quarters and the field are working and will continue to
work in Maryland to make this program a success.
Youngs is making thousands of pamphlets and counter
cards available to pharmacies.

Youngs deserves a great deal of credit for their crea-
tive approach to the leading public health problem of
youth today. Youngs is to be congratulated for its cour-
age in bringing V.D. to public awareness through its
newspaper advertising which directs the public to obtain
and use the tools of V.D. prevention—prophylactics —
which are readily available in pharmacies.

V.D. is a health problem—a challenge to all the
health professions, including pharmacy. But it is also a
unique public health service opportunity for pharmacy.

Surely here is one campaign we can expect 100%
pharmacist participation not only at this time, but as a
continuing public education project in the months ahead.

—Nathan I. Gruz

PHARMACY CALENDAR

May 13—MSHP meeting, Colony 7 Motor Inn, Balti-
more-Washington Pkwy, 6:00 P.M.

May 16-17—MPhA Annual Convention, Hunt Valley

Inn.
May 18-23—Reconvened sessions—Jamaica Hilton

May 26—School of Pharmacy Alumni Association An-
nual Meeting. Student Union Bldg. 8:00 P.M.

June—MPhA “V.D. Prevention Month”

June 2—School of Pharmacy Annual Alumni Banquet in
Honor of Graduates.

June 5—School of Pharmacy Commencement Exercises.

June 11-13—6th Annual MSHP Hospital Pharmacy Sem-
inar, Ocean City, Md.

September 7-12—3 1st International Congress of Pharma-
ceutical Sciences of the FIP, Washington, D.C.

October 10-14—National Association of Retail Druggists
Annual Convention, The Rivergate, New Orleans.

THE MARYLAND PHARMACIST

Our pricing policy results from our commitment not only to develop new
drugs but also to help the pharmacist better serve his community, his pro-
fession and himself. That’s why pharmacists with broad firsthand pharmacy
experience are in management positions at Roche. Programs, policies and
services are conceived and implemented by pharmacists for
pharmacists...to help you participate more fully in the ex- aberrant eae
panding contribution of health sciences. Division of Hoffmann-La Roche Inc.

When it comes

Maryland Board
of Pharmacy News

Pharmacy Changes

The following are the pharmacy changes for the
month of February:

New Pharmacies
None.

No Longer Operating As Pharmacies

Sussman’s Pharmacy, Samuel Wolfovitz, 3601 Park
Heights Avenue, Baltimore, Maryland 21215.

Donnybrook Pharmacy, Maurice Karpa, President,
246 East Burke Avenue, Towson, Maryland 21204.

Hoffman’s Pharmacy, Sylvan Hoffman, 2658 Hunt-
ington Avenue, Baltimore, Maryland.

Change of Ownership, Address, Ete.

Fullerton Pharmacy, Inc., Eugene Trief, President,
7542 Belair Road, Baltimore, Maryland 21222.
Taneytown Pharmacy, Inc., Julian M. Friedman,
President, 7 York Street, Taneytown, Maryland 21787.
* * #& &

The following are the pharmacy changes for the
month of March:

New Pharmacies

MEMCO Prescription Pharmacy, William H. Dyer,
Jr., President, 6411 Riggs Road, Hyattsville, Maryland
20782.

Dart Drug Corporation, Downtown, Herbert H. Haft,
President, 13625 Georgia Avenue, Silver Spring, Mary-
land 20906.

Dart Drug Corporation, Cherry Hill, Herbert H.
Haft, President, 6711 Annapolis Road, Landover Hills,
Maryland 20784.

Drug Fair No. 134, Milton L. Elsberg, President,
5203 East Drive, Baltimore, Maryland 21227.

No Longer Operating As Pharmacies
White Cross, D. M. Robinson, President, 116 East
Baltimore Street, Baltimore, Maryland 21202.
Hilton Court Pharmacy, Inc., Wesley N. Shelton,
President, 3301 Liberty Heights Avenue, Baltimore,
Maryland 21215.

Metro Drugs, No. 6, Leo Goldfeder, President, 4009
Main Street, Upper Marlboro, Maryland 20870.

Change Of Ownership, Address, Ete.
Hertz Pharmacy, Inc., Hillel Aarons, President, 6309
Kenwood Avenue, Baltimore, Maryland 21237.

Libby’s Rexall Drug Store, I. Silen and A. Schwartz-
man, 4901 Belair Road, Baltimore, Maryland 21206.

Samuel P. Jeppi, Inspector for the Maryland Board
of Pharmacy, retired April 1 after 17 years of service.
Newly appointed Inspectors for the Board are Alexander
J. Ogrinz, Jr. and Jerome S. Wittig.

Notice—Board Exams
The Maryland Board of Pharmacy will conduct an

examination for registration as Pharmacist at the School
of Pharmacy, University of Maryland, 636 West Lom-
bard Street, Baltimore, Maryland.

On Monday, Tuesday and Wednesday
June 28, 29 and 30, 1971

The examination will begin at 8:00 a.m. each day.
Applications must be in the hands of the Board by Fri-
day, June 18, 1971.

ABBOTT BUILDS NEW FACILITY
The Hospital Products Division of Abbott Labora-

tories announces that a new $6 million ampoule and
vial manufacturing facility will be constructed adjacent
to the intravenous solutions manufacturing facility in

Rocky Mount, North Carolina.

OFFER
STRAIGHT,
MEDICALLY

SOUND

GU) DANCE |
y)

A SIGN OF PROFESSIONALISM

THE MARYLAND PHARMACIST

There’s a lot more
going for you at LOEWy*

Ybeclw

COMPUTERIZED
SERVICE

puts America’s most advanced
warehouse facility behind your store

How much is it worth to you to know
that the most advanced computerized
distribution system in existence is in
motion to process your every order

. instantly, efficiently, completely?
That you needn’t ever stock more than
a minimum ofa far greater variety of
merchandise than you could ever show
before... and without investment in
excessive inventory? That your
wholesaler is never likely to be out-of
stock on any desirable item? That
every invoice and statementis assured
of up-to-the-minute accuracy? And
that there is never a lapse of more
than 60 minutes from receipt of your
order to the time it is on the loading
platform, ready to roll?

How much? You'll be able to measure
its worth by the number of customers
attracted to your store. Old customers
and new, it’s the kind of service they
aren’t likely to have known before.

FOR SERVICE AT ITS BEST...
BETTER DEAL WITH LOEWY

Call any time, day or night. An automatic order
taker will record your after-hours order.

Call lV 5-8105 for order taking.
(301) 485-8100 for the office.

em — Loewy
Geet Sue je f ~@©——sCODRUG. COMPANY

DIVISION OF

Wi)
si § Spectre Industrts, Inc.
OS
40 ye

6801 Quad Avenue
Baltimore, Md. 21206
Telephone: (301) 485-8100

Crozier Testimonial
John A. Crozier

John A. Crozier was born in Mamaroneck, New York
and there attended public school until moving to Phila-
delphia where he transferred to Our Lady of Victory
Parochial School. He continued formal education at
Strayer’s Business College in Baltimore.

John met the lovely Miss Nancy Katherine Meyers,
who on April 16, 1932 became Mrs. John A. Crozier.
Mrs. Crozier was born in Timonium, Maryland at the
present site of the Five Farms Club.

In 1928 he began his association with the Calvert
Drug Company in the bookkeeping department. Three
years later he was appointed Assistant General Manager
and in 1938 became General Manager. In 1958 he was
appointed Executive Vice President and General Manager,
a position he held until the time of his retirement, De-
cember 31, 1970. To many of his friends and associates
he was known as “Mr. Calvert Drug Company.”

He gave unstintingly of his labor, talent and time,
not only to the Calvert Drug Company, but also to vari-
ous trade and pharmaceutical associations on the local,
state and national levels. A grateful profession recognized
his contributions and honored him with appointment to
its highest offices. He is the only person ever to have
served two terms (4 years) as president of the Federal
Wholesale Drug Association of the United States and
Canada. He is a Past President of the Travelers Aux-
iliary of the Maryland Pharmaceutical Association and
was elected Honorary President of the Baltimore Metro-
politan Pharmaceutical Association in 1964.

To each of these he brought a high sense of purpose
and unswerving dedication which earned him admiration
and the respect of all his associates.

For almost half a century, John Crozier gave untir-
ingly of his abilities and energies to the many-faceted
drug and pharmaceutical field. It is therefore fitting that
his friends honored him on the evening of February 18,
1971 with his Testimonial Dinner.

Photo by Paramount

Gordon Mouat, President of Calvert Drug Company, shown
with plaque he presented to Mr. Crozier on behalf of Cal-
vert Drug Company.

SR inst BE

Photo by Paramount

Mr. and Mrs. John A. Crozier

Photo by Paramount

Reverend James B. O’Hara, left, who gave the invocation,
shown with John Crozier.

THE MARYLAND PHARMACIST

| Shown presenting awards to Mr. Crozier at the John A.
Crozier Testimonial Dinner are: left to right—top row—
Donald O. Fedder, President, Maryland Pharmaceutical As-
| sociation; Irvin Kamenetz, President, Baltimore Metropoli-
tan Pharmaceutical Association; William M. Burckart, Presi-
dent, Ellicott Drug Company, Buffalo, N.Y. who was Toast-
master for the evening shown here exhibiting a crystal
bowl presented earlier. by BMPA president.

middle row: Dora Rockman, President, Ladies Auxiliary of
the Maryland Pharmaceutical Association; William L. Nel-

APRIL 1971

Photo by Paramount

son, President, Traveler’s Auxiliary of the Maryland Phar-
maceutical Association; Joseph J. Hugg, Executive Vice-
President and General Manager of the Calvert Drug Com-
pany, Inc.

bottom row: George C. Straayer, Executive Secretary, Fed-
eral Wholesale Druggist’s Association; Joseph S. Kaufmann,
legal counsel for the BMPA and MPhA, presenting Distin-
guished Citizen Citation on behalf of Governor Marvin
Mandel; Harry R. Wille, President, Alumni Association, Uni-
versity of Maryland School of Pharmacy.

COME TOGETHER!

Maryland Pharmaceutical

89th Annual Convention
In conjunction with TAMPA and LAMPA
MAY 16 and 17, 1971
Hunt Valley Inn, Cockeysville, Maryland

Reconvened Sessions — Jamaica Hilton

Ocho Rios, Jamaica, W.I.
May 18-23 via Eastern Airlines Charter

Condensed Schedule
SATURDAY EVENING, MAY 15

Hospitality reception for early arrivals

SUNDAY, MAY 16
Golf available for Convention registrants
12:00 NOON—Registration desk opens
1:30 P.M.—First Business Session
Call to Order—President Fedder
Invocation
Greetings from Affiliated and Recognized
Associations
Committee Reports
Report of University of Maryland School
of Pharmacy—Dr. William J. Kin-
nard, Jr., Dean
Report of Maryland Board of Pharmacy—
Francis S$. Balassone, Secretary
2:00 P.M—LAMPA Hospitality Room
4:00 P.M.—Adjournment of First Session

6:30 P.M.—Limestone Valley Dinner Theatre, Beaver
Dam Road, Cockeysville

Pre-dinner cocktails

MONDAY, MAY 17
9:00 A.M.—Second Business Session
President’s Report—Donald O. Fedder
Report of Executive Director—Nathan I.
Gruz
Report of Treasurer—Morris Lindenbaum
Memorial Services
Report of Legal Counsel—Joseph S. Kauf-
man
Organization of the MPhA House of Dele-
gates

11:00 A.M.—LAMPA Business Meeting

12:00 Noon—LAMPA-TAMPA Luncheon — Speaker:
Radio and TV Personality, Arnold
Zenker
12:00 Noon—MPhA Luncheon—Guest Speaker
1:30 P.M.—Third Business Session
Meeting of House of Delegates
Old Business
New Business
Resolutions
Nominations and Election of Officers
Approval of List for appointment to Mary-
land Board of Pharmacy
4:00 P.M.—Adjournment
6:30 P.M.—Presidential Reception — Courtesy Youngs
Drug Products Corporation
7:30 P.M.—Annual Banquet
Installation of Officers
Dancing
Prizes

TUESDAY, MAY 18
9:00 A.M.—Friendship International Airport — depart
via Eastern Airlines for Jamaica and
reconvened sessions.
12:30 P.M.—Arrive Montego Bay
Continuing Educations Seminars—W ednes-
day, Thursday and Friday mornings.
Entertainment nightly.

SUNDAY, MAY 23
7:30 P.M.—Depart Montego Bay
10:30 P.M.—Arrive Friendship Internationai Airport

Photo by Paramount Photo Service

Stephen Overbeck, D.D.S. (left) was a guest of MPhA
Public Relations Committee Chairman Charles Spigelmire
(right) during Children’s Dental Health Week. Pharmacist
Spigelmire broadcasts the program “Your Best Neighbor”
Over Station WCAO every Sunday evening.

THE MARYLAND PHARMACIST

Mr. Pharmacist ~

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4, Salesman inventory control

To get the complete story—call collect [301] 243-4439

PARAMOUNT PHOTO SERVICE

3024 Greenmount Avenue
Baltimore, Maryland 21218

APRIL 1971 13

Hospital Pharmacy
Section

Maryland Society of Hospital Pharmacists
Meeting of March 11, 1971

The March 11th meeting was held at the North
Arundel Hospital. The guest speaker for the evening was
Dr. David N. Nurco, Commissioner, Maryland Drug
Abuse Authority. Dr. Nurco’s topic was “Drug Abuse.”
In his talk, Dr. Nurco explained some of the programs
that are being conducted in the state in the area of drug
addict rehabilitation and the problems that are encoun-
tered with these programs.

Dr. Lamy, chairman of the Nominating Committee,
submitted the list of nominees for office. Clarence Fort-
ner reported on the Annual Seminar. The registration
fee for those attending the seminar will be $20.00 this
year. Howard Sherman reported for the Membership Com-
mittee. A mailing was sent out to all 5th year students
inviting them to join the Society. A follow-up mailing
will be done on last year’s state-wide membership survey
while a new state-wide membership survey will be con-
ducted next fall.

June Shaw reported for the Program Committee.
The April 8th meeting will be held at H. B. Gilpin and
the May 13th meeting will be held at Schraft’s Colony 7
Motor Inn and will start with a cocktail hour at 6 P.M.

Robert Snyder mentioned that the society’s dele-
gates to the Annual Convention in San Francisco will
again vote in favor of adoption of the “Economic Status
Program” of the ASHP. The following new members
were approved: Donald W. Cathey, Philips Roxane Lab-
oratories; John M. Motsko, Mercy Hospital; and Nor-
man Yockelson, student-class of 1971.

Robert Snyder mentioned that all hospital pharma-
cists were invited to attend a demonstration of the AIM-
TWX information retrieval system on Thursday, March
25th from 1-3 P.M. at the Health Sciences Library.
June Shaw reported on the Swain Pharmacy Seminar.
Bob Snyder thanked the Roerig Company for sponsoring
the meeting and thanked Dudley Demarest for hosting
the meeting. The meeting adjourned at 10:45 P.M.

ASHP Announces 1971 Institutes

The following institutes conducted by the American
Society of Hospital Pharmacists and cosponsored by the
American Hospital Association and the American Phar-
maceutical Association are announced for 197i.

Institute on Personnel Relations in Hospital Pharmacy,
May 16-19, Atlanta, Georgia.

Institute on General Practice of Hospital Pharmacy, June
27-July 2, Williamsburg, Va.

Institute on Unit-Dose Drug Distribution Systems, July
25-28, St. Louis, Missouri.

Institute on General Practice of Hospital Pharmacy,
Sept. 12-17, San Diego, Calif.

Institute on Drug Interactions and Clinical Communica-
tions, Oct. 17-20, Key Biscayne, Fla.

For further information contact Department of Edu-

cation and Training, ASHP.

PROGRAM

Sixth Annual Hospital Pharmacy Seminar

Maryland Society of Hospital Pharmacists
JUNE 11, 12, 13, 1971
OCEAN CITY, MD.
TOPIC: “MEN — MACHINES — SERVICES”

9:00 A.M.— GREETINGS

Clarence L. Fortner, M.S., Chairman,

Head, Patient Care Pharmacy Services,
Baltimore Cancer Research Center.

Clinical Instructor in Pharmacy, Univer-
sity of Maryland.

Robert E. Snyder, President,

Director, Pharmacy Services, Maryland
General Hospital.

Clinical Assistant Professor of Pharmacy,
University of Maryland.

9:15 A.M.— MEN

“The Philosophy of Supportive Personnel
in Pharmacy,”

Henry J. Derewicz, M.S.,

Director, Pharmacy Services, The Johns
Hopkins Hospital.

Clinical Assistant Professor of Pharmacy,
University of Maryland.

10:00 A.M.—*A Review of Existing Training Programs
for Supportive Personnel in Pharmacy,”
Louis P. Jeffrey, M.S.,
Director of Pharmacy Service, Rhode
Island Hospital.
Clinical Professor, University of Rhode
Island, School of Pharmacy.

10:45 A.M.— COFFEE BREAK

11:00 A.M.—*Experiences with Supportive Personnel in
a Health Care System,”
Paul LeSage,
Deputy Director of Pharmacy Services.
U.S.P.H.S. Hospital, San Francisco, Cali-

fornia.
LUNCHEON
MACHINES

1:15 P.M.—Patrick Birmingham—Presiding,

Director of Pharmacy Services, Good Sa-
maritan Hospital.

Clinical Instructor in Pharmacy, Univer-
sity of Maryland.

“Computer Applications to the Health
Care System,”

Cornelius P. McKelvey, MS.,

Instructor, University of Maryland, School
of Pharmacy.

11:45 A.M?—

THE MARYLAND PHARMACIST

1:50 P.M.—“‘One Hospital’s Experience with the
Brewer System,”
Douglas R. Mowrey,
Director of Pharmacy Services, The Wash-

ington Hospital Center.

2:25 P.M—*The Changing Health Care System,”
Peter P. Lamy, Ph.D.,
Associate Professor and Director Institu-
tional Pharmacy Programs, University of

Maryland, School of Pharmacy.

7:00 P.M—BANQUET ADDRESS
“The Pharmacist on the Health Care
Team,”
John Collins Harvey, M.D.,
Executive Vice President and Medical Di-
rector, Good Samaritan Hospital.

SERVICES
SUNDAY
10:00 A.M.—Peter P. Lamy, Ph.D.—Presiding
“Pharmacy Service in a Small Hospital,”
R. David Anderson, M.S.,
Director of Pharmacy Service, Waynes-
boro Community Hospital.
President, American Society of Hospital
Pharmacists.

10:45 A.M.—Presentation — The Maryland Society of
Hospital Pharmacists Student Achieve-
ment Award.

10:50 A.M.—‘‘Pharmacy Service in the Emergency
Room,”
Thomas E. Patrick,
Chief Pharmacist, University of Maryland
Hospital.
Clinical Assistant Professor of Pharmacy,
University of Maryland.

11:30 A.M.—Closing Remarks: Clarence L. Fortner,
MS.

Prease Nore: All community pharmacists are invited to
attend this weekend Seminar. Many of the topics would
be of interest to those affiliated with nursing homes. For

information on registration, please contact Semfnar
Chairman, Clarence Fortner at 338-1100, Ext. 243.

Actions of the American Society of Hospital
Pharmacists House of Delegates

—Adopted Policy on Economic Status.

—Adopted a resolution to amend by-laws which will en-
able streamlining of organizational structure by reduc-
ing number of operating councils from six to four.

—Adopted a resolution to amend by-laws which will al-
low for the election of Speaker of the House of Dele-
gates by members of the House of Delegates upon nom-
ination by a committee appointed by the President. The
elected Speaker will preside over the House and repre-
sent the House as a voting, ex-officio member of the

ASHP Board of Directors.

—Adopted a resolution authorizing the ASHP to study
the feasibility of developing a Model Hospital Phar-

APRIL 1971

macy Practice Act for incorporating in the states’ Gen-
eral Pharmacy Practice Acts. .

—Adopted a resolution to foster the discontinuance of
drug sampling by pharmaceutical manufacturers, and
to commend those manufacturers who have seen fit to
discontinue drug sampling. Further to communicate

this position to individual pharmaceutical manufac-
turers.

—Adopted a resolution to endorse and support the dis-
pensing of out-patient medications in “child resistant”
containers whenever applicable and to urge pharma-
cists to promote drug usage safety.

The following resolutions were adopted with referral
to the proper committee for further study.

1) Amendment of by-laws changing dues structure.
2) Directions to patients on prescriptions.
3) Supportive personnel.

Nominations for President-Elect:
William Hotaling, III
Wendell T. Hill, Jr.

Report on American Society of
Hospital Pharmacists
28th ANNUAL MEETING
MARCH 27 - APRIL 1, 1971
San Francisco, California

by Samuel Lichter

The Maryland Society of Hospital Pharmacists was
well represented at the Annual Meeting of the American
Society of Hospital Pharmacists. The members of the
Maryland delegation participated in the House of Dele-
gates and General sessions and benefited from the mu-
tual exchange of ideas. As the Annual Meeting brought
to an end another Society year, so it began another, to
continue the expansion and development of the many
worthwhile and meaningful Society activities. The reports
of the various committees and councils of the A.S.H.P.
were elaborate in their expression of the need for greater
commitment and involvement of the Society and its mem-
bers to the improvement of the delivery of health care
services.

APhA President, William R. Whitten, noted, with
optimism, at the first session of the A.S.H.P. House of
Delegates, the advances in Pharmacy which have gradu-
ally come to the foreground. President Whitten noted
that the profession is experiencing a change in direction
due to the attraction of a greater youth to the profession.
One must also recognize the importance of the trend of
increased service by community Pharmacy to hospital
and other related institutions. He also emphasized that
in spite of increased specialization of functions and re-
sponsibilities, ““. . . we are all Pharmacists.”

A.S.H.P. Executive Director, Joseph A. Oddis, in
his annual report, announced the purchase of a building
to house the Society staff and its activities. Also an-
nounced was the recent change in the Society’s organiza-
tional structure to increase the efficiency of the enlarged
staff needed to implement the growing budget necessi-
tated by the ever expanding Society activities.

A.S.H.P. President Herbert S. Carlin foresees Hos-
pital Pharmacy on the threshold of a new era: An era
of new roles developed from without and from within—
an era of specialization of function; of increased decen-
tralization. The concept, or state-of-mind — “Clinical
Pharmacy”—is being developed and expanded into com-
munity based clinical programs, school-hospital joint
programs, and hopefully the necessary change from in-
ternship to externship programs. The necessity of attach-
ing “clinical” to the practice of Pharmacy will be obvi-
ated as pharmacist-patient relationship and involvement
expands.

In addition to the management capabilities, techni-
cal skills, and scientific knowledge required of the phar-
macist in the clinical setting, there exists the need to
effectively communicate his preparedness to the other
members of the health professions and to the patient
(consumer). The reports of the Society committees elab-
orated upon what it has done and what it plans to accom-
plish. The various General sessions of contributed papers
expounded upon the many and varied attempts of indi-
vidual practitioners to accomplish their objectives and
attain their goals. A presentation by Kenneth N. Barker
and Joseph G. Valentino, both of the United States Phar-
macopeial Convention, suggested a political and legal
foundation for Clinical Pharmacy Practice. Drug informa-
tion systems, drug interaction reporting systems, fiscal
management, third party payment programs, community
health center involvement, intravenous solution therapy
(hyperalimentation and incompatibilities) were among
the topics of the papers presented.

Sister M. Gonzales was the recipient of the H.A.K.
Whitney Lecture Award. R. David Anderson was in-
stalled as president for 1971-72.

The Emergency Health Personnel Act
of 1970 (PL 91-623)

MPhA given right to certify need for pharmacists

On December 31, 1970, President Nixon signed in-
to law the Emergency Health Personnel Act of 1970.
This bill provides for the assignment of Public Health
Service personnel to areas where health manpower short-
ages exist.

Under the bill, as reported to the floor of the House,
among other requirements for assignment of PHS per-
sonnel was a certification of need by a state or local medi-
cal or dental society. Thus, medicine and dentistry would
have been granted a veto power over the assignment of
members of other health professions.

In cooperation with other associations representing
the allied health professions, the American Pharmaceuti-
cal Association, with the assistance of the Washington
State Pharmaceutical Association, persuaded Congress-
man Brock Adams of Washington to introduce an amend-
ment on the floor to provide the professional association
for each health care profession the authority to certify
or not to certify need for assignment for members of
their profession. The Adams amendment was adopted by
the House and is incorporated in PL( 91-623). Conse-
quently, under this Act, the Maryland Pharmaceutical
Association will control the assignment of pharmacists
in Maryland.

A Service of The Drug House, Inc.

LET OUR COMPUTER WORK FOR YOU
With
lee Or

TIP TOP is a computerized procedure by which you are automatically supplied
with a monthly statement of purchases for each of your charge account

customers.

PLUS

An immediate monthly (and annual) breakdown of their pharmacy purchases

of deductible items for income tax purposes.

For information, call or write:

THE DRUG HOUSE, INC.

1011 West Butler Street
Philadelphia, Pa. 19101
(215) 223-9000

1880 Princeton Avenue
Trenton, New Jersey 08638

(609) 396-5586

3069 Newcastle Avenue
Newcastle, Del. 17920
(302) 655-7401

THE MARYLAND PHARMACIST

Offer Guardian sensitivity

ae eee Se ime
oe ee eS eer.
Pa et eae Ee
rea 3 £9 eh ‘

no X
9 Ric ns
— ROLLED LATEX PROPHYLACTICS

...and they’ll never ask for just
prophylactics again. They will be sold on
the complete sensitivity afforded by

these premium prophylactics. They’ll stay
sold because Trojan brand Guardians

are thin, pre-lubricated and sealed in foil.
And you'll be happy because the extra
profit in each Guardian makes it an ideal
product for you to recommend.

Next time your customer comes in and
asks for prophylactics, recommend
Guardian, the Trojan brand premium
lubricated product from Youngs, the

toyour customers first

| company tuned to today’s pharmacy

customers...for tomorrow’s profit.

Youngs Drug Products Corporation
™ 865 Centennial Ave., Piscataway, N.J. 08854

Spring Regional Meeting
Maryland Pharmaceutical
Association

The Spring Regional Meeting of the Maryland Phar-
maceutical Association was held on March 24th, 1971 at
the Colony Seven Motor Inn, Baltimore- Washington
Parkway. The program was preceded by a luncheon at-
tended by MPhA and LAMPA members. President Don-
ald Fedder opened the afternoon session at this last gen-
eral meeting to be held under the present Board struc-
ture. The new House of Delegates structure will be in

effect for the Annual Meeting in May.

New Medical Care Prescription Forms

The first afternoon speaker was Mr. Harry Bass,
Head of the Pharmacy Section, Division of Medical Serv-
ices, Maryland Department of Health and Mental Hy-
giene. Mr. Bass explained the new Medical Assistance
prescription forms. The new forms (Form DHMH-235 for
original prescriptions and Form DHMH-226 for refill
prescriptions ) are three-part forms, designed to be proc-
essed through a data recorder (imprinter). The first two
copies remain with the pharmacist; the third copy (hard
copy ) is submitted to: Purchased Care Services, State De-
partment of Health and Mental Hygiene, 301 West Pres-
ton Street, Baltimore, Maryland 21201. Al} pharmacies
will be mailed complete instructions concerning the new
forms.

Community pharmacies, who now have Blue Cross
data recorders (imprinters) will not be required to pur-
chase additional data recorders for the new forms. These
pharmacies will be issued plates with their pharmacy
name and Medical Assistance registration number which
can be adapted to the Blue Cross data recorders. Other
pharmacies will be provided with data recorders through

Photo by Paramount

Speakers at the Spring Regional Meeting of the Maryland
Pharmaceutical Association. left to right: Harry Bass, Head,
Pharmacy Section, Division of Medical Services, Maryland
Dept. of Health and Mental Hygiene; Vincent J. Lozowicki,
Staff Assistant for Compliance, Bureau of Narcotics and
Dangerous Drugs (Region 4); Earl Vreeland, District Sales
Director, Youngs Drug Products Corporation; Donald O.
Fedder, President, Maryland Pharmaceutical Association.

the wholesaler of their choice. A $29.50 deposit will be re-
quired which may be paid at the time of delivery or
which may be deducted from reimbursement funds.
Pharmacists are to fill in prescription blanks by hand
until their new data recorders or plate attachments are
received from the Medical Assistance Program.

Questions concerning the forms should be directed
to Miss Jean Ingram or Mr. Frederick Hormes at 383-
2688. Mr. Bass can be reached at 383-2827.

VD Awareness Program

The second afternoon speaker was Mr. Earl Vreeland
of the Youngs Drug Products Corporation. Mr. Vreeland
presented the protocol for the upcoming VD Awareness
Program. The month of June will be designated as VD
Awareness Month. Paul Freiman, chairman of the MPhA
Public Information Committee, will head up this pro-
gram. Official VD Awareness signs and pamphlets en-
titled “Plan Talk About Venereal Disease” will be dis-
tributed to pharmacies. Speaking engagements are
planned throughout the state stressing the three essen-
tials—knowledge, treatment and prevention. Efforts will
be made to marshall the opinion of community leaders.

Officials of the Youngs Drug Products Corporation
are planning a press reception to kick off the campaign.
The company will meet with MPhA staff and with state
health officials. Advertisements will be placed in news-
papers and there will be radio and television public serv-
ice announcements. Official proclamations from the mayor
and governor will be drawn up for their signatures. There
will also be meetings with schools and colleges.

Mr. Vreeland mentioned that his company has played
a major role in state legislation outlawing the sale of
prophylactics through vending machines. ‘Twenty-two
states now have such legislation. He also said that follow-
up mailings will insure that the VD Awareness Program
will continue throughout the year.

The third speaker on the program was Mr. Vincent
J. Lozowicki, Staff Assistant for Compliance, Bureau of
Narcotics and Dangerous Drugs. Mr. Lozowicki explained
the Federal Controlled Substances Act of 1979.

Business Session

President Fedder briefly reviewed the topics on the
agenda of the Annual APhA Meeting in San Francisco.
Rudy Winternitz announced that the Installation of Of-
ficers of the Prince Georges-Montgomery County Phar-
maceutical Association would be held on April 17th at a
dinner-dance and that all members were invited to at-
tend. President-elect Nathan Schwartz announced that
the registration fee for the annual MPhA Convention
would be $5.00 for Sunday, May 16th and $10.00 for
Monday, May 17th which includes lunch. A theater func- |
tion on Sunday night will be $10.00. The convention will
be held at the Hunt Valley Inn in Cockeysville.

The meeting adjourned at 4:30 P.M.

THE MARYLAND PHARMACIST

Comprehensive Drug Abuse Prevention
and Control Act

The Controlled Substances Act essentially combines
Federal controls over narcotics and stimulant and de-
pressant drugs into one statute with the responsibility for
enforcement placed in one Federal agency, the Bureau of
Narcoties and Dangerous Drugs, U.S. Department of Jus-

tice (BNDD).
The former designations of Class A, B, X and DACA

drugs are eliminated. In place of these, five schedules
are employed to classify what are now designated ‘“‘con-
trolled substances.”

Schedule I contains substances with a high potential
for abuse that have no currently accepted medical use.
Schedule II contains the former “Class A” narcotics and
injectable methamphetamine. Schedule III consists of
the former “Class B” narcotics and the majority of the
DACA drugs, plus paregoric. Schedule IV contains drugs
formerly classified as DACA drugs which have a lower
abuse potential than those in Schedule III. A main dif-
ference between Schedules HII and IV lies in the penal-
ties for violation of the law, the penalties being greater if
the violation involves a Schedule III drug. Schedule V
consists of the former “Class X” products, both prescrip-
tion and OTC items, with the exception of paregoric.

The commercial container of each controlled sub-
stance will bear an identification symbol indicating the
schedule in which the drug belongs. The symbol can ap-
pear in either of two ways: a capital C followed by the
roman numeral indicating the schedule number, or a
capital C with the roman numeral inside of it.

The requirements of this new Federal Jaw and the
regulations promulgated under it as they pertain to the
practice of pharmacy, are summarized below. It must be
kept in mind, that if the state law and Federal law differ,
the more stringent law is applicable.

Pharmacy Registration

Around April 15, all pharmacies now registered with
IRS (Narcotics Tax Stamp) or FDA (DACA Drugs) will

receive by mail a provisional registration application form.

Along with the application will be instructions for filling
out the form. It is suggested that the instructions be care-
fully reviewed before filling out the provisional applica-
tion form. The registration fee is $5 which covers all con-
trolled substances in Schedules II through V. A separate
registration will be required for each pharmacy location.
Individual pharmacists need not register unless engaged
in independent research.

When the provisional registration application is re-
ceived by pharmacies now registered with [RS and/or
FDA, a new BNDD registration number will appear in
Block No. 5 on the application form. Beginning May 1,
this number must be used on all correspondence to BNDD
as well as on all orders and any other documents of trans-
fer.

Pharmacies registering for the first time after May 1
will request from the Bureau of Narcotics and Dangerous
Drugs, P. O. Box 28083, Washington, D. C., cr from any
BNDD Regional Office, a Registration Application for
New Registrants. Complete instructions and return en-
velopes will accompany the Registration Application for
New Registrants.

APRIL 1971

Any change of address, location, business activity or
name by existing registrants will be handled as a new
registration under the system, including the payment of

the $5 fee.

Inventory Requirements

All pharmacies must make a complete and accurate
record of all stocks of controlled substances on hand as
of May 1. Thereafter, the registrant must repeat this in-
ventory procedure every two years, either on the anni-
versary of the original inventory or at the date of the
registrant’s regular general physical inventory which is
nearest to and not more than six months from the bien-
nial date which would otherwise apply.

This inventory must be taken either as of the open-
ing or the close of business on the inventory date and a
notation as to the time entered on the inventory. It must
include the kind and quantity of all controlled substances
on hand, including strength and dosage form of the con-
trolled substance. The inventory for Schedule II sub-
stances must be recorded and filed separately from the
inventory for Schedule III, IV and V substances.

For sealed containers, a bottle count is sufficient. For
opened containers of Schedule II substances, a tablet, or
capsule count is required. Schedule III, IV and V sub-
stances either require a tablet or capsule count of opened
bottles, or, if the bottle is graduated, an estimate of the
contents is sufficient.

The inventory may be taken by tape recording or
other electronic means but must be promptly reduced to
a written form.

The inventory, upon completion, must be signed by
the person responsible for taking it and must be main-
tained for at least two years at the pharmacy. It should

not be sent to BNDD.

When new drugs are added to the list of controlled
substances, each registrant will be required to make an
initial inventory of all stocks of that particular product
on hand.

General Recordkeeping Requirements

As of May 1, each pharmacy must maintain on a
current basis complete and accurate records of all con-
trolled substances received as well as all controlled sub-
stances dispensed or transferred.

Invoices:

Invoices for all Schedule II substances must be main-
tained separate from all other records. Invoices for con-
trolled substances in Schedules III, IV and V may either
be maintained separately, or may be maintained with in-
voices for non-controlled substances. In the latter case,
controlled substances in Schedules III through V must
be red-lined, asterisked, or otherwise marked so as to
make them readily distinguishable from the records of
the non-controlled substances.

Prescriptions:

A pharmacy must file all Schedule II prescriptions
separate from all other prescriptions. Prescriptions for
controlled substances in Schedules III, IV and V may
either be filed separately, or in the usual consecutively
numbered file along with prescriptions for non-controlled
substances. In the latter case, the prescriptions for con-
trolled substances must be stamped in red ink with a
letter “C” at least one inch in height on the lower right
hand corner.

Dispensing of Schedule II Controlled Substances

Schedule IL controlled substances may normally be
dispensed only pursuant to a valid written prescription.
However, under certain emergency conditions, Schedule
II substances may be dispensed pursuant to the oral au-
thorization of a prescriber.

An “emergency situation” is one in which the pre-
scriber determines:

“1. that immediate administration of the controlled
substance is necessary for proper treatment of the
intended ultimate user; and

“2. that no appropriate alternative treatment is avail-
able, including administration of a drug which
is not a controlled substance under Schedule II
of the Act, and

3. that it is not reasonably possible for the prescrib-
ing practitioner to provide a written prescription
to be presented to the person dispensing the sub-
stance, prior to the dispensing.”

In such an emergency situation, the pharmacist may
dispense a Schedule II controlled substance on an oral
prescription provided that:

1. If the prescribing physician is not known to the
pharmacist, he must make a reasonable effort to
determine the legitimacy of the authorization,
such as a check in the phone book to verify the
prescriber’s phone number, call-back, etc.;

2. The oral prescription must immediately be re-
duced to writing, containing all the information
normally contained in a written prescription, ab-
sent the physician’s signature;

3. The quantity must be limited to the amount re-
quired to treat the patient during the emergency
period.

Thereafter, within 72 hours the prescriber must
furnish the pharmacy with a written authorization for the
emergency dispensing, which must be attached to the
written notation previously made by the pharmacist and
filed in the Schedule II prescription file. The burden of
supplying the signed prescription is on the prescriber and
the prescriber, not the dispenser, will be penalized if this
requirement is not satisfied. However, the pharmacy must
inform BNDD if the prescriber fails to deliver the signed
authorization as required. The pharmacy’s failure to do
so voids the original oral authorization, and makes the
emergency dispensing unlawful.

Prescriptions for Schedule II substances may not
be refilled. NOTE: In a change from prior practice, par-
tial filling of Schedule II prescriptions will be permitted
if the balance is supplied within 72 hours. In a partial
filling situation, a notation must be made on the prescrip-
tion form and the prescriber notified.

The prescription label for a Schedule IJ controlled

substance must contain:
1. Date of filling
Name and address of the pharmacy
Name and address of the patient
Name and registration number of the practitioner

Ne wh

Directions for use and cautionary statements, if
any

6. Warning on transfer to other than patient named
on the prescription.

NOTE: The warning requirement is new. The ad-
dress of the physician or the registery number of the
pharmacy need no longer be placed on the label.

Dispensing of Schedule Ill &
IV Controlled Substances

Controlled substances in Schedules II] and IV,
whether narcotic or non-narcotic, may be dispensed pur-
suant to either a written or oral prescription. The usual
requirement that an oral prescription be promptly re-
duced to writing and filed applies. As was the case for
DACA drugs, a prescription for Schedule III and IV con-
trolled substances may not be refilled more than six
months after the date of issue nor more than five times
regardless of the date. Upon each refilling, the pharma-
cist must note on the reverse of the prescription the
quantity of drug dispensed, if less than the amount pre-
scribed, the date and the pharmacist’s initials.

After the expiration of a Schedule LI or IV _ pre-
scription, additional quantities may be dispensed only on
the basis of a new prescription.

Labeling requirements for Schedule III and IV sub-

stances are the same as those for Schedule II.

NOTE: Although former “Class B” narcotics are
subject to more liberal dispensing rules under Federal
law, the more restrictive requirements of state law will
still be applicable in many states at least until state law
is conformed to the new Federal law.

Dispensing of Schedule V Controlled Substances

Controlled substances in Schedule V may be dis-
pensed only for a legitimate medical purpose, and for
some no prescription is required. However, only a phar-
macist may dispense an OTC Schedule V substance; a
non-pharmacist employee, even under the direct super-
vision of a pharmacist, may not. However, once the phar-
macist has fulfilled his responsibility, for determining
medical need, the actual sale transaction may be com-
pleted by a non-pharmacist.

A purchaser must be at least 18 years of age and
provide suitable identification. Not more than 240 cc. (8
oz.) of any substance containing opium, nor more than
120 cc. (4 oz.) of any other Schedule V substance may be
sold without a prescription to the same purchaser in any
48 hour period.

A record book for OTC Schedule V substances must
be maintained and must include the name and address of
purchasers, the kind and quantity dispensed, the date of
the transaction and the initials of the pharmacist.

NOTE: Paregoric, which could formerly be sold on
an OTC basis under Federal law is now a Schedule III

substance requiring a prescription.

NOTE: All requirements pertaining to Schedule III
and IV substances are applicable to Schedule V_ sub-
stances dispensed pursuant to a prescription except that
the refill limitations and label warning regarding trans-
fer do not apply.

Warning Requirement

The dispensed container of all controlled substances
in Schedules Il, III and IV must contain the following
warning:

“CAUTION: Federal law prohibits the transfer of

this drug to any person other than the patient for whom
it was prescribed.”

THE MARYLAND PHARMACIST

A strip-label or a pre-printed prescription label may
be used to comply with this requirement.

Security for Storage of Controlled Substances
All controlled substances listed in Schedule II shall

be stored in at least a securely locked, substantially con-
structed cabinet.

Controlled substances listed in Schedule I1I, IV and
V must either be stored in such a locked cabinet or dis-
persed throughout non-controlled substances stock in such
a manner as to obstruct the theft or diversion of the con-
trolled substances. NOTE: Former ‘Class X” products,
including OTC’s, are subject to this requirement.

Order Forms

Order forms provided at no cost by BNDD are re-
quired to procure any controlled substance in Schedule
II. Three books, each containing six forms, will normally
be furnished per requisition.

Each form will be in triplicate. The pharmacy will
submit the original and duplicate to the distributor and
retain the triplicate separate from all other records for a
two year period. The triplicate copy must then be used to
record the number of containers for each ordered item re-
ceived and the date or dates of receipt. The distributor
will retain the original copy and forward the duplicate
copy to the BNDD Regional Office. If the distributor can-
not immediately fill a complete order, he may fill it in
part and supply the balance by additional shipments with-
in 60 days. No order form will be valid for more than
60 days after it is executed.

Theft or loss of order forms must be immediately

reported to BNDD.

NOTE: Existing IRS order forms will be valid until
April 30, 1972. If these are used, the registrant’s BNDD
number must be inserted in the block containing the old
IRS number. If not used, these forms must be marked
“VOID” and retained for a period of two years.

NOTE: An order form containing an item which is
not a Schedule I or II controlled substance will be deemed
to be improperly prepared and must be returned to the
purchaser without providing any item on such form.
Former “Class B” narcotics are in Schedule III, thus
cannot be ordered on the official order form.

Transfer Between Pharmacies

In the event a pharmacy does not have a controlled
substance required by a patient, and the patient has no
alternative source of that drug reasonably available to
him, the pharmacy may obtain it from a second phar-
macy. In such a situation neither pharmacy need register
as a distributor. Records of the transaction must be kept,
however, and the amount transferred may not exceed
that necessary for immediate dispensing. The transaction
is recorded as a dispensing by the pharmacy providing
the drug and as a receipt by the pharmacy receiving it.
Each must retain a signed receipt of the transaction,
which if it involves a Schedule II drug must be an official
order form.

NOTE: Under previous law accommodation trans-
fers of “Class A and B” narcotics between pharmacies
were not allowed.

APRIL 1971

Returns to Suppliers and/or Manufacturers

A pharmacist may return a Schedule II substance to
the supplier from whom he obtained it. An official order
form for the quantity being returned must be obtained by
the pharmacy from the supplier to whom the item is be-
ing returned.

The regulations make no provision for the authorized
return of controlled substances in Schedules III. IV or
V. In light of the fact that Schedule I and II substances
are returnable this is an apparent oversight. APhA will
file appropriate comments with the Bureau to correct this
deficiency.

Disposal of Controlled Substances

A pharmacist desiring to dispose of surplus or out-
dated controlled substances may apply to the Regional
Director of the Bureau for authority and instructions for
such disposal.

The Director will grant authorization and direct
disposition in one of the following manners:

1. By transfer to another registrant authorized to
possess
2. By delivery to an agent of the Bureau

3. By destruction in the presence of an agent of
the Bureau or other authorized person, or

4. By such other means as the Director may deter-
mine.

The United States of Mangini

MANGINI & ASSOCIATES, INC.
4850 W. Belmont Ave., Chicago, III. (312) 282-8181

11722 Studt St., St. Louis, Mo.
2760 W. Market St., Akron, Ohio
575 Savin Ave.,West Haven, Conn.
5501 Cherokee Ave., Alexandria, Va.

Drug Abuse

Potency Unpredictable
in Street Drug Sales

One of the major problems of street addicts is hav-
ing confidence in their dope. There are very few drug
users who haven’t gotten “burned’”’ at one time or an-
other. Experience shows that samples submitted by gov-
ernment agents to chemists for analysis are often not
what they are purported to be. An illegal market means
no regulation on quality or quantity of drugs. Unscrupu-
lous dealers utilize this situation to pass off undesirable
drugs or inflate their profit. Sometimes the dosage is
cut with harmless lactose, but other times it may con-
tain a lethal dose of speed, or one drug may be sold for
another,

Dr. Frances Cheek of the New Jersey Neuropsychi-
atric Institute has good rapport with young users. They

trust her and will give her samples to be analyzed, be- .

lieving that she will tell them the truth about the drug.
A number of these samples were analyzed by Bureau of
Narcotics and Dangerous Drugs chemists, and the results
were summarized.

The 14 samples said to be LSD samples were indeed
LSD, but of the 13 said to be mescaline, seven were LSD,
four were STP, one aspirin, and one consisted of nothing
identifiable. Of the two said to be psilocybin, one was
LSD and the other unknown. The one MDA sample was
MDA, while the two THC were actually phencyclidine.
There was an average amount of 100 mcg of LSD in
samples alleged to contain 250 meg.

The makers of street-purchased drugs are selling
mescaline and psilocypin because there is a good market
for these drugs, in part as a result of the LSD chromo-
sone damage scare. However, the sellers are misbranding
because no mescaline or psilocybin has been found in the
actual samples. Many persons who would hesitate to use
LSD or STP will take mescaline or psilocybin. If the
STP is unknowingly combined with LSD by teenagers,
prolonged confusional states may result. Or with the un-
even quantities from pill to pill, an illicit user may take
several to get a more pronounced reaction and may end
up with an overdose. More publicity of facts such as
these might be an effective curb on illicit drug use.

From BNDD Bulletin November/ December 1970.

New Anti-Drug Abuse Visuals are now
Available to the Public

A 16 inch by 25 inch full color poster entitled
“Wanted Dead or Alive . . . Marihuana” is available
from the Preventive Programs Division of the Bureau of
Narcotics and Dangerous Drugs, 1405 Eye Street, N.W..,
Washington, D.C. 20537. The poster serves as an excel-
lent aid to the layman in identifying marihuana in its
various stages—from the plant to the pipe. It is ideal for
public notice bulletin boards and internal employee in-
formation centers. Single prints may be obtained free of
charge; bulk copies may be obtained from the Superin-
tendent of Documents, U.S. Government Printing Office,
Washington, D.C. 20402 at 20 cents each, 25% discount
for 100 or more.

Also available is “Katy’s Coloring Book,” a delight-
ful 20-page booklet created for pre-school and primary
grade children. It teaches respect for drugs in an enter-

taining and positive way. Single copies are available from
the Bureau address above, and bulk copies from the Gov-
ernment Printing Office at 35 cents each.

Drug Arrests of City Youths up
174. per cent in Year

Arrests of youths under 18 years of age for nar-
cotics violations increased 174 per cent in Baltimore City
last year. A total of 103 juveniles—89 boys and 14 girls
—were arrested for possession or sale of heroin and other
opium derivatives. Four were under 14 years old, seven
were 15, and thirty-one were 16.

Since last March, about 1,400 city policemen have
been trained by federal narcotic agents at a series of 3-
day workshops. They are now equipped with field-testing
kits and as a result the traditional role of the depart-
ment’s 22-man narcotics unit, a subsidiary of the larger

Vice Squad, has changed.

Addict Crimes Cut 80 Percent
by Methadone

Criminal convictions of drug addicts drop more than
80 per cent after those addicts enter methadone treat-
ment programs, but very few addicts become totally in-
dependent of any form of drug. These are the major
findings in a seven month study of 569 patients at Proj-
ect Adapt, the city’s largest drug abuse center. The study
is based on program records kept since Project Adapt
opened in 1968, and on personal interviews with patients.

‘““We wanted to see exactly how much good we were
doing,” said Rev. James Hodges, director of Project
Adapt. “The study indicates very strongly that we can,
in fact, treat large numbers of people and help them.”
There are more than 700 addicts being treated at Adapt.

NABP and NPIC Agree to Use the Same
Number to Code Pharmacies

Officials of the National Association of Boards of
Pharmacy and the National Pharmacy Insurance Coun-
cil have agreed to use the same identification code system
for the nation’s pharmacies.

The six digit code number will indicate the street,
city and state location of the pharmacy. Features such as
size and type will be included in the master file. The
program will be maintained by Fisher-Stevens, Inc., Clif-
ton, New Jersey.

NPIC believes the unique pharmacy identification
code will help reduce the cost of third-party administra-
tion as well as equipment and will speed payment to
pharmacists. Also, claim identification and adjustment
will be greatly simplified.

NABP will make the code number available to
state boards of pharmacy to utilize for licensure, thus
assisting the states in their record-keeping procedures. —
Further, it will act as a check to see that those facilities
receiving legend, controlled or narcotic drugs are legally
entitled to handle them.

THE MARYLAND PHARMACIST

;

Washington Spotlight For

Pharmacists by APhA
Legal Division

Primary Duty Test to Determine
Employees in an Executive Capacity

The Wage and Hour Division of the Department of
Labor, recently clarified the “primary duty” test to de-
termine whether an employee is in an executive capacity.

This is important in determining whether a person
is exempt from the overtime requirement of the “Fair

Labor Standards Act.”

According to the clarification, a determination that

_ an employee has management as his primary duty must

be based on all the facts in a particular case. The regula-
tion goes on to indicate that the amount of time spent in
the performance of managerial duties, is a useful guide in
such a determination. In the ordinary case, a good “rule
of thumb” is that primary duty means the major part, or
over 50 per cent of the employee’s time.

Time alone, however, is not the sole test, and in

_ those situations where less than 50 per cent of the em-

ployee’s time is spent in managerial duties, other factors
may support the conclusion that management is the

primary duty.
These factors include among others;

1. Relative importance of managerial duties as com-
pared to other types of duties.

2. Frequency with which the employee exercises
discretion.

3. Relative freedom from supervision.

4. Relationship between his salary and the wages
paid other employees for the kind of non-exempt
work performed by the supervisor.

New Law on Credit Cards

An amendment to the “Truth-in-Lending Act”
passed by the 91st Congress near the end of its session,
regulates issuance and use of credit cards. The new law
was designed to remedy certain problems relating to
credit cards, and supersede the trade regulation issued
by the FTC last May, which banned the mailing of un-

solicited cards.

Beginning January 25, 1971, a cardholder may only
be held responsible for the unauthorized use of his card
by another up to a maximum of $50.00. The card issuer
can recover this from the cardholder only if the issuer:

1. Gives notice of this potential liability.

2. Provides the cardholder with a self-addressed,
prestamped notice which can be returned to the
issuer in case a card is lost or stolen.

Once the cardholder has informed the issuer that a
card is lost or stolen, no further charges can be made
against him.

All cards issued after January 25, 1971, must pro-
vide all required liability notices to the cardholder and
some identification, such as a photograph showing the
person authorized to use the card.

APRIL 1971

All credit cards, regardless of issue date must con-
tain this identification by January 25, 1972.

The unsolicited issuance of credit cards is also
banned by the law, except if the card is a renewal or
substitute for an existing card.

Narcotic Paraphernalia Sales

A recently released report of the House Select Com-
mittee on Crime, discusses heroin abuses and how these
abuses are aided by manufacturers and retailers who sell
various items used in the heroin trade in large quantities.
These sales, for the most part, are legal but in most
cases do contribute to the addiction problem.

The paraphernalia discussed, includes among others,
hypodermic needles and syringes, empty gelatin capsules
(especially No. 5’s), glassine envelopes and cutting agents
such as dextrose, lactose, mannitol and guinine.

Pharmacists are advised to use the utmost discretion
in making any large quantity sales of these products.

Federal legislation to limit such sales will no doubt
be introduced during the next session of Congress. Vari-
ous state legislatures will also consider this matter.

The State of Maryland has a statute regulating such
sales, which went into effect in July of 1970. The Mary-
land statute is aimed at the unlawful possession of such
articles, but a regulation governing the sale of various
paraphernalia by pharmacists has been promulgated. (See
January, 1971 issue of this journal, p. 10). This regu-
lation limits the sale of these articles by the pharmacist
only in good faith to patients showing proper identifica-
tion and an indication of need.

A record must be kept of these sales that contains
the name and address of the purchaser, date of sale, item
and quantity sold and signature of the pharmacist.

Maryland Blue Cross Prescription Program
New Groups effective April 1, 1971:

Hochschild Kohn and Company—%$.50 deductible.
Sheet Metal Workers Local No. 122—No deductible.

Retired employees and surviving spouses, and their de-
pendents, as well as sponsored dependents of the United
Auto Workers—$2.00 deductible.

This represents an increase of approximately 6,000
new members. The Maryland Blue Cross out-of hospital
Prescription Drug Program now covers approximately

50,000 members.

Insulin Benefit:

Insulin is a covered item under the Prescription Pro-
gram, even though no prescription is necessary for its
purchase. If you dispense insulin, Blue Cross will pay
you your reasonable charge to your regular customers
less any deductible amount. NOTE: You may dispense a
maximum of four (4) vials of insulin at one time and
collect only one deductible.

Wholesale Drug Companies
Offer Service to Pharmacists

This is the third of a series of articles describing
some of the services that the full-line, full-service drug
wholesalers can offer to assist the pharmacist in estab-
lishing and maintaining a successful operation in the face
of rising competition.

Sentry Drug Center Franchise Program

The Sentry Drug Center system is a program de-
signed to allow aggressive pharmacists to own and man-
age completely equipped modern drug centers that pro-
vide quality products and dependable service at competi-
tive prices. The Sentry Drug Center franchise offers the
qualified pharmacist the advantages of ownership while
minimizing all attendant problems and risks. Benefits
that owners will have in their franchise are experience,
consolidated management, drugstore marketing facilities,
automated consolidated bookkeeping and billing, joint
computerized inventory control and ordering procedures,
joint merchandising, advertising and promotion, market-
ing and traffic analysis, site selection, finance resources,
and store design and fixtures.

Drug Center Features

A Sentry Drug Center is completely designed and
programmed for volume business with the following fea-
tures:

1. Complete professional prescription department.

2. Full line of proprietary and OTC merchandise
and representative inventory of convalescent and
home nursing aids.

3. Quality selection of health and beauty aids.

4. Scientific selection of high-turnover sundries and
seasonal merchandise items.

High-profit camera and photo supply department.
National brand box candy.
Tobacco products and related items.

Self-service ice cream.

ep feoy C8) Ke (al

Greeting cards and gifts.

Shopping Center Sites

Sentry Drug Centers are designed primarily for the
community-strip shopping center that ranges in size
from 25,000 to 150,000 square feet. Each Sentry store
is designed to occupy space from 3,000 to 10,000 square
feet, depending upon site survey and feasibility studies
of a specific market area. The program also offers the
qualified pharmacy owner a AAA leasing facility in a
certified site location.

Qualifications

Qualifications for a Sentry Drug Center franchisee
include being a registered pharmacist and/or a qualified
investor with a proven record of experience in retailing,
references for credit and character and evidence of finan-

cial stability. Franchise and start-up costs under the Sen-
try plan are about $130,000 with a cash requirement de-
pending on store size, location and other variables of be-

tween $35,000 and $45,000.

Sentry estimates that a 3,000 square-foot store would
have 36 per cent gross profit on an annual volume be-
tween $300,000 and $600,000 with the total operating
profit amounting to about 8.34 per cent.

Sentry Drug Centers, Inc. is a wholly owned subsid-
iary of the Henry B. Gilpin Company .. . a full-line,
full-service wholesale drug company, established in 1845.
More information may be obtained from Sentry Drug
Centers, Inc., 901 Southern Ave., S.E., Washington,
D.C. 20032.

CHANGE OF ADDRESS

When you move—

Please inform this office four weeks in advance to avoid
undelivered issues.

"The Maryland Pharmacist" is not forwarded by the
Post Office when you move.

To insure delivery of "The Maryland Pharmacist" and all
mail, kindly notify the office when you plan to move
and state the effective date.

Thank you for your cooperation.

Nathan |. Gruz, Editor
Maryland Pharmacist

650 West Lombard Street
Baltimore, Maryland 21201

Associates of America, Inc.
Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)
HR-10.. Plans (Sole Proprietor-Partnerships)

Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.J.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

Pension & Investment

THE MARYLAND PHARMACIST

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
uage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for the
spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

rain.

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

A Collection of

Compounded Prescriptions

by
B. F. Allen*

Historically, one of the important professional serv-
ices performed by a pharmacist is the compounding and
formulation of even the simplest-appearing prescription
written by a medical doctor. This is a function which the
prescriptionist has executed exceedingly well, even during
the last 25 years when the percentage of compounded pre-
scriptions was less each year.

In 1964 it was estimated that 4 per cent of modern
prescriptions required some compounding operation by
the pharmacist. In 1965 a report indicated 3 per cent of
prescriptions in America were compounded. The grand
total of compounded prescriptions in 1968 was less than
1 per cent of all prescriptions dispensed.

Whenever prescription surveys are conducted, the
ratio of compounded prescriptions seems to drop to a
new all-time low. However, it is interesting to note that
one busy Baltimore metropolitan pharmacist recently
stated his average is about 2 per cent. A reason for this
slightly higher than average percentage—several pharma-
cies in his immediate area refuse to compound prescrip-
tions.

Early in 1970 it was stated that in the United States
there are about 190,000 physicians in private practice
and together they originate in a year about 1,300,000,000
prescriptions, including refills. If only 0.5 per cent of
modern prescriptions require some compounding opera-
tion, the fact that 1.5 billion prescriptions (or more)
may be filled in 1971 means the number requiring com-
pounding will be in the millions.

A teacher, who is interested in compounding prac-
tice, is often confronted by students, educators, pharma-
cists, manufacturers’ representatives, as well as the pub-
lic, with the statement that there is “no” compounding
(and similar expressions) in the modern pharmacy.

For many years, discussions with students revealed
that while some were aware of the problem and some-
what concerned, others had no information that would
indicate the situation exists. These, and other factors, led
to a decision to embark on a simple study of the problem
with the cooperation of students of the School of Phar-
macy (the writer had these students for instructional
purposes in several classes ).

The students were instructed to make a copy of the
first prescription on the “current” file, requiring some
form of compounding. This information was usually ob-
tained in a pharmacy where the student was employed.
The results of two studies were published in this Journal,
June 1964 and March 1965.

Practicing pharmacists can make a valuable contri-
bution to a teaching program involving current drug and
other chemical material combinations in compounding.
The busy practitioner often forgets that a student has
not been exposed to the great variety of combinations of

*School of Pharmacy, University of Maryland

the past, and the student many times believes it is a first
time up-to-date development.

This writer has, for a very long time, attempted to
stimulate interest in compounded prescriptions among the
students at the school. Every year students continue to
bring in prescriptions of this type and later, after gradua-
tion, often mail in some to the writer. One recent grad-
uate sent a series of compounded prescriptions from Cali-
fornia.

A young pharmacist soon finds in practice that many
of the prescription formulas requiring compounding are
mixtures and blends of unfamiliar or difficult to obtain
raw materials or highly complex compounds. It often
happens that two indviduals using the same ingredients
in the same formula get different results. This may be
due to slight deviations in the materials used or the
technique.

The following are some of the more recent examples
of prescription orders (and, at times, prescription prob-
lems) supplied to the author by students and pharma-
cists:

(1) Glycerin 4.0
Ether 8.0 Alcohol (50% ) QS 180.0
Para-Aminobenzoic Acid 150 (10)
Rose Water Qs 100.0 Ammonium Chloride 5.0
(2) Ammonium Carbonate 5,0
Salicylic Acid 5.0 Hydrocyanic Acid Diluted 2.4
Olive Oil QS 100.0 Tolu Syrup 60.0
(3) Wild Cherry Syrup 60.0
Chrysarobin 25.0 Brown Mixture OS 240.0
Chloroform Qs 100.0 (11)
(4) Benzoyl Peroxide 10.0
Ethyl Oxide 32,5 Ointment Base OSs 100.0
Alcohol 65.0 (12)
Ethereal Oil 2 Salicylic Acid 5,0
(5) Lanolin 47.5
Hexachlorophene 0.5 Petrolatum 47.5
Cocoa Butter Lotion QS 100.0 (13)
(6) Salicylic Acid 10.0
Olive Oil 70. Liquor Carbonis Detergens 20,0
Wintergreen Oil 14. Aquaphor Qs 100.0
Chloroform Liniment 14, (14)
Neutracolor 0.03
Mineral Oil 33.0 Burow’s Solution 15
Strawberry Concentrate QS Titanium Oxide 1.0
Saccharin S Qualatum Qs 30.0
Preservative QS (15)
Water Qs 100.0 Hydrocortisone 0.5 —
(8) Mycostatin 2,000,000 units —
Cudbear Tincture 3 drops Dermabase As
Euresol 4, Water Qs 30.0 —
Mercury Bichloride 0.1 (16)
Rose Water 15,0 Salicylic Acid 2.0
Alcohol (70%) OS 240.0 Ammoniated Mercury 45 §
(9) IE ACADY 3.0
Mercurie Chloride 0.13. Dermabase QS 60.0
Salicylic Acid 2.0 Euresol Procapillaris 4.0

The following chemicals or materials were also re-
quested alone in the form of a prescription order: Bur-
vundy pitch (to be used in the treatment of sores), cal-
cined magnesia, camphoric acid (12 capsules requested
each to contain 14 grain), fuming nitric acid (to be

}
.
THE MARYLAND PHARMACIST

dispensed in a glass stoppered bottle), methylcellulose
(powder to be used as a bulk laxative), sodium thiosul-
fate (25 per cent solution) and trichloroacetic acid (to
be applied to warts).

Also, as examples, the following interesting formu-
las were also prescribed:

(17) (18)
Iodine Tincture 3 fl. oz, Methyltestosterone 1/10 Gr.
KISS 3 fl. oz. Dextrose 9 Gm.
Soft Soap 1 Ib. Mix into 10 equal powders,
Pine Tar 1 pt. l-powder daily in % tsp.
Water Qs 1 gal. eggyolk

(Liniment For Horse) (For Canary To Sing)

A pharmacist in the Baltimore metropolitan area
also received a request for several pounds of glutamine
to be used as a food supplement for cattle.

Students employed in a pharmacy and involved in
the 1969-70 compounding course were instructed to
make a copy of the first prescription on the “current”
file requiring some form of compounding operation. A
total of 26 prescriptions were received from interested
students and an analysis of the formulas revealed that 66
different drugs or commercial preparations were pre-
scribed by the physicians. A tally of the relative occurrence
of items in these prescriptions is indicated in the paren-

theses: acacia (1), acetylsalicylic acid (1), Actifed-C (1),
Alugel (1), amaranth solution(1), Amytal. (1), am-
monium chloride (3), antipyrine (1), aromatic elixir
(1), belladonna tincture (5), Benylin expectorant (1),
bismuth subcarbonate (1), caffeine citrated (1), carbonis
detergens liquor (2), carron oil (1), Cheracol (1), citric
acid (1), cocaine hydrochloride (2), codeine phosphate
(1), codeine sulfate (6), Continex syrup (1), Cordran
cream (1), Creamalin (1), Demazin syrup (1), Emul-
sion base (1), Gantrisin white liquid(1), glyeyrrhiza
compound mixture (1), Hybephen elixir (1), Hycodan
syrup (1), Hydryllin compound (1), hyosecyamus tine-
ture (2), lanolin (2), magnesium carbonate (1), Metha-
jade (1), Mylanta liquid (1), Orthoxicol (1), pepper-
mint spirit (1), pepsin lactated elixir (1), petrolatum
(2), phenacetin (2), Phenergan expectorant pediatric
(1), phenobarbital (3), phenobarbital sodium (2), phe-
nol (2), potassium citrate (2), potassium iodide saturated
solution (1), Pyribenzamine expectorant with ephedrine
(1), Robitussin (1), salicylic acid (1), Sedatole (1),
Silvol (1), sodium bromide (1), sodium nitrate (1),
sodium salicylate (1), sodium thiosulfate (1), sulfur pre-
cipitated (1), Synalar cream (1), Taka-Diastase liquid
(2), tannic acid (2), terpin hydrate with codeine elixir
(1), tolu syrup (1), Trancopal (1), Triaminic syrup
(1), Tylenol elixir (1), Valium (1), and wild cherry
syrup (1).

TAILOR-MADE

Insurance Coverage

AMERICAN DRUGGISTS’ INSURANCE ...as the name im-
plies, is specifically designed for the needs of the druggist.
It’s an insurance company founded BY druggists FOR
druggists, to assure especially prompt settlement of claims
.. fire, theft, liability. And that’s exactly what we've been
doing... settling such claims rapidly, without red tape
... since 1906. Any service with that many years of

experience HAS to be reliable. You can
be certain of 100% security.

For full details on our complete
coverage plan, contact your ADI
agent NOW.

MAYER & STEINBERG
Maryland State Agents
1101 N. CALVERT STREET
BALTIMORE, MD. 21202
752-7311

DRUGGISTS’
INSURANCE CO.
700 American Building
Cincinnati, Ohio 45202

APRIL 1971

LAMPA News

How do you describe a LAMPA “Show and Tell”
program that featured approximately 46 antiques—many
very valuable, some irreplaceable—all with interesting
stories surrounding them? Ask any one of the members
that attended the Spring Regional Meeting at the Colony
7 Motor Inn on esa 24, 1971.

Through our possessions, it was obvious our Lamp-
ettes have interests as diversified as our dress sizes. Sev-
eral pharmacists’ mates displayed treasured apothecary
items, such as a rare, old quassia cup; a delicate, old,
beautifully preserved scale; and an ancient Egyptian
mortar and pestle. Cherished old silk, lace, and woolen
bed linens and wearing apparel were shown. A century
old newspaper, cook book and prayer missal, all in good
condition and written in contemporary style, were briefly
highlighted. A unique collection of old Tiffany and Kirk
silver, for a lady’s boudoir and for travel, was beautiful
to see and have explained. Rare stamps, an old car
ornament, gold coins, icons and a copper B & B warmer
(Bed and Bottle) were carefully displayed and discussed.

We had beautiful heirloom china and an irreplace-
able Catholic relic of museum quality. Even the christen
ing dress of a prominent member of our pharmacy coterie
showed up. Jewelry—old, new, symbolic and precious,
from far away places and of sentimental value evoked
many ohs and ahs. Our world travelers were represented
too, with colorful curios and interesting tales. An unusual
plant (with free seeds available) and decorative rocks
had a niche in our potpourri. We were so pleased with
the treasures our 13 participating ladies brought, we in-
vited the men attending the MPA meeting to browse too.
The warmth and pleasure that prevailed during the Show
was contagious.

A travel film extolling the food and fun on the
island of Jamaica was also shown. The business meeting
concerned itself primarily with preparations for our an-
nual convention May 16 and 17, 1971 at the Hunt Valley
Inn and the post-convention trip to Jamaica.

Each member left the meeting clutching a fresh
potted geranium.

—Anne Crane,
Communications Secretary

Photo by Paramount

Members of the Ladies Auxiliary at the MPhA Spring Re-
gional Meeting, from left to right: Mrs. Charles S. Austin
(Dorothy), treasurer; Mrs. Richard R. Crane (Ann), com-
munications secretary; Mrs. Louis Rockman (Dora), presi-
dent; Miss Mary DiGristine, recording secretary; Mrs. Man-
uel Wagner (Sadie), membership treasurer; and Mrs. Frank
Block (Eva), board member.

A.Z.O. News

Kappa Chapter of A.Z.O. Pharmaceutical Fraternity
held a breakfast meeting on Sunday, February 21 at the
Holiday Inn in Pikesville. The speaker was Mr. William
Finnegan, Vice President, Paid Prescriptions. A joint

dinner meeting was held on Sunday, March 7 at Martin’s-

West and the speaker for that occasion was the Reverend
Fred Hanna—well known in the Baltimore area for his
work with youth.

District Wholesale Moves Into New
Quarters

District Wholesale Drug Corp. division of Spectro
Industries has moved into its new $1,500,000 distribu-
tion facility in Prince George’s County, Md. Construc-
tion was started last August. The 60,000 square feet
office and warehouse is located at 7721 Polk Street,
Landover, Md. 20785.

Local Testing Being Done on
One-A-Month Birth Pill

About 250 Baltimore women are participating in
tests of a once-a-month birth control pill at Baltimore
City Hospitals. The women in the experimental research
program include both private and welfare patients. Ac-
cording to Dr. Frank Kaltreider, chief of obstetrics and
gynecology at City Hospital, experience so far is too
scant to be properly evaluated. However, he said that
the once-a-month pill’s reliability appears to be on par
with “every other type of oral contraceptive.”

“The active ingredients of the pill are similar to
the oral contraceptives now on the market,” he added.
“The major difference between the every day type and
the once-a-month type is in its rate of absorption, re-
lease and metabolic intake by the body.” Total dosage of
effective ingredients is comparable and may be even
slightly less than the total in the currently used pills.

31st International Congress of
Pharmaceutical Sciences to be Held in U.S.

The 31st International Congress of Pharmaceutical
Sciences of the International Pharmaceutical Foundation
(FIP) will be held in Washington, D.C. from September
7 to 12, 1971. Founded in 1912, FIP is an international
federation of national pharmaceutical associations which

represents pharmacy world-wide in its broadest sense.

Forty five national pharmaceutical associations from five
continents are represented in FIP.

FIP scientific congresses have been heid regularly
since the end of World War II. The 31st Congress, how-

ever, will be the first international meeting of pharmacy

to be held in the U.S. since the Fourth Pan-American

Congress of Pharmacy and Biochemistry, which met in

Washington fourteen years ago in 1957.
The Congress will be hosted by the American Phar-

maceutical Association in cooperation with the APhA

Academy of Pharmaceutical Sciences. A contribution.

campaign under the chairmanship of Dr. Thomas J.
Macek with a goal of $50,000. to help supplement the
cost of hosting the Congress had reached one-third of its
goal as of January, 1971. Contributions are being re-
ceived from national and state pharmacy organizations as
well as from the pharmaceutical industry.

THE MARYLAND PHARMACIST

(

Offering Independent Pharmacies...

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up
to making your best source of supply,
THE

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

First name in ice cream

ICE CRE A M for over a half-century

675-6000

* 1971 29

STENT SELL TE

Obituaries...
‘LEAT LAS RT NTL

Matthew Glenn

Matthew Glenn, 72, of Baltimore, died on March 5.
He had reciprocated from New Jersey in 1926 and worked
as a pharmacist in New Jersey and Maryland until his
retirement in 1967. Mr. Glenn was a native of Ayr, Scot-

land.
Arthur A. Musher

Arthur A. Musher, 57, of Silver Spring, died on
March 19, 1970. He was a 1934 graduate of the Univer-
sity of Maryland School of Pharmacy.

Zygmont W. Karwacki

Zygmont W. Karwacki, 80 died at Mercy Hospital
on March 23, 1971 after a long illness. Mr. Karwacki
was a 1914 graduate of the University of Maryland School
of Pharmacy and proprietor of a pharmacy at Eastern
Avenue and Ann Street for 41 years. He retired in 1958.

Emanuel Rosenthal

Emanuel Rosenthal, 70 died on March 26, 1971. He
was a 1923 graduate of the University of Maryland School
of Pharmacy and proprietor of a pharmacy at York Rd.
and Rossiter Ave. for 38 years. He retired in 1964.

Officer Rank Sought for Inducted

Pharmacists

The American Pharmaceutical Association has
recommended to a U.S. Senate committee an amendment
to the Selective Service Law that would assure pharma-
cists inducted into the service of commissioned officer
rank.

The proposed amendment was contained in an APhA >

statement filed March 1 with the Senate Committee on
Armed Services, which had been considering the Selec-
tive Service Act. The APhA statement also discussed
pharmacy student deferments.

Headquarters for

PHOTO-OFFSET PRINTING MAILING
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

oe (eee LO OEE EEE EEE

Be Smart!

Think Smart!

IRV NORWITZ

Stock the One and Only—
Original “SAFETY TIPS”

Always Sell Them
Smart Users Ask For Them By Name

AMERICAN HYGIENIC CO.

111 S. Paca Street, Baltimore, Md. 21201

727-8328
Represented by

Phone 727-8328

THE MARYLAND PHARMACIST.

Reputation.:

it often depe
n the compan
- you keep.

imipramine hyd

Geigy ©

1000 tablets

Caution: Pacers! !
Sotstite depos
without presets

CONVENTION TIME

MARYLAND PHARMACEUTICAL ASSOCIATION
KELLY MEMORIAL BUILDING ° 650 W. LOMBARD STREET + BALTIMORE, MD. 21201

Telephone (301) 727-0746 NATHAN I. GRUZ, Executive Director

Convention Bulletin and Advance Registration Form

89th Annual Convention
Maryland Pharmaceutical Association
In conjunction with The Ladies and Travelers Auxiliaries
Hunt Valley Inn, Shawan Road, Cockeysville, Maryland
Sunday and Monday, May 16 and 17, 1971

A brand new convention facility - easily accessible to every area

of the state. This year - a different Annual Meeting format for
MPhA's greater effectiveness and for our members' convenience.

The daytime program has been arranged to concentrate on the business
of the MPhA and the issues in pharmacy. The evenings feature enter-
tainment and above all, opportunities for good fellowship and social
conviviality. Read the convention schedule on back of this page,

REGISTRATION FEES

Men Ladies

Sunday, May 16 $ 5.00 FREE
Monday, May 17 $10.00* $10.00*

Total $15.00 $10.00

Per couple: $25.00*
*This fee includes lunch and gratuities, with either the MPhA or the
LAMPA-TAMPA group.
No additional registration fee for family, children and guests of members.
No one will be admitted to business sessions or functions who is not registered.

CHARGES FOR FUNCTIONS ONLY TO REGISTRANTS AND THEIR GUESTS

bee Sunday-— 1024540. LAMPAY TOUR wine ss siete eas no extra charge

2. Sunday- 6:00 P.M. Cocktails and Limestone Dinner Theatre........... $10.00
3. Monday- MPhA Luncheon..... Included in Monday Registration fee

4. Monday- LAMPA-TAMPA Luncheon with Arnold Zenker....Included in Monday

Registration fee
5. Monday- 6:30 P.M. Cocktail Hour and Installation Banquet and Dance... .b15,00

Urgent Notice: Register Early for complete Convention vackage as

there is only a limited capacity at the Limestone Dinner Theatre.
Seats will be reserved on a "first come" basis. Mail your regis-
tration and reservations.

Convention Registration Form
Check registration fee and function fees desired (indicate number of persons)

Sunday Men@$ 5.00 Ladies FREE
Monday _ Men@$10.00 Ladies@$10.00
Total Men@$15.00 Ladies@$10.00

Functions: Sunday - Limestone Dinner Theatre @ $10.00
Monday - Cocktail Hour, Banquet & Dance @$15.00

Complete Convention Package-registration fees and all functions:
Men - $ 40.00, Ladies - $ 35.00 - $75.00 per couple.

Complete and detach this form and mail with check made out to MPhA

in enclosed envelopes. Enclose Hunt Valley Inn Room Reservations

Card for overnight accommodations. Include all names. Use reverse side.
NAME ADDRESS

CITY STATE ZIP CODE

Computerized
Inventory

and billing

Modern wholesaling demands modern accounting and inventory procedures. That’s why we at Gilpin con-
tinually strive to up-date and streamline our operation to improve our services to you. Our computerized,
systems enable us to serve your needs faster and more accurately from complete and up-to-date inven-;
tories. It also makes possible additional data services like regular issuance of individual monthly reports
on DACA drugs as well as other specialized reports. Our wide range of services can help you to realize
the full potential of your pharmacy. Please let us Know which of these services fits your needs.

THE HENRY B.

GILPIN

COMPANY

BALTIMORE + DOVER + NORFOLK * WASHINGTON

A financial service consultant to service you on
request.

Two giant product shows each year: in January
featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing
promotional sundries.

the services required to nail down the profit dollars
which you need and deserve from your business.

The Henry B. Gilpin Company

901 Southern Ave., Washington, D.C. 20032

(301) 630-4500

OTC ile Tee Ee ee |

Sirs:

! am interested in the following programs. Please have your

representative contact me in this regard.

Name

Name of Pharmacy.

CC ee enn OLS
Cy Slate Zip

ap a a pay en

LUMAR

AH-OBINS

Donnagel’

its _
profit
_ planting
_ time!

Allbee winCh
€€C with}
s MULTIVITAMINS
bach capsule contains: % Mi

hiamine }
mon 15 ma 15007 :

f{ 10mg 834" 4

5 nig

50 mg

1 pantothenate 10 mg
Ascorbic

acid (Vitamin C) 300 mg 1000

100 CAPSULES

§ AlibeewithC

MULTIVITAMINS

30 CAPSULES
= AH 081NS sm

buy now for bigger summer and fall profits

_A.H. Robins announces money-saving deals on Alilbee® with C
and Donnagel®. Allbee with C is the number one vitamin in its once
class in drug store sales, and it also leads in drug store pur- ne eel
chases with over 25% of the market. This isn’t surprising when
you consider that it’s the B-complex with C most often pre-
scribed by the medical and dental professions. Almost one
million scripts are filled annually, and this doesn’t even
lude professional recommendations or over-the-
counter sales. More than one half of all Allbee with C oe
sales are OTC. You purchase and sell far more Allbee withC. ~.. *
isn’t it good business to also give it more facings and shelf space? ¥
The Spring Deals run from April 1-May 28. Your Robins representative
will be around soon to discuss the deals and facings with you. With
Allbee with C and Donnagel you’ve got Deal Power!

A. H. Robins Company, Richmond, Va. A-H[OBI NS
Put your facings where your profits arel

eo a a i a a i

Rie ee Se A

Volume 47

maryland
= oharmacist

Irvin Kamenetz, President of the Baltimore Metropolitan Pharmaceutical
Association, receiving donations for the Camp Glyndon restoration
project of the BMPA. The donators are Wm. Donald Schaefer, President

of the City Council of Baltimore City and Dr, Abraham Silver, Medical
Director of Camp Glyndon.

MAY 1971

Number 5

Compliments of

oxell

CORPORATION

Makers of

NOXZEMA SKIN CREAMS

NOXZEMA SHAVE CREAMS

COVER GIRL PRODUCTS

and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

Your reputation goes on the line every time you

fill a prescription—with patients and with physicians
alike. You know that seemingly minor differences

in method of manufacture—the size of the particle,
the excipient used, the character of the gelatin
capsules, solubility, disintegration rate—all can
make a crucial difference in therapeutic

effectiveness. Your professional judgment tells
you... when it comes to your prescription patient's
health (and your reputation), you want to

dispense the best.

Lilly ELI LILLY AND COMPANY

INDIANAPOLIS, INDIANA 46206

You wrap your
» reputation

around the
products

OU Clispense

No antacid can domore—

for your customers and you.

NET CONTEN

= duration of antacid effect,
high acid-consuming capacity proven in over
4 years of laboratory and clinical testing

=» extensive promotion to physicians
will generate continued sales

a 73¢ profit per bottle (based on sugg. ret. price)

Each teaspoonful (5 ml.) contains aluminum hydroxide, 720 mg.,
magnesium hydroxide, 350 mg. and calcium carbonate, 375 mg.

Contraindications: renal insufficiency, phosphate depletion.

Adverse Reactions: occasional laxation, nausea and, rarely, con-
Stipation. Theoretically, hypophosphatemia, hypermagnesemia,
hypercalcemia, milk alkali syndrome (with prolonged adminis-
tration).

Usual Adult Dosage: 2 to 3 teaspoonfuls after meals and at bed-
time, or as needed (40 to 60 ml. daily).

For complete product information, see your SK&F Representa-
tive or contact SK&F.

Trademark

Ducon

ie antacid

SF Smith Kline & French Laboratories, Philadelphia

Duration through concentration

The Maryland Pharmacist

650 WEST LOMBARD STREET

NORMAND A. PELISSIER, Assistant Editor
BALTIMORE, MARYLAND 21201

ASSOCIATION

VOLUME 47

MAY 1971 NuMBER 5

OFFICERS 1970-71
Honorary President
MORRIS L. COOPER—Baltimore
President
DONALD O. FEDDER—Dundalk

President Elect
NATHAN SCHWARTZ—Annapolis
Vice President
SYDNEY L. BURGEE, JR.—Baltimore
Vice President
BERNARD Eat LACHMAN—Baltimore

ce President
MELVIN y. SOLLOD—A delphi
Executive Director
NATHAN I. GRUZ

NATHAN |. GRUZ, Editor

650 W. Lombard Street, Baltimore 21201

Treasurer

MORRIS LINDENBAUM
5 Main Street, Reisterstown

Executive Committee
Chairman
I. EARL KERPELMAN-—Salisbury

District 1—Eastern Shore
PHILIP D. LINDEMAN—Berlin
JAMES W. TRUITT, JR.—Federalsburg

District 2—Central

MORRIS BOOKOFF—Baltimore
JOSEPH U. DORSCH—Baltimore
PAUL FREIMAN—Baltimore
IRVIN KAMBNETZ—Baltimore
JEROME MASK—Baltimore
ANTHONY G. PADUSSIS—Baltimore
DAVID I. SCOTT—Baltimore
H. NELSON WARFIELD—Baltimore

District 3—Southern
PAUL R. BERGERON, II—Bethesda
SAUL B. FRIEDMAN—Potomac
EDWARD NUSSBAUM—Rockville
DOMINIC J. VICINO—Mt. Rainier
RICHARD D. PARKER—Silver Spring

District 4—Northern

ARNOLD L. AMASS—Taneytown
ROBERT K. MOLER—Brunswick

District 5—Western
HARRY G. EISENTROUT, JR.
Cumberland
STEPHEN HOSPODAVIS—Cumberland

Committeemen at Large

JOHN R. McHUGH
ROBERT E. SNYDER

Ex-Officio Members

FRANCIS S. BALASSONE
WILLIAM J. KINNARD, JR.

Honorary Life Member of the
Executive Committee

SIMON SOLOMON

MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON
President
NORMAN J. LEVIN—Pikesville

Secretary
Hen: BALASSONE Baltimore

FRANK BLOCK—Baltimore
HOWARD L. GORDY—Salisbury
MORRIS R. YAFFE—Potomac

TABLE OF CONTENTS

Page
Editorial—The Emerging Patterns in Pharmacy Practices. 6
Maryland Board of Pharmacy NeWS cecececcccccccccsccoccoceccecececcseecoccccccccosecocscscecee. 8
Pharmacy Calendar #2... ene eee a le Oe 8
Baltimore Metropolitan Pharmaceutical ASSOCIatiON ooo.cccccccccccccscecsessecseesen 10
Washington County Pharmaceutical Association oo.....cccccccccccccccccececesecesesese. 10
Basterne shore Pharmaceutical society = 10
Prince Georges-Montgomery County Pharmaceutical Association.......... 10
The Student and the University—The Need for Responsibility
DV. aw silitin eet ners ed tee Pi Dee a ee oe en 12
Hospitals Pharmacye section esse ee ee 16
King Cstsenya NOLManG eA SPelissiGrs — 1 oes oes, tare ore eee 16
Dangers in the Misuse of Drugs by David A. Blake, Ph.D...............000000.. 18
Wasninstons potent sore Pnarmacists see eee 26
ODIGUATICS ernment eee erence ecco e eaten ee ee mt eae eo ee sae 30
INDEX TO ADVERTISERS
Page
AMGMCANEIAVSIeniC COMPANY nin ae ee ee ee A 27
BerkeyvePiliteerOcessin gy ta. Weems Se cre Gury PFS aes TW eee Tens 25
Borden-Hendicrslees Crean tate es wee 8 ke es eid 2) es aie | 27
Calvert DIug: COMmpany.. Ince myeee es ences 5s UA een ae Vion a Oi 7
Pienr Veo. holt COMPANY seein meray a eat or a nt eke eae 32
TLYDSOL RW CSCOLL Pcs DUT Ea INC cet ee ety ee eee on Ghee eet OL
Bg ral veandeCOmpanven cect) eee haces ee ee EE er 3
LOCW Ys DTUSR COMDED Vice, Gente ee ee Pesce Be a et ye 15
Manginisand s ASSOCIATES MING acres cstceosessde ee a tee 17
Marylarid News: Company ga. eee ret en Rn eter. |i gest 29

Noxell Corporation

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number. Allow four weeks for
changeover.

Editorial Ones ©

The Emerging Patterns in Pharmacy
Practice

During the past decade we have seen the following
patterns in pharmacy service emerge:

First, we see a greater role for institutional phar-
macy concomitant with the growth of the hospital as the
source of an increasing percentage of the total services
of the current health delivery “system”. This has come
about for a variety of reasons, including population shifts,
decline in availability of general practitioners and need
for specialized equipment, facilities and personnel.

Second, there is the decline of the small independent
neighborhood pharmacy, the relative growth of the “large
independent” and explosive growth of chain (including
discount and supermarket ) pharmacy. Nevertheless, many
independents who have emphasized personalized relation-
ships with their patrons have been able to retain their
loyalty in the face of the most severe competitive chal-
lenges. Where pharmacists have made it a cardinal rule
to maintain person-person contact with patrons requiring
prescription and health-related products, confidence and
trust has been generated which is able to overcome to a
considerable degree competitive appeals based solely on
price.

Where pharmacists have personal contact with pa-
trons who require prescription and other health products
and maintain medication records for them, experience has
shown that these pharmacists have established a solid
pharmacist-patient relationship. Usually this includes the
physician as well. Providing pharmaceutical services to
nursing homes, extended care facilities, small hospitals
and other health facilities is a great challenge to pharma-
cists. Here the interested pharmacist must be sure he has
become knowledgeable and expert in new developments in
systems, procedures, equipment and automation so that
he can provide the necessary services in an efficient and
economical manner. This must be done in line with good
professional practice and so that the needs for drug se-
curity, proper storage, control of distribution and, above
all, the needs of the patients are met.

This means that the opportunity for the innovative,
flexible pharmacist applying new ideas in providing phar-
maceutical services is present. It means, in many cases,
new patterns in practice and in management. Group prac-
tice by pharmacists may be the answer in some situa-
tions. Participation in neighborhood health centers estab-
lished by health professions, by governmental agencies or
jointly by government and professions will be the answer
for some.

Third, we see great change in what constitutes the
“practice of pharmacy” both in the hospital and com-
munity setting. That is, the concepts of pharmacist-pa-
tient involvement and of “clinical pharmacy” are assum-
ing greater significance in the providing of complete
health care to both hospitalized and ambulatory patients.
It is doubtful whether pharmacists will be able to escape
the full professional and legal responsibilities for which
their education and training qualify them.

This pertains especially to the pharmacist’s duties
and responsibilities to patient and physician in maintain-
ing patient drug histories and utilizing the data in re-
gard to possible drug interaction, drug over-utilization,
maintenance of the prescribed drug regimen and in gen-
eral providing prescriber and patient with appropriate in-
formation, guidance and counsel about drugs.

Why else have a five or six-year education to produce
a pharmacist?

Fourth, there are great pressures both within and
outside of pharmacy for pharmacists to assume an on-
going function in drug product selection. This has long
been the established practice in the closed system of in-
stitutional practice. The APhA and others in pharmacy
and many in labor, the consumer movement, legislators
and others are nevertheless embarked on the road to
change the status quo of “antisubstitution” laws in the
face of legal restraints and strong opposition from indus-
try and organized medicine.

Fifth, the proliferation of “third-party” patients health
insurance plans which more and more are including drug
programs, is having a critical professional and economic
impact on pharmacy.

Sixth, there is the growing acceptance of the in-
evitability of a national health insurance plan which will
include a drug program. It seems very likely, however,
that we will have for some time a variety of sources of
health care available to the public: the private, solo prac-
titioner, group practice, health centers, the medical or hos-
pital center. How these services will be financed will per-
haps be determined in the next two or three years.

Seventh, the kind of supportive personnel to be used
in pharmacy, their role and status will have to be re-
solved. Crucial professional and economic considerations
are involved which deeply affect all pharmacists—com-
munity, hospital independent, chain, proprietor, manager,
and employee.

The profession of pharmacy through its professional
organizations must address itself to all these issues.

The Maryland Pharmaceutical Association has estab-
lished a mechanism through its House of Delegates for
voice for all pharmacists in the State in developing poli-
cies in the issues outlined above as well as any other
issues. When pharmacists join and participate in the
affiliated pharmaceutical organizations, they are entitled
to maximum representation. The various recognized and
related groups including students also have delegates.

The organizational structure in pharmacy now has
the machinery for “participatory” democracy in Mary-
land. Let us act to involve every pharmacist and the en-
tire drug industry in our State so that we accelerate the
professional and economic advancement of pharmacy.
Professional growth for pharmacy will inevitably result
in the maximum contribution of pharmacy to more effec- —
tive health care for all for the benefit of both profession
and society.

—Nathan I. Gruz

THE MARYLAND PHARMACIST

Changes in Controlled
Substances Act

The regulations concerning the Controlled Sub-
stances Act were printed in the April issue of The Mary-
land Pharmacist. The Bureau of Narcotics and Dangerous
Drugs now announces the following changes:

—Patients’ address and prescribers’ registry number will
not be required on the prescription label.

—The transfer warning label will not be required until

June 15, 1971.

—Paregoric will be in Schedule III but OTC sales will be
permitted (where permitted by state and local laws).

—Prescription labels for Schedule II, III, and IV sub-
stances must contain:
a) Prescription number
b) Name and address of pharmacy
c) Name of prescriber
d) Name of patient
e) Date of dispensing
f ) Directions for use and cautionary statements, if
any.
g) Transfer warning (after June 15, 1971)

—Stocks of labels with the old IRS registry number im-
printed thereon may be exhausted.
—Prescription filing:
a) one file for Schedule II and one file for all other pre-
scriptions providing Schedule III, IV, and V_ pre-

scriptions be stamped in lower right hand corner with
red “‘C” at least one inch in height.
or

b) one file for all controlled substances providing Sched-
ule III, IV, and V prescriptions stamped as above,
plus one file for all other prescriptions.

c) one file for Schedule II prescriptions, one for Sched-
ule III, IV, and V prescriptions and one file for all
other prescriptions.

Biomedical information on iape

The National Library of Medicine will make avail-
able on subscription, magnetic tapes containing data
from the Library’s computer-based Medical Literature
Analysis and Retrieval System (MEDLARS). The tapes
contain citations to the biomedical journal articles which
are indexed to provide the data base for NLM publica-
tion and information services. Tapes will be made avail-
able in only the following format: 14” IBM 7094, 800
BPI, seven-track.

Purchase agreements are available from: Dr. Joseph
Leiter, Associate Director for Library Operations, Na-
tional Library of Medicine, 8600 Rockville Pike, Bethes-
da, Maryland 20014, ATTN: Tape Purchase Agreement.

Offering Independent

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up
to making your best source of supply,
Wels

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

Pharmacies... |

MAY 1971

Maryland Board
of Pharmacy News

Pharmacy Changes

The following are the pharmacy changes for the
month of April:

New Pharmacies

Montgomery General Hospital—Pharmacy, Edward
C. Wilson, President, 18101 Prince Philip Drive, Olney,
Maryland 20832.

No Longer Operating As Pharmacies

Princess Anne Pharmacy, Benjamin McAllister, Jr.,
Main Street, Princess Anne, Maryland 21853.

Joppa Rexall Pharmacy, Leon Levin, 1220 East Jop-
pa Road, Baltimore, Maryland 21234.

Change of Ownership, Address, Ete.

Marvin Oed, Inc., Marvin Oed, President, (Change
from Rutkowski’s Pharmacy ), 743 South Conklin Street,
Baltimore, Maryland 21224.

Kay Cee Drugs, Irving Goldberg, President, (Change
of Ownership from Leo Goldfeder, President to Irving
Goldberg, President and change of address from 4009
Main Street. Formerly Metro Drugs), Main Street, Upper
Marlboro, Maryland 20870.

Korvettes—Pharmacy, Marshall Rose, President,
1955 East Joppa Road, Towson, Maryland 21204; Kor-
vettes—Pharmacy, Marshall Rose, President, 11800 Rock-
ville Road, Rockville, Maryland 20850; Korvettes—Phar-
macy, Marshall Rose, President, Governor Plaza and
Ritchie Highway, Glen Burnie, Maryland 21061; Kor-
vettes—Pharmacy, Marshall Rose, President, 5407 Balti-
more National Pike, Baltimore, Maryland 21229.
(change of ownership from Murray Sussman to Marshall

Rose ).

__ Penn-Dol Pharmacy, Donald Schumer, President,
(Change from Individual Ownership to Corporation),
1133 Pennsylvania Avenue, Baltimore, Maryland 21201.

Notice—Board Exams

The Maryland Board of Pharmacy will conduct an
examination for registration as Pharmacist at the School
of Pharmacy, University of Maryland, 636 West Lom-
bard Street, Baltimore, Maryland.

On Monday, Tuesday and Wednesday
June 28, 29 and 30, 1971
The examination will begin at 8:00 a.m. each day.

Applications must be in the hands of the Board by Fri-
day, June 18, 1971.

Financial Statement
1970 Fiseal Year

The following statement was received following pub-
lication in the March 1971 issue of the “Maryland Phar-
macist” of the Annual Report of the Maryland Board of
Pharmacy 1969-70.

FINANCES

All funds of the Board of Pharmacy are deposited to
the credit of the Treasurer of the State of Maryland, and
disbursement covering the expenses of the Board are paid .
by voucher by the State Comptroller.

STATE BOARD OF PHARMACY FINANCIAL
STATEMENT

1970 Fiseal Year

Balance forwarded—July 31, 1969
Receipts—July 1, 1969 - June 30, 1970
Expenditures July 1, 1969 - June 30, 1970
Salaries and Per Diem of Board Members $2,047

$ 8,740
12,659

Operation Expenditures 4,303 6,350
Balance—June 30, 1970 $15,049
Transferred to General Fund Surplus $15,049
Amount forwarded—July 1, 1970 $

Effective July 1, 1970, balance of funds ($6,309) for
1970 fiscal year together with $8,740 reserve was trans-
ferred to General Fund surplus as the result of the Board
becoming a General Fund operation in lieu of operating
under Special Funds.

Respectfully submitted,
F. S. Balassone

Secretary-Treasurer

PHARMACY CALENDAR

June 5—School of Pharmacy Commencement Exercises.

June 11-13—6th Annual MSHP Hospital Pharmacy Sem-
inar, Ocean City, Md.

September 7-12—31st International Congress of Pharma-
ceutical Sciences of the FIP, Washington, D.C.

October 10-14—National Association of Retail Druggists
Annual Convention, The Rivergate, New Orleans.

October 16-21—National Wholesale Druggists’ Associa-
tion Annual Meeting, Century Plaza Hotel, Los.
Angeles.

April 22-28, 1972—American Pharmaceutical Associa-
tion Annual Meeting, Houston.

THE MARYLAND PHARMACIST

sandentpn tee tener DiI

In 1970, Roche Laboratories
broke with pharmaceutical
industry tradition by being the
first company to discontinue
mass, unsolicited sampling of
professional products. The Roche
aim is to ensure the greatest
benefit to the patient while
meeting the professional needs
of the pharmacist and physician.
All are served best by proper
handling of drugs. Better
control of all aspects of drug
distribution ensures the
highest standards of health
care for the patient, physician
and community.

This policy reflects Roche
interest in the general
problems of pharmacy
management, as well as
the pharmacist-doctor,
pharmacist-patient and
pharmacist-community
relations. There are many
of your colleagues at
Roche—practical profes-
sionals in various management positions—
yho help make the policies and provide the services
hat help you meet the challenge of pharmacy today.

ROCHE LABORATORIES
Division of Hoffmann-La Roche Inc.
Nutley, New Jersey 07110

Baltimore Metropolitan
Pharmaceutical Association

Meeting of April 22, 1971

{r. Vincent J. Lozowicki, Staff Assistant for Com-
puauce, Bureau of Narcotics and Dangerous Drugs, was
the reatured speaker at the April 22 meeting of the Balti-
more Metropolitan Pharmaceutical Association held at
the Kelly Memorial Building. Mr. Lozowicki explained the
Federal Controlled Substances Act of 1970 which went
into effect May 1.

Camp Glyndon Project

BMPA President Irvin Kamenetz then introduced
Milton Friedman, chairman for the BMPA Camp Glyn-
don Fund Raising Drive. This recreational facility for
diabetic children suffered an estimated $30,000 damage
at the hands of vandals in mid-April. The diabetic chil-
dren pay no fee for their two week stay at the summer
camp. Estimated cost of operating the facility is $125,000
per year provided by funds from the Maryland Diabetic
Association and private donations. Collection cans and
window streamers have been distributed to all community
pharmacies. Replacement cans may be obtained by con-
tacting the BMPA office or from Milton Friedman or
Charles Spigelmire.

The drive which opened on Monday, April 26 will
run for one month. It will be publicized on radio and TV
and in the newspapers. It is hoped that the camp may
be in use this summer.

Washington County
Pharmaceutical Association

The Washington County Pharmaceutical Association
met on April 21, 1971. Guest speaker was Dr. William J.
Kinnard, Dean of the University of Maryland School of
Pharmacy. Dean Kinnard spoke on continuing education
programs at the school of pharmacy. Accompanying the
Dean was Henry Seidman, Director of Continuing Educa-
tion.

The first in a series of continuing education pro-
grams for the area was held at the Washington County
Hospital on May 2, 1971. Twenty three pharmacists from
the area attended. Samuel Weisbecker, president of the
Washington County Pharmaceutical Association wel-
comed the group. Speakers included Mr. Henry G. Seid-
man, Dr. Peter P. Lamy who spoke on Cough and Cold
Remedies, Dean William J. Kinnard who spoke on Gas-
trointestinal Preparations, and Dr. Ralph F. Shangraw
who spoke on Dermatological Preparations.

Eastern Shore Pharmaceutical Society

The Spring Meeting of the Eastern Shore Pharma-
ceutical Society was held on Sunday, May 2 at the Easton
Manor Motel, Easton, Maryland. Guest speaker was
Charles Tregoe of the Maryland Board of Pharmacy. Mr.
Tregoe discussed the Controlled Substances Act of 1970.

A Continuing Education Program on O-T-C products
was presented by the University of Maryland School of
Pharmacy on Sunday, April 25 at the Easton Manor
Motel.

Prince Georges-Montgomery
County Pharmaceutical
Association

17th Annual Installation of Officers

The Prince Georges-Montgomery County Pharma-
ceutical Association held their 17th Annual Installa-
tion Dinner on Saturday, April 17 at the Burn Brae
Dinner-Theatre Club in Burtonsville, Md. Toastmaster
for the evening was Edward D. Nussbaum. Past-Presi-
dent Rudolph F. Winternitz received the A.Z.O. Dou-
ble Star Award for Meritorious Service to Pharmacy.
The award was presented by Coleman Levin, Supreme
Directorum, Alpha Zeta Omega Pharmaceutical Fra-
ternity.

The new officers of the association are: Honorary
President, Samuel Morris; President, Martin Hauer; Ist
Vice President, Edward D. Nussbaum; 2nd Vice Presi-
dent, S. Ben Friedman; 3rd Vice President, Gabriel E.
Katz; Secretary, Paul Reznek; and Treasurer, Michael
Leonard.

Joint Meeting With Montgomery County Medical
Association

The Inter-Professional Relations Committee of the
Prince Georges-Montgomery County Pharmaceutical As-
sociation, chaired by Gerald Dechter, arranged a joint
meeting with the Montgomery County Medical Associa-
tion recently to inform members of both organizations
about the new Federal Drug Control Regulations.

Photo by Paramount Photo Service

Martin Hauer, incoming President of the Prince Georges’-
Montgomery County Pharmaceutical Association (right) be-
ing presented with the President’s gavel by Ben Mulitz, Vice
President of District Wholesale Drug.

THE MARYLAND PHARMACIST

Wm. W. Gullett, Prince Georges County Executive, signing a
proclamation for National Pharmacy Week in Prince Georges
County. Looking on are Prince Georges-Montgomery County
Pharmaceutical Association members Gerald Y. Dechter,
Oliver Tibbs and Paul Reznek. A similar proclamation was
signed in Montgomery County by Stanley Kramer, County
Councilman.

The meeting which was held at the N.I.H. Audi-
torium in Bethesda, was conducted by Norman Stein,
member of the Inter-Professional Relations Committee.
Mr. Vincent J. Lozowicki of the Bureau of Narcotics and
Dangerous Drugs was the speaker. He explained the new
regulations and later answered questions from the floor.
Sharing the podium were Dr. Robert Angle, President of
the Montgomery County Medical Association and Rudolph
F. Winternitz, President of the Prince-Georges-Mont-
gomery County Pharmaceutical Association.

Women Physicians

There are 21,404 women physicians in the United
States out of a total of 306,907. This figure represents
6.7% of the total as compared to Russia’s 75%. By the
end of this decade, it is expected that women will com-
prise 15% of the physicians in the United States. In
West Germany today, 35.8% of new doctor graduates
are female. However in Spain the percentage of female
physicians is lower than that of the United States.

DID YOU HIRE A NEW PHARMACIST LATELY? ...
OPEN A NEW BRANCH? ... GET ELECTED TO
OFFICE IN YOUR SERVICE CLUB OR SOCIAL OR-
GANIZATION? . . . BECOME ASSOCIATED WITH
ANOTHER PHARMACY?

WE WOULD LIKE TO KNOW—AND SO WOULD
OUR READERS. WHY NOT DROP US A LINE AT
THE MPhA OFFICE TODAY.

MAY 1971

Medical Care Study
Shows Unexpected Results

A recent mailing to all prescribers in Maryland out-
lines the results of a study done by the Division of Medi-
cal Services on “Cost Analysis and General Prescribing
Patterns in Maryland.” A survey was performed on 10,628
prescriptions. (The State handles approximately 10,000
prescriptions on an average day.) Only four drugs were
considered for the survey. The drugs selected were Peni-
cillin G Buffered Tablets, 400,000 Units: ‘Tetracycline
Capsules 250 mg.; Chloral Hydrate Capsules 500 mg.;
and Prednisone Tablets 5 mg. An “inexpensive brand”
category was established based upon prices considered
reasonable for generic products as follows:

The following prices are per 100 tablets:

(1) $5.00 or less for Tetracycline 250 mg.
(2) $3.50 or less for Penicillin G 400,000 U.
(3) $2.50 or less for Prednisone 5 mg.

(4) $2.00 or less for Chloral Hydrate 500 mg.

There were 266 prescriptions (2.50% ) of the 10,628
prescriptions surveyed which could be included in the
study. Of the 266, 236 were written in generic terminol-
ogy or for an inexpensive brand as outlined above (ge-
neric 206, inexpensive brand 30). The preceding figures
show that 89% of all prescriptions analyzed were written
generically or for inexpensive brands by physicians prac-
ticing throughout the State.

After applying identical analytical techniques to
pharmaceutical compliance patterns it was found that
pharmacists filled 234 or 88% of the prescriptions ana-
lyzed at relatively low State expense as determined by
the criteria for inexpensive brand.

One unexpected result of this survey was the dis-
covery of a disparity between the number of prescriptions
written for expensive brand drugs, but whose cost was
included in the inexpensive brand category. This appears
to have been due to lower costs being passed on to the
State by hospital pharmacies due to their high volume
purchases.

Costs for drugs under the Maryland Medical Care
Program for the year ended June 30, 1969 were $5,843.-
000. For the year ended June 30, 1970 this cost was
$9,408,000.

Shoplifting Detection Guide

One of the nation’s fastest rising crimes—shoplifting
—is the subject for a new educational guide specifically
designed for the retail businessman.

The Shoplifting Detection Guide, fully illustrated,
contains the latest recommendations to expose shoplifters
and avoid shoplifting losses. This guide may be imprinted
with the business’ name at the top of each guide. A
multiple choice quiz comes with each guide for distribu-
tion to the business’ employees. The employee would
study the guide and return the completed quiz to his de-
partment head or immediate supervisor.

This new guide is available at quantity prices with
or without imprinting or at $1.95 each through Guardian
Publications. 915 N.E. 125th Street, North Miami,
Florida 33161.

The Student and the University
The Need for Responsibility

William J. Kinnard, Jr., Ph.D.
Dean, University of Maryland, School of Pharmacy

Reprinted from the Bi-County Pharmacist

While each succeeding generation of students down
through the ages has been influenced by major political,
sociological, or technological factors, it would seem that
the most recent generation has assimilated these factors
and developed a philosophy of life that has been unan-
ticipated by their elders.

The average student of today comes from a different
background than his parents. Most have had less religi-
ous training, many have been raised in the Spockian man-
ner (permissiveness), and they certainly have a stronger
high school education. They are children of television;
learning more vocabulary from TV than from their par-
ents and spending more time before the set than in school
attendance.

Many sociologists feel that these students have been

manipulated by society and by their companions — a
product of the constant competition in their lives, from
the nursery school through college — competing to be

the best in their class, competing to get the best grades,
competing to be accepted into college, ete. According to
Dr. Bruno Bettelheim, a noted social scientist, this has
caused a loneliness in a vast group of students—isolated
by their competition.

When one analyzes the makeup of a student body
composed of this new breed, a number of types of students
can be delineated:

1. The “typical” student-student—In this the larg-
est group, the student is primarily in school to obtain the
education offered by the various course sequences in the
University. He or she is usually goal oriented and out-
side social and political problems rarely cause this stu-
dent to be sidetracked from that goal.

2. The “‘concerned”’ student—The use of the word,
concerned, doesn’t necessarily emphasize that these stu-
dents are actually more concerned about socio-political
problems than the previous group, but is used simply to
note that they show significant outward signs of this
concern through their participation in various types of
demonstrations. Their career goal is interspersed with
a desire to correct the faults of our society. Leadership
in this group is not well structured and quite often they
will follow a certain pathway when urged by available
leaders, whoever they might be. These students are not
violent by nature.

3. The activist student—These students are extreme-
ly active in attempting to change the establishment, par-
tially or totally. There are those in this group who are
constructively working to correct obvious faults. There
are others that are working only to cause the collapse of
our society’s structure, at any cost. In this latter group we
see many subgroups: the vocal leader, one who ignites a
crowd and then disappears when physical action results;
the destructive element, that uses acts of violence to de-
stroy the status quo. Some of these radicals have now gone
underground to surface only when disruption is to occur.

Some, according to one author, have remained emotion-
ally fixated at the age of the temper tantrum.

The campus thus presents a mosaic of student-types
that display varying degrees of activism toward intra-
and extra-school problems. From this collage has erupted
demonstrations on:

The war in Indo-China,

The tenure system,

The grading system,

The killing of students at Kent and Jackson State,

The draft,

ROTC on campus,

The trials of the Black Panthers,

The low wages of maintenance workers on campus,
and

The polluted environment.

These causes, sometimes different, sometimes related,
blend into a series of demonstrations whose causative
reasons often tend to be blurred in the minds of those
observing from outside their ranks.

What about the university during this student evolu-
tion and revolution? It has generally remained unshaken
in its traditional concepts of its role in the educational
process, perhaps attempting a test of the theoretical phy-
sics problem of the immovable object meeting the irresist-
able force.

The university is called a community of scholars;
one that is hopefully free from political influence through
a set of controls developed over the years involving boards
of regents at State universities, the tenure system, etc. It
has rapidly enlarged in the last twenty years as it ab-
sorbed ever increasing numbers of students and in doing
so quite often has not sufficiently altered some of its poli-
cies to meet this physical onslaught of student numbers,
as well as the mental onslaught caused by the often un-
expected demands of these students.

Let’s look at some of the problems pinpointed by stu-
dent demands.

1. The ability of the college teacher—Often in the
first years of college students only see graduate assistants
or professors who are buffered from the individual student
by the vast number of his classmates. The professor,
who by virtue of his Ph.D., has been apparently divinely
appointed to the role of teacher; since he has usually had
no training in educational techniques. Quite often his
teaching skills are completely inadequate. In the sciences
and professions, the Ph.D. may even teach grudingly
since it takes him away from his research. These need to
be corrected by improving teaching methods, attracting
better teachers, bringing educational techniques specialists

into our schools, and by utilizing new audio visual tech- |

niques.
The tenure system for teachers was designed to en-

sure that an individual would be free from outside pres-

sures, political and otherwise, so that he might teach with
a fair degree of academic freedom. This system does
have its faults since it can follow the perpetuation of a
bad teacher until his retirement, a disadvantage probably

THE MARYLAND PHARMACIST

kor physicians
and their patients

ED +TUE «VION «-SUN «-SAT <—- FRI

O©O

DAY os ue on > 24 + 25 26 = 27 28

OVRAL-28

21 white tablets each containing

0.5 mg. norgestrel with 0.05 mg. Balt estradiol

and / pink inert tablets

To order, contact your Wyeth salesman

or nearest branch.

®
Wyeth Laboratories Philadelphia, Pa.

outweighed by the need for academic freedom. The selec-
tion of those teachers granted tenure, however, is very
important for the forementioned reason. In drawing up
the guidelines for the granting of tenure, one must define
what a teacher should be. Is he one who is well liked by
his class and relates to today’s problems? Can he be that
and nothing more? I think not! For while he is effective
today, he must be expanding his knowledge through re-
search to prepare himself for a time 10-20 years from now
when again he must pass the test of practicality and rele-
vance.

2. Grading systems—Pass or fail and other systems
are being suggested by the students involved in this
spring’s crisis. But what about next year, do we have an-
other crisis and a cry of the pass or fail system again?
Our present method of evaluation is not satisfactory and
we do need to re-examine our academic programs and see
how we can best evaluate student progress. But to move
to a pass-fail system totally is moving toward the homo-
genization of our student talent. This is a disastrous shift
away from the search for excellence. You might recognize
this as occurring in many areas of our society. Even the
new work in health care is producing a system that will
reduce the excellence of health care available to some of
our society in order to develop the broad based structure
of health care that is needed to cover all of our people.

3. Student participation in policy determination in
the university—The University has been remiss in not
listening to the voice of the student, but the degree of
involvement is debatable. As an example, the State of
New York opened a new university at Old Westbury,
L. I. four years ago. It was set up to be a program in
partnership with the student body. A recent analysis of
the effectiveness of this concept has led to serious doubts
as to the practicality of this concept. As an example, the
original students on the committee for building design
are gone and the new students are demanding that the
original plans be junked and redesigned along their
thinking. Students must have an input into policy mak-
ing, but on most committees their voice can’t be a ma-
jority or equal one to the faculty and adminisiration. The
university must go on, long after the departure of any
student no matter how gifted he or she is.

What does the University need to do to help correct
the present situation?

The university must maintain a firm, yet reasonable,
guidance of the students, it cannot yield to immature
requests because this will simply lead to additional de-
mands. The university must find ways to educate these
students who have a different definition of self. Part of
this can be accomplished through better teaching meth-
ods, by the recognition by a teacher that he should be
just that. The students should be allowed to speak about
university policy and learn the ways in which it is de-
termined. Education must also find a way to break the
vicious circle of competition in which students are thrust,
perhaps a change in the grading system could be a way
that the intense competition would be partially relieved.

What must the students do? The large group of
students that are in the student-student category must be
activated, perhaps even radicalized. They must become
more aware of problems and seek ways to solve them. In
doing so they must provide constructive leadership to
other students as a more logical alternate to anarchistic
leadership and rebellion.

In conclusion, I would like to quote from an edi-
torial in the Diamondback, the University of Maryland
student newspaper, “. . . the institution called a univer-
sity is the best friend students have in society. Nowhere
else is idealism the counterpart of reality. Nowhere else
may an individual speak, dissent, and argue to any point
as freely as within the university. To destroy the very
structure upon which these freedoms are built is suicidal
and ultimately destructive to all of society.”

This quotation needs to serve as a basic fact around
which the student body, faculty, and administration can
build a more responsive and responsible university.

NABP Holds School For Drug Law
Officers

The National Association of Boards of Pharmacy
held its Fifth School for Drug Law Officers in Washing-
ton, D.C. May 16-20. The School was made possible
through a grant from the National Pharmaceutical Coun-
cil.

Over 40 drug law officers, including Board of Phar-
macy inspectors, secretaries, etc. attended the five-day
session.

COMMUNITY

PUBLIC PHARMACIST

Rb Sula by

A CITATION HE DESERVES

THE MARYLAND PHARMACIST

There’s alot more going for you at LOEwy

Sheclvc PERSONALIZED SERVICE PLUS

provides you with the flawless backing of 100% computerization—
along with the special personal follow-through of people who care

FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY

: king. (301) 485-8100 for office and daytime order taking.
After hours, 485-8105 for order taking. (301) we ae a a
aes

LOEWY DRUG COMPANY ey: Spectro SIndustotes, Ine.

6801 Quad Avenue, Baltimore, Md. 21237 Tel.: (301) 485-8100

Hospital Pharmacy
Section

Maryland Society of Hospital Pharmacists
April Meeting

The April 8 meeting was held at the H. B. Gilpin
Co. in Baltimore. Earl Maseth, FDA Consultant to the
Bureau of Drugs, Division of Industry Services, presented
a slide-talk entitled ““What is your QA on Sterile Dis-
posable Medical Devices”? Mr. Maseth pointed out that
as consumer demands for better sterile packaging in-
crease, so must the manufacturer’s controls increase in
order to keep the Quality Assurance Quotient (Q.A.
Quotient ) constant.

Robert Snyder announced that a copy of the “Sug-
gested Guidelines and Principles for Pharmaceutical
Services in Hospitals” and the Pharmacy-Nursing Liaison
Committee statement on drug dispensing and administra-
tion would be mailed out soon to all members. The
Guidelines will also be mailed out to the Administrator

of each hospital in Maryland.

The Professional Practices Committee of the Mary-
land Hospital Association will meet on April 20 and
Henry Derewicz, our representative to this committee, will
discuss, among other topics, implementation of the Guide-
lines, development of supportive personnel, and pharma-
cist consultation in the design of new health facilities.

Robert Snyder, Mary Connelly, and Tom Patrick,
who were our three delegates to the Annual Convention
of the ASHP in San Francisco, reported on that meeting.
Nominated for President-Elect of the ASHP are Wendell
Hill and William Hotaling. R. David Anderson was in-
stalled as President.

Clarence Fortner reported on the Annual Seminar
scheduled for June 11, 12, and 13. Dr. Peter Lamy, Pro-
gram Chairman for the Seminar, reviewed the list of
speakers and topics. Howard Sherman reported on the
membership committee. Eighty-five non-member hospital
pharmacists received a follow-up mailing from last year’s
membership survey.

June Shaw announced that she was completing de-
tails on the May 13 combined Maryland-D.C. meeting.
Robert Snyder announced that he and Dr. Ralph Shan-
graw had participated in Careers Day at the Community
College of Baltimore on April 7. A display was arranged
and brochures were available to the 11th grade students.

The following were accepted for membership: J. Ed-
mond Stickell, Eaton Laboratories; Darlene F. McMahon.
Student-Class of °71; James TerBorg, Student-Class of
°71; and Marina J. Young, Student-Class of 71.

President Snyder thanked the speaker, Karl Maseth
and thanked the Henry B. Gilpin Company for sponsor-
ing the meeting. The meeting adjourned at 10:00 P.M.

SKIN TESTS

by Normand A. Pelissier

Skin tests are most useful in allergies caused by
contactants and inhalants, but are becoming increasingly
important in diagnosing and in regulating treatment of
various systemic diseases; e.g. systemic fungus infections.
The wheal and flare are characteristic positive responses,
appearing within 5 to 15 minutes in specific allergic dis-
orders. The tuberculin type of response develops slowly
over a period of 24 to 72 hours.

(1) SCRATCH TESTS are performed in rows on the
patient’s back or forearm. The scratches should
be about 1 cm. long and 2.5 cm. apart. The skin
surface should be torn rather than cut, without
drawing blood. An allergen then should be ap-
plied to each scratch.

(2) For INTRADERMAL TESTS, a tuberculin sy-
ringe is fitted with a short-bevel 26 or 27 guage
needle. A separate syringe and needle must be
used for each test substance. Not more than 0.02
ml. should be injected.

(3) INDIRECT SKIN TESTING (PASSIVE TRANS.-
FER) may be done when direct skin testing is
not feasible (as in dermographism, ichthyosis,
eczema ). Blood (5 to 10 ml.) is drawn from the
patient and centrifuged. Using the 7th cervical
vertebra as a landmark, the back of a nonallergic
adult is marked off in checkerboard fashion and
0.1 ml. of the allergic patient’s plasma introduced
at each test site. These sensitized areas may be
skin-tested with the suspected allergens 2 to 4
days later, the contralateral side of the back be-
ing used as a control.

(4) For PATCH TESTS, the suspected material is
placed on a paper, gauze, or linen patch, applied
to the skin by means of adhesive or cellophane
tape and allowed to remain in place for 24 to 48
hours unless the patch unduly irritates the skin,
in which case it must be removed at once. Com-
mercial patches may be used, but in any event
the material is kept in a closed covered system up

to 48 hours to promote penetration and to allow —

time for the delayed reaction to develop. The
area must not be bathed. A great number of varia-
tions of techniques have been proposed but none
achieve total uniformity or standardization. For
example, reactions in summer regularly exceed
those of winter.

Examples of Commonly Used Skin Tests

BLASTOMYCIN

For diagnosis of blastomycosis

BRUCELLERGEN

For diagnosis of brucellosis

THE MARYLAND PHARMACIST

|
|

COCCIDIOIDIN

For diagnosis of coccidioidomycosis

DICK TEST

For susceptibility or immunity to scarlet fever

FREI ANTIGEN

Test for lymphogranuloma venereum

HISTAMINE CUTANEOUS TEST

For nonfunctioning sensory nerves of the skin

MANTOUX TEST
(old tuberculin, human )
For diagnosis of tuberculosis

MUMPS SKIN TEST ANTIGEN

Test for hypersensitivity to mumps vaccine

SeHIGKSCKST
Test for immunity to diphtheria

TOXOPLASMIN

For diagnosis of toxoplasmosis

TUBERCULIN TINE TEST

For diagnosis of tuberculosis

TUBERCULIN, PPD
(1st, intermediate & 2nd strengths)
For diagnosis of tuberculosis

TRICHINELLA EXTRACT

Aid in diagnosis of trichinosis

Ref: Shelley, Walter B. “The Patch Test’ JAMA 200:170

(June 5), 1967

The Merck Mannual, 11th Ed. MSD Laboratories,
Rahway, N.J., 1966

MSHP Announces Election Results

Recently elected to office in the Maryland Society of
Hospital Pharmacists are the following: President-Elect-
Normand A. Pelissier, Secretary-Dolores A. Ichniowski,
Treasurer-Thomas E. Patrick, Board of Directors-Samuel
Lichter and June H. Shaw. Sydney L. Burgee, Jr. con-

tinues to serve as a member of the Board.

Incoming President Mary W. Connelly and all other
officers will be installed at the Society’s Sixth Annual Hos-
pital Pharmacy Seminar in Ocean City, Md. June 11, 12,
and/13, 1971.

Tolfnaftate (Tinactin) Preparations
Change Status April 1

Preparations of tolnaftate (Tinactin) will become
exempt from prescription order only status effective April
1. Pharmacists are cautioned, however, that even after
April 1 it would be a violation of the Food, Drug, and
Cosmetic Act to dispense on an OTC basis any tolnaftate
preparations which bear the “prescription-order-only”
legend on their package labeling—since adequate direc-
tions for use and certain warnings would not be present
on the “prescription-order” labeled stock.

MAY 1971

Pension & Investment
Associates of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)

HR-10. .

Plans (Sole Proprietor-Partnerships )
Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

The United States of Mangini

MANGINI & ASSOCIATES, INC.
4850 W. Belmont Ave., Chicago, III. (312) 282-8181

11722 Studt St., St. Louis, Mo.
2760 W. Market St., Akron, Ohio
575 Savin Ave.,West Haven, Conn.
5501 Cherokee Ave., Alexandria, Va.

Dangers in the Misuse of Drugs
By David A. Blake, Ph.D.

Associate Professor of Pharmacology
University of Maryland
School of Pharmacy

Presented at Community-University Day, Au-
gust 2, 1970, University of Maryland, College
Park, Md.

The drug problem with youth today is at least par-
tially the result of their exposure to adults who have per-
petuated the idea that the stresses of daily life require
chemical relief.

Unfortunately, drugs are potential poisons. They
possess the capacity to cause serious and sometimes fatal
damage, although deaths caused by properly used drugs

are rare.

Some of the toxic effects of drugs are grouped into
dose-related effects. The greater the dose, the greater the
effect. Too much anesthetic may prevent a patient from
waking up; an overdose of morphine or heroin may stop
breathing. Such dose-related deaths can usually be avoid-
ed if the correct amount of active ingredient is measured
in the tablet or capsule (incorrectly referred to as “pills” )
and proper dosage given.

Pharmacists and the drug industry usually produce
drugs that have the proper potency. Mistakes are rare
due to an extensive training of personnel, high standards
and quality control procedures.

The problem that sometimes arises is that not all
people require the same dose of a drug to cause the de-
sired effect without producing dose-related toxicity. Hu-
mans are not like light bulbs that require precisely 120
volts to operate properly. The proper dose of most drugs
for each individual varies widely among the population
and also changes in the same individual. Consequently,
when a person takes the “‘proper dose,” it may be too little
or too much for him because the dose was the “proper
average.” If the dose were too much in the case of digi-
talis, the heart might flutter and stop. Too much anti-
coagulant would cause serious internal bleeding. Certain
drugs are legally available only with a prescription from
an authorized prescriber because of this dosage problem.

This does not mean that drugs available without a
prescription (over-the-counter or OTC drugs) are not
dangerous. It does mean that there is less risk with these
drugs. However, OTC drugs can produce serious toxicity
if used improperly. For example, aspirin can cause ulcera-
tion of the gastrointestinal tract especially in persons
prone to peptic ulcer. Many cold remedies contain drugs
capable of causing very high blood pressure, especially in
persons with hypertension. It is apparent that the per-
son who chooses to self-medicate with OTC drugs should
seek the advice of a physician or pharmacist, or at least
take care to read the label and precautions before using
the drug.

Another hazard of self-medication stems from the
fact that many drugs can change the action of other
drugs. For instance, aspirin can cause serious internal
bleeding in the patient who is taking anticoagulants.

Some nasal decongestants can interfere with the action
of insulin in diabetics.

Drugs can also affect diagnostic tests and then pre-
vent physicians from correctly diagnosing a _patient’s
condition. For example, certain cough syrups can react
with the thyroid tests so that a person would appear to
have an overactive thyroid gland. Many drugs can change
the blood sugar concentration to mistakenly suggest a
diabetic condition.

Drug users can avoid these problems by adhering to
the following “do’s and don’ts.”

e@ Always take prescribed drugs according to the
directions and always finish the prescription unless di-
rected to the contrary. Many persons erroneously assume
they can stop taking antibiotics when they feel better
and usually suffer a relapse.

@ Never take someone else’s prescription nor offer
yours to another person. Both the drug and the dosage
were selected for you based on many factors which you
might not recognize.

@ Consult a physician or pharmacist before self-
medication, regardless of how trivial you consider the
problem. Even drugs as innocuous as the antacids can
cause problems,

@ Tell the physician or pharmacist your symptoms
and what other drugs you are taking.

@ Promptly report any side effects you were not
warned about. Most serious drug reactions are preceded by
tell-tale symptoms warning you to stop taking the drug
or take another one to counteract the effects.

@ Ask your pharmacist if he keeps a personal or
family record of your drugs. If he does not, try to find
one that does. This is the only way to learn of incorrect
combinations if you have more than one physician.

@ If you have any questions regarding the medica-
tion or its effects, don’t hesitate to question the physician
or pharmacist. Many times your query will alert them to
mistakes. They are human and also busy.

@ Don’t try to get more refills than your prescrip-
tion designates. For many drugs the law limits the num-
ber of refills to 6; otherwise, the prescriber must be con-
sulted to insure that your situation is still being checked
and that the drug will be discontinued when no longer
necessary.

® Keep the phone number of your local Poison Con-
trol Center handy in case of an emergency involving in-
gestion or contamination with drugs or household prod-
ucts.

@ Since many ingestions of drug overdoses and other
poisons are first treated by inducing vomiting, keep a one
ounce bottle of Syrup of Ipecac in your home in a safe
place. This can be obtained without a prescription from

THE MARYLAND PHARMACIST

a pharmacist. The poison control office can instruct you
when and how to use this drug.

@ Finally, teach your children the proper respect
for drugs. Don’t tell them that aspirin is candy when
they are infants and then expect them to change their
attitudes when they are older.

These suggestions, however, still do not insure drug
safety. As foreign chemicals to the body, drugs can be-
come antigens and cause various allergic reactions from
skin rash to fatal liver damage. There is no way to pre-
_ dict in advance who will become sensitized to a particular
drug, although persons who have asthma or other aller-
gies are more prone to drug allergies. Exposure to just
the dust of penicillin tablets has caused reactions in al-
lergic individuals. Drug allergy is a non-dose related

effect.

Other non-dose related effects of drugs include birth
defects, cancer, and genetic mutations. One may wonder
why these effects are not seen during animal testing and
why they can not be recognized after they are used in
humans, Thalidomide does not produce birth defects in
most animal species, but the human is exquisitely sensi-
tive. It took four years to recognize this drug as the
cause of 7000 grotesquely malformed babies in Europe.

There are drugs such as aspirin and antihistamines
that produce birth defects in animals. These drugs may
not, however, produce the same horrible action in hu-
mans. The question cannot be answered except by specu-
lation, since it would be unethical to test these drugs on
pregnant women. It is probably, however, that some of
the many pregnancies that end in miscarriage or birth
defect are the result of drug exposure during pregnancy.
The safest practice is for women of child-bearing poten-
tial to abstain from drugs unless they are absolutely
necessary. Birth defects are produced during the first
and second month of pregnancy.

Cancer is still an enigma in medical science. Many
causes have been suggested but few proven. Certain drugs
or closely related chemicals can produce cancer in ani-
mals. At least one expert has stated that anything given
at a high enough dose over a long enough period of time
can produce cancer. Cigarettes are a good example of
this fact, yet it took billions of smoker-years to establish
the relationship scientifically. Certainly this unknown
aspect of oral contraceptives is one of the reasons for the
recent concern of indiscriminant and prolonged use of
them.

Mutations, which are produced by alterations of the
chromosomes—those tiny DNA fragments that carry all
of the information necessary for proper growth, function
and reproduction—have been caused by some drugs under
experimental conditions. Most of the anti-cancer drugs
produce chromosomal changes but this is to be expected.
Surprisingly, caffeine and even certain tranquilizers have
been found to cause alterations of chromosomes.

Actually the main reason for the removal of cycla-
mate from soft drinks was that a breakdown product had
been shown to cause mutagenic effects, not because it
had been shown to cause bladder cancer in rats. The lat-
ter effect was cited as the reason, because of a law speci-
fying that food additives cannot cause cancer in animals.
There is no law concerning the mutagenic potential of

drugs.

MAY 1971

The non-dose related toxic effects of drugs shows that
every drug ingestion is associated with some risk regard-
less of the drug, the patient, or the circumstances. The
question, “Do the expected benefits outweigh the poten-
tial harm?”, must be answered by the physician, prior
to writing a prescription, or a drug user, prior to self-
medicating.

The increased use of drugs among the youth intro-
duce other hazards. Most heroin addicts die of liver
disease, infections caused by unsterile injections, or of an
overdose. Many “‘speed mainliners” experience temporary
or permanent insanity. Kids that use “downs” have died
of overdoses (0.d.’s), especially if they were drinking.

Some “acid heads” go on bad trips they wish they
had never taken. And there are numerous reports of kids
who sniffed too much model airplane glue and were as-
phixiated. Presumably these people don’t practice ra-
tional drug use or they would have decided that the po-
tential for harm exceeded their whimsical and somewhat
naive quest for a high, trip or whatever other psychoactive
experience they sought.

Although its toxic capabilities are still being studied,
marijuana represents a most disturbing and increasing
practice of society—that of self-medication with tran-
quilizing and mood altering drugs. Alcohol and nicotine
fall into the same category but neither produce the hal-
lucinations and aberrent behavior that can be caused by
marijuana and the more potent form of Cannabis known

as hashish.

Medical science knows little of addiction or drug
dependence except that many drugs that have desirable
effects on the brain will eventually cause a craving and
compulsion to continued use. Unfortunately the desire
stays after the drugs are gone. Neither the possibility of
dependence after prolonged use of marijuana nor its
comparison to alcohol matters as much as why members
of society resort to this cerebral masturbation.

Society with all its problems cannot be blamed. In-
stead, drug abusers need to ask themselves what human
good is served by this self-excision. In times past, people
resorted to religion, family, or nature for relief from
anxiety. While these “outs” may seem “square” and
“straight” today, they don’t produce physical toxicity. In
fact, dependence on them can be satisfying and reward-

ing.

Headquarters for

PHOTO-OFFSET PRINTING MAILING
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

Measles—Mumps—Rubella
Combination Vaccine Approved

A new, three-in-one vaccine against measles, mumps
and rubella has been approved for marketing in the U.S.
by the National Institutes of Health. Merck Sharp &
Dohme, Division of Merck & Co., Inc., said supplies of
its new combination vaccine, which has the trademark
‘M-M-R’, are expected to be available for use by physi-
cians this June.

Simultaneous with the action on the three-in-one
vaccine was the licensing by the N.I.H. of a double vac-
cine for use against measles and rubella, also issued to
MSD. The company said plans are now being made for
marketing the new double vaccine.

Licensing of the vaccines, which comes after more
than three years of laboratory and clinical testing, has
just been announced by the U.S. Department of Health,
Education and Welfare. Federal regulations for the vac-
cines were established by the Division of Biologics

Standards in N.I.H.

The vaccines come at a time when the nation has
nearly reached the halfway mark in its goal to immunize
48 million youngsters against rubella, and also when
health authorities are warning against the rising inci-
dence of regular measles.

The combination vaccines prompt essentially the
same antibody levels as each vaccine administered sepa-
rately. The single vaccines induced almost 98 percent
antibody response for measles, 96 percent or more for
mumps and 96 percent for rubella. In clinical trials, re-
actions to the triple and double vaccines, including fever,
have not occurred more frequently than with the single
vaccines given alone.

MSD said the triple vaccine is designed to protect
children against measles, mumps and rubella with a
single injection in order to make vaccination more con-
venient for parents and physicians and to spare children
the discomfort of two additional injections.

The combined vaccines were developed by Drs.
Maurice R. Hilleman and Eugene B. Buynak and their
associates at the Merck Sharp & Dohme Research Labora-
tories. This same group also developed the world’s first
separate measles, mumps and rubella live virus vaccines.

In August, 1970, the NIH Division of Biologics
Standards licensed the company to manufacture a double
vaccine against rubella and mumps, which has been
available to physicians since that time.

Measles, mumps and rubella are acute contagious
diseases caused by different viruses that are usually
spread by young children. Although measles is usually a
harmless disease, it can be a serious health problem. In
the past, it has accounted for several hundred deaths in
children each year, as well as thousands of cases of en-
cephalitis, which sometimes caused permanent brain dam-
age in those afflicted.

Mumps, like measles, is usually regarded as one of
the minor illnesses of childhood, and, for mumps, this
is generally true. But in some children and many adult
males, the clinical course of the viral infection may be
quite painful and distressing. On relatively rare occa-
sions, complications may include impairment of the brain,
the ears, the eyes, the heart and the reproductive organs.

Rubella is generally a mild disease in children, but
the virus may cause birth defects when it strikes preg-
nant women. As a result, public health officials have
stressed the need for widespread immunization of chil-
dren as a means of reducing the number of potential
carriers of the disease thus avoiding the exposure of
pregnant women to the virus.

The last major outbreak of rubella occurred in the
U.S. in 1964-65 and left in its wake some 30,000 fetal
deaths and 20,000 children born with birth defects.

In connection with plans for marketing of the three-
in-one vaccine in June, the company pointed out that
this vaccine is indicated for use in children between the
age of one and puberty, and that it probably fits best in
the routine immunization program for well babies start-
ing at twelve months. This is the age previously recom-
mended for the administration of live measles virus vac-
cine alone.

As with rubella vaccine alone, the triple vaccine is
contraindicated for use in pregnant women or in women
who may become pregnant within three months after
vaccination. The company’s directions note that because
the vaccine contains live rubella virus, it should not be
used for routine immunization of adolescent and adult
women. The vaccine is contraindicated in persons in
whom any of the component vaccines are contraindi-
cated. There are no known contraindications unique to
the triple vaccine.

Parke, Davis Mails ‘‘Dimpled” Capsules

Pharmacists all across the country are receiving
free “dimpled” gelatin capsules from Parke, Davis &
Company. The empty capsules, trademarked ‘“Pre-Fit,”
are being distributed to the company’s customers at no
additional cost.

The main characteristic of the capsules—two slight
indentations or “dimples” in the cap—are designed to
prevent premature separation during shipment of han-
dling. According to Romeo B. Franceschini, director of
Parke, Davis’ industrial products division, the “Pre-Fit”
capsules will eventually replace the company’s present
gelatin capsules.

Retirement Sometimes Premature

People who are young for their years should not be
retired at age 65, Dr. Irving S. Wright, an expert in
arterial diseases, strongly advises. Routine involuntary re-
tirement represents great loss to companies that have
spent years and large sums of money in training a man.

Dr. Wright describes “a biologically young person”
as one who “still has the ability to conceive, initiate,
adopt, activate, and operate new ideas, including those of
others, no matter how radically new they may be.”

Physically, the physician describes him as standing
straight, and moving quickly. “His face is full of life, he
speaks well and interestingly, and he is still an able ad-
ministrator who is much liked by the people in his de-
partment.”

THE MARYLAND PHARMACIST

| Mr. Pharmacist --

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4, Salesman inventory control

To get the complete story—call collect [301] 243-4439

PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue
Baltimore, Maryland 21218

MAY 1971

Grace Period Established For
BNDD Registration

Notice Received From

UNITED STATES DEPARTMENT OF JUSTICE,
Bureau of Narcotics and Dangerous Drugs,

Washington, D.C. 20537.

Because of unexpected problems in registering by
May 1, 1971, previously unregistered practitioners, indi-
vidual practitioners, institutional practitioners, importers
and exporters including import and export brokers, the
Bureau of Narcotics and Dangerous Drugs has found it
necessary to allow a grace period on the requirement of
a BNDD registration number by the above-mentioned in-
dividuals and institutions until our Registration Branch
is able to catch up with the backlog of new applications.
Individual practitioners would include, but not be lim-
ited to, physicians, psychiatrists, podiatrists, osteopaths,
naturopaths, dentists, veterinarians and researchers who
are attempting to obtain personal research registrations.
Institutional practitioners would include, but would not
be limited to, hospitals, nursing homes, pharmacies, pub-
lic and private laboratories, public and private university
research projects, and industry research operations.

Under this policy pharmacists may continue to fill
practitioner’s prescriptions without a registration number
providing that:

(1) They have exercised their best professional
judgement to ensure that the practitioner is au-
thorized to practice in the particular State, and; (2)
all such prescriptions contain the following state-
ment: “Federal registration applied for on (Date),”
Current dealings with the applicant practitioner
would be indicative of his present qualifications.

Manufacturers and distributors may sell schedule III
through V controlled substances to practitioners without
registration numbers providing that they satisfy them-
selves:

(1) of the authenticity of the purchaser, and; (2)
that this individual or institution normally would
have been authorized to purchase such substances
under the Controlled Substances Act had time per-
mitted processing of their application. The following
statement must be placed on all such orders: ‘“‘Fed-
eral registration applied for on (Date) .” Here
also, current dealings with the applicant practitioner
would be indicative of his present qualifications.

The industry and the professions are expected to ex-
ercise caution and good judgement when supplying con-
trolled substances or filling controlled substance prescrip-
tions of a non-registered individual. If there is any doubt,
they should contact BNDD Regional Offices before filling
controlled substance prescriptions or orders. (31 Hopkins
Place, Room 955, Baltimore, Md. 21201 Tel. 962-2224)

All intern and resident physicians authorized by
State law to make an independent judgement as to
whether a controlled substance prescription is warranted
in a particular case involving out-patients or patients
leaving the hospital, may do so using the hospital BNDD
registration number until they become registered person-

ally. However, such interns and residents must apply for
Federal registration immediately.

This policy will terminate no later than 90 days
from May 1, 1971, unless specifically extended. Intern
and resident use of the hospital’s registration number
terminates upon their personal registration or completion
of their training period, or after the expiration of 90
days from May 1, 1971, whichever comes first.

For further clarification contact your nearest BNDD
office.
Sincerely,
John Finlator
Acting Director

Cancer Immunization Theory

A renewed interest in the theory that cancer is
caused by a virus and can be brought under control by
immunization has emerged from the laboratory findings
of one of the nation’s foremost cancer research specialists
at the Bronx Veterans Administration Hospital.

Dr. Ludwik Gross, senior medical investigator and
chief of the cancer research unit at the Bronx VA Hos-
pital, has reported significant results in the immuniza-
tion of guinea pigs against leukemia.

The results of his laboratory experiments are cur-
rently featured in the Swiss scientific journal Acta Hae-
matologica and demonstrates that transmitted small
strains of leukemia implanted in guinea pigs appear to
result in successful immunization.

Dr. Gross’s experiments began by demonstrating that
leukemia can be transmitted to healthy guinea pigs.

“All inoculated animals,” he said, “develop leu-
kemia and die from the spread of this disease.”

Dr. Gross observed, however, that when small doses
of leukemia cell extracts are inoculated superficially into
the upper layer of the skin, small intracutaneous leu-
kemic cell infiltrates develop at the site of the inoculation
and that these resulting tumors in certain animals “re-
gress spontaneously without a trace.”

In experiments carried out recently in his labora-
tory, Dr. Gross reported that 42 per cent of guinea pigs
inoculated intracutaneously with small doses of leukemic
cells recovered spontaneously from intradermal leukemic
tumors. The great majority of animals that recovered
from intracutaneous tumors were found to be solidly im-
mune to reinjection of heavy doses of leukemic cells.

These laboratory observations, Dr. Gross was careful
to stipulate, have no application at present to either the
prevention or treatment of leukemia in man.

The Paris newspaper France-Soir, in commenting on
Dr. Gross’s experiments, stated, however, that his findings
in guinea pigs were of fundamental importance since it
demonstrated for the first time that active, specific im-
munity against leukemia can be obtained in laboratory
animals.

Although an ultimate development of a preventive
leukemic vaccine in man may be still far off, Dr. Gross’s
observations open an encouraging and hopeful possibility
in the fight against the dreaded and mysterious disease.

THE MARYLAND PHARMACIST

‘Display the Bidette duo for
tullmonth feminine hygiene ~

oa — - Over the past two years more
: : —-. trtsts—isi‘COsCONO than 3 million packages of
. Bidette have been sold to
women, who not only want
Bidette Mist for odor pro-

at
feminine hygiene tection during normal days

...but also want Bidette |
_ deodorant mist” | 7 Towelette for difficult days

: : when they wish to cleanse

as well as deodorize.

This year our expanded
national advertising
campaign will be sending
more women than ever
before into your pharmacy
looking for Bidette. Display
the Bidette Duo prominently
so your customers can find
them...and you’ll find your
profits growing.

Youngs Drug Products Corporation
™ 865 Centennial Ave., Piscataway, N.J. 08854

INTIMATE
FEMININE HYGIEN

Deodo ran
Mist

INTIMATE
PEMININE
HYGIENE

Joseph L. Garde

Joseph L. Garde, President of West Wholesale Drug
Company and Spectro Industries, Inc., will be honored at
the Sixty Third Annual Convention of the Drug Sales-
men’s Association of Pennsylvania on Friday, June 11,
1971 at the Westover Gulf Club in Norristown, Pennsyl-
vania.

Mr. Garde was presented the Tower of David award
in 1969 and in 1970 he received an award from the
United Jewish Appeai while also being named “Man of
the Year” by the New York Division of Pharmaceutical

Trade.

SALMONELLOSIS

Salmonellosis is an acute infectious disease with a
sudden onset of abdominal pain, diarrhea and frequent
vomiting which may last several days. Fever is nearly
always present. It can be spread by contaminated food,
or by person to person contact. The most likely sources
of food infection are poultry, eggs, egg products, salads,
meat, meat products, powdered milk and the feces of in-
fected persons or animals. Large outbreaks in nursing
homes or other institutions are usually due to contami-
nation of food during processing in the institution itself.
Although usually mild in healthy adults, the effects of
Salmonella infection may be severe at any age, and death
may result in the older and younger victims.

Although the outbreak at Gould Convalesarium be-
gan Monday, July 27, 1970, it did not come to the at-
tention of the Baltimore City Health Department until
Friday, July 31, 1970. For this reason, tracing the disease
with any certainty by food epidemiologists of the City
Health Department was difficult.

To prevent a recurrence of such Salmonellosis inci-
dents in the future, a telegram has been dispatched to
all institutions stressing the importance of reporting all
future communicable disease outbreaks to the Baltimore
City Health Department within 24 hours as required by
law and pamphlets and other information on Salmonel-

losis have also been sent. In addition a letter will be sent
regularly each year to all Baltimore institutions which
will remind them of the communicable disease reporting
law. Other regular mailings will also remind institution
personnel that to prevent Salmonellosis, eggs and poultry
must be cooked sufficiently, work surfaces where chicken
has been cut up must be thoroughly disinfected between
each use and that food handlers must wash their hands
before handling food and particularly after visiting the
bathroom. It is also required that food handiers, if they
feel sick, should avoid all hand contact with food and
should not work.

Computer Tells Nature of Lethal Drugs,
Helps Doctors Decide Correct Treatment

During the past 15 months 45 patients who have
entered Suburban Hospital in Bethesda suffering from
potentially lethal doses of barbiturates or other drugs
have survived because a computer determined the na-
ture of the drugs. Because of this the physician was
able to administer the correct treatment.

When a patient takes a sufficient amount of drugs
that may kill, the emergency room physician must act
swiftly. He must try to reduce the concentration of the
drug in the body in order to save the patient’s life and
also to prevent irreversible damage to the brain or other
vital organs. But frequently the patient is unconscious
and there may be no indication of the drug imbibed,
and the amount.

Recently the NIH National Heart and Lung Insti-
tute reported a technique that, usually within an hour,
can determine which drug or drugs the patient has in-
gested, and approximately how much he took. This sys-
tem may also help to determine whether the drug is still
mainly in the patient’s stomach or in his bloodstream.

Their method uses gas chromatography plus mass
spectrometry to analyze a sample of the patient’s stomach
contents and/or blood. The gas chromatograph rapidly
separates drugs from one another and also from normal
components of biological fluids. As the pure compounds
emerge, one by one, from the column of the gas chromato-
graph, they enter the second part of the instrument; the
mass spectrometer. Here the compounds are bombarded
by electrons to produce a complex signal, called the mass
spectrum, that provides a very precise “fingerprint” of
the drug in question.

The NHLI scientists have collected the mass spectra
of 80 of the most toxic common drugs and stored them
in a computer. The mass spectrum of the unknown drug
is read by the computer which then searches through
this list to find a drug with the same spectrum or finger-
print. The result is that, within about one hour, the
physician is told what he needs to know about the drug
taken by his patient. Now he can begin treatment to re-
move the drug from the patient’s system.

The identity of the drug determines the treatment.
In some cases, the use of an artificial kidney may be
necessary. In other cases, dialysis of the peritioneal sac —
or intestinal wall may be the treatment. With some drugs,
however, such serious surgical procedures are either un-
necessary or ineffective and the patient must rely upon
his own system for detoxification.

THE MARYLAND PHARMACIST

odd orders processed,
naturally

The oddball customer who insists he wants a print cropped “just this way.”

The man who wants cut film developed, or some positive film strips. The guy who
hands your clerk an unheard-of cartridge of film.

Welcome them. They all mean good business.

Just drop the oddball order into the Berkey bag. We'll process it with the

same professional skill, care, and dispatch we apply to all our D and P work.
Berkey’s special facilities and broad experience gives us a distinct edge in processing
every kind of film. From unfamiliar foreign films to Ultra-miniatures in color

and black-and-white, right up to 16 x 20 black-and-white blowups.

We're ready to service all your needs. Berkey does things for

you that no one else does . . . because no one else can.

Berkey

Film Processing

of Washington, D.C.
3701 Mt. Vernon Avenue
Alexandria, Virginia 22305

4 Olvisiow oF 703) 549-7500
Berkey ay (
Photo he Lee

Washington Spotlight For

Pharmacists by APhA
Legal Division

Pennsylvania Statute Prohibiting Price
Advertising of Prescription Drugs held
to be Unconstitutional

The Pennsylvania Supreme Court recently held that
state’s statute prohibiting the advertising of prices for
prescription drugs unconstitutional.

The case arose from the revocation of a pharma-
cist’s license by the State Board of Pharmacy after the
pharmacist had placed newspaper advertisements listing
prices for certain prescription drugs. The pharmacist ap-
pealed and received a six month suspension instead of
the revocation. A further appeal to the Superior Court
resulted in this suspension being affirmed. The pharma-
cist then took the next step and appealed to the Supreme
Court of Pennsylvania, which reversed the lower courts
and dismissed the complaint.

In its decision, the State Board advanced three rea-
sons for upholding this statute:

(1) to keep prescription drugs out of the public eye
and thus reduce their use.

(2) the impaired ability of the pharmacist to per-
form his “monitoring function” since price ad-
vertising would lead to increased shopping for
prescriptions.

(3) pharmacists would be encouraged to buy in
larger quantity which could result in deterio-

rated drugs being dispensed.

The court rejected these arguments finding that the
prohibition of drug price advertising does not bear a
“substantial relation” to the reasons advanced for up-
holding the statute.

The argument that the advertising of such drugs
would increase usage was rejected since they are obtain-
able only on prescription. The court reasoned that the
advertising prohibition disregards completely the profes-
sional and ethical integrity of the medical profession in
prescribing remedies for patients, and that it actually
suggests the probability of unethical conduct.

The court distinguished prohibitions on price adver-
tising of eyeglasses having previously upheld such pro-
hibitions. The court concluded there is greater public
protection in the case of drugs, because while eyeglasses
could be sold by a retailer on his own authority, the
pharmacist is not allowed to deviate from the prescrip-
tion given to him. The court concluded that while eye-
glasses damaging to the patient could be sold by a re-
tailer subjected to price competition this could not occur
with drugs.

The court did not believe that the diminished ability
of the pharmacist to perform the monitoring function
was a sufficient reason to sustain the advertising prohibi-
tion, since no evidence was introduced at the trial to
indicate the extent to which it is being done in Pennsyl-

vania. The court went on to indicate that even in those
states where this rationale has sustained prohibitions of |
this type, the courts involved have referred to this prac-
tice as being “infrequent” and “not completely effective.”
The Pennsylvania court went on to state, “it is primarily
the physician’s duty to be certain that he is not prescrib-
ing drugs antagonistic to those being taken by his pa- |
tient.” The court also rejected the argument that the pro-—
hibition of price advertising would prevent the dispens- —
ing of deteriorated drugs. The court pointed out that the
state’s Drug, Devices and Cosmetic Act as well as the
Pharmacy Act attack this problem directly.

The court thus concluded that, “we thus find that
the prohibition in question bears no substantial relation
to any of the objects which the Commonwealth .. .
assert were sought to be obtained . . . we are drawn to
the conclusion that the statute is unconstitutional . . .”’.

A common thread throughout the court’s decision
is the apparent attitude that a pharmacist functions less
as a responsible health care professional than as a mere
“seller of drugs.” Unfortunately, this viewpoint might
well have been reinforced by the very circumstances of
the case which the court was considering. In any event,
“professional”? arguments were not bolstered by sufficient
evidence in the court’s view. The case illustrates dra-
matically that in the public view professionalism may be
based not on degrees or licenses but on performance.

FDA Warns Drug Manufacturers to get
Agency’s Approval Before Marketing
Drugs

The Food and Drug Administration recently issued
a word of caution to drug manufacturers introducing
new products without their approval. The Federal agency
indicated that it is seriously concerned about the intro-
duction into the market of new products without submis-
sion and approval throughout the “New Drug” (NDA)
procedures of the Food, Drug and Cosmetie Act. The
agency indicated that this is being done either through a
misunderstanding of the legal requirements or a deliber-
ate effort to avoid the NDA procedures.

The statement pointed out the fact that anyone in-
troducing a new product, or an old product for a new
use, or a new combination of old ingredients, or any
other product that is or may be a “New Drug” must sub-
mit an (NDA) and obtain approval prior to marketing
the preparation. It was also pointed out that if a manu-
facturer or distributor decide unilaterally that any such
product does not require pre-marketing approval, he must
recognize that he risks criminal and civil regulatory ac-
tion as well as possible recall of the product from the
market. Ornex and Epitrate are two products currently
involved in an FDA-manufacturer dispute over whether
they are subject to the NDA requirements.

THE MARYLAND PHARMACIST

First name in ice cream

for over a half-century
ICE CREAM

675-6000

Be Smart!
Stock the One and Only—
Original “SAFETY TIPS”

Think Smart!
Always Sell Them
: Smart Users Ask For Them By Name

AMERICAN HYGIENIC CO.

111 S. Paca Street, Baltimore, Md. 21201

727-8328
Represented by
IRV NORWITZ Phone 727-8328

AAY 1971 27

Poison Prevention Packaging Act of 1970
The Poison Prevention Packaging Act of 1970, will

require safety closures for packages containing various
household substances. Included in the definition of house-
hold substances are: hazardous substances, economic poi-
sons, prescription and non-prescription drugs. This _re-
quirement will go into effect as soon as appropriate
closures are developed.

The following are proposed performance standards
for safety closures for containers of solid-type medica-
tions, developed by the Joint Industry—U. S$. Food and
Drug Administration Committee on Safety Closures:

1. The closure should be significantly more diffi-
cult to open initially and repeatedly (for the number of
openings customarily required for its size and contents)
by children under five years of age than the ordinary
screw cap or snap-off closure.

2. Nearly all normal adults should be able to open
and to properly reseat the closure without undue diffi-
culty.

3. Instructions for opening and closing in clear

and legible form should be provided.

4. The closure and the container should be of such
material and such design that it would preserve the
efficacy and quality of the medication under use condi-
tions.

5. A closure may be designated as a child-resistant
closure providing the tests have been done under the
protocol conditions described below, and providing further
that the closure shall successfully resist the attempts of
at least 65% of the children to open the closures without
demonstrations and at least a total of 50% with and with-
out demonstrations. In addition, at least 90% of the
adults 45 years of age and under shall be able to success-
fully open and reclose the closure before demonstrations,
and at least a total of 95% of them shall be able to open
and to close the closures after demonstration.

New Trial Ordered in Pharmacy
Malpractice Case

The Michigan Court of Appeals recently held that
a pharmacist who negligently dispensed a mild tranqui-
lizer when the prescription called for an oral contracep-
tive, with the result that a child was born to the couple,
is liable to that couple for damages. The case was re-
turned to the trial court for a determination of the dam-
ages,

The husband and wife had decided to limit the size
of their family and consulted a physician who telephoned
a prescription for an oral contraceptive to the pharma-
cist. He supplied a mild tranquilizer by mistake. The
wife took the tranquilizer on a daily basis, assuming it
to be the contraceptive, subsequently became pregnant
and delivered a healthy child.

The complaint alleged four items of damage: (1)
wife’s lost wages; (2) medical and hospital expenses;
(3) the pain and anxiety of pregnancy and childbirth;
and (4) the economic costs of rearing this eighth child.

The original trial court adopted the pharmacist’s
argument that the damage suffered by the husband and

wife were offset by the benefit of having a healthy child
and refused to allow the question of damages to go to
the jury.

The Court of Appeals reasoned that while the “bene-
fit-rule” can be used in the determination of the total
damages, it should not as a matter of law be concluded
that the services and companionship of a child, in every
case, have a greater dollar equivalent than the economic
cost of his support.

The court also ruled that the failure of the parents
to seek an abortion or place the child for adoption not
be a consideration in the determination of the damages.

Methadone Programs

The Committee on Alcoholism and Drug Dependence
of The American Medical Association and the Committee
on Problems of Drug Dependence of the National Re-
search Council has issued a joint statement on metha-
done maintenance programs.

While these recommendations are directed to the
physician, the same criteria are applicable to a pharma-
cist considering participation in such a program.

Pharmacists are also reminded that the methadone
maintenance treatment of narcotic addicts program re-
quires the advance approval of the Food and Drug Ad-
ministration. Such approval may only be obtained on the
basis of a Notice of Claimed Investigational Exemption
for a new drug justifying such a program.

The NRC/NAS-AMA recommendations are as fol-

lows:

1. Methadone maintenance programs should in-
clude at least the following elements in order to constitute
proper medical practice:

a. adequate facilities for the supervised collection of
urine and for frequent and accurate urine testing for the
presence of morphine and other drugs,

b. general medical and psychiatric services,
c. hospital facilities as needed,
d. adequate staff,

e. rigid controls of methods of dispensing methadone
to prevent diversion to illicit sale or to possible intra-
venous use.

2. Care should be exercised in the selection of pa-
tients to prevent the possibility of causing the person who
has not been dependent on heroin to become dependent
on methadone.

3. There would be continued evaluation of the long-
term effectiveness of methadone programs for persons
who are stabilized on an inpatient or an ambulatory out-
patient basis.

4. Where feasible, staff members of new methadone
maintenance programs should be trained in this tech-
nique in an established effective program.

5. Continuing research is essential particularly wit
reference to:

a. the use of properly trained practicing physician
as an extension of organized methadone maintenance pro-
grams in the management of those patients whose need
for allied services are minimal. These patients should re

THE MARYLAND PHARMACIST

Reading

iS Still the fast

to program the
man

h
brain

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
vage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for the
spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

est way

—————_——

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

main in contact with the methadone maintenance pro-
gram for periodic evaluation, including urine testing.
b. the role of methadone maintenance in the treat-
ment of heroin dependent patients under age 18 years.
c. the use of methadone maintenance in combina-
tion with other approaches to the treatment of morphine
type dependence.

Methadone maintenance is not feasible in the office
practice of private physicians. The individual physician
cannot provide all of the services for the various thera-
peutic needs of the patient. The individual physician also
is not in a position to assure control against redistribu-
tion of the drug into illicit channels, to maintain con-
trol of doses, or to establish the elements for proper eval-
uation of the treatment. Practicing physicians, however,
should cooperate with methadone maintenance programs
in their communities and offer whatever services they
may be capable of providing.

Pharmacists are advised not to provide methadone
outside of an authorized program, or in conjunction with
an individual physician who is not acting in accordance
with the recommended guidelines.

Prescription Program Fee Increases
Announced

The Department of the Army recently announced
that the CHAMPUS prescription fee has been increased
to $2.00. This marks the second increase in the CHAMP-
US prescription fee since April 1, 1970 when the fee was
increased from $1.75 to $1.85. Details of the CHAMPUS
program were published in the August 1970 issue of
The Maryland Pharmacist.

The Medimet prescription drug plan of the Metro-
politan Life Insurance Co. announced an increase in the
program’s prescription fee to $2.00 effective May 1.

Chain Store Report

Drug chain sales continue to make sharp inroads
into sales of all drug and proprietary outlets according to
the April 5 NACDS Executive Newsletter. Last year,
chain sales advanced about 14 per cent, close to double
the increase of the total group. Market penetration by
chains exceeded 34 per cent in 1970 compared with 32
per cent in 1969.

In 1971, sales are forecast to maintain their upward
momentum and total close to $5 billion, 15 per cent
higher than last year. In 1970, a disappointing year for
retail sales, drug chains were an outstanding performer.
Their sales gain was larger than that of any other major
type outlet.

Albert Lowental, of Read’s Ine. will retire April 30,
1971 after almost forty years of continuous service in-
cluding many years as an Officer and Member of the
Board of Directors. After retirement, Mr. Lowenthal will
remain a Member of the Board of Directors of Read’s.
Inc.

Pariser Named as Read’s Pharmacist
of the Month

Joseph Pariser, Baltimore pharmacist with Read’:
Drug Store, Parkville Shopping Center, was recently
named Read’s Pharmacist of the Month. Mr. Pariser was
chosen for this honor because of his prompt action taker
to save the life of a woman patient at his pharmacy. The
patient complained of indigestion and asked Mr. Parise
for a suggestion to relieve her discomfort. Mr. Parise
recognized she was having a heart attack and quickly
summoned an ambulance. She was admitted to a hos
pital beacuse of an acute attack of myocardial infractior
and is now making normal progress.

Mr. Pariser is a 1963 graduate of the University o
Maryland School of Pharmacy and has been with Read’
Drug Stores since 1962. He is a member of the Maryland
Pharmaceutical Association and the Alpha Zeta Omega
Pharmaceutical Fraternity.

Wholesale Drug Companies Offer

Service To Pharmacists

On Thursday, April 8, fire in the pharmacy at Va
ley Forge Medical Center in Norristown, Pa. destroyed
much of the usable stocks for the Center’s 72 patients
By the time the fire was out, it was 3:35 p.m., the day
before Good Friday. DRUG HOUSE representative Rich
ard Caranfa helped the Center’s pharmacists take stock
four members of the Hospital Sales Department tran
scribed the 300-item replacement order, and warehous
personnel stayed overtime to fill the order that night
Caranfa personally delivered it to the hospital by 8:01
o'clock the following morning.

This is what service is all about.

Obituaries...

Warren Louis Johnson

Warren Louis Johnson, 51, pharmacist at the D.C
General Hospital and member of the Maryland Pharm
ceutical Association, died April 11. He was a graduate o
the George Washington University School of Pharma
and is survived by his wife, 3 children, 2 brothers an
his mother. He had reciprocated to Maryland from D.C
in 1950.

Frank J. Grau

Frank J. Grau,59, died suddenly on April 16 whil
playing golf with friends. Mr. Grau graduated from th
University of Maryland School of Pharmacy in 1934.
was a former Grand Knight in the Little Flower Council ¢
the Knights of Columbus and a charter member of tha
council. Until 1958, he operated the pharmacy founde¢
by his father, George P. Grau, in 1907. At the time 4
his death he was employed by the Read’s Drug chain.

THE MARYLAND PHARMACIS

MERCUROCHROME

HW&D BRAND OF MERBROMIN

Minor injuries requiring first-aid treatment occur frequently during
the vacation season. Neglect of these injuries may cause infections
which frequently can be prevented by prompt use of Mercurochrome.
When Mercurochrome is the routine antiseptic, minor injuries are
reported more promptly, because treatment is not painful.

Include Mercurochrome in your first-aid supplies!

Detailed literature available on request.

HYNSON, WESTCOTT & DUNNING, INC.

Baltimore, Maryland 21201 <p>

(mM-6)

Two giant
product shows

each year

Gilpin offers continuing programs of merchandising ideas to its customers. The highlights of this plan include our
January product show featuring summer goods, and our July-August presentation emphasizing fall and gift selec-
tions. Dates for this year’s fall and gift merchandise show are as follows: For BALTIMORE-WASHINGTON-DOVER:

JULY 18th-25th—Gilpin Baltimore Division, 7401 Pulaski

Highway, Baltimore, Maryland. For the TIDEWATER RE-

GION: AUGUST 1st-8th—Gilpin Norfolk Division, 6435 Tidewater Drive, Norfolk, Virginia. Please mark down these
dates. We know you'll want to attend. Contact your Gilpin representative or Division Sales Manager for more details

and to make your appointment.

An experienced, pharmacy oriented sales force
trained to assist you in merchandising and store
operations. In addition to their own experience,
these men are prepared to immediately draw upon
a wealth of experience in every phase of store
operations which exist within the Gilpin company
now.
A comprehensive and up-to-date convalescent
aids program. Professional assistance is available
to design a program to meet your space and
inventory requirements and train appropriate
personnel in your store to make this a profitable
department.
A complete sundries program providing sundries
departments and inventories designed specifically
for your store, with a built-in provision for
economical and reliable restocking of your shelves.
Along with this, we maintain expanding stocks of
new promotional sundries and programs for
increasing traffic and sales.
A professional planning and remodeling service
within our organization which includes complete
service in floor design, fixture and installation.

Professional help in site selection, store
development and in lease acquisition for
desirable sites.

THE HENRY B.

GLLPIN

COMPANY

BALTIMORE + DOVER + NORFOLK « WASHINGTON

Fosacien ees yD

A financial service consultant to service you on
request.

Two giant product shows each year: in January
featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing
promotional sundries.

the services required to nail down the profit dollars
which you need and deserve from your business.

The Henry B. Gilpin Company
901 Southern Ave., Washington, D.C. 20032
(301) 630-4500

a pr ey |

Sirs:
| am interested in the following programs. Please have your J
representative contact me in this regard. i

Nane. = SS j

Name of Pharmacy j
Adis SS eee Phone j
CE ote ie

maryland
[= ~oharmacist

NATHAN SCHWARTZ

President
Maryland Pharmaceutical Association

1971-1972

(See Page 12)

Volume 47 JUNE 1971 Number 6

Compliments of

\oxell

CORPORATION

Makers of
NOXZEMA SKIN CREAMS
NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS
and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

Your prescription patients
may not know the difference
... but you do.

As a pharmacist, you know that neither brand name
nor generic drugs are any better than the demon-
strated reliability of their manufacturers. The im-
portant thing to you and your prescription patients
is not what the product is called but how expertly
it is made.

Four generations’ experience in producing fine
pharmaceuticals is one of the many reasons you
can have confidence in Lilly products.

Eli Lilly and Company * Indianapolis, Indiana 46206 EZ

100218

Open season
on stuffy noses

Winter viruses, spring 50 keep both Privine
allergies, dragging “summer —__ Nose Drops and Nasal Spray

colds,” or autumn in mind. And
hay fever—it seems keep them in
there’s always stock. They’re

something caus-
ing stuffy noses.
But whatever
the reason—what-
ever the season-—
Privine makes it
“open season” on

Sey noses. ba
ustomers want fast

relief. And that’s what
Privine is famous for.

fast acting. And
fast selling. And
Privine is OTC.

CIBA Pharmaceutical Company
Summit, New Jersey 07901

® ®@
Privine
hydrochloride
(naphazoline

hydrochloride)

2/4646 C I B A

The Maryland Pharmacist

NORMAND A. PELISSIER, Assistant Editor

NATHAN I. GRUZ, Editor
650 WEST LOMBARD STREET

VoLUME 47

BALTIMORE, MARYLAND 21201

JUNE 1971

ASSOCIATION

NUMBER 6

OFFICERS 1971-1972

Honorary President
H. NELSON WARFIELD—Pikesville

6
President
NATHAN SCHWARTZ—Annapolis

President Elect
BERNARD B. LACHMAN—Baltimore

Vice President
JOHN R. McHUGH—Potomac

Treasurer

MORRIS LINDENBAUM
5 Main St., Reisterstown, Md. 21136

Executive Director

NATHAN I. GRUZ
650 W. Lombard St., Baltimore, Md. 21201

TRUSTEES

DONALD O. FEDDER, Chairman—Dundalk
MORRIS BOOKOFF (1972)—Baltimore
PAUL FREIMAN (1974)—Baltimore
STEPHEN HOSPODAVIS (1972)

Cresaptown
PHILIP D. LINDEMAN (1973)—Berlin
ANTHONY G. PADUSSIS (1973)

Baltimore
MELVIN J. SOLLOD (1974)—Adelphi
SYDNEY L. BURGEE, JR.
Speaker of the House of Delegates
Baltimore

EX-OFFICIO MEMBERS

FRANCIS S. BALASSONE—Baltimore
WILLIAM J. KINNARD, JR.—Baltimore

HONORARY LIFE TRUSTEE
SIMON SOLOMON—Baltimore

MARYLAND BOARD OF PHARMACY

Honorary President

SIMON SOLOMON—Baltimore

President
NORMAN J. LEVIN—Pikesville

Secretary

F. S. BALASSONE—Baltimore

Member
FRANCK BLOCK—Baltimore

Member
HOWARD L. GORDY—Salisbury

Member
MORRIS R. YAF FE—Potomac

AFFILIATED ORGANIZATIONS

Allegany-Garrett County
Pharmaceutical Association
aah etesteles ere Stephen Hospodavis
VicegRresidentaae eae James Ritchie
Secretary-Treasurer....... Robert F. Tomsko

Baltimore Metropolitan
Pharmaceutical Association

PreSWent- Bre naeiea eae eee eds Irvin Kamenetz
President, Elect. o3% cess + Joseph U. Dorsch
TT EQSUT Chor ride nels ots Charles E. Spigelmire

Vice Presidents—
Paul Freiman, Harold P. Levin,
Harry R. Wille
Secretary and Executive Director
Nathan I. Gruz

Eastern Shore Pharmaceutical Society

Presidentaee certs teeeee Philip D. Lindeman
First Vice President........ Gordon Harrison
Second Vice President..... William P. Smith
SClelaryamientieieeriee ne cate teers Carl R. June
LTOGSUTET Raseeter ce esisteniactac es Thomas Payne
Honorary President ........ James W. Truitt

Prince Georges-Montgomery County
Pharmaceutical Association

Presidentins. 2 cath. wees Nas Martin Hauer
First Vice President ...Edward D. Nussbaum
Second Vice President ..... S. Ben Friedman
Third Vice President ...... Sidney Glashofer
Fourth Vice President....... Gabriel E. Katz
WQCRa MING Aacienrthonkn dancer Paul Reznek
LTCQSUTCTEtiis cleetnele aa ee Michael Leonard
Honorary President .......... Samuel Morris

Washington County
Pharmaceutical Association
Bresigentarrencs tc ctor Samuel E. Weisbecker
Vicew Presidente Joseph Davies
eenae Frederick Fahrney

University of Maryland School of
Pharmacy Student APhA-MPhA Chapter

TESILCT LM eee Darlene F. McMahon
Vicew President es en stein ne David Snyder
SECTELAT Ya ee os civ oie ss eeletie oe Margaret Karsch
LT CASUT Chatieies clocicise Coe cere aote Harriet Lee

MPhA AUXILIARIES

LAMPA — Ladies Auxiliary of The
Maryland Pharmaceutical Association
President
MRS. LOUIS M. ROCKMAN
Recording Secretary
MISS MARY DiGRISTINE
Communications Secretary
MRS. RICHARD R. CRANE
Treasurer

MRS. CHARLES S. AUSTIN

Membership Treasurer

MRS. MANUEL B. WAGNER

TAMPA — Traveler’s Auxiliary of The
Maryland Pharmaceutical Association
President
WILLIAM L. NELSON
First Vice President
PAUL J. MAHONEY
Second Vice President
JOHN MATHENY
Third Vice President
ABRIAN BLOOM
Secretary-Treasurer
WILLIAM A. POKORNY
Assistant Secretary-Treasurer
C. WILSON SPILKER
Honorary President
HOWARD DICKSON

Secretary-Treasurer Emeritus

JOHN A. CROZIER

OTHER PHARMACY ORGANIZATIONS
Maryland Society of Hospital
Pharmacists
President
MARY W. CONNELLY
President Elect
NORMAND A. PELISSIER

Secretary

DOLORES A. ICHNIOWSKI

Treasurer

THOMAS E. PATRICK

University of Maryland
School of Pharmacy
Dean
DR. WILLIAM J. KINNARD, JR.
Assistant Dean
DR. C. T. ICHNIOWSKI
Delegate and Vice Speaker—
MPhA House of Delegates
HENRY G. SEIDMAN

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number. Allow four weeks for

changeover.

TABLE OF CONTENTS

Page
Editorial—A New Era For Pharmacy in Maryland.... 6

Annual Report of the Executive Director—

Nathan Le Griz Bececcteee cece eee ae eiscnccoeecnreteucceseucces 8
Pharmacy Calendars cee ce ceettetceersecntsactres acters cers 10
Nathan Schwartz installed as President of MPHA......12
AZO PNAarmaCeutiCalls HLALCITILLY mew esssse vereesterteeess asec: 12
TEA MIP Ate NCW eirreterrrrecte cee creotenadesccnee ehtnesscocesesevtenersceissserases 12
HOSpital S Pharmacy. SCCUION we sreressecerstentiee ster tescceceeeses cence: 14
Maryland Board of Pharmacy NewWS. ..............cc:cesseee 16

Prince Georges-Montgomery County
Pharmaceutical mASSOCIAUON mes cetecessesceercnereccceteveness 18

Pharmacology in the Clinically Oriented Pharmacy
Curriculum—by David A. Blake, Ph. D.,
H. Patrick Fletcher, Ph.D., and

\eUbb Ewen) Ay Mebetetshdeh dpe, TOD), cccccnsatcanonccoccontohon 20
The Economics of Third Party Prescription Plans
by. Mavens Jee Myers i) PHD iaee uecrs cocsercrcretere aces stees 24

INDEX TO ADVERTISERS

Page
AbbDOttmelabpOratOrleSmesessersecr- tetreeerestccete ne seneercreres ic
AMericaneDIUSPISLS #1NSULANCEs © Ommrnccsstcescrsesess:tetrearses 27
Borden-Hendlermlces Creager tee tee ees 19
Calverte Drugs COMpPAany we LU Cimeesececcersrccete crersreceesestes sae te 19
Cibas Pharmaceutical COMpanViercs.eceseset eee 4
Geioys Pharmaceuticals: se LnG ameter sre ceertiner erro eae 29
Henry 95s Gilpiny COMpAany merc cener reece nereeceserree 31
Me hillye ands COMPAan Vier eececonitce canis ces tesesnesestes 3
LOeCWYy= DIugs COMPA Yurrcsrerecnssesceseetecceeces nates saceeastenetoeces es 15
Manginisand sASSOCIALCS sal Gamera eset nereceseteseteeseaeaeneneets 32
MarylanGseNe WSeCOLIDET Verner reenter eee 23
Noxell§ Corporation Gem reece eect ee eee 2
Paramount PHOtOP Service wiicceccc. sss iseeg ve -cenveieenaaes eee 21

Pension and Investment Associates of America, Inc...22

AS eee RODINS | COMPANY wewicerete etre cere eee 13
Roche; Laboratories geese ee ecco tee cee eee ee 17
D. Stuart Webb Advertising Services oo... cccccecceeeees 22
VOUNSSE DITO Ss Products sCorporationims eee 11

Editorial...

A New Era For Pharmacy In Maryland

The 89th Annual Meeting of the Maryland Pharma-
ceutical Association which was held on May 16 and 17,
1971, at the Hunt Valley Inn in Baltimore with recon-
vened sessions at the Jamaica Hilton, represented the
end of an era in the history of pharmacy in Maryland
and the beginning of what we hope will be a dynamic
new phase.

At this meeting, the House of Delegates was inaugu-
rated as the policy making and legislative body of the
MPhA. The composition of the House reflects the varied
facets of pharmacy in Maryland: all affiliated and recog-
nized pharmaceutical associations, the School of Phar-
macy, the APhA-MPhA Student Chapter, as well as the
MPhA officers and Board of Trustees.

Obviously, a great responsibility rests upon the newly
elected Speaker of the House, Sydney L. Burgee, Jr., to
assure that the House of Delegates will function as the
authentic voice of pharmacy in Maryland. During the
coming months, he will be charged with leadership in
developing the By-Laws, rules and procedures required
to translate the skeleton structure into a vigorous mecha-
nism capable of fulfilling its mission.

The beginning of this new era is a time to place
aside any lingering antagonisms within our ranks. Now
is the time—long past due—to mobilize everyone in every
area of pharmacy into a unified, cooperative posture.
Organizationally, our priorities are membership expan-

sion, adequate financial resources and effective com- —

munications.

Programmatically, our priorities include legislation,
prescription prepayment plans, new health delivery sys-
tems and their financing, employer-employee relations,
peer review, pharmaceutical education, ( undergraduate,
internship, preceptors and continuing), supportive per-
sonnel and public health information. There are, of
course, many other important areas one must be con-
cerned with. The extent to which MPhA can involve it-

self in the many issues and problems facing us and the |

effectiveness of MPhA in these areas will depend upon
its organizational strength. The nature and extent of this
strength depends upon achieving close to 100% support
from the pharmacists of Maryland. With the attainment
of support of this magnitude we can then realistically ex-
pect the resources and staff to address ourselves to the
myriad of matters crying for our attention. Such a total

mobilization of our potential can come only with more—

of our present members making a minimal contribution
of their time to their profession. We have been fortunate
that a number of dedicated pharmacists have sacrificed
some time and efforts to advance pharmacy for the
mutual benefit of all in pharmacy and most importantly
for the benefit of our patrons and patients.

With the streamlined structure of a Board of Trus-
tees and a House of Delegates and with the energetic
and dedicated leadership of incoming President Nathan
Schwartz, we look forward to the era now unfolding.

It can be—it must be—the beginning of a new,
vigorous spirit of subordinating personalities to the great

and noble goals of MPhA: representing and advancing:

pharmacy as a profession constantly working to assure
better health for all.
—Nathan I. Gruz

THE MARYLAND PHARMACIST

SELSUN BLUE

the anti-dandruff shampoo

It’s elegant. It’s ethically promoted.
And it keeps her hair in the clouds.

It isn’t often that a product
combines the best of two pos-
sible worlds—-the effectiveness
of a professional product with
the elegance of a cosmetic
= specialty. .
It’s even rarer when that product is
offered only through ethical drug
channels. On both counts, Selsun Blue
is an exception. :
TM—Trademark.

It’s an elegant, effective product that
physicians and pharmacists are highly
recommending. And customers love the

way Selsun Blue billows up into clouds

of gentle, luxurious lather . . . leaves
their hair sparkling clean . . . while

helping to control dandruff symptoms.

We hope you're getting the

business that’s rightly—-and cc)
exclusively— yours. 102294

Maryland Pharmaceutical
Association

89th Annual Convention

Report Of The Executive Director
Nathan I. Gruz
Hunt Valley Inn, May 17, 1971

Mr. President, Members and Guests,

This is my tenth annual report to the membership
in my capacity as Executive Officer of the Maryland
Pharmaceutical Association, the state professional society
of pharmacists, as it approaches 9 decades of dedicated
service to advance the health of the citizens of this state.

I am most appreciative of the support that sincere
committed pharmacists and members of the allied drug
industry have given to the Association and to me per-
sonally. We must henceforth put aside all destructive,
distracting divisiveness and concentrate on constructive
use of our time, our energies and our resources. Let us
henceforth utilize the best at our disposal, rather than
search for the ideal—the perfect Moses to lead us out of
the wilderness.

A great deal has happened in the past decade—revo-
lutionary changes in our society—revolutionary changes,
therefore, in pharmacy as well.

During the past decade we have seen the following
patterns in pharmacy service emerge:

Second, there is the decline of the small independent
neighborhood pharmacy, the relative growth of the “large
independent” and explosive growth of chain (including
discount and supermarket ) pharmacy. Nevertheless, many
independents whe have emphasized personalized relation-
ships with their patrons have been able to retain their
loyalty in the face of the most severe competitive chal-
lenges. Where pharmacists have made it a cardinal rule
to maintain person-person contact with patrons requiring
prescription and health-related products, confidence and
trust has been generated which is able to overcome to a
considerable degree competitive appeals based solely on
price.

and other health facilities is a great challenge to pharma-
cists and offers them rewarding professional opportuni-
ties. Here the interested pharmacist must be sure he has

become knowledgeable and expert in new developments in

systems, procedures, equipment and automation so that

he can provide the necessary services in an efficient and
economical manner. This must be done in line with good

professional practice and so that the needs for drug se-
curity, proper storage, control of distribution and, above

all, the needs of the patients are met.

This means that the opportunity for the innovative,

flexible pharmacist applying new ideas in providing phar-—

maceutical services is present. It means, in many cases, —

new patterns in practice and in management. Group prac-
tice by pharmacists may be the answer in some situa-
tions. Participation in neighborhood health centers estab-
lished by health professions, by governmental agencies or
jointly by government and professions will be the answer
for some.

ing greater significance in the providing of complete |

health care to both hospitalized and ambulatory patients.
It is doubtful whether pharmacists will be able to escape
the full professional and legal responsibilities for which
their education and training qualify them.

Why else have a five or six-year education to produce

a pharmacist?

I would strongly recommend that we take the steps
necessary to enable Pharmacists in Maryland to choose
the drug product to dispense pursuant to a prescription.

Fifth, the proliferation of “third-party” patients health
insurance plans which more and more are including drug

THE MARYLAND PHARMACIST

programs, is having a critical professional and economic
impact on pharmacy.

The profession of pharmacy through its professional
organizations must thave the decisive voice in all these
issues.

The organizational structure in pharmacy now has
the machinery for “participatory”? democracy in Mary-
land. Let us act to involve every pharmacist and the en-
tire drug industry in our State so that we accelerate the
professional and economic advancement of pharmacy.
Professional growth for pharmacy will inevitably result
‘in the maximum contribution of pharmacy to more effec-
tive health care for all for the benefit of both profession
and society.

In order to attempt to meet these changes, we have
made some progress, and we have had some successes.
But we must admit there is much more remaining to be
done.

What are some of these accomplishments?

The highlight of this past year—and indeed—of the
MPhA’s history in the context of its contribution to the
advancement of a unified organizational structure for
pharmacy has been our affiliation with the American
Pharmaceutical Association, our national professional
society.

There are now 16 affiliated states, comprising more
than 50% of the pharmacists of the nation. There are at
present several more states involved in negotiations with

APhA.

We are proud, too, of the completion of the affilia-
tion of all existing local pharmaceutical associations with
MPhA—an important and essential attainment.

These two accomplishments are the result of long
years of work by many devoted members of MPhA in
overcoming many obstacles. I am gratified that these two
goals which I set forth 10 years ago are a reality today,
and I wish to thank the leaders of MPhA together with
those of the Allegany-Garrett, BMPA, Eastern Shore,
Prince Georges-Montgomery and Washington County
Pharmaceutical Associations who have had the broad

\JUNE 1971

vision to recognize that strength and effectiveness must
be based on a foundation of reciprocal relationships and
coordinated efforts and were willing to lay aside local
considerations for the mutual good of all of pharmacy
in Maryland and in the nation.

Secondly, we have adopted the framework for a
more effective organizational structure and a capability
for greater participation by our constituents and allied
groups through a Board of Trustees and a House of Dele-
gates. This is now being implemented. There is much
that has to be done in proper and complete implementa-
tion, and this will be our objective during the coming
year. It will take time to set up all the procedures re-
quired for proper functioning.

Legislation, Medicaid, third-party payment plans,
professional and economic seminars, public relations and
information activities all are reported on at this Annual

Meeting.

In addition to our public health activities in the
areas of Diabetes Detection and Poison Prevention, we
are launching an extensive community wide campaign
in Venereal Disease Education. All these projects serve
to more strongly identify pharmacy with service to the
health needs of the community.

In reference to legislation, the Pharmacy Law of
Maryland, although far from completion or perfection,
is the result of a tremendous amount of work by MPhA
—hboth volunteer and staff. Some of the provisions are
vital in maintaining a professional posture. We will
have to be alert to sustain the integrity of the basic ele-
ments of this vital legal mandate. At the same time, we
will have to press vigorously forward on legislation re-
quired to strengthen our professional disciplinary ma-
chinery.

In implementing some of these changes, greater sup-
port—not lip service—will have to be given to PHARM-
PAC, the Pharmacists Political Action Committee, which
is an independent group with objectives vital to all in

pharmacy.

We are concerned—and must be more involved—in
the educational structure for educating pharmacists. Im-
portant and long overdue progress is being made in
bringing pharmaceutical education into the mainstream
of emerging patterns of health care delivery systems.
Hip, hip, hurrah for the progress in eliminating the fias-
co called the “practical experience requirements” and its
substitution by a professional type of supervised precep-
tor system for pharmacy students.

This year progress was also made in the inclusion of
our exhibit in the scientific section of the State Medical
Society’s Annual Meeting. The theme of the pharma-
cist’s contribution to better patient care through patient
medication records is one which all of us must hope will
be put into operation by all pharmacists as a recognized
essential part of the practice of pharmacy.

A happy note, too, is the improvement in the publi-
cation schedule of “The Maryland Pharmacist,” which is
now almost current. However, it is recognized that com-
munications need great improvement, and that must be
advanced during the coming year.

In addition the Maryland Pharmacy Foundation
has been activated with the goal of launching a campaign
to complete the work associated with the Swain Model

Pharmacy and the Cole Museum. All in pharmacy will
be contacted this year. Please give this your attention
when you receive the brochure being prepared under the
direction of Dr. Samuel Fox.

There is much to be done during the coming year
and during the next five years in all the areas of vital
concern to our members. We have professional, economic
and management interests which we can only address
ourselves to when certain prerequisites are met. These
are:

1. By encompassing the great majority of the phar-
macists of the state as members.

2. By operating on a budget which can realistically
finance the required programs and the staff sufficient to
implement these programs.

The leaders and the members of MPhA will have
to develop and support the plans for enlarging our mem-
bership and obtaining greater sustaining membership
commitments, more advertising participation and more
convention support.

In the critical area of membership solicitation, it
may well be necessary to use a field representative. This
has been the crucial factor in all the states experiencing
dynamic membership growth.

If we are to make a radical breakthrough in the
fields of prescription insurance plans, health planning,

legislation, Medicaid, public health, employer-employee
relations, pharmacy management, proper communica-
tions, etc. etc., we will have to have the numerical
strength and the financial resources to do the job.

Will all of you help your new leaders and me to
get the show on the road this year?

This is our challenge for 1971.

Your actions—not words—in the days and months
ahead will be the test.

PHARMACY CALENDAR

September 7-12—31st International Congress of Pharma-
ceutical Sciences of the FIP, Washington, D.C.

October 10-14—National Association of Retail Druggists
Annual Convention, The Rivergate, New Orleans.

October 16-21—National Wholesale Druggists’ Associa-
tion Annual Meeting, Century Plaza Hotel, Los
Angeles.

April 22-28, 1972—American Pharmaceutical Associa-
tion Annual Meeting, Houston.

Photo by Paramount Photo Service

THE MARYLAND PHARMACEUTICAL ASSOCIATION RECENTLY INSTALLED THE

FOLLOWING OFFICERS: (left to right)

Donald O. Fedder, Chairman, Board of Trustees, Baltimore; Morris Lindenbaum,
Treasurer, Reisterstown; H. Nelson Warfield, Honorary President, Pikesville; Nathan
Schwartz, President, Annapolis; Bernard B. Lachman, President Elect, Baltimore;
John R. McHugh, Vice President, Potomac; Nathan I. Gruz, Executive Director,

Baltimore.

THE MARYLAND PHARMACIST

| |

a Clean up..with>

wash-Up -

Your pharmacy can

make real profits by
displaying Wash-Up
pre-moistened,

towelettes in the proper
place inside your |
store. Wash-Up’s have |
SO many uses that
they make a great
impulse buy...
especially when you
display them in your |
party and picnic goods
area. Be sure you don’t
hide this premium

profit product:.. put it
in the right place and
you'll start to clean
up...yourself.

™
Rete Drug Products Corporation
865 Centennial Avenue
Piscataway, New Jersey 08854

Bees ie

NATHAN SCHWARTZ

President
Maryland Pharmaceutical Association

Nathan Schwartz, Annapolis pharmacist, was in-
stalled as president of the Maryland Pharmaceutical As-
sociation at its 89th Annual Meeting.

Mr. Schwartz, who was on the Maryland Pharma-
ceutical Association Executive Committee, for four years,
Convention Chairman and Chairman of the MPhA Medi-
caid Committee, is a 1943 graduate of the University of
Maryland School of Pharmacy. During World War II he
served in the U. S. Maritime Service for almost three
years. He is the proprietor of the South River Pharmacy
in Edgewater. He holds membership in the American
Pharmaceutical Association and the Baltimore Metropoli-
tan Pharmaceutical Association.

He has been on the Board of Governors of Kneseth
Israel Synagogue for over 16 years, serving as its young-
est elected president in 1960 and 1961. He is currently
Chairman of the Israel Bonds Committee for Annapolis.
He is also a member of the South Anne Arundel Busi-
nessmen’s Association.

Mr. Schwartz is married to the former Norma Lee
Stein and they have two children: Steven, a junior at the
Pennsylvania College of Optometry and Susan, a senior
at the University of Maryland.

A.Z.O. Pharmaceutical
Fraternity
Kappa Chapter

New officers of the AZO Pharmaceutical Fraternity
ae Chapter and the Ladies Auxiliary were installed
on Sunday, June 6 at the Hunt Valley Inn in Cockeys-
ville. They are as follows.

Directorum—Jerry Freedenberg

Graduate Sub-Directorum—Henry Leikach
Undergraduate Sub-Directorum—Steve Bierer
Excheque—Jerry Cohen

Recording Signare—Alan Stoff

Corresponding Signare—Steve Buchner
Bellarum—Dennis Klein

Executive Unit: Paul Zucker, Steve Tompakov,

Kelvin Levitt, Henry Seidman, Sam Block,
Morris Schenker.

Auxiliary Officers for 1971-1972
President—Vicki Buckner
Vice President—Norma Samson
Corresponding Secretary—Iris Bierer
Treasurer—Rozzie Stoff

Three new members from the School of Pharmacy
were welcomed into the fraternity. They are: James

Kessler, Barry Hecht, and Arnold Kaplan.

LAMPA News

CONVENTION TIDBITS

Breezewood

The rain drops kept falling on our heads—and con-
sequently LAMPA’s tour of the garden and museum of
the Alexander B. Griswold estate was called off. How-—
ever, we have been given a “rain check” for a future
date.

Art Exhibit

Our first art exhibit took place in the Noxell Suite
of the new Hunt Valley Inn on Sunday, May 16, 1971.
Eight local lady artists, including two LAMPETTES,
Camilla Ogrinz and Arlene Padussis, exhibited. While
the artists claimed amateur status, their work appeared
to be quite professional. An interesting feature was the ex-
planation each artist gave about her particular paintings,
how they came about, problems surmounted and for
whom they were painted.

Arnold Zenker

Just as he does on TV, Mr. Zenker charmed his
live audience of LAMPA and TAMPA members. He told
several very amusing stories of his experiences while in-
terviewing guests. The serious side of his personality re-
ceived equal time too, as he stressed the fact that times
have changed and are continuing to change, even though
each of us may prefer some particular facet of the past
to remain the same. He was thought provoking, and his
“show”? seemed to end much too soon. If you are curious
as to the subject about which he receives most questions,
during his personal appearances, check with a member
that attended.

Annual Business Meeting

President Dora Rockman presided and judging from
the yearly reports, we are doing well.

Our dues have been used to enhance attendance at
our meetings through interesting programs and givea-
ways. We earned that if a member attended the last
three meetings (Fall, Spring and this Convention) she
received almost double her annual dues, in gifts. Natural-
ly, this does not include whatever information and pleas-
ure she derived from attending. A shimmering, wiggly,
metal gold fish, at the end of a chain, was LAMPA’s gift
to members attending their 18th annual meeting.

LAMPA OFFICERS FOR 1971-72

President jet vatwtrcst rene eee Mrs. Louis M. Rockman
Treasurer ®s/fa. cen Mrs. Charles S. Austin
Membership Treasurer .............. Mrs. Manuel B. Wagner
Recording Secretary ©2...c-ccr01rcces Miss Mary DiGristine
Communications Secretary............ Mrs. Richard R. Crane

Executive Board
Mrs. Frank Block Mrs. Kenneth L. Mills
Mrs. Charles J. Neun Mrs. John G. Cornmesser
Mrs. William A. Pokorny Mrs. Harry L. Schrader
Mrs. George S. Stiffman Mrs. Anthony G. Padussis
Mrs. Milton A. Friedman Mrs. Nathan Schwartz

Ann Crane /
Communications Secretary —

THE MARYLAND PHARMACIST

Robitussin

(GLYCERYL GUAIACOLATE)

. _Stockupon .
the best sellers

_and put your

facings where
your pr ofits are! facings they have earned. Your Robins Representative will be around to see you

(Deal runs July 1August 31)

i a aaa I Sai 1S

VSO enone ceeeseeste tie

summer deal starts July? “~
includes 4” and7™ sizes | \\\,

ao
Again this summer you can stock up on Robitussin and oy}
Robitussin-DM at special low deal prices. Last year, drug store
sales of these two cough preparations increased 8%, while the market was up only
1%. These increases were recorded in chains and in small, medium, and large inde-
pendents. Robitussin and Robitussin-DM alone now hold a big 10% share of this
$100,000,000 market. They are also the most heavily prescribed cough syrups sold
OTC with over 2 million scripts filled annually. In fact, Robitussin is the only OTC
cough medicine among the 200 most prescribed drugs. In spite of all this Rx volume,
some 71% of all Robitussin and Robitussin-DM business is OTC. Stock up heavy on
these two leading cough preparations while they’re on deal by ordering more of the
4-ounce and a good supply of the 7-ounce size. And don’t overlook Robitussin®-PE.
It’s moving up fast in scripts and OTC sales.

You know these products are going to move off the shelf, so give them the

soon. Buy ’em while it’s hot for extra fall and winter profits.

- A. H. Robins Company, aichnche: Va. 23220 A-H-[20 BINS

Hospital Pharmacy
Section

Maryland Society Of Hospital Pharmacists
Meeting of May 13 and May 27, 1971

Members of the Maryland Society of Hospital Phar-
macists met at Schraft’s Colony Inn for a joint meeting
with the D.C. Society of Hospital Pharmacists on May
13, 1971. The social hour and dinner were sponsored by
the Organon Company.

Guest speaker for the evening was William J. Don-
nelly, Jr., Chairman of the D. C. Bar Association’s Com-
mittee on Medico-Legal Matters. His speech was entitled
“Hospital Pharmacy and the Law.” A short D.C. Society

business session followed.

The Maryland Society of Hospital Pharmacists met
on May 27, 1971 at Mercy Hospital in Baltimore to
make final amendments and to approve the proposed re-
vision of the Constitution and By-Laws. Present at the
meeting was Mr. Jules Lichter, attorney, who has been
actively involved in the Constitution and By-Laws re-
vision.

Guidelines For Hospital Pharmacy
Services Distributed

A booklet entitled “Suggested Principles and Guide-
lines for Pharmaceutical Services in Hospitals” has re-
cently been printed and distributed under the co-sponsor-
ship of the Maryland Society of Hospital Pharmacists
and the Maryland Pharmaceutical Association.

These comprehensive guidelines were developed in
1969 by the “Pharmacy Advisory Committee” appointed
by the Council on Hospital Services for the Maryland-
District of Columbia-Delaware Hospital Association fol-
lowing the initial suggestion of Mr. Henry J. Derewicz,
Director, Pharmacy Service, The Johns Hopkins Hos-
pital, Baltimore, Maryland. The Committee was com-
posed of representatives of the medical, nursing, phar-
macy, and hospital association groups located in the Mary-
land, District of Columbia, Delaware region. Morris
Bookoff and Nathan I. Gruz represented MPhA and F. S.
Balassone, the Maryland Board of Pharmacy. Since then,
a substantial majority of these groups have indicated
their endorsement of this manual.

The purposes of these guidelines are to:

1) Protect the safety and welfare of patients who re-
ceive drugs while in the hospital;

2) Recognize the interdependence of the medical care
team members in the hospital who participate in the
acts associated with drug treatmtent or usage;

3) Guide individual hospitals in establishing their own
specific policies and procedures for the safe use and
distribution of pharmaceuticals within the institution.

An initial supply of the guidelines has been dis-
tributed to each hospital in the state. Additional copies
are available at $1.00 each by contacting Dolores A.
Ichniowski, Secretary, Maryland Society of Hospital Phar-
macists, 1212 Roundhill Rd., Baltimore, Md. 21218 or
the MPhA office.

Antibiotic Booklet Available

A 25 page, pocket-size booklet describing dosages
and choices of antibiotics and antibacterials for specific
bacterial pathogens has been prepared by Dr. John H.
Mulholland, Assistant Chief of Medicine at the Union
Memorial Hospital in Baltimore in collaboration with
Sydney L. Burgee, Jr., Director of Pharmacy and Cen-
tral Supply, Howard Sherman, Staff Pharmacist, and
Richard A. Wankel, Staff Pharmacist at the Union Me-

morial Hospital.

The booklet contains valuable information such as
information on major untoward effects of the antibiotics
and antibacterials, and a chart on modification of anti-
biotic dosage in renal failure. Publication of the booklet
was financed by Eli Lilly and Company.

Individual copies are available at no charge by send-
ing a stamped, self-addressed, business size envelope to
the Union Memorial Hospital Pharmacy, Calvert and
33rd Streets, Baltimore, Md. 21218.

Burroughs Wellcome gives
$500,000 Grant to Hopkins

The Burroughs Wellcome Fund has announced a
$500,000 endowment for a professorship in clinical phar-
macology at the Johns Hopkins University School of

Medicine.

Dr. Pedro Cuatrecasas, the director of the Division
of Pharmacology, was appointed to what is believed to be
the first chair in clinical pharmacology ever endowed in
this country. In accepting the chair, Dr. Milton Eisen-
hower, the president of the university, noted that Hop-
kins created the first full-time pharmacology department
in this country almost 80 years ago. “We look forward
to developments of even greater significance to medicine
from this important development in clinical pharmacolo-
gy,” he said.

Dr. Cuatrecasas, 34, came to the Hopkins last year
from the National Institutes of Health. He was named
Young Scientist of the Year last year by the Maryland
Academy of Sciences. Burroughs Wellcome is a pharma-
ceutical firm that has operations in both this country and
Great Britain.

THE MARYLAND PHARMACIST

There’s a lot more going for you at LOEWY

a Shectc MEDICAL EQUIPMENT FRANCHISE

can make your store one of the most sought out sources for
equipment and service in America

As the local Spectro Division in your area, we not only offer the unusual advantages

of one of America’s largest drug wholesaling operations, but those of the country’s most
‘comprehensive medical equipment distributor, producer and servicing organization. As is
being demonstrated right now in Spectro markets throughout the eastern seaboard, physical
aids for the convalescent, the handicapped and the invalid can be the most significant

new profit source available to the pharmacy today. We are uniquely well endowed to
provide you with professional administrative and technical direction, the widest
available range of product, application counsel and in-home servicing.

FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY

Call any time, day or night. An automatic order
taker will record your after-hours order.

Call IV 5-8105 for order taking. (301) 485-8100 for the office.

LOEWY DRUG COMPANY

AA DIVISION OF
a °
6801 Quad Avenue, Baltimore, Md. 21206 Tel.: (301) 485-8100 aS: Spectvo Industries, Ine.

Maryland Board
of Pharmacy News

Pharmacy Changes

The following are the pharmacy changes for the
month of May:

New Pharmacies
Drug Fair No. 137, H. Lebowitz and M. Levinson,
Pharmacists, 5270 Randolph Road, Rockville, Maryland
20853.

No Longer Operating As Pharmacies
Vojik’s Pharmacy, Edward C. Vojik, 900 South
Ellwood Avenue, Baltimore, Maryland 21224.

Change of Ownership, Address, Etc.

Westview Pharmacy, Pasadena, Alder Simon, Presi-
dent (Change of name and ownership — Was Village
Drugs, Inc.), 399 Fort Smallwood Road, Baltimore,
Maryland 21122.

Final Regulations Published
for Controlled Substances

Final regulations implementing the Controlled Sub-
stances Act were published in the Federal Register on
April 24. For those who desire a copy of the complete
regulations, Volume 36, Number 80, pages 7776-7826,
Saturday April 24, 1971, copies are available at 20c
each, prepaid, from the Superintendent of Documents,
United States Government Printing Office, Washington,

D.C. 20402.

Late clarifications, according to Carl Roberts, APhA
Legal Division Director, include:

—Owners of multiple pharmacies may apply to BNDD
for a permit to maintain central records, providing spe-
cific conditions are met.

—If a date other than May 1 is elected for biennial in-
ventories, BNDD must be so informed.

—A written prescription order for Schedule II con-
trolled substances must contain the date of issue, name
and address of the patient, signature, address and
registration number of the prescriber. If the prescriber
has applied for a number, he may (until July 29,
(date) indicate—‘Federal registration applied for on
(date) .”

—A pharmacy intern can make the determinations neces-
sary for OTC dispensing of a Schedule V controlled
substance, provided he is so authorized under applica-
ble state and local laws.

—Any loss or theft of controlled substances when dis-
covered must be reported to the nearest BNDD Re-
gional Office immediately and Form 106 must be com-
pleted.

Name of Drug Must Appear on Rx Labels

Senate Bill 110 will become effective on July 1,
1971. This bill will require that all prescriptions be
labeled with the name and strength of the drug dispensed
unless otherwise indicated by the physician.

Vaginal Spermicide — Not Pill —
May Prove “‘Ideal’’ Contraceptive

In spite of the intensive search for a “perfect” con-
traceptive that, by almost universal agreement would
take the form of another pill, the ideal contraceptive of
the future may well be a new type of vaginal spermicide
that might perhaps need to be inserted only once a
month, according to Dr. Irving Scheer, Director of Or-
ganic Chemistry at Ortho Research Foundation.

That extraordinary possibility was raised at a sym-
posium conducted in San Juan, Puerto Rico, recently by
the American Chemical Society New York-New Jersey
section. Dr. Scheer said that this new type of vaginal con- —
traceptive “might readily outmode the pill and the I.U.D.—
—and make prostaglandins a kind of back-up where un-
wanted pregnancy did occur.”

ae
CU

pees cf 0 (AN om a
=) Grnancp
= Ce Su

RP Yura pr
ALWAYS TO KEEP SIGHT OF

THE MARYLAND PHARMACIST

ap yerneinseHegseed
‘stnteerehies eee TOE wnnessort
esnonenectsnein ees

of the pharmacist and physician.
All are served best by proper
handling of drugs. Better
control of all aspects of drug
distribution ensures the
highest standards of health
care for the patient, physician
and community.

This policy reflects Roche
interest in the general
problems of pharmacy
management, as well as
the pharmacist-doctor,
pharmacist-patient and
pharmacist-community
relations. There are many
of your colleagues at
Roche—practical profes-
sionals in various management positions—
ho help make the policies and provide the services
hat help you meet the challenge of pharmacy today.

ROCHE LABORATORIES
Division of Hoffmann-La Roche Inc.
Nutley, New Jersey 07110

Pharmacists Honored

Godfrey D. Kroopnick, a community pharmacist
practicing at Brookfield Avenue and Whitelock Street for
the past 40 years, was recently given an award as Out-
standing Citizen of Reservoir Hill for the year 1970. The
award was co-sponsored by the Parent-Teacher Associa-
tion of School No. 61 and the Bureau of Recreation. The
award was presented by Mr. John Graybill, Principal of
School No. 61, on Sports Award Night at the John Eager
Howard Community Hall. Chairman of the evening was
Charles “Bull’? Robinson, ex-Colt football linesman, who
is presently connected with the Bureau of Recreation in
Baltimore City.

Mr. Kroopnick has been president of the Whitelock
Business Men’s Association since 1963 and is secretary-
treasurer of the Locke Chemical Co.

Pharmacist Godfrey D. Kroopnick, center, receiving award
from Principal John Graybill of School No. 61. At right is
ex-Colt football linesman Charles ‘Bull’ Robinson.

Jacob H. Greenfeld, former president of the Uni-
versity of Maryland School of Pharmacy Alumni Asso-
ciation, was honored at a banquet held on March 21 at
the Rothstein Auditorium. The award was given for his
13 years of service as president of the Ner Tamid Con-
gregation, Greenspring Valley Center. In 1964, Mr.
Greenfeld received the Presidential Award of the Union
of Orthodox Congregations of America, an award given to
only 10 outstanding leaders of synagogues in the United
States and Canada.

Leon Albin was general chairman of the banquet.

Nathan I. Gruz, Executive Director of the Mary-
land Pharmaceutical Association and Baltimore Metro-
politan Pharmaceutical Association and Editor of The
Maryland Pharmacist, was elected President-elect of the
National Council of State Pharmaceutical Association
Executives at their annual meeting in San Francisco held
at the end of March. He will be installed at the 1972

annual meeting in Houston, Texas.

Harold Holmes, a life-long resident of Baltimore and
a pharmacist with Read’s Drug Stores since 1961 has
been chosen as Read’s Pharmacist of the Month by the 88-
year old drug chain. Mr. Holmes has been a store man-
ager with the firm since 1962 and is a member of the
Maryland Pharmaceutical Association, the Chi Delta Mu
Fraternity and the NARD. He is a graduate of the How-
ard University School of Pharmacy. :

Mr. Holmes was chosen for his professional interest
in public health.

Dorothy Levi, staff pharmacist at Lutheran Hospital,
is a member of the Steering Committee for Baltimore
City Council President William Donald Schaefer’s candi-
dacy for Mayor. Anyone interested in further informa-
tion may contact Mrs. Levi at 484-9195.

ATTENTION: ALL MEMBERS

A small quantity of jewel-studded tie tacks and clips
commemorating the 75th Annual Convention are avail-
able to members. Obtain an attractive souvenir of the
occasion . . . a sentimental remembrance for a friend or
relative.

Supply is limited. Make your request by writing the
MPhA office or by calling 727-0746 before August 1
1971;

Prince Georges-Montgomery
County Pharmaceutical
Association

The Executive Committee and Officers of the Prince Georges-Mont-
gomery County Pharmaceutical Association assembled for this photo-
graph at their recent Installation Dinner. From left to right: Michael}
Leonard, treasurer; Samuel Morris, honorary president; Edward D.)
Nussbaum, first vice president; Paul Reznek, secretary; S. Ben
Friedman, second vice president; Rudolph Winternitz, Chairman oft
Executive Committee; Martin Hauer, president; Simon Zvares ;))
Gabriel E. Katz, fourth vice president; Melvin D. Sollod; Paul
Bergeron II; Edward Sandel; and Donald O. Fedder, past president
of the Maryland Pharmaceutical Association. |

THE MARYLAND PHARMACIST

Offering Independent Pharmacies...

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up
to making your best source of supply,
THE

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

First name in ice cream
for over a half-century

ICE CREAM

675-6000

Pharmacology in the Clinically
Oriented Pharmacy Curriculum

by:

David A. Blake, Ph.D., Associate Professor and
Chairman, Department of Pharmacology and
Toxicology

H. Patrick Fletcher, Ph.D., Assistant Professor,
Departments of Pharmacy and Pharmacology.

William J. Kinnard, Jr., Ph.D.,
Dean and Professor of Pharmacology.
University of Maryland School of Pharmacy.

(Presented at the Fall Meeting, American So-
ciety of Pharmacology and Experimentai Thera-
peutics, Palo Alto, August, 1970.)

There is widespread national concern over the lack
of proper health care, the accelerating cost of medical
services and the inefficiency of the total health care sys-
tem. Recently a television network aired a documentary
entitled “Don’t Get Sick in America” which dramatically
portrayed the seriousness of the problem. How can this
complex problem be corrected? Many suggestions have
been made but the one most commonly heard is—‘we
need more doctors”! Actually the inadequacy of the num-
ber of physicians has been known for some time, how-
ever attempts to correct the situation by increasing the
financial support of medical schools has mainly resulted
in more research and an increased potential for the treat-
ment of disease. But the overall deliverance of health
care has not been greatly influenced. Rather, it is evident

that what must be done in this regard is to more effec- '

tively utilize the physician as a diagnostician by trans-
ferring the non-diagnostic responsibilities to competent,
highly-trained specialists.

With respect to the responsibility for drugs, there
has been enthusiastic support for clinical pharmacolo-
gists to specialize in this phase of health care. However,
a large number of these “M.D., Ph.D.’s’’ have been ab-
sorbed by research programs and a recent survey con-
ducted by Dr. Edward Carr of the University of Michi-
gan (Clin. Pharmacol. and Therap. 11: 455, 1970)
shows that only a fraction of the Medical Schools are en-
gaged in training medical students for this role. Some
pharmacy schools have initiated revised academic pro-
grams designed to produce highly-trained drug experts
with clinical experience who will be able to provide direct
assistance to the physician in his selection of therapeutic
agents and the effective monitoring of drug response.
This practitioner is being called a clinical pharmacist
and is receiving from 5 to 7 years of education and train-
ing and in some cases is being given a new degree—

Doctor of Pharmacy (Pharm. D.).

At the University of Maryland, we are in the 2nd
year of a 3 year transition to a revised curriculum de-
signed to produce B.S. level clinical pharmacists in 5
years. The program is divided into 3 phases: 2 years of
general studies, 2 years of pharmaceutical sciences and 1
year of clinical education and training. The pharmacologi-
cal aspects of drugs are presented in two courses: a 4th

year course in pharmacodynamics and a 5th year course
in clinical pharmacology.

During the 4th year, the pharmacology course is close-
ly integrated with courses in medicinal chemistry and
biopharmaceutics. This latter course is greatly empha-
sized and encompasses all of the factors which influence
drug action. The purpose of this coordinated lecture
series is to provide the student with a sophisticated
understanding of drug action, variability in response to
drugs and an appreciation for proper dosage formulation.
Prototype drugs are studied in depth at the molecular,
biochemical, cellular and whole animal level. Thus upon
entering the Sth year clinical courses, the student is pre-
pared to view medicinal therapeutics in the broader con-
text of the patient, his disease and his therapy and their
interactions.

Our first experience with this new program was dur
ing the Spring Semester of 1969. The second semester of
pharmacology laboratory was replaced by classroom evalu-
ations of case histories which had been summarized from
medical records. Groups of 3 students were assigned a
case which represented a major disease category and
asked to prepare 20 minute oral presentations on the
disease, the drugs and the clinical course. The cases had
been selected on a random basis and no attempt had been
made to include only uncomplicated cases. Although a
general invitation to attend these presentations had been
made to all of the other schools and hospital services,
only a few physicians were present but they played an
active role in the discussions and offered criticisms
where indicated.

It soon became apparent that much had been lost in
the preparation of the summarized case histories and stu-
dents complained of not having access to the patient,
and his physicians and nurses. Nevertheless, students
cited number of instances where questionable therapy,
mistakes and dangerous practices had occurred. For ex-
ample, a patient in cardiac failure had been overdigi-
talized and was treated with antiemetics for 5 days before
the digitalis dosage was reduced, even though a nurse
had been consistantly recording an abnormally slow
pulse and the lab results had showed hypokalemia. An-
other patient experienced several uncomfortable days of
postural hypotension because she was being given a
double dose of guanethedine as the intern did not realize
that Ismelin was the same drug. Another incident had
occurred in the E.R. where an unconscious patient was
given stat insulin in response to a high blood sugar
report from the laboratory. Unfortunately the blood had
been withdrawn from one arm while 5% glucose was
being infused into the other.

Based on the results of this experimental course, the
past year’s program (Spring, 1970) was changed so that
students would have the opportunity of evaluating actual
hospitalized cases. This was arranged by having a faculty
member of our school (Dr. Fletcher) work on general
medical wards in order to experience the same situations
that would confront the students and thereby design a
workable format. A series of lectures were given on a

THE MARYLAND PHARMACIST

Mr. Pharmacist ~

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4, Salesman inventory control

To get the complete story—call collect [301] 243-4439

PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue
Baltimore, Maryland 21218

JUNE 1971

variety of important subjects such as: medical termi-
nology, clinical chemistry, drug interactions, iatrogenic
diseases, treatment of the emotionally ill patient, derma-
tology and drug information. Where possible, experts
from the clinics and laboratories provided these lectures
which was greatly appreciated by the students.

Each student was assigned a patient who was cur-
rently hospitalized and was asked to prepare a written
and oral summary of the patient with emphasis on drug
therapy. During the 12 hours on the ward allotted to
the student, he was expected to observe the patient, take
a drug history, attend ward rounds, and answer ques-
tions posed by the physicians, nurses or the patient. The
summaries were presented in small group conferences
which were supervised by members of the pharmacology
department.

A number of observations were made during this
program; students were initially apprehensive but even-
tually became enthusiastic about this unusual learning
experience. One student devised a novel way of charting
medication frequency and dosage which permits instan-
taneous disclosure of current therapy, missed or wrong
doses etc. Students were impressed at seeing drug ac-
tion first hand such as: the dramatic improvement of
parkinson’s disease with L-DOPA, iatrogenic Cushing’s
syndrome from steroid therapy and the loss of hair caused
by anticancer agents. Some students enjoyed interview-
ing patients while others considered this an undesirable
task and obtained little information.

During the coming year, the clinical orientation will
be provided during both semesters and in the future will
also include the summer. The didactic portion of the pro-
gram will be expanded into a semester of clinical phar-
macology which will be presented by physicians and
pharmacologists. The organization of this course will be
based on major disease categories and include a con-
sideration of the pathology, comparative diagnosis and
therapeutics. For example the subject of myocardial in-
sufficiency will be covered by first describing the general
process of atherosclerosis, myocardial ischemia, altera-
tions in the ECG and the usual symptoms and com-
plaints. Following this, a comparison of the clinical
efficacy of the organic nitrate vasodilators, beta blockers,
antihypercholesterolemic agents, anticoagulants and tran-
quilizers will be made. This latter discussion will include
a consideration of untoward effects, potential interactions
of the drugs with each other and also with diagnostic
tests.

The clinical experience will be lengthened and also
extended into clinical specialties such as pediatrics, anes-
thesia, intensive care etc. In fact, our pharmacy school is
providing four “clinical pharmacists” to the hospital who
will function full-time in the role expected of students.
They will monitor patient charts, go on ward rounds,
prepare drug histories and drug profiles, supply infor-
mation to physicians and nurses, assist in drug adminis-
tration, prepare intravenous fluid mixtures and determine
blood levels of certain drugs for the rational selection of
their dosage. Additionally, the clinical pharmacist will
conduct a discharge interview with patients to instruct
them on the proper use of their discharge drugs. These
pharmacists will operate out of areas on the ward which
are satellites of the main pharmacy where distributive
drug services are handled.

Another related service which has been operating
for the past year is a drug information center. This cen-

ter provides emergency and routine information on many
aspects of drugs and is coordinated by clinical pharma-
cists. It serves as a backup to the pharmacists with ward
duty and has been a popular service.

In summary, when the role of the pharmacist is
expanded to include clinical responsibility, curriculum
changes are necessary to provide an adequate background
of knowledge. Pharmacology must be extended from the
traditional and somewhat simplistic laboratory situation
of 1 drug and an isolated organ to the complex clinical
situation of multiple drugs and a diseased patient who
has psychological as well as medical needs. It is our con-
viction that clinical pharmacists, who have a broad and
sophisticated understanding of the fundamentals of drug
action coupled with proper clinical orientation and ex-
perience, can fill an ever-expanding need—that of a clini-
cal drug specialist.

Headquarters for

PHOTO-OFFSET PRINTING MAILING
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

Pension & Investment
Associates of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)
HR-10.. Plans (Sole Proprietor-Partnerships)

Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

LSS ee
re

THE MARYLAND PHARMACIST

Reading

1S Still the fast

est way

to program the

brain.

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
vage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for the
spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

human

—
f —a1E

——)

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

The Economics of Third Party

Prescription Plans
by

Maven J. Myers, Associate Professor of
Pharmacy Administration
Philadelphia College of Pharmacy and Science

Presented to the
Maryland Pharmaceutical Association at the
Simon Solomon Pharmacy Economics Seminar,

Blue Crest North, Pikesville, Maryland
November 19, 1970

According to the occupational historians, Carr-
Saunders and Wilson, the physician in ancient Greek
civilization usually was a slave attached to some rich
man’s household. Somehow it is difficult for us to con-
ceive of a physician or other professional, including a
pharmacist, as a subservient person.

Rather, we conceive of the professional practitioner
as a dominant, dictating force in his relationship with
his clients or patients. The physician tells the patient he
must get more exercise; usually he complies. The at-
torney tells the client not to bother suing on a particular
claim; usually the client accepts this advice. The phar-
macist tells the patient to use caution if machinery must
be operated while taking an antihistamine; usually the
patient complies.

If we return to ancient Greece, we find that several
of the other professions—such as accountants, architects,
and engineers—were not free lance independent practi-
tioners, but state-employed administrators. Again, it is
difficult for one to grasp the concept of a professional
practitioner being responsible to someone other than the
patient or client. The physician’s primary duty is to con-
trol the patient’s hypertension not to minimize the cost
of a government health program; the pharmacist’s pri-
mary duty is to dispense drug products from sources. he
has confidence in, not to make sure that the welfare di-
rector’s budget is met.

Is it possible that third party payment for prescrip-
tions may cause a retrogression of the profession of phar-
macy to the status of the professions in ancient Greece?
Is it possible that the independent practice of pharmacy
may become the dependent practice of pharmacy?

The Emergence of Associations

Returning to history, we find professions emerging
with professional characteristics over a long period of
time. One of the professional characteristics which
emerged was the professional guilds which evolved into
what we, in pharmacy, now generally refer to as phar-
maceutical associations. These guilds satisfied several
needs of the professions, primarily:

a chance to associate with professional peers
for exchange and advancement of knowledge
and

an organized pressure group which could work
to achieve public acceptance of the high stand-
ards of the profession and reward these high
standards through the creation of legal mo-
nopolies,

It is this latter purpose on which our attention
should be focused. There are a number of reasons why
the professions have been able to develop into what are
referred to as “legal monopolies,” meaning, for example,
only a registered pharmacist may practice pharmacy. Not
the least of these reasons is embodied in the concept of a
profession. Among other attributes, a profession must
have a developed body of knowledge possession of which
is necessary to effectively perform certain functions.

Because of this, it was only natural that society
should want to protect itself from the performance of
these functions by someone who failed to possess the
requisite knowledge. Few of us, for example, would be
willing to have our tonsils removed by the typical cab
driver.

Thus, it was relatively easy for professions, par-
ticularly those involving important functions (such as
health services) to succeed in creating legal monopolies
on the basis of the public interest.

A second, and very important contributing factor,
may be referred to as a relative apathy on the part of the
general population with regard to these claims for legal
monopolies. While claims by the professions that these
legal monopolies were in the public interest may have ~
effectively quieted some opposition, it is not likely that
strong opposition existed. While pharmacists and their
associations were vitally concerned with the passage of
legislation creating their legal monopolies, the general
public had little direct interest in this and, probably at
the time, was unaware of the passage of this legislation.

As a historical note, Sonnedecker observes that
there is an extremely close correlation in time between
the founding of state pharmaceutical associations and the
passage of state pharmacy laws, with the latter usually
following by a few years, the former.

What thus came into existence in pharmacy and
the other health professions were organized, legal mo-
nopolies of health providers.

Provider Domination

Attempting to bargain with the organized provider
was the unorganized consumer. One can immediately
sense the disparity in bargaining power. The provider,
backed by and guided by his organized monopoly versus
the individual consumer who basically has but two
choices:

1. Accept the service on the basis offered by the
health professional

2. Do without the service.

This disparity likely is one of the root causes of
our so-called health crisis. Our entire health care delivery
system has evolved around what is convenient for the
health care provider rather than what is best for the
patient. Do fewer patients become ill on Sunday than
any other day of the week? Probably not, but the avail-—
ability of health care is substantially less on Sunday.

In the United States, one out of every fourteen dol-
lars of our gross national product goes to pay for health

THE MARYLAND PHARMACIST

care. This is approximately $60 billion per year and is
the highest figure both in terms of per capita spending
and share of GNP of any nation in the world. Yet, it is
tragic to observe that the United States ranks fifteenth
among the nations of the world in infant mortality.

How can we explain these seemingly conflicting data
of high spending but low health? The most probable ex-
planation is that health care is not necessarily being pro-
_vided to those who need it most, but, rather, to those
_who can obtain it under the conditions providers impose
on the system. Thus, providers tend to concentrate in
the more affluent suburbs rather than in the ghetto; the
person in a high income bracket is more likely to receive
care than the person who cannot afford to pay the pro-
vider; the person who becomes ill on a weekend usually
cannot receive care through the normal channel, but must
resort to treatment in hospital emergency rooms. In short,
the providers of health care have been in the driver’s
seat. They have decided to a considerable extent who gets
treatment, what kind of treatment they get, and how
much they will pay for the treatment.

The Emerging Organized Consumer

And now, for the economics. John Kenneth Gal-
braith, variously known as a Harvard economist and a
Kennedy Democrat, calls his theory, “countervailing
power.” Basically what he suggests is that when a group
gains control of one side of a market (such as the seller’s
side), there will develop a countervailing or opposing
power on the other side of the market. Thus, big labor
became organized to deal on an equal basis with big busi-
ness; farmer’s cooperatives organized to deal with the
large food processors and most importantly, what we are
seeing now are consumers organizing to deal with big
health care providers.

We saw “consumer power” at work in 1965 when,
after twenty-five years of success, the American Medical
Association finally lost out to Medicare. We saw it in the
Office of Economic Opportunity Health Centers which
were established over the bitter opposition of certain
health care providers. Legislators and politicians have be-
gun to learn that consumers vote just as much as health
care providers and there are more consumers than pro-
viders.

We are seeing it in the growth of third party pay-
ment programs for prescription care—Title XIX _ pro-
grams, Blue Cross programs, programs sponsored by cer-
tain union organizations, etc. The list is long and grow-
ing. Predictions indicate that more than half of your
prescription volume five years from now will be paid for
through these third parties, rather than through an indi-
vidual consumer’s direct payment.

Whereas in the past, the individaul consumer had
no choice but to accept pharmaceutical services as we
were willing to offer them, the organization which repre-
sents several thousand consumers is not under such re-
straints. If they dislike our existing system of delivering
pharmaceutical services, they simply set up their own
dispensary. If legislation interferes with their goals, they
lobby, sometimes very effectively, for changes.

Basically, what is happening is that we no longer
can, in isolation, control our own destiny without con-
sidering the wants of the consuming public and being
responsive to those wants. Our power is being offset by
the countervailing power of the organized consumer.

JUNE 1971

But, you may say, “What power? Certainly the
A.M.A. was and possibly is a strong power, but organized
pharmacy has never had such strength and power that it
could dictate to consumers.”

Unfortunately, you probably would be correct.
Among all the major professions, pharmacy probably has
the weakest, most poorly financed and most unsupported
organizations.

Why do you think there are strong movements to
unionize pharmacists, rather than to unionize dentists or
physicians? Dentists and physicians can look to their pro-
fessional associations and find strength and leadership
for their professional careers. Pharmacists, unable to find
this in many of our state professional associations, are
turning to organizations which they know have strength
and power—the unions.

Pharmacists looking to national associations of phar-
macy-related people find they lack not only strength, but
are more likely to be characterized by chaos, conflict and
confusion. The continuing imbroglio over the “universal
claim form” proposed by the National Pharmacy Insur-
ance Council is an outstanding example of this, and I
would like to dwell on it a little later.

Yet, we find consumer power or the consumer lobby
as a countervailing power to pharmacy. The reason is
simple to find. The countervailing consumer power arose
not in specific opposition to pharmacy, but in opposition
to the existing health care team.

Organizational Weakness

Pharmacy is a part of that health care team. This is
the theme we have been hammering into the public’s
mind. As members of the health care team, we are a part
of the target of this countervailing power. But, perhaps
more significantly, we are a most vulnerable target be-
cause of our organizational weakness.

As one example, let us look at many of the govern-
ment-financed Medical Assistance Programs. Many pro-
viders receive usual and customary charges for the serv-
ices they provide under these programs. It was just
naturally assumed that the only way these providers would
participate in the programs was on these payment terms.
And how about pharmacists? Usual and customary might
be nice, but the administrator figured he could enroll
sufficient pharmacists with a 1/3 markup or a $1.50 fee,
so he tried it and he was successful. Pharmacists com-
plain bitterly at the same time they are taping up signs
in their windows reading “We fill welfare prescriptions.”
Round one for the consumer (in this case the taxpayer )
as far as pharmacy is concerned.

In round two we get the budget squeeze. Somehow
someone underestimated the medical assistance budget
(has anyone ever overestimated one? ). Cuts have to be
made somewhere and the path of least resistance is to
reduce the pharmacist’s reimbursement by 25c per pre-
scription. Sure, he’s going to squawk; but not as loud
nor as effectively as other providers.

Unless and until we are willing to give to our pro-
fessional organizations the support they so desperately
need in this time of rapid change, pharmacy will con-
tinue to be the victim of the consumer movement when
it could actually be its hero.

A second example of our impotence can be found in
third party payment contracts negotiated under the

United Auto Workers and similar plans. Specifically, a
very sore point is the extremely high deductible, usually
$2.00, which is a part of these agreements.

A major selling point in these programs has been
that over 20% of all prescriptions written by physicians
are never filled because the patient doesn’t think she can
afford the medication. While this statistic is questionable,
its sales value appears sound.

Assuming this figure is valid, it would then seem to
be the professional obligation of the pharmacist to utilize
whatever reasonable forces he possesses to secure deducti-
bles in contracts at a level which does not inhibit patients
from obtaining prescribed drugs. If the average prescrip-
tion charge of approximately $3.75 in the private market
inhibited people from obtaining prescribed medication,
how much has been accomplished by replacing this with
a $2.00 deductible? Is it likely that many who can’t af-
ford $3.75 will be able to afford $2.00?

Pharmacists don’t like the $2.00 deductible; pre-
sumably patients would prefer a lower figure; but, the
$2.00 deductible remains. Someone must favor it.

A deductible which is so high that it discourages
utilization of prescription services is, at least in the short
run, desirable from the point of view of the one who is
footing the bill. It also is desirable from the point of
view of the underwriter for two reasons.

First, it makes it easier to predict utilization. If a
consumer without prescription insurance were suddenly
told she could go out and get all the prescribed medica-
tions she wanted ‘“‘free,”’ there is a fear that the consumer
would attempt to take advantage of this and secure un-
necessary supplies of drugs, thus significantly increasing
the costs of the program. By having “$2.00” drugs rather
than “free” drugs, this possible problem is reduced.

Second, it can be an extremely effective tool in re-
straining pharmacists’ requests for increases in fees as
costs increase with time. If some pharmacies in the area
are discounting the $2.00 deductible by, for example,
collecting only $1.00, the underwriter can point to this
discounting and claim that the fees being paid are already
higher than necessary since at least some pharmacies are
capable of operating at $1.00 less than the fee offered.

This symptom represents two underlying basic prob-
lems:
1. Our failure to establish the value of complete
pharmaceutical services

2. Our willingness to accept anything as long as
someone says, “That’s the way it has to be be-
cause of antitrust.”

“Complete” Pharmaceutical Services

You and I know that the patient receiving prescrip-
tions from the pharmacy employing the $1.00 discount
on the deductible is not receiving complete pharmaceuti-
cal services. Patient medication cards are not being main-
tained, pharmacists are not taking the time to assure
themselves that the patient completely understands the
dosage regimen, the patient is not being warned about
the concomitant use of OTC products which may affect
drug action, etc.

Why doesn’t the patient demand this service and
why isn’t she willing to pay an extra $1.00 per prescrip-
tion for it? Why don’t the carriers insist on the provision
of these services? The simple answer is that we have

never shown either the patient or the carrier (or some
might add, the pharmacist) the value of complete phar-
maceutical service. No one apparently has ever given them
any reason to believe that there is a value associated
with such service.

This must become a top priority of pharmacy if we
are to have professional growth in the coming era of pre-
payment. We must be able to establish, on a cost-benefit
basis, the value of complete pharmaceutical services.

Antitrust

The second problem is that of antitrust. Pharmacy
has been sensitive to the prospect of antitrust suits, espe-
cially since the Northern California and related cases in
the early sixties. Carriers are especially sensitive now in
light of the recent decision in Virginia holding the im-
position of a fixed fee by Blue Cross to be in violation of
the antitrust laws. Pending appeal and the final outcome,
most third party plans continue to employ the fixed fee
approach.

What we have seen with the fixed fee is the concept
of countervailing power become, in practice, the concept
of overwhelming power. As the State Department would
say, the balance of power has shifted.

In many cases today the pharmacist cannot eco-
nomically refuse to participate in some of these pro-
grams. One need only look to many areas of Michigan
where the auto industry is the dominant employer. It is

economic suicide for a pharmacist not to participate in~

the U. A. W. program in these areas, just as it will be-
come economic suicide for you as this type of coverage
expands.

On the other hand, it may be professional suicide
for us to participate. If these programs are not willing to
reimburse pharmacists reasonably for providing complete
pharmaceutical services, the pharmacist either will have
to reduce his level of services or operate at a loss. Thus,
the economic coercion of the third party becomes a
coercion of professional standards.

There does exist one additional alternative;
which makes a great deal of sense, but will require the

cooperative efforts of all pharmacists. At the direction of |

the American Pharmaceutical Association Board of Trus-

tees, Senator Hart has been requested to assist in amend- —

ing the antitrust laws to permit pharmacy associations to

negotiate fees in third party payment prescription pro-—

grams.
In requesting this assistance, Dr. Apple noted,

“Clearly, there exists in this situation a
monstrously inequitable imbalance of economic
power. No single pharmacist or pharmacy is a
match for any insurance company, employer
or Blue Cross/Blue Shield plan—As a practi-
cal matter, it is impossible for either a phar-
macist or a sponsor to negotiate individual
agreements with over 50,000 pharmacies for
participation in such programs. This is not a
‘free market’ bargaining situation, but one in
which pharmacists are captives, forced to par-
ticipate at the threat of loss of a substantial por-
tion of their practice. Moreover, failure to par-
ticipate by a significant number of pharma-
cists leaves them open to charges of ‘group boy-
cott’ in violation of the antitrust laws.”

one

THE MARYLAND PHARMACIST

4
|

Clearly there is a need for a modification of the
antitrust laws and their interpretation if pharmacy is to
be free to concern itself with its professional advance-
ment in the era of third party payment.

A final area which deserves comment in the current
environment is the chaos, conflict, and confusion at the
national level due to what appears to be a power strug-
gle to determine what group represents “pharmacy” at
_the national level.

While pharmacy in the past has been able to ad-
vance with relatively weak organization and leadership,
it has done so because there was very little organized
opposition. In the present environment we are faced with
potent countervailing powers.

The National Pharmacy Insurance Council was
established on a representative basis to provide a unified
voice for pharmacy in dealing with third party payment
programs. Both the National Association of Chain Drug
Stores and the National Association of Retail Druggists
have been invited to participate in this organization, with
seats on the Board of Governors. I feel we all should
strongly urge these organizations to work with, not
against, the National Pharmacy Insurance Council.

Pharmacy cannot afford the luxury of being divided
internally during this rapid period of change.

Summary
In summary:

1. The organized professions are now faced by or-
ganized consumer groups who, in many cases,
are dissatisfied with aspects of the current health
care system

2. Because of the traditional weak and divided or-
ganization in pharmacy, pharmacy becomes an
easy target of these dissatisfied consumer groups
and their representatives

3. Pharmacy must establish the value of the serv-
ices it can provide if it is to be adequately reim-
bursed for those services

4. Modification of the antitrust laws appears neces-
sary if pharmacy is to have power equal to that
of the third party groups

5. Pharmacy groups must work through a single
organization, such as the National Pharmacy In-
surance Council, if we are to fully utilize our
influence as providers

6. Pharmacists must increase their support of the
unified organizations which represent their inter-
ests if these interests are to be advanced.

TAILOR-MADE

Insurance Caveraze

AMERICAN DRUGGISTS’ INSURANCE .., as the name im-
plies, is specifically designed for the needs of the druggist.
It’s an insurance company founded BY druggists FOR
druggists, to assure especially prompt settlement of claims
.. fire, theft, liability. And that’s exactly what we’ve been
doing...settling such claims rapidly, without red tape
... since 1906. Any service with that many years of

experience HAS to be reliable. You can
be certain of 100% security.

For full details on our complete
coverage plan, contact your ADI
agent NOW.

MAYER & STEINBERG
Maryland State Agents
1101 N. CALVERT STREET
BALTIMORE, MD. 21202
752-7311

AMERICAN

DRUGGISTS’
INSURANCE. CO.

700 American Building
Cincinnati, Ohio 45202

| JUNE 1971

MPhA Sponsors Exhibit
at Med Chi Meeting

The Maryland Pharmaceutical Association sponsored
an exhibit on “Patient Drug Profiles” in the Scientific
Exhibit Section at the Annual Meeting of the state medi-
cal society (Medical and Chirurgical Faculty of Mary-
land) held at the Baltimore Civic Center, May 12, 13,
and 14, 1971.

The exhibit which received considerable interest
from the physicians, was arranged by the Professional
Relations Committee under the chairmanship of Sydney
L. Burgee, Jr. and stressed the value of medication rec-
ord systems in helping prevent drug interactions and in
contributing to better patient care. Many physicians in
attendance signed up for a booklet on drug interactions

to be mailed to them by MPhA.

The following pharmacists participated in manning
the exhibit: Sydney L. Burgee, Jr., H. Nelson Warfield,
Samuel J. Sheller, Charles E. Spigelmire, Donald O. Fed-
der, James P. Cragg, Jr., Victor H. Morgenroth, Jr., Mel-
vin Rubin, Joseph U. Dorsch, Paul Freiman, and Morris
Bookoff.

PRODUCT ANNOUNCEMENTS

Vasodian (Isoxsuprine HC1, Mead Johnson) is now
available in syrup form, one pint bottles, 10 mg. per tea-
spoon, and a 10 mg. tablet unit dose blister pack.

Rifampin, a new drug indicated as an adjunctive in
the treatment of pulmonary tuberculosis, was approved
for release by the Food and Drug Administration on May
21. It will be marketed by Dow Chemical Co. as Rifadin
and by Ciba as Rimactane. Rifadin (Dow) will be sup-
plied as 300 mg. capsules in bottles of 30, 60, and 100.
Rimactane (Ciba) also 300 mg. will be available in 100’s
and 500’s. Cost is expected to be about 97 cents per cap-
sule.

Pharmacy Student Exchange Program

The International Pharmaceutical Student’s Federa-
tion Student Exchange program, sponsored in the United
States by the Student American Pharmaceutical Associa-
tion provides students with the unique opportunity of
broadening their professional horizons by observing and
working in pharmaceutical establishments in foreign
countries.

Numerous applications have been received from U.S.
pharmacy students wishing to take part in the Student
Exchange Program. In order to complete an exchange,
however, a host for a foreign student must be found in
the United States for each U.S. student going abroad.
Therefore priority is given to students who are successful
in locating a host position in their own country.

Host pharmacists normally provide living expenses
and/or pocket money although exchange students must
pay travel expenses. In most countries it is not neces-
sary to speak the native language. For further informa-
tion contact Mr. J. Craig Hostetler, IPSF Liaison Secre-
tary, Student American Pharmaceutical Association, 2215
Constitution Avenue, N.W., Washington, D.C. 20037.

L-Dopa Stimulates Secretion
Of Human Growth Hormone

Scientists at Duke University have recently linked
L-Dopa (levodihydroxyphenylalanine), the “miracle”
drug used in treating Parkinson’s disease, with increased
secretion of growth hormone in such patients.

Since its release by the Food and Drug Administra-
tion in June, 1970, L-Dopa has been the focus of at-
tempts to treat Parkinson’s disease. An amino acid which
can penetrate the blood-brain barrier to reach the central
nervous system, L-Dopa aids Parkinson patients by re-
plenishing their depleted supply of dopamine. Although
the drug is not effective or tolerated in all cases, regular
doses of L-Dopa have produced promising results in a
large percentage of patients. Many of these patients did
not respond to other forms of treatment. .

In this study of 12 patients, Drs. A. E. Boyd III,
Harold E. Lebovitz, and John B. Pfeiffer found that
moderate doses of L-Dopa produced a rapid increase in
the level of growth hormone in the blood. This level
gradually returned to normal approximately two hours
after the drug was administered.

The scientists found no appreciable difference in the
growth hormone response of patients according to the
size of the L-Dopa dosage. Nor was the response to
growth hormone different in patients beginning L-Dopa
therapy and those who had at least six months of contin-
uing therapy, although patients having long-term ex-
posure to L-Dopa took longer to reach the same level of —
hormone production.

In an attempt to suppress the production of the
growth hormone, the researchers administered glucose
with L-Dopa. However, this also failed to alter the pat-
tern of hormone secretion.

The mechanism by which L-Dopa activates growth —
hormone secretion has not been determined, although the |
researchers suggest several possible mechanisms. Further
study of this response to L-Dopa is important because it |
may help elucidate the normal mechanisms controlling ©
growth hormone secretion. Careful observations of pa- |
tients in chronic L-Dopa therapy should be made for ©
possible consequences of long-term growth hormone stim- —
ulation.

Noxell Sales Executive

Named To New Post

John James Meek of the Noxe!l Corporation has
been promoted to National Field Sales Manager, having
been Central Area Field Sales Manager, Chicago, sinve
1967. Before that he was Regional Manager, Cleveland.

A graduate of McKinley High School in Chicago, Mr. —
Meek attended Northwestern University and the Univer-
sity of Illinois, and has been living with his wife and
three children in Mt. Prospect, Illinois. He will relocate
to the Baltimore area shortly.

THE MARYLAND PHARMACIST

. Caution: © ‘
on
Ms Sabsnat od Reeging re

Simple Test Developed to Detect
Digitalis Reaction in Heart Patients

Researchers have developed a fast, simple diagnostic
tool using saliva that can save lives by showing when a
heart patient is suffering a toxic reaction to digitalis, an
effective drug for heart patients that has been in use for
nearly two hundred years in the management of heart
failure and control of heart rhythm. Occasionally a heart
patient, who has been taking digitalis, has an irregular
heart beat. He could then be suffering heart symptoms
because he needs more of the drug. However, the same
signs also can indicate a toxic reaction to the drug itself,
in which case the therapy must be changed.

Dr. Stephen Wotman and a team of researchers at
Columbia-Presbyterian Medical Center in New York City
have developed a fast, simple method using whole saliva
that can diagnose digitalis toxicity. The NIH National
Institute of Dental Research supported this study as a
part of its extensive research program on salivary gland
secretions.

Dr. Wotman discovered that the level of potassium
in whole saliva rises significantly in cases of digitalis tox-
icity and that simply measuring the potassium level in
saliva can detect this. In a study of 47 patients, he found
that the potassium level actually rises in all patients tak-
ing digitalis but that the increase was significantly greater
in patients with digitalis toxicity than in other patients
on this drug.

Program Announced for FIP 31st
International Congress

Internationally known scientists from Germany,
Great Britain, Italy, Japan, and the USA will present
papers at the main symposium of the 31st International
Congress of Pharmaceutical Sciences to be held in Wash-
ington, D.C., September 7-12, 1971.

The main symposium, to be held Wednesday-Thurs-
day, September 8-9, will have as its theme * Optimizing
Drug Activity.” The colloquia on “International Refer-
ence Standards”’ will be held on Friday, September 10.

Correspondence relating to the Congress should be
addressed to George B. Griffenhagen, Secretary, Organiz-
ing Committee, 31st International Congress of Pharma-
ceutical Sciences, c/o American Pharmaceutical Associa-
tion, 2215 Constitution Avenue, N.W., Washington, D.C.
20037.

Adolescent Unit Started at University
Hospital

With the appointment of Dr. Felix P. Ifeald as di-
rector of the new division of adolescent medicine at the
University of Maryland School of Medicine, this institu-
tion has become the sixth in the United States to conduct
training and research in adolescent medicine. Univer-
sity Hospital’s new north hospital wing, now under con-
struction, will devote its eighth floor to the specialty of
adolescent medicine.

As Dr. Heald explains it, the teen-ager has been
shuffled from ward to ward in medical centers. Some-
times he is cared for by the department of pediatrics.
Other times he is treated in adult wards. The whole idea
of adolescent medicine is a young one. Dr. Heald says
that there are already a number of pediatricians who
limit their practices to the adolescent.

NIH Doubling Research
On Oral Contraceptives

Spurred by a shortage of basic information about the
effects of oral contraceptives, the Center for Population
Research of the NIH National Institute of Child Health
and Human Development plans to more than double its
expenditures for research in evaluation of contraceptive
methods.

Funds for methods evaluation research rose from
$1.6 million for fiscal year 1970 to $3.5 million in fiscal
year 1971. The evaluation program will emphasize in-
vestigations of the pharmacological properties of various
estrogen-progestogen combinations in varying doses, with
the aim of improving the clinical safety and efficacy of
these widely used drugs.

To administer the enlarged program, the Center has
formed a new division, the Fertility Regulating Methods
Evaluation Branch. The Branch will be under the direc-
tion of Dr. John Schrogie, a clinical pharmacologist and
former research division director of the Food and Drug
Administration. The research program will explore doses,
unique properties, and effects of oral contraceptive com-
ponents, to determine whether equally effective or safer
formulations can be developed. A secondary goal is to
study the side effects of presently available formulations
with as much precision as possible. Methodolgy for doing
this has improved greatly since the oral contraceptives
were introduced ten years ago.

Shifts in the Drug Industry

The 1967 Census of Business shows a continuing
trend toward increased sales through a smaller number
of retail outlets. Between 1963 and 1967, the retail drug
industry also followed the trend toward fewer and larger
outlets. Chain drug stores, between 1963 and 1967, in-
creased their share of total drug sales from 26 per cent
to over 33 per cent while the total number of chain out-
lets increased only 2.5 points—from 8.4 per cent to 10.9
per cent. In sharp contrast to this trend, large indepen-
dents increased in number by 41.4 per cent, while show-
ing gains in sales volume similar to those of chains.

Study of Independent Drug Stores
Completed

A perceptive study of “Independent Drug Stores”
prepared by the Bank of America and released as part of
its series entitled “Small Business Reporter” shows that
initial inventory and fixture costs for a 3,000 square foot
community pharmacy with a projected annual volume of

$150,000, fall within the range of $37,000 to $53,000.

Initial inventory and fixture investment for a super
merchandising drug store of 7,000 to 12,000 square feet,
is estimated between the range of $70,000 and $135,000.
The number of independents in the U.S. has dropped
from 46,550 to 38,000 in the last decade, the study notes,
despite an overall growth in the retail drug market from
$7 billion to $12 billion during the same time. Chains,
with an increase in units from 9,000 to 15,000 in 10
years, have captured a large share of the retail drug
market, according to the study.

THE MARYLAND PHARMACIST

Two giant
product shows

each year

Gilpin offers continuing programs of merchandising ideas to its customers. The highlights of this plan include our
January Product show featuring summer gvods, and our July-August presentation emphasizing fall and gift selec-
tions. Dates for this year’s fall and gift merchandise show are as follows: For BALTIMORE-WASHINGTON-DOVER:

JULY 18th-25th—Gilpin Baltimore Division, 7401 Pulaski

Highway, Baltimore, Maryland. For the TIOEWATER RE-

and to make your appointment.

BALTIMORE + DOVER + NORFOLK * WASHINGTON

A financial service consultant to service you on
request.

Two giant product shows each year: in January
featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing
promotional sundries.

the services required to nail down the profit dollars
which you need and deserve from your business.

The Henry B. Gilpin Company
901 Southern Ave., Washington, D.C. 20032
(301) 630-4500

Sirs:
| am interested in the following programs. Please have your

representative contact me in this regard. i

Name.

Name of Pharmacy.

AOd(6s6 ee ON ee

list the 150 manufacturers’ codes

explain the write-off throughout
check the % called on open bottles

tell the expiration dates |

learn the recent packaging changes

~ name the discounts and amounts
indicate the deals on major lines
divulge the case discounts

now, take inventory.

Good. Now, that you've We'll not only keep you For further information,
taken your inventory, run up-to-date. We'll keep you. write or ca// your nearest
the figures through the several steps ahead of Mangini office. The
computer and get your your competition. information is FREE and
departmental and sectional For instance, our computer without obligation.
breakdowns plus complete —qivision will have a new

HOI eC system within the next 60 a aoe
days that will enable the a
So if your present inventory busy pharmacist to meet _son o

service is not giving you the a// requirements on a single cio :
fast, accurate meet eeeg form as third part Mangini & Associates, Inc.
p Palsy 4850 W. Belmont Ave. Chicago, Ill. 60641

answers you need in your prescriptions, BNDD, (312) 282-8
anit gash iat é aoe : 11722 Studt St., St. Louis, Mo. 63141
ignly-competitive industry, family prescription files, 2760 W- Market St., Akron, Ohio 44313
ni 5 avin Ave., West Haven, Conn. 1
call Mangini. etc. 5501 Cherokee Ave., Alexandria, Va. 22312

the
maryland

=" pharmacist

B. OLIVE COLE
1883-1971
(See page 8)

Volume 47 JULY SF L97,1

Number 7

Compliments of

oxell

CORPORATION

Makers of

NOXZEMA SKIN CREAMS

NOXZEMA SHAVE CREAMS

COVER GIRL PRODUCTS

and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

> each prescription

a test of your
professional

knowledge

Even the simplest-appearing prescription requires the
exercise of your professional skill and judgment. Is it the

proper strength? Is the dosage within usual or
accepted limits? Is it compatible with other medication your

il gh : aaa
prescription patient may be taking:

This same judgment also tells you. . . when it comes
to your prescription patient’s health (and your reputation ), you

want to dispense the finest-quality pharmaceuticals available.

There are no finer-quality products than those from Lilly.

100215

Eli Lilly and Company + Indianapolis, Indiana 46206 Lilly

S
.

... your customers will want to find out all about
Venereal Disease. They'll also want to know how
you can help them prevent V.D. If you haven't yet
ordered your FREE supply of this informative 8-

page booklet . . . or if you require an additional

quantity just mail in coupon.

This pamphlet is contributed as a public service by:
Youngs Drug Products Corporation—Manufactur-
ers of “Trojan” quality brand prophylactics.
Gentlemen: ‘

{] Please send me + copies of

50 100 150 :
“Plain Talk About Venereal Disease” in English

[] Please send me __, _..., ___, copies of
— 80 100 150
“Plain Talk About Venereal Disease” in Spanish.
Name
Company
Address

City State Zig
Fill in above or affix store label.

up Youngs Drug Products Corporation 865 Centennial Ave., Piscataway, N.J.08854

5
|
|
|
!
!
!
l
|
|
|
'
!
|
!
!
|
|
|
|
|
!
'
!
'
'
|
|
!
|
'
|
!
'
!
|
|
|
!
|
!

ail
|
|
!
|
!
'
!
|
|
|
!
!
!

The Maryland Pharmacist

NATHAN I. GRUZ, Editor

650 WEST LOMBARD STREET

NORMAND A. PELISSIER, Assistant Editor
BALTIMORE, MARYLAND 21201

ASSOCIATION

VOLUME 47

JULY 1971

NUMBER 7

OFFICERS 1971-1972

Honorary President

H. NELSON WARFIELD—Pikesville
*

President
NATHAN SCHWARTZ—Annapolis

President Elect
BERNARD B. LACHMAN—Baltimore

Vice President
JOHN R. McHUGH—Potomac

Treasurer

MORRIS LINDENBAUM
5 Main St., Reisterstown, Md. 21136

Executive Director

NATHAN I. GRUZ
650 W. Lombard St., Baltimore, Md. 21201

TRUSTEES

DONALD O. FEDDER, Chairman—Dundalk
MORRIS BOOKOFF (1972)—Baltimore
PAUL FREIMAN (1974)—Baltimore
STEPHEN HOSPODAVIS (1972)

Cresaptown
PHILIP D. LINDEMAN (1973)—Berlin
ANTHONY G. PADUSSIS (1973)

Baltimore
MELVIN J. SOLLOD (1974)—Adelphi
SYDNEY L. BURGEE, JR.
Speaker of the House of Delegates
Baltimore

EX-OFFICIO MEMBERS

FRANCIS S. BALASSONE—Baltimore
WILLIAM J. KINNARD, JR.—Baltimore

HONORARY LIFE TRUSTEE
SIMON SOLOMON—Baltimore

MARYLAND BOARD OF PHARMACY

Honorary President

SIMON SOLOMON—Baltimore

President
NORMAN J. LEVIN—Pikesville

Secretary

F. S. BALASSONE—Baltimore

Member
FRANK BLOCK—Baltimore

Member
HOWARD L. GORDY—Salisbury

Member
MORRIS R. YAFFE—Potomac

AFFILIATED ORGANIZATIONS

Allegany-Garrett County
Pharmaceutical Association
HY coher ene Stephen Hospodavis
ViceeL resident: poate ee James Ritchie
Secretary-Treasurer....... Robert F. Tomsko

Baltimore Metropolitan
Pharmaceutical Association

Presideniva, \catectase ten cc} Irvin Kamenetz
ETCSLCN te Le Chae en ter: Joseph U. Dorsch
ETeasurergives sets co: Charles E. Spigelmire

Vice Presidents—
Paul Freiman, Harold P. Levin,
Harry R. Wille
Secretary and Executive Director
Nathan I. Gruz

Eastern Shore Pharmaceutical Society

Presidente. tte Gordon Harrison

First Vice President....... William P. Smith
Second Vice President....... William Connor
SECTELOTY Cae een aiscaisicetis ves Carl R. June
LV COSUTOY Mees cs ss slsct ees kes Thomas Payne

Prince Georges-Montgomery County
Pharmaceutical Association

Presulent: ie rete c ns Siam ae ok oats Martin Hauer
First Vice President....Edward D. Nussbaum
Second Vice President ..... S. Ben Friedman
Third Vice President ...... Sidney Glashofer
Fourth Vice President....... Gabriel E. Katz
WATMAUIEG AAAS DESEO oO CRAB OCE Paul Reznek
eT CASUT-CT aca en Teenie Siete ates Michael Leonard
Honorary President .......... Samuel Morris

Washington County
Pharmaceutical Association
Presid eniamrere ae Samuel E. Weisbecker
Vicon Rresidentar caine ances Joseph Davies
Ane eR ey cic Frederick Fahrney

University of Maryland School of
Pharmacy Student APhA-MPhA Chapter
Sole ae ae peers ae Paul R. Webster
Viceelresidentanane Geen Stephen B. Bierer
SCCELAT Vann SAE cro ete het: Donna S. Levin
Treasurer

MPhA AUXILIARIES

LAMPA — Ladies Auxiliary of The
Maryland Pharmaceutical Association
President
MRS. LOUIS M. ROCKMAN
Recording Secretary
MISS MARY DiGRISTINE
Communications Secretary
MRS. RICHARD R. CRANE
Treasurer

MRS. CHARLES S. AUSTIN

Membership Treasurer

MRS. MANUEL B. WAGNER

JOHN A. CROZIER

OTHER PHARMACY ORGANIZATIONS
Maryland Society of Hospital
Pharmacists
President
MARY W. CONNELLY
President Elect
NORMAND A. PELISSIER
Secretary
DOLORES A. ICHNIOWSKI

Treasurer

THOMAS E. PATRICK

University of Maryland
School of Pharmacy
Dean
DR. WILLIAM J. KINNARD, JR.
Assistant Dean
DR. C. T. ICHNIOWSKI
Delegate and Vice Speaker—
MPhA House of Delegates
HENRY G. SEIDMAN

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number. Allow four weeks for

changeover.

TABLE OF CONTENTS

Page
Editorial—Innovation in Health Care—

Wille Pharmacye Bees DIG me LOA Cierra teen 6
PHAaATMacys Calendar ccccset cee eae eee ees 7
Ins Memoriam——B® Oliver Colemrscerscesrsete tee eres 8
Maryland Board) of Pharmacy NEWS fees. 8

Installation Address—Nathan Schwartz, President....10

CONVeNGON BRGDOLUS Micmcsrccseeyoemtanees eentee ate dees eet meee eee cere 10
Metropolitan’ Gtild softs bharmacistSa= eee 14
CONVENTION EUS PtS menecese eee tee ee ee 15
HOSpItale Pharma Cy oCCllO lh meee eee eee ee 20

Prince Georges-Montgomery County
Pharmaceutical leASsOclatio net te eee 24

Baltimore Metropolitan Pharmaceutical Association..26

Washington Spotlight for Pharmacists .................ccc0..: 29

INDEX TO ADVERTISERS

Page
Borden-Hendlerulce Creamer oe eee eae 23
IBELKCy . Bile PLOGCESSIn meena eeeeeeeee ne eee 2a
Calverte rule COMPan ya Ll) Chae eee en eee ae 23
Thea Drug RH OUSC LN Cae oe ere ee ee tf
lnhsaumy 18%, (Enilvorbay (Cleyeoyeyswohye «ones. secassecrmosn nonrnenosasowneconaoe Zi
HynsSonsawestcOtpeece Dinning Lica ea een eee ot
lio Lally sand tCompanyacn. sce eee 3
MOYEN AY LDA DEE’ (CLOVEONOEN ONY geccconpscnesasssso.cpouncecoe oucrepannnrchreocsohonnte 32
Manginivand» Associates, Inc.99..0 4) a eee 9
Maryland News:.Company -2..5.5-500 72) ee 25
Noxell + Corporation iacpce ee ee ee 2
Paramount, Pooto. services: 4.1008 ee 19

Pension and Investment Associates of America, Inc...26

ALL tCODIN SO OLD ATI Vaan eee eee ee een eee 13
D. Stuart Webb Advertising Services ............................ 30
Youngs. Drus ProductsseCorporatione ee 4

Editorial...

Innovation in Health Care —

Will Pharmacy Be Able To Act?

Every gathering of two or more pharmacists in-
evitably lends to a discussion of the changes in pharmacy
and the many problems confronting the profession. There
are always references to the impact of the third-party pay-
ment prescription programs, hospital-affiliated health cen-
ters, the interrelated growth of chain (and supermarket )
pharmacies with the decline in independent practice and
so on, ad infinitum.

But perhaps the greatest impact upon pharmacy will
come from “health maintenance organizations.” These
are groups designed to develop innovative alternative sys-
tems of organizing, delivering and financing health care.

Their aim is to utilize the private sector to the maxi-
mum extent, using both governmental and nongovern-
mental funds. An example is the Maryland Health Main-
tenance Committee, Inc. Its statement of purpose says:
“One approach that holds definite promise of strengthen-
ing access to health services, cost containment, and as-
surance of quality is prepaid group practice . . . Prepaid
group practice can function in a variety of organizational —
forms; however, there are certain basic concepts which
constitute this delivery system: a prepaid plan with a
broad scope of benefits, the group practice of medicine,
integration of ambulatory, impatient, and other compre-
hensive patient services, enrollment on a voluntary basis
with choice of other systems available, and reimburse-
ment by capitation.”

This committee seeks “‘to promote, assist, and pro-
vide linkages for development of a network of geogra-
phically distributed, autonomous, community-based health
centers as a viable alternate system of health care delivery.
The committee believes that uniform basic benefit pro-
grams and compatible medical information and adminis-
trative systems would enable individual group practice
facilities to attract enrollment from the organized group
market (i.e., labor unions, federal, state, and local goy-
ernments and other employer groups) as well as benefici-
aries of public programs (such as Medicaid and Medi-
care). Both the purchasing groups and the prepaid group
practice centers will be served by insurance carriers and
other payer organizations who can offer the group prac-
tice network benefit packages as a single, clearly defined
option to conventional programs.”

Here we see a group made up of private and govern-
ment agencies, professional societies, labor unions, health
professionals and others interested in the delivery of
health services joining together. With the recognition of
the importance of this kind of an approach to the
problems of medical care, the MPhA Board of Trustees
has agreed to participate in the Maryland Health Mainte-
nance Committee.

There are, of course, many other organizations in
Maryland that are involved in health planning and in
establishing new ways of providing for the health needs
of the community. If pharmacy is to be a viable element

THE MARYLAND PHARMACIST

in the emerging new patterns for expanding accessibility
to comprehensive health care, we obviously will have to
be active participants in every effort involving health.

Are pharmacists prepared in attitude and orienta-
tion for innovations? There is an urgent need for many
pharmacists to be prepared to contribute to the work of
these organizations. In addition, the Maryland Pharma-
ceutical Association should be in a position to have suffi-
cient staff available with special training and background
to enable MPhA to provide the leadership and input into
the many private, group and governmental programs
which already exist and are now proliferating at an in-
creasing rate.

Here is yet another critical challenge that must be
faced by pharmacy—a challenge that can be met effective-
ly only by a representative professional pharmaceutical
society that is properly supported by those who have the
most at stake—pharmacists!

Time is growing short. Let us hope a positive re-
sponse will come in time.

—Nathan I. Gruz

DID YOU HIRE A NEW PHARMACIST LATELY? ...
OPEN A NEW BRANCH? ... GET ELECTED TO
OFFICE IN YOUR SERVICE CLUB OR SOCIAL OR-
GANIZATION? . . . BECOME ASSOCIATED WITH
ANOTHER PHARMACY?

WE WOULD LIKE TO KNOW—AND SO WOULD
OUR READERS. WHY NOT DROP US A LINE AT
THE MPhA OFFICE TODAY.

PHARMACY CALENDAR

September 7-12—31st International Congress of Pharma-
ceutical Sciences of the FIP, Washington, D.C.

October 1-4—31st Annual Convention of the American
College of Apothecaries, Hunt Valley Inn, Hunt Val-
ley (Baltimore), Maryland.

October 10-14—National Association of Retail Druggists
Annual Convention, The Rivergate, New Orleans.

October 16-21—National Wholesale Druggists’ Associa-
tion Annual Meeting, Century Plaza Hotel, Los
Angeles.

December 12-16—American Society of Hospital Phar-
macists Sixth Annual Midyear Clinical Meeting,
Washington, D.C.

April 22-28, 1972—American Pharmaceutical Associa-
tion Annual Meeting, Houston.

AMPHETAMINE REGULATIONS

Amphetamine and methamphetamine drugs, alone or
in combination, have been reclassified from Schedule III
to Schedule II drugs as of August 6, 1971. The change
affects some 100 single entity and 300 combination prod-
ucts. Full lists of these drugs appear in the july 17 issue
of the APhA Newsletter.

MORE PHARMACIES CHOKE TO DEATH THAN STARVE TO DEATH

2.4 times
$ 51,862- 25.9%
199,515-100.0%
124,785- 62.5%
74,730- 37.5%
25,481- 12.8%

6.7 times
$ 19,434- 9.7%

Annual Turnover Ratio

Inventory Value

Sales (Weighted) 199,515-100.0%

Cost of Goods Sold 129,284- 64.8%

Gross Margin 70,231- 35.2%
Employees’ Wages 20,890- 10.5%

Rent and
Miscellaneous 20,589- 10.3%

Total Income
(Proprietor’s Salary
and Net Profit)

HERE'S WHAT INVENTORY TURNOVER
MEANS TO PHARMACY OWNERS:

Lilly Digest statistics indicate that the turn-
over ratio in pharmacies directly influ-
ences the proprietor’s total income. The
high turnover pharmacies generated over
$6,700.00 more income than the pharma-
cies with low turnover and their inventory
investment was only 37% of that of the
low turnover pharmacies.

27,222- 13.6%

$ 28,752- 14.4%
30.5%
more income

Source: The Lilly Digest 1970
Eli Lilly and Company

$ 22,027- 11.1%

THE DRUG HOUSE, INC.—YOUR FULL-SERVICE WHOLESALER—CAN HELP YOU ACHIEVE
TURNOVER RATIOS THAT PROMOTE OPTIMUM INCOME FOR THE PHARMACIST

See Your Drug House Salesman For Details

THE DRUG HOUSE, INC.
PHILADELPHIA — TRENTON — WILMINGTON

JULY 1971 7

Jn Memoriam
B. OLIVE COLE

Dr. B. Olive Cole, well known to more than two gen-
erations of pharmacists as a unique personality in phar-
maceutical education, died on June 5 at the Maryland
General Hospital after an extended illness. She was an
Honorary Member of the Maryland Pharmaceutical As-
sociation and Baltimore Metropolitan Pharmaceutical As-
sociation.

Doctor Cole, 87, was Professor Emeritus of Pharmacy
Administration at the University of Maryland School of
Pharmacy. Born in Mount Carmel, Baltimore County,
Doctor Cole was the first woman to hold a full professor-
ship at the School of Pharmacy, earning the distinction in
1948. She also is believed to be the first woman to hold a
full professorship at any school of pharmacy in the United
States. In 1948 and 1949 she was acting Dean of the
School of Pharmacy and the first woman ever to hold
that position.

She was graduated from the Baltimore Business Col-
lege in 1903 and the University of Maryland School of
Pharmacy in 1913. Ten years later she became the first
woman graduate of the University’s School of Law, spe-
cializing in the legal aspects of pharmacy. She also at-
tended evening classes at the Johns Hopkins University
where she pursued studies in English, history and eco-
nomics.

From 1916 until 1920 she worked as a pharmacist
in Washington after which she was appointed an Associ-
ate Professor of Botany and Materia Medica at the Uni-
versity of Maryland. She retired from the University in
1953.

Doctor Cole wrote a number of articles on the his-
tory of pharmacy and also wrote histories of the Uni-
versity of Maryland School of Pharmacy and the Mary-
land Pharmaceutical Association. The latter was com-
pleted in 1957.

Doctor Cole was a life member of the American
Pharmaceutical Association. She was a charter member of
Epsilon Chapter of Lambda Kappa Sigma Sorority.

She served as President of the Baltimore Branch of
the American Pharmaceutical Association in 1935 and
was Secretary of the Alumni Association of the University
of Maryland School of Pharmacy from 1926 until 1953.
She was also a charter member and Past President of
the Quota Club International, the only woman member of
the Baltimore Veteran Druggists Association and a charter
member of the University of Maryland chapter of Rho
Chi Society.

In 1966 in tribute to Doctor Cole the Maryland
Pharmaceutical Association established the B. Olive Cole
Pharmacy Museum in the Kelly Memorial Building. The
museum contains antique apothecary equipment, most of
it obtained from the collection of L. Manuel Hendler. A
number of pieces also were collected by Doctor Cole and
some of her former students.

In 1953 Doctor Cole received the Honored Alumnus
Award of the University of Maryland School of Phar-
macy.

Survivors include 11 nieces and two nephews.

BEES

Maryland Board

of Pharmacy News
Pharmacy Changes

The following are the pharmacy changes for the
month of June:
New Pharmacies
None.

No Longer Operating As Pharmacies

Read’s, Inc., Arthur K. Solomon, President, 5857
York Road, Baltimore, Maryland 21212.

Big Valu Family Pharmacy, James Cooke, Presi-
dent, 100 Governor Ritchie Highway, Glen Burnie,
Maryland 21061.

Allentown Drugs, Richard J. Schneider, President,
6325 Allentown Road, Camp Springs, Maryland 20031.

L and M Pharmacy, Inc., Frank F. Cwynar, Presi-
dent, 703 Baltimore-Annapolis Boulevard, Glen Burnie,
Maryland 21061.

Drennen’s Pharmacy, J. Holly Drennen, 8 South
Main Street, Port Deposit, Maryland 21904.

Change of Ownership, Address, Ete.

Hancock Pharmacy, Adolph Baer, President,
(Chang of ownership), 39 West Main Street, Hancock,
Maryland 21750.

Pacifier Regulations

The first regulations in the nation governing the size,
sale and distribution of pacifiers were adopted July 1 by
the State of Maryland Department of Health and Mental
Hygiene.

The regulations were approved after a public hearing
conducted by John J. Appel, Jr., Chief Hearing Officer
of the Department of Health and Mental Hygiene.

Appearing on behalf of the Department of Health
and Mental Hygiene was Mrs. Beatrice Weitzel, Execu-
tive Assistant to Dr. Solomon, who urged that for the
protection of children who cannot help themselves, the
regulations be adopted. Mrs. Weitzel also reported that
the Maryland Pharmaceutical Association had requested
that she announce the Association’s support for the regu-
lations.

Francis S. Balassone, Chief of the Division of Drug
Control, Environmental Health Services, whose agency
will eventually be the regulation enforcement authority,
also appeared. Mr. Balassone reported approval for the
regulations from the Medical and Chirurgical Faculty of
Maryland and the Maryland Nurses Association.

The standards for the pacifiers contain these re-
quirements: the minimum width of guard must not be less
than 42 mm (approximately one and three quarter
inches), if made of collapsible soft plastic. If made of
rigid plastic material, hard rubber or other non-breakable
hard material, the guard must not be less than 38 mm
(approximately one and a half inches). The handle must
be hinged or collapsible.

Dr. Neil Solomon, Secretary of Health and Mental Hy-
giene, had earlier stated that significant evidence has
been produced to show that pacifiers below these dimen-
sions pose a serious threat to children.

THE MARYLAND PHARMACIST

Mangini can tell you
what you have.

Within 1%

Many pharmacists often esti-
mate their inventory by relat-
ing purchases to sales.

In today's competitive climate
and with the cost of merchan-
dise continuously rising, these
estimated gross profit figures
can be misleading. In fact,
this can be extremely costly
to the pharmacist who. un-

Mangini & Associates, Inc.

4850 W. Belmont Ave. Chicago, III
60641/(312) 282-8181

aware of his shrinking inven-
tory and gross profits, ts
actually paying a higher in-
come tax than he should.

So why guess? Call Mangini
for fast, computerized inven-
tory service that will tell you
within 1% how your inventory
realistically stacks up to your
turnover, sales and profits!

WRITE FOR DETAILED
INFORMATION.
IT'S FREE!

11722 Studt St., St. Lows, Mo. 63141
2760 W. Market St., Akron, Ohio 44313
575 Savin Ave., West Haven, Conn. 06516
5501 Cherokee Ave., Alexandria, Va. 22312

INSTALLATION ADDRESS

Nathan Schwartz, President

Annual Banquet
Mavyarlivcn bo tu
Hunt Valley Inn, Cockeysville

An astute statesman once said that a speech to be
immortal need not be eternal. Tonight my remarks will
not fall into either category. Nor will I insult your intelli-
gence by giving you the usual act about being humble for
in reality, my friends, humble people neither aspire to
nor ascend to the presidency of either the country, the
senate, civic organizations or the Maryland Pharmaceuti-
cal Association. A year from now after attempting to
deal with the national and local issues facing our pro-
fession, | may stand before you and say that [ am humble,
but not tonight.

I take the helm of this organization at a time in our
history when the improvement and availability of health
care services occupies the attention of us all. Now comes
a new era, new problems and new opportunities. The
drug store has changed from a “ma and pa” store to a
significantly large merchandising unit in one-stop shop-
ping centers or, in some cases, large professional pharma-
cies. Some people say that what has happened is a “‘split-
ting with tradition” or “breaking with the establish-
ment.” | say it is becoming part of the times. Some peo-
ple say it’s revolutionary; I say it is evolutionary. How-
ever, whatever one calls it, it inevitably means one thing
—change! I think Margaret Mead’s definition of change
says it all—‘No man will live in a world into which he
was born — no man will die in a world in which he
lived.” Change is inescapable; and if this premise is cor-
rect as any successful person must surmise, then with
the change will come challenge.

“Challenge!” is the key word in the year to come.
What were acceptable practices in the past are fast being
laid to rest, and in its place are failing ideas, methods
and dealings which are making today’s business market
fraught with danger, tingling with excitement and spec-
tacular with innovation.

I call upon state, local and municipal governments
to utilize some of the most brilliant, diligent, multi-
talented and clear-thinking people in the state in capaci-
ties for which they are so well suited. In the fields of
drug abuse, planned parenthood, Medicaid. Medicare,
third-party systems and venereal disease, pharmacy lead-
ership should not have to remind government to include
us in their programs. They should be coming to us.

We are afraid to blow our horns, to claim our vit-
tues, to hold our heads high and say, “We are the great-
est.” My challenge in the year ahead is to convince you
to believe in yourselves. Pharmacy has become the “whip-
ping boy” of many. We are beset by lawmakers, news
media and political aspirants because we are splintered.
It is of upmost importance that the chain operator, the
chain pharmacist, the independent pharmacist and the
hospital pharmacist realize that the problems of phar-
macy affect all of us. We are entwined and interdepen-
dent. We must combine knowledge, experience and opin-

Convention Reports...

Report of 1970-71 MPhA President
Donald O. Fedder

With mixed feelings I stand before you this morn-
ing to report to you on my year as president. As many of
my predecessors have noted, the year has flown, and there
remains so much yet to be done.

The year began for me as an active candidate for
the House of Delegates, 2nd District of Baltimore Coun-
ty. With the encouragement and support of many but
without a political base, I entered the no man’s land of a
political campaign and emerged some 13 weeks later a
bit battered and bruised but none the less for wear. Both
you and I learned much from this and from the cam-
paign of Arnold Amass—the importance of strong, dis-
ciplined political action and the need for commitment in
terms of money and active participation. Incredibly, num-
bers of people will vote for a candidate simply because
they are asked to vote for him by a friend or neighbor.

We learned that politically friends are friends as
long as there is need for support. When that need ceases,
a cold, calculated, jaundiced eye is applied to that friend-
ship, and changes are often made. We have learned the
rules used to win. Whomever we support in the future
will benefit from these lessons.

During this year I visited every local association
with the exception of the Allegeny-Garrett Pharmaceuti-
cal Association. I found the interest in what was happen-
ing genuine and refreshing. Our most frequent complaint
was the lack of communication existing between local
and state associations.

I am happy to report that “The Maryland Pharma-
cist” has been appearing with a degree of regularity. I
would like to commend the Editor and particularly the
Assistant Editor, Normand Pelissier, for their hard work.
I would like to now see a qualitative improvement in our
state journal. Such items as regular reports of the actions
of the Board of Trustees, the officers and a frequent re-
port of the activities and projects of the loval organiza-
tions would be most welcome.

The most significant achievement in the past year
has been the affiliation of our local and state organiza-
tions with the American Pharmaceutical Association. Over
the past four years we have made steady progress in solv-
ing some of our organization’s problems. In the sixties
we were constantly plagued by divisiveness between local
and state associations. At times we went to the legislature
divided. Frequently we wasted precious man-hours and
resources, duplicating efforts or just “spinning wheels.”

ion and come up with new ideas to best benefit our entire
profession.

I hope to justify your faith in me by doing all in
my power to advance the cause of pharmacy. I ask all of
you to work with me for the good of pharmacy, and in
so doing we shall maintain our faith and our pride in
our profession.

“Divided there is nothing we can accomplish —
united there is nothing we cannot accomplish.”

THE MARYLAND PHARMACIST

ee ee ee Kad

Some groups became little more than fund raisers without
goal or purpose.

This year pharmacy in Maryland has reached a de-
gree of maturity. You have said, “Enough with wasted
resources; enough with spinning wheels!’ Qne by one,
every local organization has affiliated with the Maryland
Pharmaceutical Association, and in April, I was quite
proud to stand before the American Pharmaceutical As-
- sociation Convention in San Francisco to accept the affili-
ation certificate that you, in your maturity, overwhelm-
ingly endorsed.

We now have established the conduit—the pipeline
—through which ideas and policy decisions can flow. The
rest is up to you. Action initiated locally can be swiftly
directed through the state association to the APhA, de-
veloping meaningful input and support from others, and
action will result.

With the establishment of the House of Delegates
we have another needed organizational improvement, one
in which participatory democracy can be made workable.
I must emphasize, however, there is no guarantee that
this will assure you a role in shaping policy in this asso-
ciation. The only way this role can be assumed is for you
all to work, to participate, to investigate the facts of
each issue and to be informed. Electing delegates is not
enough; they must attend the meetings of the House! Yet
attendance is meaningless without active participation in
the development of ideas and in decision making.

You, the membership, must make a personal com-
mitment to yourself and to your profession. Let your rep-
resentatives know your problems and your suggestions
for their solution. Only then can our organizational
framework develop to the maturity that we all need and
WENME G6 €

Yesterday, we had reports of the many committees
of this association, and I will not repeat them today. As
you can see, we had a busy year, with many accomplish-
ments and some glaring failures. If I can leave you with
any message today, it would be not to accept “progress”
reports on face value. We must be ever wary of the very
human tendency to accept the status quo and to allow
mediocrity to go unchallenged so that progress is re-
tarded. We have in us the power to excel! What is
needed is the will to excel!

We the membership of MPhA must be constantly
in pursuit of excellence in our leadership and in our goals.

Only then can we fulfill our mission—that of pro-
viding strong, well-informed direction to promote public
health and to assure progress of the profession of phar-
macy.

Constitution and By-Laws Committee
Melvin J. Sollod, Chairman

This year the changes in our Constitution and By-
Laws will have the greatest effect on the structure of our
organization since its inception. In the future we will
have a new House of Delegates which will expand the
number of people determining the policies of the organi-
zation.

The new Board of Trustees will replace the Execu-
tive Committee. This smaller group will be charged with
carrying out the mandates of the House of Delegates. Mail
balloting will insure participation by all members in the
election of officers.

SLUNG GAA

A requirement for membership is that the new appli-
cant be a member of the APhA. All local pharmaceutical
associations are represented in the House of Delegates as
are the Maryland Society of Hospital Pharmacists, Uni-
versity of Maryland School of Pharmacy and students at
the School of Pharmacy.

Medicaid Committee
Nathan Schwartz, Chairman

When the Annual Convention was held in July
1970 in Atlantic City, a list of 10 proposals regarding
Medicaid was drawn up, voted upon and approved by
membership. These proposals were then submitted to the
Department of Health and Mental Hygiene.

As of this date, one of these proposals has been ap-
proved and implemented, the adoption of a_ three-part
prescription form. Although the Department of Health
included a request for an increase in the Medicaid pre-
scription fee, the Budget Department deleted it. Our ef-
forts to obtain more equitable compensation, a minimum
base fee and a maximum prescription total have been un-
successful.

We shall continue in our endeavors by requesting
further discussions with other responsible personnel.

Simon Solomon Pharmacy Economics
Seminar

Alder Simon, Chairman

‘he 1970 Simon Solomon Seminar was held from
9:30 a.m. to 4 p.m. on November 19, 1970, at the War-
ren House Motor Inn in Baltimore.

The registration fee of $15 included morning coffee
and buns and a prime rib luncheon. Guest speakers from
Chicago, New York, Philadelphia and Baltimore were

featured.

The morning program was devoted to “Discounting”
applicable to the retail pharmacy. Our panelists were
Richard Schott, President of Merchants Buying Syndi-
cate, the leading hard goods resident buying office in the
United States, and Allen (Bud) Levis from Chicago, a
supermarket consultant and analyst. Immediately follow-
ing the discussion the chairman moderated questions di-
rected to our panelists. Our luncheon speaker was Dr.
Maven J. Myers, Associate Professor of Pharmacy Admin-
istration, Philadelphia College of Pharmacy and Science,
who spoke on “The Economics of Third Party Payment.”
Following lunch, Dr. Dean Levitt, Head, Department of
Pharmacy Administration and Associate Professor, Uni-
versity of Maryland School of Pharmacy, spoke on “In-
ventory Management” and then moderated a question-
and-answer period. Our concluding speaker of the day
was Raymond A. Gosselin who discussed, “Is There a
Profit in Prescriptions?”

Those who attended the seminar acclaimed the day
as well worth the time and the fee. A tremendous amount
of information not normally available to the retail phar-
macist was disseminated in a form applicable to the small-
est store.

A total of 70 registrants were in attendance, and ex-
penses exceeded income by $343.10.

Public Relations Committee
Charles E. Spigelmire, Chairman

If we are to survive as a profession, we must unite
all parts of our profession. Pharmacists must also realize
that the needs of the public must be recognized. I can
assure each and every one of you that no one is more
cognizant of these situations than the members of your
Public Relations Committee. This is why your Public
Relations Committee attempts to instill in the minds of
the consumers that the community pharmacist is truly
their best neighbor.

We try to create an image that makes you feel
proud to be a pharmacist and strive to develop an air of
permanency and stability for pharmacy in the communi-
ty. We have used radio, television, newspapers and pub-
lic appearances to stress the role of pharmacy in public
health and welfare. In a sincere effort to help your cus-
tomers obtain a comprehensive and intelligent explana-
tion of many health subjects your association is again
offering you an opportunity to create complete and di-
versified Health Information Centers in your stores.
Through the efforts of our Executive Director, Nathan
Gruz, we have been able to obtain a custom-made pamph-
let rack which will hold about 20 different pamphlets.
This rack may be obtained from your association for $15.
Many pamphlets may be obtained from the State Depart-
ment of Health free-of-charge. The success of the Health
Information Center depends upon you. You must keep it
filled with pamphlets. You must keep it neat and clean,
and you must place it in a prominent spot in your store.

Your Public Relations Committee has organized
health groups to participate in Poison Prevention Week.
As a result the Maryland Pharmaceutical Association, the
Baltimore Metropolitan Pharmaceutical Association, the
Baltimore Safety Council, the Baltimore City Health De-
partment and the Maryland Academy of Pediatrics have
contributed time, ideas and advice to help you conduct
one of the most successful Poison Prevention Weeks since
the inception of this public safety activity.

Be kind to your feet, and they will be good to you.
During Foot Health Week we presented Dr. Michael Sher-
man, a prominent Baltimore podiatrist, on our radio pro-
gram who discussed how important good foot care is.

During National Children’s Dental Health Week Dr.
Stephen Overbeck explained the importance of beginning
dental care at an early age. Doctor Overbeck also stated
that materials needed for child dental care can be pur-
chased in our community pharmacies.

Have you ever seen a small child suffering with
tetanus? If you have, you would have been deeply im-
pressed with our program on ‘Tetanus Prophylaxis.” On
this program we presented Dr. Robert E. Marxiin who dis-
cussed the disease—how to avoid it and how to treat it.
He discussed the drugs and serums used in prevention
which are available in drug prescription departments.

One of our most outstanding human interest pro-
grams was the one on alcoholism. On this program we
presented a member of the Baltimore Area Council on
Alcoholism who explained the educational work being
done by the Council in curbing alcoholism. Gf course. he
informed listeners that prescription medication used in
rehabilitation is available.

Our radio program during Pharmacy Week was de-
veloped to inform listeners of the tremendous interest
the pharmacist has in their safety and welfare. The edu-

cational background of the pharmacist, the work and ex-
pense involved in opening a pharmacy and the laws and
regulations governing the practice of pharmacy were de-
scribed.

During Diabetes Detection Week your Public Rela-
tions Committee cooperated with Dr. A. A. Silver, Chair-
man of Diabetes Detection Week activities. Our weekly
radio program was dedicated to this project. Recently
we had Dr. A. A. Silver on our Best Neighbor Program
to make an appeal for funds to help rebuild Camp Glyn-
don for Diabetic Children. The destruction of this camp
amounted to approximately $50,000. We have distributed
over 500 Camp Glyndon donation containers to our phar-
macists in an effort to raise money for this worthy cause.

For many Sundays during the past year at 10:30
p-m. our Association had the benefit of a 15-minute radio
broadcast over radio station WCAO. On these programs
we discussed many facets of pharmacy. Time and space
do not permit me to describe each radio program pre-
sented during the past year, but I can assure you that
these programs will always say that the pharmacist is,
has been and always will be the public’s best neighbor.

For their cooperation I would like to thank Mr.
Byron Millenson, Manager of Radio Station WCAO; Mr.
Charles Purcell, Public Service Director WCAO; and
Miss Harriet Goldberg, Program Director at WCAO. Our
achievement during the past year is the culmination of
the cooperative efforts of many wonderful people. The
magnificent spirit exhibited by this committee made the
heavy burden seem light. The brilliant results obtained in
our work were due to the untiring efforts of everyone
who gave of their time and ability whenever they were
called upon. For his ideas and encouragement I want to
particularly commend our Executive Director, Nathan
Gruz. For their kindness and cooperation I sincerely

thank Mrs. Martha Eckhoff and Miss Hazel Pfister.

Your Public Relations Committee can tell the people
all of the many good things about pharmacy, not boast-
fully but proudly, because pharmacy is a profession of
which the whole world can justly be proud. People do not
know unless we tell them. We can tell them by our ac-
tions in serving them each day in our stores. We can tell
them as we talk with them. There is no need to glorify
pharmacy. The honest story is enough, but we must do
the telling. If we do not, who will?

Swain Seminar Committee
June H. Shaw, Chairman

The 11th Annual Robert L. Swain Seminar was held
on Thursday, February 11, 1971 at the Good Samaritan
Hospital under the joint sponsorship of the MPhA and
the MSHP. The theme was “Pharmacy in the Seventies.”

The Committee hoped to offer understanding of the
future trends of pharmacy and to create a forum for dia-
logue for pharmacists in all areas of pharmacy. Only the
future can measure our success.

The program was well received. The committee
wishes to thank all the speakers as well as the drug
companies for their contribution to its success.

As chairman, I would like to thank the members of
my committee for their support and diligence, Miss

Pfister of the MPhA staff and the MPhA and MSHP for

the privilege of serving in this capacity.

THE MARYLAND PHARMACIST

AW ROBINS

Robitussin

(GLYCERYL GUAIACOLATE)

Robitussin

(GLYCERYL GU AIACOLATE)

i =S
4 >> summer deal starts July1* ~~
~ includes 4" and 7™ sizes / | \\\.

aang

0 aoe Again this summer you can stock up on Robitussin and
. pee “ - Robitussin-DM at special low deal prices. Last year, drug store
: ; ae sales of these two cough preparations increased 8%, while the market was up only
he 1%. These increases were recorded in chains and in small, medium, and large inde-
oe pendents. Robitussin and Robitussin-DM alone now hold a big 10% share of this
foe : $100,000,000 market. They are also the most heavily prescribed cough syrups sold
wei f ; OTC with over 2 million scripts filled annually. In fact, Robitussin is the only OTC
-— a Stock up on. » cough medicine among the 200 most prescribed drugs. In spite of all this Rx volume,
* the best sellers some 71% of all Robitussin and Robitussin-DM business is OTC. Stock up heavy on
: these two leading cough preparations while they’re on deal by ordering more of the
_and put your - 4-ounce and a good supply of the 7-ounce size. And don’t overlook Robitussin®-PE.

, facings where It’s moving up fast in scripts and OTC sales.

ee = f You know these products are going to move off the shelf, so give them the
your profits are: facings they have earned. Your Robins Representative will be around to see you

(Deal runs July 1—August 31) soon. Buy ’em while it’s hot for extra fall and winter profits.

ee . a A.H. Robins Company, Richmond, Va. 23220 AH-.OBINS

Public Health Information Committee

Paul Freiman, Chairman

The function of this Committee is to involve the
Maryland Pharmaceutical Association and its members
in the various areas of public health in which the pro-
fession of pharmacy can best serve the community. This
Committee has worked toward the goal of making the
public aware of the role of pharmacy in the health needs
of the citizens of the state.

During Poison Prevention Week, March 21-27,
1971, labels were printed for distribution by our mem-
bers to their patrons on which were printed the number
of the Poison Control Center at the University of Mary-
land School of Pharmacy. The public was informed
through newspapers, TV and the radio broadcasts that
these labels were available at their pharmacies.

Currently we are involved in a campaign on venereal
disease. With the cooperation of the Youngs Drug Prod-
ucts Corporation and the State Department of Health,
V.D. Awareness Month will be launched in June. A press
conference kicking off the campaign will be held to
which representatives of the press, radio and TV will be
invited. In attendance also will be representatives of the
various health departments and a guest speaker to pro-
vide the theme for the campaign which will be “Help
eradicate V.D. through knowledge, prevention and edu-
cation.”

During June the public will be asked to go to phar-
macies where information on the prevention of V.D. will
be available. All pharmacies will have pamphlets for dis-
tribution on this problem as well as a list of clinics pro-
viding treatment. During this month we hope to establish
a speakers’ bureau of organized pharmacists and students
who will discuss the problem and prevention of V.D. be-
fore various civic and student groups. Again the pharma-
cist’s role will be emphasized to make the public aware
of our willingness and ability to serve wherever there is

a public health problem.

Metropolitan Guild of Pharmacists

New officers of the Metropolitan Guild of Pharmacists
are:

President—John McKirgan

Vice President—Frank Frary

Secretary—Larry Jacobson

Treasurer—Edward Williams

Directors for District of Columbia—Robert Weiss, Paul
Reznek and Harold Rosen

Directors for Maryland—Leonard Rosenberg, Michael
Leonard and Robert Irby

Directors for Virginia—Lewis Bowles, Milton H. Hur-
witz and Richard Dickenson

Tick-Borne Diseases

The City Health Department has recently issued a
warning to residents of the danger of Rocky Mountain
spotted fever, tularemia, tick-bite paralysis, and other
tick-borne diseases. Ticks are most prevalent during late
spring and summer and this is the time of highest risk
for children and grown-ups who are spending more and
more time out of doors.

According to Dr. David R. Berzon, public health
veterinarian in the Baltimore City Health Department,
not all ticks are dangerous but ticks infected with various
diseases are found throughout much of the United States.
So far this year the Maryland State Department of Health
has received reports of 5 cases of Rocky Mountain
spotted fever and 3 cases of tularemia in the state.

Ticks can usually be found in grassy, wooded and
bushy areas in the city or suburbs. They transfer them-
selves to people and animals passing through these areas.
Although there is ordinarily little danger of infection un-
less an infected tick has been attached several hours, Dr.
Berzon warned that ticks should be treated with caution.
These flat, blood sucking, spider-like animals should be
removed as soon as they are felt or seen crawling on
someone, before they have a chance to bite or become

attached to the body.
To avoid being bitten by a tick the Health Depart-

ment makes the following recommendations:

1. Avoid areas of heavy vegetation where ticks
thrive and breed.

2. Remove ticks from the person as soon as they
are noticed. Use tweezers or a small piece of paper as
protection for the fingers. Destroy ticks by burning or
disposal in a flush toilet.

3. Children who have been playing out of doors
should be inspected from head to toe before they go to
bed. Special attention should be paid to the scalp and the
back of the head. This goes for adults, too.

4. Pets should be inspected frequently and ticks re-
moved and destroyed. Insecticides which keep ticks off
pets for a week or more may also be obtained from vet-
erinarians or pet departments of retail stores.

When attached to the body for any length of time,
ticks become engorged with blood and expand in size.
Should one attach itself to you or your child, don’t pull
it off or the head may remain in the skin. Alcohol or
ammonia applied to the rear of the tick will cause the
tick to let go. Grasp the tick near its head and lift gently.
A check should be made to be sure no mouth parts are
left in the bite and an antiseptic should be applied to the
bite area.

Chances are there will be no further developments.
However, should a fever over 100 degrees occur within 3
to 10 days of a bite, tick-borne illness should be suspected
and a physician seen at once.

THE MARYLAND PHARMACIST

Convention Highlights

President Nathan Schwartz receives gavel from outgoing
President, Donald O. Fedder.

Attorney General Francis B. Burch delivered banquet ad-
dress. President Schwartz (left) and Board of Trustees
Chairman Fedder (right).

Toastmaster McHugh presents award to Morris L. Cooper,
1970-71 Honorary President.

Donald O. Fedder presented Past President’s plaque to
Toastmaster John R. McHugh.

H. Nelson Warfield, selected as 1971-72 Honorary President,
delivered invocation at annual banquet.

Photo by Paramount Photo Service

JULY 1971 15

MPhA and Local Association Dues Schedule

LOCAL ASSOCIATION DUES SCHEDULE — 1971
(Outside BMPA Area)

Allegany-Garrett County Pharmaceutical ASsOcicttion rssssussssnsseaseseseesneeunsesmsssssesnssares 510.00
Eastern shore: Pharmaceutical + SOC ty eeeccentecr cect te ercrreeeccetaceceert ciate sees eee onan ee oe 5.00
Prince Georges-Montgomery County Pharmaceutical octcccssuccceussseucsosrsesssonnsotneearesenseseanternes 15.00
Washington County, Pharmacenticale ASsociction! tcc ica caneccnees meee nae eens 10.00

All local pharmaceutical associations in Maryland are now affiliated with the Maryland Pharmaceutical Asso-
ciation and their dues, therefore, must be included when joining the MPhA.

As Maryland Pharmaceutical Association is now affiliated with APhA (effective January 1, 1971), APhA dues must
also be included for new members of MPhA.

Because of the extra services provided to MPhA by APhA as an affiliated state association, in addition to those
granted all APhA members, we strongly urge all "“grandfathered’’ MPhA members (members as of Dec. 31, 1970)
to also become members of APhA. APhA dues are $35.00.

Maryland Pharmaceutical Association—Baltimore Metropolitan Pharmaceutical Association
JOINT DUES SCHEDULE—BALTIMORE METROPOLITAN AREA

Pharmacy Owner or Manager—(fee covers pharmacy and one pharmacist OF MAMCGEL) reseosssssssssssssesessssnsessnseseee $75.00*
Pharmacist—other ‘than’ cove sari ccncecsetertstccqteten ces pa te tat css ee sSoese eit rleg eee ies ee ee 50.00*
Affiliate—Non-pharmacist executive, other thar OWMer OF MANAGE reseessscsssnsssnsssnssssnsssnsestnssessssnscssnsssessssnssenessnsessenennnssiasesneees 50.00*
Hospital Pharmacisi—MemberofsMiS; Hi. Piatra eee ee tr eee ee 25.00

Faculty; medical representative and adminisirative pharmacists) 0-2 ee 15.00**
Retired pharmacist, graduate student, new registrants (for the first year), inactive and non-resident secs 15.00**
Associate—Non-pharmacist employee or represe4nntcttiveennaacscssecmeresccseeesesseesesvnsoeseseetssonsessoseserssevnssscsessrresensesenasetanssenssceereeaseeansscetesaeneseres 15.00**

* includes $25.00 BMPA dues
** includes $ 5.00 BMPA dues

Build a strong profession — Every pharmacist a member of his STATE and LOCAL Association

Approving of their objectives, I hereby apply for membership

Name in full
(Miss; Mrs.; Mr.; Dr.)

TT eee eee e errr rrr rrr rere rer rrr rere rere eee ree errr rrr eer er errr rere rrr rrr rrr irr rrr rire rrr rrr e errr rie errr rrrrirrirrrirrrri i rrrirrreer rier rr rrr rere

lalla tae TT ETP ee eee errr r errr rere r reer rere rere rere rr rrr rrr ree rr rrr reer reer rieee rere rerirrrrerrrrrrir rire reer eee

PP eee eee eee rrr Tree rere eee eee reer Terre rrr rrr rrr rr rrr rrr rrr rrr errr errr rrrr rire rrr rr rrr reer rere ere rir rir reer Tir rrr rr rrr rrrie eerie errr rrr

Member=7A.Ph.At soo ee eee INGALRD ace ee Local, etc. (name)
*Fill in all blanks.

Or eree eer re rere reer errr e rr eere errr errr eer errr rere rere rere ee eee cere eee reer eee TTT ys

REFERENCE (Member’s name)
Mail check with application.

NOTICE—This questionnaire is designed to provide information to enable the Association to serve you
more effectively.

10.

iu he

12.

Please complete, detach and return to MPhA office.

Maryland Pharmaceutical Association
650 West Lombard Street
Baltimore, Maryland 21201

BIOGRAPHICAL INFORMATION SHEET

Pharmacy/Firm/Institution
Owner [] Employee (] Partner [] Officer [] Pharaneg eNO set eters: NG ee G ee
If pharmacy, what hours open? .............::s0s000000 Te eee eect. or eee tent in ar vacant coves ates tee sheas dap onsen sce ceaeres

SCHOCUG MEIDCLVIC al Meee ttn tra Oe crs ee tees eay rece cre mace ieee feveeectnerstemte eeaeeerenuecess Full time Pet

Part time ([]

Emergency service ........ Delivery service

In your practice do you maintain patient medication records? Yes ........ Noga.

PSUSITESSMACULESS MRS rer rtt et rere eet ree tet cet oereennt crete ttc eitce ei tatisancdraconccessrs sees Lelephomne jaz yeiresetcs- eters sseccesspeere

Preferred mailing address: Home ...... Business ......

AAU CALLON mmo 1) SCHOOL OE erscicert teres ees renee eat tes eae heaters certs t ces ih oceeactedatsacésess AY CARMI ries Be ed oer terest
College meer enter ert tess eee ee teces yctegen tes tredssacencaettsacisacsenstes NV CALM eye secrcsree sete ctnertetaer- coroners
School of Pharmacy
Other postgraduate education
Professional seminars and continuing education ...... List on reverse side.

Previous positions held ...........ccccscsssessssssssececesesencsense tiesensnensesesssessnssesessnensessessssssssssserssenssesenenenenensneneeanensenscanensaenentes

Military experience oo... eeesssscsessssesessesssesesessenesesescsenscsssessseesessnsesenenseeeensnenesacsansecsnsnseccsesescescaaeasesasssnsessneseees

Professional organizations: APhA ...... Asn eee. AGAS.. NARD ...... MSHEP ......

Tet r OL Ce a irre ons ccec cia cecteaeccooutesovantielenrcevecssznconctecessenessensinesdeashectacensecssoncersbhcsaes

eee eee eee ee eee eee eee eH OSES HEHEHE SEES SES ESS EESH SEH EEE SES SEES OSTHS EES SSEEHEEH SHEE EOE
» SBRBEISOCARIIUR OCD COO BORCOODCTNIOCODOORRUCDODOCOOCICTOOCT DOOD TO LCCC OOOO OOORUR CTC OGIO GOO EO Ne TR OI BT sialic Nae

Pee eee eee eee eee eH ees eE HEHE EEE H ESTES ESO EEHS EOE SES HOSS ES SEES HESHSESHSESEH SESE EHO OHES
BINT RGCORCAROOLD CO OCORDOOO DO TTOORTISOOACUOUOF DRO RDOOU AME IOOCCONCLE OCOU OA RIOT RIO REMERON aN Sa Sad Pa = be

PoeeUeREPOEOEE CCC CTC
eee eee eee eee H HEHEHE E OEE OEEOEEHHTEE ESE SES SES SESH SESHEE HOES EED
whe saselvisins vis 6 5.0 bs cle vials celcw se 6.0'nle006.0]s6.0600 60600060 cececee cee ses e bese eneeTecsecsies 20 05S08©

If additional space is required for any item, please use reverse side or submit separate sheet.

13. Special interests: Political “Action 208. ah acs ee

Membership {promotion e000. ceee tenn eee ee Employee stelations=,.2.,th.csstecceacueetee tee reeneeee
Continuing =education gene tn. ene ere nets Public relations %7./...), .<acgersse ace ee eee
Schools of spharmacyyy, 22 MAg act niree nee Health: Centers’ 73). cacasat ete hose ene ee eee
Lastitutional | Pharmacy ew secs eeesee rete Pharmacy practices \:.or,c./icceer apenas teeta!
Publications sauce ee Convention, and imeectin gs gcc. yee rete erate
Professional relations|] (seg wnavescceekreusdectar et eee Industry) relations Gera us aetna eee
Legislation (250 Wate cn ete: CA en ere ee Third-party Rxaplansi x. 20. accr een eee ee ee
Liaison with voluntary health agencies: (cancer, heart, €tG) 5 cecvy.ecnees sone crer aman ones satan esents eee ee
14." Suggested: topics for, meetings © 5, ...scccstesno-cescecesccstecccie coseesceseavetosssutiestatadteres codes ddr ces deee Olay Hee genat ere ed te te agente tee
Professional. and scientific? semimars 62.235. cocliiscsasscecsudencovsvadendetedesouamenccacdactares. Cres taxcpa eines eetioer te eee aan ee
Management. or economic, Seminars o205.0.15, 3. boots ues vs tousncane tanateestedate tee bolls on Gg hee aatE paca eee ee
15. MPhA convention: Preferred months (1) ................ Re ocak ores rere (32) Petree te
Suggested: sitese(\1)).y. ee ee ee (Di) Sena ton andes eee tier ones (3) pti rieesaetens etecaeseereares

16. I would like to participate in a speakers’ bureau on:

Drug Abuse ...... Venereal Disease ...... Poison Prevention ...... Cost of Drugs ...... Pharmacy as a Career ......
Others © .ssisecered cock bevssveel Chssaoeledeyscescbesocutee cope ees oun eT a ee
17. Legislative and governmental contacts (patrons, friends, etc. ) i.e. ceseseseesdeacdetesdcsiotet tee

TEETER meee eee EHH EEE EEE EEE EH SESE EEEEEEEEEEEEEEE EE EEE ES EEEEES EEE EEE EEE EEEEH EEE EE HEHEHE EEEHEHEEEEHEEE EEE SEES HEHEHE EEHEEEEEEE EEE EEHEE ESHEETS ESSE HEH EEE EE EEE EE EEEEES SEES EE EEES!

MPhA MEMBERSHIP BENEFITS

Check below to receive information about plans.

Major Medical Plan |] 5. Retirement Investment Program
Tax-free Disability-Income Replacement [] 6. Hospital Money Plan
Plan || 7. Bad Debt Collection Service
bel 83

Professional Liability Plan

Employment Register
Family Life Insurance Plan

Mr. Pharmacist ~

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4. Salesman inventory control

To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE

3024 Greenmount Avenue
Baltimore, Maryland 21218

JULY 1971 19

Hospital Pharmacy
Section

MARY W. CONNELLY
President
MARYLAND Society or HospitaAL PHARMACISTS

Mary W. Connelly, Chief Pharmacist at Mercy Hos-
pital Baltimore, was installed as President of the Mary-
land Society of Hospital Pharmacists at the Society’s
Sixth Annual Hospital Pharmacy Seminar held at Ocean
City, Maryland, June 11, 12, and 13, 1971.

Miss Connelly, who has been Chief Pharmacist at
Mercy Hospital since 1968, is a 1951 graduate of the
University of Maryland School of Pharmacy. She was
Chief Pharmacist at Bon Secours Hospital in Baltimore
from 1951 to 1957. From 1958 to 1968, she was associ-
ated with the Eastpoint Medical Center.

Miss Connelly has been active in many pharmacy
organizations among which include the American Phar-
maceutical Association, American Society of Hospital
Pharmacists, Maryland Pharmaceutical Association, D.C.
Society of Hospital Pharmacists, National Catholic Phar-
macists Guild and the Maryland Pharmaceutical Foun-
dation,

She has served as Secretary of the Maryland Society
of Hospital Pharmacists from 1956 to 1968, Secretary of
the University of Maryland School of Pharmacy Alumni
Association, 1970-1971, and is presently Secretary of the
Lambda Kappa Sigma National Pharmaceutical Women’s
Sorority. She also holds membership in the Democratic
Club of Baltimore County.

Maryland Society of Hospital Pharmacists —
Sixth Annual Hospital Pharmacy Seminar

The Maryland Society of Hospital Pharmacists held
its Sixth Annual Hospital Pharmacy Seminar on July
11, 12, and 13, 1971 at the Carousel Motel in Ocean
City, Maryland. Nearly 200 registrants and guests at-
tended the three day seminar.

Included among the topics presented were: “The
Philosophy of Supportive Personnel in Pharmacy” by
Henry J. Derewicz, Director of Pharmacy Services at the
Johns Hopkins Hospital; “Computer Applications to the
Health Care System” by Cornelius P. McKelvey, Adjunct
Instructor at the University of Maryland School of Phar-
macy; “Pharmacy Services in a Small Hospital” by R.
David Anderson, Director of Pharmacy Services at the
Waynesboro Community Hospital, Waynesboro, Virginia
and “Pharmacy Service in the Emergency Room” by
Thomas E. Patrick, Chief Pharmacist at the University of
Maryland Hospital.

Other speakers included Louis P. Jeffrey, Director
of Pharmacy Service at the Rhode Island Hospital; Paul
LeSage, Deputy Director of Pharmacy Services at the
U.S.P.H.S. Hospital in San Francisco, Douglas R. Mow-
ery, Director of Pharmacy Services at the Washington
Hospital Center and Dr. Peter P. Lamy, Associate Profes-
sor and Director of Institutional Pharmacy Programs at

the University of Maryland School of Pharmacy.

The Banquet Address, entitled “The Pharmacist on
the Health Care Team,” was presented by Dr. John Col-
lins Harvey, Medical Director of the Good Samaritan
Hospital in Baltimore.

Among those receiving awards were Paul LeSage,
recipient of the W. Arthur Purdum Award; Marsha
Fruchtbaum, recipient of the M.S.H.P. Student Achieve-
ment Award and Robert E. Snyder, recipient of the Geigy
Achievement Award.

CHANGE OF ADDRESS

When you move—

Please inform this office four weeks in advance to avoid
undelivered issues.

"The Maryland Pharmacist" is not forwarded by the
Post Office when you move.

To insure delivery of "The Maryland Pharmacist" and all
mail, kindly notify the office when you plan to move
and state the effective date.

Thank you for your cooperation.

Nathan |. Gruz, Editor
Maryland Pharmacist
650 West Lombard Street

THE MARYLAND PHARMACIST

A Professional
Planning and

Remodeling Service

Should you upgrade your present location or select
a new site in order to achieve your objectives for
your business?

3. A complete sundries program providing sundries

departments and inventories designed specifically

for your store, with a built-in provision for
economical and reliable restocking of your shelves.
Along with this, we maintain expanding stocks of
new promotional sundries and programs for
increasing traffic and sales.

4 A professional planning and remodeling service
within our organization which includes complete
service in floor design, fixture and installation.

5. Professional help in site selection, store
development and in lease acquisition for
desirable sites.

THE HENRY B.

GILPIN

COMPANY
BALTIMORE * DOVER + NORFOLK + WASHINGTON

Gilpin offers professional assistance in site selec-
tion, floor design, fixturing and merchandising.
Consult your Gilpin representative. He can help you
build a better business.

A financial service consultant to service you on
request.

Two giant product shows each year: in January
featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing
promotional sundries.

the services required to nail down the profit dollars
which you need and deserve from your business.

The Henry B. Gilpin Company

901 Southern Ave., Washington, D.C. 20032

(301) 630-4500

Check the area of your particular interest or need on the
coupon below and mail it to us or phone us. We'll arrange

for Gilpin specialists to tailor the services which your
particular interest or situation requires.

Sirs:

j ! am interested in the following programs. Please have your

representative contact me in this regard.

i Name

I Name of Pharmacy
Ada¢s6 Phone.
City. States 21

Ee a oa aa a ly

™l
;
t
i
:
I
al

NEW EDITION AVAILABLE
TO
fale

PROFESSION
INTRODUCTION

TO THE PRACTICE

OF PHARMACY

a guide for preceptors

and interns

Revised and re-edited by a joint
committee of the National Association
of Boards of Pharmacy and the Amer-
ican Association of Colleges of Phar-
macy in consultation with boards of
pharmacy, colleges of pharmacy, state
and national association leaders and
pharmacists throughout the country.

This 60-page manual is the official
NABP publication for internship eval-
uation, standards and procedures. It is
an essential in training programs:

e For pharmacy preceptors who are
training students to qualify for licen-
sure — what is expected and what to
expect from the student.

e For students who are gaining ex-
perience — what activities wil/ assure
the full value from the internship
period.

e For those interested in the general
ethics and aesthetics of orienting fu-
ture pharmacists to practice — com-
munity and institutional.

INTRODUCTION
TO THE PRACTICE
OF PHARMACY

Mail to: NATIONAL ASSOCIATION
OF BOARDS
OF PHARMACY
77 West Washington Street
Chicago, Illinois 60602

Prices: Single Copies — $1.00
100 or more — $ .90
Please send copy(s) of the

PHARMACY PRECEPTOR’S GUIDE-
A Manual for Internship Training.

NAME
(Please print)

ADDRESS

Cltey,

STATE
) Payment Enclosed
L) Bill Me

ALP

TNSEELESNIEW Seer

JOSEPH D. MANGINI, president
of Mangini & Associates, Inc., inven-
tory specialists with branches in five
principal cities specializing in com-
munity and hospital pharmacy inven-
tories, was honored on June 6 by the
Chicago-Joe Fox Lodge B’nai B’rith.
Mr. Mangini was honored for his
“outstanding support and contribu-
tions” to the Jewish community in the
Chicago area. He is a past president
of the Illinois Pharmaceutical Travel-

ers and a member of the Chicago Drug
Club since 1951.

VINCENT DE PAUL BURKHART
has been appointed Assistant Chief
Pharmacist at the University of Mary-
land Hospital in Baltimore and Clini-
cal Instructor on the staff of the Uni-
versity of Maryland School of Phar-
macy.

DR. RALPH SHANGRAW of the
University of Maryland School of
Pharmacy and ROBERT E. SNY-
DER, past president of the Maryland
Society of Hospital Pharmacists, par-
ticipated in Careers Day at the Com-
munity College of Baltimore. Mr.
Snyder has recently been appointed by
ASHP president R. David Anderson
to serve a one year term on the ASHP
Council on Organizational Affairs.

DOUGLAS J. GALLOW has been
named Director of Market Research
by NOXELL Corporation, Baltimore,
Maryland.

VICTOR H. MORGENROTH, JR.
will serve as Convention Chairman of
the 31st Annual Convention of the
American College of Apothecaries,
October 1-4, 1971 at the Hunt Valley
Inn, Hunt Valley (Baltimore), Md.

ABBOTT LABORATORIES has re-
sumed full production of intravenous
solutions at its Rocky Mount, N.C.
plant. Abbott is reentering the market
with a rubber-stopper closure and new
equipment for administering intra-
venous solutions developed under an
agreement with Cutter Laboratories.

The TONI DIVISION of the Gil-
lette Company is changing its name
to The Gillette Company, Personal
Care Division.

Copies of ‘‘Guidelines”’
Available

Copies of “Suggested Principles and
Guidelines for Pharmaceutical Serv-
ices in Hospitals” are available at no
charge from the MPhA office. Since
there is only a limited supply avail-
able, please contact the office now.

Balassone Receives Harvey

Wiley Award

Francis S$. Balassone, Secretary of
the Maryland Board of Pharmacy and
Chief of Drug Control for the Mary-
land Department of Health is the first
pharmacist to receive the Harvey
Wiley Award from the Association of
Food and Drug Officials. He received
the award for “outstanding contribu-
tions” in administering state food and
drug laws.

Product Announcements

Geigy Pharmaceuticals announces
the introduction of Preludin Endurets
50 mg. (prolonged-action phenmetra-
zine hydrochloride). This new dosage
strength is intended to provide greater
flexibility in individualizing weight-
control programs.

Mead Johnson Laboratories an-
nounces that a substantia! portion of

the Vi-Sol/Vi-Flor vitamin product -

lines have been reformulated to in-
clude natural sweeteners in place of
saccharin. Taste preference for the re-
formulated products was expressed in
extensive studies carried out using
taste test panels.

Mead Johnson Laboratories is also
introducing a new product, Sustacal,
a nutritionally complete food recom-
mended for nutritional support in a
broad range of conditions that may
include physically incapacitated pa-
tients, patients with various types of
paralysis, patients with appetite loss,
and patients with food prejudices.

Important Notices

Pharmacists are urged to advise the
Association office (727-0746) regard-
ing all proposals or contracts regard-

ing prescription plans they may re-_
ceive. These plans are reviewed by
the Association legal counsel before

being endorsed by the Association.

Please note that according to re-—
cently passed Senate Bill No. 4, pre-

scriptions are not valid unless the phy-
sician’s signature is legible to the phar-
macist filling the prescription. This
would not pose a problem when the
physician has his name imprinted on
the prescription blank but could be a
factor where prescriptions originate
from hospitals where the physician
does not use his own personal blank.

THE MARYLAND PHARMACIST

Offering Independent Pharmacies...

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up
to making your best source of supply,
THE

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

First name in ice cream
for over a half-century

ICE CREAM

675-6000

JULY 1971 23

Prince Georges-Montgomery
County Pharmaceutical
Association

Samuel Morris cited for outstanding work.

Rudolph F. Winternitz presented 1970-71 Order of the Double
Star Award by Coleman Levin, National President, Alpha
Zeta Omega Fraternity.

Herman Bloom, “official photographer” presented commen-
dation certificate by Rudolph F. Winternitz.

Left to right: Samuel Morris, Honorary President; Paul President; S. B. Friedman, Second Vice President; Rudolph
Reznek, Secretary; Gabriel E. Katz, Fourth Vice President; F. Winternitz, Chairman, Executive Committee; Michael
Martin Hauer, President; Edward D. Nussbaum, First Vice Leonard, Treasurer.

Photo by Paramount Photo Service

24 THE MARYLAND PHARMACIST

_ _.. Readin
iS Still the fastest wa

to program the.

brain

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
vage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for the
spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

human
——

te |

——|
es

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

31st Annual Convention of the
ACA to be held in Baltimore

The American College of Apothecaries invites all
pharmacists and others associated with the profession to
attend its 3lst Annual Convention at Hunt Valley Inn,
Hunt Valley (Baltimore), October 1-4, 1971.

Guest speakers will include Mr. Henry J. Derewicz,
Director of Pharmacy, Johns Hopkins Hospital, Balti-
more; Dr. Ralph Shangaw, University of Maryland School
of Pharmacy; Mr. Ralph Engel, Director, National Phar-
macy Insurance Council, Washington, D.C.: Harry M.
Robinson, M.D., Dermatologist, Baltimore; Mr. William
Towle, Administrator, Columbia HMO and Henry Seidel,
M.D., Medical Director, Columbia HMO, Columbia,
Maryland; Samuel L. Fox, M.D., Ophthalmologist, Balti-
more and Dr. William J. Kinnard, Jr., Dean, University
of Maryland School of Pharmacy, Baltimore.

The program will include lectures and panel discus-
sions on Dermatology and Ophthalmology, Private Third
Party Prescription Programs, Generics and Pharmacy-
Industry Relations.

Social and food functions will include an evening
at the Limestone Valley Dinner-Theatre and a cruise on
the Chesapeake Bay featuring a Maryland crab dinner on
board.

Convention Chairman Victor H. Morgenroth, Jr.,
reminds pharmacy students that the registration fee will
be waived and a special invitation is extended to them to
attend any or all of the sessions.

Hotel and registration information are available
from the ACA, 7758 Wisconsin Avenue, Suite 412 C,
Washington, D.C. 20014.

Baltimore Metropolitan
Pharmaceutical Association

The Baltimore Metropolitan Pharmaceutical Asso-
ciation held a general meeting at the Kelly Memorial
Building on Thursday, June 10, 1971 at 8:45 P.M. The
evening's speaker was Benjamin L. Brown, Deputy State’s
Attorney for Baltimore City. Mr. Brown’s topic was en-
titled “Crime and the State’s Attorney’s Office: The Phar-
macist’s Concern With Crime—From Shoplifting to Pre-
scription Forgeries.”

Camp Glyndon collection cans were turned in at
the meeting.

Obituary

JAMES A. MEMBERT

James A. Membert, 67, retired president of Wash-
ington Wholesale Drug Exchange, died on June 8 after
a long illness. A lifelong resident of the Washington
area, he was a member of the Traveler’s Auxiliary of the
Maryland Pharmaceutical Association for many years.

A Pharmacist Speaks

The following is based upon an open letter submitted
for publication in the Prince Georges-Montgomery Coun-
ty Pharmaceutical Association “Bi-County Pharmacist”
by Simon Zvares, an MPhA member in Silver Spring:

Would you travel to the seashore and live in a room
until you leave for home without enjoying the seashore?
Would you go to the mountains just to stay in one room
and not enjoy the outside view? NO! Yet you join the
Maryland Pharmaceutical Association and do nothing to
help your profession and yourself even though the two
go together.

Why don’t you come to meetings, meet your col-
leagues, but mainly why don’t you get involved? The best
way is to serve on a committee. You can be a committee
member even if you don’t have much spare time. Just
spend a little time on the telephone as part of member-
ship, of programming meetings, public relations, or even
eight or nine other committees. You will get to know a
nice group of your kind of people—fellow pharmacists.

Do you have a yen for politics? Then we really need
you! Pharmacy is joining the politicians to prove to them
that the pharmacist is a professional man. We meet hun-
dreds of people in the community each day with more
frequency and closed contact than a physician, lawyer or
any other professional man. We really get the pulse of
the community.

Participate in a committee and see how much better
you will like being a pharmacist. Join in the committee
work; feel like somebody, and you will find that you are
somebody. Join with us to make a better way of life!

Pension & Investment
Associates of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)
HR-10.. Plans (Sole Proprietor-Partnerships)

Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

THE MARYLAND PHARMACIST —

fenlarge your service
with enlargements

5 x7’s and 8 x 10’s are fine. But the bigger the enlargement,
the bigger you make it. In profits. In customer satisfaction.
Large prints are easy to sell. They’re in demand as wall
portraits, gifts, for framing as wall decor... you name it.
When it comes to big blow-ups, Berkey does it all. 5x7,

8x 10, 11 x 14 and larger. In color, up to 11 x 14. Black and
white up to 16 x 20. We even make 11 x 14 proof sheets _
from ultra-miniatures. Berkey enlargements are better
because it’s a specialty with us — handled only by experts. -
Compare our color rendition and sparkle. 5x7’s and

8 x 10’s returned in a frame at no extra cost. You — and your
customer will appreciate Berkey’ s better quality and prompt
service. Just drop the enlargement orders, regular and
over-size into the Berkey bag. We'll give them the Berkey
treatment. Custom-care printing rigidly checked and
double-checked by the tough quality inspectors in the
business.

Berkey can do things for you that nobody else does, —
because nobody else can. And ‘‘one supplier, one bill” will
simplify bookkeeping for you too. Call or write your nearest
Berkey Laboratory now for the complete schedule of
Berkey services and prices. ©

[= Berkey Film Processing
td of Washington, D.C.
3701 Mt. Vernon Avenue Alexandria, Virginia 22305
(703) 549-7500

percey ip

Photo Inc.

Contributions...
1971 Annual Convention

Sustaining Members

Calvert Drug Company

The Henry B. Gilpin Company
Loewy Drug Company

Miller Drug Sundry Company
Maryland News Company
Borden-Hendler

Cash Contributions

Abbott Pharmaceutical Products Division
Ayerst Laboratories

Burroughs Wellcome and Company, Inc.
Ciba Pharmaceuticals

Geigy Pharmaceuticals

Eli Lilly and Company

Mead Johnson Laboratories

Merck Sharp and Dohme

Miles Laboratories, Inc.

Norwich Products

Parke, Davis and Company

Personal Products Company

Pfizer Pharmaceuticals

William P. Poythress and Company, Inc.
A. H. Robins

Smith Kline and French Laboratories

E. R. Squibb and Sons, Inc.

The Upjohn Company

Youngs Drug Products Corporation

Merchandise

Alcon Laboratories, Inc.

Allen, Son and Company
Colgate-Palmolive Company
Ex-Lax, Inc.

Father John’s Medicine Company, Inc.
Glenbrook Laboratories

The Gillette Company

Kaz, Ine.

Max Factor

The Mentholatum Company, Inc.
Noxell Corporation

Organon, Inc.

Purepac Corporation

Resinol Chemical Company

Sea Breeze Laboratories, Inc.

MPhA Commends Manufacturers For
New Starter Dose Policy

At its 89th Annual Convention Meeting, the Mary-
land Pharmaceutical Association commended those phar-
maceutical manufacturers that have eliminated traditional
prescription drug sampling. These manufacturers initi-
ated a controlled system for the introduction of new
drugs in which physicians will prescribe prescription
orders for their patients. This change produces greater
distribution controls which are important in preventing
diversion of drugs and the dangers of poisoning from
samples discarded in trash receptacles. MPhA decided to
investigate what legislative or regulatory steps might be
needed in the interest of public health.

Postage Stamp for Pharmacy

The first known organized attempt to have a post-
age stamp issued in honor of Pharmacy occurred in 1934
when a resolution was introduced at the annual meeting
of the American Pharmaceutical Association in Wash-
ington, D.C. Since that time there have been numerous
other attempts by individuals and groups to achieve this
goal. (For a history of these efforts, the reader is referred
to the January, 1964 issue of JAPhA)

According to Henry Szancer in Drugs and Pharmacy
on Stamps by George Griffenhagen (Topical Handbook
No. 55, American Topical Association), 58 personalities
connected with pharmacy, including William Sydney
Porter (licensed pharmacist in N.C.), have been pictured
on the stamps of 44 countries to date—none of these be-
ing United States stamps.

Several major health professions have been recog-
nized on U.S. stamps in the last 25 years. The American
Medical Association was so honored in 1947; the Ameri-
can Dental Association, in 1959; and the Nursing Pro-
fession, in 1961.

Many believe today that the prospects of a Phar-
macy stamp never looked brighter. The fact that Senator
Robert Griffin has presented a statement to the U.S. Sen-
ate and has written to the Postmaster General in support
of a postage stamp in honor of Pharmacy is certainly en-
couraging but a lot more support has to be demonstrated.
The 91st Congress has seen 63 resolutions and joint reso-
lutions calling for the issuance of 34 commemorative
stamps. Of these, only five have brought forth the desired
stamps and two of the five recognized major events that
occurred that same year, namely the launching of Apollo
11 and the passing away of former president Dwight D.
Eisenhower.

The Post Office generally issues about 15 commem-
orative stamps per year. Of the approximately 600 com-
memorative stamps issued to date, more than 500 have
been issued in the last 30 years. The Post Ofiice receives
from 250 to 300 proposals each year for stamps and
presently has a backlog of requests for about 3000 dif-

ferent stamps.

The final decision as to what subjects are chosen for
U.S. commemorative stamps is made by the Postmaster
General with the assistance of his Citizen’s Stamp Ad-
visory Committee which consists of approximately 12
members. To help them arrive at this decision, pharma-
cists are urged to request that their congressmen contact.
the Postmaster General in support of this stamp. In addi-
tion, pharmacists should write directly or wire the Post-
master General: The Honorable Winton M. Biount, Post-
master General, Washington, D.C. 20260.

THE MARYLAND PHARMACIST

Washington Spotlight For
Pharmacists by APhA
Legal Division

NAS-NRC Drug Efficacy Evaluations Must

Be Disclosed in Drug Labeling
And Advertising

New regulations of the Federal Food, Drug and
Cosmetic Act will require the disclosure of the National
Academy of Science—National Research Council evalua-
tions for those claimed uses of a drug classified as other
than “effective,” in the drug labeling and advertising.

The Food and Drug Administration has concluded
that the NAS-NRC evaluations must be disclosed in
labeling and other promotional material of a drug. The
failure to disclose this material fact will result in the

drug being misbranded.

Thus, where the NAS-NRC has concluded that a
drug is “ineffective,” “possibly effective,” “probably effec-
tive,” or “ineffective as a final combination” for a par-
ticular claimed use, all package labeling, promotional
labeling and advertisements shall include, as part of the
information for practitioners, an appropriate qualification
of these claims.

This requirement was objected to by the various
manufacturers associations, but supported by various
groups including APhA. In overriding these objections,
the Commissioner concluded that there is no reason why
these judgments should not be shared with the medical
profession in drug promotional material, and that such
disclosures should lead to better patient care and to a
better understanding by the physician of the drugs he
prescribes.

Unlawful Narcotics Prescriptions

A Maryland physician was recently convicted of
prescribing narcotics in a manner not authorized by the
State Narcotic Drug Act. This conviction was sustained
on appeal. The Appeal court held that his conduct fell
so far short of minimum standards of diagnosis, treat-
ment and care that it was a mere subterfuge.

A former drug addict, acting in cooperation with
the police department, introduced a policeman posing as
a drug addict to the physician. The policeman asked the
physician for methadone and secobarbital. The physician,
after asking only his name and address, wrote prescrip-
tions for these drugs. The physcian indicated that he may
have to take a urine test, “just to make it look good.”
No test or other examination was ever made. The police-
man obtained prescriptions for these items again upon the
payment of $10.00. The physician did not inquire as to
his condition, but only asked how many tablets were de-
sired.

) Federal law also prohibits this type of activity. The
regulations of the “Controlled Substances Act” require
that a prescription for a controlled substance to be effec-
tive must be issued for a legitimate medical purpose by
a practitioner acting in the usual course of his profes-
sional practice. An order purporting to be a prescription
which is not issued in the usual course of professional

JULY 1971

treatment or authorized research is not a_ prescription
within the meaning of the Act. A person who knowlingly
dispenses a controlled substance pursuant to such a pre-
scription is subject, along with the prescriber, to the
penalties provided for the violation of this law.

A prescription is also invalid under the “Controlled
Substances Act” if it is issued for the purpose of continu-
ing a person’s dependence upon such drugs.

Pharmacists are reminded of their duty under both
State and Federal law to determine the validity of a
questionable prescription order.

THE DOOR TO CONSTRUCTIVE DISCUSSION

Physician Held Negligent for Disregarding
Manufacturers Warning on Possible
Effects and Dosage Recommendations

The Minnesota Supreme Court recently held a phy-
sician negligent for his failure to heed the warnings on
possible side effects and dosage recommendations of a
drug manufacturer. The physician was held liable for
his patient’s death as a result of the side effects of the
drug, in a wrongful death suit brought by the woman’s
heirs.

The patient was suffering from acute purulent otitis
media. The patient did not respond to peniciilin therapy
and a culture indicated chloramphenicol to be the most
effective antibiotic in this situation.

The chloramphenicol produced improvement and
the prescription was renewed several times. Three months
later there was an exacerbation of the otitis and the pre-
scription was renewed again. Three days later, after a
hemoglobin test, it was again prescribed.

Six and one-half months later, the woman was ad-
mitted to a hospital for hemorrhaging. The pathologist
found severe anemia and bone marrow suppression. The
woman died several weeks later of a gastro-intestinal
hemorrhage due to aplastic anemia.

The suit was filed against the drug manufacturer
and the physician. The suit claimed that the drug manu-
facturer was negligent for placing the drug on the
market without adequate warnings, and that the physician
was negligent in prescribing the drug.

At the trial, the manufacturer introduced evidence
showing that the proper warnings were disseminated. The
physician testified that he was familiar with the warnings
and the recommended dosage.

Several other physicians testified on the warnings and
tests to detect the development of the side effects.

The trial court directed a verdict in fayor of both
the manufacturer and the physician since it had not been
shown that the failure to make the appropriate tests was
the cause of death, or what the standard of the profession
was in regard to the use of this drug.

On appeal, the court agreed that the drug company
was not liable, but reversed the directed verdict for the
physician. The court held that the deviation from the
manufacturer’s warning and dosage recommendations re-
quired him to explain the reasons for such deviation. The
court also held that there was sufficient evidence to indi-
cate that the physician may have been negligent in fail-
ing to take periodic blood tests.

While a pharmacist was not involved in this suit,
this case should serve as a reminder to all pharmacists to
obtain the proper authorization before refiiling medica-
tion for a patient. This is especially important in regard
to those drugs which are known to produce severe side
effects. A pharmacist who indiscriminately refills such
medication could find himself party to a similar suit.

TOUR AND FROLIC IN EUROPE’S CITY
OF REGAL TRADITION AND
FAST TEMPO

For Members of The Maryland
Pharmaceutical Association and Their

Immediate Families

SWINGING LONDON

November 7 to 14, 1971

All-inclusive cost—$389.00 per person (based on
double occupancy )

Federal transportation tax—$3.00 per person

Supplemental cost for single room—$48.00

Reservations on this fabulous trip can only be con-
firmed upon receipt of a deposit in the amount of $50.00
per person. All deposits and monies paid are refundable
in full until September 25, 1971. After this date, refunds
are subject to resale of reservation(s).

All Deposits Are To Be Made Payable and Seat To:

MATTERHORN TRAVEL SERVICE
1923 West Street
Annapolis, Maryland 21401

For further information, please call 269-0123 (local
Baltimore line ).

Headquarters for

PHOTO-OFFSET PRINTING MAILING
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

THE MARYLAND PHARMACIST

MERCUROCHROME

HW&D BRAND OF MERBROMIN

Include Mercurochrome in your first-aid supplies!

Detailed literature available on request.

HYNSON, WESTCOTT & DUNNING, INC.

Baltimore, Maryland 21201

(mM-6)

There’s a lot more

OE oe
Sd esti

going for you at LOEWy?

COMPUTERIZED
SERVICE

puts America’s most advanced
warehouse facility behind your store

How much is it worth to you to know
that the most advanced computerized
distribution system in existence isin
motion to process your every order

. instantly, efficiently, completely?
That you needn’t ever stock more than
a minimum ofa far greater variety of
merchandise than you could ever show
before... and without investment in
excessive inventory? That your
wholesaler is never likely to be out-of
stock on any desirable item? That
every invoice and statement is assured
of up-to-the-minute accuracy? And
that there is never a lapse of more
than 60 minutes from receipt of your
order to the time itis on the loading
platform, ready to roll?

How much? You'll be able to measure
its worth by the number of customers
attracted to your store. Old customers
and new, it’s the kind of service they
aren't likely to have known before.

FOR SERVICE AT ITS BEST...
BETTER DEAL WITH LOEWY

Call any time, day or night. An automatic order
taker will record your after-hours order.

Call IV 5-8105 for order taking.
(301) 485-8100 for the office.

LOEWY
DRUG COMPANY

DIVISION OF
AT),

aes
s(“2 GF °
or

6801 Quad Avenue
Baltimore, Md. 21206
Telephone: (301) 485-8100

aryland
ne harmacist

MPHA LAUNCHES ATTACK ON V.D.
(See page 8)

Volume 47 AUGUST 1971 Number 8

Compliments of

oxell

CORPORATION

NOXZEMA SKIN CREAMS

Makers of

NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS
and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

Your prescription patients
may not know the difference
... but you do.

Four generations’ experience in producing fine
pharmaceuticals is one of the many reasons you
can have confidence in Lilly products.

Eli Lilly and Company « Indianapolis, Indiana 46206 EZ

100218

Offer Guardian sensitivity

ee Sse. ean

RD,

Sepich
ED LATEX

PROPHYL ACT iC

WWE ROLL

-. ff
Catia ensilive

Corti Dorsilite

..and they’ll never ask for just
prophylactics again. They will be sold on
the complete sensitivity afforded by
these premium prophylactics. They'll stay
sold because Trojan brand Guardians
are thin, pre-lubricated and sealed in foil.

me yOur ( customers first

_ And you'll be happy because the extra

profit in each Guardian makes it an ideal
product for you to recommend.

Next time your customer comes in and
asks for prophylactics, recommend
Guardian, the Trojan brand premium
lubricated product from Youngs, the
company tuned to today’s pharmacy
customers...for tomorrow’s profit.

Youngs Drug Products Corporation
™ 865 Centennial Ave., Piscataway, N. J. 08854

The Maryland Pharmacist

NATHAN I. GRUZ, Editor

NORMAND A. PELISSIER, Assistant Editor

MARTHA ECKHOFF, Editorial Assistant
ROSS P. CAMPBELL, News Correspondent

650 WEST LOMBARD STREET
BALTIMORE, MARYLAND 21201

eH
YY age

Sf
Fs
4
&

ASSOCIATION

VOLUME 47

AUGUST 1971

NUMBER 8

OFFICERS 1971-1972

Honorary President

H. NELSON WARFIELD—Pikesville
s

President
NATHAN SCHWARTZ-—Annapolis

President Elect
BERNARD B. LACHMAN—Baltimore

Vice President
JOHN R. McHUGH—Potomac

Treasurer

MORRIS LINDENBAUM
5 Main St., Reisterstown, Md. 21136

Executive Director

NATHAN I. GRUZ
650 W. Lombard St., Baltimore, Md. 21201

TRUSTEES

DONALD O. FEDDER, Chairman—Dundalk
MORRIS BOOKOFF (1972)—Baltimore
PAUL FREIMAN (1974)—Baltimore
STEPHEN HOSPODAVIS (1972)

Cresaptown
PHILIP D. LINDEMAN (1973)—Berlin
ANTHONY G. PADUSSIS (1973)

Baltimore
MELVIN J. SOLLOD (1974)—Adelphi
SYDNEY L. BURGEE, JR.
Speaker of the House of Delegates
Baltimore

EX-OFFICIO MEMBERS

FRANCIS S. BALASSONE—Baltimore
WILLIAM J. KINNARD, JR.—Baltimore

HONORARY LIFE TRUSTEE
SIMON SOLOMON—Baltimore

MARYLAND BOARD OF PHARMACY

Honorary President

SIMON SOLOMON—Baltimore

President
NORMAN J. LEVIN—Pikesville

Secretary

F. S. BALASSONE—Baltimore

Member
FRANK BLOCK—Baltimore

Member
HOWARD L. GORDY-—Salisbury

Member
MORRIS R. YAFFE—Potomac

AFFILIATED ORGANIZATIONS

Allegany-Garrett County
Pharmaceutical Association
sf Sabare ele cieisieiare Stephen Hospodavis
ViccmLrestd cr a nee James Ritchie
Secretary-Treasurer....... Robert F. Tomsko

Baltimore Metropolitan
Pharmaceutical Association

BECSICCI Lata tines. tava x Irvin Kamenetz
ROA VHWAS! ocho oone Joseph U. Dorsch
IWS Gos ooeocnor Charles E. Spigelmire

Vice Presidents—
Paul Freiman, Harold P. Levin,
Harry R. Wille

Secretary and Executive Director

Nathan I. Gruz

Eastern Shore Pharmaceutical Society

LT EStCERT Rte a Cone oe. Gordon Harrison
First Vice President....... William P. Smith
Second Vice President....... William Connor
SECT CLAny Me coiclacrs «icles is scc's Carl R. June
U VEGSUTETMMes ca ches Gas tee ee Thomas Payne

Prince Georges-Montgomery County
Pharmaceutical Association

Presiden tape ettesant corm: Martin Hauer
First Vice President....Edward D. Nussbaum

Second Vice President ..... S. Ben Friedman
Third Vice President ...... Sidney Glashofer
Fourth Vice President....... Gabriel E. Katz
CCT ELOY amt reir a mteteniactats Paul Reznek
LiT-C GSUT CLS te crete cone tee Michael Leonard
Honorary President .......... Samuel Morris

Washington County
Pharmaceutical Association
Rresid en tmemetene vet Samuel E. Weisbecker
Vices Presidentgaean nicotene: Joseph Davies
aeictar Frederick Fahrney

University of Maryland School of
Pharmacy Student APhA-MPhA Chapter

Presidentoaoninnsee sacs cele Paul R. Webster
Viceelresic citar eee Stephen B. Bierer
SECHELOTY © Meron o Mens sicitepuain Donna S. Levin
LT COSUT Ceears teat cle eto steiclere Dennis R. Reaver

MPhA AUXILIARIES

LAMPA — Ladies Auxiliary of The
Maryland Pharmaceutical Association
President
MRS. LOUIS M. ROCKMAN
Recording Secretary
MISS MARY DiGRISTINE
Communications Secretary
MRS. RICHARD R. CRANE
Treasurer
MRS. CHARLES S. AUSTIN
Membership Treasurer

MRS. MANUEL B. WAGNER

Secretary-Treasurer Emeritus

JOHN A. CROZIER

OTHER PHARMACY ORGANIZATIONS
Maryland Society of Hospital
Pharmacists
President
MARY W. CONNELLY
President Elect
NORMAND A. PELISSIER
Secretary
DOLORES A. ICHNIOWSKI

Treasurer

THOMAS E. PATRICK

University of Maryland
School of Pharmacy
Dean
DR. WILLIAM J. KINNARD, JR.
Assistant Dean
DR. C. T. ICHNIOWSKI
Delegate and Vice Speaker—
MPhA House of Delegates
HENRY G. SEIDMAN

Change of address may be made by sending old nddress (us it appears on
your journal) and new address with zip code number. Allow four weeks for

changeover.

TABLE OF CONTENTS

Page
Editorial—Pharmacy Services—How, Where
andSBy WHOM 2, ee etcetera eee eee 6
Pharmacy, Calendarey. ices. ten en eee 7
VD BOUCatIONals Cam palgriiers, cnpeesnray cer eee rere 8
Maryland Board of Pharmacy News \.1cc...5.cc;cc.ccesecsssest=s 11
Proceedings of the 89th Annual Meeting of the
Maryland Pharmaceutical Association ................ 12
Drug Abuse and the Maryland Drug Abuse
AUtTHOLIGVAND Ve DAVICM VEIN ULL CO meets eee 20
Hospitalepharmacye sections eee 24
Classified 2AdS i203 aie oe Si eee ene 26
ODICUATICS e eeke, ree scere eset eres etesaoteae cong eecees aac cca enon ne RET 26
INDEX TO ADVERTISERS
Page
American Druggists’ Insurance CoO. 00.....cecccccecececeessceeees 7
Borden-Hendlers Ice | Creamiiwe see ee eee 21
BUrroughnsswellCOmes Co mesaee eee eee eee 28
CalvercuDrugeCompany,71ncy .c.saccic eee ee 21
Geigy [Pharmaceuticalsge 2 cc ee eee ee 23
Henrys DG) Ding COMPANY mete ee 13
Rlishillysands Company eos cnc eee ere 3
LoewyeDrug, Company 4.3 ee 27
ManginigandsASSOClates lll Cisse 1s:
MarylandaNewssCOmpanyiae eee 25
Noxell. Corporation s.c.5.1cse- sea eee ee eee ee 2
Paramount: Photo Service gia. eee 17

Pension and Investment Associates of America, Inc...18

Roches Laboratories a ee ee eee 19

THE MARYLAND PHARMACIST

Editorial...

Pharmacy Services — How, Where and
By Whom ?

The future of pharmacy may well be decided by the

nature of the answers to the following question:

How and where will the public receive their phar-
maceutical services as we move well into the nineteen-
seventies?

In addition we must also ask by whom?

Today, in mid-1971, pharmacy services are pro-
vided primarily to ambulatory patients by community
and hospital pharmacies and by some mai! order and
“clinic” pharmacies.

The financing mechanism is still predominantly by
dues payment by the patient. An increasingly significant
share is being paid by third-party payment programs,
either private such as Blue Cross or governmental such

as Medicaid.

The “How”

Observers agree that the majority of our population
will be covered by some kind of national health insur-
ance within a few short years. By this we mean that
health care will be financed for the most part by a pro-
gram of compulsory health insurance. This will, of course,
be a form of third-party payment mechanism which
could involve many kinds of medical practice. That is,
the health care paid for could be provided by private
solo practitioners, group or clinic physicians, hospitals or
health centers. It could be based on fee for service or
capitation.

The “Where”

The site where pharmaceutical services will be pro-
vided as we proceed into the 1970’s may be crucial to
the fate of pharmacy as a health vocation with a future
as a free, independent profession. This matter will often
be interlocked with the “How” pharmacy service will be
financed and by whom.

What is emerging are governmentally fostered pro-
grams for delivering comprehensive health care such as
through comprehensive health centers. These are innova-
tive systems involving existing elements of private, gov-
ernmental, institutional, labor, insurance, individual and
entrepreneural sectors of our society.

Pharmacy services may be provided by on-site phar-
macies with or without “freedom of choice” for the
patient. Or, where no pharmacy was established on-site,
there would be freedom of choice for patient among ex-
isting pharmacies in the community. |

Community pharmacies can provide the service from
their existing locations; or if the decision-making authori-
ties opt for on-site pharmacies, one or more pharmacies
(acting cooperatively ) could provide the service.

Certainly community pharmacies as a class are in a
stronger position to be selected to provide the pharma-
ceutical service required (either on an in- or off-site

AUGUST 1971

basis) if a number of conditions prevail at the time of
planning and decision.

These conditions include the relationship of the phar-
macy management and pharmacists to the community,
both rank and file and its leaders.

The reputation, deserved or not, of these pharmacists
is a factor. The appearance, inside and outside, of the
pharmacy weights heavily. Are non-health related cate-
gories of products overwhelming the image cf the phar-
macy? Does the pharmacy appear to be primarily a part
of professional health service or does the space devoted
and outside and inside signs project identification as food
or liquor establishments? These are factors which rightly
or wrongly have been brought out in hearings on this
subject.

It is becoming more and more difficult for the pri-
vate sector of pharmacy to ignore these considerations.
Neglect of these factors in the past, and so often today,
permits non-pharmacist firms and individuals as well as
government, hospitals and so forth to leap into the oppor-
tunities presented in the emerging patterns of health
care.

Let us all concentrate on emphasizing our profes-
sional capabilities so that we can preserve the maximum
opportunities for pharmacists to contribute to better health
for all through a free, independent profession.

—Nathan I. Gruz

PHARMACY CALENDAR

September 16—BMPA meeting, Kelly Memorial Build-
ing, 8:30 p.m.

October 1-4—31st Annual Convention of the American
College of Apothecaries, Hunt Valley Inn, Hunt Val-
ley (Baltimore), Maryland.

October 3-9—National Pharmacy Week

October 10-14—National Association of Retail Druggists
Annual Convention, The Rivergate, New Orleans.

October 16-21—National Wholesale Druggists’ Associa-
tion Annual Meeting, Century Plaza Hotel, Los
Angeles.

December 12-16—American Society of Hospital Phar-
macists Sixth Annual Midyear Clinical Meeting,

Washington, D.C.

April 22-28, 1972—American Pharmaceutical Associa-
tion Annual Meeting, Houston.

More than 39 per cent of all traffic fatalities in 1970
were due to excessive speed. Speeding accounted for 17,-
700 persons killed and 988,000 injured.

TAILOR-MADE

Insurance Coveraze

AMERICAN DRUGGISTS’ INSURANCE ..,as the name im-
plies, is specifically designed for the needs of the druggist.
It’s an insurance company founded BY druggists FOR

druggists, to assure especially prompt settlement of claims
.. fire, theft, liability. And that’s exactly what we've been
doing...settling such claims rapidly, without red tape
... since 1906. Any service with that many years of
experience HAS to be reliable. You can
be certain of 100% security.

For full details on our complete
coverage plan, contact your ADI
agent NOW.

MAYER & STEINBERG
Maryland State Agents
1101 N. CALVERT STREET
BALTIMORE, MD. 21202
752-7311

AMERICAN

DRUGGISTS’
INSURANCE CO.

700 American Building
Cincinnati, Ohio 45202

THE MARYLAND PHARMACIST

V.D. Awareness Begins...

The Maryland Pharmaceutical Association has
launched a V.D. educational campaign. Paul Freiman,
Chairman, MPhA Public Health Committee, is planning
and directing the project which began with a press con-
ference in June.

At the press conference held at the Kelly Memorial
Building, officers of the Maryland Pharmaceutical Asso-
ciation and local health officials stressed the significance
of the soaring rate of venereal disease in Maryland. Rating
ninth as a city, Baltimore is far above the national aver-
age in incidence of V.D. while in Maryland, as a whole,
384 cases were reported for every 100,000 population
in 1970—35% higher than the reported national average.

According to Nathan Schwartz, MPhA President,
“Pharmacists . . . work under both personal and_pro-
fessional obligations to dispense medications and other
aides to public health in the manner prescribed by law.”
As he further stated, “The role that pharmacy can fill
and should fill is truly made up of equal parts of re-
sponsibility and opportunity . . . which adds up,” he con-
tinued, “to a combination of dispensing the means to as-
sure better health and giving information and advice
where (the pharmacist’s) special place on the public
health team permits.”

“The pharmacists of Maryland,” stated Donald O.
Fedder, Chairman of the Board of Trustees. “have re-
solved to become very personally involved in a concerted
effort to combat what has now become recognized as this
nation’s ‘public disease enemy number one’.”

In a written proclamation read by William Donald
Schaefer, President, Baltimore City Council, Mayor
Thomas J. D’Alesandro, Jr.. urged “all public health
agencies, health professionals and all other groups and
individuals involved in health education, prevention and
treatment as well as the general public to participate and
cooperate in this greatly needed work.”

Education, prevention and treatment, cur speakers
emphasized, are needed to stem the “epidemic” spread-
ing through all levels of our society. In their speeches
Messrs. Fedder and Schwartz continued to elaborate on
the facts of venereal disease, its prevalence and the means
by which pharmacy may assist in alleviating it. Questions
from the floor stimulated the discussion among our phar-
macists, health officials and news reporters. Cameras
clicked, lights flashed and television cameras rolled, turn-
ing the lower level conference room of the Kelly Me-

Have You Returned Your
Biographical Information Sheet?

If you haven’t done so, please complete and return
the biographical information sheet which appeared
in the July 1971 issue of “The Maryland Pharma-
cist.” Return of the questionnaire by each member
will assist the Association in serving the profession
more effectively.

Le |

8 THE MARYLAND PHARMACIST

morial Building into bustling activity during the hour
and one-half cocktail-luncheon conference.

And the reporting was excellent as evidenced by
“top spot’” coverage by WMAR TV on the evening news.
“The Maryland Pharmaceutical Association’” was heard
over radio, and newspaper writeups appeared in many
paper throughout the state.

Subsequently, thousands of pamphlets entitled
“Plain Talk About Venereal Disease,” published by
Youngs Drug Products Corporation, were distributed
from the MPhA office to pharmacies throughout the state
as well as to individuals. Lists of V.D. clinics in Mary-
land where individuals requesting treatment can be di-
rected in a year-round effort to help eradicate the disease
were distributed to pharmacies in the state. Pharmacists
were encouraged to set-up counter V.D. prevention dis-
plays. An MPhA speakers bureau with the cooperation
of the students at the School of Pharmacy, University of
Maryland, will bring speakers to civic, school and other
community groups. For the benefit of private groups
speeches have been made available to those requesting
them.

Executive Director, Nathan I. Gruz, focused on the
constructive roles that pharmacists can play because they
have more contacts per week with the public than any
other health professional. He spoke of the accessibility of
all people to their pharmacists.

Dr. Howard J. Garber, Chief, Division of Communi-
cable Diseases, State Department of Health, following his
attendance at the conference moderated by Chairman
Paul Freiman, wrote, “I would like to commend the
Maryland Pharmaceutical Association’s efforts in making

the public aware of the V.D. problem in Maryland.”

Other representatives from the State Department of
Health included Leland C. King and Thomas A. Sweeney,
Public Health Advisors. From the Baltimore City Health
Department were Dr. E. Walter Shervington, V.D. Clini-
cal Director; Dr. Ralph E. Bennett, G.C. Coordinator,
and John Supinski, Public Health Advisor. Dr. John A.
Mullan, Chairman, Public Relations Committee, repre-
sented the Medical and Chirurgical Faculty of Maryland
and Dr. John Room, the Baltimore County Health De-

partment.

Assisting in the press conference arrangements were
Youngs Drug Products Corporation staff, Messrs. Melvin
Clark, Frank Hewens, Louis Rindone and Earl Vree-
land; MPhA official photographer, Herman Bloom;
TAMPA President, William L. Nelson; Co-chairman,
MPhA Professional Relations Committee, H. Nelson War-.
field; and BMPA President, Irving Kamenetz.

During 1970, 6,500 people were killed as a result:
of driving off the roadway. Reasons for this type of acci-
dent are tired motorists, unsafe cars, and those under the
influence of alcohol. |

AUGUST 1971

Photos courtesy of Paramount

AUGUST

1971

aOR i neither

i
"

THE MARYLAND PHARMACIST

MPhA’s PRESS CONFERENCE ON V.D.

TOP LEfT—Donald O. Fedder answers questions directed by health
officials and newsmen. MIDDLE LEFT—Dr. Paul A. Mullan, second
from left, hears of rising V.D. rate, pointed out by Donald O. Fedder,
right. Nathan Schwartz, left, looks on. BOTTOM LEFT—wWilliam Donald
Schaefer, second from left is presented Mayor's proclamation by Irvin
Kamenetz, second from right. Standing on the left is Paul Freiman: on
the right, Nathan I. Gruz. TOP RIGHT—Dr. Ralph E. Bennett, second
from left, and Leland King, left, in conversation with Tom Ross
(WBAL) and Nathan I. Gruz. MIDDLE RIGHT—Standing left to right:
-aul Freiman, Thomas A. Sweeney, Dr. Howard J. Garber, Donald O.
Fedder, and John Supinsky. CENTER—Dr. E. Walter Shervington di-
rects question to speakers’ table. BOTTOM RIGHT—Mr. and Mrs. Irvin
left, enjoy conversation of William Donald Schaefer, right,

Kamenetz,
and Nathan Schwartz, second from right.

V.D. is an Epidemic in Maryland, in 1971

a quick glimpse of the trend, latest data
ce)

1/2301
J hiy an
a | Qo

| | |
| | | | |
1960 ’61 "62 "63 "64 "65 "66 "67 "68 "69 1970

Venereal Disease Trend, In Order of Rate (Gonorrhea — cases per 100,000 population)

Baltimore City — 1,088.3
Dorchester — 916.9 WABABBABABEALEBAREAAAAAARARAREEEEEE'
Talbot— 5228 PWWRABRRRARBARARARARRERE ET
Wicomico— 469.9 PWBBABRRRRARBABARRRRERR™
MARYLAND— 347.3 ,WBBRRBRARRRRRERRER Twice as much vener-
Anne Arundel — 281.1 BWA Bada daaaaaaeaa’ eal disease is reported as
Woreste— 2743 RWWRRRRRRRREREE Ol other seortble com
Caroline— 2649 PBBABARARRRARR bined.
Somerset— 247.0 PRBRABRRRRRRRBA
Harford— 194.8 PRWRBBaadastas
Saint Mary’s— 192.8 BWaARBaAABaaaaae
Kent— 151.4 JRBRRRRRRS
Charles — 103.1 BWaaaa
Queen Anne’s— 95.7 Wa Bay
Cecil— 84.7 RWWA aN
Montgomery — 84.7 AXANAAN
Washington — 76.0 ~RRBAY
Prince George’s — 67.2 BRAN
Allegany— 43.8 BAYAWaN
Howard— 36.2 ww

\.D.can be prevented

Prophylactic products, properly used, are the
best ‘‘control device’’ against V.D.; effective
against both Gonorrhea and Syphilis. Prophy-
lactics, and free V.D. literature, from any

Baltimore County — 34.9 \\
Calvert— 31.0 pharmacy.
& _ 26.5 . A :
Ne Maryland Pharmaceutical Association
rederick — 18.6
Garrett — 12.7 a

Maryland Board
of Pharmacy News

Registrations Granted

| The following pharmacists recently became registered
by the Maryland State Board of Pharmacy: Mary H.
_ Brumback, Donald W. DeGroff, Stanley E. Gierhan,
_ Michael R. Litton, Chester A. Schwer, Charles E. Thoma-
son and James W. Wheatley.

The Board also announced 15 candidates who have
_ previously passed the theoretical examination and recent-
ly passed the practical examination will be granted regis-
tration to practice within the state.

Included were: Donna K. Barr, Herman Bell, Jr..,
Larry Bierley, Douglas Bjornson, Michael G. Buddie,
Ted Cohen, William Harding, Tommy Hedge, Mike Mc-
Cagh, E. D. McKeever, Jr., Donald Moor, Donald Phil-
lips, Maurice Rumbarger, John Verhulst and Richard

Walsh.

Pharmacy Changes

The following are the pharmacy changes for the

month of July:
New Pharmacies

Read’s, Inc., Ronald Sanford and Morris Feldman,
Pharmacists, 711 West 40th Street, Baltimore, Maryland
ei2ii.

University of Maryland Hospital Pharmacy, Thomas
E. Patrick, Pharmacist, 22 South Greene Street, Balti-
more, Maryland 21201.

No Longer Operating As Pharmacies

Pride Pharmacy, Samuel Adams, President, 2305
East Chase Street, Baltimore, Maryland 21213.

Gwynn Oak Pharmacy, Harold D. Mondell, 5500
Gwynn Oak Avenue, Baltimore, Maryland 21207.

Carney Pharmacy, William S. Karr, 9515 Harford
Road, Baltimore, Maryland 21234.

Change of Ownership, Address, Ete.
None.

CHANGE OF ADDRESS

When you move—
Please inform this office four weeks in advance to avoid
undelivered issues.
"The Maryland Pharmacist'' is not forwarded by the
Post Office when you move.

To insure delivery of ''The Maryland Pharmacist" and all
mail, kindly notify the office when you plan to move
and state the effective date.

Thank you for your cooperation.
Nathan |. Gruz, Editor

Maryland Pharmacist
650 West Lombard Street

AUGUST 1971

BNDD Regulations Amended To Allow
Unlicensed Interns and Residents to
Prescribe Controlled Substances

On July 21, 1971, the Department of Justice pub-
lished proposed new regulations in the Federal Register
regarding BNDD registration of hospital interns and resi-
dents.

According to an interpretation of these regulations
by the Attorney General’s office of the State of Maryland,
interns and residents who are not licensed in the State
of Maryland may prescribe controlled substances under
the registration of the hospital or other institution which
is registered and by whom he is employed.

The individual practitioner must be acting only
within the scope of his employment in the hospital or
institution and such prescribing must be done in the
usual course of his professional practice. Il'urthermore,
the intern or resident must be authorized by the hospital
or other institution to prescribe under the hospital regis-
tration and the hospital or institution musi designate a
specific internal code number for each intern or resident
so authorized. The code number shall consist of numbers,
letters, or a combination thereof and shall be a suffix to
the institution’s BNDD registration number, preceded by
a hyphen (e.g., APO123456-10 or APO123456-A12);
and a current list of internal codes and the correspond-
ing individual practitioner must be kept by the hospital
or other institution and must be made available to the
public upon request for the purpose of verifying the au-
thority of the prescribing individual practitioner.

Prescriptions for controlled substances prescribed by
an intern or resident during the usual course of his pro-
fessional practice and bearing the individual practitioner’s
assigned registration number for a hospital outpatient or
discharged inpatient at the time of discharge may be filled
by a community pharmacist.

BNDD Warning

The Bureau of Narcotics and Dangerous Drugs ad-
vises all pharmacists that they may encounter patients
with possible boric acid intoxication.

A potentially harmful mixture of cocaine and boric
acid has been found in the illicit drug market in at least
three cities. BNDD chemists have analyzed samples of
the mixture obtained in New York and Chicago. U. S.
Customs Service has also encountered samples of the mix-
ture in San Antonio. The boric acid content runs as high
as 50%. Based on use of cocaine by abusers this may
result in an intake of up to 150 mg. of boric acid a day.

Almost 40 per cent of all highway deaths occur on
weekends—56 per cent between 6 p.m. and 6 a.m. “Never
on weekends” might be a driver motto worth observing.

THE MARYLAND PHARMACIST It

Proceedings of

the 89th Annual Meeting of
the Maryland Pharmaceutical
Association

Held At The Hunt Valley Inn,
Cockeysville, Maryland,
May 16 and 17, 1971

First Session, Sunday, May 16

The first session of the 89th Annual Convention of
the Maryland Pharmaceutical Association was called to
order at 2 p.m. by President Donald O. Fedder in the
Maryland Room of the Hunt Valley Inn, Cockeysville,
Maryland.

The invocation was delivered by H. Nelson Warfield,
MPhA Executive Committee member and past Vice Presi-
dent.

President Fedder then extended greetings and wel-
comed all in attendance.

The following representatives of pharmaceutical as-
sociations were called upon to bring greetings and
messages from their respective groups:

Robert E. Snyder, President of the Maryland Society
of Hospital Pharmacists; Paul Freiman, Vice President
of the Baltimore Metropolitan Pharmaceutical Associa-
tion; Stephen Hospodavis, President of the Allegany-
Garrett Counties Pharmaceutical Association; Gordon M.
Harrison, President of the Eastern Shore Pharmaceutical
Society; Edward D. Nussbaum, First Vice President of
the Prince Georges-Montgomery County Pharmaceutical
Association; 5. Ben Friedman, Maryland Director, Metro-
politan Guild of Pharmacists.

The following were recognized and introduced by
President Fedder: Paul Reznek, Secretary, Prince-
Georges-Montgomery County Pharmaceutical Association;
F. S. Balassone, Secretary of the Maryland Board of Phar-
macy and Chief, Division of Drug Control, Maryland
State Department of Health and Mental Hygiene; Dr.
William J. Kinnard, Jr., Dean, University of Maryland
School of Pharmacy; Dr. C. Jelleff Carr, former Profes-
sor of Pharmacology, now Adjunct Professor of Pharma-
cology and Toxicology; Gerald Freedenberg, Directorum
of Kappa Chapter, Alpha Zeta Omega Pharmaceutical
Fraternity, and Simon Solomon, the first and only Hon-
orary Life Member of the Executive Committee of the

MPhA.

Executive Director Nathan I. Gruz then read the
following communications:

“Since its founding in 1883, the Maryland Pharma-
ceutical Association has worked to advance the profession
of pharmacy and the public health in Maryland. Your
forthcoming annual meeting will provide the opportunity
to build upon past accomplishments and to give new direc-
tion to the profession of pharmacy in Maryland. We now
are at a time when pharmacists can assume a greater
role in the delivery of health care services ts the public
than ever before. Pharmacists are looking to their state

12 THE MARYLAND PHARMACIST

and national professional societies to provide direction in
assisting them to fulfill their full potential as health pro-
fessionals.

“The issues discussed, positions taken and _ policies
adopted at your annual meeting can shape the direction
of pharmacy for years to come. As you make final prep-
arations for your annual meeting, I extend you the best
wishes of the officers and Trustees of the American Phar-
maceutical Association for a most successful meeting and
offer our pledge of continued cooperation.” (signed)
William S. Apple, Ph.D., Executive Director, American

Pharmaceutical Association.

“We extend best wishes to your officers and mem-
bers for a successful convention and assure you of our
continued cooperation with your fine organization. Our
mutual interests involve a number of legislative, pro-
fessional and economic issues and objectives. The role of
retail pharmacists in present and proposed health insur-
ance programs must provide adequate compensation under —
these programs and hopefully correction of discriminatory
pricing policies relating to purchasing and distribution
of drug store products. We are looking forward to your
continued cooperation in developing constructive legisla-
tive and educational programs concerning pharmacy par-
ticipation in public health and welfare efforts. We can
achieve many objectives by exerting unity of purpose. We ©
hope that many pharmacists will be with es when our —
73rd annual meeting convenes in New Orleans, Louisiana,
October 10-14, 1971.” (signed) Williard B. Simmons,
Executive Secretary, National Association of Retail Drug-
gists.

Mr. Joseph S. Kaufman, MPhA Legal Counsel, re-
viewed the past year’s activities from the legal and legis-
lative viewpoints. He commented on emerging and antici-
pated development for the coming year.

President Fedder then presented the following MPhA
past presidents: George M. Schmidt (1957), Gordon A.
Mouat (1959), Alexander J. Ogrinz, Jr. (1965), Morris
R. Yaffe (1966), and I. Earl Kerpelman (1969).

Reports of committees were then delivered by com-
mittee chairmen. The reports were published in the July
issue of “The Maryland Pharmacist.”

Dr. William J. Kinnard, Jr., Dean, University of
Maryland School of Pharmacy, delivered a report sum-
marizing some of the current and projected activities of
the School. He referred to a Task Force on Supportive
Personnel and work to be done in the area of third-party
payment programs.

There was discussion regarding implementing joint
meetings of the MPhA-School of Pharmacy Committee
and the School of Pharmacy.

F. S. Balassone presented the Annual Report of the
Maryland Board of Pharmacy for 1970-71 which will be
published in a later issue of the journal.

The Session adjourned at 4:00 p.m.

AUGUST 1971

An Experienced
Pharmacy Orientated

Sales Force

Running a successful pharmacy takes a lot of effort and experience. That’s where the Henry B. Gilpin
Co. can help you. Our expert sales force can assist you in both merchandising programs and store opera-
tions. Within the Gilpin staff exists a depth of Knowledge in all phases of store operations. We are pre-
pared to provide assistance and service wherever pharmacy is practiced.

3] A complete sundries program providing sundries
departments and inventories designed specifically

THE HENRY B.

GILPIN

COMPANY

BALTIMORE * DOVER * NORFOLK + WASHINGTON

Ta ae a |

A financial service consultant to service you on
request.

Two giant product shows each year: in January
featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing
promotional sundries.

the services required to nail down the profit dollars
which you need and deserve from your business.

The Henry B. Gilpin Company
901 Southern Ave., Washington, D.C. 20032
(301) 630-4500

ar Pre ree rere art |

Sirs:
/ am interested in the following programs. Please have your
representative contact me in this regard.

Name of Pharmacy
Address > Phone
eS a eee Zip eee
eget eS ee |

Name. j

Second Session, Monday, May 17

The second session of the 89th Annual Convention
of the Maryland Pharmaceutical Association was called
to order in the Maryland Room by President-elect Nathan

Schwartz at 10 a.m.

MEMORIAL SERVICES

Paul R. Bergeron began the services with the read-
ing of the 23rd Psalm. Francis S. Ballassone followed

with the Necrology.

NECROLOGY

Sheldon S. Barke
Vincent L. Blocher
William L. Brunnett
Irvin J. Cohen

Joseph L. Cohen
Chester A. Duncan
Webster K. Edwards
Dominic Felicetti
Marshall Fox

Albert C. Gakenheimer
Earl A. Gates

Matthew Glenn

Frank J. Grau

Harry Greenberg
Harold J. Hocking
James E. Johnson
Warren L. Johnson
John J. Kairis
Zygmont W. Karwacki
George F. Kieffer

Morris Levin

Lester Levine
Aaron M. Libowitz
Joseph Lutsky
James E. McMichael
Frederick Minder
Arthur A. Musher
Frank M. Noll
Joseph H. Pazel
John A. Pelcher
Clarence H. Pierson
Wilkin M. Roddick
Emanuel Rosenthal
Nathan Rudo
Arthur P. Shields, Sr.
L. Rex Springer
Harvey Todd
William H. Webster
Luther White
Samuel Wolfovitz

Abraham A. Lemler

David I. Scott offered the memorial prayer.

Nathan Schwartz called upon Executive Director
Nathan I. Gruz for his report which appeared in full in
the June issue of ‘The Maryland Pharmacist.”

The report was accepted on motion of Sydney L.
Burgee, Jr., seconded by Morris Bookoff.

The report of Treasurer Morris Lindenbaum was
presented. It was accepted on motion of Henry Seidman,
seconded by S. Ben Friedman.

The Speaker Pro Tem of the House of Delegates,
Sydney L. Burgee, Jr., was called upon to organize the
House of Delegates. The following were recognized as
delegates from their respective organizations:

Affiliated Organizations:

1. Allegany-Garrett County Pharmaceutical Association

Harry G. Eisentrout, Jr.
Stephen Hospodavis

James R. Ritchie
Alternate: John H. Balch
9

2. Baltimore Metropolitan Pharmaceutical Association

(19)

Delegates: Alternates:
Arnold Amass John Ayd
Morris Bookoff Harry Bass

Mary Connelly
Joseph U. Dorsch
Gerald Freedenberg
Paul Freiman
Irvin Kamenetz

Frank Block
Jerome Block
James P. Crage
Irving Galperin

Henry Glaeser

14 THE MARYLAND PHARMACIST

Alternates

Wilfred Gluckstern
Dorothy Levi
Norman J. Levin
William I. Lottier, Jr.
Richard Metz
William Morgenstern
David S. Pearlman
Allan B. Shenker
Morton Silverstein
George Stiffman
Charles W. Wagner

Maurice Weiner

Delegates

Bernard Lachman
Harold Levin
Ronald Lubman
Jerome Mask

John Padousis
Anthony G. Padussis
Melvin Rubin
David I. Scott
Charles E. Spigelmire
H. Nelson Warfield
Harry R. Wille
Stanley J. Yaffe

3. Eastern Shore Pharmaceutical Society (3)

Philip D. Lindeman James W. Truitt, Jr.
Gordon M. Harrison Alternate: Donald R. Young

4. Prince Georges-Montgomery County Pharmaceutical
Association (7)
Paul Bergeron, II
S. Ben Friedman
John R. McHugh
Louis N. Nobel

Edward D. Nussbaum

Richard D. Parker

Dominic J. Vicino

Alternates: Michael Leonard
Morris R. Yaffe

5. Recognized Organizations

Maryland Society of Hospital Pharmacists (2)

Sydney L. Burgee, Jr. Robert E. Snyder
Alternate: Normand A. Pelissier

University of Maryland School of Pharmacy (1)
Henry G. Seidman

Officers and Board of Trustees (Executive Committee )
MPhA (not represented in other capacities )
President—Donald O. Fedder
President elect—Nathan Schwartz
Vice President—Melvin J. Sollod
Executive Director—Nathan I. Gruz
Treasurer—Morris Lindenbaum
Immediate Past Presidents (3)

I. Earl Kerpelman
Milton A. Friedman

Mr. Alder Simon took the floor to take issue on the
manner that the BMPA selected delegates. BMPA Presi-
dent Kamenetz announced that a special meeting of the
BMPA Executive Committee would be held following
adjournment of the Second Session to consider the matter.

Mr. S. Ben Friedman requested representation for
the Metropolitan Guild of Pharmacists.

Speaker Pro-Tem Burgee ruled that the request be
brought up for action at the first regular session of the
House of Delegates to be convened after lunch.

The Second Session was adjourned at 11:30 a.m.

Third Session, Monday afternoon, May 17

President Fedder called the Third Session to order.
President-elect Schwartz then presided, calling upon Pres-
ident Fedder to deliver his Annual Report. President
Fedder then called upon Speaker Pro Tem, Sydney L.
Burgee, Jr., to convene the House of Delegates and con-
duct the meeting.

A motion was made by S. Ben Friedman and see-
onded to recognize the Metropolitan Guild of Pharma-
cists as an officially recognized organization with delegate
representation in the House. Mr. Freedenberg moved to

AUGUST 1971

Mangini can tell you
what you have.

Within 1%

Many pharmacists often esti-
mate their inventory by relat-
Ing purchases to sales.

In today’s competitive climate
and with the cost of merchan-
dise continuously rising, these
estimated gross profit figures
can be misleading. In fact,
this can be extremely costly
to the pharmacist who, un-

Mangini & Associates, Inc.

4850 W. Belmont Ave. Chicago, III.
60641/(312) 282-8181

aware of his shrinking inven-
tory and gross profits, is
actually paying a higher in-
come tax than he should.

So why guess? Call Mangini
for fast, computerized inven-
tory service that will tell you
within 1% how your inventory
realistically stacks up to your
turnover, sales and profits!

WRITE FOR DETAILED
INFORMATION.
IT’S FREE!

11722 Studt St., St. Louis, Mo. 63141
2760 W. Market St., Akron, Ohio 44313
575 Savin Ave., West Haven, Conn. 06516
5501 Cherokee Ave., Alexandria, Va. 22312

table the motion and refer it to the Board of Trustees.
Seconded and passed.

Sydney L. Burgee, Jr., was elected as speaker of the
House of Delegates on nomination of Richard D. Parker.

S. Ben Friedman moved for nomination of John Mc-
Hugh as Vice Speaker. Seconded by Mr. Sollod. Mr. Me-
Hugh declined.

Richard D. Parker moved for nomination of S. Ben
Friedman as Vice Speaker. He declined, nominating
Henry G. Seidman, who was elected unanimously.

The BMPA Executive Committee having met, re-
affirmed the list of delegates originally recommended and
added Alder Simon and Robert Kabik to the list of alter-
nate delegates.

President Fedder reviewed the action of the APhA
House of Delegates at its 1971 Annual Meeting.

On motion of Mr. Schwartz the MPhA House of

Delegates was adjourned.

President Fedder then called the General Session to
order again and called for New Business.

Mr. Sollod read the following proposed Amend-
ment to the Constitution recommended by the Board of
Trustees:

“Article VI ORGANIZATION (to read)

The functions of the ASSOCIATION shall be per-
formed by the members through the agency of the Gen-
eral Sessions, the House of Delegates, the Board of Trus-
tees, and such other Subdivisions as may be authorized
in the By-Laws.

Article VIT.
Change ARTICLE VI. Quorum, to ARTICLE VII.”

There being no objection, the first reading of the
Amendment was completed.

RESOLUTION

1. Mr. Vicino read a resolution supporting the recog-
nition of “P.D.” (“Pharmacy Doctor’) for all pharma-
cists.

2. He then read a resolution calling for national re-
ciprocity in licensing pharmacists.

On motion of Mr. Freedenberg Mr. Vicino’s resolu-
tions were referred to Professional Relations Committee
for review.

3. Mr. Seidman stated that a resolution should be
passed calling for educational programs to be included in
the Business Sessions of the Convention and at the same
site. The chair ruled that this would be referred to the
Board of Trustees as a recommendation.

4. Mr. Bookoff moved that manufacturers be com-
mended for adopting drug sampling policies of distribu-
tion through pharmacies. He cited Smith, Kline and
French and Roerig and recommended that other manu-
facturers be urged to adopt similar policies. Seconded
and passed.

5. Mr. Schwartz presented a request from Ciba to
protest the FDA policy in combination drugs. On motion
of Mr. Lachman it was referred to the Professional Rela-
tions Committee.

6. Mr. Freiman moved that the routine distribution
of drug samples directly to physicians be banned in the
interest of public health. Motion was seconded and re-
ferred to the Legislative Committee.

16 THE MARYLAND PHARMACIST

REPORT OF THE NOMINATING COMMITTEE

Chairman Kerpelman announced the following slate:

For President-elect
Sydney L. Burgee, Jr.

For Vice President
John R. McHugh

For Treasurer
Morris Lindenbaum

Trustees:
Eastern Shore (1)
Gordon M. Harrison
Central (BMPA (3)
Morris Bookoff
Joseph U. Dorsch
Paul Freiman
Southern (1)
Richard D. Parker
Western (1)

Stephen Hospodavis
Samuel O. Weisbecker

Mr. Kerpelman stated that Mr. Burgee would not be
a nominee as he was elected Speaker of the House of
Delegates.

On motion of Mr. Freiman, Mr. Warfield was unani-
mously elected Honorary President.

On motion of Mr. Bookoff, Mr. Lachman was unani-
mously elected President-elect.

Mr. S. B. Friedman nominated Richard D. Parker
for Vice President. In the vote Mr. McHugh was elected |
Vice President.

On motion of Morris Yaffe, Mr. Lindenbaum was
unanimously elected Treasurer.

Bernard B. Lachman

Philip D. Lindeman

Irvin Kamenetz
Anthony Padussis
Nelson Warfield

Dominic J. Vicino

The following action was taken on Trustees:

Mr. Bookoff was elected by unanimous ballot for a
one-year term (1972).

Messrs. M. Rubin, I. Kamenetz and Melvin J. Sollod
were then nominated from the floor. Messrs. Rubin and
Kamenetz withdrew.

The following were then elected: Anthony G. Pa-
dussis (1973) in contest with Mr. Vicino; Messrs. Paul
Freiman (1974), Philip D. Lindeman (1973), Melvin J.
Sollod (1974) and Stephen Hospodavis (1972) unani-

mously.

MARYLAND BOARD OF PHARMACY

For the vacancy of Howard L. Gordy in 1972 the
Nominating Committee presented the following slate, one
person to be selected by the Governor for appointment.

I. Earl Kerpelman

Philip D. Lindeman

James W. Truitt

On motion of Chester L. Price, seconded by Gerald
Freedenberg, Irving I. Lottier was nominated from the
floor.

The original slate was elected as the MPhA nomi-
nees to the vacancy.

The General Membership then confirmed the action
of the Executive Committee at its last meeting in unani-
mously electing Simon Solomon as the First Honorary

Life Member of the Board of Trustees.

The final session of the 89th Annual Convention
was adjourned at 4:14 p.m.

AUGUST 1971

Mr. Pharmacist -

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4, Salesman inventory control

To get the complete story—call collect [301] 243-4439

PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue
Baltimore, Maryland 21218

AUGUST 1971 THE MARYLAND PHARMACIST

Jamaica Welcomes MPhA
for Holiday in the Sun

Via Eastern Airlines charter flight 139 MPhA mem-
bers and their wives departed on the morning of May 18,
1971, from Friendship Airport to join other MPhA mem-
bers for reconvened sessions at the Jamaicu Hilton in
Ocho Rios, Jamaica.

As a result of the planning of Nathan Schwartz, Con-
vention Chairman, and Alder Simon, Convention Co-
chairman, everyone relaxed, enjoying luxurious atmos-
phere, tropical sun and candlelight dinners.

During the day reconvened sessions included contin-
uing education seminars. On Wednesday, Frederick A.
Glass, M.D. spoke on “Dermatology for Pharmacists.”
Morris Lasover, J.D., discussed “Professional Liability of
Health Professionals” on Thursday, May 20. “Drugs in
Dental Practice” was delivered by Irving Littman, D.D.S.
on Friday.

A romantic highlight was the Saturday evening
cocktail party sponsored by the Calvert Drag Company
held on the hotel patio. Calypso rhythms beat in the dis-
tance while the gentle Caribbean waters rippled just be-
yond the wall of colorful native flowers surrounding the
patio—a perfect setting for a memorable occasion.

After six funfilled days of golf, fishing, shopping
and learning, everyone reluctantly returned to Baltimore,
agreeing that the “Jamaica Trip” was unquestionably a
success.

Reservations Still Being
Accepted For London Trip

MPhA members and their immediate families will
be visiting London from November 7 to 14, 1971. The
group will depart from Friendship Airport in Baltimore
on Sunday evening, November 7, via Air India’s Mahara-
jah 707 Jet for a non-stop flight to London. Upon arrival
Monday morning, local time, passengers will be met and
transferred, with their baggage, to the beautiful Royal
Garden Hotel, situated on the edge of Kensington Gar-
dens adjacent to the Palace of Her Royal Highness,
Princess Margaret. Here tour members will spend six
unforgettable nights of sheer luxury.

In London the following will be included: Full
multi-course English breakfast will be served each morn-
ing at the hotel. A half-day tour of the oldest part of
London, reliving history at the Tower of London where
the magnificent Crown Jewels of England are on display.
A half-day tour of the fashionable West End of London
including Westminster Abbey and the Buckingham Pal-
ace. A half-day excursion through the lovely countryside
to stately Windsor Castle, built by William the Conqueror
and royal residence for nearly 1,000 years.

Evening activities: The MPhA Hospitality Room
will be open for pre-dinner complimentary cocktails be-
fore beginning each night’s festivities. Dine sumptuously
at such outstanding restaurants as_ the Mirabelle, the
luxurious Caprice, Churchill’s-London’s smartest night
spot and the fashionable Twenty-One Club, once the
townhouse of Lord Chesterfield. A delightful evening at
the theatre . . a ticket will be provided for an orchestra
seat of your choice at any of London’s many hit shows.

18 THE MARYLAND PHARMACIST

Guest membership in the Victoria Sporting Club, one of
Europe’s largest casinos, where you may “try your luck”
at anything from craps to blackjack to chemin de fer.

Return flight and arrival in Baltimore via non-stop
707 Jet on Sunday, November 14.

All-inclusive cost—$389.00 per person (based on
double occupancy). Federal transportation tax—$3.00
per person. Supplemental cost for single room—$48.00.
Reservations on this fabulous trip can only be confirmed
upon receipt of a deposit in the amount of $50.00 per
person. All deposits and monies paid are refundable in
full until September 25, 1971. After this date, refunds
are subject to resale of reservation(s).

All deposits are to be made payable and sent to:
Matterhorn Travel Service, 1923 West Street, Annapolis,
Maryland 21401. For further information, please call
269-0123 (local Baltimore line).

Headquarters for

PHOTO-OFFSET PRINTING MAILING |
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

Pension & Investment
Associates of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans (Prototypes Available)
HR-10.. Plans (Sole Proprietor-Partnerships )

Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

|
Ss
SS ene

AUGUST 1971

In 1970, Roche Laboratories
broke with pharmaceutical
industry tradition by being the

first company to discontinue
mass, unsolicited sampling of
professional products. The Roche
aim is to ensure the greatest
benefit to the patient while
meeting the professional needs
of the pharmacist and physician.
All are served best by proper
handling of drugs. Better
control of all aspects of drug
distribution ensures the
highest standards of health
care for the patient, physician
and community.

This policy reflects Roche
interest in the general
problems of pharmacy

management, as well as

the pharmacist-doctor,
pharmacist-patient and
pharmacist-community
relations. There are many
of your colleagues at

Roche—practical profes-

sionals in various management positions—

hat help you meet the challenge of pharmacy today.

ROCHE LABORATORIES
Division of Hoffmann-La Roche Inc.
Nutley, New Jersey 07110

Drug Abuse and the
Maryland Drug Abuse
Authority

by Dr. David R. Nurco

Former Commissioner, Maryland Drug Abuse
Authority

Presented to the Maryland Society of Hospital
Pharmacists, North Arundel Hospital, March
1 he re

What Is Drug Abuse?

It is not possible to understand the meaning of the
term “drug abuse” without first recognizing that using
drugs is not necessarily the same thing as abusing them.
Since all drugs are taken for their effect—which is some-
times good and sometimes bad—it is necessary to know
what drugs can do, taking into account that they can have
side effects as well as direct effects.

What Are The Effects of Drugs?

The consequences of taking drugs are determined
by a large number of interacting factors. Some of the ob-
vious and important ones are the kind of drug used; the
amount, manner, frequency, and duration of its usage;
the person who uses it; and the total circumstances sur-
rounding that person’s use of it, including his expecta-
tions of what the drug will do. In other words, a person’s
response or reaction to any drug is basically the result of
an interaction between an ingested or injected chemical,
and a physically and psychologically complex individual.
It is this interaction that gives drugs their potential to
affect mind as well as body.

The possibility always exists that any drug taken
(with or without official medical approval) can have an
unexpected undesirable side effect—that is, an abusive
outcome. It would be difficult to find even one drug
which is net potentially dangerous for some people, under
some conditions, at some dose level. The opposite is also
true: some individuals can sometimes tolerate without
any negative consequences a drug that most people react

to badly.
Who Takes Drugs, And Why?

The incalculable number of people who take drugs
includes those who smoke cigarettes and other substances,
drink alcoholic beverages, ingest diet pills, and take seda-
tives at bedtime. It also includes individuals who sniff
glue, smoke marijuana and hashish, take LSD, and in-
ject heroin. Obviously a complete list of drug users and
the kinds of drugs they use would be very long, and if it
were fully descriptive, it would reflect great differences
among both individuals and drugs.

But all drug users, regardless of the kind, amount,
and frequency of the drug they use, share one important
trait: they all take drugs because of some need. The na-
ture and origin of their needs differ, of course, and in
special circumstances such as medical emergencies, the
drug-taking may be involuntary. In most cases, however,
people freely choose to use a drug. This choice is made
when someone buys an over-the-counter drug just as
much as when an individual obtains and then smokes
marijuana.

20 THE MARYLAND PHARMACIST

Etiology

Being informed requires, among other things, some
understanding of why people get into trouble with drugs
in the first place, and then—once they have a drug prob-
lem—why they don’t simply stop taking drugs. These
are matters that have already been studied at great length,
and continue to be studied, because the issues are very
complicated. | would like to review in detail only one of
many concepts that are part of a theory of why people be-
come and remain drug abusers. This is the concept of a
“deviant subculture.”

Deviant Subculture
First I would like to quote Albert Cohen, a sociolo-

gist who has offered a general explanation of why deviant —

individuals ultimately become involved in the develop-
ment of deviant subculture.

Cohen begins by pointing out that most people ex-
perience a great deal of frustration from the strain of what
he calls “ambivalence relative to institutional expecta-

tions.”' Nevertheless, most people generally conform to—
. . 4
these expectations because the consequences of conformity |

are defined as less costly than the consequences of devi-
ance.

However, if the strain is great enough, some indi-
viduals will transfer to a different reference group—one
which provides legitimate sanction for their deviant in-
clinations.

A third possible course for a potentially deviant in-
dividual is for him to act out his deviance on a “go it

alone” basis. However, most persons reject this course,
Cohen says, because it is the most costly of the three al-

ternatives.

Apparently, then, deviant individuals wil) not choose
the first alternative because it is too conformist, or the
third because it is too costly. That leaves the second:
joining a group that sanctions deviance.

In choosing this course, the deviant may participate
in the building and perpetuation of a membership group
geared to the satisfaction of illicit desires. Other mem-
bership groups of similar character may then interact

with his, so that together they create a network of parts |

that reinforce the whole. The totality becomes a mutually
supportive subculture.

History

The reinforcing value that a deviant subculture has
for a drug addict has been obvious for a very long time—
we have extensive historical basis for making this and a
number of other statements about drug-taking. Drugs
have been around for many, many centuries.

Various kinds of records show that they have been
used to relieve pain and change the emotions of man for
thousands of years. This is documented in Assyrian medi-

1Albert K. Cohen, “The Study of Social Disorganization
and Deviant Behavior,’ in Sociology Today: Problems and
Prospects, Vol II, ed. by Robert K. Merton, Leonard Broom,
and Leonard S. Cottrell, Jr. (New York and Evanston:
Harper and Row, 1959), pp. 468-71.

AUGUST 1971

Offering Independent Pharmacies...

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up
to making your best source of supply,

THE

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

ICE CREAM for over a half-century

675-6000

I
I,
rf
Ii
if
[
i
ji oy y AlN y / ep y/
| KO RDEN. First name in ice cream
[
r
f
i

AUGUST 1971 THE MARYLAND PHARMACIST 21

cal tablets. Egyptian inscriptions, and numerous other
sources from antiquity. However, most of the information
about drugs that is pertinent to modern civilization dates
from the nineteenth century. In the late 1800’s the Brit-
ish issued a series of drug reports that are still a hallmark.
One of these is a 3000-page study of marijuana use in
India; it is a rich classic that I recommend highly.

During the same period—the late 1800’s—the Brit-
ish convinced the Emperor of China that opium pro-
duced in India and shipped by British merchants should
be admitted for sale in China. By “convinced,” I mean
that under threat from the British Navy, the Emperor
complied. He did not want to, but when a British gun-
boat in the harbor pointed its guns toward shore, he de-
cided to open up China to traffic in opium.

There is real irony here, it seems to me, because this
drug problem that was forced upon Oriental civilization
quickly returned uninvited to Western civilization, and
has been haunting us ever since. Orientals who came to
America after having become addicted to opium in China,
comprised one of three major groups who were using nar-
cotics—chiefly opium and its derivatives—in this country
by the turn of the century. (The other two were women
who suffered from gynecological difficulties before ap-
propriate medicines were developed, and Civil War vet-
erans who became addicted to narcotics involuntarily as
a result of medical treatment for severe wounds. )

Gradually, pharmaceutical chemistry added new syn-
thetic drugs to the natural ones already known and used
—for example, barbiturates were introduced into medi-
cine in 1903, and then in the 1930’s amphetamines were
discovered. The history of drug manufacture and drug-
taking through the years is well known, and now we are
becoming acquainted also with the facts surrounding the
emergence of drug abuse as distinguished from drug use.
It is clear that more and more people are continuing to
seek escape from reality with the aid of opium, heroin,
morphine, dilaudid, codeine, a whole series of hallucino-
genic drugs, and tranquilizers.

Most of these drugs are subject to special laws and
regulations, of course. The earliest ordinance that I know
of in this country was passed in San Francisco in 1875.
Michigan followed suit two years later, passing a law in
1877 that restricted drugs. A few years later Tennessee
did the same.

In 1902 the Federal government passed its own
legislation to prohibit giving drugs to any natives of the
Philippines. In 1909 the United States and several other
major nations participated in a conference in Shanghai
to discuss international control of drugs. Another inter-
national conference on this matter occurred at the Hague
Convention of 1912, after which this country passed the
Harrison Act. The Harrison Act outlawed the sale of all
narcotics in the United States without a prescription. This
law became the precursor of all subsequent Federal laws
related to drugs.

At this time we have a solid structure of laws. state
and Federal, for dealing with drug matters. In 1965 the
Federal government passed the Drug Abuse Amendments
to place further restrictions on stimulants and depressants.
The Federal Controlled Substances Act of 1970 which
went into effect on May 1, 1971 is similar to Maryland’s
new omnibus drug law that went into effect on July Ist,

1970.
Frequently Abused Drugs
Both the Federal Drug Abuse Amendments of 1965

and certain provisions of Maryland’s omnibus law aim

22 THE MARYLAND PHARMACIST

specifically at amphetamines and barbiturates. Ampheta-
mines are stimulant drugs, and are often called “pep
pills’ —the pills that pep you up. Barbiturates, common-
ly called “‘goof balls,” are depressant drugs—the pills
that put you to sleep.

Narcotics are a different kind of drug: they are
analgesics or pain relievers. Penalties for possessing and
selling them for non-medical use are very strict. The

most frequently abused narcotics—all of which are ad-

dicting—are heroin, morphine, codeine, and synthetic
drugs such as demerol, dilaudid, and methadone.

Heroin is the drug that most narcotic addicts prefer,
with the exception of medical personnel: they prefer dem-
erol because it is readily available to them. (“Them”
means doctors, nurses, and ancillary medical personnel. )

Marihuana is not a narcotic; it is a hallucinogen-
like drug which is similar to though not so potent as LSD.
Only two of the components of marihuana are active: they
are known as Delta 8 and Delta 9. Together they give
marihuana one consistent level of strength, and the level
is low. Marihuana comes from the plant Cannabis sativa,
and so does hashish, which is much more concentrated
and thus stronger than marihuana.

It is possible to form a concentrate of the two active
components of the Cannabis sativa plant: Delta 8 and
Delta 9, which I mentioned a moment ago. This con-
centrate is called tetrahydrocannabinol, and it is much
stronger than either marihuana or hashish. The activity

of tetrahydrocannabinol has been compared to that of —

LSD. So far no medical purpose has been found for tetra-
hydrocannabinol, but there is some reason to believe that

further research will reveal it to be an effective anti-de- |

pressant drug. It may eventually become the preferred
drug of addits who are now using heroin, so tetrahydro-

cannabinol is some thing we must be very concerned —

about.

LSD and marihuana are—or can be—habit-forming,

but they are not addicting drugs. By this I mean that they
may be psychologically habit-forming or habituating, but
not physically addicting.

The addicting drugs that I mentioned earlier (heroin,
morphine, demerol, dilaudid, methadone, etc.) are some-
times inhaled, but usually they are taken intravenously.
Intravenous injection is what addicts call “mainlining.”
For most addicts the initial injection is generally un-
pleasant, and produces nausea and vomiting. However,
this does not deter those who have a need to continue, and
with repetition the unpleasant effects disappear and are re-
placed by a feeling of euphoria together with a sensation
called “flash.” “Flash’” has been compared to a sexual-
like orgasm, followed by a feeling of having escaped
wrom the worrisome aspects of reality. This “flash” gives
the addict a promise of everything he has ever wanted in
his life but never had, and without any work at all.
Maryland Drug Abuse Authority

In closing I would like to say a few words about the
Drug Abuse Authority, and its responsibility for providing
services in four major areas. I would like to outline what
is planned in each of the four: education, prevention,
treatment, and evaluation and planning.

EDUCATION

Education about drug abuse will be undertaken in
several different areas, with the schools receiving par-
ticular attention. A detailed curriculum on drugs will
be worked out in cooperation with the State Board of
Education, and will then be taught in public and private

AUGUST 1971

por ks smal

Ns,
Sha PRS Oe ei

Reputation...»

often dapends

you keep.

Butazolidin

phenylbutazone »

ERO

Geigy ©

4000 tablets 7

Ss Sascha: Fesara) em
: Ptitete dapece
nee orate

elementary and secondary schools. This curriculum will
make an honest presentation of facts about drugs, eXx-
plaining objectively what drugs actually are; distin-
guishing carefully the difference between their use and
abuse; and teaching what is now known about the conse-
quences to the individual of drug-taking.

This same kind of basic information about drugs
needs to be communicated also at an adult level to the
general public, and to particular segments of the public
who deal extensively with young people—teachers and
clergymen, for example, and of course parents. The Au-
thority plans to reach this audience through informa-
tional brochures and other materials written by its own
staff to insure that their content is accurate and relevant
to Marylanders.

PREVENTION

To help prevent drug abuse, the Authority will work
toward early detection of the problem by protessional per-
sons and others who are in a position to note potential
drug abuse. This will be accomplished chiefly through
four prevention centers that are planned. They will be
called Coordinating and Counseling Centers, and they will
serve and be located in Metropolitan Baltimore, Western
Maryland, Southern Maryland and Metropolitan Wash-
ington, and the Eastern Shore.

While these Centers will try to help all persons who
seek assistance, they will aim especially at helping young
persons and their families who need guidance in drug-
related matters. They will make a particular effort to
identify potential problems of drug abuse, emphasizing
the importance of early detection.

Short-term counseling for individuals and families
will be available at these Centers, but if long-term help
with an on-going or potential drug-related problem seems
indicated, staff members at the Centers will make ar-
rangements for referral to appropriate helping agencies
within the community.

Another activity of the Drug Abuse Authority aimed
at prevention is the maintenance of a Drug Abuse Regis-
ter to identify narcotic addicts, and determine whether
they are using properly the programs designed to help
them.

TREATMENT

The Drug Abuse Authority will create standards for
treatment programs dealing with drug abuse. and licens-
ing procedures for hospitals and other treatment centers.

Tt will assist in as many ways as it can, outpatient
programs that are currently functioning under private
auspices. All of these require continuing laboratory serv-
ices to test whether patients are maintaining their thera-
peutic regimens, and the Drug Abuse Authority will
help meet the cost of this testing. Alternative methods of
outpatient treatment need to be developed, and the Au-
thority will help to explore promising new possibilities.

Services for drug abusers must be comprehensive,
and the Authority’s activities in the area of treatment in-
clude post-acute management and rehabilitation after im-
mediate treatment needs have been met.

EV ALUATION

All programs dealing with drug problems will receive
continuous evaluation by the Authority to insure that they
carry out their intent, and to change their goals and
methods when changes are required.

24 THE MARYLAND PHARMACIST

Hospital Pharmacy

Section

APhA, ASHP Elect National Officers _
APhA president-elect for 1972-1973 is Clifton J.

Latiolais, a practicing hospital pharmacist in Columbus,
Ohio. Mr. Latiolais is director of pharmacy services at
the Ohio State University Hospitals. He defeated Mary
Louise Anderson, Wilmington, Delaware community
pharmacist. Both nominees are former speakers of the
APhA House of Delegates.

ASHP president-elect for 1972-1973 is Wendell T.
Hill Jr., director of pharmacy services at Detroit General
Hospital. Mr. Hill defeated William H. Hotaling, hos-
pital pharmacist from Schenectady, New York. Mr. Hiill
is also Associate Professor of Hospital Pharmacy at the
College of Pharmacy, Wayne State University in Detroit.

New Collection of Drug Interaction
Information Offered

An important new collection of drug interaction in-
formation will soon be available to pharmacists, physi-
cians, nurses and other health care practitioners. “Drug
Interactions-1,” the first in a series of compilations of
abstracts of articles dealing with the interactions of
drugs, is being published by the American Society of
Hospital Pharmacists. The abstracts included in “Drug
Interactions-1’’ were originally printed in International
Pharmaceutical Abstracts (IPA), a semimonthly journal
published by ASHP that covers over 1,100 scientific and
professional periodicals from throughout the world. All
IPA abstracts since January 1970 have been on magnetic
tape, and the “Drug Interactions-1” publication will be
generated from this computer bank of abstracts.

“Drug Interactions-1” will include abstracts of the
300 articles on drug interactions covered by [PA from
January 1970 to June 1971. The abstracts will be printed
in the same format as in [PA and will contain the essen-
tial qualities and sense of the original article. A maxi-
mum of information in a minimum of words will be pro-
vided. This compilation will be over 50 pages long and
will be thoroughly indexed according to the names and
the pharmacologic classes of drugs involved in the inter-
actions reported. As an indication of the depth of index-
ing, each abstract wil have an average of five subject
index entries.

Commenting on “Drug Interactions-1,” [PA Edito
Dwight R. Tousignaut said, “This new publication wil
be a tremendous help to the practitioner or student who
is concerned about keeping up with the flood of informa-
tion on drug interactions. Drug interactions are being re-
ported every day, not just in this country, but through-
out the world. Since “Drug Interactions-1’ is derived fro
IPA which covers the literature worldwide, much of th
information presented here is probably not available any-
where else as a single source.”

“Drug Interactions-1” will be available next month
and may be purchased from ASHP for $5.00. Orders ar
being accepted now and should be sent to: Drug Inter
actions-1, c/o American Society of Hospital Pharmacists
4630 Montgomery Avenue, Washington, D.C. 20014

Payment must accompany all orders.

AUGUST 197

1S Still th
to de
brain."

Reading

efastest v way
in ia

In an era of “information explosion,” how do you “pro-

gram” information to the human brain? Spoken lang-
vage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for the
spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

Pharmacy School Plans
Continuing Education Courses

Based upon the interest and probable attendance in-
dicated by return of a questionnaire mailed out to all of
the State’s pharmacists, the Continuing Education Di-
vision of the School of Pharmacy is planning to offer a
two-semester course in Pharmacology and a series of one-
day lecture programs this coming year.

According to Henry G. Seidman, Director of Con-
tinuing Education Programs, the success of programs
during the past two years and the widespread response to
several questionnaires submitted to pharmacists through-
out the State has prompted the Division to consider in-
creasing its offerings to include additional subjects most
requested by respondents.

Planned programs are:

(1) Pharmacologic Basis for Therapeutics: A 2-semester
course, one night weekly from 7:00 to 9:30 p.m., begin-
ning September 19, 1971 at the University of Maryland
downtown campus. Estimated cost: $125.00.

(2) Management of the Maintenance Care Patient: A
Sunday series of 4 programs at monthly intervals from
12:00 noon to 4:30 p.m., beginning January 23, 1972.
Probable site: UMBC.

Tentative schedule:

January 23, 1972—The cardiac and diabetic patient.

February 27, 1972—The epileptic, asthmatic and
emphysematous patient.

March 26, 1972—The patient with peptic ulcer,
ileitis or colitis; the thyroid patient.

April 16, 1972—The pregnant and pediatric pa-
tient; home nursing care in all these areas.

Estimated cost: Complete $30.00, individual session $10.

(3) A one-day program with lectures in the area of Antt-
biotics and Biological and Clinical Chemistry (diagnostic
agents, metabolic diseases) for presentation during Octo-
ber or November, 1971.

For further information call 955-7589 or 955-7650.

CLASSIFIED ADS

As a service to MPhA members, we offer a
free classified ad service. Maximum number of
words permitted under this free service is 25.

In replying to “blind” ads, address Ad No....... :
Maryland Pharmacist, 650 W. Lombard St., Bal-
timore, Md. 21201.

Commercial classified ads (single issue inser-
tion) will be carried at 15 cents a word, mini-
mum charge per insertion, $5.00. PAYMENT
TO ACCOMPANY ORDER.

Closing date for copy—15th of preceding month.

FOR SALE: Pharmacy in growing Gladstone, Oregon-
Streeter fixtures, volume over 225,000, terms to qualified
buyer. Richard M. Olson, Olson Drug, 920 7th St., Ore-
gon City, Ore. 97045. Phone 656-1977.

26 THE MARYLAND PHARMACIST

Student APhA

APhA Executive Director Apple has named William
F. McGhan, a 1970 Pharm.D. Degree recipient from the
University of California at San Francisco, as the Execu-
tive Secretary of the Student American Pharmaceutical
Association, effective August 1, 1971.

Under APhA sponsorship, the Student American
Pharmaceutical Association has been awarded a $36,225
National Institute of Mental Health contract to test the
effectiveness of an interdisciplinary approach to drug edu-
cation and to determine the feasibility of launching such
a program on a nationwide basis.

Under terms of the one-year contract, Student APhA
will identify sites for and assist in the organization and
implementation of drug education programs carried out
by interdisciplinary student teams and aimed at students
in secondary and elementary schools.

In The News...
SAMUEL LICHTER has been appointed Chief

Pharmacist at the Union Memorial Hospital in Baltimore.
A 1960 graduate of the University of Maryland School of
Pharmacy, Mr. Lichter has been with the Union Memorial
since 1964. He is a past president of the Maryland So-
ciety of Hospital Pharmacists. Sydney L. Burgee, Jr. will
continue as Director of Pharmacy and Central Supply.

KARL WAGNER of Salisbury, Md. has been named
Read’s Pharmacist of the Month for the professional com-
petence he has shown in the interest of public health.
Mr. Wagner recently assisted in giving first aid treatment
to a victim of a shooting which occurred in the vicinity
of the pharmacy where he is employed.

FREDERICK M. FRANKENFELD, 1967 graduate
of the University of Maryland School of Pharmacy, has
been named Manager, Drug Data Processing Systems
and Services, American Society of Hospital Pharmacists
Frankenfeld is currently completing a master’s degree
thesis at the University of Lowa based on his research on
formulary automation. He is a past recipient of eo
MSHP Student Achievement Award and has been electe
to the Rho Chi Society.

Obituaries

LAFAYETTE L. PIERPONT

Lafayette L. Pierpont, 86, died on June 6, 1971 a
his home following a brief illness. Mr. Pierpont was a re
tired wholesale drug salesman who at one iime worke
for Loewy Drug in Baltimore.

RICHARD D. GIBBS

Richard D. Gibbs, 69, retired vice president and d
rector of Peoples Drug Stores, died July 22 after a hea
attack at his home in Fort Lauderdale, Florida.

Mr. Gibbs began his career with Peoples as a stock
clerk in 1921. Three years later he became a registere

pharmacist and stayed with Peoples until his retireme
Inv ep ag

AUGUST 197

There’s alot more going for you at LOEwy

Siecle PERSONALIZED SERVICE PLUS

provides you with the flawless backing of 100% computerization—
along with the special personal follow-through of people who care

RUM DIVISION OF
LOEWY DRUG COMPANY £52 Ysectoe Sndusloiis, Inc

6801 Quad Avenue, Baltimore, Md. 21237 Tel.: (301) 485-8100

All joking aside, Empirin
Compound is one of your most
profitable analgesics. And
Empirin is making waves it’s
never made before, so it really
deserves a little more of your
attention.

Now, there are more than two
million opportunities a month
for practically all physicians,
all nurses and all dentists to see
the new advertising for Empirin
Compound.

And when these health
professionals recommend
Empirin, their patients won’t be
looking for it in supermarkets—

EMPIRIN
but in pharmacies.

Should you put EMPIRIN’ Compound
next to your most profitable item?

So, look to your stock. In
addition to good profits from
> Empirin Compound, the extra
traffic should help you move a
e lot of other items as well.
Display Empirin Compound
for greater sales and profit.

When customers ask your
professional advice:
Recommend two Empirin tablets
every three hours, for minor
aches and pains, simple
headache and toothache, and

to help relieve the discomfort

of colds.

Empirin Compound.
Consistent relief.

Burroughs Wellcome Co.
Research Triangle Park
Wellcome / North Carolina 27709

item next to EMPIRIN Compound?

the
>” maryland

=" pharmacist

National October 3-9.
Pharmac 1971
We

ek -

Voluntary Disaster
oe

See your pharmacist for the

National Pharmacy Week
October 3-9, 1971

.
:
|
;
BA luniamAZ SEPTEMBER 1971 Nambenko
q

Compliments of

oxell

CORPORATION

Makers of
NOXZEMA SKIN CREAMS
NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS
and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

Your written assurance of quality

Lilly

Eli Lilly and Company « Indianapolis, Indiana 46206

This policy reflects Roche
interest in the general
problems of pharmacy
management, as well as
the pharmacist-doctor,
pharmacist-patient and
pharmacist-community
relations. There are many
of your colleagues at
Roche—practical profes-
sionals in various management positions—
sho help make the policies and provide the services
hat help you meet the challenge of pharmacy today.

ROCHE LABORATORIES
Division of Hoffmann-La Roche Inc.
Nutley, New Jersey 07110

The Maryland Pharmacist

NATHAN I. GRUZ, Editor

NORMAND A. PELISSIER, Assistant Editor
MARTHA ECKHOFF, Editorial Assistant
ROSS P. CAMPBELL, News Correspondent

VOLUME 47

650 WEST LOMBARD STREET
BALTIMORE, MARYLAND 21201

SEPTEMBER 1971

_s
ASSOCIATION

NUMBER 9

OFFICERS 1971-1972

Honorary President

H. NELSON WARFIELD—Pikesville
*

President
NATHAN SCHWARTZ—Annapolis

President Elect
BERNARD B. LACHMAN—Baltimore

Vice President
JOHN R. McHUGH—Potomac

Treasurer

MORRIS LINDENBAUM
5 Main St., Reisterstown, Md. 21136

Executive Director

NATHAN I. GRUZ
650 W. Lombard St., Baltimore, Md. 21201

TRUSTEES

DONALD O. FEDDER, Chairman—Dundalk
MORRIS BOOKOFF (1972)—Baltimore
PAUL FREIMAN (1974)—Baltimore
STEPHEN HOSPODAVIS (1972)

Cresaptown
PHILIP D. LINDEMAN (1973)—Berlin
ANTHONY G. PADUSSIS (1973)

Baltimore
MELVIN J. SOLLOD (1974)—Adelphi
SYDNEY L. BURGEE, JR.
Speaker of the House of Delegates
Baltimore
EX-OFFICIO MEMS8ERS

FRANCIS S. BALASSONE—Baltimore
WILLIAM J. KINNARD, JR.—Baltimore

HONORARY LIFE TRUSTEE
SIMON SOLOMON—Baltimore

MARYLAND BOARD OF PHARMACY

Honorary President

SIMON SOLOMON—Baltimore

President

NORMAN J. LEVIN—Pikesville

Secretary

F. S. BALASSONE—Baltimore

Member
FRANK BLOCK—Baltimore

Member
HOWARD L. GORDY—Salisbury

Member
MORRIS R. YAFFE—Potomac

AFFILIATED ORGANIZATIONS

Allegany-Garrett County
Pharmaceutical Association

President Men eee re Stephen Hospodavis
Vice-Presilent< a ee James Ritchie
Secretary-Treasurer....... Robert F. Tomsko

Baltimore Metropolitan
Pharmaceutical Association

Bresigent@cc 8), 120), = yeeros Irvin Kamenetz
Presidents Elect so). ee Joseph U. Dorsch
LPCUSULEr ae eee oe ee Charles E. Spigelmire

Vice Presidents—
Paul Freiman, Harold P. Levin,
Harry R. Wille
Secretary and Executive Director
Nathan I. Gruz

Eastern Shore Pharmaceutical Society

President mete irs te Gordon Harrison
First Vice President....... William P. Smith
Second Vice President....... William Connor
DECICLAFVA eae eaten ee, Carl R. June
T FECSUr Grete. ce etn nk os os Thomas Payne

Prince Georges-Montgomery County
Pharmaceutical Association

RIEStd ent teen rie ce ce eae Martin Hauer
First Vice President....Edward D. Nussbaum
Second Vice President ..... S. Ben Friedman
Third Vice President ...... Sidney Glashofer
Fourth Vice President....... Gabriel E. Katz
WECrOlary Mey cathe e ee ec Paul Reznek
TT CGSURCh ae ce te ee eek oe Michael Leonard
Honorary President .......... Samuel Morris

Washington County
Pharmaceutical Association

Presiden tamercmtneca Samuel E. Weisbecker
HiceeP resident meen ene Joseph Davies
Secretary-Treasurer ...... Frederick Fahrney

University of Maryland School of
Pharmacy Student APhA-MPhA Chapter

President parca ot oe Paul R. Webster
Vicew Presid cn tae een Stephen B. Bierer
SCCTCLOTY tener eto. are Donna S. Levin
Treastr erage: sclee cetee: Dennis R. Reaver

MPhA AUXILIARIES

MRS. MANUEL B. WAGNER

TAMPA — Traveler’s Auxiliary of The
Maryland Pharmaceutical Association
President
PAUL J. MAHONEY
First Vice President
JOHN C. MATHENY
Second Vice President
ABRIAN E. BLOOM
Third Vice President
C. WILSON SPILKER
Secretary-Treasurer
WILLIAM A. POKORNY
Assistant Secretary-Treasurer
WILLIAM L. NELSON
Honorary President
JOSEPH GRUBB
Secretary-Treasurer Emeritus

JOHN A. CROZIER

OTHER PHARMACY ORGANIZATIONS
Maryland Society of Hospital
Pharmacists
President
MARY W. CONNELLY
President Elect
NORMAND A. PELISSIER
Secretary

DOLORES A. ICHNIOWSKI

Treasurer

THOMAS E. PATRICK

University of Maryiand
School of Pharmacy

Dean
DR. WILLIAM J. KINNARD, JR.
Assistant Dean
DR. C. T. ICHNIOWSKI
Delegate and Vice Speaker—
MPhA House of Delegates
HENRY G. SEIDMAN

St. La aie aati ee Sess SSNSDSRSSNNSNNUSGISSSemeo=isst

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number. Allow four weeks for

changeover.

TABLE OF CONTENTS

Page

Editorial—Pharmacy and Public Health Education.... 6

Pharmacy, Calendartsec. ee ee 7
Summary of Minutes of Executive Committee

and Board of Trustees Meetings 00.........ccccccccccccceseeee 8
Washington Spotlight For Pharmacists ..........cccccccccc0. 12
Interactions of Drugs by Richard A. Wankel

ANOS YON Ye le ULe eC) 1 meee ene 14
Prince Georges-Montgomery County

Pharmaccutica meASSOCLAt]O lime etee eee 21
University of Maryland School of Pharmacy ............ 22
FOSspitalm Pharma Cys SCCLLO nee tee a enn 24
AZ.O] Pharmaceuticalerraternity ease nee eee 25
Obituaries tsctivie- enc) cok ee Re ee ee ee 26

INDEX TO ADVERTISERS

Page
Berkey * Filmy 1Processin caec vent eee 23
Calvert Drug \ Company) ae eee 21
Henry, Bi Gupin Companys .e eee 28
Hynson Westcott: 62. Dunning... (nc... eee eee eee Dy
EeligLillveanduCompaly sec. oe ee eee ee 3
Loew ys, Dries Company a. eee ee eee ils)
Manginit and Associates, Inco as. ae eee Ath
Maryland yNews:-Company. 050.5) ee 19
Noxell Corporation ineee. ee ee 2
Paramount) Photos Service chee ee ee ILA

Pension and Investment Associates of America,Inc... 7

AJA. 2 Robins! Company aac. ene ee ee 13
Roches Laboratoricsmre 2a ee 4
D. Stuart Webb Advertising Services ............................ 21
Youngs Drug Products Corporation ...0..0...022.-.............. 9

THE MARYLAND PHARMACIST

Editorial...

Pharmacy and Public Health Education

No other health profession has either ease of access
to or the frequency of contact with the public that phar-
macy has.

Through the years the Maryland Pharmaceutical
Association has fostered the concept of the pharmacy be-
ing the ready, convenient source of health information.
For a number of years MPhA has had Health Informa-
tion Racks available to its members as well as pamphlets
on a wide variety of health subjects.

During the past 12 months MPhA has focused on
the following public health areas among others:

—Drug abuse

—Diabetes detection
—Children’s dental health
—Poison prevention

—Drug interactions
—Patient medication records
—Venereal disease

As an example of the catalytic effects of MPhA
leadership in a recent campaign, we would like to relate
some of the results of just one of our programs.

In Maryland in spite of a raging venereal disease
epidemic, efforts on both state and local levels to com-
bat V.D. did not seem to achieve the sense of urgency
the crisis deserved. In the spring of 1971 the MPhA
Executive Committee, realizing the gravity of the situa-
tion, decided to initiate a program to alert the public to
the magnitude of the VD problem with the view of pub-
lic health education in the prevention and treatment of

VED}

Under the chairmanship of Paul Freiman, a press
conference was called which was attended by representa-
tives of state and local health officials and medical so-
ciety representatives as well as the media. The confer-
ence was most successful in achieving its goals.

The result has been publicity in the press and on
radio and TV, with favorable editorial comment. The
Medical and Chirurgical Faculty of Maryland (state
medical society) has decided to join with the MPhA in
an educational campaign. The State Department of
Health is establishing a Commission on V.D. and has
asked for a representative from MPhA. A seminar for
health professionals has been arranged by the State De-
partment of Health and the Johns Hopkins University.
The Baltimore City Health Department is also interested
in working out a joint program with MPhA and Med
Chi.

This year the theme of National Pharmacy Week has
been designated appropriately “V.D. — Voluntary Dis-
aster.”

Members will receive posters and additional informa-
tional pamphlets to distribute to their patrons. News-
papers, radio and TV announcements will direct the
public to their pharmacies for information. A speakers’

SEPTEMBER 1971

program involving physicians, pharmacists and phar-
macy and medical students will be available throughout
the coming year to bring the message to young people.

During the coming months other activities of MPhA,
both alone and with the medical society and_ health
agencies, will be announced.

Pharmacists are uniquely qualified to “rap” with
their patrons, young and old. Pharmacists are readily
accessible in all the neighborhoods of our cities. in every
town and in most hospitals. We look forward to more
and more pharmacists participating in all the many pub-
lic health programs in which MPhA is engaged. These
are constructive projects which identify pharmacists with
the public interest, creating an image in the public mind

which we trust will be justly deserved.

These are certainly the kinds of ongoing activities

that all health professionals—pharmacists included —
commit themselves to when they embark on a career in

providing health care in their communities.

KERMIT D. WHITE

In June, a senseless tragedy occurred involving a
dedicated community pharmacist, Kermit D. White, who
lost his life in the line of duty at the hands of a desper-
ate drug addict seeking to obtain drugs and money. He
was a fine human being, a devoted husband and father.
a friend to all the community and a worker on behalf

of young people.

We remember him as one who responded to the re-
sponsibilities of his profession by participating in the
MPhA committee working on the problems associated
with neighborhood comprehensive health centers.

The Maryland and Baltimore Metropolitan Pharma-
ceutical Associations mourn the death of Kermit White
and extend sincere sympathy to his family. In order to
perpetuate his memory, MPhA and BMPA have brought
together representatives of the community as well as
pharmacists to plan a suitable memorial tribute.

The initial meetings suggest the establishment of a
community project, perhaps in the field of drug abuse,
in service to the youth of West Baltimore where Kermit
White practiced and where he sponsored youth activities.

We are sure that the entire city as well as all phar-
macists will respond when called upon to contribute to
the memorial for Kermit White.

Nathan I. Gruz

CHANGE OF ADDRESS

When you move—
Please inform this office four weeks in advance to avoid
undelivered issues.

"The Maryland Pharmacist" is not forwarded by the
Post Office when you move.

To insure delivery of "The Maryland Pharmacist" and all
mail, kindly notify the office when you plan to move
and state the effective date.

Thank you for your cooperation.

Nathan I. Gruz, Editor
Maryland Pharmacist
650 West Lombard Street

EPTEMBER 1971

PHARMACY CALENDAR

October 3-9—National Pharmacy Week
October 7—MPhA Fall Regional Meeting, Playboy Club,

Baltimore.

October 10-14—National Association of Retail Druggists
Annual Convention, The Rivergate, New Orleans.

October 16-21—National Wholesale Druggists’ Associa-
tion Annual Meeting, Century Plaza Hotel, Los
Angeles.

October 14—MSHP meeting at St. Joseph’s Hospital,
October 21—( Thursday )—BMPA regular meeting.
November 4—( Thursday )—TAMPA Ladies’ Night, Gar-

land Dinner Theatre, Columbia.
7:30 p.m.

November 11—MSHP meeting at the USPHS Hospital,
7:30 p.m.

November 18—( Thursday )—BMPA Annual Meeting.

December 12-16—American Society of Hospital Phar-
macists Sixth Annual Midyear Clinical Meeting,
Washington, D.C.

January 30, 1972—56th Annual Installation Banquet &
Dance, Baltimore Metropolitan Pharmaceutical Asso-
ciation, Blue Crest North.

April 22-28, 1972—American Pharmaceutical Associa-
tion Annual Meeting, Houston.

Pension & Investment
Associates of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)
HR-10..

Plans (Sole Proprietor-Partnerships)
Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

THE MARYLAND PHARMACIST 7

Summary of Minutes of
Executive Committee and
Board of Trustees Meetings

March 4, 1971

Communications included letter from International
Congress of Pharmaceutical Sciences requesting sup-
port for meeting September 7-12, 1971, in Washing-
ton, D.C. Letter from manufacturer regarding ad-
vertising products changing from “available in gro-
ceries” to “your favorite dealer.”

The President reported that Washington County
Pharmaceutical Association had voted to affiliate
with MPhA. The affiliation was endorsed. President
attended Tri-Partite Committee meeting of School,
Board of Pharmacy and MPhA to review changes in

curriculum and new preceptor programs.

The Executive Director reported on H.B. No. 569
which would establish a Board of Health Service
Assistants. The bill was written with very broad
implications which could affect Pharmacy and sup-
ersede some of the functions of the Maryland Board
of Pharmacy. Other activities included Swain Semi-
nar, BMPA Executive Committee meeting, Crozier
Testimonial Dinner, Maryland Society of Associa-
tion Executives meeting; guest at AZO Breakfast
Meeting featuring speaker from Paid Prescriptions,
Inc.; meeting with William Donald Schaefer, Presi-
dent of Baltimore City Council; Med-Chi Pharmacy

Liaison Committee meeting.

New Federal Controlled Substances Act discussed.
Details to be presented at Spring Regional Meeting.

Effective date of the APhA “grandfather” provision
for the local associations was put in line with their
membership years, such as March 31, 1971 for
Prince Georges-Montgomery County Pharmaceutical
Association.

- Details for observance of Poison Prevention Week in-

cluding the printing and sale of labels with Poison
Control Center telephone number were outlined.

The general format of the Convention and recon-
vened sessions in Jamaica was reviewed. Report
was made on the Spring Regional Meeting. Prince
Georges-Montgomery County Pharmaceutical Asso-
ciation will assist in the promotion.

Dean Kinnard reported on the new curriculum and
preceptorship plan. A questionnaire will be sent out
to all pharmacists regarding supportive personnel.
A Task Force has been meeting on this issue. The
entire Poison Information Center is to be moved
with State Health Department approval, from the
Baltimore City Hospitals to the School of Pharmacy.

A legislative report was made on Senate Bill No.
110 requiring placing name of drug on prescription
label. Mr. Gruz testified for resolution regarding the
role of advertising of proprietary drugs in drug
abuse.

A report was heard on Prescription Drugs, Inc. Con-
ferences have been held with some of the individuals
involved. Paid Prescriptions contract discussed.

THE MARYLAND PHARMACIST

Lek

12.

13.

14.

Paul Reznek was appointed a delegate to the APhA
House of Delegates in place of Mr. Burgee who
could not attend.

The Board voted to participate in the Maryland
Science Fair.

Procedure adopted for nomination by mail ballot.
General membership and affiliated associations will
be asked to recommend nominees for the various
offices, with a biographical sketch and qualifications
for the office submitted to the Nominating Commit-
tee. There will be two nominees each for President-
Elect; Vice-President and Treasurer. For the Board
of Trustees there will be six pairs of candidates, the
two opposing candidates being from the same area.
Election Committee or Board of Canvassers to be
composed of one member from each affiliated asso-
ciation selected by each organization. Function will
be to insure all ballots remain sealed until opened
by the Board, counted and certified for eligibility
to vote.

Senate Bill No. 415 to place exempt narcotics on
prescription only discussed. MPhA position reaf-
firmed for sale personally by the pharmacist in ac-
cordance with the present federal and state law regu-
lations.

Mareh 24, 1971

Communications included letter from APhA stating
BNDD would mail inventory forms to all pharma-
cies. Letter from Dean Kinnard regarding Executive
Committee action on School support of Rho Chi dis-
tribution of Poison Control Center labels. Letter
from APhA to the Congress to place pharmacists
under the same Selective Service provisions as other
health professionals. Letter from Lt. Governor Lee
acknowledging letter from President Fedder urging
greater funding of the Drug Abuse Authority and
stating this had now been done.

The President reported on his testifying before
State Legislative Committee on a bill initiated by
two pharmacists from Prince Georges-Montgomery
County area to place exempt narcotics on prescrip-
tion. He attended Open House at School of Phar-
macy and taped radio program on Poison Preven-
tion.

Executive Director reported on his attendance at
legislative committee hearings, meeting with Pre-
scription Drugs, Inc., meeting of Affiliated Mer-
chant’s Association, and meetings on Medicaid Pro-
gram and Venereal Disease Education Program. Also
meetings on Poison Prevention and Convention plan-
ning were attended.

The Membership Committee report indicates an in-
crease in the non-owner-manager category of phar-
macists but owner-manager category is behind. Mem-
bership figures to date are 445 compared to 432

last year.

SEPTEMBER 1971

V.D. PREVENTION &
CAMPAIGN REINFORCES
PHARMACISTS’ EFFORTS

Youngs Drug Products Cor-
poration, a leading producer of
prophylactic products, has
budgeted special funds for infor-
mative V.D. awareness and
prevention advertising; it is help-
ing to organize V. D. control
campaigns, currently in eleven
states and cities; its executives
have been making presentations to
teenagers and adults in organi-
zations, colleges, service clubs,
‘parents’ groups and schools.

More than 4 million copies in both
Spanish and English of Youngs’
pocket-size pamphlet, “Plain Talk
About Venereal Diseases,”

have been distributed from coast
to coast. .

A major purpose of the Youngs
program is to reinforce the role
of pharmacists and their state
associations as front-line fighters
in the current battle against
V.D. Company materials empha-
size that pharmacists are the
best sources for both prevention
advice and prophylactic needs.

NEW V. D. PUBLICITY
PROGRAM INVOLVES
PHARMACISTS

As part of the many activities
which make up its V. D. awareness
and V.D. prevention program,
Youngs Drug Products Corpora-
tion has launched a national
publicity program. The company
maintains a steady flow of infor-
mation about the venereal disease
problem and its prevention to

all media—television, radio, news-
papers and magazines. This has
brought continuing editorial cov-
erage on the magnitude of the
V.D. problem and its control. The
coverage highlights the pharma-
cists’ key rolein V.D. control work.

YOUTH NEEDS V.D.
INFORMATION

America’s young people badly
need information about venereal
disease, according to Melvin
Clark, sales manager of Youngs
Drug Products.

“Young people,” says Mr. Clark,
“are the prime ‘V.D.-prone’ age
group. And it seems evident that
much of this may be because

they are not given the facts about
V.D., particularly V.D. preven-
tion. The average high school text
on biology or hygiene contains
dozens of pages of text about
typhus, scurvy, beri-beri, bubonic
plague, cholera, smallpox, even
varicose veins. But most texts—
we estimate about 98 percent—
contain nothing, not even a sen-
tence, about venereal disease.”

“Students and their teachers,
however, want the facts, and we
welcome their inquiries,”

says Clark.

NEW HIGH SCHOOL V.D.
PROGRAM STARTED
Venereal disease and its preven-
tion were the subjects of a
day-long session of New York
City’s giant Bronx High School
of Science recently. Youngs Drug
Products Corporation served as
invited-guest impresario.

Unique thus far in venereal disease
“awareness” activity, the pro-
grams started at 9:30a.m.ona
school day and continued for six
successive large classes.

Youngs’ program on V.D. was
shown each group, witha
question period following each
discussion. The speaker advised
that the pharmacist was an

prevention news

excellent source for both
prevention advice and prophy-
lactic needs.

LICENSE PLATE CARRIES
V. D. MESSAGE

Dr. Warren A. Ketterer, Head,
Venereal Disease Section, Califor-
nia State Department of Public
Health, carries his anti-V.D.
message with him wherever he
goes. His automobile has a very
special license plate: “END V.D.”

The plate attracts considerable
attention on the roads, and has
received favorable press mention
in California.

YOUNGS EXECUTIVE
ON TV

CBS-TV Station KNXT, Los
Angeles, recently granted free air
time to a sales executive of Youngs
Drug Products Corporation to
broadcast a hard-hitting plea for
greater accuracy in describing

the V.D. problem and for greater
emphasis on V.D. prevention as
the “prime dependable device in
bringing V.D. under control.”

According to Youngs, its West
Coast sales manager, Harold
Halberstadt, was given this free
time over KNXT to answer one
of the station’s own broadcast
editorials on the current epidemic
scale V.D. increase.

John C. MacFarlane, president of
Youngs, commented that KNXT’s
offer of prime T’V time was “a
gratifying example of the type of
total community effort that can
be mustered behind the all-out
attack on the V.D. epidemic.”

Produced by Youngs Drug Products Corporation,

Manufacturers of Trojans Brand Quality Prophylactics, 865 Centennial Avenue, Piscataway, New Jersey 08854.

Convention Committee chairman reported on status
of Convention program. Original airplane for Ja-
maica trip was sold out and arrangements were be-
ing made for a larger plane.

Professional Relations Committee reported on forth-
coming Med Chi exhibit on patient medication pro-

files.

A legislative report was made on Senate Bill 4
amendment requiring physician’s signature to be
legible on prescriptions.

A motion was passed concerning approving appoint-
ment of Executive Director and the consideration of
employment of assistants.

Third-Party Payment Programs were reviewed along
with activities of National Pharmacy Insurance
Council. Motion passed on endorsement of policy
whereby third-party payment programs would only
be endorsed if dispensing of drugs is limited to
pharmacists. “Paid Prescriptions” program for sam-
ple distribution by means of prescriptions through
pharmacies was endorsed.

May 16, 1971

Communications included letter from Irvin Rubin,
Editor of Pharmacy Times requesting support for a
commemorative postage stamp in honor of Phar-
macy.

The President noted in his report that this would
be the last Executive Committee meeting before re-
organization and thanked all for their cooperation
extended to him.

The Treasurer’s report indicated net income for
the year of $24,704; expenditures, $17,621.10;
$5,600 was temporarily transferred to the savings
account.

Executive Director reported on his attendance at
meeting of National Council of State Pharmaceutical
Association Executives in connection with APhA
convention. Work is proceeding under Dr. Samuel
Fox on the campaign of the Maryland Pharmaceuti-
cal Foundation. Also attended the installation affair
of the Prince Georges-Montgomery County Pharma-
ceutical Association. Major activities included:
MPhA Convention planning and arrangements; in-
quiries regarding the Controlled Dangerous Sub-
stances Act (MPhA furnished rubber stamps and
pads); APhA Annual Meeting—main topics: repeal
of antisubstitution laws, ‘Pharmacy Doctor” degree,
pharmacy recruitment; V.D., BMPA Camp Glyndon
reconstruction project; “Suggested Guidelines for
Pharmacy Practice” has been issued, published

jointly by MPhA and MSHP.

The Membership Committee reported total mem-
bership to date at 586 versus 630 at the same time
last year. Most of the new 1971 members are chain
pharmacists.

The Public Health Information Committee outlined
plans for V.D. Awareness Month in June. A press
conference is scheduled in early June. The Speakers’
Bureau on V.D. is also being set up.

The Legislative Committee reported on the 197]
legislative session and noted that Senate Bill 110 re-
quiring labeling of ingredients on prescriptions was
enacted.

THE MARYLAND PHARMACIST

LO:

WA.

The Third-party Payment Programs Committee re-
ported on the increase for CHAMPUS prescription
fees for Maryland from $1.85 to $2.00 and that the
MEDI-MET program had increased its prescription
fee to $2.00. There was discussion on some of the
Union Prescription Prepayment Plans extending the
maximum supply of drugs on a prescription to 90
days.

The motion to nominate Sydney Burgee as Speaker
Pro-Tem of the House was passed.

The recommended budget of $44,500 was approved

after a review of income and disbursements.

The Nominating Committee recommended the fol-
lowing names for filling the vacancy of Howard L.
Gordy on the Board of Pharmacy for 1972: I. Earl
Kerpelman, James W. Truitt, and Philip B. Linde-
man. Simon Solomon was voted as an Honorary Life
Member of the Board of Trustees.

June 10, 1971

The President asked committee chairmen to assume
a more active role in the work of the Association and
to delegate responsibilities.

The Treasurer’s report showed that income from
dues for the first five months of 1971 was lower than
the same period of 1970. The Annual Convention
this year was more of a financial success than last
year’s. Office expenses have been higher in 1971,
attributed to the increased charges for mailing and
printing.

The Executive Director asked for a moment of
silence in memory of Dr. B. Olive Cole. Attendance
was higher at the 1971 Annual Convention than in
previous years. Other recent activities included the
V.D. Awareness Campaign launched with a press
conference that proved to be extremely effective. The
exhibit at the Med Chi meeting was successful.
About 50 pamphlets entitled “Drug Interactions”
were mailed from the office as the result of requests
from physicians who visited the exhibit. Director
Gruz attended the meeting of the Maryland So-
ciety of Association Executives and attended the
Governor’s Commission on Aging meeting in prepa-
ration for the White House Conference on Aging.
Approval was granted for Director Gruz to attend
the third year of a three-year course in organiza-
tion management to be held in Philadelphia in
early August.

The membership committee is currently meeting
with the membership committee chairmen in the sub-
groups. Because 30 pharmacies have closed last year.
the membership figures in the owner-manager cate-

gory are behind.

It was suggested that educational programs be in-
cluded in the next Convention.

The Prepaid Prescription Program Committee chair-
man reported on the possible use of the standard
form of the National Pharmacy Insurance Council.
The need for legislation to allow negotiations by
pharmaceutical associations was pointed out.

The matter of county Commissions on Aging list-
ing pharmacies offering discounts was reported and
was referred to legal counsel.

SEPTEMBER 197!

oi.

12.

13.

14.

EPTEMBER 1971

MPhA policy concerning the use of unregistered
personnel in prescription departments was discussed.
A committee chairman was appointed to study and
report on this.

zt committee was appointed to study and report on
this.

The Legal Counsel reported on scheduled House
Small Business Committee hearings on July 7, 8
and 9 on prepayment prescription plans. There was
discussion regarding operation of pharmacies by
corporations and nonpharmacists.

The following committee chairmen were approved:
Prescription Insurance Plans: M. Bookoff

Finance: J. McHugh

Legislative: P. Freiman

Membership: M. Rubin

School of Pharmacy: D. Fedder

Public Relations: C. Spigelmire

Professional Relations: S. Hospodavis; N. Warfield
Co-chairman

Public Health Information: P. Freiman
Constitution and By-Laws: M. Sollod

Institutional Pharmacy: R. Snyder

Bowl of Hygeia Award: Charles E. Spigelmire was
approved as the recipient of the Robin Bowl of
Hygeia Award for 1972.

Discussion was held concerning joint committees
between MPhA and MSHP. The matter will be dis-
cussed with the new MSHP officers with a report
to the Board of Trustees later.

Plans were reviewed for the London Trip November
atone 197 1.

Brief discussion regarding increased representation
on the Board for the Prince Georges-Montgomery
area was held and the matter referred to the Consti-
tution and By-Laws Committee.

July 8, 1971

Communications included a letter from Mr. Balas-
sone regarding adoption of regulations on pacifiers,
the first such regulation in the nation and a letter
from the Maryland Diabetic Association requesting
participation of MPhA in mobile testing program.

The Executive Director reported that Mr. Balassone
has received the Wiley Award by the Association of
Food and Drug officials of the U.S. and reported on
attendance at the annual meeting in Washington of
the National Coordinating Council on Drug Abuse
Education as representative of state association exe-
cutives. Mr. Gruz also attended the Maryland Health
Careers meeting where health assistants legislation
was discussed. He also reported on his correspon-
dence to Governor Mandel regarding the inclusion
of representatives of the MPhA on various govern-
mental commissions. He noted that the Association
is not endorsing the United Prescription Centers at
the present time.

The membership committee reported a membership
as of June 30 of 619 compared to 698 at the same
time last year. The proprietor-manager category has

decreased by 58.

The Prescription Insurance Plans Committee pro-
posed the possibility of developing a formulary in
conjunction with Med Chi for use on Medicaid and
other prescriptions. Request made for increase in

Medicaid Fee.

Dean Kinnard reported on the article in the Ameri-
can Druggist on the preceptor program. The Reg-
ional Medical Program is considering funding of a
drug information center at the University which
will be regional in scope and provide community
service. The School will provide a two and one-half
hour session at the 1972 annual Med Chi meeting
on the new role of Pharmacy in drug interactions.
The anticipated total of incoming students in the
School is 65-68. Total incoming students must ex-
ceed the previous class by 10% for the School to
qualify for federal funds.

Mr. Kaufman, the legal counsel, reported a Chicago
meeting indicated that although there may be a
shortage of pharmacists in Maryland, there is a na-
tional oversupply according to statistics.

The Metropolitan Guild of Pharmacists has requested
representation in the House of Delegates. After con-
siderable discussion, it was decided that the matter
be brought up again for discussion at the next Board
of Trustees meeting.

It was suggested that an appropriate memorial to
Kermit White be established. Mr. White was fatally
shot in a holdup attempt. A committee was ap-
pointed to suggest an appropriate tribute to him.

MAKE IT A DAILY EXHIBIT

THE MARYLAND PHARMACIST 11

Washington Spotlight For

Pharmacists by APhA
Legal Division

Security And The Controlled Substances
Act

The security requirements for amphetamines, meth-
amphetamines and their combinations are effective as of
October 1, 1971.

The security controls for practitioners require that
controlled substances in Schedules 1 and II shall be
stored in a securely locked, substantially constructed
cabinet. While pharmacies do not have Schedule I sub-
stances under normal circumstances, they may have sub-
stantial inventories of Schedule II substances, especially
since the transfer of the amphetamine products.

Controlled substances in Schedule III, IV and V
may either be stored in the same manner as Schedule II
substances, or dispersed throughout the stock of non-con-
trolled substances in such a manner as to obstruct the
theft or diversion of the controlled substances.

Some pharmacies, may not at present have suffici-
ent secure areas to store the Schedule II substances. The
need to maintain excessive quantities of slow moving
controlled substances is minimized under the Controlled
Substances Act. The regulations allow for inter-pharmacy
transfers of any controlled substance in an emergency
situation, and a prescription for any controlled substance
may be partially filled and the remainder dispensed with-
in 72 hours for Schedule II substances and six months
for Schedule III, IV or V substances. There are several
ways in which pharmacies can maximize their present
storage areas, and perhaps avoid the expenditure required
to obtain more secure storage areas.

Dispense Schedule HI Narcotic Substances

The most obvious way to achieve this, is to remove
the former “Class B” narcotics from the secure areas.
Under prior law, these products were required to be kept
under lock and key, along with the “Class A” narcotics.
The former “Class B”’ narcotics, are now in Schedule III.
thus, they may be removed from the special storage area
and dispersed throughout the stock of the non-controlled
substances. This should increase the storage area avail-

able for the Schedule II products.

Return Or Disposal Of Excessive Stocks

Another way to achieve greater storage space for
these substances, is to reduce the inventory of Schedule
II substances. This could be accomplished in part by re-
turning or disposing of those Schedule II substances
which are either no longer in demand, outdated, or too
old to dispense. Many pharmacists, have been reluctant
in the past to remove these old narcotic products from
their inventory and continue to carry them, rather than
go through the “red tape” necessary to dispose of them.
It may well be that the time involved in preparing such

12 THE MARYLAND PHARMACIST

items for return or disposal, at this time, could result
in appreciable savings. The disposal of these old stocks
of narcotic drugs could, in some cases, result in enough
of an increase in available security storage space to pre-
clude further construction of such areas.

There are two major mechanisms by which a phar-
macy may reduce its inventory of these substances.

Returns

The first method to consider, is the return of the
substances to the manufacturer or supplier from whom
they were obtained. The advantage in this method is the
possibility that some credit may be issued to the phar-
macy. A written record must be maintained for such re-
turns of controlled substances which indicates:

a. the date of the transaction
b. the name, form and quantity of the substance

name, address and registration number of the
person making the distribution; and

d. the name, address and registration number of the
supplier or manufacturer.

A return of a Schedule II substance, requires the
use of the official order form. The manufacturer or sup-
plier must provide the pharmacy with Copy 1, of the
official order form for the pharmacy records.

Disposal

The second method of removing excess controlled
substances from a pharmacy’s stock is disposal. The phar-
macy will receive no credit using this method, but it is
the only mechanism to dispose of those controlled sub-
stances which can no longer be returned. To dispose of
controlled substances by this method, a request is filed
with the appropriate Regional Director of BNDD (use
BND Form 41) in triplicate. The form is available from
the BNDD Regional Offices. The Regional Director, upon
authorizing the disposal, will instruct the pharmacist to
dispose of the controlled substances in one of the follow-
ing manners.

1. By delivery to an agent of the Bureau or to the
nearest office of the Bureau.

2. By destruction in the presence of an agent of the
Bureau or other authorized person; or

3. By such other means as the Regional Directo
may determine to assure that the substance does
not become available to unauthorized persons.

The time invested in returning or disposing of thes
controlled substances which are no longer needed or us-
able may help solve the security problem and save tim
in the taking of future inventories required by the Con
trolled Substances Act.

SEPTEMBER 197!

buy now for bigger fall and winter profits

A.H. Robins announces a special money-saving deal on Allbee with C.

_Here’s your chance to get the very best buy on the number one vit-

“ amin in its class in drug store sales. Last-year, Allbee with C led

‘in purchases with 25% of this big $20 million plus market. This in-

Li _.creased to a whopping 32% share during the fist part of 1971. Such

Put your facings
~ where your

profits arel
(Deal runs Oct. 1—28)

an outstanding performance isn’t surprising when you consider that
“it’s the B-complex. with C most often prescribed by the medical and
dental professions. More than a million scripts were filled last year,
and this didn’t even include professional recommendations or over-
the-counter sales. Over oné»half of all Allbee with C sales are OTC!
You purchase and sell far more Allbee with C. Isn’t it good busi-
ness to also give it more facings’and shelf space? Your Robins rep-
resentative will be around soon to discuss the deal and facings with
you. You’ve got Deéal,Power with Allbee with C, and that means a
better deal for you. ~~

A.H. he ’ ompany, Richmond, Va. A-HROBINS

Interactions of Drugs*

by Richard A. Wankel, Staff Pharmacist and
Sydney L. Burgee, Jr., Director of Pharmacy and
Central Supply, The Union Memorial Hospital,
Baltimore, Maryland

Reprinted from Hospital Pharmacy, 5,10 (1970)

Patients can be seriously harmed through interac-
tion of drugs, especially by those that are unsuspected by
the physician. These can be unrecognized or misinter-
preted. The compounded activity of two drugs that affect
the same receptor, same organ, or same system are usual-
ly expected, recognized, and understood. It is the more
subtle, apparently unrelated, and poorly understood in-
teractions that cause concern. Five pharmacological fac-
tors affect the activity of systemically administered drugs.
They are absorption, protein binding, metabolism ( de-
toxication ), tissue distribution, and excretion. If a second
agent changes one or more of these factors, the entire
effect pattern of the original drug is altered. It has be-
come obvious that such alterations of activity are not ab-
stract laboratory principles, but real, serious clinical
problems.

The principle of absorption

Proper absorption of weak acids and weak bases de-
pends upon the pH of gastrointestinal fluids. Most or-
ganic molecules are absorbed in the nonionized form, so
that acidic interactants tend to increase absorption of
weak acids and retard absorption of weak bases. Alkaline
salts, such as antacids, have the opposite effect. Drugs
that are weak acids and bases are listed in Table 1 Ab.

Table 1. Weak Bases and Acids
A. Weak Bases B. Weak Acids

Anticholinergics Barbiturates
Antihistamines Clofibrate
Antimalarials Ethacrynic acid

Mefenamic acid

Nalidixie acid

Cardiac depressants
Narcotic analgesics and

derivatives Nitrofurantoin
Phenothiazines Phenylbutazone
Sympathomimetics Salicylates
Tricyclic antidepressants Sulfonamides
Sulfonylureas
Thiazides
Thyroxine

Mono-amine oxidase inhibitors increase the action of
sympathomimetics, narcotic analgesics and tricyclic anti-
depressants that are destroyed by mono-amine oxidase.

Vegetable oils increase absorption of nonionized me-
dicinal agents, while mineral oil has the opposite effect.

Intestinal absorbants, e.g., Kaopectate, nearly always
inhibit availability of concurrently administered drugs.

Surfactants, e.g., Colace, generally enhance the ab-
sorption of drugs, particularly those with poor lipid solu-
bility.

*Author’s Note: This article is intended to be a guide, not a

compendium. It is not a complete list of all possible drug
interactions; therefore, absence of a particular drug can-
not be interpreted to mean that the agent would not cause
an interaction.

14 THE MARYLAND PHARMACIST

Displacement from protein binding sites

Many drugs are bound to serum protein to a great
extent. The bound portion is inactive but also protected
from metabolic breakdown. An equilibrium exists be-
tween the amount of free drug and the ameunt that is
protein bound. If a second drug having a greater affinity
for the protein binding sites is introduced, the first drug
may be released in overwhelming amounts, resulting in
effects of overdosage followed later by symptoms of drug
absence as the unbound drug is metabolized or excreted.

Drugs in Table 2A displace drugs in Table 2B, there-
fore increasing the action of the drugs in Table 2B; but
there may also be interactions within each group of drugs.
Coumarins may be considered as a middle point between
the two groups of drugs; that is, able to be displaced by
many drugs in Table 2A and able to displace many
drugs in Table 2B.

Table 2. Drugs with Strong and Weak Affinity
for Protein Binding Sites

A. Drugs With a Strong —_B. Drugs With A Weak

Affinity Affinity
Phenylbutazone Coumarins
Phenyramidol Alcohol
Sulfonamides Sulfonylureas
Diphenyhydantoin Methotrexate
Clofibrate Steroid hormones
Dextrothyroxine Penicillin
Indomethacin Bilirubin
Salicylates

Mefenamic Acid
Chloral Hydrate

Coumarins

Tissue concentration and excretion

After absorption, some drugs remain primarily in
the circulatory system. Others are distributed more or
less equally with body water to all tissues. Still others are
rapidly concentrated in particular tissues, such as adipose
tissue, or at special organ receptor sites. As with protein
binding, an agent that alters the usual distribution of a
drug can change its effects.

Alcohol releases barbiturates from fat storage depots,

causing an increase in the concentration of barbiturates
in the blood stream.

Cholinestrase inhibitors, when combined with tri-
cyclic antidepressants, increase penetration of the blood-
brain barrier and cause more pronounced effects from
the psychotherapeutic agent.

Antihistamines potentiate the pressor effects of
levarterenol, apparently by interfering with tissue uptake. —
Drug-induced modification of renal or biliary activity
can potentiate or diminish the effects of many agents. In
addition to its effect on absorption, pH changes alter kid-

SEPTEMBER 1971

There’s alot more going for you at LOEwY

a Shiectro MEDICAL EQUIPMENT FRANCHISE

can make your store one of the most sought out sources for
equipment and service in America

As the local Spectro Division in your area, we not only offer the unusual advantages

FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY

Call any time, day or night. An automatic order
taker will record your after-hours order.

Call IV 5-8105 for order taking. (301) 485-8100 for the office.

LOEWY DRUG COMPANY

DIVISION OF
we | |
oe Spectre Industetes, Ine.

6801 Quad Avenue, Baltimore, Md. 21206 Tel.: (301) 485-8100

ney excretion patterns. Urinary acidifiers, for example
aminonium chloride, inhibit excretion of weak acids (see
Table 1A) and thereby potentiate their action. Conversely,
the acidifiers enhance excretion of weak bases (see Table
1B) and decrease their action. Urinary alkalizers, for ex-
ample sodium bicarbonate, produce the opposite effects in
both groups mentioned.

At the end of the article are listed some categories
of drugs (Appendix 1) and interactions (Appendix 2).

Medications can alter the metabolic rates of other
agents by stimulating (Table 3) or inhibiting (Table 4)
the metabolic enzymes of the liver microsomes, thereby
speeding or slowing the detoxication of the other agent.
Pharmacologic activity of the affected agent will increase
if its metabolism is retarded and will decrease if its me-
tabolism is accelerated.

Drugs that increase or decrease the action of other
drugs may produce both desirable and/or undesirable re-
sults. A popular example of a desirable drug interaction
is the potentiation of narcotic analgesics, e.g., Demerol by
antihistamines, e.g., Phenergan. When drug action is de-
creased (for example the inactivation of tetracycline by
antacids ) or increased (for example the CNS depressant
potentiation of barbiturates by alcohol), serious conse-
quences may result.

The potentiality of drug interaction does not pre-
clude the use of more than one therapeutic agent con-
currently. It does, however, require that the prescriber
be well informed and observant, and that he adjust dos-
age accordingly, if the patient is to benefit from the
therapy.

Table 3. Enzyme Induction

Stimulator Enhanced Metabolism
Phenobarbital and other Diphenylhydantoin, griseo-
barbiturates fulvin, coumarins, digi-
toxin, testosterone,
bilirubin, cortisol
Glutethimide Warfarin, dipyrone,
glutethimide
Phenylbutazone Aminopyrine, cortisol,
coumarins
Haloperidol Coumarin anticeagulants
Meprobamate Meprobamate
Ethanol Pentobarbital, tolbutamide
Diphenylhydantoin Cortisol
Nikethimide Bilirubin
Table 4. Enzyme Inhibition
Inhibitors Decreased Metabolism
Coumarins —— Tolbutamide
Phenylbutazone = Tolbutamide
Phenothiamizines en Alcohol
Desipramine ——— Amphetamines
Phenyramidol == Coumarins, Diphenylhydan-
toin, Tolbutamide
Quinidine — Coumarins
16 THE MARYLAND

Appendix 1. Categories of drugs

Anticholinergics include:
Atropine
Belladonna
Adiphenine (Trasentine )
Thiphenamil (Trocinate )
Trihexyphenidy! ( Artane )
Propantheline ( Pro-Banthine )
Dicyclomine ( Bentyl])
Mepenzolate (Cantil )
Procyclidine (Kemadrin )

Antihistamines include:
Diphenhydramine (Benadry] )
Tripelennamine ( Pyribenzamine )
Promethazine ( Phenergan )
Carbinoxamine ( Clistin )
Chlorpheniramine (Chlor-Trimeton, Teldrin, etc.)
Brompheniramine ( Dimetane )
Phenindamine (Thephorin )
Cyproheptadine ( Periactin )

Antimalarials include:
Quinine

Chloroquine ( Aralen)

Cardiac depressants include:
Procainamide ( Pronesty])
Propranolol (Inderal)
Quinidine
Lidocaine ( Xylocaine )

Cholinestrase inhibitors include:
Edrophonium (Tensilon )

Neostigmine ( Prostigmin )

Coumarins include:
Bishydroxycoumarin (Dicumarol )
Phenprocoumon (Liquamar )
Warfarin (Coumadin, Panwarfin)

Mono-amine oxidase inhibitors include:
Isocarboxazid (Marplan )
Nialamide ( Niamid )
Phenelzine ( Nardil )
Tranyleypromine ( Parnate )

Narcotic analgesics and derivatives include:
Morphine
Dihydromorphinone ( Dilaudid)
Levorphanol (Levo-Dromoran )
Codeine
Methadone (Dolophine )
Meperidine (Demerol )
Proproxyphene (Darvon)

Pentazocine (Talwin )

Phenothiazines include:
Pfobethazine (Phenergan )
Chlorpromazine (Thorazine )
Promazine (Sparine )
Prochlorperazine (Compazine )
Perphenazine (Trilafon )
Trifluoperazine (Stelazine )
Fluphenazine (Prolixin, Permitil)
Thioridazine (Mellaril )

Sulfonamides include:
Sulfadimethoxine (Madribon )
Sulfamethizole (Thiosulfil )
Sulfamethoxazole (Gantanol)

PHARMACIST SEPTEMBER 1971

Mr. Pharmacist ~

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4, Salesman inventory control

To get the complete story—call collect [301] 243-4439

PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue
Baltimore, Maryland 21218

SEPTEMBER 1971 THE MARYLAND PHARMACIST

Sulfamethoxypyridazine (Kynex, Midicel )
Sulfisoxazole ( Gantrisin )

Sulfonylureas include:
Tolbutamide (Orinase )
Chlorpropamide ( Diabinese )
Acetohexamide (Dymelor )
Tolazamide ( Tolinase )

Sympathomimetics include:
Levarterenol ( Levophed )
Metaraminol ( Aramine )
Mephentermine ( Wyamine )
Methoxamine ( Vasoxy1)
Ephedrine
Pseudoephedrine (Sudafed )
Phenylephrine (Neo-Synephrine )
Dextro-Amphetamine (Dexedrine )
Methamphetamine (Desoxyn, Methedrine )

Tetracyclines include:
Demethylchlortetracycline (Declomycin )
Oxytetracycline (Terramycin )
Tetracycline (Achromycin, Tetracyn, Tetrachel,
Panmycin, Sumycin )

Thiazides include:
Chlorothiazide ( Diuril )
Hydrochlorothiazide (Hydrodiuril, Esidrix, ete.)
Benzthiazide (Exna)
Bendroflumethiazide (Naturetin )

Tricyclic antidepressants include:
Amitriptyline (Elavil )
Desipramine (Pertofrane, Norpramin )
Imipramine (Tofranil )

Appendix 2. Alphahetical list of some drugs
and their interactions

Acetazolamide (Diamox )—increases action of Table 1B
drugs; decreases action of Table 1A drugs

Alcohol—increases action of barbiturates, chloral hy-
drate, glutethimide, narcotic analgesics; decreases ac-
tion of sulfonylureas; action is increased by Table 2A
drugs, phenothiazines, mono-amine oxidase inhibitors.

Aminosalicylic acid (Pamisyl)—action is increased by
probenecid.

Ammonium chloride—increases action of Table 1A
drugs; decreases action of Table 1B drugs

Antacids—increase action of Table 1B drugs; decrease
action of Table 1A drugs, tetracyclines

Anticholinergics—increase action of Table 1B drugs; de-
crease action of Table 1A drugs

Antihistamines—increase pressor effect of levarterenol;
action is increased by Table 1B drugs; action is de-
creased by Table 1A drugs

Antimalarials—action is increased by Table 1B drugs;
action is decreased by Table 1A drugs

Barbiturates—action is increased by Table 1A drugs,
alcohol, probenecid; action is decreased by Table 1B
drugs; decrease action of coumarins, diphenlhydan-

Calcium chloride—increases action of Table 1A drugs;
decreases action of Table 1B drugs

Cardiac depressants—action is increased by Table 1B
drugs; action is decreased by Table 1A drugs

Chloral hydrate (Noctec, Somnos)—increases action of
coumarins and diphenylhydantoin; action is increased
by alcohol

Cholinestrase inhibitors—increase action of tricyclic anti-
depressants

Clofibrate (Atromid-S )—increases action of Table 2B
drugs; action is increased by Table 1A drugs and
probenecid; action is decreased by Table iB drugs

Cortisone drugs—action is decreased by phenylbutazone,
barbiturates, diphenylhydantoin

Coumarins—increase action of Table 2B drugs; action is
increased by quinidine and methylphenidate; action
is decreased by Table 2A drugs, griseofulvin, diazepam,
barbiturates, chloral hydrate, glutethimide

Cyclamates—decrease action of lincomycin

Dextrothyroxine (Choloxin)—increases action of Table

2B drugs
Diazepam (Valium )—decreases action of coumarins
Digitalis drugs—toxicity increased by thiazides
Digitoxin—( Crystodigin, Purodigin )—action is decreased
by barbiturates

Diphenylhydantoin (Dilantin)—action is increased by
phenyramidol, methylphenidate and probenecid; action

is decreased by barbiturates, chloral hydrate and —

glutethimide; increases action of Table 2B drugs; de-
creases action of cortisone drugs

Ethacrynic acid (Edecrin )—action is increased by Table
1A drugs and probenecid; action is decreased by Table
1B drugs

G
Gentamicin (Garamycin )—decreases action of neomycin
Glutamic acid HCL (Acidulin)—increases action of
Table 1A drugs; decreases action of Table 1B drugs
Glutethimide (Doriden)—increases action of sulfony-
lureas; decreases action of coumarins and diphenylhy-
dantoin; action is increased by alcohol
Griseofulvin, (Grifulvin Fulvicin)—decreases action of
coumarins; action is decreased by barbiturates
Guanethidine (Ismelin)—action is increased by pheno-

thiazines; action is decreased by tricyclic antidepres-
sants

Hematinics—decrease action of tetracyclines

Indomethacin (Indocin )—increases action of Table 2B
drugs
L

Levarterenol (Levophed)—pressor action increased by
antihistamines

Linomyecin (Lincocin )—action is decreased by cyclamates

Mefenamic acid (Ponstel )—action is increased by Table

toin, griseofulvin, digitoxin, corticosteroids, — testos- 1A drugs and probenecid; increases action of Table
terone 2B drugs; action is decreased by Table 1B drugs
18 THE MARYLAND PHARMACIST SEPTEMBER 1971

ag Reading
iS Still the fastest vi way

oram a
mani...

fo pro
h
brain a

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
vage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for the
spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

Methotrexate—action is increased by Table 2A drugs

Methylphenidate ( Ritalin )—increases action of tricyclic
antidepressants, coumarins, diphenylhydantoin, primi-
done

Mineral oil—decreases absorption of fat soluble vitamins

Monoamide oxidase inhibitors—increase action of alco-
hol, narcotic analgesics, sympathomimetics, tricyclic
antidepressants

N
Nalidixie acid (Neggram )—action is increased by Table
1A drugs and probenecid; decreases absorption of oral
penicillin; action is decreased by Table 1B drugs
Narcotic analgesics and derivatives—action is increased
by Table IB drugs, mono-amine oxidase inhibitors,
alcohol; action is decreased by Table IA drugs

Neomycin—decreases absorption of oral penicillin; action
is decreased by gentamicin

Nitrofurantoin (Furadantin, Macrodantin )—action is in-
creased by Table 1A drugs and probenecid; action is

decreased by Table 1B drugs
Pp

Penicillin-oral absorption is decreased by nalidixic acid
and neomycin; action is increased by Table 2A drugs
and probenecid. Cerebrospinal fluid level is increased
by probenecid

Phenothiazines—increase action of aleohol and guanethi-
dine; action is increased by Table 1B drugs; action is
decreased by Table 1A drugs

Phenylbutazone ( Butazolidin )—increases action of Table
2B drugs; decreases action of coumarins and cortisone
drugs; action is increased by Table 1A drugs and
probenecid; action is decreased by Table 1b drugs

Phenyramidol ( Analexin )—increases action of Table 2B
drugs, diphenylhydantoin, sulfonylureas

Primidone (Mysoline )—action is increased by methy]-
phenidate

Probenecid (Benemid)—increases action of Table 1B
drugs, penicillin, diphenylhydantoin, para-aminosali-
cylic acid; increases cerebrospinal level of penicillin

Quinidine—increases action of coumarins

Reserpine (Serpasil)—action is decreased by tricyclic

antidepressants
NS)

Salicylates—increase action of Table 2B druys; decrease
action of coumarins; action is increased by Table 1A
drugs and probenecid; action is decreased by Table 1B
drugs

Sodium bicarbonate—increases action of Table 1B drugs;
decreases action of Table 1A drugs

Steroid hormones—action is increased by Table 2A drugs

Sulfonamides—increase action of Table 2B drugs; action
is increased by Table 1A drugs and probenecid; action
is decreased by Table 1B drugs

Sulfonylureas—action is increased by Table 1A and 2A
drugs, probenecid and glutethimide; action is decreased
by alcohol

Sympathomimetics—action is increased by Table 1B drugs
and mono-amine oxidase inhibitors; action is decreased

by Table 1A drugs

20 THE MARYLAND PHARMACIST

Testosterone—action is decreased by barbiturates

Tetracyclines—action is decreased by antacids and hema-
tinics

Thiazides—increase toxicity of digitalis drugs; action is
increased by Table 1A drugs and probenecid; action is
decreased by Table 1B drugs

Thyroxine (Synthroid )—action is increased by Table 1A
drugs and probenecid; action is decreased by Table 1B-
drugs

Tricyclic antidepressants—action is increased by Table
16 drugs, mono-amine oxidase inhibitors, methylpheni-
date, cholinestrase inhibitors; action is decreased by
Table 1A drugs; decreases action of guanethidine and
reserpine

Vitamins, fat soluble—absorption is decreased by mineral
oil

References

1. Azarnoff, D. and Hurwitz, A.: Drug Interactions. Pharmacol.
for Physicians 4:2, 1970.

2. Conney, A.: Drug metabolism and therapeutics. New Eng. J.
Med. 280:653, 1969.

3. Conney, A.: Microsomal enzyme induction by drugs. Pharma-
col. for Physicians 3:12, 1969.

4. Conney, A.: Pharmacological implications of microsomal
enzyme induction. Pharmacol. Rev. 19:317, 1967.

5. Cucinell, S.; Conney, A.; Sansur, M. and Burns, J.: Drug
interactions in man J]. Lowering effect of phenobarbital on plasma
levels of bishydroxycoumarin (dicumarol) and diphenylhydantoin -
(dilantin). Clin. Pharmacol. Ther. 6:420, 1965.

6. Dinel, B. and Latiolais, C.: Drug Interaction-enzyme induc-
tion. Hosp. Form. Manag. 2:35—39, 1967. {

7. Dunphy, T.: The pharmacist’s role in the prevention of ad-
verse drug reactions. Am. J. Hosp. Pharm. 26:367, 1969.

8. Goldstein, A. and Aronow, L. and Kalman, S.: Principles of
drug Action. Hoeber Medical Division, New York, Harper & Row,
1968.

9. Goodman, L. and Gilman, A.: The Pharmacological Basis of
Therapeutics. 3rd Ed., New York, The Macmillan Co., 1965.

10. Hartshorn, E. A.: Drug interactions—How drugs interact.
Drug Intell., 2:58—65, 1968.

11. Hunninghake, D. and Azarnoff, D.: Drug interactions with
warfarin. Arch. Int. Med. 121:349, 1968:

12. Hussar, D.: Tabular compilation of drug interactions Am. J.
Pharm. 141: 109, 1969.

13. MacDonald, M.; Robinson, D.; Sylwester, D. and Jaffe, J.:
The effects of phenobarbital, chloral betaine, and glutethimide ad-
ministration on warfarin plasma levels and hypoprothrombinemic re-
sponses in man. Clin. Pharmacol. Ther. 10:80, 1969.

14. Myers, D.: Drug interaction. Tile and Till 56: 1, 1970.

15. Penna, R.: A screening procedure for drug interactions. J.
Am. Pharm. Assn. NS10:66—67, 1970.

16. Stuart, D.: Drug metabolism. Part II Drug interactions.
Pharmindex Oct. 1968.

17. Welch, R.: Harrison, A.: Conney, A.: Burns, J.: An ex-
perimental model in dogs for studying interactions of drugs with
bishydroxycoumarin. Clin Pharmacol. Ther. 10:817, 1969.

18. Zupko, A.: A practical guide to drug interactions. Resident
and Staff Physician Mar., 1970. |

New Prescription Forms Must be Used
After December 31

Pharmacies will be requested to discontinue use of
MS-6A refill blanks after December 31, 1971. Also, pre-
scribers will be asked to discontinue using the old MS-6
prescription form when ordering medication for Mary-
land Medical Assistance patients.

After December 31, all prescriptions must be writ-
ten on the new Prescription and Pharmacist’s Invoice

Form, DHMH-235 and refills on form DHMH-236.

SEPTEMBER 1971

Prince Georges-Montgomery
County Pharmaceutical
Association

The Prince Georges-Montgomery Pharmaceutical
Association held a special meeting on Health Maintenance
Organizations (H.M.O.) on Thursday, September 9, at
the National Institutes of Health Clinical Center Audi-
torium. Dr. Daniel Y. Patterson, Director, Office of
Health Maintenance Organizations, H.E.W., discussed
HMO’s with a question and answer period following. The
meeting was arranged by Program Chairman, Edward D.
Nussbaum.

Mangini can tell you
what you have.

Headquarters for Within 1%

PHOTO-OFFSET PRINTING MAILING Many pharmacists often esti-

PRINTING ROBOTYPED LETTERS Paes ican
call — MUlberry 59-3232, 33, 34 In today’s competitive climate

and with the cost of merchan-

D. STUART WEBB Gee eon RUGHEN Wieinduibese

estimated gross profit figures

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

Mangini & Associates, Inc.

4850 W. Belmont Ave. Chicago, Ill.
60641/(312) 282-8181

can be misleading. In fact.
this can be extremely costly
to the pharmacist who, un-
aware of his shrinking inven-
tory and gross profits. is
actually paying a higher in-
come tax than he should

So why guess? Call Mangini
for fast, computerized inven-
tory service that will tell you
within 1% how your inventory
realistically stacks up to your
turnover, sales and profits!

WRITE FOR DETAILED
INFORMATION.
{iS FREE!

11722 Studt St, St. Louis, Mo 63141
2760 W. Market St, Akron, Ohio 44313
575 Savin Ave , West Haven, Conn 06516
5501 Cherokee Ave, Alexandria, Va. 22312

Offering Independent Pharmacies...

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up
to making your best source of supply,
THE

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

SEPTEMBER 1971 THE MARYLAND PHARMACIST

University of Maryland
School of Pharmacy

School of Pharmacy Alumni Association

The following officers were installed at the Alumni
Banquet of the University of Maryland School of Phar-
macy on June 2, 1971: President, Anthony G. Padussis;
First Vice President, Ronald Sanford; Second Vice Presi-
dent, Charles Tregoe; Executive Secretary, Dorothy S.
Levi; Treasurer, H. Nelson Warfield.

Executive Committee members installed were: Harry
R. Wille, Arnold Amass, Mary W. Connelly, Nicholas
Lykos, Marvin Goldberg, Charles Sandler and David
Serpick.

Appointments and Promotions at
School of Pharmacy Announced

Dr. William J. Kinnard, dean of the University of
Maryland School of Pharmacy, has announced the fol-
lowing appointments and promotions for the academic
year:

Appointed coordinator of the professional experience
program and associate in the department of pharmacy:
William J. Edmondson.

Appointed clinical associate, pharmacology and
toxicology: Karen T. Collins.

Appointed adjunct professor, pharmacology and
toxicology: Dr. C. Jelleff Carr; adjunct professor, micro-
biology: Dr. Donald E. Shay.

Appointed adjunct associate professor, pharmacology
and toxicology: Dr. Helmut F. Cascorbi.

Appointed adjunct assistant professor, pharmacy and
medicinal chemistry: William J. Mader; adjunct assist-
ant professor, pharmacy: Winifred Sewell.

Appointed clinical instructors (institutional pharma-
cists): Adolph Biasini, Holy Cross Hospital; Richard J.
Brodeur, Georgetown University Hospital; Mary W. Con-
nelly, Mercy Hospital; Kent Johnson, U.S. Public Health
Service Hospital, Baltimore; Douglas R. Mowrey, Wash-
ington Hospital Center.

Appointed clinical instructors (community pharma-
cists): Morton Abarbanel, Daniel S. Baker, Richard Bay-
lis, Samuel Bialek, Jerome Block, Morris Bookoff, Gerald
I. Cohen, John W. Conrad, Jr., James B. Culp, -Jra
Joseph U. Dorsch, Donald B. Elliott, Jr., Donald O. Fed-
der, Paul Freiman, Robert W. Henderson, Mare Lach-
man, Ronald Lubman, Richard A. Metz, Martin B.
Mintz, Victor H. Morgenroth, Jr., Anthony J. Padussis,
Chester I. Price, Edward B. Roth, Melvin N. Rubin,
Irving E. Swartz, John R. Thomas, Vito Tinelli.

Student APhA-MPhA Chapter
Elects New Officers

The University of Maryland School of Pharmacy
Student APhA-MPhA Chapter recently announced the

following election results:

President: Paul R. Webster

Vice President: Stephen B. Bierer
Secretary: Donna S. Levin
Treasurer: Dennis R. Reaver

All correspondence may be sent to them at the Uni-
versity of Maryland School of Pharmacy, 636 W. Lom-
bard Street, Baltimore, Maryland 21201.

Pictured at the School of Pharmacy Annual Alumni Banquet held on June 2 at Eudowood
Gardens are: (1 to r) top left—Harry R. Wille, out-going president of the Alumni Association

presenting certificates commemorating 50 years of

Shannon, W. Chester Shoemaker, and Robert Wo

service in Pharmacy to Samuel Block, Donald
oten; top right—Dr. C. T. Ichniowski presents

Honorary Alumni President’s Award to Robert Wooten; bottom left—Dr. Samuel L. Fox, Presi-
dent of the Alumni Foundation, receives award from Dr. John C. Krantz; bottom center—Kenneth
Walters, President of graduating class, addresses group; bottom right—Harry R. Wille turns over
gavel to incoming president, Anthony G. Padussis as Dr. Frank Slama, former professor of
Pharmacology and Mary W. Connelly, past secretary of the Alumni Association, stand by.

22 THE MARYLAND PHARMACIST

SEPTEMBER 1971

amiliar service
or strange film

Are customers bringing in “strange” film brands lately? Have these mysterious
“unknowns” been confusing your people?

They don’t have to. Big, small, foreign or domestic, just drop them into
the Berkey bag and leave the rest to us.
Who makes the film or where it comes from doesn’t matter. Whether it’s branded
or unbranded, Berkey will process it.
Our custom quality and custom service means satisfied customers for you.

Customers who come back. Again.and again,

Berkey can do things for you that nobody else does, because nobody else can.

Trust all your D and P work to Berkey. It’s good business. You uncomplicate life for

your staff. And with one bill from one supplier, your bookkeeper will love you.

toy Berkey
Film Processing
of Washington, D.C.
3701 Mt. Vernon Avenue

now's oF Ta Alexandria, Virginia 22305

Berke
Photo nt Lind (703) 549-7500

Hospital Pharmacy
Section

Maryland Society of Hospital Pharmacists
Meeting of September 9, 1971

The September 9 meeting of the Maryland Society
of Hospital Pharmacists was held at the Johns Hopkins
Hospital in Baltimore. Guest speaker for the evening
was Dr. Norman Fost, Assistant Professor of Pediatrics,
Children’s Medical and Surgical Center, The Johns Hop-
kins Hospital. His talk was entitled ““Drugs and the Pedi-
atric Patient.’”’ Dr. Fost reviewed types of drugs that are
contraindicated during pregnancy and described some of
the problems that newborn can have with certain drugs.

The Squibb Past President’s Award was presented
to Robert E. Snyder by F. Daniel Kammen, Hospital Di-
vision Manager of E. R. Squibb & Co. The Society nom-
inated Milton Skolaut and Dr. Peter P. Lamy as candi-
dates for the 1972 Harvey A. K. Whitney Lecture Award.
Clarence Fortner reported on the 1971 Hospital Phar-
macy Seminar and announced that the 1972 seminar
dates were tentatively set for June 9 through June 11 at
the Carousel Motel in Ocean City, Maryland.

Other reports included those of Dr. Peter P. Lamy,
Chairman of the Peer Review Committee; Samuel Lich-
ter, representative to MPhA’s Medicaid Committee; and
Charlotte B. Sholleck, representative to MPhA’s Legisla-
tive Committee. Bernie Fisher and Samuel Lichter were
recently appointed to the position of Chief Pharmacist at
St. Agnes and Union Memorial Hospital respectively. A
one-day joint seminar is planned for the Washington and
Maryland Societies on October 23, 1971 at Friendship
Airport Motel.

The President, Mary Connelly, thanked Henry Dere-
wicz for hosting the meeting, Vincent dePaul Burkhart
for arranging the meeting and E. R. Squibb and Co. for
sponsoring the meeting. The meeting adjourned at 9:30
p-m.

ASHP’s Midyear Clinical Meeting
Will Focus on Health Care Delivery

Hospital pharmacists will focus their attention on
America’s health care delivery system when ASHP’s Sixth
Annual Midyear Clinical Meeting convenes December 12-
16, 1971. The meeting will be held in Washington, D.C.,
a fitting location for discussing health care delivery, cur-
rently one of the nation’s hottest political issues. In two
general sessions, the ASHP Midyear Meeting will explore
the pressures for change in the health care delivery sys-
tem and will discuss possible responses to these pressures.
Leaders from throughout the health care professions and
the political arena are slated to appear on the program.
The speakers will keep in mind the unique role pharma-
cists play in health care and how this role may be ex-
panded as new approaches to the delivery of health care
evolve.

Following the format of the 1970 Midyear Meeting,
the entire four-day program will consist of three general
sessions, four contributed papers sessions, an exhibit pro-
gram and eight clinic forums. The program will be de-
void of the many conflicting activities of the Annual

24 THE MARYLAND PHARMACIST

Meeting, allowing registrants to devote their full atten
tion to specific areas of study.

In addition to the two general sessions devoted te
topics on health care delivery, a third session will be de:
voted to current drug therapy. Specific topics covered in
this session will be “drugs and the newborn,” “burn
therapy,” and “drug treatment of leukemia.”

The contributed papers sessions are expected to cover
a wide range of topics of interest to hospital pharmacists
and community pharmacists providing service to small
hospitals and nursing homes. Individuals wishing to pre:
sent contributed papers must submit titles and abstracts
(200-250 words) before September 1, 1971. The dead-
line for completed manuscripts is November 1. Titles
and abstracts should be submitted to Warren E. McCon-
nell, Ph.D., Director, Education and Training, ASHP.

The clinic forums, held for the first time last year
at the Anaheim Midyear Meeting, will be open discussion
sessions on various topics in hospital pharmacy. Regis-
trants will be permitted to move freely from one discus:
sion group to another to allow maximum participation
and to stimulate an uninhibited flow of ideas.

The exhibit program will add an important dimen-
sion to this educational meeting. Registrants will have an
opportunity to discuss with company representatives the
latest developments in the hospital pharmacy field.

The Sixth Annual Midyear Clinical Meeting will be
held in Washington’s famous Shoreham Hotel. The regis-
tration fee is $45.00 for ASHP members and $55.00 for
nonmembers. Residents in hospital pharmacy programs
may register for $22.50 and undergraduate students for
$10.00. One-day registration is $15.00 for members and
$17.50 for nonmembers. A registration form and_ hotel
reservation information may be obtained by writing to
the Director of Education and Training, American So-
ciety of Hospital Pharmacists, 4630 Montgomery Ave-
nue, Washington, D.C. 20014.

ASHP, USP and FDA Cooperate
In Defect Reporting Program

The American Society of Hospital Pharmacists, the
United States Pharmacopeial Convention, and the Food
and Drug Administration are cooperating in « pilot drug
product defect reporting program. The program is de-
signed to detect the various problems in pharmaceutical
quality associated with the manufacturing and packaging
of pharmaceuticals and to establish a central reporting
system. |

In addition to coordinating the entire program, USP.
will take the reported problems into account when it
revises or devises drug standards. Copies of the reports
will be forwarded to the Office of Scientific Coordinatio
of the FDA and to the manufacturer or distributor in-.
volved.

Drug product defects include the entire spectrum o
defects which might be noted by a pharmacist when h
receives or dispenses a drug product. A reportable defec
could involve packaging, labeling, the immediate con-,
tainer, closure, contents, or the drug itself.

SEPTEMBER 1971

A.Z.O. Pharmaceutical
Fraternity
Ae Chapter of the Alpha Zeta Omega Pharma-

ceutical Fraternity will host the organization’s Fall Re-
ee Meeting on November 6 and 7 at the Hunt Valley
nn.

The Registration and Hospitality Room will open
at noon on Saturday and the Board meetings will start
at 3:00 p.m. for both the Fraternity and Women’s Aux-
iliary. Highlight of the Awards Night Banquet on Satur-
day evening, will be the presentation of Honorary Mem-
bership to Dr. William J. Kinnard, Jr., Dean of the Uni-
versity of Maryland School of Pharmacy. The conven-
tion winds up Sunday with a Brunch, national fraternity
and auxiliary meetings, and a Farewell Dinner.

Gerald Freedenberg is President of Kappa Chapter
this year, and Mrs. Steven Buckner is President of the
Women’s Auxiliary.

Spectro Industries Reports Substantial
Increase In Sales And Earnings

) Spectro Industries, Inc., the country’s fifth largest
distributor of drugs, medical supplies and equipment, re-
ported a substantial increase in sales and earnings for
the first 12 week period ended June 23, 1971. Loewy
Drug and District Wholesale are among its five distribu-
tion centers.

Net earnings rose 80 percent to $172,693 or 11 cents
a share from $95,962 or seven cents a share for the same
period a year ago. Sales increased 18 percent to $16,704.-
269 from $14,176,450.

) pel es
NARD Announces Program
For New Orleans Convention

The 73rd Annual Convention and Drug Show of the
National Association of Retail Druggists to be held in
New Orleans, Louisiana, October 10-14, 1971 at the
Rivergate Exhibition Center and Convention Hall will
have as its central theme: “The Community’s first line
of defense in providing effective health care for all citi-
zens lies in the efficiency of the independent retail phar-
macist.””

Among the distinguished speakers who will address
the convention will be: Senator Hubert H. Humphrey
(D-Minn.) and Representative Gerald R. Ford (R-Mich.),

‘Minority Leader, United States House of Representatives.

Three special panel presentations will be presented

during the Convention:

(1) “Controlled Substances Act of 1970.”

(2) “The Future of Third Party Prescription Payment
and Community Pharmacists.”

(3) “Cosmetic Merchandising.”

A new film of interest to the entire field will be pre-
sented by the Pharmaceutical Manufacturers Association.
Special entertainment features will include a concert by
Al Hirt, internationally known trumpet player; Pete
Fountain, eminent jazz clarinetist; a night on the town
and a parade of authentic Bourbon Street entertainment.

Post convention trips will include a seven-day Carib-
bean cruise or an 8-day 7-night Mexican trip to Mexico

City and Acapulco.

SEPTEMBER 1971

Product Announcements

Ortho Diagnostics has introduced a diagnostic sys-
tem for detecting the antigen associated with hepatitis.
The new test called Hapindex Diagnostic Test will help
curb this highly contagious liver disorder by identifying
blood containing the antigen associated with hepatitis so
that it will not be given in transfusion. Starting October
1, all blood banks inspected for American Association of
Blood Banks accreditation must test for the hepatitis
antigen.

The test is based on a phenomenon called counter-
electrophoresis. When current is passed through blood
samples containing the antigen associated with hepa-
titis, a thin white band forms, indicating a positive
test. The Hapindex System was developed jointly by
scientists at the Ortho Research Foundation and Milli-
pore Corporation.

Mor-tek U, a low-cost, compact kit used to identify
the heroin user quickly and easily, has been developed by
RPC Corporation. The contents of the kit are used with
a urine specimen from the suspect. Morphine in the
specimen, even in minute quantities, can be detected in
minutes. For more information, contact RPC Corpora-
tion, 1222 East Grand Avenue, El Segundo, Calif. 90245.

Lederle Laboratories announces the introduction of
Flu-Immune X-31, a new bivalent influenza vaccine avail-
able in 10ce vials.

Eaton Laboratories has recently marketed a new
form of Chloraseptic. The new product is called Chlora-
septic Aerosol Spray and is available in 1.5 oz. size.

USV Pharmaceutical announces the introduction of
DBI-TD 100 mg. (timed-disintegration phenformin HC1)
packaged in 100’s and 500’s.

In The News...

PAUL FREIMAN has been designated as MPhA
representative to the newly formed Maryland State Ve-
nereal Disease Commission established by the State of
Maryland Department of Health and Mental Hygiene.

WILLIAM B. HENNESSY, past president of the
APhA in 1969-70, has been named as the 1971 recipient
of the J. Leon Lascoff Memorial Award presented by
the American College of Apothecaries. The award will
be presented during the 31st Annual ACA Convention at
Hunt Valley, Maryland, October 1-4, 1971.

LINWOOD F. TICE, past president of the APhA
in 1966-67 and Dean of the Philadelphia College of
Pharmacy and Science, has been named recipient of the
1971 Remington Honor Medal of the American Pharma-
ceutical Association. Presentation will be made on De-

cember 2, 1971, at the Remington Medal Dinner in the
Statler Hilton Hotel, New York City.

BERNARD FISHER, pharmacist at St. Agnes Hos-
pital was recently promoted to Chief Pharmacist at the

hospital.

THE MARYLAND PHARMACIST 25

Obituaries

KERMIT D. WHITE
See Editorial, page 7

The following obituary is based on a presentation
at the funeral service of Kermit D. White on July 6, 1971,
following his death on July 2 as the result of gunshot
wound:

Kermit Donald White, son of the late Lena and
Peter White, was born on May 28, 1929, in Baltimore,
Maryland. At an early age he was baptized at the Metro-
politan Methodist Church. A devoted husband and father
he believed in praying and would see that his children
prayed each night before going to sleep.

After attending the Baltimore City Schools and
graduating from Frederick Douglass High in 1947, he
attended Morgan State College. His education was inter-
rupted during this period while he served in the U.S.
Air Force. Following honorable discharge he attended
Howard University School of Pharmacy and was gradu-
ated in 1963.

Well known as an affable pharmacist at Read’s
Drug Store, North and Pennsylvania Avenue, he later
became manager of Read’s Drug Store at Liberty Heights
Avenue and Garrison Boulevard. His life’s aspiration
was to own and operate a drug store, and in 1967 he
opened the White’s Pharmacy at Edmondson Avenue
and Wildwood Parkway.

He was a member of the Chi Delta Mu Fraternity
and the American Pharmaceutical Association. He also
sponsored the Edmondson Village Little League Baseball
Team. His demise has affected the lives of many people,
particularly those in the neighborhood of the drug store.
He loved his customers who knew him as “Doc,” and
he went beyond the call of duty to serve each and every
one.

He is survived by a devoted wife, Sylvia; two sons
and a step-son, Kermit and Wayne White and Gilbert
Dolby; two aunts, Mrs. Beulah DePree of Baltimore and
Mrs. Carolyn Jackson of Portsmouth, Virginia; a mother-
in-law, Mrs. Bertha Williamson of Baltimore; and a host
of relatives and friends.

BERNARD A. PETTIT

Bernard A. Pettit, 67, retired Washington pharma-
cist, died on July 24 at Rogers Memorial Hospital, Wash-
ington, D.C. Mr. Pettit was registered in Maryland by
reciprocity in 1928.

HARVEY E. TODD

Harvey E. Todd, a 1914 graduate of the University
of Maryland School of Pharmacy, died recently in An-
derson, S.C.

VICTOR E. PASS

Victor E. Pass, 68, died on July 29 after a long ill-
ness. He was a 1924 graduate of the University of Mary-
land School of Pharmacy. Mr. Pass had operated the

26 THE MARYLAND PHARMACIST

Lead Paint Poisoning

The City Health Department now has reports of nine
children who have become ill with lead paint poisoning so
far this year. According to Mr. George W. Schucker,
Assistant Commissioner for Sanitary Services, this toll
will increase unless parents maintain close supervision of
their teething-age children. In 1970 twenty children were
reported to have lead poisoning and one child died.

A crippling and sometimes fatal illness, lead paint
poisoning is caused when children eat peeling paint from
walls or other objects either inside or outside the house.
Nibbling on windowsills, painted plaster and furniture
painted with a lead paint have also caused poisonings.

In addition to supervision of the child, Mr. Schucker
offers the following advice:

1. Use lead free paint when painting indoor sur-
faces, windowsills and furniture. The use of lead paint
for interior painting of dwellings has been illegal since
1958. In addition, effective July 1, 1971 State Law pro-
hibits the use of lead based paint on any exterior surface
of a dwelling to which children may be exposed.

2. If you are a tenant and the owner is starting to
paint be sure he uses lead free paint as required by law.

3. If there is peeling paint in the house scrape the
surface until it is smooth and cannot be picked at by the
child and eaten.

4. If you see your child eating paint take him to a
physician or clinic without delay and be sure he has a
blood test for lead. Early diagnosis and prompt treatment
to remove lead from the body usually result in a good re-
covery.

5. Symptoms of lead paint poisoning include abdom-
inal pains, nausea and vomiting, persistent constipation,
irritability, frequent headaches and convulsions. If you
see any of these signs your child’s life may be in danger.
Take him to a physician or hospital at once. Tell the
doctor or nurse you suspect lead poisoning and ask for a
blood test for lead.

Stadium Pharmacy, Wolf and Lanvale, for 40 years. He
was a member of the Maryland Pharmaceutical Associa-
tion, Baltimore Metropolitan Pharmaceutical Association,

and the Alpha Zeta Omega Fraternity.

IRVING M. MORRIS
Irving M. Morris, 79, died on August 4. Mr. Mor-

ris was a pharmacist at the Union Memorial Hospital
for many years until his retirement in 1961 as the result
of an accident.

EDWARD A. MARKIN

Edward A. Markin, 58, a 1934 graduate of the Uni-
versity of Maryland School of Pharmacy, died on August
13. His brother, Samuel Markin, is also a pharmacist.

PETER J. SLETTERDAHL
Former NARD Journal Editor

Peter J. Sletterdahl, editor of the NARD Journal’
(1947-1965), died on August 25, in his home in Florida,
after a long illness.

SEPTEMBER 1971

Thantis, the reliable throat lozenge.

(#740/171)

) HYNSON, WESTCOTT & DUNNING, INC.
ee Baltimore, Maryland 21201

A comprehensive
Convalescent

aids program

Medicare and other insurance programs have made it possible tor more people to buy and rent needed surgi-
cal supplies and convalescent aids. Gilpin makes it easy and PROFITABLE for you to maintain a compre-
hensive selection. Professional assistance is available to provide a program to meet your space and inventory

rojuirements. Call us today. Or mail the coupon:

THE HENRY B.

GILPIN

COMPANY

BALTIMORE + DOVER + NORFOLK + WASHINGTON

Wee ai.

your ‘‘short-cut’’ to profitable plus business.

A financial service consultant to service you on
request.

Two giant product shows each year: in January
featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing
promotional sundries.

the services required to nail down the profit dollars
which you need and deserve from your business.

The Henry B. Gilpin Company

901 Southern Ave., Washington, D.C. 20032

(301) 630-4500

Check the area of your particular interest or need on the
coupon below and mail it to us or phone us. We'll arrange

for Gilpin specialists to tailor the services which your
particular interest or situation requires.

ee errr tert me re tre mer eral |

Sirs:

| am interested in the following programs. Please have your

representative contact me in this regard.

Name

Name of Pharmacy

Addcs3 = enone
City Slate eID

j
:
:
i
]
al

Volume 47

maryland

ASSOCIATION

=" pharmacist

Editorial—Third-Party Programs:

A Role for Pharmacists

Drug Storage and Stability

by Ralph F. Shangraw, Ph.D.

Controlled Drug Regulation Changes

OCTOBER 1971

Number 10

Compliments of

oxell

CORPORATION

Makers of
NOXZEMA SKIN CREAMS
NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS
and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

f it's for your family,
which product

would you dispense?

The choice would probably be Crystodigin®
(digitoxin, Lilly).

Pharmacists know that quality is built into Lilly
products... with exacting control procedures to
provide uniform potency and, therefore, consistent

therapeutic effectiveness.

Your professional judgment tells you... when it
comes to your prescription patient’s health (and your
reputation), you want to dispense the best.

Sete s.

Ce tn iad

ewer

Ned thts ©

Se pewme Ree ee
URES RRS OS

;
-
£
:
a
ee

g
4
~

call
i
Bad

CRYSTODIGIN® (digitoxin, Lilly)

Indications: Heart failure, atrial flutter, atrial
fibrillation, and supraventricular tachycardia.

Contraindications and Precautions: Crysto-
digin should not be used in ventricular
tachycardia.

Patients taking digitalis preparations must
not be given the rapid digitalizing dose of
Crystodigin or parenteral calcium.

Adverse Reactions: Overdosage causes side-
effects, such as mental depression, anorexia,
nausea, vomiting, premature beats, com-
plete heart block, AV dissociation, ventricu-
lar tachycardia, ventricular fibrillation, rest-
lessness, yellow vision, mental confusion,
disorientation, and delirium.

Administration and Dosage: Slow Digitaliza-
tion—0.2 mg. twice daily for a period of four
days, followed by maintenance dosage.
Rapid Digitalization—Preferably 0.6 mg. in-
itially, followed by 0.4 mg. and then 0.2 mg.
at intervals of four to six hours. Mainte-
nance Dosage—Ranges from 0.05 to 0.3 mg.
daily, the most common dose being 0.15
mg. daily. [051972]

Lilly

100246

Eli Lilly and Company

Indianapolis, Indiana 46206

A computerized
“Accounts Receivable”
system.

Hand-prepared charge account statements are costly, time-consuming and liable to error.

Enhance your image as a professional pharmacy with a Gilpin computerized-accurate system that shows
your customers their deductible medical expenses for the month and year to date, at the same time provid-
ing yourself an up-to-date record of aging accounts. Call today or rush the coupon for full information.

THE HENRY B.

GILPIN

COMPANY

BALTIMORE + DOVER » NORFOLK * WASHINGTON

t
I
t
d
L.

A financial service consultant to service you on
request.

Two giant product shows each year: in January
featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing
promotional sundries.

the services required to nail down the profit dollars
which you need and deserve from your business.

The Henry B. Gilpin Company

901 Southern Ave., Washington, D.C. 20032

(301) 630-4500

Check the area of your particular interest or need on the
coupon below and mail it to us or phone us. We’ arrange

for Gilpin specialists to tailor the services which your
particular interest or situation requires.

Sirs:
| am interested in the following programs. Please have your
representative contact me in this regard.

Nene SS eae eee

Name of Pharmacy = sees Se ee

Addéss) = a Phones
City. state= Zip

The Maryland Pharmacist

NATHAN I. GRUZ, Editor

NORMAND A. PELISSIER, Assistant Editor
MartHA Eckuorr, Editorial Assistant
Ross P. CampsBeti, News Correspondent
HERMAN J. BLoom, Photographer

650 WEST LOMBARD STREET
BALTIMORE, MARYLAND 21201

-
ASSOCIATION

VOLUME 47

OCTOBER 1971 NuMBER 10

OFFICERS 1971-1972

Honorary President

H. NELSON WARFIELD—Pikesville
e

President
NATHAN SCHWARTZ—Annapolis

President Elect
BERNARD B. LACHMAN-—Baltimore

Vice President
JOHN R. McHUGH—Potomac

Treasurer

MORRIS LINDENBAUM
5 Main St., Reisterstown, Md. 21136

Executive Director

NATHAN I. GRUZ
650 W. Lombard St., Baltimore. Md. 21201

TRUSTEES

DONALD O. FEDDER, Chairman—Dundalk
MORRIS BOOKOFF (1972)—Baltimore
PAUL FREIMAN (1974)—Baltimore
STEPHEN HOSPODAVIS (1972)

Cresaptown
PHILIP D. LINDEMAN (1973)—Berlin

ANTHONY G. PADUSSIS (1973)
Baltimore

MELVIN J. SOLLOD (1974)—Adelphi

SYDNEY L. BURGEE, JR.
Speaker of the House of Delegates
Baltimore

EX-OFFICIO MEMBERS
- FRANCIS S. BALASSONE—Baltimore

WILLIAM J. KINNARD, JR.—Baltimore

HONORARY LIFE TRUSTEE
SIMON SOLOMON-—Baltimore

MARYLAND BOARD OF PHARMACY

Honorary President

SIMON SOLOMON-—Baltimore

President
NORMAN J. LEVIN—Pikesville

Secretary

F. S. BALASSONE—Baltimore

Member
FRANK BLOCK—Baltimore

Member
HOWARD L. GORDY—Salisbury

Member
MORRIS R. YAFFE—Potomac

TABLE OF CONTENTS

6 Editorial—Third-Party Programs: A Role For Pharmacists
8 Maryland Board of Pharmacy
10 Baltimore Metropolitan Pharmaceutical Association
10 Pharmacy Calendar
P27 MER AS News
14 Prince Georges-Montgomery Pharmaceutical Association
14 Metropolitan Guild of Pharmacists
16 Drug Storage and Stability by Ralph F. Shangraw, Ph.D.
22 University of Maryland School of Pharmacy
26 Obituaries
26 Pharmaceutical Directory

INDEX TO ADVERTISERS

24 American Druggists’ Insurance Co,

9 Calvert Drug Company, Inc.

11 Ciba Pharmaceutical Company
22 The Drug House, Inc.
23 Geigy Pharmaceuticals

4 Henry B. Gilpin Company

3 Eli Lilly and Company

17. Loewy Drug Company
22 Mangini and Associates, Inc.

19 Maryland News Company

7 Merck Chemical Division, Merck & Co., Inc.
14 Metropolitan Guild of Pharmacists

2 Noxell Corporation

13. Paramount Photo Service
24 Pension & Investment Associates of America
21 A. H. Robins Company

15 Roche Laboratories
25. Smith Kline & French Laboratories
20 D. Stuart Webb Advertising Services
27. Youngs Drug Products Corporation

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number, Allow four weeks for
changeover. APhA members—please include APhA number,

The Maryland Pharmacist is published monthly by the Maryland Pharma-
ceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription
price $5.00 a year. Entered as second class matter December 10, 1925, at the Post

Office at Baltimore, Maryland, under the Act of March 8, 1879.

Editorial...

Third-Party Programs:
A Role For Pharmacists

One of the crucial factors that will determine the
professional and economic future of pharmacy is how the
profession will fare in third-party prescription programs.

At present governmental, union and other plans
cover a minority of the population although Medicaid
patients already comprise a large or a major part of the
prescription practice of many pharmacies. But this situa-
tion is, of course, only a slight portent of things to come.

Every day, it seems, brings news of additional third-
party programs being established by employers, unions
or under governmental auspices.

Whenever possible the Maryland Pharmaceutical Asso-
ciation has sought to participate in the development and
evaluation of third-party prescription programs. Many
members have requested our guidance and have abided
by our suggestions. On the other hand, many pharmacy
proprietors have enrolled in programs without seeking or
obtaining any information about a particular plan. It is
hard to understand how an intelligent decision can be
made without regard to the nature of the sponsors of a
plan and its impact upon the practice of pharmacy. Often
pharmacists will promptly sign up with a plan with poli-
cies which are not in the best interest of either the pa-
tient or pharmacist. Some of the plans are merely promo-
tional or public relations gimmicks to advance the inter-
ests of a sponsoring group, administrators or a particular
group of pharmacy providers.

MPhA’s policy in the third-party payment field has
been to assert the vital principle of “free choice of phar-
macy’ and of quality of pharmaceutical service. We be-
lieve that these factors are essential in the best interest of
achieving accessibility to pharmaceutical services and the
highest standards of professional health care.

MPhA is now embarking on a program of assuring,
whenever legally and administratively feasible, the princi-
ple of free choice and high standards of pharmacy service.
Details will be mailed to members regarding a prescrip-
tion insurance plan previously available to employees of
a firm only from one pharmacy chain. All participating
pharmacies will be thus able to submit their prescriptions
for payment through the MPhA office. Several other plans
are now being worked on by MPhA.

Pharmacists must be in a position to influence the
policies of all third-party prescription programs. They
must play a role in the decision-making process which
affects their professional and economic futures.

Administrators of plans are only impressed and in-
fluenced by presentations made by organized professional
associations on behalf of providers of service. In turn the
representative association must comprise a majority of
the providers and must be equipped through adequate
financial resources with staff to effectively achieve the
objectives of the members.

MPhA will serve the needs of its members to the
maximum of its resources. but a substantial expansion of

6 THE MARYLAND PHARMACIST

activities in the third-party area will necessitate the estab.
lishment under pharmacy auspices of a separate nonprofit
corporation as a pharmaceutical services foundation.

In the interim MPhA will meet with plan admin-
istrators and will perform clearinghouse services so that
the interests of patients, programs, sponsors and pharma-
cists will be met.

Pharmacists can contribute to the success of these
objectives by voluntarily accepting the discipline of an
organized approach, by participating in the work of MPhA
and assuming the obligations and responsibilities of the
guidelines that will be promulgated by their representa-
tives.

— Nathan I. Gruz

Current Literature of Interest

DRUG INTERACTIONS by Philip D. Hansten,
Pharm. D., Assistant Professor of Clinical Pharmacy,
Washington State University. June, 1971, Lea & Febiger,
Washington Square, Philadelphia, Pa. 19106, $9.50.

ESSENTIALS OF TOXICOLOGY by Ted A. Loomis,
Ph.D., M.D., Professor of Pharmacology, University of
Washington School of Medicine, Seattle. January, 1968,
Lea & Febiger, Washington Square, Philadelphia, Pa.
19106, $6.50.

PHARMACOLOGY AND THERAPEUTICS by
Grollman and Grollman, 7th Edition, April, 1970, Lea
& Febiger, Washington Square, Philadelphia, Pa. 19106,
$19.50.

CLINICAL PHARMACY HANDBOOK by Hugh F.
Kabat, Ph.D., Professor and Head of Dept. of Clinical
Pharmacy, University of Minnesota College of Pharmacy.
August, 1969, Lea & Febiger, Washington Square, Phila-
delphia, Pa. 19106, $6.50.

PLANNING AND DESIGN OF HOSPITAL PHAR-
MACY FACILITIES Reprint from the American Jour-
nal of Hospital Pharmacy, June, 1971, Single copies (22
pages) $1.50. Payment must accompany order. Ameri-
can Society of Hospital Pharmacists, 4630 Montgomery
Avenue, Wachinores D.C. 20014.

FORMULARY DRUG LISTING SERVICE (FDLS)
Subscription for an individualized, computer-produced
formulary. Prerelease price $950.00. American Society of
Hospital Pharmacists, 4630 Montgomery Avenue, Wash-
ington, D.C. 20014.

Statistics suggest it is safer to ride in a truck than
in a car. In 1970, over 54,000 passenger care were in-
volved in fatal accidents compared to 12,400 commercial
vehicles.

OCTOBER 197!

Maintain your professional image

Merck
Prescription (hemicals

& Narcotics

Many prescriptions such as
ointments, nose drops and

cough syrups, to mention a few, still
require the know-how of a registered
: pharmacist. Even a casual observer
inany pharmacy is mightily impressed
when he sees a prescription being
compounded. There is an intan-
gible value gained by watching
: an expert at work. It
instills even greater respect
and confidence for the
rofession and the man who has
chosen it for his life’s work.
The use of Merck Prescription
Chemicals will not only enhance
your professional ability, it will
establish you as one who demands
the highest quality in chemicals
used for compounding.

CHEMICAL DIVISION, MERCK & CO., INC., Rahway, N. J.

Merck Chemicals are distributed by MERCK

Maryland Board
of Pharmacy News

Board of Pharmacy Moves

The new location of the Maryland Board of Phar-
macy is 610 North Howard Street as of September 24
WO ele

Pharmacy Changes

The following are the pharmacy changes for the
month of August:

New Pharmacies

Drug Fair No. 141, D. Beer and J. Rhoades, Phar-
macists, Patuxent Shopping Center, Crofton, Maryland
76 SE

The Treasury Drug Center, N. Moritz and J. Chave-
rini, Pharmacists, 180 Shangrila Drive, North Lexington
Park, Maryland 20653.

No Longer Operating as Pharmacies
Rockville Drugs, Joel Shulman, President, 1069
Rockville Pike, Rockville. Maryland 20852.

Kay Cee Drugs, Irving Goldberg, President, Main
Street, Upper Marlboro, Maryland 20870.

Carville’s Corner Pharmacy, Carville B. Hopkins, 3
Mile Oak, Annapolis, Maryland 21401.

Changes of Ownership, Address

Fallston Pharmacy, Chester L. Price, President

(Change of ownership ), 1916 Belair Road, Bel Air, Mary-
land 21047.

Amphetamines in Schedule I

In accordance with Section 278 (c) and (d), Arti-
cle 27 of the Annotated Code of Maryland, notice is
hereby given to reschedule, update, and republish the
substances in Section 279 (c) a. 1. of Article 27 (Sched-
ule III Substances) of the Annotated Code of Maryland
to Section 279 (b) of Article 27 (Schedule II Substances )
of the Annotated Code of Maryland.

The effect of this order is to place amphetamine, its
salts, optical isomers, and salts of its optical isomers in
Schedule II from Schedule III. Drugs in Schedule II
may not be dispensed without the written prescription of
a practitioner, except that in emergency situations the drug
may be dispensed on oral prescription, reduced to writing
promptly and filed and within 72 hours after authorizing
the emergency oral prescription, the prescribing indi-
vidual practitioner shall cause a written prescription for
the emergency quantity prescribed to be delivered to the
dispensing pharmacy.

This action is being taken in order for the Maryland
Controlled Dangerous Substances Act to conform with the
Federal Comprehensive Drug Abuse Prevention and Con-

trol Act of 1970 (Public Law 915513);

8 THE MARYLAND PHARMACIST

Registration of Interns, Resident and
Foreign Physicians Under The Controlled
Substances Act:

As a result of the new BNDD regulation, a pharma-
cist may notice that the prescribing physicians registra-
tion number contains more than the characteristic com-
bination of two letters and seven numbers. Such a registra-
tion number is representative of the optional, internal
registration code now authorized for use by hospitals and
other institutions who have elected to have their interns,
residents and foreign-trained physicians use the institu-
tion’s registration rather than have them register indi-
vidually.

A practitioner will usually receive such prescrip-
tions when a patient has come from a hospital emergency
room or an out-patient clinic where an intern, resident
or foreign-trained physician is authorized to practice.

Former Section 301.24 of the BNDD Rules and Reg-
ulations provided a waiver of the regisration requirement
for such an individual practitioner who was an agent or
employee of a hospital or other institution which was
registered to dispense controlled substances. When acting
in the usual course of his employment, the individual
practitioner could administer and dispense a controlled
substance if permitted to do so in the jurisdiction in
which they practiced. These individual practitioners were
permitted to use the institutional practitioner’s registra-
tion number for internal medication orders but were not
authorized to issue prescriptions for out-patients unless
they had registered with the Bureau.

It was recognized by the Bureau that on certain oc-
casions, interns, residents and foreign-trained physicians
would be required, during the regular course of their
employment, to attend to patients and issue prescriptions
for controlled substances to be compounded and dispensed
on an out-patient basis.

Rather than require that all such individual practi-
tioners personally register with the BNDD, the Bureau
afforded the hospitals and other institutions an option to
utilize an internal code based on the institution’s registra-
tion number.

The hospital or institution must ascertain from the
appropriate state agency whether or not the intern, resi-
dent or foreign-trained physician is authorized or per-
mitted to prescribe controlled substances. If the institu-
tional practitioner then verifies that the individual prac-
titioner is so permitted, he may dispense and_ prescribe
controlled substances under the registration of the hos-
pital or other institution, in lieu of being registered him-
self, if these functions are performed within the scope
of the individual practitioners employment and during
the usual course of his professional practice.

The institutional practitioner authorizes the indi-
vidual practitioner to dispense or prescribe under the
hospital registration by designating a specific internal
code number. This code number consists of numbers,

OCTOBER 1971.

letters or a combination thereof and will be a suffix to
the institution BNDD registration number, preceded by a
hyphen. For example, AP1234567-10, or AP1234567-
Al2.

The hospital or institution must keep a current list
of internal codes and corresponding practitioners. This
list must be made available at all times to other regis-
trants and law enforcement agencies upon request for
the purpose of verifying the authority of the prescribing
individual practitioner.

It should be noted that this registration procedure
is optional and hence, a particular hospital or other in-
stitution may not wish to adopt an internal code system.
If such is the case, then the intern, resident or foreign-
trained physician must register individually, if he is to
issue out-patient prescriptions for controlled substances.

If an individual practitioner has registered with the
Bureau and has received a registration number then he
may not use the institution’s registration number.

BNDD Schedule Transfers

As of October 17, 1971, phenmetrazine ( Preludin)
and methylphenidate (Ritalin) have been transferred
from Schedule III to Schedule II of the Controlled Sub-
stances Act. Additionally, the drug Naloxone Hydrochlo-
ride (Endo) has been removed from Schedule IL and all
regulatory controls of the Controlled Substances Act.

Rubber “C”’ stamps and red inked pads are still
available from MPhA office at $1.00 for each item.
Check should accompany order.

Effect of Physicians’ Curb on
Prescribing of Amphetamines Noted

Physicians in many states are responding to the
challenge to assume leadership in combating drug abuse.
Many have already acted to curb the use of amphetamines
and other stimulant drugs.

In Texas, James H. Sammons, M.D., president of
the 11,000-member Texas Medical Association, asked
physicians to limit their prescribing of amphetamines to
specific, well-recognized medical indications. Earlier this
year, nearly 600 physicians in Utah agreed not to pre-
scribe amphetamines or similar drugs in the treatment
of obesity.

The Utah Pharmaceutical Association reported an
unusual effect of a joint effort by the Utah State Medical
Association and the Utah Society of Internal Medicine
to curb the use of amphetamines in treatment of obesity.
According to the UPA, there has been a “precipitous” de-
cline in the number of break-ins at pharmacies since
word got around that the stores were stocking only mini-
mum inventories of the drugs, in contrast to the thou-
sands of doses they had on hand before.

Study Continues For Cure For Common Cold

A synthetic variation of ribonucleic acid (RNA)
called Poly-I:C is being investigated for its possible role
in the prevention of the common cold. The polynucleotide
stimulates the production of interferon, a protein which
prevents penetration by a virus into cells. By stimulating
the cells with Poly-I:C to produce more interferon, the
rest of the body would be defended from virus infection.

Offering Independent Pharmacies...

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up
to making your best source of supply,
THE

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

OCTOBER 1971

THE MARYLAND PHARMACIST 9

Baltimore Metropolitan
Pharmaceutical Association

The Baltimore Metropolitan Pharmaceutical Associ-
ation held a general meeting at the Kelly Memorial
Building on September 16, 1971. The meeting was called
to order at 9:00 p.m. by President Irvin Kamenetz.

Program Chairman Melvin Rubin introduced the
first speaker, Victor Kardon of Ciba Laboratories, who
spoke on “The Use of Rimactane in Antitubercular Ther-
apy.’ Mr. Kardon pointed out that tuberculosis patients
usually require six months to two years of continuous
drug therapy and one of the most common problems is
that patients discontinue taking their medication before
they should. The standard drugs that have been in use-
isoniazid, aminosalicylic acid, streptomycin-are bacterio-
static agents. It is postulated that rifampin (Rimactane,
Rifadin) is bactericidal at higher concentrations but this
has yet to be proven. The advantages of rifampin over
other anti-TB drugs is that it attacks the TB germ sooner.
Results are shorter hospitalization and a more rapid re-
turn to normal life. Rifampin is indicated to be taken
with other anti-TB drugs such as isoniazid or ethambutol.
Rifampin increases the anticoagulant requirements of
the coumarins. Mr. Kardon then answered questions pre-
sented to him from the audience.

The second part of the evening’s program dealt
with the topic of “Drug Product Selection” and more
specifically with repeal of the antisubstitution laws. Pre-

Among the speakers at the September 16 meeting of the BMPA were Dr. John S.
Ruggiero, second from left, Director of Pharmacy Relations, Pharmaceutical Manu-
facturers Association and James D. Hawkins, third from left, Assistant Executive Di-
rector, American Pharmaceutical Association. Standing at left is Irvin Kamenetz,
President of BMPA and at extreme right is Melvin Rubin, BMPA Program Chairman.

10 THE MARYLAND PHARMACIST

PHARMACY CALENDAR

November 11—MSHP meeting at the USPHS Hospital,
7:30 p.m.

November 18—( Thursday }—BMPA Annual Meeting.

December 12-16—American Society of Hospital Phar-
macists Sixth Annual Midyear Clinical Meeting,
Washington, D.C. |

January 30, 1972—56th Annual Installation Banquet &
Dance, Baltimore Metropolitan Pharmaceutical Asso-
ciation, Blue Crest North.

April 22-28, 1972—American Pharmaceutical Associa-
tion Annual Meeting, Houston.

May 7-9, 1972—Annual Convention, Maryland Phar-
maceutical Association, Washington Motel and
Country Club, Gaithersburg Maryland.

senting the American Pharmaceutical Association’s point
of view on this subject was James D. Hawkins, Assistant
Executive Director, American Pharmaceutical Associa-
tion.

Presenting another point of view was Dr. John S.
Ruggiero, Director of Pharmacy Relations, Pharmaceuti-
cal Manufacturers Association.

An extensive question and answer period followed
the presentations. :

The meeting was adjourned at 11:30 p-m.

Photos by Paramount Photo Service

OCTOBER 1971

Open season
ons uffy noses

Winter viruses, spring So keep both Privine
allergies, dragging “summer — Nose Drops and Nasal Spray

colds,” or autumn in mind. And
hay fever—it seems keep them in
there’s always stock. They’re

something caus-
ing stuffy noses.
But whatever
the reason—what-
ever the season-—
Privine makes it
“open season” on

a noses. et
ustomers want fast

relief. And that’s what
Privine is famous for.

fast acting. And
fast selling. And
Privine is OTC.

CIBA Pharmaceutical Company
Division of CIBA-GEIGY Corporation
Summit, New Jersey 07901

ce) 8
Privine
hydrochloride
(naphazoline

hydrochloride) )

Ca 1 Baek

TAMPA News

The Traveler's Auxiliary of the
Maryland Pharmaceutical Association
held their annual installation dinner
on September 16 at Bernie Lee’s Penn
Hotel in Towson, Maryland. The eve-
ning started with a social hour from
6:00 to 7:00 followed by a dinner at
7:00 p.m.

New officers installed for 1971-1972
are as follows: Joseph Grubb, Honor-
ary President, Paul J. Mahoney, Presi-
dent; John C. Matheny, First Vice
President; Abrian E. Bloom, Second
Vice President; C. Wilson Spilker,
Third Vice President: John A. Cro-
zier, Secretary-Treasurer Emeritus:
William A. Pokorny, Secretary-Treas-
urer; and William L. Nelson. Assist-
ant Secretary-Treasurer.

Installed as members of the Board
of Trustees were: William L. Nelson,
Chairman; Herman J. Bloom; Joseph
J. Huge; Kenneth L. Mills; Joseph
Grubb; Albert J. Binko: Joseph A.
Costanza; Francis J, Watkins; A. G.
Leatherman; and J. William Gehring.

The committees for 1971-1972 con-
sist of: Attendance, John H. Fagan,
Chairman; Sherman FE. Levy; Earl V.
Parr. Custodian, Robert ‘G. Rade-
baugh, Chairman; Edgar G. Cumor:
David H. Mervis. Welcome, C. Wilson
Spilker, Chairman: Joseph A. Cos-
tanza; J. Donald Brown. Luncheon,
Paul J. Mahoney, Chairman: Natt
Levy; Dick Brauer. Special Events,
William L. Nelson. Chairman; Wil-
liam A. Pokorny. Program, John C.
Matheny, Chairman: Laurance A.
Rorapaugh. Membership, Melvin M.
Cernak, Chairman: E. Allan Turner;
William R. Kolb, Jr. Maryland Phar-
macist, Herman J. Bloom. Chairman:
Joseph Grubb; Richard R. Crane. Pub-
licity, Kenneth L. Mills. Chairman;
Abrian E. Bloom: Edwin M. Kaber-
nagel, Jr. Welfare, John G. Cornmes-
ser, Chairman; Howard L. Dickson.
Memorial Fund, Louis M. Rockman,
Chairman; Ken Mills. Ways and
Means, Joseph J. Hugg, Chairman:
and Past Presidents.

Among other TAMPA activities
held this year was a Crab Feast held
on August 19 at Don Dever’s in Edge-
wood, Md. The group has scheduled
their annual T.A.M.P.A. Ladies Night
for Thursday, November 4, at Garland
Theatre in Columbia.

WUXILIARY® | ; _\*auxtary®

ORGANIZED (916 ORGANIZED 1916
*

Photos by Paramount Photo Service

Top (left to right)—William A. Pokorny, Secretary-Treasurer; Abrian E. Bloom,
Second Vice President; John C. Matheny, First Vice President and Paul J.
Mahoney, President; incoming officers at T.A.M.P.A. Installation Dinner on
September 16. Bottom left (1 to r) William L. Nelson, Immediate Past Presi-
dent turns over gavel to new president Paul J. Mahoney. Bottom right (1 to r)
Howard Dickson, Immediate Past Honorary President, receives award from
William A. Pokorny.

THE MARYLAND PHARMACIST CTOBER 1971

Mr. Pharmacist ~

YOU Are Number 1

In Photo Finishing
when You are With

WHY? Because you get —

1. Quality — Assuring customer satisfaction
2. Service — True 24 hour delivery

3. Personalized consumer attention

4. Salesman inventory control

To get the complete story—call collect [301] 243-4439

PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue
Baltimore, Maryland 21218

:
: OCTOBER 1971 THE MARYLAND PHARMACIST 13

Prince Georges-Montgomery
County Pharmaceutical
Association

The Prince Georges-Montgomery County Pharma-
ceutical Association will host the 1972 Maryland Phar-
maceutical Association Annual Convention. The conven-
tion site will be the Washingtonian in Gaithersburg,
Maryland and will be held on Sunday, Monday and Tues-
day, May 7, 8 and 9th, 1972.

The post convention trip to Acapulco will leave
Baltimore on May 17 and return on May 22.

The Prince Georges-Montgomery County Pharma-
ceutical Association held a general membership meeting
on October 5 at the Hampshire Motor Inn, Langley Park,

Maryland.

The program began at 9:00 p.m. with a continuing
education feature “Chemotherapy in Drug Abuse and
Drug Addiction” from the St. Louis College of Pharmacy
Library Cassette Series. At 10:00 p-m., Dr. Robert J.
Taylor, Lecturer, School of Medicine and Dentistry, Uni-
versity of Maryland, spoke on “Treatment and Rehabili-
tation of Drug Addicts.’ Several former drug addicts also
spoke on their experiences with drug addiction. A busi-
ness session followed.

Photos by Paramount Photo Service

“Health Maintenance Organizations” was the topic of a
Speech given by Dr. Daniel Y. Patterson, second from left,
at the September 9 meeting of the Prince Georges-Mont-
gomery County Pharmaceutical Association. Others in photo
are: (1 to r) Martin Hauer, President; Paul Reznek, Secre-
tary and Editor of the “Bi-County Pharmacist”; and Ed-
ward D. Nussbaum, lst Vice President.

CHANGE OF ADDRESS

When you move—

Please inform this office four weeks in advance to avoid
undelivered issues.

| “The Maryland Pharmacist" is not forwarded by the
| Post Office when you move.

To insure delivery of The Maryland Pharmacist" and all
mail, kindly notify the office when you plan to move
and state the effective date. APhA members—please in-
clude APhA number.

Thank you for your cooperation.
| Nathan I. Gruz, Editor

| Maryland Pharmacist
650 West Lombard Street

14 THE MARYLAND

Metropolitan Guild of
Pharmacists

by David Leise, Chairman of the Board

The Metropolitan Guild of Pharmacists is composed

solely of employee pharmacists and is governed by em-_

ployee pharmacists only. None of our officers receives pay-
ment of any kind. We are an independent, voluntary or-
ganization and are not affiliated with any other group.
We are a guild and not a union and we are the only
group locally which represents and protects the employee
pharmacist exclusively.

Purpose

The Guild was formed for the purpose of improving
the professional, economic and social status of all area
pharmacists. Our main objective is to elevate the profes-
sion of pharmacy. Guild members are encouraged to join
other professional and civic organizations so as to im-
prove and advance the status and respect of Pharmacy.
To encourage membership in the APhA, the Guild pays
half the dues for each member who wishes to join.

Our By-Laws state that a Guild member should re-
fuse to practice pharmacy under conditions environmental
or personal, which tend to interfere with or which would

compromise him into endorsing unethical conduct or

practices.

The Guild has been recognized by the Maryland —

Pharmaceutical Association and is represented in the
House of Delegates of the Association.

Representing

EMPLOYED PHARMACISTS
P.O. BOX NO. 2322
ROCKVILLE, MARYLAND 20852

PHARMACIST OCTOBER 1971

' benefit to the patient while
meeting the professional needs

This policy reflects Roche
interest in the general
problems of pharmacy
management, as well as
the pharmacist-doctor,
pharmacist-patient and
pharmacist-community
relations. There are many
of your colleagues at
Roche—practical profes-
sionals in various management positions—
ho help make the policies and provide the services
hat help you meet the challenge of pharmacy today.

ROCHE LABORATORIES
Division of Hoffmann-La Roche Inc.
Nutley, New Jersey 07110

Drug Storage and Stability

by
Ralph F. Shangraw
Professor and Chairman
Department of Pharmacy
University of Maryland, School of Pharmacy

If the curriculums of most schools of pharmacy
were closely examined, it would become obvious that
there are areas of knowledge which are currently being
overlooked. These deficiencies are most often not inten-
tional but reflect failure of faculties to reexamine course
content in line with today’s technology and tomorrow’s
practice of pharmacy.

An outstanding example of such an omission is
drug packaging at both the manufacturing and dispens-
ing level. All of us realize that a revolution in packaging
has and continues to take place. The utilization of plas-
tics for packaging of every conceivable type of product
has reached proportions that are almost impossible to
comprehend. Yet, few of us ever studied plastics in
school. An excellent series of articles in the use of plastic
in packaging was published in the January, February,
and April — 1969 issues of Drug and Cosmetic Indus-
try (1,2,3) and I highly recommend that you read them.
Even though we are living in an age of plastics, many
of us can still remember the sleeve type cardboard pill
boxes which were common in the 30’s or the simple
white envelopes with the name of the patient, doctor and
direction. I am willing to bet that there are not a half a
dozen schools of pharmacy that are not teaching students
how to fold divided powder papers even though poly-
ethylene pouches are readily available and represent a
much more utilittarian package for powders and other
bulk solids. On the other hand, I doubt that there are
even a half a dozen schools of pharmacy which have
strip or unit dose solid and liquid packaging equipment
available for demonstration and teaching. How many
schools of pharmacy give a course or even a few lectures
in packaging technology? What chemistry course in a
school of pharmacy discusses the chemistry of plastics
and their properties?

If schools of pharmacy are still not teaching in these
areas there is no reason to believe that pharmacists who
have already graduated would be prepared to consult
intelligently about such matters. Yet, these are subjects
which pharmacists encounter every day.

I would like to review some of the things that you
do know but might have forgotten as well as some new
concepts relative to the stability and storage of drug
products. Hopefully, at least one of the problems dis-
cussed will hit home and you will be able to improve even
if slightly, your professional practices in regard to these
very important areas.

Lets take a look at drug stability first. Is there any
part of your operation in which there is a danger in re-
gards to the stability of the products which you are
handling? What conditions influence the chemical sta-
bility of a drug, i.e., increase the rate at which it might
decompose? The two main considerations are:

1. Temperature
2. Moisture

16 THE MARYLAND PHARMACIST

In addition to these we may have chemicals which
are subject to oxidation, or photolysis. For instance, the
USP contains the names of over 300 drugs which spe-
cifically require protection from light and when the NF
is included the total list exceeds 500 (4). The Public
Health Service adopted light resistance as a requirement
for all prescription containers more than 17 years ago.
In 1945, the then assistant FDA Commissioner Crawford
issued the following statement:

“Where light protection is indicated for a USP
preparation and that preparation is dispensed
by a pharmacist in a container not assuring
this protection, that prescription when sold in
interstate commerce would be deemed mishan-
dled under the Federal Food, Drug and Cos-

metic Act.”

It is fortunate for many pharmacists that most pre-
scriptions are not dispensed in interstate commerce.

Fortunately, amber glass will afford the pharmacist
with an easy method to comply with official regulations.
According to Swartz et al., green glass will not give a
product the same degree of protection (5).

Let us return, however, to the two most important
considerations in drug stability—heat and moisture.

The speed of many chemical reactions increases
about 2 to 3 times with each 10° rise in temperature.
The storage of drugs at reduced temperature is simply a
reflection of this basic chemical law. All drugs are chem-
ically more stable at lower temperatures. This is true for
two reasons. An increase in temperature increases the
frequency with which two interacting molecules will col-
lide and it increases the probability that they will collide
with sufficient energy to undergo a reaction. When liquid
products are frozen, rates of chemical reaction are re-
duced dramatically approaching zero.

In spite of this, many drug storage areas in hos-
pitals, extended care facilities or nursing homes, and for
that matter, community pharmacies, are in areas of ex-
cessive heat. The increased utilization of air conditioning
has been extremely helpful in improving conditions of
drug storage but surprisingly enough, drug storage areas
are often the last part of a facility to be air conditioned.

In order to clear up misunderstandings as to storage
conditions, new definitions of the terms used to designate
storage temperatures will appear in NF XII and USP
XVIII. In addition to narrowing the temperature ranges
which apply to existing terms, two new terms have been
introduced. They are Cool Place and Room Temperature.

The new definitions are:
Cold Place—one having a temperature not exceed-
ing 8°C (46°F)
Refrigerator—a cold place in which the temperature

is held between 2° and 8°C.
(36 and 46°F)

OCTOBER 1971

dastytes y
:

There’s a lot more

going for you at LOEWY?

LOO1Nt

COMPUTERIZED
SERVICE

puts America’s most advanced
warehouse facility behind your store

How much is it worth to you to know
that the most advanced computerized
distribution system in existence is in
motion to process your every order
...instantly, efficiently, completely ?
That you needn't ever stock more than
a minimum of a far greater variety of
merchandise than you could ever show
before... and without investment in
excessive inventory? That your
wholesaler is never likely to be out-of
stock on any desirable item? That
every invoice and statement is assured
of up-to-the-minute accuracy? And
that there is never a lapse of more
than 60 minutes from receipt of your
order to the time it is on the loading
platform, ready to roll?

How much? You'll be able to measure
its worth by the number of customers
attracted to your store. Old customers
and new, it’s the kind of service they
aren’t likely to have known before.

FOR SERVICE AT ITS BEST...
BETTER DEAL WITH LOEWY

Call any time, day or night. An automatic order
taker will record your after-hours order.

Call IV 5-8105 for order taking.
(301) 485-8100 for the office.

LOEWY
DRUG COMPANY

DIVISION OF

()
ya 7 .
foes Spectro Industries, Ine.
6801 Quad Avenue
Baltimore, Md. 21206
Telephone: (301) 485-8100

Cool Place—a cool place is one having a tempera-
ture between 8° and 15°C
(46° and 59°F)

Room Temperature—room temperatures between
Wsrands30 7G
(59 and 86°F)

Excessive Heat—designates temperatures above 40°C

(104°F)

Storage areas near heating pipes, autoclave equip-
ment or hot water lines may very well fall into the area
of excessive heat.

When an official monograph does not list any spe-
cific storage conditions, room temperature should be as-
sumed,

Before going on to another subject, I would like to
say a word about the second most important factor in
drug stability and that is moisture. Very few chemical
reactions take place in a completely dry state as it is
extremely difficult for molecules to come together in a
medium which does not allow for mobility. The basic
cause of decomposition of many drugs is hydrolysis. Hy-
drolysis can be prevented by keeping drugs completely
dry or by adjusting the pH of a solution to a value where
the rate of the chemical reaction is low. For instance, we
know that aspirin when kept completely dry possesses a
high degree of stability but when even small amounts of
moisture are present, hydrolysis will occur (6). The
acetylsalicylate acid dissolves in the water absorbed on
the surface of the crystal and undergoes hydrolysis into
acetic acid and salicylic acid. More aspirin then dissolves
and the process continues.

The rate of degradation of procaine penicillin solu-
tions was shown by Swindowsky to be due only to that
portion in solution (7). Many drugs in solution have
reasonable stability at an optimum pH bui decompose
rapidly when that pH is changed.

For instance, procaine and tetracaine have almost
identical rates of deterioration at room temperature
(25°C) and pH 5.0. It would take 19 years for either
compound to decompose 50% when in solution. At auto-
clave temperatures (121°C) and the same pH it would
take 36 hours. At autoclave temperatures and a pH of
6.8 it would take only 10 minutes (8).

Remember, anytime you change the pH of a liquid
drug product there is a good chance you will change the
stability of the drug—in many cases decreasing it.

It is extremely important that we not only avoid
high temperature in drug storage but also moisture. The
two best ways of insuring minimum damage to drugs is
to (a) dispense in tightly closed containers and (b) avoid
high humidity environments. For instance, in many
homes and some nursing homes the medicine cabinet is
in the bath room or washing area where relative humidi-
ties are often 100%.

One indication that a drug is moisture sensitive is
the presence of a dessicant package in the manufacturer’s
bottle. It should be remembered that the moisture capaci-
ty of these dessicants is limited and they soon become
saturated when the bottle is opened regularly or left
opened. The continued use of these dessicant packages
without regeneration is worthless.

One of the major problems that has existed for many
years is the one associated with the preparation of paren-
teral products by the nurse just prior to administration.
Although in many cases this involves a compounding funce-
tion such as reconstitution of freeze dried preducts or in-

18 THE MARYLAND PHARMACIST

corporation of drugs with intravenous fluids, the nurse
traditionally has been burdened with this responsibility.
It is now becoming more and more customary for these
functions to be carried out by pharmacists supplying the
nurse with a dosage form ready to be administered. The
pharmacist must take the responsibility for accurate prep-
aration, complete labeling, and storage of the reconsti-
tuted or combined drugs. He can also check to make sure
that drugs which are pharmaceutically or therapeutically
incompatible are not dispensed. Numerous lists of such
incompatibilities have appeared in the literature (9).

As manufacturers have found out more and more
about drug stability and the Food and Drug Administra-
tion has set tighter restrictions on such products, there
has been significant increase in the number of drug
products with very limited stability after reconstitution.
Some are stable for only a few hours, others for as long
as a month or more without significant loss of potency.
In many cases, this stability is dependent upon storage in
a refrigerator or cool place after reconstitution.

Under no circumstances (except in an extreme
emergency ) should drugs be administered beyond their
indicated stability period as the therapeutic effectiveness
is diminished and the decomposition of some drugs re-
sults in the formation of chemical by-products which
may cause untoward or toxic manifestations. It is the
pharmacists’ responsibility to see that no such extreme
emergency ever arises.

An excellent compilation of the stability of drugs
after reconstitution appeared in the December 1967 issue
of the American Journal of Hospital Pharmacy (10). In
many cases the information in this compilation is much
more complete than is supplied by the manufacturer and
I heartily recommend that you have a copy in your
pharmacy.

It should always be remembered that the stability
data of a reconstituted product applies only when the
stated diluent or vehicle is used. This applies to all
type products such as oral suspensions, eye, ear, nose
drops as well as to parenteral products. If another vehicle
is used or the reconstituted product is further added to a
standard IV solution, a whole new ball game arises and
stability would have to be determined or ascertained from
the manufacturer. It is mandatory that the expiration
time (hours) or date (days) be placed on the label of
each product. .

One approach that some hospital pharmacists have
taken to increasing shelf-life after reconstitution is to
quick-freeze the reconstituted liquid immediately on prep-
aration and store the frozen product in a deep freeze.
Stolar et al. (11), showed that sodium methicillin for
injection can be reconstituted and stored at freezer tem-
perature for prolonged periods of time without deteriora- ~
tion. Upon receipt of an order the pharmacist removes
the vial from the freezer, permits the solution to thaw
and dispenses the medication to the nursing unit. Small
portable units for transferring frozen products from the
community pharmacy to the nursing home are available
or can be constructed. A number of precautions must be
observed.

(1) The pharmacist must be sure that the product
is stable when frozen. (Ampicillin is less stable
in frozen dilute solutions than at room tem-
perature. )

(2) Removal of a ce. of a very cold solution will
give more drug than at room temperature due —
to the increased density of the solution.

OCTOBER 1971

__ Reading
iS Still the fast

to proer:
poe

brain

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
vage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for the
spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
ment.

uman

est way
m the

Ng SPEEDS

6 [0

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

(3) All products cannot be frozen due to physical
changes which occur during the freezing proc-
ess.

This latter point is important. We all know, for in-
siance, that Milk of Magnesia should not be frozen but
few people stop to think why? Remember when you
freeze any material which is hydrated, the water freezes
in a pure state and separates itself from the chemical to
which it is attached. When the frozen product is thawed
the water may or may not associate itself in the same
manner as it was originally and this may lead to insolu-
bility and precipitation.

The storage of insulin is particularly important as
many types are sensitive to both freezing and to high
temperatures. (12) Storage can be summarized as fol-
lows:

(1) All insulin products except a vial in current
use should be stored in a cool or cold place
(2-15°C). They should not be frozen. Freezing
does not affect potency but affects the physical
form, preventing uniform redispersion. This is
particularly true of the modified protein-insulin
and lente preparations.

(2) The lente insulins, NPH insulin and protamine
zine insulin all tend to coagulate at elevated
temperatures. Exposure to temperatures above
79°F for a few days or 100°F for a few hours
can produce a granular or clumped precipitate.
Although potency may not be affected, the phy-
sical change prevents withdrawal and adminis-
tration of a uniform dose. Prolonged exposure
to elevated temperatures will destroy potency.

(3) Normal room temperatures (68°-75°F) will not
cause clinically significant lowering of activity
of insulin during the use time of a single vial—
up to a few weeks.

In regards to expiration dates on prescription prod-
ucts, many of you may not be aware of the fact that the
pharmaceutical industry is rapidly moving to the stage
where all prescription drugs will have an expiration date.

For those products which would have unlimited sta-
bility if stored at room temperature, an arbitrary expira-
tion date such as five years will be set.

It is interesting to note that manufacturers were
much more willing to set an expiration date on their
products than to indicate the date of manufacture.

I realize that I have touched a number of different
areas of drug storage and stability but hope that at least
one of the points I have made will motivate you to im-
prove your present drug storage procedures.

In closing, I would like to review a stability study
on packaging of nitroglycerine which we recently com-
pleted here at the University of Maryland School of
Pharmacy (13). We have long been concerned with the
preparation and stability of nitroglycerin tablets for sub-
lingual use. Although pharmacists are generally aware of
the fact that nitroglycerin tablets can lose their potency,
they fail to translate this awareness into sound dispens-
ing habits. The experiment was designed to show the sta-
bility of hypodermic tablets of nitroglycerin when dis-
pensed in a variety of containers including strip packag-
ing at both room and elevated temperatures.

The nitroglycerin tablets were stable when packaged
in glass regardless of whether a plastic snap cap or screw
cap type closure was used.

20 THE MARYLAND PHARMACIST

Nitroglycerin tablets packaged in polystyrene vials
showed almost identical rates of decomposition regardless
of the type of cap employed. The stability was not suf-
ficient to justify use of these types of containers.

Nitroglycerin tablets dispensed in a pill box showed
rapid loss of potency even at room temperature.

The results of the strip packaging study were even
more dramatic. Tablets were packaged using aluminum
foil on one side and either (a) paper, (b) polyethylene,
or (c) aluminum foil on top. The loss in potency in al
systems was so rapid that accelerated aging passes through
the paper layer completely. On the other hand, it dis-
solves in the polyethylene and effectively partitions out
of the tablet. In the case of the aluminum-aluminum strip
package, the nitroglycerin apparently escapes through
the thin layer of adhesive material on the surface of the
foil which is present to enable the foil layers to seal to-
gether. It is obvious that strip packaging of nitroglycerin
in any of these systems would be disastrous. However,
when I recently mentioned this to a pharmacist who is
involved in one of the largest experimental unit dose
studies in the country, he was frank to admit that they
had been strip packaging nitroglycerin in this manner
for over two years.

I would like to close with a simple question: How
do you package nitroglycerin in your pharmacy or nurs-
ing home?

BIBLIOGRAPHY

1. Varsano, Jacob, Drug and Cosm. Ind., 104, 88 (Jan. 1969).

2. Varsano, Jacob, ibid, 104, 72 (Feb. 1969).

3. Varsano, Jacob, ibid, 104, 98 (March 1969).

4. “These 305 Drugs Need Light Protection,’ Armstrong Cork Co.,
Lancaster, Pa.

5. Swartz, C. J., et al., J. Pharm. Sci., 50, 145-148 (1961).

6. Leeson, L. T. and Mattocks, A. M., J. Am. Pharm. Assoc., Sci.
Ed., 47, 329, 1958.

7. Swintowsky, J. V., et al., ibid. 45, 34, 37 (1956).

8. Higuchi, T. et al., ibid, 39, 405 (1950).

9. Pelissier, N. A. and Burgee, S. L., Hosp. Pharm., 3, (1) 1968.

10. Latiolais, C. J. et al., Am. J. Hosp. Pharm., 24, 667 (1967).

11. Stolar, M. H., et al., ibid, 25, 32 (1968).

12. Shangraw, R. F. and Lamy, P. P., J. Am. Pharm. Assoc., NS9,
117 (1969).

13. Edelman, Barre A.; Contractor, Avinash M.; and Shangraw,
Ralph F.; ibid., NS11, 30 (1971).

PHI DELTA CHI

Members interested in joining the alumni chapter of
Phi Delta Chi Fraternity should contact Mr. William Ed-
mondson, 955-7619, 955-7591: Mr. John Vakoutis, 661-
9088 or Mr. Ed Poklis, 477-4399.

Headquarters for

PHOTO-OFFSET PRINTING MAILING
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

—_——

OCTOBER 1971

Put your facings
-« swhere your

profits arel
(Deal runs Oct. 1—28)

buy now for bigger fall and winter profits
A.H. Robins announces a special money-saving deal on Allbee with C.
Here’s your chance to get the very best buy on the number one vit-
min in its class in drug store sales. Last year, Allbee with C led
_ (inpurchases with 25% of this big $20 million plus market. This in-
~ creased to a whopping 32% share during the fitst part of 1971. Such

_an outstanding performance isn’t surprising when you consider that
~~ it’s the B-complex with C most often prescribed by the medical and
“dental professions. More than a million scripts were filled last year,

and this didn’t even include professional recommendations or over-
the-counter sales. Over onehalf of all Allbee with C sales are OTC.

You purchase and sell far more Allbee with C. Isn’t it good busi-
ness to also give it more facings’and shelf space? Your Robins rep-
resentative will be around soon to discuss the deal and facings with
you. You’ve got Déal,Power with Allbee with C, and that means a
better deal for you. ~~

A.'H. Ro bing Company, Richmond, Va. A-H-[20 B | N )

Bi sinn
bees

University of Maryland
School of Pharmacy

Dr. David A. Knapp has joined the faculty of the
School of Pharmacy as associate professor in the depart-
ment of pharmacy administration. He will be responsible
for teaching and research in the area of social sciences in
pharmacy and will assist in the development of educa-
tion and service programs including not only the School
of Pharmacy but also other health profession schools and
programs,

Nominations are now being received for the Honored
Alumnus Award to be presented at the Annual Gradua-
tion Banquet.

Names for nomination may be submitted to Harry
R. Wille, 306 Marydell Road, Baltimore, Maryland
21229.

A. Z. O. News

Kappa Chapter of Baltimore will be the host chap-
ter for the 1971 Fall Regional Meeting of the Alpha Zeta
Omega Pharmaceutical Fraternity. Recent appointments
on the national level include those of Paul Reznek, who
has been appointed Legislative Representative for the
fraternity and Gerald Freedenberg, Directorum of Kappa
Chapter, has been appointed A.Z.O. Historian.

Mangini can tell you
what you have.

Within 1%

Many pharmacists often esti-
mate their inventory by relat-
ing purchases to sales

In today’s competitive climate
and with the cost of merchan-
dise continuously rising, these
estimated gross profit figures

Mangini & Associates, Inc.
4850 W. Belmont Ave. Chicago, III

6064 1/(312) 282-8181

can be misleading. In _ fact.
this can be extremely costly
to the pharmacist who, un-
aware of his shrinking inven-
tory and gross profits, is
actually paying a higher in-
come tax than he should.

So why guess? Call Mangini
for fast, computerized inven-
tory service that will tell you
within 1% how your inventory
realistically stacks up to your
turnover, sales and profits!

WRITE FOR DETAILED
INFORMATION.
tiosEREES

11722 Studt St., St. Louis, Mo. 63141
2760 W. Market St., Akron, Ohio 44313
575 Savin Ave., West Haven, Conn. 06516
5501 Cherokee Ave, Alexandria, Va. 22312

WHEN YOU WANT Health and Beauty Products that offer:

Dependability
Real Profits

Uniformity

Competitive Pricing

Outstanding Acceptance

YOU WANT DRUCO Quality Products!

YOU can display and recommend DRUCO Products with confidence.
DRUCO — the Quality Line of Pharmacy Produets since 1898.

DRUCO consumer ads direct customers to your Pharmacy for

THE DRUG HOUSE, INC.

Philadelphia

Trenton

Wilmington

U.
i
Y DRUCO Products and all their Health Needs.
0

22 THE MARYLAND PHARMACIST

OCTOBER 1971

phenylbutazone

pres

Geigy «

1000 tablets i 2 ofan
Tofranil
imipramine hydro"

STATEMENT OF OWNERSHIP, MANAGEMENT AND CIRCULATION
‘Act of August 12, 1970; Section 3685), Title 39, United State Code)
Title of Publication: MARYLAND PHARMACIST

Date of filing: October 1, 1971.

Frequency of issue: Monthly

4. Location of known office of publication: 306 N. Gay Street, Baltimore,
Maryland 21202

5. Location of the headquarters or general business offices of the pub-
lishers: 650 W. Lombard Street, Baltimore, Maryland 21201

6. Names and addresses of publisher, editor and managing editor:
Publisher: Maryland Pharmaceutical Association, 650 W. Lombard St.,
Baltimore, Md. 21201

Editor: Nathan I. Gruz, 650 W. Lombard Street, Baltimore, Md. 21201
Managing Editor: Nathan I. Gruz, 650 W. Lombard Street, Baltimore,
Md. 21201

7. Owner (If owned by a corporation, its names and address must be stated
and also immediately thereunder the names and addresses of stockholders
owning or holding 1 percent or more of total amount of stock. If not
owned by a corporation, the names and addresses of the individual owners
must be given. If owned by a partnership or other unincorporated firm,
its name and address, as well as that of each individual must be given.)
Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore,
Maryland 21201, (Non-Profit Corporation)

8. Known bondholders, mortgagees and other security holders owning or
holding 1 percent or more of total amount of bonds, mortgages or other
securities: None

9. For optional completion by publishers mailing at the regular rates (Sec-
tion 132.121, Postal Service Manual

39 U. S. C. 3626 provides in pertinent part: ‘‘No person who would have
been entitled to mail matter under former section 4359 of this title shall
mail such matter at the rates provided under this subsection unless he files
annually with the Postal Service a written request for permission to mail
matter at such rates.’’

In accordance with the provisions of this statute, I hereby request permis-
sion to mail the publication named in item 1 at the reduced postage rates

Che

presently authorized by 39 U. S. C. 3626. Nathan I. Gruz, Editor
11. Extent and nature of circulation
AS Total= Now Copies) Printed) 72, soe ee sng Leos 1450+

B. Paid Circulation
1. Sales Through Dealers and Carriers, Street

Vendors and Counter Sales ....... eRe Soke eras None None
2. Mall “Subseriptlons vi ves cece eee eee ee eer eel ae 1250 1250
C.cotal Paid: Cireulation’ 77, kant re mls cope ee one aes 1250 1250
D. Free Distribution by Mail, Carrier or by Other Means
1. Samples, complimentary, and other free copies hee LOO 150
2. Copies Distributed to News Agents, but not sold....None None
me, Lotal. Distribution © a. 3... Saye te, gets I, Latha ye 1400 1322
F. Office Use, Left-Over, Unaccounted, Spoiled
After: PrintMeg i... <ea se eee ee De Roast ls TEU 138
G. Total Rete teed .. . 1450 1450

*Average No. Copies Each Issue During Preceding 12 months.
+Single Issue Nearest to Filing Date
I certify that the statements made by me above are correct and com-

plete.
NATHAN I. GRUZ

TAILOR-MADE
Insurance Coverage

AMERICAN DRUGGISTS’ INSURANCE ...as the name im-
plies, is specifically designed for the needs of the druggist.
It'S an insurance company founded BY druggists FOR
druggists, to assure especially prompt settlement of claims
.. fire, theft, liability. And that’s exactly what we’ve been
doing... settling such claims rapidly, without red tape

... Since 1906. Any service with that many years of
experience HAS to be reliable. You can
be certain of 100% security.

For full details on our complete
coverage plan, contact your ADI
agent NOW.

MAYER & STEINBERG
Maryland State Agents
1101 N. CALVERT STREET
BALTIMORE, MD. 21202
752-7311

DRUGGISTS’
INSURANCE CO.

700 American Building
Cincinnati, Ohio 45202

Pension & Investment
Associates of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)
HR-10.. Plans (Sole Proprietor-Partnerships)

Mutual Funds

Prospectuses Available Upon Reyuest

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

Each teaspoonful (5 ml.) contains aluminum hydrox-
ide, 720 mg., magnesium hydroxide, 350 mg., and
calcium carbonate, 375 mg.

Contraindications: renal insufficiency, phosphate de-
pletion.

Adverse Reactions: occasional laxation, nausea and,
rarely, constipation. Theoretically, hypophosphatemia,
hypermagnesemia, hypercalcemia, milk alkali syn-
drome (with prolonged administration).

Usual Adult Dosage: 2 to 3 teaspoonfuls between
meals and at bedtime, or as needed (40 to 60 ml.
daily).

For complete product information, see your SK&F
Representative or contact SK&F.

Ail antacids
are not alike.

DUCON™: DUration through CONcentration

DUration means patients may be able to take
‘DUCON' less frequently.

CONceniration means ‘DUCON' has a high
acid-consuming capacity.

And the taste of ‘DUCON'’ means antacids
don't have to taste like chalk soup.

LAST BUT NOT LEAST:
The 73¢ profit per bottle means

“DUCON is the most profitable item

in your antacid section.

*based on suggested retail price
Trademark

Ducon
antacid

SF smith Kline & French Laboratories, Phila., Pa. 19101

Obituaries

S. L. Anderson

S. L. Anderson, 59, died suddenly
on September 20 in M.C.V. Hospital,
Richmond, Virginia. He was a 1934
graduate of the University of Mary-
land School of Pharmacy.

John A. Strevig

John A. Strevig, 82, a 1912 grad-
uate of the University of Maryland
School of Pharmacy, died on October
1. A past president of the Alumni
Association, Mr. Strevig was a former
hospital representative for Eli Lilly
and Co. until his retirement in 1954.
He was a member of the Baltimore
Veteran Druggists Association.

Jacob H. Greenfeld

Jacob H. Greenfeld, 63, died on
September 30, 1971 at Sinai Hospital.
Mr. Greenfeld graduated from the
University of Maryland School of
Pharmacy in 1929. He was president
for the past 13 years of the Ner Tamid
Congregation, Greenspring Valley
Synagogue and was active in raising
money for development programs in
Israel.

John F. Neutze

John F. Neutze, 55, owner of a
Govans pharmacy for the past 20
years, died on September 16 at St.
Joseph Hospital after being ill for
several days. He was a 1937 graduate
of the University of Maryland School
of Pharmacy. In 1951, he and a part-
ner opened the Combs and Neutze
Pharmacy at 5925 York Road. He
was a member of the Ancient Scottish
Rite and Tuscan Lodge.

Mr. Neutze was also a member of
the Maryland Pharmaceutical Associ-
ation, served as vice president of the
Baltimore Pharmaceutical Association,
and was a member of the Wedgewood
Club, and the National Association of
Retail Druggists.

In The News...
SAMUEL MORRIS, Publicity Chairman of the

Prince Georges-Montgomery County Pharmaceutical Asso-
ciation, is now on the staff of the Easton Memorial Hos-
pital. Dean WILLIAM J. KINNARD will be presented
with an honorary membership in Kappa Chapter of AZO
at AZO’s Fall Regional Con-
vention. Also SAM BLOCK, MORRIS SCHENKER and

Pharmaceutical Fraternity

PHARMACEUTICAL DIRECTORY

AFFILIATED ORGANIZATIONS

Allegany-Garrett County
Pharmaceutical Association

Rdalaciencte neko: Stephen Hospodavis
Bicisto tate tye no ne James Ritchie

Secretary-Treasurer....... Robert F. Tomsko

Baltimore Metropolitan
Pharmaceutical Association

Presidentaeess «Cee ree Irvin Kamenetz
Presidentellecta eee ren Joseph U. Dorsch
LCOSUT erin wr coetaee Charles E. Spigelmire

Vice Presidents—
Paul Freiman, Harold P. Levin,
Harry R. Wille

Secretary and Executive Director

Nathan I. Gruz

Eastern Shore Pharmaceutical Society

President it haere ane Gordon Harrison
First Vice President....... William P. Smith
Second Vice President....... William Connor
Secretary wage ota ee oe Carl R. June
Theastrera tare es nea tee Thomas Payne

Prince Georges-Montgomery County
Pharmaceutical Association

Presidentsc: sa oo ey ck vO Martin Hauer
First Vice President....Edward D. Nussbaum
Second Vice President ..... S. Ben Friedman
Third Vice President ...... Sidney Glashofer
Fourth Vice President....... Gabriel E. Katz
Secretary Ws f=) see a eee. Paul Reznek
Treasurer’ {Ose ine Michael Leonard
Honorary President .......... Samuel Morris

Washington County
Pharmaceutical Association
ear ee Samuel E. Weisbecker
SOPHO SA iam Heb Baie Joseph Davies
AS: Frederick Fahrney

University of Maryland School of
Pharmacy Student APhA-MPhA Chapter

Presidents ccc ce nee Paul R. Webster
Vicew Presidente eee Stephen B. Bierer
Secretaryer ne se eee Donna S. Levin
Trédsurer tx kaudeue ee Dennis R. Reaver

NATHAN COHEN will receive pins acknowledging their
90 years of participation in Kappa Chapter. A very suc-
cessful I.V. Additive Workshop, under the Direction of
Dr. PETER P. LAMY, was recently conducted at the
downtown Holiday Inn. Dr. SAMUEL FOX, U. of Md.
School of Pharmacy graduate, has been appointed full
Professor of Ophthalmology at the University of Mary-
land School of Medicine.

THE MARYLAND PHARMACIST

MPhA AUXILIARIES

LAMPA — Ladies Auxiliary of The
Maryland Pharmaceutical Association

President
MRS. LOUIS M. ROCKMAN
Recording Secretary
MISS MARY DiGRISTINE

Communications Secretary

MRS. RICHARD R. CRANE

Treasurer

MRS. CHARLES S. AUSTIN
Membership Treasurer

MRS. MANUEL B. WAGNER i

TAMPA — Traveler’s Auxiliary of The ]

Maryland Pharmaceutical Association

President
PAUL J. MAHONEY .
First Vice President ;
JOHN C. MATHENY |

Second Vice President
ABRIAN E. BLOOM

Third Vice President
C. WILSON SPILKER

Secretary-T reasurer

WILLIAM A. POKORNY |
WILLIAM L. NELSON |

Assistant Secretary-Treasurer
Honorary President
JOSEPH GRUBB

Secretary-Treasurer Emeritus

JOHN A. CROZIER

OTHER PHARMACY ORGANIZATIONS
Maryland Society of Hospital
Pharmacists
President
MARY W. CONNELLY
President Elect
NORMAND A. PELISSIER
Secretary

DOLORES A. ICHNIOWSKI

Treasurer

THOMAS E. PATRICK

University of Maryiand
School of Pharmacy

|
|
.
f

Dean
DR. WILLIAM J. KINNARD, JR.
Assistant Dean
DR. C. T. ICHNIOWSKI
Delegate and Vice Speaker—
MPhA House of Delegates
HENRY G. SEIDMAN

Metropolitan Guild of Pharmacists

President
JOHN McKIRGAN
Vice President
FRANK FRARY
Secretary
LARRY JACOBSON
Treasurer

EDWARD WILLIAMS

OCTOBER 1971

Youngs tells it as itis

Inmagazines,
newspapers,
in-store.
promotions,

booklets,
publicity and
billboards.

Across the nation, through
every promotional device we
can use, we’re telling it as it is
about the only positive V.D.
preventative and male
contraceptive product...the
condom. Through mass media
advertising and national
public relations programs
we’re making the community
pharmacy the strongest
weapon in the war on V.D....
and sending thousands of
customers into pharmacies
everywhere. We’re the only
major manufacturer of
prophylactics who
recommends the pharmacist
in every ad we run.

Advertising
In 1969 Youngs ran the first
prophylactic ad in a consumer
publication. This year we will
carry more than 485 million
advertising impressions to people
throughout the U.S. Also, millions
of additional V.D. messages are
being made by our buttons,
matches and billboards.

Counter Displays

Across the nation, we’re telling it
as it is about the only positive
V.D. preventative and male
contraceptive product...the
condom. And...we’re making the
pharmacy the strongest weapon in
the war on V.D....and creating
new prophylactic users for
pharmacies everywhere.

7 V.D. Literature

| Plain Tatk
! about ;
| Venereal Disease |

oer |

Over 4 million Youngs informative
Plain Talk About V.D. booklets
have been distributed in
pharmacies, high schools and
clinics. Many other important
educational items such as
Youngs’ “‘How to Use a Condom’”’
pamphlet have also been gaining
widespread distribution.

Ne
P25
Publicity
Our continuing publicity program
is attacking V.D. through radio,
T.V., newspapers, magazines,
telephone messages and seminars.
It's done a tremendous job in
educating young adults, teachers
and parents on V.D. And—we’ve
singled out the pharmacist as the
best source for medically
recommended products that aid
in preventing V.D.

se Dn gat y

up Youngs Drug Products Corporation

Manufacturers of “Trojan” brand prophylactics—sold only in drugstores
865 Centennial Avenue, Piscataway, New Jersey 08854

The Maryland Pharmaceutical pga

Presents

MEXICAN FUN FEST

and Convention Round-Up
in Acapulco

6 FANTASTIC DAYS! pre
5 FUN-FILLED NITES! 9 =~ -
WEDNESDAY thru MONDAY, MAY 17 thru 09,1972

®Non-stop round trip jet flight via Eastern Airlines
Deluxe Trip with OPEN FREE BAR and deluxe
meal during flight.

@Deluxe twin bedded accommodation with private
bath at the Super Deluxe PIERRE MARQUIS Hotel
and Golf Club on Acapulco’s famous REVOLCADERO
BEACH — 2 blocks long and one block wide, with
the surf from the Pacific constantly rolling in.

® Transportation and transfers to and from hotel to
airport and porterage. (Hotel only 5 minutes from
airport).

®Full Course Breakfasts; Gourmet Dinners with
dancing nitely from your ringside dinner table
until the wee hours for FREE in the exotic Tabochin
Dining Room.

@Cocktail Party plus
Many Surprises!

®ALL Taxes and ie REG. *800°°

Gratuities Paid In Full S .00
ALL FOR ONLY... Oe
Leave Friendship Airport, 8 A.M. PER Cou PLE!

Wednesday, May 17th — Arrive Plus $39.00 Tax and Gratuities

Acapulco 12:30 P.M.

(10:30 A.M. Their Time)

Leave Acapulco Airport, 4 P.M.
Monday, May 22nd — Arrive

Baltimore 10:30 P.M.
(Checkeut Time: 3 P.M.) * ;
Educational Sessions Daily EARLY BUY PRICE!

Reservations on this fabulous trip can be confirmed only upon receipt of $50.00
deposit per couple. All monies refundable in full until April 17th, 1972,
after which date refunds are subject to resale of the reservations.

CHECKS MADE PAYABLE AND MAILED TO:

MARYLAND PHARMACEUTICAL ASSOCIATION
650 W. LOMBARD ST., BALTO., MD. 21201- Phone 727-0746

Volume 47

the
maryland

ASSOCIATION

=" pharmacist

Editorial—

Unity In Pharmacy: Necessity For Survival

MPhA Fall Regional Meeting

Third-Party Prescription Programs-
Delight or Dilemma

by Morris Bookoff

NOVEMBER 1971

Number 11

Compliments of

oxell

CORPORATION

NOXZEMA SKIN CREAMS

Makers of

NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS
and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

Your reputation goes on the line every time you

fill a prescription—with patients and with physicians
alike. You know that seemingly minor differences

in method of manufacture—the size of the particle,
the excipient used, the character of the gelatin
capsules, solubility, disintegration rate—all can
make a crucial difference in therapeutic
effectiveness. Your professional judgment tells
you... when it comes to your prescription patient's
health (and your reputation), you want to

dispense the best.

Lilly ELI LILLY AND COMPANY

INDIANAPOLIS, INDIANA 46206

You wrap your
» reputation

around the

products
you dispense

lee «

Announcing an
Important Price Reduction

The Leading Tablet Form
of Erythromycin

Erythrocin —
Stearate,250 Mil

(ERYTHROMYCIN STEARATE As0TT STEARATE TABLETS

250 mg. icivig

Caution: Federal (U.S.A.)

Nowcosts = = Siem
31.8% less S

New Low Price Takes
Effect Immediately

Direct Price $14.99 per 100

Health Care World Wide

— es

The Maryland Pharmacist

NATHAN I. GRUZ, Editor

Normanp A. PE ttssier, Assistant Editor
Martua Ecxkuorr, Editorial Assistant
Ross P. CampsBet_, News Correspondent

650 WEST LOMBARD STREET
BALTIMORE, MARYLAND 21201

HERMAN J. BLoom, Photographer ASSOCIATION
VoLuME 47 NOVEMBER 1971 NumeBer 11
OFFICERS 1971-1972
Honorary President
H. NELSON WARFIELD—Pikesville TABLE OF CONTENTS
jad ialy 6 Editorial—Unity in Pharmacy: Necessity For Survival

NATHAN SCHWARTZ—Annapolis

President Elect
BERNARD B. LACHMAN—Baltimore

Vice President

JOHN R. McHUGH—Potomac

Treasurer

MORRIS LINDENBAUM
5 Main St., Reisterstown, Md. 21136

Executive Director

NATHAN I. GRUZ
650 W. Lombard St., Baltimore, Md. 21201

TRUSTEES

DONALD O. FEDDER, Chairman—Dundalk
MORRIS BOOKOFF (1972)—Baltimore
PAUL FREIMAN (1974)—Baltimore

STEPHEN HOSPODAVIS (1972)
Cresaptown
PHILIP D. LINDEMAN (1973*—Berlin
ANTHONY G. PADUSSIS (1973)
Baltimore
MELVIN J. SOLLOD (1974)—Adelphi

| SYDNEY L. BURGEE, JR.
Speaker of the House of Delegates
Baltimore

EX-OFFICIO MEMS5ERS

FRANCIS S. BALASSONE—Baltimore
WILLIAM J. KINNARD, JR.—Baltimore

HONORARY LIFE TRUSTEE
SIMON SOLOMON—Baltimore

MARYLAND BOARD OF PHARMACY

Honorary President

SIMON SOLOMON—Baltimore

President
NORMAN J. LEVIN—Pikesville

Secretary
F. S. BALASSONE—Baltimore

Member
FRANK BLOCK—Baltimore

Member
HOWARD L. GORDY-—Salisbury

Member
MORRIS R. YAFFE—Potomac

8 Washington Spotlight For Pharmacists

8 Maryland Board of Pharmacy

10 MPhA Fall Regional Meeting

10 Pharmacy Calendar

12 LA.M.P.A. News

129 2, Om News

12.) LAMP ASNews

12 Prince Georges‘-Montgomery Pharmaceutical Association

12 Eastern Shore Pharmaceutical Society

14 Hospital Pharmacy Section

16 Baltimore Metropolitan Pharmaceutical Association

18 Third-Party Prescription Programs—Delight or Dilemma
by Morris Bookoff

21 University of Maryland School of Pharmacy

26 Obituaries

26 State Pharmaceutical Directory

INDEX TO ADVERTISERS

4 Abbott Laboratories
23 Berkey Film Processing

19 Calvert Drug Company, Inc.

20 Ciba Pharmaceutical Company

17. Henry B. Gilpin Company
27 Hynson, Westcott & Dunning, Inc.

7 Lederle Laboratories

3 Eli Lilly and Company

9 Loewy Drug Company

24 Mangini and Associates, Inc.
25 Maryland News Company
22 Metropolitan Guild of Pharmacists

2 Noxell Corporation

13. Paramount Photo Service
22 Pension & Investment Associates of America
15 Roche Laboratories
21 OD. Stuart Webb Advertising Services
11 Youngs Drug Products Corporation

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number. Allow four weeks for
changeover. APhA members—please include APhA number.

Editorial...

Unity In Pharmacy:
Necessity For Survival

The pharmaceutical literature and association meet-
ings for many years have pointed to the lack of national
organizational unity in the profession of pharmacy.

It is hard to believe that there is one pharmacist
around who doesn’t recognize that the posture of antagon-
ists that has prevailed between our two national groups—
the American Pharmaceutical Association and the Na-
tional Association of Retail Druggists—has not contrib-
uted to the inability to achieve many of the goals and
aspirations of the profession.

The following statement was not written in 1971.
It is quoted from the first report of this editorialist as

Executive Secretary. The date of delivery was June 25,
1962:

“When we approach the national pharmaceutical
scene, one dominant feature must be recognized.
Over the years, many of the aspirations of pharma-
cists to achieve their urgently needed professional
and economic goals, as well as to secure a properly
recognized role in shaping policies regarding the pro-
vision of medicinal agents, has been the absence of
a national front for pharmacy. For the defensive and
offensive needs of the country, we have a Joint
Chiefs of Staff under a Secretary of Defense. Phar-
macy is engaged in a total war. The pharmaceutical
situation also demands a unified command. As long
as rivalry continues between our two national groups,
we will continue to be divided and, therefore, to be
defeated. Whatever courageous steps must be taken
to achieve cooperation and harmony between our
two essential national groups—the APhA and NARD
—must be taken. No personality differences, no in-
dividual ambitions, no organizational competitive-
ness can any longer be allowed to stand in the way.
Pharmacy resources of experienced and competent
leadership, intelligent and dedicated members, and
financial wherewithal are too valuable to be used,
except in an integrated, unified manner. Our peril
is too great, our enemies too strong, our forces too
fragmented to permit continuation of this increas-
ingly disastrous internecine warfare which stands in
pharmacy’s path of progress.”

The state pharmaceutical associations represent in
their totality more pharmacists than either the APhA or
the NARD. We believe that it is the responsibility of the
leadership of these state societies to demand that efforts
for an integrated national organizational structure for
pharmacy be initiated immediately. This is no time for
half-way measures, such as an agreement for the execu-
tive bodies of the two groups meeting twice during the
coming year.

In addition, it is the duty of the pharmacists who are
members of the APhA and of the NARD to advise these
groups that they will counternance no delay. They should
demand and expect to see concrete implementation of
steps taken in good faith to proceed toward the ultimate
goal of cementing the fragmented structure of pharmacy.

6 THE MARYLAND PHARMACIST

Every facet of the world of pharmacy has the right
lo organize, to work and to fight for what is its own legiti-
mate and what we hope is its enlightened self-interest.
This goes for the pharmaceutical manufacturing industry,
wholesalers, educators, licensing boards, hospitals and the
allied health professions.

Pharmacists, too, have legitimate self-interests that
are entitled to the benefits of the vigorous advocacy of
a dynamic, enlightened, responsive national body. Phar-
macists are providing their splintered national organiza-
tions with more than $3,000,000 annually to represent
them.

The APhA and the American Society of Hospital
Pharmacists are to be commended for recognizing the
need for an objective study of the current organizational
structure of pharmacy with the view of de!e:mining what
changes are required to cope with the challenges of today
and tomorrow. They have agreed to proceed with this
study and have invited the NARD to join them.

The American College of Apothecaries and the Na-
tional Council of State Pharmaceutical Association Execu-
tives have also exercised incentives in bringing about

face-to-face discussion between the APhA and NARD.

The patience of pharmacists is wearing thin. They
expect a plan—a set of priorities—a program for their
implementation and progress toward fulfillment during
the coming 12 months.

The leadership of APhA and NARD bear grave re-
sponsibilities for the resolution of this long-festering, com-

plex problem.

Certainly pharmacists will expect an accounting of
the action of the executive bodies of the groups by the
time of their annual meetings in April and October 1972.

— Nathan I. Gruz

CHANGE OF ADDRESS

When you move—

Please inform this office four weeks in advance to avoid
undelivered issues.

“The Maryland Pharmacist" is not forwarded by the
Post Office when you move.

To insure delivery of "The Maryland Pharmacist" and all

mail, kindly notify the office when you plan to move
and state the effective date. APhA members—please in-
clude APhA number.

Thank you for your cooperation.

Nathan I. Gruz, Editor
Maryland Pharmacist
650 West Lombard Street

NOVEMBER 197!

.
.

%
yor

wo '

Developed by Lederle

Semisynthetic

MINOCIN

MINOCYCLINE HCI

Available: Bottles of 50,
Blister Packs of 10 x 10

200,000 MD’s are getting the word on MINOCIN.
Be ready to meet the Rx demand. Stock up.

LEDERLE LABORATORIES °¢ A Division of American Cyanamid Company, Pearl River, New York 10965

Washington Spotlight For

Pharmacists by APhA
Legal Division

The Transfer of Controlled Substances
By Pharmacies

A recent change in the Controlled Substances Act
regulations allows a pharmacy to transfer a controlled
substance to either another pharmacy or a_ prescriber,
under certain conditions, without being registered as a
distributor. These new regulations supersede the prior
regulations which prohibited a pharmacy from_provid-
ing a physician with stocks of controlled substances for
his office use—unless the pharmacy was registered as a
distributor, and the regulations which allowed inter-
pharmacy transfers, only in “emergency situations” and
only in the quantity needed for immediate dispensing.

The new regulation ($307.11) reflects the BNDD
recognition that pharmacies and other dispensers per-
form a vital and necessary service function by providing
limited supplies of drugs, including controlled substances
to other practitioners.

The Controlled Substances Act authorizes the Bu-
reau to waive registration requirements for certain dis-
tributors where it is consistent with public health and
safety. The Bureau, has indicated by this recent change
that the infrequent distribution of controlled substances
by a practitioner, without registration as a distributor, is
consistent with the public health and safety.

The new regulation is intended only to provide a
mechanism for the accommodation transfers between
pharmacies and the servicing of physicians, by supplying
them with office supplies of controlled substances. It is
not intended to allow large scale transfers between phar-
macies nor to allow pharmacies or other practitioners to
engage in wholesale distribution of these substances.

In line with the rationale of this section and the
purposes for which it was formulated, a “five percent”
limitation is imposed.

FIVE (5) PERCENT TEST

The total number of dosage units of all controlled
substances distributed by a practitioner pursuant to this
section ($307.11), may not exceed 5% of the total num-
ber of dosage units of all controlled substances distributed
and dispensed by the practitioner during a twelve month
period. This figure is based on dosage units, not dollar
volume.

If a pharmacist or other practitioner distributes in
excess of this figure, he is considered to be engaged in a
significant wholesaling business and must register addi-
tionally, as a distributor.

RECORDKEEPING REQUIREMENTS

All distributions and receipts, under this section,
must be recorded. The record should contain the name.
address and registration number of each practitioner, the
quantity, strength and dosage form of the controlled sub-
stance involved, and the date of the transaction.

8 THE MARYLAND PHARMACIST

The Bureau will accept either of two systems for

the records distributions:

1. Invoices, order forms, or other documents evi-
dencing the transfer may be stamped and filed
in the same manner as prescriptions, provided
it clearly states that it was a distribution and
not a dispensing or prescription.

The documents may be filed separately from all
other records.

Records of receipts should be filed in the same
manner as receipts of controlled substances from whole-
salers or manufacturers.

RECORDS FOR SCHEDULE II
CONTROLLED SUBSTANCES

Schedule II controlled substances may also be trans-
ferred or distributed under this regulation. An official
order form must be utilized for any distribution or re-
ceipt of Schedule II drugs.

The records for Schedule II drugs distributed or

received under this regulation must be kept separate from
the records for Schedule III, IV or V controlled sub-

stances, as required by the Act for all records.

Maryland Board
of Pharmacy News

Pharmacy Changes

The following are the pharmacy changes for the
month of September:

New Pharmacies

Larken Pharmacare, Inc., Kenneth S. Sumida, Presi-
dent, 5202 Baltimore National Pike, Baltimore, Mary-
land 21229.

Northwest Community Professional Pharmacy, Roger
C. Lipitz, President, 3140 Oakford Avenue, Baltimore,
Maryland 21215.

Plaza Drugs, Jonas Yousem, President, 2244 Hanson
Road, Edgewood, Maryland 21040.

No Longer Operating as Pharmacies

Drug Fair No. 61, Milton L. Elsberg, President, 6891
George Palmer Highway, Seat Pleasant, Maryland 20027.

Changes of Ownership, Address

Crestlyn Pharmacy, Marvin Anshell (Change in
ownership), 3840 Crestlyn Road, Baltimore, Maryland
21218.

Asbill Pharmacy, Alfred H. Alessi, President
(Change of address), 42 West Chesapeake Avenue, Tow-
son, Maryland 21204.

NOVEMBER 1971

ila tt a

There’s a lot more going for you at LOEwy

Sfectre PERSONALIZED SERVICE PLUS

provides you with the flawless backing of 100% computerization—
along with the special personal follow-through of people who care

Drug wholesaling divisions of Spectro were among the first in the industry to
know the unprecedented advantages of fully computerized warehousing and
delivery service. But as a retailing-oriented distributor, we Know, too, that
nothing can take the place of personalized understanding and service follow-
through. That’s why every one of us at the management, sales and service levels
is vitally concerned about any phase of service that is of special concern to you.
This happy combination of automation and personalization adds up to a quality
and completeness of service that just isn’t likely to be matched through any
other source.

FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY

- taking. (301) 485-8100 for office and daytime order taking.
After hours, 485-8105 for order taking (301) aw So en

LOEWY DRUG COMPANY $52 Yrentr Sochotiin, Sa

6801 Quad Avenue, Baltimore, Md. 21237. Tel.: (301) 485-8100

MPhA Fall Regional
Meeting

The Maryland Pharmaceutical Association held its
Fall Regional Meeting in conjunction with TAMPA and
LAMPA on Thursday, October 7, 1971 at the Baltimore
Playboy Club. Luncheon and cocktails were served prior
to the meeting.

The Squibb Past Presidents Award was presented to
Donald O. Fedder by Gerald Bringenburg, District Man-
ager for E. R. Squibb & Co. Charles E. Spigelmire, Bal-
timore pharmacist, received the A. H. Robins “Bowl of
Hygeia” award for outstanding community service by
pharmacists from Roger L. Elgin, district manager in the
Capitol Division of A. H. Robins Company. Mr. Spigel-
mire is treasurer of the Baltimore Metropolitan Pharma-
ceutical Association.

Samuel W. Kidder, Pharm. D., M.P.H., of the Com-
munity Health Service, Division of Medical Care Stand-
ards of the federal Department of Health, Education and
Welfare was the guest speaker. The topic of discussion
was “Health Maintenance Organizations.”

Sydney L. Burgee, Speaker of the House of Dele-
gates, called the meeting of the House to order. A report
from the Prescription Insurance Plans Committee was
given by chairman Morris Bookoff. Mr. Bookoff reported
that he was awaiting guidelines from the National Phar-
macy Insurance Council before the association estab-
lishes a pharmacy services foundation for handling third
party area activities.

Other activities of this committee which were re-
ported were: formulation of guidelines for pharmaceuti-
cal services to the medically indigent, establishment of a
pharmacy and therapeutics committee with the Maryland
State Medical Society, development of a formulary, and
processing of the Esskay Meat Company office and sales
employees’ prescription insurance program which former-
ly was available only through one drug chain in the Bal-
timore area.

The committee is looking into other prescription in-
surance plans such as the Teamsters Plan No. 355, Sen-
ior Citizens Plan and the AFL-CIO Plan. It was
pointed out that non-MPhA members will also be able to
participate in any prescription insurance programs ad-
ministered by MPhA.

Chairman of the Board of Trustees, Donald O. Fed-
der, explained the Drug Product Selection issue and
made a motion for endorsement of a proposal to amend
State anti-substitution laws to permit pharmacists to dis-
pense another brand than which the prescriber indicates
on his prescription unless the prescriber also denotes the
name of the manufacturer of the drug which he orders.
After some discussion and an unsuccessful attempt to
amend the motion, the motion was approved as presented.

The meeting was adjourned at 4:45 p.m.

10 THE MARYLAND PHARMACIST

Photo courtesy of Jerome L, Fine and Paramount Photo Service

Charles E. Spigelmire receives Bowl of Hygeia Award at MPhA Fall
Regional. Roger L. Elgin, right, representative of A. H. Robins
Company makes presentation.

APhA Asks Senator Humphrey
To Help Gain Commissions

APhA has asked Senator Hubert H. Humphrey (D-
Minn) to seek amendment of the Selective Service Act
to assure commissions and pharmacy assignments in the
military.

“It would seem that the time is right for such an
amendment to the Selective Service Act,” APhA Execu-
tive Director Apple wrote to Senator Humphrey. Dr.
Apple reviewed APhA’s continuing efforts in the area
and concluded: “There is ample justification for such a
position in view of the contribution pharmacists could
make to optimal health care in the military and in view
of the long standing inequity which has existed whereby
pharmacists are the only remaining major health pro-
fessionals who are not granted the status and authority
necessary for them to exercise their professional responsi-
bilities while in the service of their country.”

PHARMACY CALENDAR

December 9—( Thursday )—Maryland Society of Hospital
Pharmacists meeting at University Hospital, 7:30
p-m.

December 12-16—American Society of Hospital Phar-
macists Sixth Annual Midyear Clinical Meeting,
Washington, D.C.

January 30, 1972—56th Annual Installation Banquet &
Dance, Baltimore Metropolitan Pharmaceutical Asso-
ciation, Blue Crest North.

April 22-28, 1972—American Pharmaceutical Associa-
tion Annual Meeting, Houston.

May 7-9, 1972—Annual Convention, Maryland Phar-
maceutical Association, Washington Motel and
Country Club, Gaithersburg Maryland.

May 17-22, 1972——Post-convention trip, Maryland Phar-
maceutical Association, Pierre Marquis Hotel, Aca-
pulco, Mexico.

NOVEMBER 1971

Display the Bidette duo for
Tull month feminine hygiene

oe PEPLOAL OEE LAD LCL LR GLARED ED PE SELLOEOLO LR AAC CROLCIP CRED FEE EE

—mewintimate
feminine hygiene
deodorant mist

Size.

with

Purchase
of

5 OZ. SIZE

.. INTIMATE
FEMININE HYGIEN

Deodoran
. Mist

INTIMATE
FEMININE
HYGIENE

deodora
Mist

Over the past two years more
than 3 million packages of
Bidette have been sold to
women, who not only want
Bidette Mist for odor pro-
tection during normal days
...but also want Bidette
Towelette for difficult days
when they wish to cleanse
as well as deodorize.

Youngs Drug Products Corporation
™ 865 Centennial Ave., Piscataway, N. J. 08854

LAMPA News

Ladies Auxiliary Maryland
Pharmaceutical Association

The newly refurbished Playboy Club in Baltimore
was the locale for LAMPA’s Fall Regional Meeting on
Thursday, October 7, 1971. Over a hundred men and
women enjoyed a delicious filet mignon lunch, served by
the well-publicized “‘bunnies.”

After lunch, Donald Fedder, MPhA Board of Trus-
tees Chairman, was awarded the Squibb Past President’s
Award—a beautiful Delft Mortar and Pestle. Charles
Spigelmire, Treasurer of the BMPA, received the 1972
Robins Bowl of Hygeia Award for community service—
a handsome brass bowl, in silhouette, mounted on a wood-
en plaque, and appropriately engraved.

During LAMPA’s business meeting, the revised Con-
stitution was approved by a unanimous vote of the mem-
bers present. President Dora Rockman announced that
the MPhA would sponsor a trip to Acapulco, Mexico, May
17 thru 22, 1972, as part of the annual convention. All
other reports reflected favorable news, both financial and
social.

“Tools of the Apothecary” a presentation by Morris
L. Cooper, curator of the MPhA Cole Pharmacy Museum,
was another first for LAMPA. The Cooper Collection
has been shown in Europe and South America, but has
not had too much local exposure. The color slides, which
were unusually clear, showed a large number of mortars
and pestles, of varied sizes and shapes, in metal, wood
and ceramic and ranging in age from the present to a
rare 10th century Islamic antique. Elaborate show globes,
as well as archaic drug chopping machines were shown.
Also, the more familiar pill tile and tablet machines of
50 years ago. Several delicate and unusual scales; a cork
reducer, as well as a cork retriever; and a quassia cup;
all elicited spontaneous questions. Even a round, metal
hot water bottle appeared on the scene.

Especially interesting was a collection of old com-
pounds, the labels describing the many and diverse uses,
brought forth chuckles. Suppository molds, for man or
beast; a labeling machine, and a blood letting gadget, for
relieving hypertension, were carefully explained.

At the conclusion of the slide showing, Mr. Cooper
showed and explained several very old articles he had
brought to the meeting, such as a banjo scale, used to
weigh opium; an elaborate doctor’s kit; and silver pills.
All the artifacts shown were of museum quality; many
having been authenticated by officials of the Smithsonian
Institute in Washington, D.C.

It is almost impossible to adequately summarize a
collection so varied, but you leave with a distinct feeling
that the collector is sincerely dedicated to his profession
and enjoys seeking out and studying the treasures of the
past—the foundation upon which some of today’s prog-
ress is built.

—Ann Crane
Communications Secretary

A. Z. O. News

An AZO Breakfast Meeting was held on Sunday,
October 24 at the Quality Courts Motel on Reisterstown
Road. The AZO Fall Regional Meeting was scheduled for
November 6 and 7 at the Hunt Valley Inn, Baltimore.

12 THE MARYLAND PHARMACIST

TAMPA News

The Traveler’s Auxiliary of the Maryland Pharma-
ceutical Association held a dinner meeting at Peerce’s.

Plantation in Dulaney Valley on October 7. The fea-
tured speaker was Mr. Charles Keller of the Baltimore
Sun, who showed slides of his recent trip behind the Iron
Curtain,

The group held its very successful ‘Ladies’ Nite” on
Thursday, November 4 at the Garland Dinner Theater
in Columbia, Md. Members saw the hilarious play “A
Very Uncomplicated Girl.”

Prince Georges—Montgomery County

The Prince Georges-Montgomery County Pharma-

ceutical Association held its 17th Annual Scholarship
Fund Affair on Saturday, October 30, at the Washing-
tonian Country Club in Gaithersburg, Maryland. Pro-
ceeds from the affair will be used to provide scholarship
assistance at the University of Maryland School of Phar-
macy. The program was entitled “A Night at the Races”
and included a buffet dinner and auction.

An executive committee meeting was held on Octo-
ber 20 in Silver Spring.

Eastern Shore Pharmaceutical Society, Inc.

The Eastern Shore Pharmaceutical Society held its
annual Fall Meeting on Sunday, October 17 at the Har-
bor Vue Inn, St. Michaels, Maryland. The evening’s
speaker was Mr. Richard J. Holt, Curator of the St.
Michaels Museum.

Members of the group attended a meeting of the
Delaware Pharmaceutical Association held at the Cen-
tury Club in Milford, Delaware on October 20. A physi-
cian from the Wilmington area spoke on “The Pharma-
cist’s Role in Management of the Diabetic.” Also, a
P.M.A. film was shown entitled “Mr. Galen Goes to
Town.”

Have You Returned Your
Biographical Information Sheet?

NOVEMBER 1971

Paramount Photo Service

The Quality and Service Photofinisher

Is Pleased to Announce
They’re Moving to Their New Laboratory
To Serve You With
The Most Modern and Latest Equipment.

Note our new address and telephone number:

PARAMOUNT PHOTO SERVICE

2920 Greenmount Avenue
Baltimore, Maryland 21218

Telephone: Baltimore 366-1155
Washington Area [Local call] 484-4050

NOVEMBER 1971 THE MARYLAND PHARMACIST 13

Hospital Pharmacy
Section

Maryland Society of Hospital Pharmacists
Meeting of October 14, 1971

The Maryland Society of Hospital Pharmacists held
its October 14 meeting at St. Joseph’s Hospital in Tow-
son. The guest speaker was Sharon K. Chapman, Ph. D..
Assistant Professor, Pharmacology and Toxicology, Uni-
versity of Maryland, School of Pharmacy. Her topic was
entitled “Drug Therapy and the Cardiae Patient.”

New members admitted in the Society at the meet-
ing were: David M. Arrington, pharmacy resident at the
Johns Hopkins Hospital; Tuong Anh Bui Nguyen, phar-
macy resident at Maryland General Hospital; Robert T.
Wheeler, Jr., Ciba representative; and the following stu-
dents: Brenda M. Brandon, Geoffrey J. C. Boyd, Linda
Susan Craig, Michael A. Grover and Donna S. Levin.

Reports were heard from Clarence Fortner. the semi-
nar committee chairman: Samuel Lichter, the seminar
program chairman; Paul Burkhart, the monthly meetings
program chairman; and Howard Sherman, the member-
ship committee chairman.

Dr. Peter P. Lamy and Vincent dePaul Burkhart
will present a paper entitled ‘Patient Education Using
Audio-Visual Aids” at the annual meeting of the Asso-
ciation for the Advancement of Science on December 26

in Philadelphia.

Mary Connelly announced that the Board of Di-
rectors, at its meeting of September 22, had decided to
institute a continuing education program which would
recognize the society members’ attendance at society
functions during the year by issuing credits. The Society
approved a motion to adopt this continuing education pro-
gram. The Board also met on October 13 with attorney
Joseph S. Kaufman, legal counsel for the Maryland Phar-
maceutical Association, in reference to legal implementa-
tion of the “Guidelines for Pharmacy Services in Hos-
pitals.” At a meeting of the Board held on October 14,
some proposed changes in the medicaid prescription pro-
gram were discussed.

All-American Hospital
Pharmacy Seminar

An All-American Hospital Pharmacy Seminar was
held on October 23, 1971 at the Friendship International
Hotel in Baltimore. The seminar was attended by nearly
200 pharmacists from the District of Columbia and Mary-
land areas. The seminar was presented by Eli Lilly and
Company in cooperation with the District of Columbia
Society of Hospital Pharmacists and the Maryland So-
ciety of Hospital Pharmacists.

Mary Connelly, president of the Maryland Society
of Hospital Pharmacists, gave the opening remarks. Loren

14 THE MARYLAND PHARMACIST

Platte of the Professional Relations Department of Eli —
Lilly introduced the panelists.

The program included: “The Shape of Things to Come” —
by Dr. Glen J. Sperandio, Professor and Head of the De- —
partment of Clinical Pharmacy, Purdue University; “A
Response to the Challenge” by John A. Oliver, Clinical
Pharmacy Practitioner and Educator, San Diego, Cali- ©
fornia; “Drug Interactions” by Dr. Edward A. Harts- —
horn, Director of Pharmacy Service, Evanston Hospital
Association, Evanston, Illinois; ‘The Impact of Unit Dose
on Drug Distribution” by Carl B. Burnside, Head, Tech-
nical Services, Equipment Sales, Elanco Products Com- —
pany, Indianapolis; and the dinner speech, “You Are the —
Master of Your Future” was given by Martin S. Ulan,
Vice President, Hackensack Hospital, Hackensack, New
Jersey. .

ASHP Council Meets

The American Society of Hospital Pharmacists held
a three day meeting of its Council on Organizational
Affairs at ASHP headquarters on October 4, 5 and 6,
1971. The meeting which was attended by council mem-
ber Robert E. Snyder of Baltimore consisted of a two day
conference and a one day retreat on clinical problems at

which all ASHP councils participated.

One of the main objectives accomplished at the
council meeting was a reorganization of the affiliated —
state chapters arrangement.

American Medical Association Contracts

For ASHP’s Computer Drug Code

The American Medical Association has recognized
the outstanding utility and versatility of the Drug Prod-
ucts Information File (DPIF) in the recent signing of a
two-year contract for its use. According to the terms of
the contract, ASHP’s computer code of information on
drug products will be employed in revising each chapter
of AMA Drug Evaluations. With data on over 20,000
drug products and their packages, DPIF will provide in-
formation on dosage forms, routes of administration,
strengths, packages, etc., for incorporation into the AMA
book.

The AMA utilizes an IBM 360/Model 50 computer
at its headquarters in Chicago. About fifteen researchers,
five systems analysts and fifteen programmers work on
various AMA computer-related projects.

More than 40 hospitals in the United States, Canada
and Israel now utilize ASHP’s Drug Products Information
File in a wide range of computer systems including in-
ventory control, patient billing, cost analysis, preparation
of drug lists and abridged formularies, and maintenance
of records on controlled drugs.

NOVEMBER 197!

ROCHE LABORATORIES
Division of Hoffmann-La Roche Inc.
Nutley, New Jersey 07110

Baltimore Metropolitan
Pharmaceutical Association

Baltimore Metropolitan Pharmaceutical
Association Meeting of October 21, 1971

The Baltimore Metropolitan Pharmaceutical Asso-
ciation held a general meeting at the Kelley Memorial
Building in Baltimore on October 21, 1971 at 8:30 p.m.

The meeting began with a presentation on antibiotic
therapy by Paul V. Niznik of the Eli Lilly Company.
This was followed by a panel discussion on “Prescription
Insurance Programs—New and Old” moderated by Mor-
ris Bookoff, Maryland Delegate to the National Phar-
macy Insurance Council. (Note: Mr. Bookoff’s presenta-
tion is published on page 18 of this issue).

Other participating panelists were Stuart L. Ballti-
more, Jr., Manager of Pharmacy Relations, Maryland
Blue Cross and Robert E. Snyder, Pharmacy Consultant,
Prescription Drugs, Inc. A business meeting followed.

Presentation Made to Camp Glyndon

Photo by Paramount Photo Service

Irvin Kamenetz, President, Baltimore Metropolitan Phar-
maceutical Association, presents check to Dr. A. A. Silver
(left), Medical Director, Camp Glyndon Camp for Dia-
betic Children. More than $3300 was collected through
pharmacies in the Baltimore area to help rebuild the
vandalized facility.

16 THE MARYLAND PHARMACIST

BMPA Meeting

Founded

: : BN
Photo by Paramount Photo Service
Left to right: Melvin Rubin, Program Chairman; Paul V. Niznik,
Eli Lilly Company; Stuart L. Baltimore, Jr., Manager of Pharmacy
Relations, Blue Cross; Irvin Kamenetz, President, Baltimore Metro-
politan Pharmaceutical Association; and Morris Bookoff, Moderator.
Robert E. Snyder, Pharmacy Consultant to Prescription Drugs, Inc.,
and panelist, not photographed.

MPhA To Serve As Clearing House
In Third-party Drug Program

The Maryland Pharmaceutical Association will serve
as a clearinghouse for the prescription program for sales
and office employees of the Esskay (Schluderberg-Kurdle
Co., Inc.), a group representing about 400 families. The
plan will be served through all pharmacies as a result of

efforts of the MPhA office.

MPhA is currently engaged in efforts to set up the
machinery for an operation under pharmacy auspices to
serve as a clearing house for all third-party drug pro-
grams. This work is proceeding under Morris Bookoff,
Chairman of MPhA’s Prescription Insurance Plans Com-
mittee.

The objectives are to have pharmacy input into ev-
ery aspect of third-party payment systems that affect the
profession and develop a unified, disciplined posture vis-
a-vis sponsors and administrators of these programs.
Under consideration to implement these goals is the estab-
lishment of a nonprofit corporation which will be com-
posed of participating pharmacists.

NOVEMBER 1971

|
;

BR 7;

ed eeere
o” 2 %%e 2” ,0%%e
e

.s °
Pa eee Sits ees

COMPANY ! : d
BALTIMORE + DOVER » NORFOLK +» WASHINGTON ww : ‘ ° t?
AS. \
\
iD es

3 o
phen eer a
$ e @ e
an taeians a
i Dea Pe |
t: 3 A wt
: t emee x Geom.
. §& :¢ 9 $
we fS2 AY
FFE E PE
ry $ : fins
egy { me } fogs
ENGEL NA cee 2

Third-Party Prescription
Programs--Delight or Dilemma

by Morris Bootkoff,
Maryland Delegate to the National Pharmacy
Insurance Council

Based on presentations at the annual meeting
of the American College of Apothecaries, Coc-
keysville, Maryland held on October 3, 1971
and at the meeling of the Baltimore Metropoli-
tan Pharmaceutical Association on October 21,

1971

Prior to 1968 third-party programs were of little
magnitude, and in most states they were present only in
the form of Medicaid or state welfare programs. Pharma-
cists, of course, being noted for their philanthropy and
public spirit mindfulness were asked, in most instances,
to subsidize these programs through the payment of fees
below prevailing rates, and in many states this situation
still persists.

Since 1968, however, it’s been a new ball game.
Here in Maryland, pharmacists, in addition to participat-
ing in state programs, are also serving the “Blues,” union
prescription plans, PAID, Prescription Drugs, Inc., Medi-
Met and Champus. And _ those pharmacies near Wash-
ington serve even more!

Unfortunately, when third-party programs became a
fact, pharmacy was unprepared. Policy was dictated to us.
\7e found ourselves faced with a different form, a dif-
ferent fee and a different basis for computing cost with
each developing program.

Initial forms were so poorly designed that the first
task of the Maryland committee was to redesign them so
that someone other than a Ph.D. in computer technology
could complete one. With this accomplished, we sought
to broaden the use of plastic I.D. cards and imprinters.
Blue Cross cooperated by allowing pharmacies to use
their imprinters for state Medicaid Rx’s. Of even greater
importance is the work being done by the National Phar-
macy Insurance Council in the development of a standard
claim form and a single I.D. number for each pharmacy.

Fees . . . How are they determined? Oh! That
formula is very simple. It was devised by a clever third-
party administrator and goes like this: current state Medi-
caid fees plus ten cents equals a happy pharmacist, de-
lighted to make an extra dime . . . That’s his opinion!
I guess this is where our philanthropy has finally caught
up with us.

A recent survey of Rx fees for private patients in
Maryland revealed an average fee of $2.25. However, the
third-party fees average only $1.85. Are these third-party
fees realistic when one considers the additional time in-
volved in filling out forms and the delays in payment by
these programs?

In the light of this, shouldn’t third-party fees be
greater rather than less than regular fees? Take the
problem of a different basis for computing cost of in-
gredients. Why should someone in Detroit with no knowl-
edge of pharmacy operations, make the decision that ac-
quisition cost should be used to compute cost when nor-

18 THE MARYLAND PHARMACIST

mally we use wholesale cost. Let’s be realistic. What is
acquisition cost? Is that the cost to the door or the cost
to the Rx counter? For those who warehouse, is it the
cost to the warehouse, or is it the cost to the store? It just
doesn’t make sense to purchase drugs in quantity only to
pass the savings on to General Motors, Chrysler, Ford,
etc. Would they sell me my delivery vehicles at acquisi-
tion cost plus a fee determined by me? Why is it that
under the Noerr Doctrine, pharmaceutical associations
may negotiate and discuss fees with federal, state and
local governments; but we must petition the government
to negotiate with other third parties? Isn’t it ironic that
we cannot negotiate, but that those who are receiving the
benefits of our services negotiate for these very benefits?

I refer to the N.A.R.D. bill—a proposed measure
entitled the “Prepaid Prescription Negotiation Act.” It
would permit negotiation of reimbursement and details
of program operation. The interim guidelines proposed
to the Federal Trade Commission and Justice Department
would allow representative pharmacy groups to give third-
party program administrators information on operational
costs of retail pharmacies, costs incurred in dispensing
prescription drugs and costs related to professional serv-
ices performed by pharmacists. These guidelines, how-
ever, will not permit any pharmacy group to enter into
any binding agreements. Nor may the advisory groups
engage in any boycott activity relating to a proposed or
existing third-party program. In my opinion, this will
accomplish very little.

In Maryland I have met informally with third-party
administrators and sponsors on a one-to-one basis and,
in fact, have done exactly what the guidelines suggest.
Will the administrators or sponsors be any more recep-
tive just because a committee of three or four is involved?
I would like to think so, but I highly doubt it. Without
some of the tools used by others who bargain collectively,
I feel our efforts will be in vain.

Let me address myself to the area which concerns
me the most, and | hope everyone here agrees. That is,
the failure of these programs to establish guidelines as to
what constitutes proper pharmacy service. I quote Dr.
Donald Rucker, Senior Health Analyst, Social Security
Administration, ‘The goal of a large third-party program
(should be) to develop an objective basis for calculating
the economic value of dispensing services.”' I say that
the goal of a large third-party program should be to be
certain that the recipients of service get proper pharmacy
care—then, to worry about cost. Mr. Administrator, don’t
force those pharmacies which have sought to improve the
quality of pharmacy care to return to the dark ages. Don’t
make us abandon the use of patient record cards and the
ability to find drug interactions. Just two weeks ago my
associate discovered a patient on Coumadin being given
a prescription for Butazolidin. Should this patient now be

' American Druggist, August 9, 1971

NOVEMBER !971

among the dead because administrators who are totally
ignorant of their impact determine that patient record
ecards are a nonreimbursable service?

Many of us feel that prscription delivery is vital to
proper pharmacy service. Just last week someone called
and didn’t ask if we deliver but how soon we could de-
liver since the patient was hemorrhaging. Should the
patient bleed to death because administrators don’t recog-
nize delivery as being important to good pharmacy care?

Again, let me quote Dr. Rucker, “Delivery is an-
other matter which will have to be determined. Should
this be included as a necessary operating cost?’ * Recent-
ly, the state of Maryland budgeted $2,000,000 to provide
for transportation of indigents to physicians and_hos-
pitals yet no reimbursement is budgeted for pharmacists
who provide delivery service.

Let me briefly mention some services not generally
recognized by administrators:

(1) Compounding—Do third-party programs have
adequate fees for compounding? Is it any wonder that
some pharmacies refuse to fill these prescriptions, causing
great inconvenience to the patients.

(2) Twenty-four hour emergency service — Shall
those of us who provide this type of service discontinue
at?

(3) Unit dose—With all the cry about the care of
the aged, does our state recognize this method of pre-
scription delivery system. Yes, but the payment is the
same: no payment for packaging and no payment for

*F.D.C, Report, August 9, 1971

extra cost of dispensing. How archaic can a system be
when it stifles improvement?

(4) Patient record cards—I just can’t over empha-
size its importance. The responsibility of pharmacy to the
public concerning drug and medication control and dis-
semination of drug information demands an adequate
pharmaceutical record system. A pharmaceutical record
system serves as positive proof of the willingness of a
pharmacist to accept additional responsibilities concern-
ing patient health care.

(5) Continuing education—Shall those who strive
to keep abreast of the times be treated as those who mere-
ly go through the motions?

(6) Delivery
And I’m sure you can add even more.

Obviously, the need is great to develop guidelines
for pharmacy service and the establishment of dual or
variable fees so that those pharmacies providing some of
the vital services that I have mentioned are properly
compensated.

It is relatively easy for us to overlook unjust fees
when they represent such a small portion of our volume.
But if current predictions on the growth of third-party
programs are correct and certainly if a national health
insurance bill is passed, this will not be the case. There-
fore, Mr. Administrator, don’t let pharmacy be subject
to criticism for failing to give proper care when our hands
have been tied. Let us work together to establish guide-
lines in order that we may have control of our future
and so that we may give to the American public the type
of pharmacy service to which it is entitled.

Offering Independent Pharmacies...

Top Discounts off of Traditional “list” prices
ASTRO advertising-merchandising program
CAL-SERV rack service

Full line service. The slow-moving as well as
the fast-selling products.

Plus many other servies—all of which add up
to making your best source of supply,

NOVEMBER 1971!

THE

CALVERT DRUG COMPANY, INC.
901 Curtain Avenue
Baltimore, Maryland 21218

Phone 467-2780

THE MARYLAND PHARMACIST 19

You know the fellow up front — he’s your CIBA
Representative. But what about the hundreds be-
hind the scenes whom you never see? What con-
nection do they have with you? You'd probably be
surprised. No less than four CIBA departments
are charged with servicing the pharmacist. For
example:

Customer Service sees to it that your orders are
processed within 24 hours. They also manage your
account, credit your returns, resolve your com-
plaints.

Do you ever come up against a difficult question
from a doctor concerning the use of a CIBA prod-
uct? If so, and you need help, write to Medical Com-
munications. Several knowledgeable staff physi-
cians stand ready to answer your inquiries promptly
and thoroughly.

Or how about the problems you confront in your
profession? Compatibility. Stability. Quality. Bio-
availability. These are always of serious concern
among pharmacists, especially when an unex-
pected reaction occurs. If ever a CIBA product is

involved, Pharmacy Research usually has an ex-
planation, for it is their responsibility to check and
recheck all of our products during the develop-
mental stage so that we can anticipate how our
medications will react under almost any conditions.

Professional Relations serves as your personal liai-
son with CIBA’s “home office.” It is this department
that coordinates the policies and procedures that
affect you. For instance, policies for return goods,
disaster assistance, expiration dating, and product
identification drug codes all originate in Profes-
sional Relations. Members of this department also
represent CIBA at many local and national meet-
ings, so stop by and discuss anything that’s on your
mind. They’re at your disposal.

There certainly is a lot more to CIBA than meets the
eye — when you look a little deeper. 27 466s

CIBA Pharmaceutical Company
Division of CIBA-GEIGY Corporation
Summit, New Jersey 07901

Carbs

Ne, a

First Maryland Health Care

Corporation to Coordinate
HMO’s

The First Maryland Health Care Corporation, a
Baltimore non-profit organization affiliated with the City
Health Department, has been funded with a $98,880
planning grant from the U.S. Office of Economic Oppor-
tunity.

Incorporated early in the year, this new organization
is now in the process of designing health maintenance
organizations (HMOs) to offer prepaid family health
care packages to potentially as many as 200,000 Balti-
moreans in the northwest and west sections of the city.
Over the next two years First Maryland anticipates an
additional two to three million dollars in OEO funds to
help pay for health services. When completely organized,
this non-profit health agency will coordinate a network
of consumers, interested physicians, medical groups, hos-
pitals, neighborhood health centers and community health
councils.

The First Maryland Health Care Corporation will be
one of 11 model HMOs funded through OKO to carry
President Nixon’s national health strategy to inner city
residents. Dr. Robert M. Vidaver, former director of edu-
cation in the Maryland State Department of Health and
Mental Hygiene, is the agency’s first president. Health
maintenance organizations are a new direction in health
care. HMOs under First Maryland would provide total
health care services from neighborhood centers for a
single monthly premium. Subscribers and their partici-
pating family members could have any number of doc-
tors’ visits, consultations or days if general hospital care.
Two HMOs are operating now in the First Maryland
area: one is sponsored by the West Baltimore Communi-
ty Corporation and the other by Provident Hospital.

City Health Department studies indicate large num-
bers of Baltimoreans go without ordinary medical care
simply because there are no physicians nearby. Fifteen of
the city’s census tracts are without a single primary care
physician. Many more are woefully understaffed. In
search of solutions, Dr. John B. DeHoff, Deputy Commis-
sioner of Health, was assigned the job of implementing a
pilot Baltimore HMO having particular concern for inner
city people. First Maryland, which is patterned after the
academic health manpower organization, the Maryland
Consortorium for the Health Sciences, grew out of this
effort. Representatives of the Sinai, Provident, Lutheran
and Bon Secours hospitals, the Provident OEO and West
Baltimore neighborhood care centers, the Gar-Wyn Medi-
cal Group, the Baltimore City Medical Society and the
Northwest Community Organization have joined with
City Health Department physicians Dr. James D. Carr,
Dr. Jimmie L. Rhyne, and Dr. DeHoff in the corpora-
tion. To be sure First Maryland’s consumers get the
services they need, its guiding Board of Trustees includes
one-half consumers, two-thirds of whom are poor people.

The First Maryland Health Care Corporation, like
other health maintenance organizations, seeks to develop
group practice alternatives to the time-honored solo prac-
titioner, fee-for-service medicine. Rising costs, doctor
shortages and crowded emergency rooms are adding im-
petus to HMO formation, the more so since Mr. Nixon’s
February “Health Message” endorsement.

NOVEMBER 1971

University of Maryland
School of Pharmacy

William J. Kinnard, Jr., Ph.D., dean of the School
of Pharmacy, University of Maryland at Baltimore, has
announced new faculty appointments.

Laurence H. Hurley, Ph.D., has been appointed
assistant professor of pharmacognosy. Herbert Kushner,
M.D. has been appointed assistant professor of pharmacy.
Dr. Kushner is presently assistant professor of medicine
at the University of Maryland School of Medicine and
will be responsible for coordinating the therapeutics
course given to senior students in the School of Pharmacy.
He will also serve as consultant in the clinical pharmacy
program which is run by the School of Pharmacy and

the University of Maryland Hospital.

Also appointed to the clinical pharmacy staff, serv-
ing jointly with the School of Pharmacy and the Univer-
sity of Maryland Hospital, is Robert A. Kerr, Pharm. D.
John F. Fader, Il has been appointed lecturer in_phar-
macy administration. Mr. Robert J. Michocki and Mr. J.
Kenneth Walters, both B.S. in pharmacy graduates from
the University of Maryland in 1971, have been appointed
associates in pharmacy, serving the School of Pharmacy
and University Hospital in the area of clinical pharmacy.
Mrs. Karen T. Collins has been appointed clinical asso-
ciate in pharmacology and toxicology. Mrs. Collins has
been poison control officer in the Poison Information
Center located at the School of Pharmacy.

Mr. William J. Edmondson has been appointed co-
ordinator of the professional experience program and
associate in the department of pharmacy. Mr. Edmond-
son, who will coordinate the school’s educational program
with the clinical instructors in community and hospital
pharmacy, will be teaching the pharmacy students dur-
ing the professional part of their education.

Alabama Trains Preceptors

Effective August 1, 1971, all pharmacists who have
been approved by the Alabama State Board of Pharmacy
as preceptors must attend a training seminar for precep-
tors at least once every two years. Such training seminar
shall have prior approval of the board.

Headquarters for

PHOTO-OFFSET PRINTING MAILING
PRINTING ROBOTYPED LETTERS

call — MUlberry 5-3232, 33, 34

D. STUART WEBB

Advertising Services, Inc.
306 N. GAY STREET
Baltimore, Maryland 21202

THE MARYLAND PHARMACIST 21

J.T. Baker Signs Agreement
With Hadassah

The J. T. Baker Chemical Company, division of
Richardson-Merrell Inc., has signed a formal agreement
with Hadassah for the rights to a cancer diagnostic test
developed at the Hadassah Hebrew University Medical
Center in Jerusalem. Announcement of the signing of
the agreement was made by A. L. Baldock, President of
J. T. Baker and Mrs. Max Schenk, President of Hadas-
sah, the Women’s Zionist Organization of America. Mr.
Baldock emphasized that development of this test for
use in the United States will be prolonged and that it is
not possible to predict what its commercial significance
will be to Baker.

The evaluation program for this diagnostic test
known as the T-globulin test, will be carried on jointly
by the scientific staffs of J. T. Baker and Merrell-Na-
tional Laboratories Division of Richardson-Merrell Inc.
These chemical and pharmaceutical divisions of Richard-
son-Merrell Inc. bring together a combination of the skills
necessary to perfect the test.

The test, developed by Dr. Chloe Tal, an immunolo-
gist at the Hadassah Hebrew University Medical Center
in Jerusalem, shows promise for the early detection of
cancer.

Joseph G. King Elected President of The
American College of Apothecaries —
College Adopts Single Resolution

At the 31st Annual Convention in Hunt Valley
(Baltimore), Maryland, October 1-4, the following off-
cers were elected and installed: Joseph G. King, Chatta-
nooga, Tennessee, President; Casimir H. Srutwa, Scotts-
dale, Arizona, President-Elect: Lynn H. Cook, Flint,
Michigan, Vice President and Minter B. Ralston, Jr..,
Weston, West Virginia, Treasurer. M. Donald Pritchard,
Buffalo, New York is the new Chairman of the Board of

Directors.

For only the second time in its history, the ACA
concerned itself with a single resolution. The resolution
follows:

WHEREAS the hiking of minimum orders for di-
rect purchasing to unrealistic levels is prejudicial to the
best interests of the independent community pharmacist
and is discriminatory to those Pharmacy practitioners
who operate single pharmacies; and

WHEREAS unrealistically high minimum orders
preclude the individual pharmacy owner from competing
with the multiple pharmacy operator in today’s highly
competitive market-place;

BE IT RESOLVED that the American College of
Apothecaries in convention assembled urge Pharma-
ceutical Manufacturers to review these policies in order
that minimum direct orders may achieve a more realistic
level.

22 THE MARYLAND PHARMACIST

Representing

EMPLOYED PHARMACISTS
P.O. BOX NO. 2322
ROCKVILLE, MARYLAND 20852

Pension & Investment
Associates of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)
HR-10.. Plans (Sole Proprietor-Partnerships)

Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

$$
—_—_ooOoOoOO LL eeeseSSSsSSseSs
en

NOVEMBER 1971]

odd orders processed,
naturally

The oddball customer who insists he wants a print cropped “just this way.”

The man who wants cut film developed, or some positive film strips. The guy who
hands your clerk an unheard-of cartridge of film.

Welcome them. They all mean good business.

Just drop the oddball order into the Berkey bag. We'll process it with the

and black-and-white, right up to 16 x 20 black-and-white blowups.

We’re ready to service all your needs. Berkey does things for

you that no one else does . . . because no one else can.

Berkey

Film Processing

of Washington, D.C.
3701 Mt. Vernon Avenue
Alexandria, Virginia 22305

Balvision OF 703) 549-7500
Al ‘
need wg

PMA Announces New ‘Starter’
Research Grants

The Pharmaceutical Manufacturers Association
Foundation announced a new program of “starter” re-
search grants aimed at helping young college investiga-
tors to develop their independent research capabilities.

Foundation President C. Joseph Stetler said the
Foundation will make approximately 15 two-year grants
of $5,000 a year. Research fields covered by the pro-
gram are pharmacology, clinical pharmacology, and drug
toxicology.

“The purpose of the Research Starter Grant Program
is to provide financial support to young investigators who
need initial funding,” Stetler said.

Funds generally will be unrestricted, except the grant
cannot be used for salary support and no more than $500
can be used for travel.

Information describing the grant program has been
mailed to colleges and universities throughout the coun-
try. Grants will be made to the institution on behalf of
the applicant.

Those holding academic rank through assistant pro-
fessor and investigators at the doctoral level with equiva-
lent positions are eligible to apply for starter grants, pro-
vided their proposed research is neither directly nor in-
directly subsidized to any significant degree by extramural
support. Applicants will be judged on the merits of the
proposed research and the degree of need by the investi-
gator.

The deadline for awards beginning January 1, 1972,
is January 1, 1972, is October 15, 1971.

Recipients will be selected by the Foundation’s Board
of Directors, based on recommendations from its Scientific
Advisory Committee.

Alabama Becomes 18th State
To Affiliate With APhA

The Alabama Pharmaceutical Association became
the 18th state pharmaceutical association to vote to
affiliate with APhA since 1962 and the second to do
so this year. Almost two out of every three pharmacists
reside or practice in states affiliated with APhA.

Other states that have affiliated with APhA are:
California, Delaware, Florida, Illinois, Indiana, Iowa,
Kansas, Kentucky, Maryland, Michigan, New Jersey,
Ohio, Pennsylvania, South Carolina, Texas. Virginia and
Wisconsin.

APhA Is Clearinghouse For Wage-Price

Questions

In cooperation with the Office of Emergency Pre-
paredness, APhA will serve as a clearinghouse for ques-
tions from pharmacists regarding President Nixon’s 90-
day wage and price freeze.

Under this arrangement, questions submitted to
APhA by pharmacists and state pharmaceutical associa-
tions will be compiled and submitted to OEP. Questions
requiring policy determination will be submitted to the
Cost of Living Council by OEP. OEP will respond to
APhA in writing and answers will be disseminated to
state pharmaceutical associations and published in the
APhA Newsletter, as appropriate.

Mangini can tell you
what you have.

Within 1%

Many pharmacists often esti-
mate their inventory by relat-
ing purchases to sales

In today’s competitive climate
and with the cost of merchan-
dise continuously rising, these
estimated gross profit figures

Mangini & Associates, Inc.

4850 W. Belmont Ave. Chicago, III
60641/(312) 282-8181

ROFESS)\ONA
A SERV us

can be misleading. In fact,
this can be extremely costly
to the pharmacist who, un-
aware of his shrinking inven-
tory and gross profits, ts
actually paying a higher in-
come tax than he should

So why guess? Call Mangini
for fast, computerized inven-
tory service that will tell you
within 1% how your inventory
realistically stacks up to your
turnover, sales and profits!

WRITE FOR DETAILED
INFORMATION.
ihSaEREE!

11722 Studt St, St Louis, Mo 63141
2760 W. Market St, Akron, Ohio 44313
575 Savin Ave , West Haven, Conn. 06516
5501 Cherokee Ave . Alexandria, Va. 22312

FRIENDLY
RELIABLE.

WINNING LOYAL CUSTOMERS

24 THE MARYLAND PHARMACIST

NOVEMBER 197!

a ee

———— ee eee ee

_ _.. Reading
IS Still the fastest way

to program the
man

h
brai

)

In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang-
vage is far too slow. The average person speaks about
150 words per minute. Fast readers can read up to
1,500 words a minute—ten times the average rate for the
spoken word. Perhaps this is why millions of people
regularly purchase from pharmacies, magazines, paper-
backs, comics and newspapers from insight and enjoy-
iment.

MARYLAND NEWS COMPANY

1621 COLE STREET — BALTIMORE, MD. 21223
Telephone: 233-4545

Obituaries

Henry J. August

Henry J. August, 61, died sudden-
ly on October 25 at Thurmont, Mary-
land where, for the past 15 years, he
had been proprietor of the only town
pharmacy. He was a 1933 graduate
of the University of Maryland School
of Pharmacy and former proprietor of
Medford Pharmacy on Eastern Ave-
nue.

A member of the Maryland Phar-
maceutical Association, Mr. August is
survived by his widow Mary, son,
Henry J., Jr., and two brothers and
two sisters.

Joseph P. Marmor

Joseph P. Marmor, 70, died at the
Veteran’s Administration Hospital at
Perry Point, Md. on October 16. A
former life member of the Maryland
Pharmaceutical Association, Mr. Mar-
mor was proprietor of the Modern
Pharmacy in Frederick for 27 years
until his retirement in 1965.

Samuel A. Romanoff

Samuel A. Romanoff, 74, former
proprietor of Ruxton Pharmacy, died
on October 13, 1971 at Fort Lauder-
dale, Florida.

Grant Downs, Jr.

Grant Downs, Jr., 62, 1933 grad-
uate of the University of Maryland,

School of Pharmacy died at Montgom-
ery, Alabama on October 24, 1971.

Naney K. Crozier

Nancy K. Crozier, 71, died on Octo-
ber 21, 1971 after a long illness. She
was the wife of John A. Crozier, for-
mer general manager of Calvert Drug
Company. Mrs. Crozier was a member
of the Ladies Auxiliary of the Mary-
land Pharmaceutical Association.

STATE PHARMACEUTICAL DIRECTORY

AFFILIATED ORGANIZATIONS

Allegany-Garrett County
Pharmaceutical Association

RANA sdeicnsadooodec Stephen Hospodavis
VicesPrestdent pinata. tn aes James Ritchie
Secretary-Treasurer....... Robert F. Tomsko

Baltimore Metropolitan
Pharmaceutical Association

Presid ent@ewcts dy foes cee Irvin Kamenetz
President. Elects jesse Joseph U. Dorsch
Tyeasirer cae. Come ee Charles E. Spigelmire

Vice Presidents—
Paul Freiman, Harold P. Levin,
Harry R. Wille

Secretary and Executive Director

Nathan I. Gruz

Eastern Shore Pharmaceutical Society

President’ at. 2 2 Po ee Gordon Harrison
First Vice President....... William P. Smith
Second Vice President....... William Connor
SECTELATY Se rAL Bat yes eee ae Carl R. June
Tfeasiiner2 a eke ee ees Thomas Payne

Prince Georges-Montgomery County
Pharmaceutical Association

Presidente lng 6 ee Martin Hauer
First Vice President....Edward D. Nussbaum
Second Vice President ..... S. Ben Friedman
Third Vice President ...... Sidney Glashofer
Fourth Vice President....... Gabriel E. Katz
DSOCTCLOsY: buds Sean ee ee ie Paul Reznek

Ae oe ae A Michael Leonard

Honorary President .......... Samuel Morris

Treasurer

Washington County
Pharmaceutical Association

eee ee Samuel E. Weisbecker

Vicer President eee eee Joseph Davies
sats Frederick Fahrney

University of Maryland School of
Pharmacy Student APhA-MPhA Chapter

PG OIG McG Paul R. Webster
Vices Presidenta eee Stephen B. Bierer
SECTELETY Foe ieee Donna S. Levin
Treastirers. hearers Dennis R. Reaver

MPhA AUXILIARIES

LAMPA — Ladies Auxiliary of The
Maryland Pharmaceutical Association
President

MRS. LOUIS M. ROCKMAN
Recording Secretary
MISS MARY DiGRISTINE
Communications Secretary
MRS. RICHARD R. CRANE
Treasurer
MRS. CHARLES S. AUSTIN

Membership Treasurer
MRS. MANUEL B. WAGNER

TAMPA — Traveler’s Auxiliary of The
Maryland Pharmaceutical Association
President
PAUL J. MAHONEY
First Vice President
JOHN C. MATHENY
Second Vice President
ABRIAN E. BLOOM
Third Vice President
C. WILSON SPILKER
Secretary-T reasurer
WILLIAM A. POKORNY
WILLIAM L. NELSON
Assistant Secretary-Treasurer
Honorary President
JOSEPH GRUBB

Secretary-Treasurer Emeritus

JOHN A. CROZIER

OTHER PHARMACY ORGANIZATIONS
Maryland Society of Hospital
Pharmacists
President
MARY W. CONNELLY
President Elect
NORMAND A. PELISSIER
Secretary
DOLORES A. ICHNIOWSKI
Treasurer

THOMAS E. PATRICK

University of Marviand
School of Pharmacy

Dean
DR. WILLIAM J. KINNARD, JR.
Assistant Dean
DR. C. T. ICHNIOWSKI
Delegate and Vice Speaker—
MPhA House of Delegates
HENRY G. SEIDMAN

Metropolitan Guild of Pharmacists
President

JOHN McKIRGAN
Vice President
FRANK FRARY
Secretary
LARRY JACOBSON
Treasurer

EDWARD WILLIAMS

eee

Drug Strike Force Set for Baltimore
A federal grant of $201,540. made by the Law En-

forcement Assistance Administration, has been received
by the City of Baltimore for purposes of funding a spe-
cial narcotics strike force that will operate out of the
state’s attorney’s office. The strike force will be com-
prised of seven prosecutors, seven investigators and four

torney.

THE MARYLAND PHARMACIST

administrative and clerical personnel and will be headed
by Lt. Stephen Tabeling, a veteran detective in the police
department, and Peter D. Ward, an assistant state’s at-

The strike force will aim at three basic targets: the
source of narcotics, the drug pusher, and the basic net-
work that supports narcotics and drug traffic.

NOVEMBER 197]

Thantis, the reliable throat lozenge.

(#740/171)

HYNSON, WESTCOTT & DUNNING, INC.
Baltimore, Maryland 21201

The Maryland Pharmaceutical Association

Presents

_ MEXICAN FUN FEST

and Convention Round-Up
in Acapulco

6 FANTASTIC DAYS!
5 FUN-FILLED NITES!

WEDNESDAY thru MONDAY, MAY 17 thru 22, 1972

®Non-stop round trip jet flight via Eastern Airlines
Deluxe Trip with OPEN FREE BAR and deluxe
meal during flight.

®Deluxe twin bedded accommodation with private
Nal bath at the Super Deluxe PIERRE MARQUIS Hotel
and Golf Club on Acapulco’s famous REVOLCADERO
\Ni\ BEACH — 2 blocks long and one block wide, with
NO i the surf from the Pacific constantly rolling in.

® Transportation and transfers to and from hotel to
Q airport and porterage. (Hotel only 5 minutes from
1 airport).

ES! Course Breakfasts; Gourmet Dinners with

LAN dancing nitely from your ringside dinner table

v until the wee hours for FREE in the exotic Tabochin
~ Dining Room.

SOL ®Cocktail Party plus

Many Surprises!

1 @ALL Taxes and REG. *800°°
OV ° Gratuities Paid In Full S .00
ALL FOR ONLY... BOe

Leave Friendship Airport, 8 A.M. PER COUPLE!
Wednesday, May 17th — Arrive Plus $39.00 Tax and Gratuities
Acapulco 12:30 P.M. oct Cette ae |
(10:30 A.M. Their Time)

Leave Acapulco Airport, 4 P.M.
Monday, May 22nd — Arrive
Baltimore 10:30 P.M.
(Checkeut Time: 3 P.M.)
Educational Sessions Daily

* EARLY BUY PRICE!

Reservations on this fabulous trip can be confirmed only upon receipt of $50.00

deposit per couple. All monies refundable in full until April 17th, 1972,
after which date refunds are subject to resale of the reservations.

CHECKS MADE PAYABLE AND MAILED TO:

MARYLAND PHARMACEUTICAL ASSOCIATION
650 W. LOMBARD ST., BALTO., MD. 21201 - Phone 727-0746

maryland

ASSOCIATION

= pharmacist

Editorial-A Revolutionary Decade: 1961-71

ls A Congress of American
Pharmacy Needed?

Annual Report of the
Maryland Board of Pharmacy

Summary of Minutes of
MPhA Board of Trustees Meetings

EY olume. 47. DECEMBER 1971 Number 12

Compliments of

oxell

CORPORATION

NOXZEMA SKIN CREAMS

Makers of

NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS

and

THERA-BLEM

11050 York Road

Baltimore, Maryland 21203

NTNISININTNININININAAININNINININATNTSIAINININTSISIN
NINININISTSTSININININININININY AINTSPSISINTNINTNAININTNTS
INININININISISINININININTSINININT SINISINTSININISININT STS]
NINTNTNINININ TSAI ST SINININININ] SISNISINININININIVIAAS
SINTISINTININTISNININININNINININTNINAININTINININININIAINN]
REBRERNANNERRERNSRARERARERRERERED
DIDSDIDSDSISINN DDD RDINDISPDPDDPPDDAISDDD DI
NAISRIAAINAANBSARERRANBSSRERBISNIINAING
NSSISINISISRANISNISISINSINISISBININISINAANISISISSS
SNEENSESNEERSERSSRSNSENESSENS
RERARSRERNSERNRANEEERERNENENERN
SN NSE SE SS RENNER ENNENENENSES
NNRENSERSSESSSSEREBSERINRRRERIRBSRAERA

SEESESESSE SRE EERESERERSESESES

RRRRERERRRERERRRERRRRRRRRBRRE
CRNAARBRERANINAEIRNSBISRBREERRARIRINBSBEEY
NAAAAIRNENARAAININAABAIRAINAESIABRIAAIGGBRBI
SNARE ARIRRININNINININNBABNB]
AARBRRARBERRERAISSIRRIRARISSINGRISBERBY
TREE RRIRERIRISRAERNANISBSSI
NENENNEENSSSESREENSNERERESNAYS
NINSISSISRISRIANIAINGISAISRSIRARERBSIRBSIRISESANI
RSNNSRER SNS SESE SSNS SNS
SSERISBRERERAGSEASSISEISSEBIAENESEA
me RRRERERRARRRERARRERECRERARE

: mle ee Checks

i ae 809. were ai it soit be made.

When you fill a prescription with a Lilly product, you can rest assured

Lilly

Eli Lilly and Company
Indianapolis, Indiana 46206

uar-
tion

finer is available. For example, one Lilly product undergoes 808
excipients, stability, tablet compression, and
decided difference in therapeutic efficacy.

g your professional judgment, consider the consistent, g
anteed quality of Lilly products. When it comes to your prescrip

separate quality checks before reaching your pharmacy.

g
Absolute control of ‘variables’ is essential. Even minor differences in

patient’s health (and your reputation), you want to dispense the best.

particle size, solubility,
other factors can make a

In exercisin

nothin

“ January
“7 Summer

Merchandise Shows

Gilpin offers continuing programs of merchandis-
ing ideas. Highlights include our January mer-
chandise shows featuring summer sundries. For
Baltimore-Dover-Washington, Sunday, January 23,
1972 through Sunday, January 30, 1972 (continu-
ous), at Gilpin’s Baltimore Branch, 7401 Pulaski

BALTIMORE + DOVER + NORFOLK * WASHINGTON

Highway, Baltimore, Maryland; for Tidewater Re-
gion, Sunday/Monday, January 30/31, 1972 and
Sunday/Monday, February 6/7, 1972 at Gilpin’s
Norfolk Branch, 6435 Tidewater Drive, Norfolk,
Virginia. Please contact your Gilpin representative
or sales manager for details or show appointment.

A financial service consultant to service you on
request.

Two giant product shows each year: in January
featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing
promotional sundries.

the services required to nail down the profit dollars
which you need and deserve from your business.

The Henry B. Gilpin Company
901 Southern Ave., Washington, D.C. 20032
(301) 630-4500

| ERE Ea eS rae ete

Sirs:
| am interested in the following programs. Please have your
representative contact me in this regard.

Nine ee eee eee
Name of Pharmacy > = eee
Address SS eee Phone.

City State _—__ Zip

fa eee poems “noone eet hee

Weadeectn gitar ean

The Maryland Pharmacist

NATHAN I. GRUZ, Editor

NorMAnp A. PELIssiER, Assistant Editor
Marrua Ecxuorr, Editorial Assistant
Ross P. CAMPBELL, News Correspondent
HERMAN J. BLtoom, Photographer

650 WEST LOMBARD STREET
BALTIMORE, MARYLAND 21201

ASSOCIATION

VOLUME 47

DECEMBER 1971 NUMBER 12

OFFICERS 1971-1972

Honorary President

H. NELSON WARFIELD—Pikesville

*
President
NATHAN SCHWARTZ—Annapolis

President Elect
BERNARD B. LACHMAN—Baltimore

Vice President

JOHN R. McHUGH—Potomac

Treasurer

MORRIS LINDENBAUM
5 Main St., Reisterstown, Md. 21136

Executive Director

NATHAN I. GRUZ
650 W. Lombard St., Baltimore, Md. 21201

TRUSTEES

DONALD O. FEDDER, Chairman—Dundalk
MORRIS BOOKOFF (1972)—Baltimore
PAUL FREIMAN (1974)—Baltimore

STEPHEN HOSPODAVIS (1972)

Cresaptown
PHILIP D. LINDEMAN (1973‘—Berlin
ANTHONY G. PADUSSIS (1973)

Baltimore
MELVIN J. SOLLOD (1974)—Adelphi
SYDNEY L. BURGEE, JR.
Speaker of the House of Delegates
Baltimore

EX-OFFICIO MEMBERS

FRANCIS S. BALASSONE—Baltimore
WILLIAM J. KINNARD, JR.—Baltimore

HONORARY LIFE TRUSTEE
SIMON SOLOMON—Baltimore

MARYLAND BOARD OF PHARMACY

Honorary President

SIMON SOLOMON—Baltimore

President
NORMAN J. LEVIN—Pikesville

Secretary
F. S. BALASSONE—Baltimore

Member
FRANK BLOCK—Baltimore

Member
HOWARD L. GORDY—Salisbury

Member
MORRIS R. YAFFE—Potomac

TABLE OF CONTENTS

6 Editorial—A Revolutionary Decade: 1961-71. Is a Congress of
American Pharmacy Needed?

8 Maryland Board of Pharmacy News

10 Summary of Minutes of Board of Trustees Meetings

12. Washington County Pharmaceutical Association

12. University of Maryland School of Pharmacy Alumni Association
16 Annual Report of the Maryland Board of Pharmacy

22 Baltimore Metropolitan Pharmaceutical Association

23 A.Z.O. News

24 Maryland Society of Hospital Pharmacists

26 Obituaries

26 State Pharmaceutical Directory

INDEX TO ADVERTISERS

21 American Druggists’ Insurance Co.
25 Calvert Drug Company, Inc.

13. Geigy Pharmaceuticals

Henry B. Gilpin Company

Eli Lilly and Company

Loewy Drug Company

NW f

Mangini and Associates, Inc.

11 Maryland News Company

25 Metropolitan Guild of Pharmacists

2 Noxell Corporation
27 Paramount Photo Service
25 Pension & Investment Associates of America

14-15 Smith Kline & French Laboratories

21 D. Stuart Webb Advertising Services

9 Youngs Drug Products Corporation

Change of address may be made by sending old address (as it appears on
your journal) and new address with zip code number. Allow four weeks for
changeover. APhA members—please include APhA number.

Editorial...

A REVOLUTIONARY DECADE: 1961-71

Is A Congress of American Pharmacy
Needed?

The completion of a decade as the executive officer
of the Maryland Pharmaceutical Association is the occa-
sion to look at what has transpired. It has been a revolu-
tionary decade for the world, for society, for our nation,
for attitudes and practices in the area of health care. So
why should we think pharmacy should stand still? Phar-
macy like every aspect of society has also undergone
radical change.

Upon assuming the executive and editorial posts
with MPhA in November 1961, the major issues were
maintenance of “Fair Trade,” effects of Kefauver hear-
ings (“generic equivalents” and prices of drugs and _pre-
scriptions ), APhA-NARD relations, “Medical care’ pro-
grams (welfare and for the aged), entrance of food
chains into pharmacy, discounting, the “professional fee”
concept, outpatient hospital dispensing.

Some of these issues of 1961 have gone from the
scene; some are still here but in a drastically changed
form. But most important, we believe, is that the attitude
of the profession has changed drastically.

Pharmacists today in greatly increasing numbers are
reacting as more knowledgeable and sophisticated mem-
bers of the health care professions. They are more mili-
tant in their approach to the forces which obstruct their
legitimate professional and economic aspirations as they
seek to fulfill their essential roles in the delivery of health
care.

Pharmacists seek to integrate their organizational
structure in order to consolidate their limited manpower
and financial resources. They recognize that a unified or-
ganizational structure must be forged. Once a pharmacist
would make a commitment to become part of his volun-
lary professional representative democracy network, he
would be able to enter it only through a single portal. It
would be either all or none.

The form and substance of such a structure could be
developed by convening a “Congress of American Phar-
macy” with representation from every state.

Such a “C.A.P.”—Congress of American Pharmacy
—made up of pharmacist representatives elected by the
pharmacists of each state and including representatives
of every facet of pharmacy practice and interest, could
address itself to the resolution of the competitive and
overlaping activities of APhA, NARD, ASHP and ACA.
The agenda for American pharmacy can be laid down, the
priorities spelled out and organizational roles delineated.

A difficult but not impossible task if pharmacists
have but the wisdom and the will. In order for pharma-
cists in Maryland to exert leverage, we must increase our
voice in the APhA House of Delegates. The enrollment of
every MPhA member as an APhA member will grant us
the additional delegates. Affiliation with APhA also
brings us new MPhA members.

6 THE MARYLAND PHARMACIST

In a decade—perhaps in a half-decade—we could
thus mobilize all the elements of the profession of phar-
macy into an instrument for maximum utilization of
pharmacists as full-time health professionals.

— Nathan I. Gruz

MPhA Esskay Prescription
Plan

MPhA is pleased to announce the completion of
arrangements to serve as a clearinghouse for the Esskay
Company’s Prescription Drug Program. Previously this
program for the office and sales employees was limited
to one pharmacy chain.

In line with the MPhA commitment to a policy of
“free choice of pharmacy” in the prescription practice,
all pharmacies will be eligible to participate by complet-
ing and returning the required form available from

MPhA.
Eligible employees of Esskay (Schluderberg-Kurdle

Company) will present an orange I.D. card which in-
cludes the EXPIRATION DATE and deductible amount
per prescription of $.50 to be collected by the pharmacist.
Coverage includes husband, wife and their children.

All prescription claims will be submitted on the
MPhA Rx form, which conforms to the National Phar-
macy Insurance Council (NPIC) standard Rx form. The
form fits standard imprinting machines. The professional
fee or service charge is $1.95 per prescription. The whole-
sale price of ingredients is used as a basis for this cost.

Insulin Benefit

Pharmacists may dispense a maximum of four (4)
vials of insulin at one time and collect only one deducti-
ble. Payment will be the reasonable charge to regular
customers.

This MPhA service is a pilot program. In addition,
work is progressing with several other prescription in-
surance and third-party plans. Consideration is being
given for the establishment of a nonprofit foundation
under pharmacy auspices to provide for a full adminis-
trative and processing capability.

CORRECTION

The editorial in the November 1971
issue, fourth paragraph from the end.
should read as follows: “have also exercised
initiatives in bringing about.”

DECEMBER 1971

There’s a lot more going for you at LOEWY

reathing Machines :

7 Shc 4 MEDICAL EQUIPMENT FRANCHISE

can make your store one of the most sought out sources for
equipment and service in America

As the local Spectro Division in your area, we not only offer the unusual advantages

FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY

Call any time, day or night. An automatic order
taker will record your after-hours order.

Call IV 5-8105 for order taking. (301) 485-8100 for the office.

LOEWY DRUG COMPANY

th, DIVISION OF
28 Sheclso Industries, Ine.

6801 Quad Avenue, Baltimore, Md. 21206 Tel.: (301) 485-8100

DECEMBER 1971 THE MARYLAND PHARMACIST

Maryland Board
of Pharmacy News

BOARD OF PHARMACY REVOKES
LICENSES

At hearings held before the Maryland Board of Phar-
macy on October 13, 1971, the licenses of Maurice A i
Karpa and James W. Poindexter to practice pharmacy in
the state of Maryland were revoked.

Mr. Karpa answered charges of having been con-
victed of a crime involving the Controlled Dangerous
Substances Act and of being guilty of grossly unprofes-
sional conduct. Mr. Karpa had been tried in the Circuit
Court of Baltimore County. He had been sentenced to
pay a fine and to serve a term of six months in the Balti-
more County Jail. Sentence was suspended on the condi-
tion that Mr. Karpa discontinue the practice of pharmacy
and that he not be in any manner interested in or em-

ployed in a pharmacy. He had operated the Donnybrook
Pharmacy.

Mr. Poindexter, charged with having been con-
victed of a crime by the Criminal Court of Baltimore
City involving professional misconduct respecting the
pharmacy or drug laws and having been convicted of a
crime involving the State Uniform Narcotic Drug Act or
the Federal Narcotic Laws, did not appear to testify. He
had been convicted of the crimes of false pretense and
conspiracy. On the basis of the evidence presented, his
license to practice pharmacy in the state of Maryland
was revoked. He formerly operated the Sav-On Pharmacy.

Pharmacy Changes

The following are the pharmacy changes for the
month of October:

New Pharmacies

Dart Drug Corporation, Waldorf, Herbert H. Haft,
President, Route 301, Waldorf, Maryland 20601.

MEMCO Prescription Pharmacy, Wayne H. Fisher.
President, 12550 Rockville Pike, Rockville. Maryland
20850.

No Longer Operating As Pharmacies
None

Change of Ownership, Address

GEM Pharmacy, Irving Wiggs, President ( Change
of Corporate Officers), 3130 Branch Avenue. Suitland,
Maryland 20023.

GEM Pharmacy, Irving Wiggs, President (Change
of Corporate Officers), 5100 Nicholson, Kensington,
Maryland 20795.

GEM Pharmacy, Irving Wiggs, President (Change
of Corporate Officers), 6501 Baltimore National Pike,
Baltimore, Maryland 21228.

GEM Pharmacy, Irving Wiggs, President (Change
of Corporate Officers), 7930 Eastern Boulevard, Balti-
more, Maryland 21224,

GEM Pharmacy, Irving Wiggs, President (Change
of Corporate Officers), 2421 Chillum Road, Hyattsville,
Maryland 20780.

8 THE MARYLAND PHARMACIST

The following are the pharmacy changes for the
month of November:

New Pharmacies
None

No Longer Operating As Pharmacy

Combs and Neutze Pharmacy, John F. Neutze, 5925
York Road, Baltimore, Maryland 21212.

Change of Ownership, Address

Thurmont Pharmacy, Gordon and Joyce Hair
(Change of ownership), 12 East Main Street, Thurmont,
Maryland 21788.

Macek’s Pharmacy, Bernard F. Macek, President
(Change of name and ownership), 900 South Ellwood
Avenue, Baltimore, Maryland 21224.

Finksburg Pharmacy, A. Neuburger and T. Suter
(Change of ownership), Finksburg, Maryland 21048.

can be misleading. In fact.
this can be extremely costly
to the pharmacist who, un-
aware of his shrinking inven-
tory and gross profits. is
actually paying a higher in-
Many pharmacists often esti- come tax than he should.
mate their inventory by relat-
ing purchases to sales

Mangini can tell you
what you have.

Within 1%

So why guess? Call Mangini
for fast, computerized inven-
In today’s competitive climate tory service that will tell you
and with the cost of merchan- within 1% how your inventory
dise continuously rising, these realistically stacks up to your
estimated gross profit figures turnover, sales and profits!

WRITE FOR DETAILED
INFORMATION.
{T'S FREE!

11722 Studt St., St. Louis, Mo. 63141

es P 2760 W. Market St, Akron, Ohio 44313
Mangini & Associates, Inc. 575 Savin Ave., West Haven, Conn. 06516

4850 W. Belmont Ave. Chicago. Ill. 5501 Cherokee Ave . Alexandria, Va. 22312
60641/(312) 282-8181

DECEMBER 1971

_ Offer Guardian sensitivity
to yYOUT customers first

ya
Rich.
VE ROLLED L

____“

oe
___

<*>

s és
é Rich’

E ROLLED LATEX PROPHYLACTICS

ditto tesenienn coe HS

EDT,

{,
CORLL |

be Bee ey LATEX eee

ATEX oe YLACTICS

..and they’ll never ask for just
prophylactics again. They will be sold on
the complete sensitivity afforded by
these premium prophylactics. They’ll stay
sold because Trojan brand Guardians
are thin, pre-lubricated and sealed in foil.
And you Il be happy because the extra
profit in each Guardian makes it an ideal
product for you to recommend.

up Youngs Drug Products Corporation

865 Centennial Ave., Piscataway, N.J. 08854

Summary of Minutes of
Board of Trustees Meetings

Li)

September 9, 1971

Communications included letter from Governor’s
office in response to letters written by President
Schwartz and Mr. Gruz regarding appointment of
MPhA representatives to health commissions. The
Governor has indicated that consideration will be
given to MPhA recommendations. Letter regarding
Kidney Foundation of Maryland (referred to Pro-
fessional Relations Committee ). Letter involving Bal-
timore City Health Department’s interest in the avail-
ability of 24-hour pharmacy service in the inner city.

The President reported that he had participated in
hearings in Annapolis regarding the use of suppor-
tive personnel in pharmacies.

The Executive Director reported on his appearance
before the zoning commission on behalf of Dr. John
C. Krantz, Maryland Psychiatric Research Center,
regarding the opening of Epoch House, a research
center for drug abuse. The office has been receiving
numerous inquiries related to the wage and _ price
freeze. APhA is collating all questions and will sub-
sequently provide the information to affiliated asso-
ciations. Two meetings have been held regarding the
Kermit White Memorial at which the establishment
of a drug abuse program in Edmondson Village area
was proposed. Other activities: meetings of the
Board of Pharmacy and health centers and con-
ferred with Attorney General’s office.

The Membership Committee report indicated a de-
crease in owner category and an increase in non-

owner category. The 1972 campaign will begin in
October.

The Public Health Information Committee report
related that the MPhA V.D. Campaign resulted in
meetings with Public Relations Committee of the
state medical society. Dr. Howard J. Garber, Chief
of Communicable Diseases, Maryland State Depart-
ment of Health, advised MPhA of formation of a
state commission on V.D. which will include Mr.
Freiman as MPhA representative.

The Prescription Insurance Plans Committee report
noted MPhA recommendations regarding Medical
Assistance Program including recommendations for
a prescription fee of $2.35 for FY 1973. Conference
was held with Mr. Benjamin Jaffe of United Pre-
scription Program regarding new prescription poli-
cies. MPhA position was that “wholesale” should be
used rather than “acquisition cost” and to limit
number of abuse items to 30-day supply which would
be taken up with state as well. The need for a staff
employee to work on third-party plans was discussed.

The Legislative Committee reported it had reviewed
resolutions for control of advertising of drugs on tele-
vision, Other proposals included removal of geo-
graphical limitations by Board of Pharmacy, use of
supportive personnel, nursing home ownership of
offsite pharmacies, freedom of choice of pharmacy in
third-party programs, mailing of samples, registra-

THE MARYLAND PHARMACIST

103

1 x.

12.

13.

14.

ibsy

16.

tion of detail men, establishment by Board of Phar-
macy and MPhA of a Commission on Pharmacy Dis-
cipline and mandatory continuing education. Phar-
maceutical services in nursing homes are to be sur-
veyed. Opposition to a prefiled bill requiring phar-
macists to place expiration date on label of prescrip-
tions was approved.

The Convention Committee chairman reported that
the postconvention trip for 1972 would leave Balti-
more on May 17 to Acapulco, Mexico, returning on
May 22. Arrangements are being made for approxi-
mately 200 at the Pierre Marques Hotel. The 1972
Convention will be held at the Washingtonian on
May 7, 8 and 9th.

Representatives of the Maryland Society of Hospital
Pharmacists met with the Board regarding “Guide-
lines for Pharmaceutical Services in Hospitals.’”’ The
“Guidelines” will be redrafted in regulatory terms
and condensed before submission to the Attorney
General.

The Board of Trustees approved the Metropolitan
Guild of Pharmacists as a “recognized organization”
in the House of Delegates under Article V, Section
2.32 of the By-Laws.

The following new members were approved: Stephen
Needel, Arnold Smolen, Charles Marsiglia, David R.
Chason, Michael Cohen, Wayne Dyke of Baltimore;
Milton Moskowitz, Laura Tepper, Ralph Sigman of
Silver Spring; Robert W. Elliott, Ocean City; Charles
D. Reynolds, Hyattsville; Darlene F. McMahon, Mt.
Ranier; Joel Serin, Landover; Herbert Niefield.
Rockville; Charles W. Kelly, Cambridge, Gary
Boyer, Frederick; Edward B. Roth, Olney; Robert R.
Hayward, Kensington.

The APhA Pledge Plan was approved as follows:
First year, $10, second year, $15, third year, $20;
and fourth year, $25 MPhA dues.

In response to the Maryland Comprehensive Health
Planning Agency adopted motion to present to the
Board of Pharmacy a proposal in cooperation with
the School of Pharmacy and all facets of pharmacy
for regulations on use of supportive personnel.
There was discussion on the possibility of working
out a formulary system with the state medical so-
ciety and Board of Pharmacy utilizing statement on
each prescription form.

Voted support for Senator Hart’s Bill “Regulation
of Trade in Drugs” to prevent physicians from phar-
macy ownership or ownership in drug repackaging
companies.

Agreed to support position of D.C. Medical Society
in regards to expelling of physicians prescribing
methadone other than for detoxification purposes pro-
vided the addicts are provided with adequate care.

October 7, 1971

Communications included new Controlled Danger-
ous Substances Act received from Maryland Board
of Pharmacy, offer of support for the 1972 Swain

DECEMBER 1971]

_ The only thing worse than
beingill is being bored |

The cold and flu weather is on its way.

And most people can put up with the sneezing and

coughing.

But finding something to do ne all those hours in
bed, that’s a real pain.

A person can only stand those game shows and soap
operas for so long, before all they want to do is lay back
with something good to read. “

Maybe a sports magazine, a hobby book, a paperback
novel or a news magazine.

What medicine does for their body, reading does for
their mind.

And at Maryland News ace gh we're proud to be

your area’s prime source of fine reading material.

We are constantly supplying your racks with the most
current reading material to keep your customers reader
interest at its highest.

The mathematics are quite simply: for an initial outlay
of $100 you can expect a return of $127 within thirty
days. And any unsold copies are returnable for full credit.

And when you have the very best reading material on
sale in your pharmacy, people develop a habit of com-
ing back.

So give us a call at 233-4545.

Maybe we're just what the doctor ordered.

. Maryland News Company -

Seminar from MSHP, American Council of Pharma-
ceutical Education concerning its revision of the ac-
cereditation manual for schools and colleges of phar-
macy in the United States and requesting comments,
Maryland Diabetes Association again asking for
MPhA participation during National Diabetes Week.
Myr. Freiman will meet with representatives of MSHP
and MPhA legal counsel Joseph S. Kaufman regard-
ing adoption of “Suggested Principles and Guide-
lines for Pharmaceutical Services in Hospitals’ as
state regulation by the Board of Pharmacy. Morris
Bookoff will represent MPhA at November 17 meet-
ing of National Pharmacy Insurance Council in
Washington.

The President commended Mr. Rubin for his efforts
as Membership Committee Chairman in bringing in
delinquent dues. Mr. Fedder will serve as chairman
of the Nominating Committee for the coming year.
The President attended the Washington County
Pharmaceutical Association meeting in Hagerstown.

The Treasurer’s report indicated expenses for the
year average about $4,000 per month. Mr. Gruz was
commended for controlling office expenses. The
Metropolitan Guild of Pharmacists will be paying
one-half of the members APhA dues beginning in
1972;

The Executive Director reported on plans of the
East Baltimore Community Corporation to establish
onsite pharmacy. A meeting was held with represen-
tatives from APhA regarding membership _pro-
cedures. Maryland dues structure is lower than that
of most other affiliated organizations. Attended the
funeral of Eileen Brooks, Executive Secretary of the
D.C. Pharmaceutical Association. Also meetings of
the American College of Apothecaries and Washing-
ton County Pharmaceutical Association.

Membership Committee. A total of 784 members
was reported in September as compared with 781 in
1970. The need for adequate MPhA staffing for
membership work and improved communications
was pointed out.

Public Health Information Committee. “V.D. —
Voluntary Disaster” is theme of National Pharmacy
Week. Posters have been distributed to member
pharmacies and press releases have been published
by newspapers and. carried by television and radio
stations. Mr. Freiman has been appointed to a Task
Force on V.D. formed by the State Department of
Health.

The Legislative Committee Chairman reported that
proposed legislation preventing any third-party pro-
gram from the interference with freedom of choice
of pharmacy will be introduced. The sponsor of a
bill requiring the expiration date to appear on Rx
labels has withdrawn the bill. Revision of the label-
ing law seems indicated to require “label” and “‘do
not label” to appear on prescriptions.

The Professional Relations Committee Chairman re-
ported on the meeting with the state medical society
concerning drug product selection. There was discus-
sion of a formulary system for Medicaid patients
while maintaining physicians’ prerogatives of speci-
fying manufacturer. The possibility of a combined

THE MARYLAND PHARMACIST

convention with the state medical society and the
state dental association has been suggested.

9. The following applications for membership were ap-
proved: Philip Bogash, Donald A. Schumer, Leon R.
Catlett, Milton Watkowski, Stanton M. Rudo, Wil-
liam Tabak, Sidney Sober, Harold W. Clinksdale,
Sidney Litvin, Albert Lichtman, William Jackson,
Angelo C. Tompros, Paul L. Goldstein, John R.
Newcomb, Milton Hillmian, C. Herbert Wagner,
Robert M. Plummer, Alvin Perkins.

10. The Nominating Committee was approved by the
Board as follows: Donald O. Fedder, Chairman; I.
Earl Kerpelman, Alder Simon, Rudolph Winternitz,
Bernard B. Lachman, Stephen Hospodavis, H. Nel-
son Warfield, Joseph U. Dorsch and Mary W. Con-
nelly.

11. There was a detailed review of the status of MPhA
activities concerning governmental and other third-
party programs. Conferences were held with Medi-
caid, Esskay, Senior Citizens groups, Maryland Com-
mission on Aging, Benjamin Jaffe Associates and
Maryland Health Maintenance Committee. Esskay
has agreed to an MPhA plan to act as a clearing-
house for third-party prescriptions. The School of
Pharmacy has set up a task force on third-party
programs. There was discussion on activating the ~
MPhA initiated Maryland Pharmaceutical Service
Corporation for the handling of work involved with
third-party payment plans.

Washington County Pharmaceutical
Association

The Washington County Pharmaceutical Association
held a meeting on November 17, 1971, in Hagerstown.
Mr. Albert Metts, Executive Director of the Appalachian
Regional Health Planning Council, was guest speaker
for the evening. Mr. Metts discussed health planning for
the future in Garrett, Allegany and Washington counties.
He also spoke briefly on Health Maintenance Organiza-
tions and their potential role in the Washington County
area.

University of Maryland School of
Pharmacy Alumni Association

Alumni are invited to submit nominations for the
Honored Alumnus Award presented by the University of
Maryland School of Pharmacy Alumni Association.

Nominations together with a brief statement of in-
formation about the nominee should be submitted in writ-
ing to Harry R. Wille, Chairman, Honored Alumnus
Award Committee, 306 Marydell Road, Baltimore, Mary-
land 21229.

The presentation will be made at the Alumni Asso-
ciation Annual Banquet in honor of the graduating class

on May 31, 1972.

DECEMBER 1971]

“a

*, soy

pends
on the company”

he Keep. : |

phenylbutazone

gaeine

Geigy . tie

NOW
ONFIDENCE
COSTS LESS

SK-AMPICILLIN™

brand ot AMPICILLIN TRIHYDRATE

SK-APAP™

brand of ACETAMINOPHEN

SK-BAMATE™

| brand ot MEPROBAMATE
SK-ESTROGENS"

von ot ESTERIFIED ESTROGENS U.S.P.

SK-PENICILLIN VK"

brand ot POTASSIUM PHENOXYMETHYL PENICILLIN

SK-PETN"

brand of PENTAERYTHRITOL TETRANITRATE

SK-SOXAZOLE™

Trad 2mMark brand ot SULFISOXAZOLE
L |

LINE SK-TETRACYCLINE™

brand of TETRACYCLINE HCL

yrTivinvdea

EE ——

NEW FROM SK&F:
SK-LINE PHARMACEUTICALS

SK-AMPICILLIN™

brand of AMPICILLIN TRIHYDRATE
Capsules: 250 mg., 500 mg.
Chewable tablets: 125 mg.
For oral suspension: 125 mg.,

250 mg./5 mi.
Pediatric drops: 100 mg./ml.

brand of SODIUM AMPICILLIN
Single dose vials: 500 mg.

SK-APAP ©

brand of ACETAMINOPHEN
Tablets: 325 mg.
Elixir: 120 mg./5 ml.

SK-BAMATE ~

brand of MEPROBAMATE
Tablets: 200 mg., 400 mg.

SK-ESTROGENS ©

brand of ESTERIFIED ESTROGENS U.S.P.
Tablets: 0.3 mg., 0.625 mg.,
1.25 mg., 2.5 mg.

SK-PENIGILLIN VK

brand of POTASSIUM PHENOXYMETHYL
PENICILLIN

Tablets: 250 mg., 500 m ™
For oral solution: 125 he 250 mg./5 mi. SK-LINE Dp ARMA e TI
SK-PETN

brand of PENTAERYTHRITOL a line of basic

Stee ee pharmaceuticals
SK-SOXAZOLE” of high quality
brand of SULFISOXAZOLE at low prices.

Tablets: 500 mg.

~ SK-TETRACYCLINE®

brand of TETRACYCLINE HYDROCHLORIDE
Capsules: 250 mg. SK-LINE™ PHARMACEUTICALS FOR QUALITY, ECONOMY, AVAILABILITY

brand of TETRACYCLINE exclusively from
Syrup: 125 mg./5 mi. SMITH KLINE & FRENCH LABORATORIES, PHILADELPHIA, PA. 19101

Annual Report
of the
Maryland Board of Pharmacy

1970 1971

F. S. BALASSONE

Secretary-Treasurer

In compliance with the provisions as set forth in
Section 258 of Article 43 of the Annotated Code of Mary-
land, this report is submitted to the Honorable Marvin
Mandel, Governor of Maryland, and to the Maryland
Pharmaceutical Association. This is the sixty-eighth re-
port to the Governor of the State and the fifty-eighth to
the Association. The report covers the activities of the
Maryland Board of Pharmacy for the fiscal year ending
June 30, 1971. This report is also being submitted to
the Secretary of the Department of Health and Mental
Hygiene.

Personnel

During the year the Board held 13 meetings, five
of which were held at the School of Pharmacy of the
University of Maryland, for the purpose of conducting
examinations for registration of pharmacists.

At its first meeting the Board reorganized and elected
Mr. Norman J. Levin, President and Mr. F. S. Balas-
sone, Secretary-Treasurer. The other members of the
Board were: Messrs. Howard L. Gordy, Morris R. Yaffe
and Frank Block.

At the annual meeting of the Maryland Pharma-
ceutical Association held in Atlantic City, New Jersey on
July 12-16, 1970, the Nominating Committee submitted
the following names which were later submitted to the
Governor as possible successors for Morris R. Yaffe whose
term would expire on April 30, 1971:

Morris R. Yaffe
William I. Lottier, Jr.
Victor H. Morgenroth, Jr.

Governor Mandel reappointed Morris R. Yaffe a
member of the Board for a term of five years, beginning
May 1, 1971.

Examination

The Board will conduct two examinations for regis-
tration of pharmacists during the fiscal year. They were
held at the School of Pharmacy of the University of
Maryland on November 2, 3 and 4, 1970 and will also
be held on June 28, 29 and 30, 1971.

There were nineteen applicants for the full Board
in November. Seventeen passed both the theoretical and
practical portions of the examination and were subse-
quently registered. Two failed the examination.

Having previously passed the theoretical portion of
the examination, seventy-two candidates took the practi-
cal examination in November. All of these candidates
passed and were subsequently registered.

Six applicants took only the theoretical portion of
the examination. All of these passed and will take the

16 THE MARYLAND PHARMACIST

practical examination upon completion of their practical
experience.

Three applicants took only the practical portion of
the examination, as they did not have the required ex-
perience for reciprocity. These applicants passed and
were subsequently licensed by reciprocity in Maryland.

There were eight applicants eligible to take the full
Board in June. Seven passed both the theoretical and
practical portions of the examination and were subse-
quently registered. One failed the examination.

Having previously passed the theoretical portion of
the examination, sixteen took the practical portion of the
examination. All of these candidates passed and were sub-
sequently registered.

Eighty-five applicants were eligible to take only the
theoretical portion of the examination. Seventy-nine
passed this portion of the examination and six failed the
examination. Upon completion of their practical experi-
ence, they will be eligible to take the practical portion of
the examination.

Four applicants took only the practical portion of
the examination, as they did not have the required ex-
perience for reciprocity. All of these applicants passed
and will subsequently be registered by reciprocity.

The Board has decided to use the Standard Examina-
tion of the National Association of Boards of Pharmacy,
and this examination was given for the first time in No-
vember in the following subjects:

Chemistry
Pharmacy
Mathematics
Pharmacology

The practical portion of the examination was prepared

by the Board.

For the June examination all portions including the
practical portion of the Standard Examination of the Na-
tional Association of Boards of Pharmacy will be given
to all applicants.

Record of Examination Held

November 2, 3 and 4, 1970

Applicants Passed Withheld Failed
oF 89 6 2
June 28, 29 and 30, 1971
Applicants Passed Withheld Failed
109 23 79 7
Total Number Examined for Registration as Pharmacists
Applicants Passed Withheld Failed
206 112 85 9

DECEMBER 1971

__ The following table shows the number of pharma-
cists who were registered by examination during the past

ten years:

YEAR
1961-1962
1962-1963
1963-1964
1964-1965
1965-1966
1966-1967
1967-1968
1968-1969
1969-1970
1970-1971

NUMBER OF PHARMACISTS

_ As in the past many pharmacists applied for re-
ciprocal registration in Maryland in order to accept posi-
tions with their employers who are opening stores in

Maryland.

Those applicants who did not meet our requirements
concerning practical experience prior to or after registra-
tion were advised that they must take our practical ex-
amination in order to verify their qualifications.

In all cases an applicant for reciprocal registration
must appear for a personal interview. The entire Board
must act on whether or not to grant registration to such
applicants, who must sign an agreement to comply with
Maryland’s laws pertaining to drugs and pharmacy.

The following table shows those granted registration
by reciprocity during the 1971 Fiscal Year:

Registered By Reciprocity

Certificate

Name Number Dated State
William A. Koerner 7230 July 10,1970 New York
Ellen McC. Suber 7231 July 10,1970 South Carolina
Gerald S. Fine 7232 July 10,1970 Massachusetts
Donald K. Fellows, Jr. 7233 July 10,1970 Louisiana
Stuart N. Morris 7234 July 10,1970 Pennsylvania
Bonnie E. Walt 7235 July 13,1970 Oregon
Jack A. Chaverini 7236 Aug. 3, 1970 Pennsylvania
Charles D. Conway 7237 Aug. 3, 1970 ‘Massachusetts
Jerome B. Horwitz 7238 Aug. 3, 1970 Pennsylvania
Aaron J. Kauffman 7239 Aug. 3, 1970 Pennsylvania
Albert L. Moore 7240 Aug. 3, 1970 Oklahoma
Arthur D. Schatz 7241 Aug. 3, 1970 Pennsylvania
Joseph B. Summey 7242 Aug. 3, 1970 Georgia
Joe Bill Dickerson 7243 Aug. 25, 1970 Georgia
Elizabeth A. Ingrassia 7244 Aug. 25, 1970 Ohio
Alan D. Levitt 7245 Aug. 25, 1970 New York
James J. McKeever 7246 Aug. 25, 1970 Virginia
Robert J. Preston 7247 Aug. 25, 1970 Michigan
Morris L. Shapiro 7248 Aug. 25, 1970 Dist. of Columbia
John G. Smith 7249 Aug. 25, 1970 Dist. of Columbia
Oliver L. Thagard, II 7250 Aug. 25, 1970 Alabama
James E. Gilghman 7251 Aug. 25, 1970 Missouri
Haskell Bronstein 7257 Sept. 14, 1970 Massachusetts
George M. Davenport, Jr. 7258 Sept. 14, 1970 Alabama
Salvatore LaVerde 7259 Sept. 14, 1970 New Jersey
Robert J. Ollins 7260 Sept. 14, 1970 New York
Richard P. Stern 7261 Sept. 14, 1970 Pennsylvania
Myron H. Winget, Jr. 7262 Sept. 14, 1970 Dist. of Columbia
Albert H. Angel 7265 Sept. 30, 1970 Delaware
Martin L. Jones, Jr. 7266 Sept. 30, 1970 Dist. of Columbia
Sandra C. Woronow 7262 Sept. 30, 1970 New Jersey
James C. Bradshaw, Jr. 7268 Oct. 20, 1970 Dist. of Columbia
Barbara N. Dulichan 7269 Oct. 20, 1970 Dist. of Columbia
Janet R. Waddell 7270 Oct. 20, 1970 Pennsylvania
Donhue McD. Wilson 7271 Oct. 20, 1970 New York
Nathan Zapolsky 7272 Oct. 20, 1970 New Jersey
Steve C. Ippolito 7273 Oct. 23, 1970 Virginia
James M. Deneen 7274 Oct. 30, 1970 [Illinois ;
James F. Coover 7975 Nov. 12, 1970 Dist. of Columbia
Robert F. Kaplan 7276 Nov. 12, 1970 Pennsylvania
Frederick G. Marks 7277 Nov. 12, 1970 South Carolina

DECEMBER 1971

Certificate

Name Number Dated State
Katherine Z. Petrone 7278 Nov. 12, 1970 New York
Robert J. Roissier 7279 Nov. 12, 1970 Pennsylvania
Charles H. Ziemianski 7280 Nov. 12, 1970 Pennsylvania
Darnell Arnold 7281 Nov. 17, 1970 Texas
Nathan Cooper 7282 -Nov. 17, 1970 Tennessee
James David Ford 7283 Nov. 17, 1970 Tennessee
Roger W. Mosley 7284 Nov. 17, 1970 Nevada
Harvey B. Press 7285 Nov. 17, 1970 Dist. of Columbia
Frederick M. Updike 7286 Nov. 17, 1970 Massachusetts
Douglas A. Gregory 7331 Dec. 4, 1970 Oregon
Hubert J. Malloy 7332 Dec. 4, 1970 Pennsylvania
William G. Pigeon, III 7333 Dec. 4, 1970 Oregon
Thomas E. Platek 7334 Dec. 4, 1970 New York
Millard R. Robinson 7335 Dec. 4, 1970 Pennsylvania
Darrell J. Bauer 7336 Dec. 7, 1970 Michigan
Carl R. Grimes 7337 Dec. 7, 1970 Georgia
Walter S. Szot 7338 Dec. 7, 1970 Massachusetts
Daniel J. Lageman 7370 Jan. 19, 1971 Kentucky
Albert H. Hurwitz 7373 Jan. 29, 1971 Pennsylvania
Edith B. Kale 7374 Jan. 29, 1971 Dist. of Columbia
Gary D. Leggett 7375 Jan. 29, 1971 Dist. of Columbia
Simon L. Levin 7376 Jan. 29, 1971 Dist. of Columbia
Kendal F. Melton 7377 Jan. 29, 1971 Tennessee
Alan Schreiber 7378 Jan. 29, 1971 Illinois
Maurice Cohen 7382 Feb. 17, 1971 Massachusetts
Abraham R. Cooper 7383. Feb. 17, 1971 Dist. of Columbia
David Vollmer 7384 Feb. 17, 1971 Pennsylvania
Frederick L. Wendt 7385 Feb. 17, 1971 New York
Melvin J. Wolfe 7386 Feb. 17, 1971 Pennsylvania
Charles E. Kight 7389 Mar. 3, 1971 Pennsylvania
Margaret F. Rumrill 7390 Mar. 3, 1971 South Carolina
Thomas V. McKeever, Jr. 7394 Mar. 19, 1971 Virginia
Richard C. Radwick 7395 Mar. 19, 1971 New York
Philip Rubin 7398 April 16, 1971 Dist. of Columbia
Johnnie Bingham, Jr. 7400 April 22, 1971 Dist. of Columbia
Basil L. Giandonato, Jr. 7401 April 22, 1971 Pennsylvania
Charles E. Hall 7402 April 22, 1971 Texas
Helen O. Ross 7403 April 22, 1971 Dist. of Columbia
John M. Torris 7404 April 22, 1971 Pennsylvania
Eva A. Mead 7405 May 3, 1971 Puerto Rico
Jerry L. Overbeck 7406 May 3, 1971 Texas
Ray Howard Bragg 7407 May 13, 1971 Alabama
Duncan Elliott Cameron 7409 May 13, 1971 Michigan
James L. Goodson, Jr. 7410 June 1, 1971 Georgia
Jimmie Wayne Bryant 7412 June 9, 1971 Virginia
Irving Sacks 7413 June 10, 1971 Dist. of Columbia
Leonardo S. John 7414 June 10, 1971 Dist. of Columbia
Marie Theresa Luschas 7415 June 10, 1971 Pennsylvania
Nicholas G. Sfakianos 7416 June 10, 1971 Pennsylvania
Lawrence A. Trissel 7417 June 10, 1971 Indiana
Paul David Chenoweth 7418 June 25. 1971 Virginia

The following table shows
cists granted registration by reciprocity and the number
who were certified to register by reciprocity in other
states during the past ten years:

the number of pharma-

Certified for

Fiscal Year Reciprocity Registration in
Other States
1961-1962 oD 20
1962-1963 54 18
1963-1964 46 23
1964-1965 63 20
1965-1966 44 25
1966-1967 61 AT
1967-1968 64 20
1968-1969 84 Pa
1969-1970 ne 40
1970-1971 92 26
Total 618 246

The table shows Maryland gained 372 pharmacists

by reciprocity during the past ten years.

THE MARYLAND PHARMACIST

Pharmacy Permits

Location 1969-1970 1970-1971
Counties:
Allegany 22 21
Anne Arundel 53 54
Baltimore 144 148
Calvert I, 2
Caroline 5) 3
Carroll i) LZ
Cecil 10 9
Charles 7 i
Dorchester 3 4
Frederick 14 14
Garrett # S
Harford mA 20
Howard 10 10
Kent 3 a
Montgomery 86 ousy4
Prince George’s 98 98
Queen Anne’s 4 4
Saint Mary’s 4 4
Somerset oS 4
Talbot 9 8
Washington 16 16
Wicomico he 12
Worcester fl 6
County Totals 547 544
Baltimore City 238 223
State-wide Totals 785 767

The above figures include permits issued to hos-
pitals in the counties as follows:

Allegany 2 Montgomery t
Anne Arundel 2 Prince George’s 3
Baltimore 5 Talbot 1
Cecil 1 Washington 1
Frederick 1 Wicomico if
Harford 1 oe
Howard 1‘ Total 23

In Baltimore City, 14 hospitals received a permit to
operate a pharmacy. Thus, a total of 37 hospitals have a
licensed pharmacy. Five nursing homes have received a
“limited” pharmacy permit, and one State Penal Institu-
tion was also licensed.

From July 1, 1970 through June 30, 1971 permits
have been issued to 23 new pharmacies. A total of 34
pharmacies have closed and have not, as yet, been re-
opened as pharmacies.

The following table shows the number of pharma-
cies opened, changes in ownership, and closed during the
year:

Changes in Ownership
Corporation, and/or

The following table shows the number of pharma-
cies opened, changes in ownership, etc. and closed in the
past ten years:

Fiscal Year Opened Changes Closed
1961-1962 34 31 15
1962-1963 39 45 22
1963-1964 20 38 20
1964-1965 ve 34 20
1965-1966 eal 46 44
1966-1967 41 Ae! 25
1967-1968 24 oh 35
1968-1969 34 19 a.
1969-1970 20 Pail 19
1970-1971] 24 28 40

Certificate of Registration Renewals

There are some who are still not aware of the bien-
nial registration renewal which became effective in June
1961. The following shows the renewal periods, the num-
ber of new renewals during the past year, and the total
renewals to date:

Renewal During

Renewal Period Fiscal Year

Total Renewals

1961-1962 14 2,359
1963-1964 14 2,411
1965-1966 14 2,648
1967-1968 14 2,747
1969-1970 16 2,877
1971-1972 3,032 3,032

Manufacturer’s Permits

Permits to manufacture drugs, medicine, toilet arti-
cles, dentifrices or cosmetics during 1971 were issued to
47 firms, 37 of which were “limited” permits. An appli-
cant applying for a permit for a newly established com-
pany is required to appear before the Board and to fur-
nish all information the Board considers pertinent to the
conducting of such operation.

Dangerous Drug Distributors’ Permit

The Board issued 130 permits to sell, distribute,
give or in any way dispose of dangerous drugs during
1971. It is not necessary for a subsidiary or subsidiaries
of a company to have a separate permit, as they are
covered under the permit held by the parent company.

Legislation

There were many Bills introduced in the 1971 ses-
sion of the legislature. However, the following Bills are
of most interest to pharmacists and to the Board.

Senate Bill 729

Of particular importance to the Board is the passage
of Senate Bill 729, sponsored by Senators Snyder and

tH Opened GS ace Schweinhaut. This Bill concerns itself with the qualifica-

Pate. ae tions for registration as a pharmacist and raising the
2 1 Pains ; : Aer ee

Bente Cas : 7 a6 fee for application for such registration. This Bill de-

agers he ne leted the reference that a person must have had 4 years
7 oe Eres . . 66

28 40 of experience and substitutes the language, “or has

ell 4 oe ; served an internship program regulated by the Board”

18 THE MARYLAND PHARMACIST DECEMBER 1971

and raises the fee from twenty-five dollars to “forty d l-
lars.” This Bill passed, 3 aes chi

261. Who may be registered; proof of qualifications, fee.

Any person of good moral character, who has had
four years’ actual experience in a pharmacy where phy-
sicians’ prescriptions are daily compounded, OR HAS
SERVED AN INTERNSHIP PROGRAM REGULATED
BY THE BOARD and has attained the age of twenty-
one years, who shall present satisfactory evidence to the
Maryland Board of Pharmacy that he or she has had at
least four years standard high school or college of phar-
macy approved by the said Board OR accredited by the
American Council on Pharmaceutical Education, as pub-
lished in their official listing and who after examination
by the said Board shall be by it deemed competent, shall
be registered as a pharmacist and be given a certificate of
such registration, provided, however, that (not more
than three years may be deducted from the four years of
actual drugstore experience aforesaid, for the actual time
of attendance at a reputable school or college of phar-
macy.) OR an internship program to be regulated by
said Board be served. Such person shall make applica-
tion to the secretary of said Board at least ten days be-
fore any stated meeting of the Board and shall pay to the
said Board a fee of forty (twenty-five) dollars.

No applicant for examination before the Board of
Pharmacy having the other qualifications herein set forth
shall be disapproved because he took his course of studies
at a night school or college and nothing in this subtitle
shall be held to abridge or abrogate the rights and _priv-
ileges heretofore conferred by law upon any person now
registered as assistant pharmacist in this State.

Any person enrolling as a student of pharmacy in
any school or college of pharmacy in this State shall, not
later than thirty days after so enrolling, file with the
secretary of the Maryland Board of Pharmacy, an appli-
cation for registration as a student of pharmacy in which
_ said application he shall be required to furnish such in-
formation as the Board may deem appropriate, and simul-
taneously with the filing of said application, shall pay to
the Board a fee of one dollar; all such students of phar-
macy shall, at the beginning of any subsequent school or
college year, submit to the said Board a sworn statement
of any and all (actual drugstore experience acquired
during the preceding vacation months) OR AN intern-
ship experience acquired during the preceding year as
requested by the Board.

Sec. 2. And be it further enacted, That this Act
shall take effect July 1, 1971.

EXPLANATION: Italics indicate new matter added to exist-
ing law. (Brackets) indicate matter stricken from
existing law.

Senate Bill 110

Senate Bill 110 sponsored by Senator Abrams makes
it mandatory that when a pharmacist sells or dispenses
any medications on prescription issued by a physician or
dentist, he shall affix to the contained in which the medi-
cation is sold or dispensed, unless the prescriber indicates
that he should not, a label showing the name and strength
of the medication prescribed, in addition to all other in-
formation required by law. This Bill passed.
254A.

Whenever a pharmacist sells or dispenses any medi-
cations on prescription issued by a physician or a dentist,
he shall affix to the container in which the medication is

DECEMBER 1971

sold or dispensed, unless the prescriber indicates that he
should not, a label showing the name and strength of
medication prescribed, in addition to all other informa-
tion required by law. In listing the established or trade
name, the label shall conform to the name used by the
practitioner in his prescription. No person shall alter,
deface, or remove any label so affixed so long as any of
the original contents remain. Any person failing to ob-
serve the provisions of this section is guilty of a misde-
meanor, and upon conviction thereof, shall be fined fifty
dollars ($50.00). Pharmacists violating this section shall
be subject to disciplinary action by the Board of Phar-
macy,

SECTION 2. And be it further enacted, That this
Act shall take effect July 1, 1971.

EXPLANATION: Italics indicate new matter added to exist-
ing law. (Brackets) indicate matter stricken from
existing law.

Senate Bill 734

Senate Bill 734 was sponsored by Senator Snyder.
This Bill sought to change the geographical residency
requirement for members of the Maryland Board of
Pharmacy and to change the salaries and expenses of
members of the Board and to allow for the salaries to
be fixed in the Annual State Budget. This Bill failed. It

was not reported out of Committee.

ale

The Governor, upon the recommendations of the
Secretary of Health and Mental Hygiene, shall appoint
five persons to be Commissioners of Pharmacy, said Com-
missioners to constitute and be known as the Maryland
Board of Pharmacy, which Board shall constitute part of
the Department of Health and Mental Hygiene. Said
Commissioners shall be skilled and competent pharma-
cists, who have had at least five years’ active pharma-
ceutical experience in compounding and dispensing phy-
sicians’ prescriptions, and of whom at least four are
actively engaged in the practice of pharmacy. None of
said Commissioners shall be connected with any school
of pharmacy either as teacher, instructor, or member of
the board of trustees. (Two of said Commissioners shall
be residents of the City of Baltimore, two residents of
the counties of the State and the fifth a resident of either
the City of Baltimore or the counties of the State.) The
persons serving as Commissioners on June 1, 1947, shall
continue to serve as such until the expiration of the term
for which they have heretofore been appointed and their
successors are duly appointed and qualified pursuant to
the provisions of this section, and the Commissioners
thereafter appointed shall serve as members of said Board
for the term of five years. In the case of any vacancy or
vacancies, whether from expiration of term, resignation,
death or otherwise, the Governor, upon the recommenda-
tion of the Secretary of Health and Mental Hygiene, shall
appoint a successor from a list of pharmacists of three
times the number of vancancies to be filled, said list to
be submitted by the Maryland Pharmaceutical Associa-
tion. The said Commissioners shall, after notification of
their appointment each subscribe to the oath prescribed
by the Constitution of the State of Maryland.

259.

(The salaries of said Board except the secretary-
treasurer shall be $20.00 per day for each member, for
each and every day upon which he is engaged upon the
duties of the Board and all legitimate expenses incurred

THE MARYLAND PHARMACIST 19

in the discharge of his official duties. The secretary-
treasurer of the said Board shall receive a salary to be
fixed by the Board, and not to exceed one thousand dol-
lars per annum; and all legitimate expenses incurred in
the discharge of his official duties.) The members of the
Board shall have the salaries fixed in the annual State
budget, and shall receive such reasonable expenses as
may be provided in the budget. All moneys collected
under this subtitle shall be paid over the State Treasurer,
and shall become general funds of the State. Such moneys
shall thereafter be disbursed by the Comptroller only
pursuant to an appropriation made in accordance with
Sections 32 and 52 of Article 3 of the Constiution or
pursuant to the provisions of Sections 1 through 15 in-
clusive, of Article 15A of this Code, title “Budget and

Fiscal Planning,” as amended from time to time.

Sec. 2. And be it further enacted, That this Act
shall take effect July 1, 1971.

EXPLANATION: Italics indicate new matter added to exist-
ing law. (Brackets) indicate matter stricken from
existing law.

Senate Bill 4

Senate Bill 4 was introduced by the President of
the Senate. This Bill sought to bring up to date in con-
formity with the Federal Law the Food, Drug and Cos-
metic Law. The Bill expands the sections on adultera-
tion and misbranding. It adds new sections on cosmetic,
devices, embargo and new drugs. The Bill was also an
administration bill and we were very fortunate to have
the Legislative Staff of the Governor to assist us in ev-
ery phase of the development of the new mini Food,
Drug and Cosmetic Law. This Bill represents the first
major overhaul of the initial food and drug law and is
indeed a landmark in consumer protection as it relates
to food, drugs and cosmetics. This Bill passed.

Senate Bill 793.

Senate Bill 793 was introduced by Senator Snyder
and sought to amend the Controlled Dangerous Sub-
stances Act which was passed during the 1970 legislative
session of the General Assembly. The amendments were
designed to bring the Maryland Law in conformity to
the Federal Controlled Substances Act which became
effective May 1, 1971. This Bill passed.

Senate Bill 415

Senate Bill 415 introduced by Senator Crawford
sought to remove all codeine preparation now allowable
for over the counter sale by the Controlled Dangerous
Substances Act of 1970 and to relegate them to prescrip-
tion use only. This Bill did not come out of Committee

A 9
hence did not pass.

Prescription Survey

The following table shows a survey of prescriptions

filled in 1970:

PRESCRIPTION SURVEY — 1970
Baltimore City

Average Number New Prescriptions Filled in

Average Price of Prescriptions
in 93 out of 211 Pharmacies $3.54

Estimated New Prescriptions Filled
iIngZUigeharmacies eaves: sete 3,117,947

Estimated Prescriptions Refilled

ine leeehanmnacies manic eee see 1,602,545 4,720,492

Counties
Average Number New Prescriptions Filled in
150. 0m ole 16s Pharmacies: amie aaeeee ae: 18,981

Average Number Prescriptions Refilled in
lS5s0utsor sol 6seharmaciesas seen 13,959 32,940

Average Price of Prescriptions

in 155 out of 516 Pharmacies $3.75

Estimated New Prescriptions Filled in
SlOePharmaciesnaeee eee eee ee 9,794,196

Estimated Prescriptions Refilled
ano 16% Pharmacies: ee ecketts oe aoe eee 7,202,844.

16,997,040
State
Estimated New Prescriptions Filled in
(2a Pharmaciteswaceeme cine ec clas eee 12,912,143

Estimated Prescriptions Refilled

ime(2i weharmacies wae ncerae ue cinerea 8,805,389 21,717,532

Cooperative Activities

The Board maintained membership in the National
Association of Boards of Pharmacy. The annual meeting
of the Association which was held in conjunction with
the American Pharmaceutical Association was held in
San Francisco, California on March 27 - April 2, 1971.
The Board was represented by President Norman Levin,
Secretary F. S. Balassone and Frank Block.

The Board also maintained membership in the Con-
ference of Boards and Colleges of Pharmacy of the Na-
tional Association of Boards of Pharmacy, District Num-
ber Two, comprising the States of New York, New Jersey,
Pennsylvania, Delaware, Maryland, the District of Co-
lumbia, Virginia, and West Virginia. The annual meet-
ing was held in Williamsburg, Virginia on October 22-
24, 1970. Secretary Balassone was the official delegate of
the Board at the meeting.

Secretary-Treasurer, F. S. Balassone was the official
delegate of the National Association of Boards of Phar-
macy to the annual meeting of the Assiciation of Food
and Drug Officials of the United States which will be
held in Columbus, Ohio, June 20-25, 1971.

At the Wiley Award Banquet, Secretary F. S. Balas-
sone was awarded and presented the Harvey W. Wiley
Award “in recognition of outstanding service and devo-
tion to duty in administering the Food and Drug Laws —
of his State and the leadership, guidance and inspiration
he has provided to his fellow workers throughout the na-
tion.” This fitting tribute is indeed the highest attain-
ment any person in this field could aspire to. Secretary
Balassone was the first pharmacist ever to receive this
award.

Secretary Balassone served as a member of the
Awards Committee of the Central Atlantic States Asso-
ciation of Food and Drug Officials of the United States
and will attend the annual meeting in Philadelphia,

80 20UL Ole 2) Lb’ pharmacies aa eae ees 14,777 Pennsylvania on May 26-28, 1971.
Average Number Prescriptions Refilled in : : : Ag ray A
So outiot 2298Pharmacies see eee 7,995 PPI PL The Board maintained cooperative activities with
eee the State Department of Health and Mental Hygiene, the
20 THE MARYLAND PHARMACIST DECEMBER 1971

School of Pharmacy - University of Maryland, the Mary-
land Pharmaceutical Association, the Baltimore Metro-
politan Pharmaceutical Association, Federal Bureau of
Narcotics and Dangerous Drugs, Food and Drug Admin-
istration, City, County and State Police.

Finances

All funds of the Board of Pharmacy are deposited
to the credit of the Treasurer of the State of Maryland,
and disbursement covering the expenses of the Board
are paid by voucher by the State Comptroller.

Charge Accounts
Increasing .. .

Collections Slowing Down . .

One of the excellent services the Maryland Pharma-
ceutical Association sponsors is a low-cost but most effec-
tive collection system. In these times of short profit, col-
lection of receivables is important.

The U. S. Department of Commerce appraises the
value of accounts receivable as follows:

Current Accounts — are worth 100c on the dollar

2 Months past due — are worth 90c on the dollar

6 Months past due — are worth 67c on the dollar

1-Year-old accounts — are worth 45c on the dollar

2-Year-old accounts — are worth 23c on the dollar
3-Year-old accounts — are worth 15e on the dollar
5-Year-old accounts — are worth le on the dollar

Every day an increasing number of our members
are finding the help they need in collecting their DELIN-
QUENT ACCOUNTS, including BAD CHECKS, NOTES,
CONTRACTS, and JUDGMENTS, and in most cases for

less than half the usual collection fee.

Your total cost for this service is $1.00 per account
plus 25% of the amount actually collected. Your Associa-
tion will appreciate the opportunity of assisting you.
Contact the MPhA office for full particulars.

D. STUART

WEBB

OFFSET
PRINTING

PRINTING
ADDRESSING

MAILING

306 N. Gay St., Baltimore, Md. 21202

peuivery 689-3232

PERSONALIZED
LETTERS

DUPLICATING

ADVERTISING
NOVELTIES

TAILOR-MADE

Insurance Coveraze

AMERICAN DRUGGISTS’ INSURANCE ...as the name im-
plies, is specifically designed for the needs of the druggist.

It’s an insurance company founded BY druggists FOR
druggists, to assure especially prompt settlement of claims
.. fire, theft, liability. And that’s exactly what we’ve been
doing... settling such claims rapidly, without red tape
... since 1906. Any service with that many years of

experience HAS to be reliable. You can

be certain of 100% security.
AMERICAN

DRUGGISTS’
INSURANCE CO.

700 American Building
Cincinnati, Ohio 45202

For full details on our complete
coverage plan, contact your ADI
agent NOW.

MAYER & STEINBERG
Maryland State Agents
1101 N. CALVERT STREET
BALTIMORE, MD. 21202
752-7311

DECEMBER 1971 THE MARYLAND PHARMACIST 21

Baltimore Metropolitan
Pharmaceutical Association

Report of Annual Meeting

The Baltimore Metropolitan Pharmaceutical Asso-
ciation held its Annual Meeting on Tuesday, November
30, 1971 at the Kelly Memorial Building in Baltimore.

The meeting was called to order at 10:00 p.m. by
President Irvin Kamenetz. The reports of the President,
Treasurer, Charles E. Spigelmire, and Secretary, Nathan
I. Gruz, were presented and accepted.

Report of Secretary and Executive Director
Nathan I. Gruz

This month marks the tenth anniversary of my ten-
ure as Secretary of the Baltimore Metropolitan Pharma-
ceutical Association and my eleventh annual report.

Ten years ago the preservation of Fair Trade was the
priority issue, followed by the fee schedule of the Medi-
cal Care Program. Then Medical Care was the only third-
party payment program we had to contend with. The
fees were 50c and 70c, $1 and $2 for an average fee of
78e.

Today, third party prescription plans occupy a ma-
jor portion of the time and effort of organized pharmacy.
There are both positive and negative results to report.

As to Medicaid, MPhA recommended a fee of $2.35.
The State Department of Health has requested a fee of
$2 in next year’s fiscal budget. The outcome will depend
upon the Department of Budget, the Governor and the
Legislature.

We are working strenuously to establish freedom of
choice of pharmacy in all programs. We were able to
arrange for the participation by all pharmacies in the
Ksskay prescription plan and work is in progress on other
plans presently restricted to one pharmacy organization.
Changes were also made in the AFL-CIO Council/Giant
Pharmacy program, but the major accomplishment was
in establishing the Association office as a clearinghouse
for prescription prepayment programs. There are sey-
eral other proposals under consideration including union
plans and Model Cities.

A major public health information accumplishment
was in the area of venereal disease. Pharmacy took the
initiative in Baltimore and, in fact, the entire state. As
a result the local and state health departments and the
state medical society has been stimulated to address
themselves anew to the V.D. problem. The State Depart-
ment of Health has now appointed a Task Force on V.D.
with Vice President Paul Freiman representing Phar-
macy.

During the year, the Association participated in other
public health and public relations activities which will be
reported by Charles Spigelmire and Paul Freiman. These
areas include Poison Prevention, Diabetes Detection, Med-
ical Society exhibits and National Pharmacy Week.

We are proud to say that more cases of diabetes
were detected in the screening program through Dreypaks

22 THE MARYLAND PHARMACIST

distributed by pharmacists than through tests in the
armories.

At our initiative a committee of pharmacists and
community representatives has been formed to establish
a memorial to Kermit White. He was a dedicated phar-
macist, operating a community pharmacy in a place of
need and was ruthlessly shot in a holdup. We hope all
will respond when called upon to make a memorial to
him a reality.

Pharmacists are to be commended for the coopera-
tion in helping to collect funds for restoration of Camp
Glyndon. More than $3,200 was turned over as the re-
sult of the hard work of Milton A. Friedman and Charles
E. Spigelmire.

An important development is the new Professional
Experience Program involving many of our members as
preceptors. This is an important step in advancing phar-
macy professionally and much credit is due our col-
leagues, Dean Kinnard and Henry Seidman, in initiating
the change.

This past year was the first under the MPhA affilia-
tion agreement with APhA. This has involved working
with computer printouts, and we hope this will result in
greater efficiency when the records are properly inte-
grated. Membership work has required a great deal of
effort, but with Mel Rubin and Ron Lubman and their
committee devoting themselves to this time-consuming
activity, we are ending up with more members than in
the year before.

We are receiving many more benefits now from
APhA in the way of membership services, information,
legal counsel and in certain administrative expenses.

Our major concern, and where I believe we must do
a great deal more, is in the area of HMO’s—Health
Maintenance Organizations—and health centers in gen-
eral. We must make this priority one in the coming year,
and I hope we can have a number of you working on
this problem in various parts of the Baltimore Metro-
politan area.

In closing, I wish to express my appreciation to the
group of dedicated officers and committee chairmen with
whom I have had the pleasure of working with during
the past year. President Kamenetz, President elect Joe
Dorsch, Chairman Tony Padussis, as well as the ones I
referred to earlier in this report, are conscientious and
devoted to pharmacy. They have been supported by many
others, especially our hard-working Banquet Ticket Chair-
man, George Stiffman.

There have been many frustrations, setbacks and
destructive roadblocks, but nevertheless it has been grati-
fying in many ways to have served the pharmacists of
the Baltimore area and the entire state this past ten
years. I was honored this year by election as President
Elect of the National Council of State Pharmaceutical

DECEMBER 1971

Association Executives, | hope to make some constructive
contributions to the profession of pharmacy nationally.

To the many sincere and devoted members who have

helped make it all worthwhile—Thank you.

Committee Reports

The Program Committee report was given by the
Chairman, Melvin Rubin. Membership Committee Chair-
man, Ronald Lubman, reported a membership total of
475 against 465 at the same time last year.

Public Relations Committee Chairman, Charles E.
Spigelmire, presented his report.

_ Joseph U. Dorsch, Chairman of the 1971 Installa-
tion Banquet Committee, presented his report.

Paul Freiman, Chairman of the 1972 Installation
Banquet Committee, reported that all arrangements for
the 1972 Banquet had been completed. The Banquet
will be held on January 30, 1972 at the Blue Crest North
in Pikesville.

Mr. Freiman, who is also Chairman of the Public
Health Information Committee, reported on the increased
recognition of Pharmacy in the area of Venereal Disease
education. He was appointed to the State Department of

Health’s V.D. Task Force.

Election of Officers

The Nominating Committee report was presented.
Charles E. Spigelmire moved that nominations be closed.
The Officers and Executive Committee members were
elected unanimously as per the slate presented by the
Nominating Committee.

Honorary President—Philip Levin

President—Joseph U. Dorsch

President Elect—Paul Freiman

Vice Presidents—Ronald Lubman
Melvin Rubin
Henry G. Seidman

Secretary—Nathan I. Gruz

Treasurer—Charles E. Spigelmire

Executive Committee

Irvin Kamenetz, Chairman

Gerald Freedenberg
Herman Glassband
Harold Holmes Harry R. Wille
Mark Levi Stanley J. Yaffe

The Nominating Committee submitted its list of
nominees to the House of Delegates. Mark Levi nomi-
nated I. Dennis Klein from the floor.

John Padousis
Ralph T. Quarles

The following delegates and alternates received the
largest number of votes and were declared elected.

Delegates (22)

I. Dennis Klein
Mark Levi

Barry Levin
Harold Levin
Norman J. Levin
Ronald Lubman

Jerome Mask

Mary W. Connelly
Joseph U. Dorsch
Gerald Freedenberg
Herman Glassband
Wilfred H. Gluckstern
Robert Kabik

Irvin Kamenetz

DECEMBER 1971

John Padousis
Ralph T. Quarles
Melvin Rubin
Alder Simon

Charles E. Spigelmire
H. Nelson Warfield
Harry R. Wille
Stanley J. Yaffe

Alternates (22)

Sidney R. Klavens
Richard Metz
William Morgenstern
David S. Pearlman
Morton Pollack
Stanley Protokowicz
Allan B. Shenker
Morton Silverstein
George Stiffman
Charles Wagner
Maurice Weiner

Morton Abarbanel
John Ayd

Harry Bass
Frank Block
Jerome Block
James P. Cragg
Irving Galperin
Henry Glaeser
Marvin Goldberg
David D. Greenfeld
Harold Holmes

Paul Freiman, MPhA Legislative Committee Chair-
man, conducted a discussion of the MPhA proposal for
drug product selection by pharmacists through amend-
ment of the State “antisubstitution” laws.

The meeting adjourned at 11:30 p.m.

A.Z.O. News

Kappa Chapter Hosts Regional Convention

Kappa Chapter hosted the Fall Regional Convention
of the Alpha Zeta Omega Pharmaceutical Fraternity held
on November 5, 6 and 7 at the Hunt Valley Inn, Cockeys-
ville, Maryland. The convention included business meet-
ings and_ several social functions. National President
Mitchell Ross presided. Gerald Freedenberg is the Presi-
dent of Kappa Chapter.

The highlight of the meeting was the Awards Ban-
quet held on November 6 at which Dr. William J. Kin-
nard, Jr., Dean of the University of Maryland School of
Pharmacy, was presented an honorary membership in the

A.Z.O. Fraternity.

Fifty-year service pins were presented to Samuel
Block, Nathan Cohen and Morris Schenker. Receiving 25-
year service pins were: Max Ansell, Morton Cohen, Al-
bert Friedman, Irving Pruce, Stuart Shpritz, Paul Siegel.
Samuel Robbins, Benjamin Scheinin, Morris Walman
and Irvin Zerwitz.

The Spring Regional of A.Z.O. will be held in Louis-
ville, Kentucky, and the National Convention, in Miami
on July 23.

A.Z.O. Men in the News

Morris Walman has been appointed to the Maryland
State Drug Abuse Administration. Gerald Freedenberg,
Donald Schumer and Harry Bass have been appointed to
the School of Pharmacy Task Force for Third-Party Pay-
ments. Paul Freiman has been appointed to the Maryland

State V.D. Task Force.

Names In The News

MPhA member Ernest J. Gregg, proprietor of
Gregg’s Pharmacy in Oakland, Maryland, is the current
foreman of the grand jury in Garrett County.

THE MARYLAND PHARMACIST 23

Maryland Society of Hospital Pharmacists

On November 11, 1971, the Maryland Society of
Hospital Pharmacists met at the Officers Club of the U.S.
Public Health Service Hospital in Baltimore. President
Mary Connelly introduced the speaker, Dr. Samuel L.
Fox, Director of Ophthalmology and Chief of Ophthal-
mology Services at South Baltimore General Hospital.
Doctor Fox discussed ocular therapy, both present and
future.

Following a question-and-answer period President
Connelly called the business meeting to order. Samuel
Lichter, Program Chairman for the Society’s Seventh
Annual Hospital Pharmacy Seminar, reported that F.
Regis Kenna, Director of University of Chicago Hospital
and Clinics, and Paul Burkhart, Assistant Chief Pharma-
cist, University of Maryland Hospital, have been added
to the list of speakers. Harry Hamet, Financial Chair-
man for the 1972 Seminar, reported on the status of re-
quests for financial assistance.

Monthly meeting Program Chairman, Paul Burk-
hart, announced that the December 9 meeting will be
held at the University of Maryland Hospital. Dr. William
S. Spicer, Associate Dean, Health Care Programs, Uni-
versity of Maryland School of Medicine, will discuss
“The Changing Health Care System.” A meeting will be
held on January 13, 1972, at St. Agnes Hospital.

Dr. Peter P. Lamy, Chairman of the Peer Review
Committee, gave his report. Various upcoming meeting
announcements were made by President Connelly. Darryl
Zellers will be a speaker at the Virginia Society of Hos-
pital Pharmacists Seminar on November 13, 1972.

The Guidelines Committee, consisting of Chairman
Robert E. Snyder, Henry J. Derewicz, Morris Bookoff,
Wilfred H. Gluckstern, and Mary W. Connelly, ex-officio
member, will meet with Attorney Joseph S. Kaufman,
legal counsel for the Maryland Pharmaceutical Associa-
tion.

Allan Jaskulski has been appointed to represent the
Society on a Committee for Third-Party Prescription Pay-
ments chaired by Dr. Dean E. Leavitt. A position has
been created for a Society member to review M.S.H.P.
meetings and other functions and assign credit hours for
continuing education purposes.

Applicants Josehp P. Crisalli and Charles J. Mc-
Teague, were approved for membership. President Con-
nelly expressed appreciation to the evening’s host, Kent
Johnson, Director of Pharmacy Service, U.S.P.H.S. Hos-
pital, who introduced his three hospital pharmacy resi-
dents to the group.

City Tuberculosis Cases on Decrease

For the first time since records were kept, the num-
ber of cases of tuberculosis occurring in the City of Bal-
timore is less than half the total for the whole state. This
was noted in the Weekly Communicable Disease Report
of the Maryland State Department of Health for the
week ending August 26 in which the state total was
given as 584 cases whereas the city figure was 290. It is
encouraging to reflect that the City of Baltimore is mak-
ing progress in the control of this disease which has for
many years given the city an undesirable record.

24 THE MARYLAND PHARMACIST

Philatelic Recognition for
Pharmacists Announced

The United States Postal Service announced that a
postage stamp in tribute to the service role played by the
nation’s pharmacists will be issued next year. The com-
memorative stamp will be issued next year. The com-
memorative stamp will be keyed to “Partners in Health.”

As the Postal Service points out, a stamp was issued
honoring physicians in 1947, the centennial of the Amer-
ican Medical Association; and a stamp was issued in 1959
saluting the centennial of the American Dental Associa-
tion. Furthermore nurses had their stamp in 1961, and
earlier this year America’s hospitals were commemorated
with a postal card.

Design of the pharmacy stamp and date and place
of issuance will be announced later, concluded the U. S.
Postal Service.

APhA President Lloyd M. Parks has written the
U. S. Postal Service commending this announcement,
pointing out that the American Pharmaceutical Associa-
tion has long been active in seeking a commemorative
U.S. postage stamp honoring the profession of pharmacy.
As early as 1934, APhA officially endorsed an effort to
issue a commemorative postage stamp on the occasion of
opening the American Institute of Pharmacy (headquar-
ters of the American Pharmaceutical Association) in
Washington, D.C.

In 1939 APhA supported organized efforts to com-
memorate the 120th anniversary of the United States
Pharmacopeia and in the late 1940’s, a concerted effort
was made to commemorate the centennial anniversary of
the American Pharmaceutical Association. In 1966,
APhA proposed two deserving anniversaries for a com-
memorative postage stamp (the 150th anniversary of the
birth of William Proctor, Jr., the “father of American
pharmacy”) or the 100th anniversary of the founding
of the first (Maine) state pharmaceutical association.

Then, in 1969, APhA again proposed two equally
suitable occasions for a commemorative postage stamp—
the 150th anniversary of the United States Pharmacopeia
(for 1970) or the 150th anniversary of the founding of
the first pharmaceutical association in the U.S. which
eventually became the first school of pharmacy — the
Philadelphia College of Pharmacy and Science (for
1971). Motivated by the remarks made on the floor of
Congress by Senator Robert P. Griffin (R-Mich) on
April 26, 1971, APhA lent its full support to the most
recent efforts initiated by Irving Rubin, editor of Phar-
macy Times.

Dr. Parks offered the U.S. Postal Service the serv-
ices of the American Pharmaceutical Association to assist
in the design, and urged that the First Day of Issue be
held during the 120th anniversary of the American Phar-
maceutical Association’s Annual Meeting in Houston,
Texas, April 22-28, 1972.

More Than 1200 Attend FIP Sessions

More than 1,200 pharmacists and pharmaceutical
scientists from throughout the world gathered in Wash-
ington, D.C. on September 7-12 to attend FIP’s 31st In-
ternational Congress of Pharmaceutical Sciences. This
was the first meeting of the International Pharmaceuti-
cal Federation ever held in the United States.

DECEMBER 1971

Representing

EMPLOYED PHARMACISTS
P.O. BOX NO. 2322
ROCKVILLE, MARYLAND 20852

Pension & Investment
Associatcs of America, Inc.

Pension Consultants to

MARYLAND
PHARMACEUTICAL ASSOCIATION

Individual Retirement Plans
Corporate Pension Plans(Prototypes Available)
HR-10.. Plans (Sole Proprietor-Partnerships )

Mutual Funds

Prospectuses Available Upon Request

For an immediate appointment with a P.I.A.A. rep-
resentative, please contact P.I.A.A., 2000 Spruce
Street, Trenton, New Jersey 08638, Phone: (609)
883-0696.

What is ASTRO?

* ASTRO — is a cooperative advertising PROGRAM available

to any or all Calvert members interested in merchandising

and presenting merchandise to the consumer in a discreet

intelligent, attractive, competitive manner.

Its success is lauded by its members.

For further information, contact your Calvert representative,

Wilson Spilker or Kenneth Mills. Phone 467-2780.

THE CALVERT DRUG COMPANY

*A subsidiary

DECEMBER 1971

THE MARYLAND PHARMACIST

Obituaries

Dr. Elvin E. Goffdiener

Dr. Elvin E. Goffdiener, 64, a 1926
graduate of the University of Mary-
land School of Pharmacy who later be-
came a radiologist, died on June 21
at Poughkeepsie, New York.

Raymond M. Morstein

Raymond M. Morstein, 61, a 1931
graduate of the University of Mary-
land School of Pharmacy, died on
November 15.

Raymond S. Porterfield

Raymond S. Porterfield, 74-year-old
pharmacist, died on November 13. A
brother, M. Perry Porterfield, is a
practicing pharmacist in Hagerstown.

Harry C. Lewis

Harry C. Lewis, 82, 1911 graduate
of the University of Maryland, School
of Pharmacy, died on November 23
in Cumberland.

The Hart Bill

Senator Philip Hart reintroduced
his bill in this year’s session “To regu-
late trade in drug and devices by pro-
hibiting the dispensing of drugs and
devices by medical practitioners and
their participation in profits from the
dispensing of such products, except
under certain circumstances and for
other purposes.” In the new version
there will be a prohibition of physi-
cians ownership in HMO’s_ pharma-
cies.

You are urged to write, wire or
call Senators Charles McC. Mathias,
Jr., and J. Glenn Beall, The U.S. Sen-
ate, Washington, D.C. 20510, urging
their support.

STATE PHARMACEUTICAL DIRECTORY

AFFILIATED ORGANIZATIONS

Allegany-Garrett County
Pharmaceutical Association

President 20, ieee ere Stephen Hospodavis
Vice. Presented tae meee James Ritchie
Secretary-Treasurer....... Robert F. Tomsko

Baltimore Metropolitan
Pharmaceutical Association
She SomMaea sess Irvin Kamenetz
BA ta oe Joseph U. Dorsch
Sa I alae Charles E. Spigelmire

Vice Presidents—
Paul Freiman, Harold P. Levin,
Harry R. Wille

Secretary and Executive Director
Nathan I. Gruz

Eastern Shore Pharmaceutical Society

PlOSIAEN Tee neers ee Gordon Harrison
First Vice President....... William P. Smith
Second Vice President....... William Connor
SOCTetary nc ata ee Carl R. June
Treasurer st, scene ae Thomas Payne

Prince Georges-Montgomery County
Pharmaceutical Association

Presidente yy) Sto, ce ee Martin Hauer
First Vice President....Edward D. Nussbaum

Second Vice President ..... S. Ben Friedman
Third Vice President ...... Sidney Glashofer
Fourth Vice President....... Gabriel E. Katz
SCChELaT YN ETD eee ee Paul Reznek
UTEGSUTERA. rein ae cee Michael Leonard
Honorary President .......... Samuel Morris

Washington County
Pharmaceutical Association

Ranincawear Samuel E. Weisbecker
Vice, Presidentioe: . oe eee Joseph Davies
Mitel a Frederick Fahrney

University of Maryland School of
Pharmacy Student APhA-MPhA Chapter

Presidents de Hs aoe Paul R. Webster
Vice President ¥ Acaigeren Stephen B. Bierer
SeOCreltany: Rae facts eae as Donna S. Leyin
TTedsUT er wns tome xd ote Dennis R. Reaver

MPhA AUXILIARIES

Membership Treasurer

MRS. MANUEL B. WAGNER

TAMPA — Traveler’s Auxiliary of The
Maryland Pharmaceutical Association
President
PAUL J. MAHONEY
First Vice President
JOHN C. MATHENY
Second Vice President
ABRIAN E. BLOOM
Third Vice President
C. WILSON SPILKER
Secretary-Treasurer
WILLIAM A. POKORNY
WILLIAM L. NELSON
Assistant Secretary-Treasurer
Honorary President
JOSEPH GRUBB

Secretary-Treasurer Emeritus

JOHN A. CROZIER

OTHER PHARMACY ORGANIZATIONS
Maryland Society of Hospital
Pharmacists
President
MARY W. CONNELLY
President Elect
NORMAND A. PELISSIER
Secretary
DOLORES A. ICHNIOWSKI
Treasurer

THOMAS E. PATRICK

University of Marviand
School of Pharmacy

Dean
DR. WILLIAM J. KINNARD, JR.
Assistant Dean
DR. C. T. ICHNIOWSKI
Delegate and Vice Speaker—
MPhA House of Delegates
HENRY G. SEIDMAN

Metropolitan Guild of Pharmacists

President
JOHN McKIRGAN
Vice President
FRANK FRARY rs
Secretary :
LARRY JACOBSON
Treasurer

EDWARD WILLIAMS

re ee
MPhA—Acapulco, Mexico Trip Almost Sold Out

May 17-22, 1972

Act at once to make reservations: for the MPhA Convention Trip to Acapulco via Eastern Airlines
Charter. A fabulous package at the luxurious Pierre Marques Hotel. Only $599 per couple plus $39.00
taxes and gratuities. Send deposit of $100 to MPhA, 650 W. Lombard Street, Baltimore, Maryland 21201.

THE MARYLAND PHARMACIST

DECEMBER 1971]

Paramount Photo Service

The Quality and Service Photofinisher

Is Pleased to Announce
They’re Moving to Their New Laboratory
To Serve You With
The Most Modern and Latest Equipment.

Note our new address and telephone number:

PARAMOUNT PHOTO SERVICE

2920 Greenmount Avenue
Baltimore, Maryland 21218

Telephone: Baltimore 366-1155
Washington Area [Local call] 484-4050

Ya AAA SO

, DECEMBER 1971 THE MARYLAND PHARMACIST 27

NOW IS THE TIME TO
MAIL IN YOUR RESERVATIONS

for the

S6TH ANNUAL

DINNER -DANCE
INSTALLATION

of the

BALTIMORE METROPOLITAN
PHARMACEUTICAL ASSOCIATION

SUNDAY, JANUARY 30, 1972
N

e Many valuable

e 6:00 P.M. BLUE CREST NORTH surprises
Geesiausa’ 401 Reisterstown Road (Pikesville) « Music by
Hors D’Oeuvres Morgan Baer
Orchestra

e Featuring

e 7:00 P.M. Buddy Aaron

Dinner

TICKET INCLUDES
e FREE VALET PARKING e FREE SET UPS and
e FREE CHECKING SERVICE | ¢ BAR AFTER DINNER
NO TIPPING

e Vienesset Table

TICKET ORDER FORM B.M.P.A. DINNER DANCE
Phone 542-7933/727-6440
GEORGE STIFFMAN

Ticket Chairman
650 West Lombard St. 2120]

Please place my order for .......... Tickets at $17.50 each.
Tables for ten (10) $175.00

Check enclosed'fom. 0a ae eee dollars

NAMES OF PERSONS IN PARTY:

Bhd ts Kispht he lore ad OR) ee Name

=
=

ij
| ti

4 4

ie ; ; ee ao |
. a hs 5 iad | a Are
Be ¥ “ i >

oe rea *
are tet aera

ae BS At AE
Rea ie ak te eee

mene SL
* Sus

at ee ee Roe aed 5
Scere reo rene

Breas edie eho :
FF ph ae

See AIOSN

OHA eee ey EEE HO
aha hon cee onde

Racially ee Nt ME ti ek ae RN

Internet Archive Audio

Featured

Top

Images

Featured

Top

Software

Featured

Top

Books

Featured

Top

Video

Featured

Top

Mobile Apps

Browser Extensions

Archive-It Subscription

Save Page Now

Full text of "The Maryland Pharmacist 47:no. 1-12 (1971)"

See other formats